id	abstract_id	offset_start	offset_finish	type	mention	entity_ids
0	1353340	11	39	DiseaseOrPhenotypicFeature	metachromatic leukodystrophy	D007966
1	1353340	111	126	GeneOrGeneProduct	arylsulfatase A	410
2	1353340	128	132	GeneOrGeneProduct	ARSA	410
3	1353340	159	187	DiseaseOrPhenotypicFeature	metachromatic leukodystrophy	D007966
4	1353340	189	192	DiseaseOrPhenotypicFeature	MLD	D007966
5	1353340	210	220	SequenceVariant	arginine84	rs74315458
6	1353340	264	277	GeneOrGeneProduct	arylsulfatase	410
7	1353340	363	366	DiseaseOrPhenotypicFeature	MLD	D007966
8	1353340	372	395	SequenceVariant	arginine84 to glutamine	rs74315458
9	1353340	442	446	GeneOrGeneProduct	ARSA	410
10	1353340	484	488	GeneOrGeneProduct	ARSA	410
11	1353340	562	570	OrganismTaxon	patients	9606
12	1353340	576	579	DiseaseOrPhenotypicFeature	MLD	D007966
13	1353340	655	659	GeneOrGeneProduct	ARSA	410
14	1353340	712	715	DiseaseOrPhenotypicFeature	MLD	D007966
15	1671881	49	64	DiseaseOrPhenotypicFeature	phenylketonuria	D010661
16	1671881	66	91	DiseaseOrPhenotypicFeature	Classical phenylketonuria	D010661
17	1671881	98	125	DiseaseOrPhenotypicFeature	autosomal recessive disease	D030342
18	1671881	138	185	DiseaseOrPhenotypicFeature	deficiency of hepatic phenylalanine hydroxylase	OMIM:261600
19	1671881	187	190	GeneOrGeneProduct	PAH	5053
20	1671881	272	275	GeneOrGeneProduct	PAH	5053
21	1671881	362	376	SequenceVariant	272gly----stop	rs62514952
22	1671881	381	394	SequenceVariant	273ser----phe	rs62514953
23	1671881	606	609	DiseaseOrPhenotypicFeature	PKU	D010661
24	1671881	684	700	DiseaseOrPhenotypicFeature	PAH deficiencies	OMIM:261600
25	1848636	0	12	ChemicalEntity	Debrisoquine	D003647
26	1848636	52	67	GeneOrGeneProduct	beta-2 receptor	154
27	1848636	88	98	ChemicalEntity	metoprolol	D008790
28	1848636	171	181	ChemicalEntity	metoprolol	D008790
29	1848636	214	226	ChemicalEntity	debrisoquine	D003647
30	1848636	227	236	ChemicalEntity	sparteine	D013034
31	1848636	390	409	GeneOrGeneProduct	beta-1 adrenoceptor	153
32	1848636	442	452	ChemicalEntity	metoprolol	D008790
33	1848636	511	530	GeneOrGeneProduct	beta-2 adrenoceptor	154
34	1848636	545	555	ChemicalEntity	metoprolol	D008790
35	1848636	603	613	ChemicalEntity	metoprolol	D008790
36	1848636	617	628	ChemicalEntity	terbutaline	D013726
37	1848636	637	648	DiseaseOrPhenotypicFeature	hypokalemia	D007008
38	1848636	732	742	ChemicalEntity	metoprolol	D008790
39	1848636	838	848	ChemicalEntity	metoprolol	D008790
40	1848636	944	955	ChemicalEntity	terbutaline	D013726
41	1848636	1059	1069	ChemicalEntity	metoprolol	D008790
42	1848636	1149	1160	ChemicalEntity	terbutaline	D013726
43	1848636	1227	1236	ChemicalEntity	potassium	D011188
44	1848636	1238	1249	ChemicalEntity	terbutaline	D013726
45	1848636	1251	1261	ChemicalEntity	metoprolol	D008790
46	1848636	1294	1317	ChemicalEntity	alpha-hydroxymetoprolol	C029504
47	1848636	1389	1399	ChemicalEntity	metoprolol	D008790
48	1848636	1409	1419	ChemicalEntity	metoprolol	D008790
49	1848636	1434	1445	ChemicalEntity	terbutaline	D013726
50	1848636	1512	1522	ChemicalEntity	metoprolol	D008790
51	1848636	1523	1546	ChemicalEntity	alpha-hydroxymetoprolol	C029504
52	1848636	1652	1662	ChemicalEntity	metoprolol	D008790
53	1848636	1691	1701	ChemicalEntity	metoprolol	D008790
54	2422478	11	20	ChemicalEntity	serotonin	D012701
55	2422478	31	34	OrganismTaxon	rat	10116
56	2422478	59	70	DiseaseOrPhenotypicFeature	hypotensive	D007022
57	2422478	81	91	ChemicalEntity	methyldopa	D008750
58	2422478	167	177	ChemicalEntity	methyldopa	D008750
59	2422478	217	226	ChemicalEntity	serotonin	D012701
60	2422478	260	271	DiseaseOrPhenotypicFeature	hypotensive	D007022
61	2422478	432	441	ChemicalEntity	serotonin	D012701
62	2422478	517	529	DiseaseOrPhenotypicFeature	hypertensive	D006973
63	2422478	531	537	DiseaseOrPhenotypicFeature	stroke	D020521
64	2422478	544	548	OrganismTaxon	rats	10116
65	2422478	568	578	ChemicalEntity	methyldopa	D008750
66	2422478	611	620	ChemicalEntity	serotonin	D012701
67	2422478	671	682	DiseaseOrPhenotypicFeature	hypotension	D007022
68	2422478	769	778	ChemicalEntity	serotonin	D012701
69	2422478	790	813	ChemicalEntity	5,7-dihydroxytryptamine	D015116
70	2422478	815	822	ChemicalEntity	5,7-DHT	D015116
71	2422478	894	901	ChemicalEntity	5,7-DHT	D015116
72	2422478	956	965	ChemicalEntity	serotonin	D012701
73	2422478	1017	1028	DiseaseOrPhenotypicFeature	hypotension	D007022
74	2422478	1039	1046	ChemicalEntity	5,7-DHT	D015116
75	2422478	1057	1066	ChemicalEntity	serotonin	D012701
76	2422478	1164	1173	ChemicalEntity	serotonin	D012701
77	2422478	1252	1261	ChemicalEntity	serotonin	D012701
78	2422478	1262	1272	ChemicalEntity	methyldopa	D008750
79	2422478	1366	1376	ChemicalEntity	methyldopa	D008750
80	2422478	1385	1396	DiseaseOrPhenotypicFeature	hypotension	D007022
81	2422478	1437	1446	ChemicalEntity	serotonin	D012701
82	2422478	1489	1500	DiseaseOrPhenotypicFeature	hypotensive	D007022
83	2422478	1511	1521	ChemicalEntity	methyldopa	D008750
84	2491010	37	45	OrganismTaxon	patients	9606
85	2491010	100	138	GeneOrGeneProduct	Duchenne muscular dystrophy (DMD) gene	1756
86	2491010	174	201	DiseaseOrPhenotypicFeature	Duchenne muscular dystrophy	D020388
87	2491010	203	206	DiseaseOrPhenotypicFeature	DMD	D020388
88	2491010	210	235	DiseaseOrPhenotypicFeature	Becker muscular dystrophy	D020388
89	2491010	237	240	DiseaseOrPhenotypicFeature	BMD	D020388
90	2491010	312	315	GeneOrGeneProduct	DMD	1756
91	2491010	558	566	OrganismTaxon	patients	9606
92	2491010	592	602	GeneOrGeneProduct	dystrophin	1756
93	2491010	809	817	OrganismTaxon	patients	9606
94	2491010	908	916	OrganismTaxon	patients	9606
95	2491010	953	956	DiseaseOrPhenotypicFeature	DMD	D020388
96	2491010	958	961	DiseaseOrPhenotypicFeature	BMD	D020388
97	2491010	1071	1074	DiseaseOrPhenotypicFeature	BMD	D020388
98	2491010	1075	1083	OrganismTaxon	patients	9606
99	2491010	1105	1112	OrganismTaxon	patient	9606
100	2491010	1186	1189	DiseaseOrPhenotypicFeature	DMD	D020388
101	2491010	1190	1198	OrganismTaxon	patients	9606
102	2491010	1215	1223	OrganismTaxon	patients	9606
103	2491010	1231	1234	DiseaseOrPhenotypicFeature	BMD	D020388
104	2491010	1235	1242	OrganismTaxon	patient	9606
105	7468724	0	28	DiseaseOrPhenotypicFeature	Cardiovascular complications	D002318
106	7468724	45	56	ChemicalEntity	terbutaline	D013726
107	7468724	71	84	DiseaseOrPhenotypicFeature	preterm labor	D007752
108	7468724	93	121	DiseaseOrPhenotypicFeature	cardiovascular complications	D002318
109	7468724	147	155	OrganismTaxon	patients	9606
110	7468724	169	180	ChemicalEntity	terbutaline	D013726
111	7468724	185	198	DiseaseOrPhenotypicFeature	preterm labor	D007752
112	7468724	211	225	ChemicalEntity	corticosteroid	D000305
113	7668252	11	16	OrganismTaxon	human	9606
114	7668252	17	62	GeneOrGeneProduct	very-long-chain acyl-coenzyme A dehydrogenase	37
115	7668252	119	127	OrganismTaxon	patients	9606
116	7668252	220	225	OrganismTaxon	human	9606
117	7668252	240	285	GeneOrGeneProduct	very-long-chain acyl-coenzyme A dehydrogenase	37
118	7668252	287	292	GeneOrGeneProduct	VLCAD	37
119	7668252	543	548	GeneOrGeneProduct	VLCAD	37
120	7668252	603	618	DiseaseOrPhenotypicFeature	VLCAD-deficient	C536353
121	7668252	619	627	OrganismTaxon	patients	9606
122	7668252	637	645	OrganismTaxon	patients	9606
123	7668252	649	693	SequenceVariant	105-bp deletion encompassing bases 1078-1182	c|DEL|1078-1182|
124	7668252	697	702	GeneOrGeneProduct	VLCAD	37
125	7668252	794	799	GeneOrGeneProduct	VLCAD	37
126	7668252	864	880	DiseaseOrPhenotypicFeature	VLCAD deficiency	C536353
127	7668252	921	926	OrganismTaxon	human	9606
128	7668252	927	932	GeneOrGeneProduct	VLCAD	37
129	7668252	954	962	OrganismTaxon	patients	9606
130	7668252	1033	1071	DiseaseOrPhenotypicFeature	deficiency of the normal VLCAD protein	C536353
131	7668252	1088	1109	ChemicalEntity	long-chain fatty acid	D005227
132	7668252	1141	1149	OrganismTaxon	patients	9606
133	7668252	1166	1173	OrganismTaxon	patient	9606
134	7668252	1195	1200	GeneOrGeneProduct	VLCAD	37
135	7668252	1276	1289	ChemicalEntity	palmitic acid	D019308
136	7668252	1450	1466	DiseaseOrPhenotypicFeature	VLCAD deficiency	C536353
137	7905839	0	5	OrganismTaxon	Human	9606
138	7905839	6	24	GeneOrGeneProduct	mu opiate receptor	4988
139	7905839	112	117	OrganismTaxon	human	9606
140	7905839	118	136	GeneOrGeneProduct	mu opiate receptor	4988
141	7905839	225	228	OrganismTaxon	rat	10116
142	7905839	229	247	GeneOrGeneProduct	mu opiate receptor	25601
143	7905839	258	263	OrganismTaxon	human	9606
144	7905839	264	282	GeneOrGeneProduct	mu opiate receptor	4988
145	7905839	284	292	GeneOrGeneProduct	h mu OR1	4988
146	7905839	334	337	OrganismTaxon	rat	10116
147	7905839	362	368	GeneOrGeneProduct	mu OR1	25601
148	7905839	387	393	ChemicalEntity	opiate	D053610
149	7905839	404	419	ChemicalEntity	opioid peptides	D018847
150	7905839	425	431	ChemicalEntity	sodium	D012964
151	7905839	437	440	ChemicalEntity	GTP	D006160
152	7905839	521	524	OrganismTaxon	rat	10116
153	7905839	525	543	GeneOrGeneProduct	mu opiate receptor	25601
154	7905839	556	566	ChemicalEntity	cyclic AMP	D000242
155	7905839	602	605	OrganismTaxon	rat	10116
156	7905839	606	624	GeneOrGeneProduct	mu opiate receptor	25601
157	7905839	670	678	GeneOrGeneProduct	h mu OR1	4988
158	7905839	815	820	OrganismTaxon	human	9606
159	7905839	1030	1056	DiseaseOrPhenotypicFeature	neuropsychiatric disorders	D001523
160	8755918	48	69	DiseaseOrPhenotypicFeature	ataxia-telangiectasia	D001260
161	8755918	107	128	DiseaseOrPhenotypicFeature	ataxia-telangiectasia	D001260
162	8755918	130	133	DiseaseOrPhenotypicFeature	A-T	D001260
163	8755918	160	163	GeneOrGeneProduct	ATM	472
164	8755918	261	264	DiseaseOrPhenotypicFeature	A-T	D001260
165	8755918	361	377	SequenceVariant	137-bp insertion	c|INS||137
166	8755918	476	479	DiseaseOrPhenotypicFeature	A-T	D001260
167	8755918	520	527	OrganismTaxon	patient	9606
168	8755918	577	585	OrganismTaxon	patients	9606
169	8755918	787	795	OrganismTaxon	patients	9606
170	8755918	824	841	DiseaseOrPhenotypicFeature	cerebellar ataxia	D002524
171	8755918	1004	1007	DiseaseOrPhenotypicFeature	A-T	D001260
172	8755918	1008	1016	OrganismTaxon	patients	9606
173	8755918	1095	1098	DiseaseOrPhenotypicFeature	A-T	D001260
174	8755918	1298	1301	GeneOrGeneProduct	ATM	472
175	8829135	0	11	ChemicalEntity	Nefiracetam	C058876
176	8829135	13	20	ChemicalEntity	DM-9384	C058876
177	8829135	31	42	ChemicalEntity	apomorphine	D001058
178	8829135	51	58	DiseaseOrPhenotypicFeature	amnesia	D000647
179	8829135	143	154	ChemicalEntity	Nefiracetam	C058876
180	8829135	166	177	ChemicalEntity	pyrrolidone	D011760
181	8829135	206	217	ChemicalEntity	scopolamine	D012601
182	8829135	226	275	DiseaseOrPhenotypicFeature	learning and post-training consolidation deficits	D007859
183	8829135	288	299	ChemicalEntity	apomorphine	D001058
184	8829135	437	448	ChemicalEntity	nefiracetam	C058876
185	8829135	462	469	DiseaseOrPhenotypicFeature	amnesia	D000647
186	8829135	481	501	ChemicalEntity	dopaminergic agonism	D018491
187	8829135	559	570	ChemicalEntity	nefiracetam	C058876
188	8829135	585	596	ChemicalEntity	apomorphine	D001058
189	8829135	738	749	ChemicalEntity	nefiracetam	C058876
190	8829135	754	765	ChemicalEntity	apomorphine	D001058
191	8829135	829	836	DiseaseOrPhenotypicFeature	amnesic	D000647
192	8829135	872	883	ChemicalEntity	nefiracetam	C058876
193	8829135	924	931	DiseaseOrPhenotypicFeature	amnesia	D000647
194	8829135	943	954	ChemicalEntity	apomorphine	D001058
195	8829135	1080	1091	ChemicalEntity	nefiracetam	C058876
196	8829135	1150	1152	ChemicalEntity	3H	D014316
197	8829135	1153	1162	ChemicalEntity	SCH 23390	C534628
198	8829135	1167	1169	ChemicalEntity	3H	D014316
199	8829135	1170	1179	ChemicalEntity	spiperone	D013134
200	8829135	1193	1219	GeneOrGeneProduct	D1 or D2 dopamine receptor	1812,1813
201	8829135	1265	1276	ChemicalEntity	nefiracetam	C058876
202	9294109	0	33	GeneOrGeneProduct	Myotonic dystrophy protein kinase	13400
203	9294109	71	75	ChemicalEntity	Ca2+	D002118
204	9294109	114	132	DiseaseOrPhenotypicFeature	Myotonic dystrophy	D009223
205	9294109	134	136	DiseaseOrPhenotypicFeature	DM	D009223
206	9294109	158	175	DiseaseOrPhenotypicFeature	muscular disorder	D009135
207	9294109	262	279	GeneOrGeneProduct	DM protein kinase	13400
208	9294109	281	285	GeneOrGeneProduct	DMPK	13400
209	9294109	398	402	GeneOrGeneProduct	DMPK	13400
210	9294109	462	467	ChemicalEntity	Ca2 +	D002118
211	9294109	522	527	ChemicalEntity	Ca2 +	D002118
212	9294109	559	562	ChemicalEntity	ATP	D000255
213	9294109	631	635	GeneOrGeneProduct	DMPK	13400
214	9294109	651	655	OrganismTaxon	mice	10090
215	9294109	681	685	GeneOrGeneProduct	DMPK	13400
216	9294109	727	732	ChemicalEntity	Ca2 +	D002118
217	9294109	830	835	ChemicalEntity	Ca2 +	D002118
218	9294109	840	844	ChemicalEntity	Na +	D012964
219	9294109	902	907	ChemicalEntity	Ca2 +	D002118
220	9294109	937	950	ChemicalEntity	acetylcholine	D000109
221	9294109	968	971	ChemicalEntity	K +	D011188
222	9294109	1009	1014	ChemicalEntity	Ca2 +	D002118
223	9294109	1075	1080	ChemicalEntity	Ca2 +	D002118
224	9294109	1100	1105	ChemicalEntity	Ca2 +	D002118
225	9294109	1155	1170	ChemicalEntity	Na +/K + ATPase	-
226	9294109	1175	1211	ChemicalEntity	sarcoplasmic reticulum Ca2 + -ATPase	D053498
227	9294109	1228	1232	GeneOrGeneProduct	DMPK	13400
228	9294109	1279	1283	GeneOrGeneProduct	DMPK	13400
229	9647766	66	71	OrganismTaxon	human	9606
230	9647766	72	135	GeneOrGeneProduct	nuclear encoded iron sulphur protein (IP) subunits of complex I	4720,4722,4726
231	9647766	141	146	OrganismTaxon	human	9606
232	9647766	147	149	GeneOrGeneProduct	IP	4720,4722,4726
233	9647766	173	215	GeneOrGeneProduct	NADH:ubiquinone oxidoreductase (complex I)	4720,4722,4726
234	9647766	278	290	GeneOrGeneProduct	flavoprotein	-
235	9647766	292	294	GeneOrGeneProduct	FP	-
236	9647766	297	316	GeneOrGeneProduct	iron-sulfur protein	4720,4722,4726
237	9647766	318	320	GeneOrGeneProduct	IP	4720,4722,4726
238	9647766	327	346	GeneOrGeneProduct	hydrophobic protein	-
239	9647766	348	350	GeneOrGeneProduct	HP	-
240	9647766	369	371	GeneOrGeneProduct	IP	4720,4722,4726
241	9647766	535	540	OrganismTaxon	human	9606
242	9647766	541	580	GeneOrGeneProduct	NADH:ubiquinone oxidoreductase subunits	4720,4722,4726
243	9647766	589	591	GeneOrGeneProduct	IP	4720,4722,4726
244	9647766	606	612	GeneOrGeneProduct	NDUFS2	4720
245	9647766	623	629	GeneOrGeneProduct	NDUFS3	4722
246	9647766	644	650	GeneOrGeneProduct	NDUFS6	4726
247	9647766	905	911	OrganismTaxon	bovine	9913
248	9647766	1068	1073	OrganismTaxon	human	9606
249	9647766	1113	1118	OrganismTaxon	human	9606
250	9647766	1150	1155	OrganismTaxon	human	9606
251	9647766	1189	1195	GeneOrGeneProduct	NDUFS2	4720
252	9647766	1200	1206	GeneOrGeneProduct	NDUFS3	4722
253	9647766	1274	1280	GeneOrGeneProduct	NDUFS6	4726
254	9647766	1390	1396	GeneOrGeneProduct	NDUFS2	4720
255	9647766	1425	1441	GeneOrGeneProduct	protein kinase C	5578
256	9647766	1471	1477	GeneOrGeneProduct	NDUFS3	4722
257	9647766	1514	1530	GeneOrGeneProduct	casein kinase II	1457
258	9647766	1627	1656	DiseaseOrPhenotypicFeature	enzymatic complex I-deficient	C537475
259	9647766	1657	1665	OrganismTaxon	patients	9606
260	9672936	0	9	ChemicalEntity	Pethidine	D008614
261	9672936	21	28	DiseaseOrPhenotypicFeature	seizure	D012640
262	9672936	63	72	ChemicalEntity	pethidine	D008614
263	9672936	77	95	DiseaseOrPhenotypicFeature	postoperative pain	D010149
264	9672936	172	181	ChemicalEntity	pethidine	D008614
265	9672936	188	195	OrganismTaxon	patient	9606
266	9672936	246	264	DiseaseOrPhenotypicFeature	postoperative pain	D010149
267	9672936	339	346	DiseaseOrPhenotypicFeature	seizure	D012640
268	9672936	360	369	ChemicalEntity	pethidine	D008614
269	9672936	374	386	ChemicalEntity	norpethidine	C002752
270	9672936	522	530	DiseaseOrPhenotypicFeature	toxicity	D064420
271	9672936	592	601	ChemicalEntity	pethidine	D008614
272	9672936	652	661	ChemicalEntity	pethidine	D008614
273	9672936	666	678	ChemicalEntity	norpethidine	C002752
274	9672936	699	708	ChemicalEntity	pethidine	D008614
275	9672936	734	757	DiseaseOrPhenotypicFeature	postoperative analgesia	D010149
276	9746003	21	34	ChemicalEntity	carbamazepine	D002220
277	9746003	39	49	ChemicalEntity	vigabatrin	D020888
278	9746003	61	77	DiseaseOrPhenotypicFeature	absence seizures	D004832
279	9746003	79	92	ChemicalEntity	Carbamazepine	D002220
280	9746003	97	107	ChemicalEntity	vigabatrin	D020888
281	9746003	139	155	DiseaseOrPhenotypicFeature	absence seizures	D004832
282	9746003	271	284	ChemicalEntity	carbamazepine	D002220
283	9746003	324	334	ChemicalEntity	Vigabatrin	D020888
284	9746003	445	458	ChemicalEntity	carbamazepine	D002220
285	9746003	486	501	DiseaseOrPhenotypicFeature	myoclonic jerks	D009207
286	9746003	535	548	ChemicalEntity	carbamazepine	D002220
287	9746003	595	605	ChemicalEntity	vigabatrin	D020888
288	9746003	694	710	ChemicalEntity	sodium valproate	D014635
289	9746003	712	723	ChemicalEntity	lamotrigine	D000077213
290	9746003	728	740	ChemicalEntity	ethosuximide	D005013
291	10491763	0	27	GeneOrGeneProduct	Hepatocyte nuclear factor-6	3175
292	10491763	74	90	DiseaseOrPhenotypicFeature	type II diabetes	D003924
293	10491763	140	147	GeneOrGeneProduct	insulin	3630
294	10491763	184	217	GeneOrGeneProduct	hepatocyte nuclear factor (HNF)-6	3175
295	10491763	292	315	DiseaseOrPhenotypicFeature	maturity-onset diabetes	D003924
296	10491763	389	394	GeneOrGeneProduct	HNF-6	3175
297	10491763	430	479	DiseaseOrPhenotypicFeature	Type II (non-insulin-dependent) diabetes mellitus	D003924
298	10491763	497	504	GeneOrGeneProduct	insulin	3630
299	10491763	518	525	ChemicalEntity	glucose	D005947
300	10491763	620	625	GeneOrGeneProduct	HNF-6	3175
301	10491763	676	680	GeneOrGeneProduct	MODY	3172,3651,6927
302	10491763	715	720	GeneOrGeneProduct	MODY1	3172
303	10491763	722	727	GeneOrGeneProduct	MODY3	6927
304	10491763	732	737	GeneOrGeneProduct	MODY4	3651
305	10491763	754	762	OrganismTaxon	patients	9606
306	10491763	779	795	DiseaseOrPhenotypicFeature	Type II diabetes	D003924
307	10491763	1070	1079	SequenceVariant	Pro75 Ala	rs74805019
308	10491763	1143	1151	SequenceVariant	Pro75Ala	rs74805019
309	10491763	1216	1224	OrganismTaxon	patients	9606
310	10491763	1230	1255	DiseaseOrPhenotypicFeature	Type II diabetes mellitus	D003924
311	10491763	1304	1311	ChemicalEntity	glucose	D005947
312	10491763	1379	1386	ChemicalEntity	glucose	D005947
313	10491763	1413	1420	ChemicalEntity	glucose	D005947
314	10491763	1443	1459	DiseaseOrPhenotypicFeature	Type II diabetic	D003924
315	10491763	1460	1468	OrganismTaxon	patients	9606
316	10491763	1573	1580	ChemicalEntity	glucose	D005947
317	10491763	1595	1602	GeneOrGeneProduct	insulin	3630
318	10491763	1606	1615	GeneOrGeneProduct	C-peptide	3630
319	10491763	1667	1672	GeneOrGeneProduct	HNF-6	3175
320	10491763	1702	1718	DiseaseOrPhenotypicFeature	Type II diabetes	D003924
321	10491763	1738	1745	GeneOrGeneProduct	insulin	3630
322	10491763	1759	1766	ChemicalEntity	glucose	D005947
323	10661407	0	8	GeneOrGeneProduct	Langerin	50489
324	10661407	18	31	GeneOrGeneProduct	C-type lectin	50489
325	10661407	156	185	GeneOrGeneProduct	type II Ca2+-dependent lectin	50489
326	10661407	197	204	ChemicalEntity	mannose	D008358
327	10661407	284	292	GeneOrGeneProduct	Langerin	50489
328	10661407	447	455	GeneOrGeneProduct	Langerin	50489
329	10661407	514	522	GeneOrGeneProduct	Langerin	50489
330	10661407	590	598	GeneOrGeneProduct	Langerin	50489
331	10661407	699	707	GeneOrGeneProduct	Langerin	50489
332	10661407	890	898	GeneOrGeneProduct	Langerin	50489
333	10788334	25	30	GeneOrGeneProduct	BRCA1	672
334	10788334	60	81	DiseaseOrPhenotypicFeature	breast-ovarian cancer	D061325
335	10788334	147	152	GeneOrGeneProduct	BRCA1	672
336	10788334	157	162	GeneOrGeneProduct	BRCA2	675
337	10788334	260	266	DiseaseOrPhenotypicFeature	cancer	D009369
338	10788334	321	345	DiseaseOrPhenotypicFeature	breast or ovarian cancer	D001943,D010051
339	10788334	358	364	DiseaseOrPhenotypicFeature	cancer	D009369
340	10788334	474	500	DiseaseOrPhenotypicFeature	breast and ovarian cancers	D001943,D010051
341	10788334	517	532	DiseaseOrPhenotypicFeature	ovarian cancers	D010051
342	10788334	559	573	DiseaseOrPhenotypicFeature	breast cancers	D001943
343	10788334	667	672	OrganismTaxon	woman	9606
344	10788334	719	724	GeneOrGeneProduct	BRCA1	672
345	10788334	729	734	GeneOrGeneProduct	BRCA2	675
346	10788334	970	975	GeneOrGeneProduct	BRCA1	672
347	10788334	982	1001	DiseaseOrPhenotypicFeature	BRCA1 abnormalities	OMIM:604370
348	10788334	1044	1058	DiseaseOrPhenotypicFeature	ovarian cancer	D010051
349	10788334	1097	1122	DiseaseOrPhenotypicFeature	breast and ovarian cancer	D001943,D010051
350	10788334	1155	1168	DiseaseOrPhenotypicFeature	breast cancer	D001943
351	10788334	1200	1205	GeneOrGeneProduct	BRCA2	675
352	10788334	1223	1253	DiseaseOrPhenotypicFeature	breast-ovarian cancer syndrome	D061325
353	10788334	1448	1467	DiseaseOrPhenotypicFeature	BRCA1 abnormalities	OMIM:604370
354	10788334	1470	1478	SequenceVariant	5382insC	c|INS|5382|C
355	10788334	1480	1484	SequenceVariant	C61G	rs28897672
356	10788334	1490	1498	SequenceVariant	4153delA	c|DEL|4153|A
357	11009181	0	11	ChemicalEntity	Apomorphine	D001058
358	11009181	42	61	DiseaseOrPhenotypicFeature	Parkinson's disease	D010300
359	11009181	63	74	ChemicalEntity	Apomorphine	D001058
360	11009181	89	106	ChemicalEntity	dopaminergic drug	D004298
361	11009181	138	157	DiseaseOrPhenotypicFeature	Parkinson's disease	D010300
362	11009181	273	292	DiseaseOrPhenotypicFeature	Parkinson's disease	D010300
363	11009181	327	338	ChemicalEntity	apomorphine	D001058
364	11009181	493	504	ChemicalEntity	apomorphine	D001058
365	11009181	590	598	ChemicalEntity	levodopa	D007980
366	11009181	608	619	ChemicalEntity	apomorphine	D001058
367	11009181	678	686	OrganismTaxon	patients	9606
368	11009181	745	756	ChemicalEntity	apomorphine	D001058
369	11009181	827	835	OrganismTaxon	patients	9606
370	11009181	930	947	ChemicalEntity	dopamine agonists	D018491
371	11009181	951	966	ChemicalEntity	COMT inhibitors	D065098
372	11009181	1055	1066	ChemicalEntity	apomorphine	D001058
373	11009181	1174	1185	ChemicalEntity	apomorphine	D001058
374	11009181	1248	1256	ChemicalEntity	levodopa	D007980
375	11009181	1265	1276	DiseaseOrPhenotypicFeature	dyskinesias	D004409
376	11009181	1316	1327	ChemicalEntity	apomorphine	D001058
377	11009181	1407	1432	DiseaseOrPhenotypicFeature	psychiatric complications	D001523
378	11009181	1505	1516	ChemicalEntity	apomorphine	D001058
379	11009181	1542	1561	DiseaseOrPhenotypicFeature	Parkinson's disease	D010300
380	11054569	0	5	GeneOrGeneProduct	Rab6c	84084
381	11054569	27	30	GeneOrGeneProduct	rab	5870,84084
382	11054569	78	87	CellLine	MCF7/AdrR	9606
383	11054569	101	105	GeneOrGeneProduct	Rab6	5870
384	11054569	120	125	GeneOrGeneProduct	Rab6c	84084
385	11054569	207	212	OrganismTaxon	human	9606
386	11054569	239	252	DiseaseOrPhenotypicFeature	breast cancer	D001943
387	11054569	264	273	CellLine	MCF7/AdrR	9606
388	11054569	361	366	GeneOrGeneProduct	Rab6c	84084
389	11054569	402	411	CellLine	MCF7/AdrR	9606
390	11054569	416	426	CellLine	MES-SA/Dx5	9606
391	11054569	430	435	OrganismTaxon	human	9606
392	11054569	440	455	DiseaseOrPhenotypicFeature	uterine sarcoma	D014594
393	11054569	516	525	CellLine	MCF7/AdrR	9606
394	11054569	557	562	GeneOrGeneProduct	Rab6c	84084
395	11054569	627	638	ChemicalEntity	doxorubicin	D004317
396	11054569	640	643	ChemicalEntity	DOX	D004317
397	11054569	646	651	ChemicalEntity	taxol	D017239
398	11054569	653	664	ChemicalEntity	vinblastine	D014747
399	11054569	670	681	ChemicalEntity	vincristine	D014750
400	11054569	821	824	ChemicalEntity	DOX	D004317
401	11054569	892	897	GeneOrGeneProduct	Rab6c	84084
402	11054569	927	932	GeneOrGeneProduct	Rab6c	84084
403	11054569	967	976	CellLine	MCF7/AdrR	9606
404	11773892	0	23	DiseaseOrPhenotypicFeature	End-stage renal disease	D007676
405	11773892	25	29	DiseaseOrPhenotypicFeature	ESRD	D007676
406	11773892	83	94	GeneOrGeneProduct	calcineurin	5530
407	11773892	167	178	GeneOrGeneProduct	calcineurin	5530
408	11773892	190	202	ChemicalEntity	cyclosporine	D016572
409	11773892	207	217	ChemicalEntity	tacrolimus	D016559
410	11773892	239	250	DiseaseOrPhenotypicFeature	nephrotoxic	D007674
411	11773892	392	400	OrganismTaxon	patients	9606
412	11773892	436	459	DiseaseOrPhenotypicFeature	end-stage renal disease	D007676
413	11773892	461	465	DiseaseOrPhenotypicFeature	ESRD	D007676
414	11773892	533	537	DiseaseOrPhenotypicFeature	ESRD	D007676
415	11773892	542	563	DiseaseOrPhenotypicFeature	chronic renal failure	D007676
416	11773892	565	568	DiseaseOrPhenotypicFeature	CRF	D007676
417	11773892	578	586	OrganismTaxon	patients	9606
418	11773892	597	605	OrganismTaxon	Patients	9606
419	11773892	797	805	OrganismTaxon	Patients	9606
420	11773892	851	854	DiseaseOrPhenotypicFeature	CRF	D007676
421	11773892	858	862	DiseaseOrPhenotypicFeature	ESRD	D007676
422	11773892	871	874	DiseaseOrPhenotypicFeature	CRF	D007676
423	11773892	892	902	ChemicalEntity	creatinine	D003404
424	11773892	925	929	DiseaseOrPhenotypicFeature	ESRD	D007676
425	11773892	1051	1055	DiseaseOrPhenotypicFeature	ESRD	D007676
426	11773892	1092	1096	DiseaseOrPhenotypicFeature	ESRD	D007676
427	11773892	1155	1172	DiseaseOrPhenotypicFeature	renal dysfunction	D007674
428	11773892	1184	1187	DiseaseOrPhenotypicFeature	CRF	D007676
429	11773892	1197	1201	DiseaseOrPhenotypicFeature	ESRD	D007676
430	11773892	1231	1239	OrganismTaxon	patients	9606
431	11773892	1241	1244	DiseaseOrPhenotypicFeature	CRF	D007676
432	11773892	1249	1253	DiseaseOrPhenotypicFeature	ESRD	D007676
433	11773892	1254	1262	OrganismTaxon	patients	9606
434	11773892	1293	1303	ChemicalEntity	creatinine	D003404
435	11773892	1336	1344	OrganismTaxon	patients	9606
436	11773892	1350	1370	DiseaseOrPhenotypicFeature	hepatorenal syndrome	D006530
437	11773892	1480	1490	ChemicalEntity	creatinine	D003404
438	11773892	1627	1637	ChemicalEntity	creatinine	D003404
439	11773892	1762	1765	DiseaseOrPhenotypicFeature	CRF	D007676
440	11773892	1769	1773	DiseaseOrPhenotypicFeature	ESRD	D007676
441	11773892	1948	1956	OrganismTaxon	patients	9606
442	11773892	1965	1969	DiseaseOrPhenotypicFeature	ESRD	D007676
443	11773892	2027	2035	OrganismTaxon	Patients	9606
444	11773892	2047	2051	DiseaseOrPhenotypicFeature	ESRD	D007676
445	11773892	2089	2093	DiseaseOrPhenotypicFeature	ESRD	D007676
446	11773892	2109	2117	OrganismTaxon	patients	9606
447	11773892	2162	2170	OrganismTaxon	patients	9606
448	11773892	2182	2186	DiseaseOrPhenotypicFeature	ESRD	D007676
449	11773892	2246	2254	OrganismTaxon	Patients	9606
450	11773892	2297	2300	DiseaseOrPhenotypicFeature	CRF	D007676
451	11773892	2305	2309	DiseaseOrPhenotypicFeature	ESRD	D007676
452	11773892	2345	2349	DiseaseOrPhenotypicFeature	ESRD	D007676
453	11773892	2392	2400	OrganismTaxon	patients	9606
454	11773892	2429	2437	OrganismTaxon	Patients	9606
455	11773892	2450	2454	DiseaseOrPhenotypicFeature	ESRD	D007676
456	11773892	2499	2509	ChemicalEntity	creatinine	D003404
457	11773892	2538	2558	DiseaseOrPhenotypicFeature	hepatorenal syndrome	D006530
458	11773892	2590	2600	ChemicalEntity	creatinine	D003404
459	11773892	2675	2678	DiseaseOrPhenotypicFeature	CRF	D007676
460	11773892	2682	2686	DiseaseOrPhenotypicFeature	ESRD	D007676
461	12442272	0	4	SequenceVariant	D90A	rs80265967
462	12442272	5	9	GeneOrGeneProduct	SOD1	6647
463	12442272	19	48	DiseaseOrPhenotypicFeature	amyotrophic lateral sclerosis	D000690
464	12442272	207	239	GeneOrGeneProduct	copper/zinc superoxide dismutase	6647
465	12442272	241	245	GeneOrGeneProduct	SOD1	6647
466	12442272	266	274	OrganismTaxon	patients	9606
467	12442272	280	309	DiseaseOrPhenotypicFeature	amyotrophic lateral sclerosis	D000690
468	12442272	311	314	DiseaseOrPhenotypicFeature	ALS	D000690
469	12442272	325	350	DiseaseOrPhenotypicFeature	neurodegenerative disease	D019636
470	12442272	362	366	SequenceVariant	D90A	rs80265967
471	12442272	367	371	GeneOrGeneProduct	SOD1	6647
472	12442272	585	589	SequenceVariant	D90A	rs80265967
473	12442272	590	594	GeneOrGeneProduct	SOD1	6647
474	12442272	659	662	DiseaseOrPhenotypicFeature	ALS	D000690
475	12442272	777	780	DiseaseOrPhenotypicFeature	ALS	D000690
476	12442272	1041	1045	SequenceVariant	D90A	rs80265967
477	12442272	1346	1350	GeneOrGeneProduct	SOD1	6647
478	12442272	1459	1463	SequenceVariant	D90A	rs80265967
479	12442272	1464	1468	GeneOrGeneProduct	SOD1	6647
480	12442272	1511	1514	DiseaseOrPhenotypicFeature	ALS	D000690
481	14722929	17	25	DiseaseOrPhenotypicFeature	deafness	D003638
482	14722929	37	41	GeneOrGeneProduct	GJB2	2706
483	14722929	80	84	GeneOrGeneProduct	GJB2	2706
484	14722929	117	159	DiseaseOrPhenotypicFeature	non-syndromic autosomal recessive deafness	C567134
485	14722929	161	166	DiseaseOrPhenotypicFeature	NSARD	C567134
486	14722929	217	221	GeneOrGeneProduct	GJB2	2706
487	14722929	251	255	GeneOrGeneProduct	GJB2	2706
488	14722929	389	411	DiseaseOrPhenotypicFeature	non-syndromic deafness	D003638
489	14722929	538	542	GeneOrGeneProduct	GJB2	2706
490	14722929	729	733	GeneOrGeneProduct	GJB2	2706
491	14722929	749	760	SequenceVariant	g.3318-6T>A	g|SUB|T|3318-6|A
492	14722929	762	774	SequenceVariant	g.3318-15C>T	g|SUB|C|3318-15|T
493	14722929	776	788	SequenceVariant	g.3318-34C>T	g|SUB|C|3318-34|T
494	14722929	790	802	SequenceVariant	g.3318-35T>G	g|SUB|T|3318-35|G
495	14722929	829	843	SequenceVariant	g.3455_3460del	g|DEL|3455_3460|
496	14722929	845	867	SequenceVariant	p.Asp46_Gln48delinsGlu	p|INDEL|46_48|Glu
497	14722929	906	915	SequenceVariant	g.3512C>A	rs763572195
498	14722929	917	925	SequenceVariant	p.Tyr65X	rs763572195
499	14722929	950	959	SequenceVariant	g.3395C>T	g|SUB|C|3395|T
500	14722929	961	968	SequenceVariant	p.Thr26	p|Allele|T|26
501	14722929	971	980	SequenceVariant	g.3503C>T	g|SUB|C|3503|T
502	14722929	982	989	SequenceVariant	p.Asn62	p|Allele|N|62
503	14722929	992	1001	SequenceVariant	g.3627A>C	g|SUB|A|3627|C
504	14722929	1003	1011	SequenceVariant	p.Arg104	p|Allele|R|104
505	14722929	1047	1056	SequenceVariant	g.3816C>A	rs111033360
506	14722929	1058	1069	SequenceVariant	p.Val167Met	rs111033360
507	14722929	1120	1130	SequenceVariant	g.3352delG	g|DEL|3352|G
508	14722929	1152	1158	SequenceVariant	30delG	c|DEL|30|G
509	14722929	1162	1169	SequenceVariant	35 delG	c|DEL|35|G
510	14722929	1172	1181	SequenceVariant	g.3426G>A	rs72474224
511	14722929	1183	1193	SequenceVariant	p.Val37Ile	rs72474224
512	14722929	1196	1205	SequenceVariant	g.3697G>A	rs111033196
513	14722929	1207	1218	SequenceVariant	p.Arg127His	rs111033196
514	14722929	1221	1230	SequenceVariant	g.3774G>A	rs111033186
515	14722929	1232	1243	SequenceVariant	p.Val153Ile	rs111033186
516	14722929	1250	1259	SequenceVariant	g.3795G>A	rs34988750
517	14722929	1261	1272	SequenceVariant	p.Gly160Ser	rs34988750
518	14722929	1313	1325	SequenceVariant	g.3318-34C>T	g|SUB|C|3318-34|T
519	14722929	1330	1340	SequenceVariant	g.3352delG	g|DEL|3352|G
520	14722929	1490	1495	DiseaseOrPhenotypicFeature	NSARD	C567134
521	14722929	1558	1566	DiseaseOrPhenotypicFeature	deafness	D003638
522	14722929	1611	1615	GeneOrGeneProduct	GJB2	2706
523	14722929	1718	1726	DiseaseOrPhenotypicFeature	deafness	D003638
524	15000256	56	60	GeneOrGeneProduct	FMR1	2332
525	15000256	69	77	DiseaseOrPhenotypicFeature	autistic	D001321
526	15000256	82	99	DiseaseOrPhenotypicFeature	mentally retarded	D008607
527	15000256	119	137	DiseaseOrPhenotypicFeature	Fragile X syndrome	D005600
528	15000256	174	192	DiseaseOrPhenotypicFeature	mental retardation	D008607
529	15000256	207	215	OrganismTaxon	patients	9606
530	15000256	221	239	DiseaseOrPhenotypicFeature	fragile X syndrome	D005600
531	15000256	261	267	DiseaseOrPhenotypicFeature	autism	D001321
532	15000256	371	375	GeneOrGeneProduct	FMR1	2332
533	15000256	407	415	OrganismTaxon	patients	9606
534	15000256	500	504	GeneOrGeneProduct	FMR1	2332
535	15000256	530	538	DiseaseOrPhenotypicFeature	autistic	D001321
536	15000256	542	559	DiseaseOrPhenotypicFeature	mentally retarded	D008607
537	15000256	699	707	OrganismTaxon	patients	9606
538	15000256	729	736	OrganismTaxon	patient	9606
539	15000256	802	839	SequenceVariant	A to C substitution at nucleotide 879	rs782013865
540	15000256	1103	1107	GeneOrGeneProduct	FMR1	2332
541	15000256	1131	1137	DiseaseOrPhenotypicFeature	autism	D001321
542	15000256	1142	1160	DiseaseOrPhenotypicFeature	mental retardation	D008607
543	15000256	1173	1181	OrganismTaxon	patients	9606
544	15018851	25	40	OrganismTaxon	cytomegalovirus	10358
545	15018851	55	62	OrganismTaxon	patient	9606
546	15018851	68	76	DiseaseOrPhenotypicFeature	lymphoma	D008223
547	15018851	120	150	DiseaseOrPhenotypicFeature	Long-term anti-cytomegalovirus	D003586
548	15018851	152	155	DiseaseOrPhenotypicFeature	CMV	D003586
549	15018851	189	197	OrganismTaxon	patients	9606
550	15018851	359	362	DiseaseOrPhenotypicFeature	CMV	D003586
551	15018851	424	427	DiseaseOrPhenotypicFeature	CMV	D003586
552	15018851	506	513	OrganismTaxon	patient	9606
553	15018851	519	541	DiseaseOrPhenotypicFeature	non-Hodgkin's lymphoma	D008228
554	15018851	566	569	DiseaseOrPhenotypicFeature	CMV	D003586
555	15018851	650	653	DiseaseOrPhenotypicFeature	CMV	D003586
556	15018851	682	689	OrganismTaxon	patient	9606
557	15018851	775	789	GeneOrGeneProduct	glycoprotein B	2813
558	15018851	791	793	GeneOrGeneProduct	gB	2813
559	15018851	853	856	DiseaseOrPhenotypicFeature	CMV	D003586
560	15018851	895	902	OrganismTaxon	patient	9606
561	15018851	934	937	DiseaseOrPhenotypicFeature	CMV	D003586
562	15018851	999	1010	ChemicalEntity	ganciclovir	D015774
563	15018851	1012	1021	ChemicalEntity	cidofovir	D000077404
564	15018851	1026	1035	ChemicalEntity	foscarnet	D017245
565	15018851	1091	1110	GeneOrGeneProduct	UL97 protein kinase	3077517
566	15018851	1149	1160	ChemicalEntity	ganciclovir	D015774
567	15018851	1261	1270	ChemicalEntity	foscarnet	D017245
568	15018851	1328	1333	SequenceVariant	N495K	p|SUB|N|495|K
569	15018851	1381	1392	ChemicalEntity	ganciclovir	D015774
570	15018851	1397	1406	ChemicalEntity	cidofovir	D000077404
571	15018851	1422	1427	SequenceVariant	L501I	p|SUB|L|501|I
572	15018851	1459	1462	DiseaseOrPhenotypicFeature	CMV	D003586
573	15018851	1490	1497	OrganismTaxon	patient	9606
574	15033202	0	26	DiseaseOrPhenotypicFeature	Nijmegen breakage syndrome	D049932
575	15033202	69	89	DiseaseOrPhenotypicFeature	primary microcephaly	D008831
576	15033202	95	121	DiseaseOrPhenotypicFeature	Nijmegen breakage syndrome	D049932
577	15033202	132	184	DiseaseOrPhenotypicFeature	autosomal recessive chromosomal instability disorder	D043171
578	15033202	208	226	DiseaseOrPhenotypicFeature	growth retardation	D006130
579	15033202	228	251	DiseaseOrPhenotypicFeature	congenital microcephaly	D008831
580	15033202	253	269	DiseaseOrPhenotypicFeature	immunodeficiency	D007153
581	15033202	325	353	DiseaseOrPhenotypicFeature	lymphoreticular malignancies	D049932
582	15033202	360	386	DiseaseOrPhenotypicFeature	Nijmegen breakage syndrome	D049932
583	15033202	387	395	OrganismTaxon	patients	9606
584	15033202	476	497	SequenceVariant	5 nucleotide deletion	c|DEL||5
585	15033202	505	509	GeneOrGeneProduct	NBS1	4683
586	15033202	516	528	DiseaseOrPhenotypicFeature	Microcephaly	D008831
587	15033202	552	578	DiseaseOrPhenotypicFeature	Nijmegen breakage syndrome	D049932
588	15033202	579	587	OrganismTaxon	patients	9606
589	15033202	656	682	DiseaseOrPhenotypicFeature	Nijmegen breakage syndrome	D049932
590	15033202	703	723	DiseaseOrPhenotypicFeature	primary microcephaly	D008831
591	15033202	854	862	OrganismTaxon	patients	9606
592	15033202	958	962	GeneOrGeneProduct	NBS1	4683
593	15033202	979	1005	DiseaseOrPhenotypicFeature	Nijmegen breakage syndrome	D049932
594	15033202	1101	1127	DiseaseOrPhenotypicFeature	Nijmegen breakage syndrome	D049932
595	15033202	1128	1136	OrganismTaxon	patients	9606
596	15033202	1353	1379	DiseaseOrPhenotypicFeature	Nijmegen breakage syndrome	D049932
597	15033202	1394	1420	DiseaseOrPhenotypicFeature	Nijmegen breakage syndrome	D049932
598	15033202	1575	1601	DiseaseOrPhenotypicFeature	Nijmegen breakage syndrome	D049932
599	15033202	1748	1774	DiseaseOrPhenotypicFeature	Nijmegen breakage syndrome	D049932
600	15033202	1775	1783	OrganismTaxon	patients	9606
601	15033202	1925	1951	DiseaseOrPhenotypicFeature	Nijmegen breakage syndrome	D049932
602	15033202	1952	1960	OrganismTaxon	patients	9606
603	15042318	0	19	DiseaseOrPhenotypicFeature	Atrial fibrillation	D001281
604	15042318	79	95	DiseaseOrPhenotypicFeature	gastric lymphoma	C535648
605	15042318	101	108	OrganismTaxon	patient	9606
606	15042318	114	132	DiseaseOrPhenotypicFeature	myotonic dystrophy	D009223
607	15042318	134	152	DiseaseOrPhenotypicFeature	Steinert's disease	D009223
608	15042318	223	239	DiseaseOrPhenotypicFeature	gastric lymphoma	C535648
609	15042318	244	262	DiseaseOrPhenotypicFeature	myotonic dystrophy	D009223
610	15042318	294	312	DiseaseOrPhenotypicFeature	muscular dystrophy	D009136
611	15042318	325	344	DiseaseOrPhenotypicFeature	atrial fibrillation	D001281
612	15042318	368	379	ChemicalEntity	doxorubicin	D004317
613	15042318	411	418	OrganismTaxon	patient	9606
614	15042318	420	439	DiseaseOrPhenotypicFeature	Atrial fibrillation	D001281
615	15042318	449	468	DiseaseOrPhenotypicFeature	cardiac arrhythmias	D001145
616	15042318	498	506	OrganismTaxon	patients	9606
617	15042318	538	554	DiseaseOrPhenotypicFeature	cardiac toxicity	D066126
618	15042318	668	678	DiseaseOrPhenotypicFeature	arrhythmia	D001145
619	15042318	717	724	OrganismTaxon	patient	9606
620	15064320	39	45	GeneOrGeneProduct	SRD5A2	6716
621	15064320	63	87	DiseaseOrPhenotypicFeature	male pseudohermaphrodite	D058490
622	15064320	88	95	OrganismTaxon	patient	9606
623	15064320	153	177	GeneOrGeneProduct	5-alpha-reductase type 2	6716
624	15064320	184	190	GeneOrGeneProduct	SRD5A2	6716
625	15064320	206	230	DiseaseOrPhenotypicFeature	male pseudohermaphrodite	D058490
626	15064320	232	235	DiseaseOrPhenotypicFeature	MPH	D058490
627	15064320	237	244	OrganismTaxon	patient	9606
628	15064320	257	269	ChemicalEntity	testosterone	D013739
629	15064320	271	272	ChemicalEntity	T	D013739
630	15064320	296	313	GeneOrGeneProduct	androgen receptor	367
631	15064320	315	317	GeneOrGeneProduct	AR	367
632	15064320	344	351	OrganismTaxon	patient	9606
633	15064320	439	440	ChemicalEntity	T	D013739
634	15064320	457	485	ChemicalEntity	human chorionic gonadotropin	D006063
635	15064320	487	490	ChemicalEntity	hCG	D006063
636	15064320	559	561	GeneOrGeneProduct	AR	367
637	15064320	588	594	GeneOrGeneProduct	SRD5A2	6716
638	15064320	642	644	GeneOrGeneProduct	AR	367
639	15064320	680	686	GeneOrGeneProduct	SRD5A2	6716
640	15064320	786	860	SequenceVariant	T nucleotide deletion, which predicts a frameshift mutation from codon 219	c|DEL|CODON219|T
641	15064320	929	959	SequenceVariant	guanine (CGA) by adenine (CAA)	rs9332964
642	15064320	971	1004	SequenceVariant	glutamine replacement of arginine	rs9332964
643	15064320	1006	1011	SequenceVariant	R227Q	rs9332964
644	15064320	1091	1098	OrganismTaxon	patient	9606
645	15064320	1131	1137	GeneOrGeneProduct	SRD5A2	6716
646	15064320	1185	1192	OrganismTaxon	patient	9606
647	15064320	1203	1208	SequenceVariant	R227Q	rs9332964
648	15064320	1269	1272	DiseaseOrPhenotypicFeature	MPH	D058490
649	15064320	1273	1281	OrganismTaxon	patients	9606
650	15064320	1323	1330	SequenceVariant	Tdel219	c|DEL|CODON219|T
651	15064320	1389	1406	GeneOrGeneProduct	5-alpha-reductase	6716
652	15069170	28	36	ChemicalEntity	thiazide	D049971
653	15069170	47	67	GeneOrGeneProduct	Na-Cl co-transporter	6559
654	15069170	85	93	OrganismTaxon	patients	9606
655	15069170	99	118	DiseaseOrPhenotypicFeature	Gitelman's syndrome	D053579
656	15069170	132	151	DiseaseOrPhenotypicFeature	Gitelman's syndrome	D053579
657	15069170	153	155	DiseaseOrPhenotypicFeature	GS	D053579
658	15069170	163	191	DiseaseOrPhenotypicFeature	autosomal recessive disorder	D030342
659	15069170	237	245	ChemicalEntity	thiazide	D049971
660	15069170	256	276	GeneOrGeneProduct	Na-Cl co-transporter	6559
661	15069170	278	282	GeneOrGeneProduct	NCCT	6559
662	15069170	463	467	GeneOrGeneProduct	NCCT	6559
663	15069170	491	499	OrganismTaxon	patients	9606
664	15069170	505	507	DiseaseOrPhenotypicFeature	GS	D053579
665	15069170	572	580	OrganismTaxon	patients	9606
666	15069170	586	588	DiseaseOrPhenotypicFeature	GS	D053579
667	15069170	668	672	GeneOrGeneProduct	NCCT	6559
668	15069170	790	798	OrganismTaxon	patients	9606
669	15069170	930	938	SequenceVariant	c.185C>T	rs371443644
670	15069170	940	948	SequenceVariant	Thr60Met	rs371443644
671	15069170	951	960	SequenceVariant	c.1712C>T	rs79351185
672	15069170	962	971	SequenceVariant	Ala569Val	rs79351185
673	15069170	974	983	SequenceVariant	c.1930C>T	rs200697179
674	15069170	985	994	SequenceVariant	Arg642Cys	rs200697179
675	15069170	997	1006	SequenceVariant	c.2552T>A	rs185927948
676	15069170	1008	1017	SequenceVariant	Leu849His	rs185927948
677	15069170	1023	1033	SequenceVariant	c.1932delC	c|DEL|1932|C
678	15069170	1066	1074	OrganismTaxon	patients	9606
679	15069170	1087	1089	DiseaseOrPhenotypicFeature	GS	D053579
680	15069170	1090	1098	OrganismTaxon	patients	9606
681	15069170	1155	1161	SequenceVariant	c.7A>T	c|SUB|A|7|T
682	15069170	1163	1170	SequenceVariant	Met1Leu	p|SUB|M|1|L
683	15069170	1173	1192	SequenceVariant	c.1181_1186+20del26	c|DEL|1181_1186+20|26
684	15069170	1194	1210	SequenceVariant	c.1811_1812delAT	c|DEL|1811_1812|AT
685	15069170	1215	1225	SequenceVariant	IVS16+1G>A	c|SUB|G|IVS16+1|A
686	15069170	1262	1269	OrganismTaxon	patient	9606
687	15069170	1275	1294	SequenceVariant	c.1181_1186+20del26	c|DEL|1181_1186+20|26
688	15069170	1394	1402	OrganismTaxon	patients	9606
689	15069170	1408	1418	SequenceVariant	IVS16+1G>A	c|SUB|G|IVS16+1|A
690	15069170	1434	1449	SequenceVariant	96 bp insertion	c|INS||96
691	15069170	1505	1513	OrganismTaxon	patients	9606
692	15069170	1655	1659	GeneOrGeneProduct	NCCT	6559
693	15069170	1683	1691	OrganismTaxon	patients	9606
694	15069170	1697	1699	DiseaseOrPhenotypicFeature	GS	D053579
695	15069170	1772	1776	GeneOrGeneProduct	NCCT	6559
696	15069170	1794	1796	DiseaseOrPhenotypicFeature	GS	D053579
697	15069170	1797	1805	OrganismTaxon	patients	9606
698	15086325	24	26	GeneOrGeneProduct	F5	2153
699	15086325	58	99	DiseaseOrPhenotypicFeature	inherited coagulation factor V deficiency	D005166
700	15086325	193	227	DiseaseOrPhenotypicFeature	inherited factor V (FV) deficiency	D005166
701	15086325	314	349	DiseaseOrPhenotypicFeature	inherited coagulation FV deficiency	D005166
702	15086325	387	389	GeneOrGeneProduct	FV	2153
703	15086325	456	458	GeneOrGeneProduct	F5	2153
704	15086325	712	722	SequenceVariant	IVS8 -2A>G	c|SUB|A|IVS8-2|G
705	15086325	745	747	GeneOrGeneProduct	F5	2153
706	15086325	952	1001	SequenceVariant	insertion introduced eight additional amino acids	p|INS||8
707	15086325	1016	1018	GeneOrGeneProduct	FV	2153
708	15086325	1058	1060	GeneOrGeneProduct	F5	2153
709	15086325	1100	1112	SequenceVariant	2238-9del AG	c|DEL|2238_2239|AG
710	15086325	1167	1173	SequenceVariant	689 AA	c|Allele|A|689
711	15086325	1198	1208	SequenceVariant	G6410 by T	g|SUB|G|6410|T
712	15086325	1250	1260	SequenceVariant	Gly2079Val	p|SUB|G|2079|V
713	15086325	1268	1270	GeneOrGeneProduct	F5	2153
714	15086325	1287	1297	SequenceVariant	IVS8 -2A>G	c|SUB|A|IVS8-2|G
715	15086325	1299	1311	SequenceVariant	2238-9del AG	c|DEL|2238_2239|AG
716	15086325	1316	1322	SequenceVariant	G6410T	g|SUB|G|6410|T
717	15086325	1374	1398	DiseaseOrPhenotypicFeature	congenital FV deficiency	D005166
718	15111599	0	9	GeneOrGeneProduct	CRYBA3/A1	1411
719	15111599	55	101	DiseaseOrPhenotypicFeature	autosomal dominant congenital nuclear cataract	C565137
720	15111599	147	161	DiseaseOrPhenotypicFeature	genetic defect	D030342
721	15111599	177	204	DiseaseOrPhenotypicFeature	congenital nuclear cataract	C565137
722	15111599	447	455	DiseaseOrPhenotypicFeature	cataract	D002386
723	15111599	749	787	DiseaseOrPhenotypicFeature	congenital nuclear lactescent cataract	C565137
724	15111599	917	926	GeneOrGeneProduct	CRYBA3/A1	1411
725	15111599	977	990	SequenceVariant	3-bp deletion	c|DEL||3
726	15111599	1002	1011	SequenceVariant	279delGAG	c|DEL|279|GAG
727	15111599	1039	1061	SequenceVariant	deletion of glycine-91	p|DEL|91|G
728	15111599	1311	1319	SequenceVariant	DeltaG91	p|DEL|91|G
729	15111599	1332	1341	GeneOrGeneProduct	CRYBA3/A1	1411
730	15111599	1364	1421	DiseaseOrPhenotypicFeature	autosomal dominant congenital nuclear lactescent cataract	C565137
731	15111599	1442	1451	SequenceVariant	IVS3+1G/A	c|SUB|G|IVS3+1|A
732	15111599	1489	1505	DiseaseOrPhenotypicFeature	zonular cataract	C535342
733	15122711	0	4	GeneOrGeneProduct	POLG	5428
734	15122711	31	47	DiseaseOrPhenotypicFeature	Alpers' syndrome	D002549
735	15122711	52	79	DiseaseOrPhenotypicFeature	mitochondrial DNA depletion	D028361
736	15122711	81	97	DiseaseOrPhenotypicFeature	Alpers' syndrome	D002549
737	15122711	109	130	DiseaseOrPhenotypicFeature	neurogenetic disorder	D009422
738	15122711	215	242	DiseaseOrPhenotypicFeature	mitochondrial DNA depletion	D028361
739	15122711	297	317	GeneOrGeneProduct	DNA polymerase gamma	5428
740	15122711	319	323	GeneOrGeneProduct	POLG	5428
741	15122711	356	364	DiseaseOrPhenotypicFeature	seizures	D012640
742	15122711	366	383	DiseaseOrPhenotypicFeature	neurodegeneration	D019636
743	15122711	389	402	DiseaseOrPhenotypicFeature	liver disease	D008107
744	15122711	434	450	DiseaseOrPhenotypicFeature	Alpers' syndrome	D002549
745	15122711	531	535	GeneOrGeneProduct	POLG	5428
746	15122711	556	566	SequenceVariant	Glu873Stop	rs121918047
747	15122711	689	695	SequenceVariant	G1681A	rs113994095
748	15122711	730	739	SequenceVariant	Ala467Thr	rs113994095
749	15122711	756	760	GeneOrGeneProduct	POLG	5428
750	15130900	0	22	DiseaseOrPhenotypicFeature	Urinary bladder cancer	D001749
751	15130900	26	50	DiseaseOrPhenotypicFeature	Wegener's granulomatosis	D014890
752	15130900	74	90	ChemicalEntity	cyclophosphamide	D003520
753	15130900	142	156	DiseaseOrPhenotypicFeature	bladder cancer	D001749
754	15130900	178	194	ChemicalEntity	cyclophosphamide	D003520
755	15130900	199	207	OrganismTaxon	patients	9606
756	15130900	213	237	DiseaseOrPhenotypicFeature	Wegener's granulomatosis	D014890
757	15130900	292	301	OrganismTaxon	Inpatient	9606
758	15130900	328	336	OrganismTaxon	patients	9606
759	15130900	342	366	DiseaseOrPhenotypicFeature	Wegener's granulomatosis	D014890
760	15130900	426	432	DiseaseOrPhenotypicFeature	Cancer	D009369
761	15130900	486	500	DiseaseOrPhenotypicFeature	bladder cancer	D001749
762	15130900	623	639	ChemicalEntity	cyclophosphamide	D003520
763	15130900	644	658	DiseaseOrPhenotypicFeature	bladder cancer	D001749
764	15130900	738	752	DiseaseOrPhenotypicFeature	bladder cancer	D001749
765	15130900	759	783	DiseaseOrPhenotypicFeature	Wegener's granulomatosis	D014890
766	15130900	829	843	DiseaseOrPhenotypicFeature	bladder cancer	D001749
767	15130900	872	896	DiseaseOrPhenotypicFeature	Wegener's granulomatosis	D014890
768	15130900	959	975	ChemicalEntity	cyclophosphamide	D003520
769	15130900	1066	1080	DiseaseOrPhenotypicFeature	bladder cancer	D001749
770	15130900	1117	1133	ChemicalEntity	cyclophosphamide	D003520
771	15130900	1325	1339	DiseaseOrPhenotypicFeature	bladder cancer	D001749
772	15130900	1394	1418	DiseaseOrPhenotypicFeature	Wegener's granulomatosis	D014890
773	15130900	1437	1451	DiseaseOrPhenotypicFeature	bladder cancer	D001749
774	15130900	1532	1556	DiseaseOrPhenotypicFeature	Wegener's granulomatosis	D014890
775	15130900	1628	1644	ChemicalEntity	cyclophosphamide	D003520
776	15130900	1661	1675	DiseaseOrPhenotypicFeature	bladder cancer	D001749
777	15130900	1784	1808	DiseaseOrPhenotypicFeature	Wegener's granulomatosis	D014890
778	15177686	34	38	GeneOrGeneProduct	HIRA	7290
779	15177686	39	45	GeneOrGeneProduct	Tuple1	7290
780	15177686	59	98	DiseaseOrPhenotypicFeature	DiGeorge and Velocardiofacial syndromes	D004062
781	15177686	100	139	DiseaseOrPhenotypicFeature	DiGeorge and Velocardiofacial syndromes	D004062
782	15177686	141	144	DiseaseOrPhenotypicFeature	DGS	D004062
783	15177686	145	149	DiseaseOrPhenotypicFeature	VCFS	D004062
784	15177686	204	258	DiseaseOrPhenotypicFeature	cardiovascular, craniofacial, and thymic malformations	D018376,D019465
785	15177686	608	611	DiseaseOrPhenotypicFeature	DGS	D004062
786	15177686	612	616	DiseaseOrPhenotypicFeature	VCFS	D004062
787	15177686	675	679	GeneOrGeneProduct	HIRA	7290
788	15177686	680	686	GeneOrGeneProduct	Tuple1	7290
789	15177686	724	727	DiseaseOrPhenotypicFeature	DGS	D004062
790	15177686	728	732	DiseaseOrPhenotypicFeature	VCFS	D004062
791	15177686	845	849	GeneOrGeneProduct	HIRA	7290
792	15177686	850	856	GeneOrGeneProduct	Tuple1	7290
793	15177686	1214	1217	DiseaseOrPhenotypicFeature	DGS	D004062
794	15177686	1218	1222	DiseaseOrPhenotypicFeature	VCFS	D004062
795	15184369	0	4	ChemicalEntity	Ca2+	D002118
796	15184369	23	27	ChemicalEntity	Ca2+	D002118
797	15184369	38	43	GeneOrGeneProduct	TRPV6	55503
798	15184369	116	121	GeneOrGeneProduct	TRPV6	55503
799	15184369	133	136	CellLine	HEK	9606
800	15184369	169	175	ChemicalEntity	Ca(2+)	D002118
801	15184369	184	190	ChemicalEntity	Ca(2+)	D002118
802	15184369	250	256	ChemicalEntity	fura-2	D016257
803	15184369	292	298	ChemicalEntity	Ca(2+)	D002118
804	15184369	399	405	ChemicalEntity	Ca(2+)	D002118
805	15184369	422	426	ChemicalEntity	EGTA	D004533
806	15184369	471	474	CellLine	HEK	9606
807	15184369	502	507	OrganismTaxon	human	9606
808	15184369	508	513	GeneOrGeneProduct	TRPV6	55503
809	15184369	629	633	ChemicalEntity	EGTA	D004533
810	15184369	669	675	ChemicalEntity	Ca(2+)	D002118
811	15184369	773	778	GeneOrGeneProduct	TRPV6	55503
812	15184369	817	823	ChemicalEntity	Ca(2+)	D002118
813	15184369	860	865	GeneOrGeneProduct	TRPV6	55503
814	15184369	902	908	ChemicalEntity	Ca(2+)	D002118
815	15184369	972	977	GeneOrGeneProduct	TRPV6	55503
816	15184369	1137	1141	ChemicalEntity	EGTA	D004533
817	15184369	1147	1152	GeneOrGeneProduct	TRPV6	55503
818	15184369	1188	1194	ChemicalEntity	Ca(2+)	D002118
819	15184369	1310	1315	GeneOrGeneProduct	TRPV6	55503
820	15184369	1351	1357	ChemicalEntity	Ca(2+)	D002118
821	15184369	1424	1429	GeneOrGeneProduct	TRPV6	55503
822	15184369	1473	1478	OrganismTaxon	human	9606
823	15184369	1479	1484	GeneOrGeneProduct	TRPV6	55503
824	15184369	1500	1505	OrganismTaxon	human	9606
825	15184369	1506	1511	GeneOrGeneProduct	TRPV6	55503
826	15184369	1512	1524	SequenceVariant	Delta695-725	p|DEL|695-725|
827	15184369	1574	1580	ChemicalEntity	Ca(2+)	D002118
828	15184369	1657	1662	OrganismTaxon	human	9606
829	15184369	1663	1668	GeneOrGeneProduct	TRPV6	55503
830	15184369	1669	1674	SequenceVariant	D542A	p|SUB|D|542|A
831	15184369	1797	1802	GeneOrGeneProduct	TRPV6	55503
832	15184369	1870	1873	CellLine	HEK	9606
833	15191352	15	41	DiseaseOrPhenotypicFeature	thyroid hormone resistance	D018382
834	15191352	47	54	OrganismTaxon	patient	9606
835	15191352	94	105	GeneOrGeneProduct	T3 receptor	7068
836	15191352	112	150	DiseaseOrPhenotypicFeature	Resistance to thyroid hormone syndrome	D018382
837	15191352	152	155	DiseaseOrPhenotypicFeature	RTH	D018382
838	15191352	227	235	OrganismTaxon	Patients	9606
839	15191352	241	244	DiseaseOrPhenotypicFeature	RTH	D018382
840	15191352	323	337	DiseaseOrPhenotypicFeature	thyrotoxicosis	D013971
841	15191352	353	367	DiseaseOrPhenotypicFeature	hypothyroidism	D007037
842	15191352	436	465	GeneOrGeneProduct	thyroid hormone receptor beta	7068
843	15191352	472	479	GeneOrGeneProduct	TR-beta	7068
844	15191352	495	502	OrganismTaxon	patient	9606
845	15191352	508	511	DiseaseOrPhenotypicFeature	RTH	D018382
846	15191352	563	570	GeneOrGeneProduct	TR-beta	7068
847	15191352	612	617	SequenceVariant	I280S	p|SUB|I|280|S
848	15191352	619	628	SequenceVariant	1123T-->G	g|SUB|T|1123|G
849	15191352	738	743	SequenceVariant	I280S	p|SUB|I|280|S
850	15191352	793	800	OrganismTaxon	patient	9606
851	15191352	838	871	DiseaseOrPhenotypicFeature	impaired intellectual development	D008607
852	15191352	873	885	DiseaseOrPhenotypicFeature	hyperkinetic	D006948
853	15191352	897	908	DiseaseOrPhenotypicFeature	tachycardia	D013610
854	15191352	910	939	DiseaseOrPhenotypicFeature	hearing and visual impairment	D006311,D014786
855	15191352	995	1000	SequenceVariant	I280S	p|SUB|I|280|S
856	15191352	1050	1057	GeneOrGeneProduct	TR-beta	7068
857	15198485	18	27	SequenceVariant	Lys198Asn	rs5370
858	15198485	32	40	SequenceVariant	-134delA	rs1800997
859	15198485	70	82	GeneOrGeneProduct	endothelin-1	1906
860	15198485	89	101	GeneOrGeneProduct	Endothelin-1	1906
861	15198485	103	107	GeneOrGeneProduct	ET-1	1906
862	15198485	225	229	GeneOrGeneProduct	ET-1	1906
863	15198485	236	240	GeneOrGeneProduct	EDN1	1906
864	15198485	315	324	SequenceVariant	Lys198Asn	rs5370
865	15198485	386	396	DiseaseOrPhenotypicFeature	overweight	D050177
866	15198485	440	448	SequenceVariant	-134delA	rs1800997
867	15198485	542	551	SequenceVariant	Lys198Asn	rs5370
868	15198485	568	572	GeneOrGeneProduct	ET-1	1906
869	15198485	665	669	GeneOrGeneProduct	ET-1	1906
870	15198485	748	752	GeneOrGeneProduct	ET-1	1906
871	15198485	811	815	GeneOrGeneProduct	ET-1	1906
872	15198485	824	828	GeneOrGeneProduct	ET-1	1906
873	15198485	910	914	GeneOrGeneProduct	ET-1	1906
874	15198485	922	926	GeneOrGeneProduct	ET-1	1906
875	15198485	939	973	SequenceVariant	Asn-type and Lys-type transfectant	rs5370
876	15198485	1022	1026	GeneOrGeneProduct	ET-1	1906
877	15198485	1033	1045	DiseaseOrPhenotypicFeature	hypertensive	D006973
878	15198485	1046	1054	OrganismTaxon	patients	9606
879	15198485	1094	1120	SequenceVariant	Lys to Asn at position 198	rs5370
880	15198485	1154	1167	DiseaseOrPhenotypicFeature	hypertensives	D006973
881	15198485	1240	1244	GeneOrGeneProduct	ET-1	1906
882	15198485	1358	1367	SequenceVariant	Lys198Asn	rs5370
883	15198485	1405	1409	GeneOrGeneProduct	ET-1	1906
884	15198485	1418	1422	GeneOrGeneProduct	ET-1	1906
885	15198485	1458	1462	GeneOrGeneProduct	EDN1	1906
886	15198485	1503	1512	SequenceVariant	Lys198Asn	rs5370
887	15198485	1605	1609	GeneOrGeneProduct	EDN1	1906
888	15198485	1610	1619	SequenceVariant	Lys198Asn	rs5370
889	15198485	1659	1666	DiseaseOrPhenotypicFeature	obesity	D009765
890	15200408	29	34	OrganismTaxon	human	9606
891	15200408	35	44	GeneOrGeneProduct	uroplakin	11045,7380
892	15200408	54	75	DiseaseOrPhenotypicFeature	vesicoureteral reflux	C564042
893	15200408	137	158	DiseaseOrPhenotypicFeature	vesicoureteral reflux	C564042
894	15200408	160	163	DiseaseOrPhenotypicFeature	VUR	C564042
895	15200408	170	189	DiseaseOrPhenotypicFeature	hereditary disorder	D030342
896	15200408	343	362	DiseaseOrPhenotypicFeature	hereditary diseases	D030342
897	15200408	379	390	DiseaseOrPhenotypicFeature	nephropathy	D007674
898	15200408	416	439	DiseaseOrPhenotypicFeature	end-stage renal failure	D007676
899	15200408	513	518	OrganismTaxon	mouse	10090
900	15200408	519	537	GeneOrGeneProduct	uroplakin (UP) III	22270
901	15200408	647	650	DiseaseOrPhenotypicFeature	VUR	C564042
902	15200408	655	669	DiseaseOrPhenotypicFeature	hydronephrosis	D006869
903	15200408	723	725	GeneOrGeneProduct	UP	11045,7380
904	15200408	753	758	OrganismTaxon	human	9606
905	15200408	759	762	DiseaseOrPhenotypicFeature	VUR	C564042
906	15200408	786	788	GeneOrGeneProduct	UP	11045,7380
907	15200408	801	809	OrganismTaxon	patients	9606
908	15200408	845	848	DiseaseOrPhenotypicFeature	VUR	C564042
909	15200408	1162	1165	DiseaseOrPhenotypicFeature	VUR	C564042
910	15200408	1214	1217	DiseaseOrPhenotypicFeature	VUR	C564042
911	15200408	1298	1301	DiseaseOrPhenotypicFeature	VUR	C564042
912	15200408	1302	1310	OrganismTaxon	patients	9606
913	15200408	1425	1428	DiseaseOrPhenotypicFeature	VUR	C564042
914	15200408	1447	1452	GeneOrGeneProduct	UP Ia	11045
915	15200408	1470	1476	SequenceVariant	C to T	rs373513519
916	15200408	1495	1502	SequenceVariant	Ala7Val	rs373513519
917	15200408	1523	1529	GeneOrGeneProduct	UP III	7380
918	15200408	1542	1548	SequenceVariant	C to G	c|SUB|C||G
919	15200408	1566	1575	SequenceVariant	Pro154Ala	p|SUB|P|154|A
920	15200408	1616	1619	DiseaseOrPhenotypicFeature	VUR	C564042
921	15200408	1766	1772	GeneOrGeneProduct	UP III	7380
922	15200408	1781	1784	DiseaseOrPhenotypicFeature	VUR	C564042
923	15200408	1982	1991	GeneOrGeneProduct	uroplakin	11045,7380
924	15200408	2037	2040	DiseaseOrPhenotypicFeature	VUR	C564042
925	15200408	2044	2050	OrganismTaxon	humans	9606
926	15200408	2219	2222	DiseaseOrPhenotypicFeature	VUR	C564042
927	15200408	2223	2231	OrganismTaxon	patients	9606
928	15200408	2293	2299	GeneOrGeneProduct	UP III	22270
929	15200408	2309	2313	OrganismTaxon	mice	10090
930	15200408	2347	2350	DiseaseOrPhenotypicFeature	VUR	C564042
931	15200408	2368	2382	DiseaseOrPhenotypicFeature	hydronephrosis	D006869
932	15200408	2387	2401	DiseaseOrPhenotypicFeature	neonatal death	D066087
933	15200408	2437	2446	GeneOrGeneProduct	uroplakin	11045,7380
934	15200408	2505	2511	OrganismTaxon	humans	9606
935	15233872	27	48	ChemicalEntity	tincture of Crataegus	C007145
936	15233872	52	65	ChemicalEntity	isoproterenol	D007545
937	15233872	74	95	DiseaseOrPhenotypicFeature	myocardial infarction	D009203
938	15233872	99	103	OrganismTaxon	rats	10116
939	15233872	105	126	ChemicalEntity	Tincture of Crataegus	C007145
940	15233872	128	131	ChemicalEntity	TCR	C007145
941	15233872	137	181	ChemicalEntity	alcoholic extract of the berries of hawthorn	C007145
942	15233872	183	202	ChemicalEntity	Crataegus oxycantha	C007145
943	15233872	316	319	ChemicalEntity	TCR	C007145
944	15233872	346	367	DiseaseOrPhenotypicFeature	myocardial infarction	D009203
945	15233872	371	375	OrganismTaxon	rats	10116
946	15233872	393	396	ChemicalEntity	TCR	C007145
947	15233872	490	495	ChemicalEntity	lipid	D008055
948	15233872	552	565	ChemicalEntity	isoproterenol	D007545
949	15233872	574	578	OrganismTaxon	rats	10116
950	15233872	635	638	ChemicalEntity	TCR	C007145
951	15233872	653	666	ChemicalEntity	isoproterenol	D007545
952	15233872	746	749	ChemicalEntity	ADP	D000244
953	15233872	761	767	ChemicalEntity	oxygen	D010100
954	15233872	807	810	ChemicalEntity	TCR	C007145
955	15233872	861	874	ChemicalEntity	isoproterenol	D007545
956	15233872	878	881	OrganismTaxon	rat	10116
957	15233872	929	932	ChemicalEntity	TCR	C007145
958	15233872	983	996	ChemicalEntity	isoproterenol	D007545
959	15233872	1000	1003	OrganismTaxon	rat	10116
960	15241482	0	13	GeneOrGeneProduct	Paraoxonase 1	5444
961	15241482	65	78	GeneOrGeneProduct	paraoxonase 1	5444
962	15241482	80	84	GeneOrGeneProduct	PON1	5444
963	15241482	145	167	DiseaseOrPhenotypicFeature	coronary heart disease	D003327
964	15241482	169	172	DiseaseOrPhenotypicFeature	CHD	D003327
965	15241482	201	206	DiseaseOrPhenotypicFeature	death	D003643
966	15241482	255	260	SequenceVariant	55M/L	p|SUB|M|55|L
967	15241482	265	271	SequenceVariant	192Q/R	p|SUB|Q|192|R
968	15241482	297	304	SequenceVariant	-107C/T	c|SUB|C|-107|T
969	15241482	369	372	DiseaseOrPhenotypicFeature	CHD	D003327
970	15241482	843	848	SequenceVariant	192RR	p|Allele|R|192
971	15241482	1148	1153	OrganismTaxon	women	9606
972	15241482	1183	1205	DiseaseOrPhenotypicFeature	ischemic heart disease	D017202
973	15241482	1236	1239	GeneOrGeneProduct	PON	5444
974	15241482	1240	1246	SequenceVariant	192Q/R	p|SUB|Q|192|R
975	15241482	1281	1284	DiseaseOrPhenotypicFeature	CHD	D003327
976	15241482	1326	1331	SequenceVariant	192RR	p|Allele|R|192
977	15241482	1348	1353	OrganismTaxon	women	9606
978	15241482	1407	1411	GeneOrGeneProduct	PON1	5444
979	15241482	1412	1417	SequenceVariant	192RR	p|Allele|R|192
980	15241482	1473	1478	OrganismTaxon	women	9606
981	15241482	1563	1566	DiseaseOrPhenotypicFeature	CHD	D003327
982	15241482	1595	1598	DiseaseOrPhenotypicFeature	CHD	D003327
983	15241482	1644	1647	DiseaseOrPhenotypicFeature	CHD	D003327
984	15266215	15	31	GeneOrGeneProduct	cyclooxygenase-2	5743
985	15266215	51	61	ChemicalEntity	valdecoxib	C406224
986	15266215	69	105	ChemicalEntity	nonsteroidal antiinflammatory agents	D000894
987	15266215	136	146	DiseaseOrPhenotypicFeature	thrombotic	D013927
988	15266215	157	165	OrganismTaxon	patients	9606
989	15266215	171	180	DiseaseOrPhenotypicFeature	arthritis	D001168
990	15266215	239	249	DiseaseOrPhenotypicFeature	thrombotic	D013927
991	15266215	276	298	GeneOrGeneProduct	cyclooxygenase (COX)-2	5743
992	15266215	337	372	ChemicalEntity	nonsteroidal antiinflammatory drugs	D000894
993	15266215	374	380	ChemicalEntity	NSAIDs	D000894
994	15266215	426	436	ChemicalEntity	valdecoxib	C406224
995	15266215	444	449	GeneOrGeneProduct	COX-2	5743
996	15266215	491	499	OrganismTaxon	patients	9606
997	15266215	505	519	DiseaseOrPhenotypicFeature	osteoarthritis	D010003
998	15266215	524	544	DiseaseOrPhenotypicFeature	rheumatoid arthritis	D001172
999	15266215	632	642	DiseaseOrPhenotypicFeature	thrombotic	D013927
1000	15266215	713	723	DiseaseOrPhenotypicFeature	thrombotic	D013927
1001	15266215	760	770	ChemicalEntity	valdecoxib	C406224
1002	15266215	802	807	ChemicalEntity	NSAID	D000894
1003	15266215	809	819	ChemicalEntity	diclofenac	D004008
1004	15266215	831	840	ChemicalEntity	ibuprofen	D007052
1005	15266215	856	864	ChemicalEntity	naproxen	D009288
1006	15266215	913	927	DiseaseOrPhenotypicFeature	osteoarthritis	D010003
1007	15266215	932	952	DiseaseOrPhenotypicFeature	rheumatoid arthritis	D001172
1008	15266215	1047	1055	OrganismTaxon	patients	9606
1009	15266215	1113	1120	ChemicalEntity	aspirin	D001241
1010	15266215	1148	1155	ChemicalEntity	aspirin	D001241
1011	15266215	1210	1220	DiseaseOrPhenotypicFeature	thrombotic	D013927
1012	15266215	1245	1255	ChemicalEntity	valdecoxib	C406224
1013	15266215	1257	1263	ChemicalEntity	NSAIDs	D000894
1014	15266215	1298	1308	DiseaseOrPhenotypicFeature	thrombotic	D013927
1015	15266215	1342	1352	ChemicalEntity	valdecoxib	C406224
1016	15266215	1359	1369	DiseaseOrPhenotypicFeature	Thrombotic	D013927
1017	15266215	1412	1419	ChemicalEntity	aspirin	D001241
1018	15266215	1443	1450	ChemicalEntity	aspirin	D001241
1019	15266215	1474	1484	ChemicalEntity	valdecoxib	C406224
1020	15266215	1501	1507	ChemicalEntity	NSAIDs	D000894
1021	15266215	1557	1564	ChemicalEntity	aspirin	D001241
1022	15266215	1616	1626	ChemicalEntity	valdecoxib	C406224
1023	15266215	1751	1761	ChemicalEntity	valdecoxib	C406224
1024	15266215	1818	1828	DiseaseOrPhenotypicFeature	thrombotic	D013927
1025	15266215	1861	1867	ChemicalEntity	NSAIDs	D000894
1026	15266215	1882	1896	DiseaseOrPhenotypicFeature	osteoarthritis	D010003
1027	15266215	1901	1921	DiseaseOrPhenotypicFeature	rheumatoid arthritis	D001172
1028	15266215	1922	1930	OrganismTaxon	patients	9606
1029	15459183	0	4	GeneOrGeneProduct	CD72	971
1030	15459183	81	86	OrganismTaxon	human	9606
1031	15459183	87	115	DiseaseOrPhenotypicFeature	systemic lupus erythematosus	D008180
1032	15459183	151	157	GeneOrGeneProduct	FCGR2B	2213
1033	15459183	197	203	GeneOrGeneProduct	FCGR2B	2213
1034	15459183	204	213	SequenceVariant	Ile232Thr	rs1050501
1035	15459183	219	247	DiseaseOrPhenotypicFeature	systemic lupus erythematosus	D008180
1036	15459183	249	252	DiseaseOrPhenotypicFeature	SLE	D008180
1037	15459183	306	310	GeneOrGeneProduct	CD72	12517
1038	15459183	372	378	OrganismTaxon	murine	10090
1039	15459183	379	382	DiseaseOrPhenotypicFeature	SLE	D008180
1040	15459183	398	403	OrganismTaxon	human	9606
1041	15459183	404	408	GeneOrGeneProduct	CD72	971
1042	15459183	454	457	DiseaseOrPhenotypicFeature	SLE	D008180
1043	15459183	496	502	GeneOrGeneProduct	FCGR2B	2213
1044	15459183	524	527	DiseaseOrPhenotypicFeature	SLE	D008180
1045	15459183	554	557	DiseaseOrPhenotypicFeature	SLE	D008180
1046	15459183	612	615	DiseaseOrPhenotypicFeature	SLE	D008180
1047	15459183	877	880	DiseaseOrPhenotypicFeature	SLE	D008180
1048	15459183	947	956	DiseaseOrPhenotypicFeature	nephritis	D009393
1049	15459183	976	984	OrganismTaxon	patients	9606
1050	15459183	1103	1108	CellLine	COS-7	9606
1051	15459183	1341	1347	GeneOrGeneProduct	FCGR2B	2213
1052	15459183	1348	1354	SequenceVariant	232Thr	rs1050501
1053	15459183	1364	1367	DiseaseOrPhenotypicFeature	SLE	D008180
1054	15459183	1405	1409	GeneOrGeneProduct	CD72	971
1055	15459183	1468	1474	GeneOrGeneProduct	FCGR2B	2213
1056	15459183	1475	1481	SequenceVariant	232Ile	rs1050501
1057	15459183	1491	1495	GeneOrGeneProduct	CD72	971
1058	15459183	1844	1848	GeneOrGeneProduct	CD72	12517
1059	15459183	1875	1881	OrganismTaxon	murine	10090
1060	15459183	1882	1885	DiseaseOrPhenotypicFeature	SLE	D008180
1061	15459183	1932	1936	GeneOrGeneProduct	CD72	971
1062	15459183	1966	1971	OrganismTaxon	human	9606
1063	15459183	1972	1975	DiseaseOrPhenotypicFeature	SLE	D008180
1064	15459183	1989	1995	GeneOrGeneProduct	FCGR2B	2213
1065	15459183	1996	2002	SequenceVariant	232Thr	rs1050501
1066	15459183	2045	2049	GeneOrGeneProduct	CD72	971
1067	15459975	52	56	GeneOrGeneProduct	SSH1	54434
1068	15459975	60	106	DiseaseOrPhenotypicFeature	disseminated superficial actinic porokeratosis	D017499
1069	15459975	108	154	DiseaseOrPhenotypicFeature	Disseminated superficial actinic porokeratosis	D017499
1070	15459975	156	160	DiseaseOrPhenotypicFeature	DSAP	D017499
1071	15459975	204	227	DiseaseOrPhenotypicFeature	keratinization disorder	D007642
1072	15459975	267	284	DiseaseOrPhenotypicFeature	keratotic lesions	D007642
1073	15459975	367	371	DiseaseOrPhenotypicFeature	DSAP	D017499
1074	15459975	734	744	SequenceVariant	p.Ser63Asn	p|SUB|S|63|N
1075	15459975	748	752	GeneOrGeneProduct	SSH1	54434
1076	15459975	791	806	SequenceVariant	p.Ser19CysfsX24	p|FS|S|19|C|24
1077	15459975	848	852	GeneOrGeneProduct	SSH1	54434
1078	15459975	899	914	SequenceVariant	p.Pro27ProfsX54	p|FS|P|63|P|54
1079	15459975	977	981	DiseaseOrPhenotypicFeature	DSAP	D017499
1080	15459975	983	987	GeneOrGeneProduct	SSH1	54434
1081	15459975	1173	1177	DiseaseOrPhenotypicFeature	DSAP	D017499
1082	15461822	86	105	OrganismTaxon	dengue virus type 2	11060
1083	15461822	121	140	OrganismTaxon	dengue virus type 2	11060
1084	15461822	142	147	OrganismTaxon	DEN-2	11060
1085	15461822	262	267	OrganismTaxon	DEN-2	11060
1086	15461822	332	354	SequenceVariant	30 nucleotide deletion	c|DEL||30
1087	15461822	356	363	SequenceVariant	Delta30	c|DEL||30
1088	15461822	398	403	OrganismTaxon	DEN-4	11070
1089	15461822	433	438	OrganismTaxon	DEN-2	11060
1090	15461822	505	510	OrganismTaxon	DEN-2	11060
1091	15461822	549	554	OrganismTaxon	DEN-2	11060
1092	15461822	556	562	OrganismTaxon	rDEN-2	11060
1093	15461822	568	573	OrganismTaxon	rDEN2	11060
1094	15461822	573	580	SequenceVariant	Delta30	c|DEL||30
1095	15461822	629	633	OrganismTaxon	mice	10090
1096	15461822	652	657	OrganismTaxon	human	9606
1097	15461822	658	666	DiseaseOrPhenotypicFeature	hepatoma	D006528
1098	15461822	674	684	CellLine	SCID-HuH-7	9606
1099	15461822	685	689	OrganismTaxon	mice	10090
1100	15461822	714	728	OrganismTaxon	rhesus monkeys	9544
1101	15461822	808	822	OrganismTaxon	rhesus monkeys	9544
1102	15461822	837	842	OrganismTaxon	rDEN2	11060
1103	15461822	842	849	SequenceVariant	Delta30	c|DEL||30
1104	15461822	895	905	CellLine	SCID-HuH-7	9606
1105	15461822	906	910	OrganismTaxon	mice	10090
1106	15461822	950	956	OrganismTaxon	rDEN-2	11060
1107	15461822	989	1005	OrganismTaxon	Aedes mosquitoes	1245352
1108	15461822	1033	1057	OrganismTaxon	Toxorynchites mosquitoes	2498889
1109	15461822	1062	1076	OrganismTaxon	rhesus monkeys	9544
1110	15461822	1078	1083	OrganismTaxon	rDEN2	11060
1111	15461822	1083	1090	SequenceVariant	Delta30	c|DEL||30
1112	15461822	1196	1203	DiseaseOrPhenotypicFeature	viremia	D014766
1113	15461822	1257	1262	OrganismTaxon	rDEN2	11060
1114	15461822	1262	1269	SequenceVariant	Delta30	c|DEL||30
1115	15461822	1282	1287	OrganismTaxon	rDEN2	11060
1116	15461822	1287	1299	SequenceVariant	Delta30-4995	c|DEL|4995|30
1117	15461822	1381	1384	GeneOrGeneProduct	NS3	5130010
1118	15461822	1393	1398	OrganismTaxon	DEN-4	11070
1119	15461822	1440	1445	OrganismTaxon	rDEN2	11060
1120	15461822	1445	1452	SequenceVariant	Delta30	c|DEL||30
1121	15461822	1456	1466	CellLine	SCID-HuH-7	9606
1122	15461822	1467	1471	OrganismTaxon	mice	10090
1123	15461822	1490	1495	OrganismTaxon	rDEN2	11060
1124	15461822	1495	1502	SequenceVariant	Delta30	c|DEL||30
1125	15461822	1507	1512	OrganismTaxon	rDEN2	11060
1126	15461822	1512	1524	SequenceVariant	Delta30-4995	c|DEL|4995|30
1127	15461822	1569	1575	OrganismTaxon	humans	9606
1128	15461822	1611	1617	DiseaseOrPhenotypicFeature	dengue	D003715
1129	15464247	13	28	GeneOrGeneProduct	interleukin 12B	3593
1130	15464247	30	35	GeneOrGeneProduct	IL12B	3593
1131	15464247	102	129	DiseaseOrPhenotypicFeature	hepatitis C virus infection	D006526
1132	15464247	148	162	GeneOrGeneProduct	Interleukin-12	3593
1133	15464247	164	169	GeneOrGeneProduct	IL-12	3593
1134	15464247	271	284	DiseaseOrPhenotypicFeature	HCV-infection	D006526
1135	15464247	314	319	GeneOrGeneProduct	IL12B	3593
1136	15464247	362	385	SequenceVariant	4 bp insertion/deletion	c|INDEL||4
1137	15464247	403	411	SequenceVariant	1188-A/C	c|SUB|A|1188|C
1138	15464247	452	457	GeneOrGeneProduct	IL-12	3593
1139	15464247	504	517	DiseaseOrPhenotypicFeature	HCV infection	D006526
1140	15464247	573	576	OrganismTaxon	HCV	11103
1141	15464247	604	616	DiseaseOrPhenotypicFeature	HCV infected	D006526
1142	15464247	617	625	OrganismTaxon	patients	9606
1143	15464247	653	658	GeneOrGeneProduct	IL12B	3593
1144	15464247	748	763	ChemicalEntity	oligonucleotide	D009841
1145	15464247	861	866	GeneOrGeneProduct	IL12B	3593
1146	15464247	966	989	DiseaseOrPhenotypicFeature	HCV genotype 1-infected	D006526
1147	15464247	990	998	OrganismTaxon	patients	9606
1148	15464247	1018	1025	DiseaseOrPhenotypicFeature	viremia	D014766
1149	15464247	1039	1044	GeneOrGeneProduct	IL12B	3593
1150	15464247	1052	1058	SequenceVariant	1188-C	c|Allele|C|1188
1151	15464247	1273	1278	GeneOrGeneProduct	IL12B	3593
1152	15464247	1286	1292	SequenceVariant	1188-C	c|Allele|C|1188
1153	15464247	1456	1461	GeneOrGeneProduct	IL12B	3593
1154	15464247	1493	1506	DiseaseOrPhenotypicFeature	HCV infection	D006526
1155	15485686	8	13	GeneOrGeneProduct	SCN5A	6331
1156	15485686	56	72	DiseaseOrPhenotypicFeature	long QT syndrome	D008133
1157	15485686	97	108	DiseaseOrPhenotypicFeature	tachycardia	D013610
1158	15485686	109	120	DiseaseOrPhenotypicFeature	bradycardia	D001919
1159	15485686	144	160	DiseaseOrPhenotypicFeature	long QT syndrome	D008133
1160	15485686	162	166	DiseaseOrPhenotypicFeature	LQTS	D008133
1161	15485686	292	299	OrganismTaxon	patient	9606
1162	15485686	311	322	DiseaseOrPhenotypicFeature	bradycardia	D001919
1163	15485686	328	350	DiseaseOrPhenotypicFeature	atrioventricular block	D054537
1164	15485686	355	378	DiseaseOrPhenotypicFeature	ventricular tachycardia	D017180
1165	15485686	482	504	DiseaseOrPhenotypicFeature	atrioventricular block	D054537
1166	15485686	555	564	ChemicalEntity	lidocaine	D008012
1167	15485686	592	602	ChemicalEntity	mexiletine	D008801
1168	15485686	630	653	DiseaseOrPhenotypicFeature	ventricular tachycardia	D017180
1169	15485686	685	689	DiseaseOrPhenotypicFeature	LQTS	D008133
1170	15485686	767	775	GeneOrGeneProduct	Na(v)1.5	6331
1171	15485686	784	790	ChemicalEntity	sodium	D012964
1172	15485686	807	839	SequenceVariant	G-->A substitution at codon 1763	c|SUB|G|CODON1763|A
1173	15485686	857	891	SequenceVariant	valine (GTG) to a methionine (ATG)	p|SUB|V||M
1174	15485686	1018	1024	CellLine	tsA201	9606
1175	15485686	1092	1104	ChemicalEntity	tetrodotoxin	D013779
1176	15485686	1119	1128	ChemicalEntity	lidocaine	D008012
1177	15485686	1366	1372	SequenceVariant	V1764M	p|SUB|V|1764|M
1178	15485686	1408	1414	SequenceVariant	I1762A	p|SUB|I|1762|A
1179	15485686	1557	1565	GeneOrGeneProduct	Na(v)1.5	6331
1180	15485686	1566	1572	SequenceVariant	V1763M	p|SUB|V|1763|M
1181	15485686	1731	1735	DiseaseOrPhenotypicFeature	LQTS	D008133
1182	15485686	1760	1771	DiseaseOrPhenotypicFeature	arrhythmias	D001145
1183	15485686	1790	1799	ChemicalEntity	lidocaine	D008012
1184	15485686	1804	1814	ChemicalEntity	mexiletine	D008801
1185	15523499	27	51	GeneOrGeneProduct	beta adrenergic receptor	153,154,155
1186	15523499	102	127	GeneOrGeneProduct	beta-adrenergic receptors	153,154,155
1187	15523499	129	136	GeneOrGeneProduct	beta-AR	153,154,155
1188	15523499	183	194	ChemicalEntity	epinephrine	D004837
1189	15523499	199	213	ChemicalEntity	norepinephrine	D009638
1190	15523499	296	303	GeneOrGeneProduct	beta-AR	153,154,155
1191	15523499	311	316	GeneOrGeneProduct	ADRB1	153
1192	15523499	318	323	GeneOrGeneProduct	ADRB2	154
1193	15523499	328	333	GeneOrGeneProduct	ADRB3	155
1194	15523499	428	466	DiseaseOrPhenotypicFeature	cardiovascular and metabolic disorders	D002318,D008659
1195	15523499	584	589	GeneOrGeneProduct	ADRB1	153
1196	15523499	590	599	SequenceVariant	Arg389Gly	p|SUB|R|389|G
1197	15523499	604	612	SequenceVariant	Gly49Ser	p|SUB|G|49|S
1198	15523499	614	619	GeneOrGeneProduct	ADRB2	154
1199	15523499	620	628	SequenceVariant	Arg16Gly	p|SUB|R|16|G
1200	15523499	633	641	SequenceVariant	Gln27Glu	p|SUB|Q|27|E
1201	15523499	647	652	GeneOrGeneProduct	ADRB3	155
1202	15523499	653	661	SequenceVariant	Arg64Trp	p|SUB|R|64|W
1203	15523499	788	795	GeneOrGeneProduct	beta-AR	153,154,155
1204	15523499	1479	1486	GeneOrGeneProduct	beta-AR	153,154,155
1205	15523499	1557	1564	GeneOrGeneProduct	beta-AR	153,154,155
1206	15579441	0	7	DiseaseOrPhenotypicFeature	Hypoxia	D000860
1207	15579441	11	24	DiseaseOrPhenotypicFeature	renal disease	D007674
1208	15579441	30	41	DiseaseOrPhenotypicFeature	proteinuria	D011507
1209	15579441	60	72	DiseaseOrPhenotypicFeature	hypertension	D006973
1210	15579441	247	254	DiseaseOrPhenotypicFeature	hypoxia	D000860
1211	15579441	290	297	DiseaseOrPhenotypicFeature	hypoxia	D000860
1212	15579441	327	361	GeneOrGeneProduct	vascular endothelial growth factor	83785
1213	15579441	404	411	DiseaseOrPhenotypicFeature	hypoxia	D000860
1214	15579441	431	434	OrganismTaxon	rat	10116
1215	15579441	509	516	DiseaseOrPhenotypicFeature	hypoxia	D000860
1216	15579441	524	539	DiseaseOrPhenotypicFeature	diseased kidney	D007674
1217	15579441	600	607	DiseaseOrPhenotypicFeature	hypoxia	D000860
1218	15579441	615	640	ChemicalEntity	puromycin aminonucleoside	D011692
1219	15579441	649	667	DiseaseOrPhenotypicFeature	nephrotic syndrome	D009404
1220	15579441	692	699	DiseaseOrPhenotypicFeature	hypoxia	D000860
1221	15579441	747	754	DiseaseOrPhenotypicFeature	hypoxia	D000860
1222	15579441	857	882	ChemicalEntity	puromycin aminonucleoside	D011692
1223	15579441	958	992	GeneOrGeneProduct	vascular endothelial growth factor	83785
1224	15579441	1079	1086	DiseaseOrPhenotypicFeature	hypoxia	D000860
1225	15579441	1134	1159	DiseaseOrPhenotypicFeature	tubulointerstitial injury	D007674
1226	15579441	1264	1268	GeneOrGeneProduct	ED-1	302424
1227	15579441	1292	1296	ChemicalEntity	dUTP	C027078
1228	15579441	1336	1343	DiseaseOrPhenotypicFeature	hypoxic	D000860
1229	15579441	1466	1473	DiseaseOrPhenotypicFeature	hypoxia	D000860
1230	15579441	1490	1509	DiseaseOrPhenotypicFeature	glomerular diseases	D007674
1231	15583840	0	5	DiseaseOrPhenotypicFeature	Tumor	D009369
1232	15583840	60	68	OrganismTaxon	patients	9606
1233	15583840	74	87	DiseaseOrPhenotypicFeature	breast cancer	D001943
1234	15583840	89	102	DiseaseOrPhenotypicFeature	Breast cancer	D001943
1235	15583840	142	149	DiseaseOrPhenotypicFeature	cancers	D009369
1236	15583840	187	192	DiseaseOrPhenotypicFeature	tumor	D009369
1237	15583840	355	368	DiseaseOrPhenotypicFeature	breast cancer	D001943
1238	15583840	450	463	DiseaseOrPhenotypicFeature	breast cancer	D001943
1239	15583840	464	472	OrganismTaxon	patients	9606
1240	15583840	709	722	DiseaseOrPhenotypicFeature	breast cancer	D001943
1241	15583840	723	731	OrganismTaxon	patients	9606
1242	15583840	736	748	DiseaseOrPhenotypicFeature	colon cancer	D015179
1243	15583840	749	757	OrganismTaxon	patients	9606
1244	15583840	1286	1298	DiseaseOrPhenotypicFeature	colon cancer	D015179
1245	15583840	1299	1307	OrganismTaxon	patients	9606
1246	15583840	1486	1491	DiseaseOrPhenotypicFeature	tumor	D009369
1247	15583840	1515	1520	OrganismTaxon	human	9606
1248	15583840	1521	1534	DiseaseOrPhenotypicFeature	breast cancer	D001943
1249	15599941	21	46	GeneOrGeneProduct	prostate specific antigen	354
1250	15599941	74	91	GeneOrGeneProduct	androgen receptor	367
1251	15599941	117	132	DiseaseOrPhenotypicFeature	prostate cancer	D011471
1252	15599941	198	223	GeneOrGeneProduct	prostate specific antigen	354
1253	15599941	225	228	GeneOrGeneProduct	PSA	354
1254	15599941	243	258	DiseaseOrPhenotypicFeature	prostate cancer	D011471
1255	15599941	260	262	DiseaseOrPhenotypicFeature	PC	D011471
1256	15599941	274	277	GeneOrGeneProduct	PSA	354
1257	15599941	294	297	SequenceVariant	G/A	c|SUB|G||A
1258	15599941	318	326	ChemicalEntity	androgen	D000728
1259	15599941	364	381	GeneOrGeneProduct	androgen receptor	367
1260	15599941	383	385	GeneOrGeneProduct	AR	367
1261	15599941	518	520	DiseaseOrPhenotypicFeature	PC	D011471
1262	15599941	541	543	DiseaseOrPhenotypicFeature	PC	D011471
1263	15599941	555	558	GeneOrGeneProduct	PSA	354
1264	15599941	608	610	GeneOrGeneProduct	AR	367
1265	15599941	666	668	DiseaseOrPhenotypicFeature	PC	D011471
1266	15599941	669	677	OrganismTaxon	patients	9606
1267	15599941	710	737	DiseaseOrPhenotypicFeature	benign prostate hyperplasia	D011470
1268	15599941	826	829	GeneOrGeneProduct	PSA	354
1269	15599941	895	900	GeneOrGeneProduct	Nhe 1	6548
1270	15599941	935	938	SequenceVariant	G/A	c|SUB|G||A
1271	15599941	948	950	GeneOrGeneProduct	AR	367
1272	15599941	951	969	SequenceVariant	CAG and GGC repeat	c|DUP||CAG_GGC|
1273	15599941	1076	1079	GeneOrGeneProduct	PSA	354
1274	15599941	1099	1101	DiseaseOrPhenotypicFeature	PC	D011471
1275	15599941	1120	1148	DiseaseOrPhenotypicFeature	benign prostatic hyperplasia	D011470
1276	15599941	1150	1153	DiseaseOrPhenotypicFeature	BPH	D011470
1277	15599941	1276	1279	OrganismTaxon	men	9606
1278	15599941	1329	1332	GeneOrGeneProduct	PSA	354
1279	15599941	1368	1378	SequenceVariant	CAG repeat	c|DUP||CAG|
1280	15599941	1415	1418	DiseaseOrPhenotypicFeature	BPH	D011470
1281	15599941	1552	1555	GeneOrGeneProduct	PSA	354
1282	15599941	1601	1603	DiseaseOrPhenotypicFeature	PC	D011471
1283	15599941	1629	1632	OrganismTaxon	men	9606
1284	15599941	1685	1701	SequenceVariant	glutamine repeat	c|DUP||G|
1285	15599941	1770	1787	DiseaseOrPhenotypicFeature	malignant disease	D009369
1286	15602202	16	38	DiseaseOrPhenotypicFeature	interstitial nephritis	D009395
1287	15602202	50	62	ChemicalEntity	azithromycin	D017963
1288	15602202	111	123	ChemicalEntity	azithromycin	D017963
1289	15602202	139	161	DiseaseOrPhenotypicFeature	interstitial nephritis	D009395
1290	15602202	260	274	ChemicalEntity	corticosteroid	D000305
1291	15602202	341	351	ChemicalEntity	antibiotic	D000900
1292	15602202	366	388	DiseaseOrPhenotypicFeature	interstitial nephritis	D009395
1293	15602202	423	431	OrganismTaxon	patients	9606
1294	15602202	458	470	DiseaseOrPhenotypicFeature	renal injury	D007674
1295	15609295	69	77	SequenceVariant	Asn45Ser	rs5030764
1296	15609295	103	118	GeneOrGeneProduct	glycoprotein IX	2815
1297	15609295	129	136	OrganismTaxon	patient	9606
1298	15609295	142	166	DiseaseOrPhenotypicFeature	Bernard-Soulier syndrome	D001606
1299	15609295	168	192	DiseaseOrPhenotypicFeature	Bernard-Soulier syndrome	D001606
1300	15609295	194	197	DiseaseOrPhenotypicFeature	BSS	D001606
1301	15609295	209	236	DiseaseOrPhenotypicFeature	inherited bleeding disorder	D025861
1302	15609295	302	327	GeneOrGeneProduct	glycoprotein (GP) Ib/IX/V	2811,2814,2815
1303	15609295	347	368	GeneOrGeneProduct	von Willebrand factor	7450
1304	15609295	524	527	GeneOrGeneProduct	GPV	2814
1305	15609295	543	546	DiseaseOrPhenotypicFeature	BSS	D001606
1306	15609295	615	618	DiseaseOrPhenotypicFeature	BSS	D001606
1307	15609295	652	659	OrganismTaxon	patient	9606
1308	15609295	730	743	GeneOrGeneProduct	glycoproteins	2811,2814,2815
1309	15609295	751	760	GeneOrGeneProduct	GPIb/IX/V	2811,2814,2815
1310	15609295	805	812	OrganismTaxon	patient	9606
1311	15609295	868	872	GeneOrGeneProduct	GPIX	2815
1312	15609295	887	937	SequenceVariant	nine-nucleotide deletion starting at position 1952	c|DEL|1952|9
1313	15609295	955	1065	SequenceVariant	changes asparagine 86 for alanine and eliminates amino acids 87, 88, and 89 (arginine, threonine, and proline)	p|SUB|NRTP|86_89|A
1314	15609295	1130	1177	SequenceVariant	asparagine (AAC) for serine (AGC) at residue 45	rs5030764
1315	15609295	1215	1223	SequenceVariant	Asn45Ser	rs5030764
1316	15609295	1356	1360	GeneOrGeneProduct	GPIX	2815
1317	15609295	1390	1393	DiseaseOrPhenotypicFeature	BSS	D001606
1318	15609295	1411	1418	OrganismTaxon	patient	9606
1319	15630069	0	7	ChemicalEntity	Glucose	D005947
1320	15630069	36	49	DiseaseOrPhenotypicFeature	schizophrenia	D012559
1321	15630069	72	92	ChemicalEntity	antipsychotic agents	D014150
1322	15630069	127	134	ChemicalEntity	glucose	D005947
1323	15630069	223	240	DiseaseOrPhenotypicFeature	diabetes mellitus	D003920
1324	15630069	276	289	DiseaseOrPhenotypicFeature	schizophrenia	D012559
1325	15630069	320	340	ChemicalEntity	antipsychotic agents	D014150
1326	15630069	408	415	ChemicalEntity	glucose	D005947
1327	15630069	471	479	DiseaseOrPhenotypicFeature	diabetes	D003920
1328	15630069	538	547	ChemicalEntity	clozapine	D003024
1329	15630069	552	562	ChemicalEntity	olanzapine	C076029
1330	15630069	568	579	ChemicalEntity	risperidone	D018967
1331	15630069	619	626	ChemicalEntity	glucose	D005947
1332	15630069	709	722	DiseaseOrPhenotypicFeature	schizophrenia	D012559
1333	15630069	772	779	ChemicalEntity	glucose	D005947
1334	15630069	1069	1076	ChemicalEntity	glucose	D005947
1335	15630069	1127	1140	DiseaseOrPhenotypicFeature	schizophrenia	D012559
1336	15630069	1144	1168	DiseaseOrPhenotypicFeature	schizoaffective disorder	D011618
1337	15630069	1221	1230	ChemicalEntity	clozapine	D003024
1338	15630069	1232	1242	ChemicalEntity	olanzapine	C076029
1339	15630069	1247	1258	ChemicalEntity	risperidone	D018967
1340	15630069	1329	1336	ChemicalEntity	glucose	D005947
1341	15630069	1355	1362	ChemicalEntity	insulin	D007328
1342	15630069	1430	1448	DiseaseOrPhenotypicFeature	insulin resistance	D007333
1343	15630069	1454	1461	ChemicalEntity	glucose	D005947
1344	15630069	1553	1572	ChemicalEntity	antipsychotic agent	D014150
1345	15630069	1599	1608	ChemicalEntity	clozapine	D003024
1346	15630069	1633	1643	ChemicalEntity	olanzapine	C076029
1347	15630069	1665	1676	ChemicalEntity	risperidone	D018967
1348	15630069	1693	1700	ChemicalEntity	insulin	D007328
1349	15630069	1764	1773	ChemicalEntity	clozapine	D003024
1350	15630069	1774	1784	ChemicalEntity	olanzapine	C076029
1351	15630069	1785	1796	ChemicalEntity	risperidone	D018967
1352	15630069	1835	1844	ChemicalEntity	clozapine	D003024
1353	15630069	1849	1860	ChemicalEntity	risperidone	D018967
1354	15630069	1889	1899	ChemicalEntity	olanzapine	C076029
1355	15630069	1904	1915	ChemicalEntity	risperidone	D018967
1356	15630069	2043	2052	ChemicalEntity	clozapine	D003024
1357	15630069	2053	2063	ChemicalEntity	olanzapine	C076029
1358	15630069	2064	2075	ChemicalEntity	risperidone	D018967
1359	15630069	2105	2114	ChemicalEntity	clozapine	D003024
1360	15630069	2119	2129	ChemicalEntity	olanzapine	C076029
1361	15630069	2153	2171	DiseaseOrPhenotypicFeature	insulin resistance	D007333
1362	15630069	2217	2228	ChemicalEntity	risperidone	D018967
1363	15630069	2230	2239	ChemicalEntity	clozapine	D003024
1364	15630069	2243	2254	ChemicalEntity	risperidone	D018967
1365	15630069	2279	2289	ChemicalEntity	olanzapine	C076029
1366	15630069	2293	2304	ChemicalEntity	risperidone	D018967
1367	15630069	2377	2395	DiseaseOrPhenotypicFeature	insulin resistance	D007333
1368	15630069	2462	2471	ChemicalEntity	clozapine	D003024
1369	15630069	2472	2482	ChemicalEntity	olanzapine	C076029
1370	15630069	2483	2494	ChemicalEntity	risperidone	D018967
1371	15630069	2497	2506	ChemicalEntity	clozapine	D003024
1372	15630069	2510	2521	ChemicalEntity	risperidone	D018967
1373	15630069	2547	2557	ChemicalEntity	olanzapine	C076029
1374	15630069	2561	2572	ChemicalEntity	risperidone	D018967
1375	15630069	2649	2656	ChemicalEntity	glucose	D005947
1376	15630069	2696	2705	ChemicalEntity	clozapine	D003024
1377	15630069	2706	2716	ChemicalEntity	olanzapine	C076029
1378	15630069	2717	2728	ChemicalEntity	risperidone	D018967
1379	15630069	2767	2776	ChemicalEntity	clozapine	D003024
1380	15630069	2781	2792	ChemicalEntity	risperidone	D018967
1381	15630069	2822	2832	ChemicalEntity	olanzapine	C076029
1382	15630069	2837	2848	ChemicalEntity	risperidone	D018967
1383	15630069	2902	2911	ChemicalEntity	clozapine	D003024
1384	15630069	2917	2927	ChemicalEntity	olanzapine	C076029
1385	15630069	2965	2983	DiseaseOrPhenotypicFeature	insulin resistance	D007333
1386	15630069	3002	3009	ChemicalEntity	glucose	D005947
1387	15630069	3038	3049	ChemicalEntity	risperidone	D018967
1388	15630069	3084	3093	ChemicalEntity	clozapine	D003024
1389	15630069	3098	3108	ChemicalEntity	olanzapine	C076029
1390	15630069	3130	3148	DiseaseOrPhenotypicFeature	insulin resistance	D007333
1391	15649253	0	39	DiseaseOrPhenotypicFeature	Primary malignant lymphoma of the brain	D016543
1392	15649253	84	87	GeneOrGeneProduct	p14	11102
1393	15649253	88	93	DiseaseOrPhenotypicFeature	tumor	D009369
1394	15649253	115	155	DiseaseOrPhenotypicFeature	primary central nervous system lymphomas	D016543
1395	15649253	157	162	DiseaseOrPhenotypicFeature	PCNSL	D016543
1396	15649253	164	179	DiseaseOrPhenotypicFeature	brain lymphomas	D016543
1397	15649253	199	202	GeneOrGeneProduct	p14	11102
1398	15649253	723	726	GeneOrGeneProduct	p14	11102
1399	15649253	924	930	DiseaseOrPhenotypicFeature	tumors	D009369
1400	15649253	965	969	SequenceVariant	L50R	p|SUB|L|50|R
1401	15649253	1050	1053	GeneOrGeneProduct	p14	11102
1402	15649253	1147	1150	GeneOrGeneProduct	p14	11102
1403	15649253	1263	1280	DiseaseOrPhenotypicFeature	systemic lymphoma	D008223
1404	15649253	1290	1293	GeneOrGeneProduct	p14	11102
1405	15649253	1374	1388	DiseaseOrPhenotypicFeature	carcinogenesis	D063646
1406	15649253	1397	1402	DiseaseOrPhenotypicFeature	PCNSL	D016543
1407	15649253	1407	1424	DiseaseOrPhenotypicFeature	systemic lymphoma	D008223
1408	15668505	7	12	GeneOrGeneProduct	BRCA2	675
1409	15668505	42	67	DiseaseOrPhenotypicFeature	breast and ovarian cancer	D001943,D010051
1410	15668505	76	81	GeneOrGeneProduct	BRCA1	672
1411	15668505	177	182	SequenceVariant	N372H	rs144848
1412	15668505	190	195	GeneOrGeneProduct	BRCA2	675
1413	15668505	280	305	DiseaseOrPhenotypicFeature	breast and ovarian cancer	D001943,D010051
1414	15668505	343	349	DiseaseOrPhenotypicFeature	cancer	D009369
1415	15668505	381	386	SequenceVariant	N372H	rs144848
1416	15668505	453	461	SequenceVariant	203G > A	g|SUB|G|203|A
1417	15668505	470	475	GeneOrGeneProduct	BRCA2	675
1418	15668505	488	512	DiseaseOrPhenotypicFeature	breast or ovarian cancer	D001943,D010051
1419	15668505	521	526	GeneOrGeneProduct	BRCA1	672
1420	15668505	569	574	OrganismTaxon	women	9606
1421	15668505	586	591	GeneOrGeneProduct	BRCA1	672
1422	15668505	646	651	GeneOrGeneProduct	BRCA2	675
1423	15668505	875	888	DiseaseOrPhenotypicFeature	breast cancer	D001943
1424	15668505	903	908	GeneOrGeneProduct	BRCA1	672
1425	15668505	965	979	DiseaseOrPhenotypicFeature	ovarian cancer	D010051
1426	15668505	1017	1022	SequenceVariant	N372H	rs144848
1427	15668505	1107	1111	SequenceVariant	203A	g|Allele|A|203
1428	15668505	1322	1327	SequenceVariant	N372H	rs144848
1429	15668505	1351	1356	GeneOrGeneProduct	BRCA1	672
1430	15668505	1447	1453	DiseaseOrPhenotypicFeature	cancer	D009369
1431	15668505	1457	1462	GeneOrGeneProduct	BRCA1	672
1432	15668505	1538	1543	SequenceVariant	N372H	rs144848
1433	15673851	25	55	GeneOrGeneProduct	N-methyl-D-aspartate receptors	24408
1434	15673851	132	140	ChemicalEntity	morphine	D009020
1435	15673851	174	194	DiseaseOrPhenotypicFeature	spinal cord ischemia	D020760
1436	15673851	296	333	GeneOrGeneProduct	N-methyl-d-aspartate (NMDA) receptors	24408
1437	15673851	350	358	ChemicalEntity	morphine	D009020
1438	15673851	396	412	DiseaseOrPhenotypicFeature	aortic occlusion	D001157
1439	15673851	416	420	OrganismTaxon	rats	10116
1440	15673851	422	442	DiseaseOrPhenotypicFeature	Spinal cord ischemia	D020760
1441	15673851	458	474	DiseaseOrPhenotypicFeature	aortic occlusion	D001157
1442	15673851	583	591	ChemicalEntity	morphine	D009020
1443	15673851	675	683	ChemicalEntity	morphine	D009020
1444	15673851	962	968	ChemicalEntity	MK-801	D016291
1445	15673851	1034	1042	ChemicalEntity	morphine	D009020
1446	15673851	1051	1070	DiseaseOrPhenotypicFeature	spastic paraparesis	D020336
1447	15673851	1081	1089	ChemicalEntity	morphine	D009020
1448	15673851	1121	1130	ChemicalEntity	glutamate	D018698
1449	15673851	1258	1264	ChemicalEntity	MK-801	D016291
1450	15673851	1338	1346	ChemicalEntity	morphine	D009020
1451	15673851	1355	1374	DiseaseOrPhenotypicFeature	spastic paraparesis	D020336
1452	15673851	1435	1443	ChemicalEntity	morphine	D009020
1453	15673851	1452	1471	DiseaseOrPhenotypicFeature	spastic paraparesis	D020336
1454	15673851	1507	1516	ChemicalEntity	glutamate	D018698
1455	15673851	1539	1552	GeneOrGeneProduct	NMDA receptor	24408
1456	15673851	1581	1588	ChemicalEntity	opioids	D000701
1457	15673851	1596	1606	DiseaseOrPhenotypicFeature	neurotoxic	D020258
1458	15673851	1625	1645	DiseaseOrPhenotypicFeature	spinal cord ischemia	D020760
1459	15673851	1650	1663	GeneOrGeneProduct	NMDA receptor	24408
1460	15686794	6	19	DiseaseOrPhenotypicFeature	low back pain	D017116
1461	15686794	57	67	ChemicalEntity	amiodarone	D000638
1462	15686794	92	102	ChemicalEntity	Amiodarone	D000638
1463	15686794	127	146	ChemicalEntity	antiarrhythmic drug	D000889
1464	15686794	181	200	DiseaseOrPhenotypicFeature	atrial fibrillation	D001281
1465	15686794	202	204	DiseaseOrPhenotypicFeature	AF	D001281
1466	15686794	263	271	OrganismTaxon	patients	9606
1467	15686794	300	319	DiseaseOrPhenotypicFeature	atrial fibrillation	D001281
1468	15686794	358	371	DiseaseOrPhenotypicFeature	low back pain	D017116
1469	15686794	418	428	ChemicalEntity	amiodarone	D000638
1470	15748645	185	190	OrganismTaxon	human	9606
1471	15748645	253	284	DiseaseOrPhenotypicFeature	basal and squamous cell cancers	D002294,D018295
1472	15748645	286	294	DiseaseOrPhenotypicFeature	melanoma	D008545
1473	15748645	296	305	DiseaseOrPhenotypicFeature	cataracts	D002386
1474	15748645	410	421	DiseaseOrPhenotypicFeature	skin cancer	D012878
1475	15748645	633	644	DiseaseOrPhenotypicFeature	skin cancer	D012878
1476	15748645	665	676	DiseaseOrPhenotypicFeature	skin cancer	D012878
1477	15748645	945	959	DiseaseOrPhenotypicFeature	carcinogenesis	D009369
1478	15748645	1116	1121	DiseaseOrPhenotypicFeature	Tumor	D009369
1479	15748645	1160	1166	DiseaseOrPhenotypicFeature	cancer	D009369
1480	15748645	1345	1350	DiseaseOrPhenotypicFeature	Tumor	D009369
1481	15748645	1480	1485	DiseaseOrPhenotypicFeature	tumor	D009369
1482	15748645	1511	1522	DiseaseOrPhenotypicFeature	skin cancer	D012878
1483	15748645	1603	1615	DiseaseOrPhenotypicFeature	inflammation	D007249
1484	15748645	1636	1657	DiseaseOrPhenotypicFeature	epidermal hyperplasia	D006965
1485	15748645	1698	1709	ChemicalEntity	antioxidant	D000975
1486	15748645	1777	1791	GeneOrGeneProduct	cyclooxygenase	5742
1487	15748645	1805	1818	ChemicalEntity	prostaglandin	D011453
1488	15748645	1847	1870	GeneOrGeneProduct	ornithine decarboxylase	4953
1489	15748645	1963	1974	DiseaseOrPhenotypicFeature	skin cancer	D012878
1490	15748645	2036	2048	ChemicalEntity	antioxidants	D000975
1491	15748645	2103	2108	OrganismTaxon	human	9606
1492	15748645	2190	2195	OrganismTaxon	human	9606
1493	15748645	2784	2795	DiseaseOrPhenotypicFeature	skin cancer	D012878
1494	15748645	2799	2805	OrganismTaxon	humans	9606
1495	15749661	21	26	SequenceVariant	L490R	rs80338886
1496	15749661	31	36	SequenceVariant	V561X	rs80338887
1497	15749661	45	67	GeneOrGeneProduct	transferrin receptor 2	7036
1498	15749661	85	93	OrganismTaxon	patients	9606
1499	15749661	99	114	DiseaseOrPhenotypicFeature	hemochromatosis	D006432
1500	15749661	169	174	SequenceVariant	C282Y	rs1800562
1501	15749661	191	194	GeneOrGeneProduct	HFE	3077
1502	15749661	246	261	DiseaseOrPhenotypicFeature	hemochromatosis	D006432
1503	15749661	274	282	OrganismTaxon	patients	9606
1504	15749661	339	347	OrganismTaxon	patients	9606
1505	15749661	371	392	SequenceVariant	AVAQ 594-597 deletion	p|DEL|594_597|AVAQ
1506	15749661	400	420	GeneOrGeneProduct	transferrin receptor	7036
1507	15749661	422	426	GeneOrGeneProduct	TfR2	7036
1508	15749661	457	461	GeneOrGeneProduct	TfR2	7036
1509	15749661	482	497	DiseaseOrPhenotypicFeature	hemochromatosis	D006432
1510	15749661	510	518	OrganismTaxon	patients	9606
1511	15749661	545	553	OrganismTaxon	patients	9606
1512	15749661	580	595	DiseaseOrPhenotypicFeature	hemochromatosis	D006432
1513	15749661	704	707	GeneOrGeneProduct	HFE	3077
1514	15749661	712	716	GeneOrGeneProduct	TfR2	7036
1515	15749661	829	832	GeneOrGeneProduct	HFE	3077
1516	15749661	846	850	GeneOrGeneProduct	TfR2	7036
1517	15749661	876	884	SequenceVariant	1469T->G	rs80338886
1518	15749661	886	891	SequenceVariant	L490R	rs80338886
1519	15749661	897	905	SequenceVariant	1665delC	rs80338887
1520	15749661	907	912	SequenceVariant	V561X	rs80338887
1521	15749661	931	939	OrganismTaxon	patients	9606
1522	15749661	960	964	SequenceVariant	714C	rs34242818
1523	15749661	968	973	SequenceVariant	I238M	rs34242818
1524	15749661	998	1005	OrganismTaxon	patient	9606
1525	15749661	1011	1016	SequenceVariant	L490R	rs80338886
1526	15749661	1022	1029	OrganismTaxon	patient	9606
1527	15749661	1050	1055	SequenceVariant	L490R	rs80338886
1528	15749661	1060	1065	SequenceVariant	I238M	rs34242818
1529	15749661	1105	1120	DiseaseOrPhenotypicFeature	hemochromatosis	D006432
1530	15749661	1159	1168	DiseaseOrPhenotypicFeature	cirrhotic	D008103
1531	15749661	1186	1190	ChemicalEntity	iron	D007501
1532	15749661	1220	1227	ChemicalEntity	glucose	D005947
1533	15749661	1263	1280	DiseaseOrPhenotypicFeature	diabetes mellitus	D003920
1534	15749661	1286	1293	OrganismTaxon	patient	9606
1535	15749661	1309	1314	SequenceVariant	V561X	rs80338887
1536	15749661	1326	1339	DiseaseOrPhenotypicFeature	iron overload	D019190
1537	15749661	1358	1367	DiseaseOrPhenotypicFeature	cirrhosis	D008103
1538	15749661	1369	1386	DiseaseOrPhenotypicFeature	diabetes mellitus	D003920
1539	15749661	1391	1408	DiseaseOrPhenotypicFeature	skin pigmentation	D010859
1540	15749661	1518	1526	OrganismTaxon	patients	9606
1541	15749661	1532	1547	DiseaseOrPhenotypicFeature	hemochromatosis	D006432
1542	15749661	1595	1599	GeneOrGeneProduct	TfR2	7036
1543	15749661	1612	1616	GeneOrGeneProduct	TfR2	7036
1544	15749661	1653	1668	DiseaseOrPhenotypicFeature	hemochromatosis	D006432
1545	15754732	14	18	GeneOrGeneProduct	MEN1	4221
1546	15754732	48	75	DiseaseOrPhenotypicFeature	primary hyperparathyroidism	D049950
1547	15754732	123	150	DiseaseOrPhenotypicFeature	Primary hyperparathyroidism	D049950
1548	15754732	152	156	DiseaseOrPhenotypicFeature	pHPT	D049950
1549	15754732	170	187	DiseaseOrPhenotypicFeature	endocrine disease	D004700
1550	15754732	267	286	DiseaseOrPhenotypicFeature	inherited disorders	D030342
1551	15754732	311	339	DiseaseOrPhenotypicFeature	multiple endocrine neoplasia	D009377
1552	15754732	341	351	DiseaseOrPhenotypicFeature	MEN1 and 2	D018761,D018813
1553	15754732	375	379	GeneOrGeneProduct	MEN1	4221
1554	15754732	422	440	DiseaseOrPhenotypicFeature	parathyroid tumors	D010282
1555	15754732	499	503	GeneOrGeneProduct	MEN1	4221
1556	15754732	527	535	OrganismTaxon	patients	9606
1557	15754732	575	579	DiseaseOrPhenotypicFeature	pHPT	D049950
1558	15754732	589	623	DiseaseOrPhenotypicFeature	parathyroid adenoma or hyperplasia	D010282
1559	15754732	634	643	DiseaseOrPhenotypicFeature	carcinoma	D002277
1560	15754732	724	732	ChemicalEntity	paraffin	D010232
1561	15754732	807	811	GeneOrGeneProduct	MEN1	4221
1562	15754732	826	830	GeneOrGeneProduct	MEN1	4221
1563	15754732	870	878	OrganismTaxon	patients	9606
1564	15754732	886	911	DiseaseOrPhenotypicFeature	benign parathyroid lesion	D010279
1565	15754732	971	981	DiseaseOrPhenotypicFeature	carcinomas	D002277
1566	15754732	994	998	GeneOrGeneProduct	MEN1	4221
1567	15754732	1067	1074	SequenceVariant	222insT	c|INS|222|T
1568	15754732	1110	1118	SequenceVariant	912delTA	c|DEL|912|TA
1569	15754732	1152	1160	SequenceVariant	835del18	c|DEL|835|18
1570	15754732	1197	1202	SequenceVariant	P291A	p|SUB|P|291|A
1571	15754732	1249	1253	SequenceVariant	L89R	p|SUB|L|89|R
1572	15754732	1290	1295	SequenceVariant	Q536X	p|SUB|Q|536|X
1573	15754732	1398	1403	SequenceVariant	R171Q	rs607969
1574	15754732	1423	1429	DiseaseOrPhenotypicFeature	tumors	D009369
1575	15754732	1440	1445	SequenceVariant	D418D	rs2071313
1576	15754732	1460	1467	SequenceVariant	GAC/GAT	rs2071313
1577	15754732	1491	1497	DiseaseOrPhenotypicFeature	tumors	D009369
1578	15754732	1719	1723	GeneOrGeneProduct	MEN1	4221
1579	15754732	1724	1729	DiseaseOrPhenotypicFeature	tumor	D009369
1580	15754732	1784	1802	DiseaseOrPhenotypicFeature	parathyroid tumors	D010282
1581	15755837	7	30	GeneOrGeneProduct	dihydrofolate reductase	1719
1582	15755837	31	52	SequenceVariant	19-base pair deletion	c|DEL||19
1583	15755837	85	101	DiseaseOrPhenotypicFeature	preterm delivery	D047928
1584	15755837	115	121	ChemicalEntity	Folate	D005492
1585	15755837	194	217	GeneOrGeneProduct	Dihydrofolate reductase	1719
1586	15755837	219	223	GeneOrGeneProduct	DHFR	1719
1587	15755837	252	262	ChemicalEntity	folic acid	D005492
1588	15755837	318	331	ChemicalEntity	dihydrofolate	C010920
1589	15755837	344	364	GeneOrGeneProduct	thymidylate synthase	7298
1590	15755837	401	407	ChemicalEntity	folate	D005492
1591	15755837	532	536	GeneOrGeneProduct	DHFR	1719
1592	15755837	563	579	DiseaseOrPhenotypicFeature	preterm delivery	D047928
1593	15755837	633	638	OrganismTaxon	women	9606
1594	15755837	656	662	ChemicalEntity	Folate	D005492
1595	15755837	688	694	ChemicalEntity	folate	D005492
1596	15755837	824	829	OrganismTaxon	women	9606
1597	15755837	867	872	OrganismTaxon	Women	9606
1598	15755837	932	948	DiseaseOrPhenotypicFeature	preterm delivery	D047928
1599	15755837	1052	1057	OrganismTaxon	Women	9606
1600	15755837	1070	1074	GeneOrGeneProduct	DHFR	1719
1601	15755837	1099	1105	ChemicalEntity	folate	D005492
1602	15755837	1192	1208	DiseaseOrPhenotypicFeature	preterm delivery	D047928
1603	15755837	1375	1380	OrganismTaxon	women	9606
1604	15755837	1418	1424	ChemicalEntity	folate	D005492
1605	15755837	1466	1470	GeneOrGeneProduct	DHFR	1719
1606	15755837	1471	1492	SequenceVariant	19-base pair deletion	c|DEL||19
1607	15755837	1525	1541	DiseaseOrPhenotypicFeature	preterm delivery	D047928
1608	15755837	1574	1580	ChemicalEntity	folate	D005492
1609	15770495	58	66	OrganismTaxon	patients	9606
1610	15770495	72	114	DiseaseOrPhenotypicFeature	steroid 5alpha-reductase deficiency type 2	C535830
1611	15770495	133	164	GeneOrGeneProduct	steroid 5alpha-reductase type 2	6716
1612	15770495	166	172	GeneOrGeneProduct	SRD5A2	6716
1613	15770495	339	345	GeneOrGeneProduct	SRD5A2	6716
1614	15770495	473	481	OrganismTaxon	patients	9606
1615	15770495	497	539	DiseaseOrPhenotypicFeature	steroid 5alpha-reductase type 2 deficiency	C535830
1616	15770495	594	600	GeneOrGeneProduct	SRD5A2	6716
1617	15770495	672	680	OrganismTaxon	patients	9606
1618	15770495	686	691	SequenceVariant	G183S	rs121434247
1619	15770495	702	707	SequenceVariant	R246W	rs121434244
1620	15770495	718	725	SequenceVariant	del642T	c|DEL|642|T
1621	15770495	736	741	SequenceVariant	G196S	rs121434250
1622	15770495	756	767	SequenceVariant	217_218insC	c|INS|217_218|C
1623	15770495	777	781	SequenceVariant	A49T	rs9282858
1624	15770495	860	865	SequenceVariant	Q126R	rs368386747
1625	15770495	866	875	SequenceVariant	IVS3+1G>A	c|SUB|G|IVS3+1|A
1626	15770495	886	891	SequenceVariant	Q126R	rs368386747
1627	15770495	892	899	SequenceVariant	del418T	c|DEL|418|T
1628	15770495	923	928	SequenceVariant	Q126R	rs368386747
1629	15770495	929	934	SequenceVariant	G158R	p|SUB|G|158|R
1630	15770495	943	951	OrganismTaxon	patients	9606
1631	15770495	974	979	SequenceVariant	A207D	rs767564684
1632	15770495	981	986	SequenceVariant	G196S	rs121434250
1633	15770495	992	997	SequenceVariant	R266W	p|SUB|R|266|W
1634	15770495	1017	1021	SequenceVariant	V89L	rs523349
1635	15770495	1083	1088	SequenceVariant	A207D	rs767564684
1636	15770495	1150	1154	SequenceVariant	A49T	rs9282858
1637	15770495	1262	1270	OrganismTaxon	patients	9606
1638	15770495	1296	1302	GeneOrGeneProduct	SRD5A2	6716
1639	15770495	1349	1356	SequenceVariant	del642T	c|DEL|642|T
1640	15770495	1361	1366	SequenceVariant	G158R	p|SUB|G|158|R
1641	15770495	1420	1429	SequenceVariant	IVS3+1G>A	c|SUB|G|IVS3+1|A
1642	15770495	1465	1476	SequenceVariant	217_218insC	c|INS|217_218|C
1643	15770495	1593	1599	GeneOrGeneProduct	SRD5A2	6716
1644	15770495	1687	1692	SequenceVariant	G183S	rs121434247
1645	15770495	1742	1750	OrganismTaxon	patients	9606
1646	15807692	29	41	GeneOrGeneProduct	VII collagen	1294
1647	15807692	77	119	DiseaseOrPhenotypicFeature	recessive dystrophic epidermolysis bullosa	D016108
1648	15807692	267	279	GeneOrGeneProduct	VII collagen	1294
1649	15807692	296	338	DiseaseOrPhenotypicFeature	recessive dystrophic epidermolysis bullosa	D016108
1650	15807692	340	357	DiseaseOrPhenotypicFeature	Hallopeau-Siemens	D016108
1651	15807692	367	374	DiseaseOrPhenotypicFeature	HS-RDEB	D016108
1652	15807692	404	454	SequenceVariant	single base pair deletion of a cytosine nucleotide	c|DEL||C
1653	15807692	478	486	SequenceVariant	3472delC	c|DEL|3472|C
1654	15807692	648	653	SequenceVariant	G-->A	c|SUB|G||A
1655	15807692	730	744	SequenceVariant	IVS51 + 1G-->A	c|SUB|G|IVS51+1|A
1656	15807692	1129	1136	DiseaseOrPhenotypicFeature	HS-RDEB	D016108
1657	15811908	0	16	DiseaseOrPhenotypicFeature	Pheochromocytoma	D010673
1658	15811908	29	40	ChemicalEntity	amisulpride	D000077582
1659	15811908	45	53	ChemicalEntity	tiapride	D063325
1660	15811908	95	111	DiseaseOrPhenotypicFeature	pheochromocytoma	D010673
1661	15811908	117	124	OrganismTaxon	patient	9606
1662	15811908	138	149	ChemicalEntity	amisulpride	D000077582
1663	15811908	154	162	ChemicalEntity	tiapride	D063325
1664	15811908	198	201	OrganismTaxon	man	9606
1665	15811908	218	230	DiseaseOrPhenotypicFeature	hypertension	D006973
1666	15811908	243	251	DiseaseOrPhenotypicFeature	headache	D006261
1667	15811908	256	264	DiseaseOrPhenotypicFeature	vomiting	D014839
1668	15811908	298	309	ChemicalEntity	amisulpride	D000077582
1669	15811908	321	329	ChemicalEntity	tiapride	D063325
1670	15811908	388	395	OrganismTaxon	patient	9606
1671	15811908	423	434	ChemicalEntity	nicardipine	D009529
1672	15811908	439	448	ChemicalEntity	verapamil	D014700
1673	15811908	573	589	DiseaseOrPhenotypicFeature	pheochromocytoma	D010673
1674	15811908	628	644	DiseaseOrPhenotypicFeature	pheochromocytoma	D010673
1675	15811908	694	709	ChemicalEntity	benzamide drugs	D001549
1676	15811908	848	860	DiseaseOrPhenotypicFeature	hypertensive	D006973
1677	15811908	872	883	ChemicalEntity	amisulpride	D000077582
1678	15811908	888	896	ChemicalEntity	tiapride	D063325
1679	15811908	976	987	ChemicalEntity	amisulpride	D000077582
1680	15811908	993	1001	ChemicalEntity	tiapride	D063325
1681	15811908	1010	1022	DiseaseOrPhenotypicFeature	hypertensive	D006973
1682	15811908	1035	1042	OrganismTaxon	patient	9606
1683	15811908	1048	1064	DiseaseOrPhenotypicFeature	pheochromocytoma	D010673
1684	15811908	1164	1172	ChemicalEntity	tiapride	D063325
1685	15811908	1177	1188	ChemicalEntity	amisulpride	D000077582
1686	15814629	14	35	DiseaseOrPhenotypicFeature	lymph node metastases	D009362
1687	15814629	39	53	DiseaseOrPhenotypicFeature	gastric cancer	D013274
1688	15814629	74	105	GeneOrGeneProduct	angiotensin I-converting enzyme	1636
1689	15814629	229	260	GeneOrGeneProduct	angiotensin I-converting enzyme	1636
1690	15814629	262	265	GeneOrGeneProduct	ACE	1636
1691	15814629	270	284	DiseaseOrPhenotypicFeature	gastric cancer	D013274
1692	15814629	352	366	DiseaseOrPhenotypicFeature	gastric cancer	D013274
1693	15814629	497	500	GeneOrGeneProduct	ACE	1636
1694	15814629	534	541	ChemicalEntity	agarose	D012685
1695	15814629	658	661	GeneOrGeneProduct	ACE	1636
1696	15814629	738	752	DiseaseOrPhenotypicFeature	gastric cancer	D013274
1697	15814629	753	761	OrganismTaxon	patients	9606
1698	15814629	845	848	GeneOrGeneProduct	ACE	1636
1699	15814629	918	926	OrganismTaxon	patients	9606
1700	15814629	935	949	DiseaseOrPhenotypicFeature	gastric cancer	D013274
1701	15814629	964	967	GeneOrGeneProduct	ACE	1636
1702	15814629	1008	1029	DiseaseOrPhenotypicFeature	lymph node metastases	D009362
1703	15814629	1080	1085	DiseaseOrPhenotypicFeature	tumor	D009369
1704	15814629	1093	1101	OrganismTaxon	Patients	9606
1705	15814629	1168	1189	DiseaseOrPhenotypicFeature	lymph node metastases	D009362
1706	15814629	1233	1238	DiseaseOrPhenotypicFeature	tumor	D009369
1707	15814629	1261	1269	OrganismTaxon	patients	9606
1708	15814629	1325	1330	DiseaseOrPhenotypicFeature	tumor	D009369
1709	15814629	1337	1342	DiseaseOrPhenotypicFeature	tumor	D009369
1710	15814629	1359	1364	DiseaseOrPhenotypicFeature	tumor	D009369
1711	15814629	1381	1391	DiseaseOrPhenotypicFeature	metastases	D009362
1712	15814629	1401	1404	GeneOrGeneProduct	ACE	1636
1713	15814629	1433	1436	GeneOrGeneProduct	ACE	1636
1714	15814629	1440	1454	DiseaseOrPhenotypicFeature	gastric cancer	D013274
1715	15814629	1510	1518	OrganismTaxon	patients	9606
1716	15814629	1520	1523	GeneOrGeneProduct	ACE	1636
1717	15814629	1590	1595	DiseaseOrPhenotypicFeature	tumor	D009369
1718	15814629	1659	1662	GeneOrGeneProduct	ACE	1636
1719	15814629	1687	1701	DiseaseOrPhenotypicFeature	gastric cancer	D013274
1720	15817013	23	42	DiseaseOrPhenotypicFeature	atrial fibrillation	D001281
1721	15817013	46	54	ChemicalEntity	warfarin	D014859
1722	15817013	74	84	DiseaseOrPhenotypicFeature	hemorrhage	D006470
1723	15817013	89	95	DiseaseOrPhenotypicFeature	stroke	D020521
1724	15817013	113	120	OrganismTaxon	patient	9606
1725	15817013	189	199	DiseaseOrPhenotypicFeature	hemorrhage	D006470
1726	15817013	204	210	DiseaseOrPhenotypicFeature	stroke	D020521
1727	15817013	244	263	DiseaseOrPhenotypicFeature	atrial fibrillation	D001281
1728	15817013	281	289	ChemicalEntity	warfarin	D014859
1729	15817013	500	508	OrganismTaxon	patients	9606
1730	15817013	612	631	DiseaseOrPhenotypicFeature	atrial fibrillation	D001281
1731	15817013	635	643	ChemicalEntity	warfarin	D014859
1732	15817013	701	709	DiseaseOrPhenotypicFeature	bleeding	D006470
1733	15817013	720	727	DiseaseOrPhenotypicFeature	strokes	D020521
1734	15817013	733	741	ChemicalEntity	warfarin	D014859
1735	15817013	764	772	OrganismTaxon	patients	9606
1736	15817013	860	868	OrganismTaxon	patients	9606
1737	15817013	874	877	OrganismTaxon	men	9606
1738	15817013	967	975	ChemicalEntity	warfarin	D014859
1739	15817013	1028	1039	DiseaseOrPhenotypicFeature	hemorrhages	D006470
1740	15817013	1130	1136	DiseaseOrPhenotypicFeature	bleeds	D006470
1741	15817013	1149	1155	DiseaseOrPhenotypicFeature	stroke	D020521
1742	15817013	1181	1189	ChemicalEntity	warfarin	D014859
1743	15817013	1230	1240	DiseaseOrPhenotypicFeature	hemorrhage	D006470
1744	15817013	1345	1351	DiseaseOrPhenotypicFeature	stroke	D020521
1745	15817013	1360	1368	ChemicalEntity	warfarin	D014859
1746	15817013	1406	1414	ChemicalEntity	warfarin	D014859
1747	15820770	0	25	GeneOrGeneProduct	Vitamin D-binding protein	2638
1748	15820770	61	65	GeneOrGeneProduct	IA-2	5798
1749	15820770	84	99	DiseaseOrPhenotypicFeature	type 1 diabetes	D003922
1750	15820770	113	138	GeneOrGeneProduct	Vitamin D-binding protein	2638
1751	15820770	140	143	GeneOrGeneProduct	DBP	2638
1752	15820770	181	192	ChemicalEntity	1.25(OH)2D3	D002117
1753	15820770	292	295	GeneOrGeneProduct	DBP	2638
1754	15820770	335	410	SequenceVariant	GAT-->GAG substitution replaces aspartic acid by glutamic acid in codon 416	p|SUB|D|416|E
1755	15820770	416	451	SequenceVariant	ACG-->AAG substitution in codon 420	p|SUB|T|420|K
1756	15820770	476	496	SequenceVariant	threonine for lysine	p|SUB|T||K
1757	15820770	504	507	GeneOrGeneProduct	DBP	2638
1758	15820770	557	568	ChemicalEntity	1.25(OH)2D3	D002117
1759	15820770	591	594	GeneOrGeneProduct	DBP	2638
1760	15820770	607	622	DiseaseOrPhenotypicFeature	type 1 diabetes	D003922
1761	15820770	733	736	GeneOrGeneProduct	DBP	2638
1762	15820770	788	803	DiseaseOrPhenotypicFeature	type 1 diabetes	D003922
1763	15820770	876	884	OrganismTaxon	patients	9606
1764	15820770	953	956	GeneOrGeneProduct	DBP	2638
1765	15820770	998	1001	GeneOrGeneProduct	DBP	2638
1766	15820770	1173	1181	DiseaseOrPhenotypicFeature	diabetic	D003920
1767	15820770	1207	1211	GeneOrGeneProduct	IA-2	5798
1768	15820770	1256	1259	GeneOrGeneProduct	DBP	2638
1769	15820770	1340	1345	GeneOrGeneProduct	GAD65	2572
1770	15820770	1395	1404	ChemicalEntity	vitamin D	D014807
1771	15820770	1451	1466	DiseaseOrPhenotypicFeature	type 1 diabetes	D003922
1772	15858223	0	13	ChemicalEntity	Valproic acid	D014635
1773	15858223	32	37	ChemicalEntity	lipid	D008055
1774	15858223	63	77	DiseaseOrPhenotypicFeature	liver toxicity	D056486
1775	15858223	83	96	ChemicalEntity	valproic acid	D014635
1776	15858223	118	122	OrganismTaxon	rats	10116
1777	15858223	141	154	ChemicalEntity	valproic acid	D014635
1778	15858223	156	159	ChemicalEntity	VPA	D014635
1779	15858223	185	203	ChemicalEntity	antiepileptic drug	D000927
1780	15858223	244	248	OrganismTaxon	rats	10116
1781	15858223	297	317	ChemicalEntity	15-F(2t)-isoprostane	C075750
1782	15858223	319	332	ChemicalEntity	15-F(2t)-IsoP	C075750
1783	15858223	398	401	ChemicalEntity	VPA	D014635
1784	15858223	434	448	DiseaseOrPhenotypicFeature	hepatotoxicity	D056486
1785	15858223	476	480	OrganismTaxon	rats	10116
1786	15858223	502	505	ChemicalEntity	VPA	D014635
1787	15858223	655	668	ChemicalEntity	15-F(2t)-IsoP	C075750
1788	15858223	670	690	ChemicalEntity	lipid hydroperoxides	D008054
1789	15858223	692	695	ChemicalEntity	LPO	D008054
1790	15858223	702	741	ChemicalEntity	thiobarbituric acid reactive substances	D017392
1791	15858223	743	748	ChemicalEntity	TBARs	D017392
1792	15858223	768	781	ChemicalEntity	15-F(2t)-IsoP	C075750
1793	15858223	833	836	ChemicalEntity	VPA	D014635
1794	15858223	874	877	ChemicalEntity	LPO	D008054
1795	15858223	982	987	ChemicalEntity	TBARs	D017392
1796	15858223	1053	1067	DiseaseOrPhenotypicFeature	Liver toxicity	D056486
1797	15858223	1107	1138	GeneOrGeneProduct	alpha-glutathione S-transferase	24421
1798	15858223	1140	1149	GeneOrGeneProduct	alpha-GST	24421
1799	15858223	1175	1184	GeneOrGeneProduct	alpha-GST	24421
1800	15858223	1252	1266	DiseaseOrPhenotypicFeature	hepatotoxicity	D056486
1801	15858223	1307	1340	DiseaseOrPhenotypicFeature	inflammation of the liver capsule	D006505
1802	15858223	1342	1350	DiseaseOrPhenotypicFeature	necrosis	D009336
1803	15858223	1356	1365	DiseaseOrPhenotypicFeature	steatosis	D005234
1804	15858223	1438	1441	ChemicalEntity	VPA	D014635
1805	15858223	1488	1497	ChemicalEntity	4-ene-VPA	C045022
1806	15858223	1506	1519	ChemicalEntity	2,4-diene-VPA	C556631
1807	15858223	1598	1601	ChemicalEntity	VPA	D014635
1808	15858223	1666	1679	ChemicalEntity	15-F(2t)-IsoP	C075750
1809	15858223	1709	1717	DiseaseOrPhenotypicFeature	necrosis	D009336
1810	15858223	1719	1728	DiseaseOrPhenotypicFeature	steatosis	D005234
1811	15858223	1759	1768	GeneOrGeneProduct	alpha-GST	24421
1812	15859361	10	19	ChemicalEntity	celecoxib	C105934
1813	15859361	45	59	DiseaseOrPhenotypicFeature	skin reactions	D003875
1814	15859361	63	76	ChemicalEntity	acetaminophen	D000082
1815	15859361	78	89	ChemicalEntity	paracetamol	D000082
1816	15859361	95	105	ChemicalEntity	nimesulide	C012655
1817	15859361	136	173	ChemicalEntity	non-steroidal anti-inflammatory drugs	D000894
1818	15859361	187	200	ChemicalEntity	Acetaminophen	D000082
1819	15859361	202	213	ChemicalEntity	paracetamol	D000082
1820	15859361	215	216	ChemicalEntity	P	D000082
1821	15859361	222	232	ChemicalEntity	Nimesulide	C012655
1822	15859361	234	235	ChemicalEntity	N	C012655
1823	15859361	263	274	ChemicalEntity	antipyretic	D058633
1824	15859361	275	298	ChemicalEntity	anti-inflammatory drugs	D000893
1825	15859361	320	336	DiseaseOrPhenotypicFeature	hypersensitivity	D004342
1826	15859361	397	434	ChemicalEntity	non-steroidal anti-inflammatory drugs	D000894
1827	15859361	436	442	ChemicalEntity	NSAIDs	D000894
1828	15859361	485	494	ChemicalEntity	Celecoxib	C105934
1829	15859361	496	498	ChemicalEntity	CE	C105934
1830	15859361	556	561	GeneOrGeneProduct	COX-2	4513
1831	15859361	614	616	ChemicalEntity	CE	C105934
1832	15859361	675	694	DiseaseOrPhenotypicFeature	cutaneous reactions	D003875
1833	15859361	698	699	ChemicalEntity	P	D000082
1834	15859361	704	705	ChemicalEntity	N	C012655
1835	15859361	735	741	ChemicalEntity	NSAIDs	D000894
1836	15859361	779	795	DiseaseOrPhenotypicFeature	hypersensitivity	D004342
1837	15859361	799	800	ChemicalEntity	P	D000082
1838	15859361	805	806	ChemicalEntity	N	C012655
1839	15859361	855	861	ChemicalEntity	NSAIDs	D000894
1840	15859361	880	881	ChemicalEntity	P	D000082
1841	15859361	886	887	ChemicalEntity	N	C012655
1842	15859361	896	910	DiseaseOrPhenotypicFeature	skin reactions	D003875
1843	15859361	1064	1066	ChemicalEntity	CE	C105934
1844	15859361	1363	1371	DiseaseOrPhenotypicFeature	erythema	D004890
1845	15859361	1381	1390	DiseaseOrPhenotypicFeature	urticaria	D014581
1846	15859361	1391	1401	DiseaseOrPhenotypicFeature	angioedema	D000799
1847	15859361	1487	1489	ChemicalEntity	CE	C105934
1848	15859361	1529	1539	DiseaseOrPhenotypicFeature	angioedema	D000799
1849	15859361	1574	1590	DiseaseOrPhenotypicFeature	hypersensitivity	D004342
1850	15859361	1603	1605	ChemicalEntity	CE	C105934
1851	15859361	1629	1630	ChemicalEntity	P	D000082
1852	15859361	1635	1636	ChemicalEntity	N	C012655
1853	15859361	1644	1650	ChemicalEntity	NSAIDs	D000894
1854	15859361	1695	1697	ChemicalEntity	CE	C105934
1855	15859361	1774	1775	ChemicalEntity	P	D000082
1856	15859361	1780	1781	ChemicalEntity	N	C012655
1857	15867855	24	53	GeneOrGeneProduct	T-cell immunoglobulin mucin 1	26762
1858	15867855	66	95	GeneOrGeneProduct	T-cell immunoglobulin mucin 3	84868
1859	15867855	121	127	DiseaseOrPhenotypicFeature	asthma	D001249
1860	15867855	179	206	GeneOrGeneProduct	T-cell immunoglobulin mucin	26762,84868
1861	15867855	209	212	GeneOrGeneProduct	TIM	26762,84868
1862	15867855	300	317	DiseaseOrPhenotypicFeature	allergic diseases	D004342
1863	15867855	379	384	GeneOrGeneProduct	TIM-1	26762
1864	15867855	389	394	GeneOrGeneProduct	TIM-3	84868
1865	15867855	406	412	DiseaseOrPhenotypicFeature	asthma	D001249
1866	15867855	672	683	GeneOrGeneProduct	TIM-1 and 3	26762,84868
1867	15867855	696	701	GeneOrGeneProduct	TIM-3	84868
1868	15867855	725	742	OrganismTaxon	hepatitis A virus	208726
1869	15867855	870	879	SequenceVariant	rs2277025	rs2277025
1870	15867855	917	929	SequenceVariant	157delMTTTVP	p|DEL|157|MTTTVP
1871	15867855	957	962	GeneOrGeneProduct	TIM-1	26762
1872	15867855	986	994	OrganismTaxon	patients	9606
1873	15867855	1000	1008	OrganismTaxon	patients	9606
1874	15867855	1014	1020	DiseaseOrPhenotypicFeature	asthma	D001249
1875	15867855	1301	1313	SequenceVariant	157delMTTTVP	p|DEL|157|MTTTVP
1876	15867855	1410	1427	OrganismTaxon	hepatitis A virus	208726
1877	15867855	1489	1494	GeneOrGeneProduct	TIM-3	84868
1878	15867855	1545	1551	DiseaseOrPhenotypicFeature	asthma	D001249
1879	15867855	1555	1561	DiseaseOrPhenotypicFeature	asthma	D001249
1880	15867855	1648	1653	GeneOrGeneProduct	TIM-1	26762
1881	15867855	1666	1671	GeneOrGeneProduct	TIM-3	84868
1882	15867855	1691	1697	DiseaseOrPhenotypicFeature	asthma	D001249
1883	15893386	0	15	ChemicalEntity	Succinylcholine	D013390
1884	15893386	24	48	DiseaseOrPhenotypicFeature	masseter muscle rigidity	D014313
1885	15893386	106	130	DiseaseOrPhenotypicFeature	Masseter muscle rigidity	D014313
1886	15893386	218	240	DiseaseOrPhenotypicFeature	malignant hyperthermia	D008305
1887	15893386	358	382	DiseaseOrPhenotypicFeature	masseter muscle rigidity	D014313
1888	15893386	419	443	DiseaseOrPhenotypicFeature	masseter muscle rigidity	D014313
1889	15893386	445	457	DiseaseOrPhenotypicFeature	jaw of steel	D014313
1890	15893386	465	480	ChemicalEntity	succinylcholine	D013390
1891	15893386	482	485	ChemicalEntity	Sch	D013390
1892	15893386	642	650	ChemicalEntity	propofol	D015742
1893	15893386	716	738	DiseaseOrPhenotypicFeature	malignant hyperthermia	D008305
1894	15897593	0	11	ChemicalEntity	Dexrazoxane	D064730
1895	15897593	29	45	DiseaseOrPhenotypicFeature	myelosuppression	D001855
1896	15897593	84	93	ChemicalEntity	etoposide	D005047
1897	15897593	98	110	ChemicalEntity	daunorubicin	D003630
1898	15897593	119	130	ChemicalEntity	doxorubicin	D004317
1899	15897593	145	159	ChemicalEntity	anthracyclines	D018943
1900	15897593	160	172	ChemicalEntity	daunorubicin	D003630
1901	15897593	177	188	ChemicalEntity	doxorubicin	D004317
1902	15897593	197	215	ChemicalEntity	epipodophyllotoxin	D011034
1903	15897593	216	225	ChemicalEntity	etoposide	D005047
1904	15897593	318	334	DiseaseOrPhenotypicFeature	myelosuppression	D001855
1905	15897593	339	355	DiseaseOrPhenotypicFeature	cardiac toxicity	D066126
1906	15897593	373	384	ChemicalEntity	Dexrazoxane	D064730
1907	15897593	386	394	ChemicalEntity	ICRF-187	D064730
1908	15897593	434	447	ChemicalEntity	anthracycline	D018943
1909	15897593	456	470	DiseaseOrPhenotypicFeature	cardiotoxicity	D066126
1910	15897593	530	550	DiseaseOrPhenotypicFeature	hematologic toxicity	D006402
1911	15897593	581	592	ChemicalEntity	dexrazoxane	D064730
1912	15897593	688	693	OrganismTaxon	human	9606
1913	15897593	698	704	OrganismTaxon	murine	10090
1914	15897593	731	740	ChemicalEntity	etoposide	D005047
1915	15897593	742	754	ChemicalEntity	daunorubicin	D003630
1916	15897593	760	771	ChemicalEntity	doxorubicin	D004317
1917	15897593	776	787	ChemicalEntity	dexrazoxane	D064730
1918	15897593	878	882	OrganismTaxon	mice	10090
1919	15897593	901	910	ChemicalEntity	etoposide	D005047
1920	15897593	912	924	ChemicalEntity	daunorubicin	D003630
1921	15897593	930	941	ChemicalEntity	doxorubicin	D004317
1922	15897593	959	970	ChemicalEntity	dexrazoxane	D064730
1923	15897593	1081	1092	ChemicalEntity	dexrazoxane	D064730
1924	15897593	1101	1117	DiseaseOrPhenotypicFeature	myelosuppression	D001855
1925	15897593	1122	1133	DiseaseOrPhenotypicFeature	weight loss	D015431
1926	15897593	1139	1151	ChemicalEntity	daunorubicin	D003630
1927	15897593	1156	1165	ChemicalEntity	etoposide	D005047
1928	15897593	1169	1173	OrganismTaxon	mice	10090
1929	15897593	1252	1263	ChemicalEntity	dexrazoxane	D064730
1930	15897593	1280	1296	DiseaseOrPhenotypicFeature	myelosuppression	D001855
1931	15897593	1298	1309	DiseaseOrPhenotypicFeature	weight loss	D015431
1932	15897593	1328	1340	DiseaseOrPhenotypicFeature	cytotoxicity	D064420
1933	15897593	1346	1357	ChemicalEntity	doxorubicin	D004317
1934	15897593	1422	1433	ChemicalEntity	dexrazoxane	D064730
1935	15897593	1499	1510	ChemicalEntity	doxorubicin	D004317
1936	15897593	1548	1560	ChemicalEntity	daunorubicin	D003630
1937	15897593	1718	1727	ChemicalEntity	etoposide	D005047
1938	15897593	1778	1789	ChemicalEntity	dexrazoxane	D064730
1939	15897593	1830	1840	DiseaseOrPhenotypicFeature	metastases	D009362
1940	15897593	1851	1862	ChemicalEntity	dexrazoxane	D064730
1941	15897593	1881	1890	ChemicalEntity	etoposide	D005047
1942	15897593	1957	1977	DiseaseOrPhenotypicFeature	hematologic toxicity	D006402
1943	15897593	2082	2091	DiseaseOrPhenotypicFeature	cytotoxic	D064420
1944	15951966	46	50	GeneOrGeneProduct	MSH2	4436
1945	15951966	55	59	GeneOrGeneProduct	MLH1	4292
1946	15951966	101	105	GeneOrGeneProduct	MSH2	4436
1947	15951966	110	114	GeneOrGeneProduct	MLH1	4292
1948	15951966	172	177	DiseaseOrPhenotypicFeature	HNPCC	D003123
1949	15951966	377	381	GeneOrGeneProduct	MLH1	4292
1950	15951966	386	390	GeneOrGeneProduct	MSH2	4436
1951	15951966	544	548	GeneOrGeneProduct	MLH1	4292
1952	15951966	565	569	GeneOrGeneProduct	MSH2	4436
1953	15951966	764	769	DiseaseOrPhenotypicFeature	HNPCC	D003123
1954	15951966	770	778	OrganismTaxon	patients	9606
1955	15951966	868	875	OrganismTaxon	patient	9606
1956	15951966	932	936	GeneOrGeneProduct	MSH2	4436
1957	15951966	1141	1145	GeneOrGeneProduct	MLH1	4292
1958	15951966	1150	1154	GeneOrGeneProduct	MSH2	4436
1959	15951966	1167	1172	DiseaseOrPhenotypicFeature	HNPCC	D003123
1960	15951966	1173	1181	OrganismTaxon	patients	9606
1961	15983230	21	27	GeneOrGeneProduct	SLC2A2	6514
1962	15983230	29	34	GeneOrGeneProduct	GLUT2	6514
1963	15983230	81	107	DiseaseOrPhenotypicFeature	impaired glucose tolerance	D018149
1964	15983230	111	126	DiseaseOrPhenotypicFeature	type 2 diabetes	D003924
1965	15983230	140	148	DiseaseOrPhenotypicFeature	Diabetes	D003920
1966	15983230	167	193	DiseaseOrPhenotypicFeature	Impaired insulin secretion	D003920
1967	15983230	221	236	DiseaseOrPhenotypicFeature	type 2 diabetes	D003924
1968	15983230	350	357	GeneOrGeneProduct	insulin	3630
1969	15983230	369	375	GeneOrGeneProduct	SLC2A2	6514
1970	15983230	386	391	GeneOrGeneProduct	GLUT2	6514
1971	15983230	394	397	GeneOrGeneProduct	GCK	2645
1972	15983230	399	403	GeneOrGeneProduct	TCF1	6927
1973	15983230	414	424	GeneOrGeneProduct	HNF-1alpha	6927
1974	15983230	427	432	GeneOrGeneProduct	HNF4A	3172
1975	15983230	434	437	GeneOrGeneProduct	GIP	2695
1976	15983230	443	448	GeneOrGeneProduct	GLP1R	2740
1977	15983230	490	516	DiseaseOrPhenotypicFeature	impaired glucose tolerance	D018149
1978	15983230	518	521	DiseaseOrPhenotypicFeature	IGT	D018149
1979	15983230	526	541	DiseaseOrPhenotypicFeature	type 2 diabetes	D003924
1980	15983230	573	581	DiseaseOrPhenotypicFeature	Diabetes	D003920
1981	15983230	622	628	GeneOrGeneProduct	SLC2A2	6514
1982	15983230	679	694	DiseaseOrPhenotypicFeature	type 2 diabetes	D003924
1983	15983230	713	719	GeneOrGeneProduct	SLC2A2	6514
1984	15983230	748	756	DiseaseOrPhenotypicFeature	diabetes	D003920
1985	15983230	762	768	SequenceVariant	rs5393	rs5393
1986	15983230	805	820	DiseaseOrPhenotypicFeature	type 2 diabetes	D003924
1987	15983230	926	941	DiseaseOrPhenotypicFeature	type 2 diabetes	D003924
1988	15983230	1100	1106	GeneOrGeneProduct	SLC2A2	6514
1989	15983230	1133	1141	DiseaseOrPhenotypicFeature	diabetes	D003920
1990	15983230	1145	1150	DiseaseOrPhenotypicFeature	obese	D009765
1991	15983230	1165	1168	DiseaseOrPhenotypicFeature	IGT	D018149
1992	15991002	0	8	ChemicalEntity	Nicotine	D009538
1993	15991002	21	29	ChemicalEntity	caffeine	D002110
1994	15991002	39	57	ChemicalEntity	pentylenetetrazole	D010433
1995	15991002	66	83	DiseaseOrPhenotypicFeature	anxiogenic effect	D001008
1996	15991002	87	91	OrganismTaxon	mice	10090
1997	15991002	104	112	ChemicalEntity	Nicotine	D009538
1998	15991002	117	125	ChemicalEntity	caffeine	D002110
1999	15991002	152	170	ChemicalEntity	psychoactive drugs	D011619
2000	15991002	409	416	DiseaseOrPhenotypicFeature	anxiety	D001008
2001	15991002	486	494	ChemicalEntity	nicotine	D009538
2002	15991002	498	505	DiseaseOrPhenotypicFeature	anxiety	D001008
2003	15991002	517	525	ChemicalEntity	caffeine	D002110
2004	15991002	538	553	ChemicalEntity	anxiogenic drug	D014151
2005	15991002	555	573	ChemicalEntity	pentylenetetrazole	D010433
2006	15991002	578	582	OrganismTaxon	mice	10090
2007	15991002	663	670	DiseaseOrPhenotypicFeature	anxiety	D001008
2008	15991002	706	710	OrganismTaxon	mice	10090
2009	15991002	732	740	ChemicalEntity	nicotine	D009538
2010	15991002	788	796	ChemicalEntity	caffeine	D002110
2011	15991002	816	834	ChemicalEntity	pentylenetetrazole	D010433
2012	15991002	884	888	OrganismTaxon	mice	10090
2013	15991002	1104	1112	ChemicalEntity	Nicotine	D009538
2014	15991002	1202	1210	ChemicalEntity	caffeine	D002110
2015	15991002	1226	1244	ChemicalEntity	pentylenetetrazole	D010433
2016	15991002	1268	1285	DiseaseOrPhenotypicFeature	anxiogenic effect	D001008
2017	15991002	1339	1347	ChemicalEntity	Nicotine	D009538
2018	15991002	1386	1394	ChemicalEntity	caffeine	D002110
2019	15991002	1404	1422	ChemicalEntity	pentylenetetrazole	D010433
2020	15991002	1431	1438	DiseaseOrPhenotypicFeature	anxiety	D001008
2021	15991002	1606	1614	ChemicalEntity	nicotine	D009538
2022	15991002	1618	1626	ChemicalEntity	caffeine	D002110
2023	15991002	1635	1642	DiseaseOrPhenotypicFeature	anxiety	D001008
2024	15991002	1658	1666	ChemicalEntity	caffeine	D002110
2025	15991002	1781	1789	ChemicalEntity	nicotine	D009538
2026	15991002	1794	1802	ChemicalEntity	caffeine	D002110
2027	16000134	24	34	ChemicalEntity	argatroban	C031942
2028	16000134	59	74	DiseaseOrPhenotypicFeature	vein thrombosis	D020246
2029	16000134	80	87	OrganismTaxon	patient	9606
2030	16000134	93	127	DiseaseOrPhenotypicFeature	congenital antithrombin deficiency	D020152
2031	16000134	143	148	OrganismTaxon	woman	9606
2032	16000134	167	208	DiseaseOrPhenotypicFeature	superior mesenteric vein (SMV) thrombosis	D020246
2033	16000134	270	282	GeneOrGeneProduct	antithrombin	462
2034	16000134	345	357	GeneOrGeneProduct	antithrombin	462
2035	16000134	477	485	GeneOrGeneProduct	thrombin	2147
2036	16000134	497	507	ChemicalEntity	argatroban	C031942
2037	16000134	527	539	GeneOrGeneProduct	antithrombin	462
2038	16000134	571	612	DiseaseOrPhenotypicFeature	type I congenital antithrombin deficiency	D025861
2039	16000134	660	672	GeneOrGeneProduct	antithrombin	462
2040	16000134	681	720	SequenceVariant	nucleotide T insertion at 7916 and 7917	c|INS|7916_7917|T
2041	16000134	722	737	SequenceVariant	Glu 272 to stop	p|SUB|E|272|X
2042	16000134	765	775	ChemicalEntity	Argatroban	C031942
2043	16000134	830	864	DiseaseOrPhenotypicFeature	congenital antithrombin deficiency	D020152
2044	16000134	870	884	DiseaseOrPhenotypicFeature	SMV thrombosis	D020246
2045	16005363	26	30	GeneOrGeneProduct	WFS1	7466
2046	16005363	41	54	SequenceVariant	AFF344-345ins	p|INS|344_345|AFF
2047	16005363	68	76	OrganismTaxon	patients	9606
2048	16005363	82	98	DiseaseOrPhenotypicFeature	Wolfram syndrome	D014929
2049	16005363	100	116	DiseaseOrPhenotypicFeature	Wolfram syndrome	D014929
2050	16005363	118	121	DiseaseOrPhenotypicFeature	WFS	D014929
2051	16005363	129	157	DiseaseOrPhenotypicFeature	autosomal recessive disorder	D030342
2052	16005363	187	204	DiseaseOrPhenotypicFeature	diabetes mellitus	D003920
2053	16005363	218	231	DiseaseOrPhenotypicFeature	optic atrophy	D009896
2054	16005363	233	255	DiseaseOrPhenotypicFeature	sensorineural deafness	D006319
2055	16005363	260	278	DiseaseOrPhenotypicFeature	diabetes insipidus	D003919
2056	16005363	315	340	DiseaseOrPhenotypicFeature	renal tract abnormalities	D007674
2057	16005363	367	388	DiseaseOrPhenotypicFeature	psychiatric syndromes	D001523
2058	16005363	390	394	GeneOrGeneProduct	WFS1	7466
2059	16005363	471	474	DiseaseOrPhenotypicFeature	WFS	D014929
2060	16005363	559	563	GeneOrGeneProduct	WFS1	7466
2061	16005363	578	586	OrganismTaxon	patients	9606
2062	16005363	622	647	SequenceVariant	nine nucleotide insertion	c|INS||9
2063	16005363	649	662	SequenceVariant	AFF344-345ins	p|INS|344_345|AFF
2064	16005363	691	699	OrganismTaxon	patients	9606
2065	16005363	716	731	DiseaseOrPhenotypicFeature	hypopituitarism	D007018
2066	16005363	764	767	DiseaseOrPhenotypicFeature	WFS	D014929
2067	16005363	835	838	DiseaseOrPhenotypicFeature	WFS	D014929
2068	16005363	905	908	DiseaseOrPhenotypicFeature	WFS	D014929
2069	16018252	23	26	GeneOrGeneProduct	SRY	6736
2070	16018252	45	60	DiseaseOrPhenotypicFeature	sex reversal XY	OMIM:400044
2071	16018252	74	77	GeneOrGeneProduct	SRY	6736
2072	16018252	191	194	GeneOrGeneProduct	SRY	6736
2073	16018252	393	396	GeneOrGeneProduct	SRY	6736
2074	16018252	427	442	DiseaseOrPhenotypicFeature	XY sex reversal	OMIM:400044
2075	16018252	483	491	OrganismTaxon	patients	9606
2076	16018252	511	529	DiseaseOrPhenotypicFeature	46,XY sex reversal	OMIM:400044
2077	16018252	575	578	GeneOrGeneProduct	SRY	6736
2078	16018252	698	701	GeneOrGeneProduct	SRY	6736
2079	16018252	1014	1022	OrganismTaxon	patients	9606
2080	16018252	1079	1112	SequenceVariant	A was replaced by a G in codon 38	c|SUB|A|CODON38|G
2081	16018252	1166	1169	GeneOrGeneProduct	SRY	6736
2082	16018252	1223	1243	SequenceVariant	glutamate by glycine	p|SUB|E||G
2083	16018252	1266	1315	SequenceVariant	T to A transition at the nucleotide position +387	c|SUB|T|387|A
2084	16018252	1336	1368	SequenceVariant	Tyrosine (Tyr) instead of a Term	c|SUB|Y||X
2085	16018252	1530	1535	OrganismTaxon	Human	9606
2086	16018252	1697	1700	GeneOrGeneProduct	SRY	6736
2087	16018252	1846	1858	DiseaseOrPhenotypicFeature	sex reversal	OMIM:400044
2088	16018252	1944	1947	GeneOrGeneProduct	SRY	6736
2089	16018252	2032	2039	OrganismTaxon	patient	9606
2090	16018252	2045	2070	DiseaseOrPhenotypicFeature	46,XY female sex reversal	OMIM:400044
2091	16046395	32	37	OrganismTaxon	human	9606
2092	16046395	38	56	GeneOrGeneProduct	mu opioid receptor	4988
2093	16046395	58	63	GeneOrGeneProduct	OPRM1	4988
2094	16046395	83	88	SequenceVariant	A118G	rs1799971
2095	16046395	145	163	GeneOrGeneProduct	mu opioid receptor	4988
2096	16046395	165	170	GeneOrGeneProduct	OPRM1	4988
2097	16046395	192	196	DiseaseOrPhenotypicFeature	pain	D010146
2098	16046395	243	248	GeneOrGeneProduct	OPRM1	4988
2099	16046395	291	305	DiseaseOrPhenotypicFeature	drug addiction	D019966
2100	16046395	356	361	SequenceVariant	A118G	rs1799971
2101	16046395	377	381	SequenceVariant	N40D	rs1799971
2102	16046395	509	514	GeneOrGeneProduct	OPRM1	4988
2103	16046395	518	523	OrganismTaxon	human	9606
2104	16046395	553	558	SequenceVariant	A118G	rs1799971
2105	16046395	612	616	SequenceVariant	A118	rs1799971
2106	16046395	669	673	SequenceVariant	G118	rs1799971
2107	16046395	700	715	OrganismTaxon	Chinese hamster	10029
2108	16046395	777	782	GeneOrGeneProduct	OPRM1	100770962
2109	16046395	793	854	SequenceVariant	adenosine, guanosine, cytidine, and thymidine in position 118	rs1799971
2110	16046395	904	909	GeneOrGeneProduct	OPRM1	100770962
2111	16046395	910	914	SequenceVariant	G118	rs1799971
2112	16046395	944	949	GeneOrGeneProduct	OPRM1	100770962
2113	16046395	1079	1092	ChemicalEntity	actinomycin D	D003609
2114	16046395	1175	1179	SequenceVariant	A118	rs1799971
2115	16046395	1184	1188	SequenceVariant	G118	rs1799971
2116	16046395	1283	1288	GeneOrGeneProduct	OPRM1	100770962
2117	16046395	1289	1293	SequenceVariant	G118	rs1799971
2118	16046395	1489	1503	DiseaseOrPhenotypicFeature	drug addiction	D019966
2119	16051693	20	24	GeneOrGeneProduct	PEMT	10400
2120	16051693	52	84	DiseaseOrPhenotypicFeature	nonalcoholic fatty liver disease	D065626
2121	16051693	86	91	DiseaseOrPhenotypicFeature	NAFLD	D065626
2122	16051693	94	138	GeneOrGeneProduct	Phosphatidylethanolamine N-methyltransferase	10400
2123	16051693	140	144	GeneOrGeneProduct	PEMT	10400
2124	16051693	156	175	ChemicalEntity	phosphatidylcholine	D010713
2125	16051693	187	191	GeneOrGeneProduct	PEMT	18618
2126	16051693	201	205	OrganismTaxon	mice	10090
2127	16051693	211	223	DiseaseOrPhenotypicFeature	fatty livers	D005234
2128	16051693	253	259	OrganismTaxon	humans	9606
2129	16051693	261	293	DiseaseOrPhenotypicFeature	nonalcoholic fatty liver disease	D065626
2130	16051693	295	300	DiseaseOrPhenotypicFeature	NAFLD	D065626
2131	16051693	327	331	GeneOrGeneProduct	PEMT	10400
2132	16051693	372	378	OrganismTaxon	humans	9606
2133	16051693	387	398	DiseaseOrPhenotypicFeature	fatty liver	D005234
2134	16051693	411	417	OrganismTaxon	humans	9606
2135	16051693	423	428	DiseaseOrPhenotypicFeature	NAFLD	D065626
2136	16051693	494	498	GeneOrGeneProduct	PEMT	10400
2137	16051693	517	522	SequenceVariant	V175M	rs7946
2138	16051693	537	542	SequenceVariant	V175M	rs7946
2139	16051693	617	631	CellLine	McArdle-RH7777	10116
2140	16051693	667	671	GeneOrGeneProduct	PEMT	25511
2141	16051693	698	703	SequenceVariant	V175M	rs7946
2142	16051693	712	734	SequenceVariant	Met/Met at residue 175	rs7946
2143	16051693	783	788	DiseaseOrPhenotypicFeature	NAFLD	D065626
2144	16051693	902	907	OrganismTaxon	human	9606
2145	16051693	908	912	GeneOrGeneProduct	PEMT	10400
2146	16051693	919	924	SequenceVariant	V175M	rs7946
2147	16051693	998	1003	DiseaseOrPhenotypicFeature	NAFLD	D065626
2148	16112787	77	87	ChemicalEntity	vancomycin	D014640
2149	16112787	96	110	DiseaseOrPhenotypicFeature	nephrotoxicity	D007674
2150	16112787	126	136	ChemicalEntity	erdosteine	C048498
2151	16112787	177	187	ChemicalEntity	vancomycin	D014640
2152	16112787	189	192	ChemicalEntity	VCM	D014640
2153	16112787	247	270	ChemicalEntity	reactive oxygen species	D017382
2154	16112787	272	275	ChemicalEntity	ROS	D017382
2155	16112787	308	318	ChemicalEntity	erdosteine	C048498
2156	16112787	357	368	ChemicalEntity	antioxidant	D000975
2157	16112787	419	422	ChemicalEntity	VCM	D014640
2158	16112787	431	447	DiseaseOrPhenotypicFeature	renal impairment	D007674
2159	16112787	451	455	OrganismTaxon	rats	10116
2160	16112787	457	461	OrganismTaxon	Rats	10116
2161	16112787	500	503	ChemicalEntity	VCM	D014640
2162	16112787	508	511	ChemicalEntity	VCM	D014640
2163	16112787	517	527	ChemicalEntity	erdosteine	C048498
2164	16112787	529	532	ChemicalEntity	VCM	D014640
2165	16112787	617	627	ChemicalEntity	Erdosteine	C048498
2166	16112787	653	656	ChemicalEntity	VCM	D014640
2167	16112787	683	687	OrganismTaxon	rats	10116
2168	16112787	718	733	ChemicalEntity	malondialdehyde	D008315
2169	16112787	735	738	ChemicalEntity	MDA	D008315
2170	16112787	752	783	GeneOrGeneProduct	N-acetyl-beta-d-glucosaminidase	154968
2171	16112787	785	788	GeneOrGeneProduct	NAG	154968
2172	16112787	802	822	DiseaseOrPhenotypicFeature	renal tubular injury	D007674
2173	16112787	848	868	ChemicalEntity	superoxide dismutase	D013482
2174	16112787	870	873	ChemicalEntity	SOD	D013482
2175	16112787	879	887	GeneOrGeneProduct	catalase	24248
2176	16112787	889	892	GeneOrGeneProduct	CAT	24248
2177	16112787	906	916	ChemicalEntity	Erdosteine	C048498
2178	16112787	937	940	ChemicalEntity	VCM	D014640
2179	16112787	989	992	ChemicalEntity	MDA	D008315
2180	16112787	1005	1008	GeneOrGeneProduct	NAG	154968
2181	16112787	1034	1037	ChemicalEntity	SOD	D013482
2182	16112787	1056	1059	GeneOrGeneProduct	CAT	24248
2183	16112787	1104	1107	ChemicalEntity	VCM	D014640
2184	16112787	1115	1125	ChemicalEntity	Erdosteine	C048498
2185	16112787	1170	1173	ChemicalEntity	VCM	D014640
2186	16112787	1182	1196	DiseaseOrPhenotypicFeature	nephrotoxicity	D007674
2187	16112787	1294	1301	DiseaseOrPhenotypicFeature	atrophy	D001284
2188	16112787	1303	1315	DiseaseOrPhenotypicFeature	desquamation	D012871
2189	16112787	1321	1329	DiseaseOrPhenotypicFeature	necrosis	D009336
2190	16112787	1333	1336	ChemicalEntity	VCM	D014640
2191	16112787	1345	1349	OrganismTaxon	rats	10116
2192	16112787	1389	1399	ChemicalEntity	erdosteine	C048498
2193	16112787	1408	1418	ChemicalEntity	Erdosteine	C048498
2194	16112787	1555	1558	ChemicalEntity	VCM	D014640
2195	16112787	1567	1581	DiseaseOrPhenotypicFeature	nephrotoxicity	D007674
2196	16112787	1626	1636	ChemicalEntity	erdosteine	C048498
2197	16112787	1649	1652	ChemicalEntity	VCM	D014640
2198	16112787	1661	1674	DiseaseOrPhenotypicFeature	kidney damage	D007674
2199	16116131	59	70	DiseaseOrPhenotypicFeature	dyskinesias	D004409
2200	16116131	74	91	DiseaseOrPhenotypicFeature	Parkinson disease	D010300
2201	16116131	141	149	ChemicalEntity	levodopa	D007980
2202	16116131	158	168	DiseaseOrPhenotypicFeature	dyskinesia	D004409
2203	16116131	294	302	OrganismTaxon	patients	9606
2204	16116131	317	334	DiseaseOrPhenotypicFeature	Parkinson disease	D010300
2205	16116131	434	444	DiseaseOrPhenotypicFeature	dyskinetic	D004409
2206	16116131	473	484	ChemicalEntity	apomorphine	D001058
2207	16116131	540	564	DiseaseOrPhenotypicFeature	drug-induced dyskinesias	D004409
2208	16120104	70	75	GeneOrGeneProduct	hPER2	8864
2209	16120104	124	131	GeneOrGeneProduct	PERIOD2	8864
2210	16120104	133	137	GeneOrGeneProduct	PER2	8864
2211	16120104	262	267	OrganismTaxon	human	9606
2212	16120104	268	272	GeneOrGeneProduct	PER2	8864
2213	16120104	308	337	DiseaseOrPhenotypicFeature	advanced sleep phase syndrome	C565789
2214	16120104	339	343	DiseaseOrPhenotypicFeature	ASPS	C565789
2215	16120104	418	423	GeneOrGeneProduct	hPER2	8864
2216	16120104	478	485	SequenceVariant	C-1228T	c|SUB|C|-1228|T
2217	16120104	542	547	SequenceVariant	C111G	c|SUB|C|111|G
2218	16120104	577	583	SequenceVariant	G3853A	c|SUB|G|3853|A
2219	16120104	595	615	SequenceVariant	glycine to glutamine	p|SUB|G||Q
2220	16120104	978	982	SequenceVariant	111G	c|Allele|G|111
2221	16120104	1226	1230	SequenceVariant	111G	c|Allele|G|111
2222	16120104	1382	1387	SequenceVariant	C111G	c|SUB|C|111|G
2223	16120104	1526	1530	GeneOrGeneProduct	PER2	8864
2224	16120104	1531	1535	SequenceVariant	111G	c|Allele|G|111
2225	16120104	1618	1622	DiseaseOrPhenotypicFeature	ASPS	C565789
2226	16152606	30	37	SequenceVariant	657del5	c|DEL|657|5
2227	16152606	45	49	GeneOrGeneProduct	NBS1	4683
2228	16152606	91	99	OrganismTaxon	patients	9606
2229	16152606	105	135	DiseaseOrPhenotypicFeature	sporadic lymphoid malignancies	D008223
2230	16152606	137	163	DiseaseOrPhenotypicFeature	Nijmegen breakage syndrome	D049932
2231	16152606	165	168	DiseaseOrPhenotypicFeature	NBS	D049932
2232	16152606	175	180	OrganismTaxon	human	9606
2233	16152606	181	208	DiseaseOrPhenotypicFeature	autosomal recessive disease	D030342
2234	16152606	259	265	DiseaseOrPhenotypicFeature	cancer	D009369
2235	16152606	299	307	DiseaseOrPhenotypicFeature	lymphoma	D008223
2236	16152606	312	320	DiseaseOrPhenotypicFeature	leukemia	D007938
2237	16152606	412	416	GeneOrGeneProduct	NBS1	4683
2238	16152606	427	434	SequenceVariant	657del5	c|DEL|657|5
2239	16152606	472	502	DiseaseOrPhenotypicFeature	sporadic lymphoid malignancies	D008223
2240	16152606	530	550	DiseaseOrPhenotypicFeature	non-Hodgkin lymphoma	D008228
2241	16152606	552	555	DiseaseOrPhenotypicFeature	NHL	D008228
2242	16152606	588	594	SequenceVariant	643C>T	c|SUB|C|643|T
2243	16152606	596	601	SequenceVariant	R215W	p|SUB|R|215|W
2244	16152606	653	681	DiseaseOrPhenotypicFeature	acute lymphoblastic leukemia	D054198
2245	16152606	683	686	DiseaseOrPhenotypicFeature	ALL	D054198
2246	16152606	769	799	DiseaseOrPhenotypicFeature	sporadic lymphoid malignancies	D008223
2247	16152606	864	872	OrganismTaxon	patients	9606
2248	16152606	878	882	GeneOrGeneProduct	NBS1	4683
2249	16152606	892	899	SequenceVariant	657del5	c|DEL|657|5
2250	16152606	936	944	OrganismTaxon	patients	9606
2251	16152606	950	953	DiseaseOrPhenotypicFeature	ALL	D054198
2252	16152606	997	1000	DiseaseOrPhenotypicFeature	NHL	D008228
2253	16152606	1032	1040	OrganismTaxon	patients	9606
2254	16152606	1046	1062	DiseaseOrPhenotypicFeature	Hodgkin lymphoma	D006689
2255	16152606	1064	1066	DiseaseOrPhenotypicFeature	HL	D006689
2256	16152606	1096	1101	SequenceVariant	R215W	p|SUB|R|215|W
2257	16152606	1168	1175	SequenceVariant	657del5	c|DEL|657|5
2258	16152606	1251	1258	OrganismTaxon	patient	9606
2259	16152606	1360	1372	DiseaseOrPhenotypicFeature	malignancies	D009369
2260	16152606	1429	1436	SequenceVariant	657del5	c|DEL|657|5
2261	16152606	1644	1652	OrganismTaxon	patients	9606
2262	16152606	1658	1661	DiseaseOrPhenotypicFeature	ALL	D054198
2263	16152606	1666	1669	DiseaseOrPhenotypicFeature	NHL	D008228
2264	16152606	1695	1699	GeneOrGeneProduct	NBS1	4683
2265	16152606	1751	1772	DiseaseOrPhenotypicFeature	lymphoid malignancies	D008223
2266	16157158	2	15	SequenceVariant	Cys 23-Ser 23	rs6318
2267	16157158	36	53	GeneOrGeneProduct	5-HT(2C) receptor	3358
2268	16157158	109	136	DiseaseOrPhenotypicFeature	seasonal affective disorder	D016574
2269	16157158	198	225	DiseaseOrPhenotypicFeature	seasonal affective disorder	D016574
2270	16157158	227	230	DiseaseOrPhenotypicFeature	SAD	D016574
2271	16157158	293	319	DiseaseOrPhenotypicFeature	weight gain when depressed	D015430
2272	16157158	325	346	GeneOrGeneProduct	serotonin 2C receptor	3358
2273	16157158	348	356	GeneOrGeneProduct	5-HT(2C)	3358
2274	16157158	413	421	GeneOrGeneProduct	5-HT(2C)	3358
2275	16157158	422	432	SequenceVariant	Cys 23 Ser	rs6318
2276	16157158	494	504	SequenceVariant	Cys 23 Ser	rs6318
2277	16157158	517	525	GeneOrGeneProduct	5-HT(2C)	3358
2278	16157158	560	568	GeneOrGeneProduct	5-HT(2C)	3358
2279	16157158	600	610	SequenceVariant	Cys 23 Ser	rs6318
2280	16157158	656	659	DiseaseOrPhenotypicFeature	SAD	D016574
2281	16157158	716	719	DiseaseOrPhenotypicFeature	SAD	D016574
2282	16157158	764	767	DiseaseOrPhenotypicFeature	SAD	D016574
2283	16157158	801	811	SequenceVariant	Cys 23 Ser	rs6318
2284	16157158	864	872	OrganismTaxon	patients	9606
2285	16157158	950	958	OrganismTaxon	patients	9606
2286	16157158	986	996	SequenceVariant	Cys 23 Ser	rs6318
2287	16157158	1212	1220	OrganismTaxon	patients	9606
2288	16157158	1222	1232	SequenceVariant	Cys 23 Ser	rs6318
2289	16157158	1356	1366	SequenceVariant	Cys 23 Ser	rs6318
2290	16157158	1435	1438	DiseaseOrPhenotypicFeature	SAD	D016574
2291	16157158	1518	1528	SequenceVariant	Cys 23 Ser	rs6318
2292	16158428	54	59	GeneOrGeneProduct	OPHN1	4983
2293	16158428	200	205	GeneOrGeneProduct	OPHN1	4983
2294	16158428	269	287	DiseaseOrPhenotypicFeature	mental retardation	D008607
2295	16158428	331	352	DiseaseOrPhenotypicFeature	cerebellar hypoplasia	C562568
2296	16158428	388	396	OrganismTaxon	patients	9606
2297	16158428	448	475	DiseaseOrPhenotypicFeature	X-linked mental retardation	D038901
2298	16158428	495	500	GeneOrGeneProduct	OPHN1	4983
2299	16158428	683	704	DiseaseOrPhenotypicFeature	cerebellar hypoplasia	C562568
2300	16158428	853	871	DiseaseOrPhenotypicFeature	mental retardation	D008607
2301	16167916	26	36	ChemicalEntity	raloxifene	D020849
2302	16167916	70	74	GeneOrGeneProduct	TAFI	1361
2303	16167916	76	79	GeneOrGeneProduct	tPA	5327
2304	16167916	85	90	GeneOrGeneProduct	PAI-1	5054
2305	16167916	129	172	GeneOrGeneProduct	thrombin-activatable fibrinolysis inhibitor	1361
2306	16167916	174	178	GeneOrGeneProduct	TAFI	1361
2307	16167916	181	214	GeneOrGeneProduct	tissue-type plasminogen activator	5327
2308	16167916	216	219	GeneOrGeneProduct	tPA	5327
2309	16167916	226	259	GeneOrGeneProduct	plasminogen activator inhibitor-1	5054
2310	16167916	261	266	GeneOrGeneProduct	PAI-1	5054
2311	16167916	332	342	ChemicalEntity	raloxifene	D020849
2312	16167916	376	381	OrganismTaxon	women	9606
2313	16167916	419	424	OrganismTaxon	women	9606
2314	16167916	430	440	DiseaseOrPhenotypicFeature	osteopenia	D001851
2315	16167916	444	456	DiseaseOrPhenotypicFeature	osteoporosis	D010024
2316	16167916	531	536	OrganismTaxon	women	9606
2317	16167916	548	572	ChemicalEntity	raloxifene hydrochloride	D020849
2318	16167916	590	597	ChemicalEntity	calcium	D002118
2319	16167916	658	665	ChemicalEntity	calcium	D002118
2320	16167916	674	678	GeneOrGeneProduct	TAFI	1361
2321	16167916	680	683	GeneOrGeneProduct	tPA	5327
2322	16167916	689	694	GeneOrGeneProduct	PAI-1	5054
2323	16167916	977	987	ChemicalEntity	raloxifene	D020849
2324	16167916	1055	1059	GeneOrGeneProduct	TAFI	1361
2325	16167916	1137	1140	GeneOrGeneProduct	tPA	5327
2326	16167916	1241	1245	GeneOrGeneProduct	TAFI	1361
2327	16167916	1372	1394	DiseaseOrPhenotypicFeature	venous thromboembolism	D054556
2328	16167916	1402	1412	ChemicalEntity	raloxifene	D020849
2329	16167916	1451	1454	GeneOrGeneProduct	tPA	5327
2330	16167916	1471	1475	GeneOrGeneProduct	TAFI	1361
2331	16181814	13	17	GeneOrGeneProduct	POLG	5428
2332	16181814	98	105	OrganismTaxon	patient	9606
2333	16181814	111	126	DiseaseOrPhenotypicFeature	Alpers syndrome	D002549
2334	16181814	128	143	DiseaseOrPhenotypicFeature	Alpers syndrome	D002549
2335	16181814	170	197	DiseaseOrPhenotypicFeature	mitochondrial DNA depletion	D028361
2336	16181814	301	314	DiseaseOrPhenotypicFeature	liver disease	D008107
2337	16181814	368	372	GeneOrGeneProduct	POLG	5428
2338	16181814	426	435	GeneOrGeneProduct	pol gamma	5428
2339	16181814	443	451	OrganismTaxon	patients	9606
2340	16181814	457	472	DiseaseOrPhenotypicFeature	Alpers syndrome	D002549
2341	16181814	569	573	GeneOrGeneProduct	POLG	5428
2342	16181814	581	585	GeneOrGeneProduct	POLG	5428
2343	16181814	758	765	OrganismTaxon	patient	9606
2344	16181814	771	786	DiseaseOrPhenotypicFeature	Alpers syndrome	D002549
2345	16181814	807	815	SequenceVariant	E873stop	rs121918047
2346	16181814	816	821	SequenceVariant	A467T	rs113994095
2347	16181814	827	835	SequenceVariant	E873stop	rs121918047
2348	16181814	906	911	SequenceVariant	A467T	rs113994095
2349	16181814	932	952	SequenceVariant	threonine to alanine	rs113994095
2350	16181814	1039	1047	SequenceVariant	E873-TAG	rs121918047
2351	16181814	1147	1156	GeneOrGeneProduct	pol gamma	5428
2352	16181814	1372	1376	GeneOrGeneProduct	POLG	5428
2353	16181814	1422	1427	SequenceVariant	A467T	rs113994095
2354	16181814	1468	1476	SequenceVariant	E873stop	rs121918047
2355	16181814	1527	1531	GeneOrGeneProduct	POLG	5428
2356	16181814	1575	1580	SequenceVariant	A467T	rs113994095
2357	16181814	1629	1636	OrganismTaxon	patient	9606
2358	16181814	1689	1694	SequenceVariant	A467T	rs113994095
2359	16181814	1756	1764	SequenceVariant	E873stop	rs121918047
2360	16186368	20	48	DiseaseOrPhenotypicFeature	Bietti crystalline dystrophy	C535440
2361	16186368	49	57	OrganismTaxon	patients	9606
2362	16186368	63	69	GeneOrGeneProduct	CYP4V2	285440
2363	16186368	107	113	GeneOrGeneProduct	CYP4V2	285440
2364	16186368	149	164	GeneOrGeneProduct	cytochrome P450	285440
2365	16186368	224	232	OrganismTaxon	patients	9606
2366	16186368	238	266	DiseaseOrPhenotypicFeature	Bietti crystalline dystrophy	C535440
2367	16186368	268	271	DiseaseOrPhenotypicFeature	BCD	C535440
2368	16186368	357	360	DiseaseOrPhenotypicFeature	BCD	C535440
2369	16186368	361	369	OrganismTaxon	patients	9606
2370	16186368	437	445	OrganismTaxon	patients	9606
2371	16186368	451	454	DiseaseOrPhenotypicFeature	BCD	C535440
2372	16186368	524	530	GeneOrGeneProduct	CYP4V2	285440
2373	16186368	571	579	OrganismTaxon	patients	9606
2374	16186368	662	670	OrganismTaxon	patients	9606
2375	16186368	874	879	SequenceVariant	S482X	rs146494374
2376	16186368	884	889	SequenceVariant	K386T	rs199476200
2377	16186368	921	929	OrganismTaxon	patients	9606
2378	16186368	975	989	SequenceVariant	15-bp deletion	c|DEL||15
2379	16186368	1057	1065	OrganismTaxon	patients	9606
2380	16186368	1076	1084	OrganismTaxon	patients	9606
2381	16186368	1154	1162	OrganismTaxon	patients	9606
2382	16186368	1283	1291	OrganismTaxon	patients	9606
2383	16186368	1390	1398	OrganismTaxon	patients	9606
2384	16186368	1613	1619	GeneOrGeneProduct	CYP4V2	285440
2385	16186368	1639	1642	DiseaseOrPhenotypicFeature	BCD	C535440
2386	16186368	1677	1691	SequenceVariant	15-bp deletion	c|DEL||15
2387	16200390	73	81	DiseaseOrPhenotypicFeature	migraine	D008881
2388	16200390	112	120	DiseaseOrPhenotypicFeature	Migraine	D008881
2389	16200390	154	171	DiseaseOrPhenotypicFeature	headache disorder	D020773
2390	16200390	248	264	ChemicalEntity	neurotransmitter	D018377
2391	16200390	265	284	ChemicalEntity	5-hydroxytryptamine	D012701
2392	16200390	286	290	ChemicalEntity	5-HT	D012701
2393	16200390	292	301	ChemicalEntity	serotonin	D012701
2394	16200390	389	397	DiseaseOrPhenotypicFeature	migraine	D008881
2395	16200390	495	499	ChemicalEntity	5-HT	D012701
2396	16200390	535	543	DiseaseOrPhenotypicFeature	migraine	D008881
2397	16200390	618	623	OrganismTaxon	human	9606
2398	16200390	624	646	GeneOrGeneProduct	tryptophan hydroxylase	7166
2399	16200390	648	651	GeneOrGeneProduct	TPH	7166
2400	16200390	654	678	GeneOrGeneProduct	amino acid decarboxylase	1644
2401	16200390	680	684	GeneOrGeneProduct	AADC	1644
2402	16200390	690	709	GeneOrGeneProduct	monoamine oxidase A	4128
2403	16200390	711	715	GeneOrGeneProduct	MAOA	4128
2404	16200390	726	734	DiseaseOrPhenotypicFeature	migraine	D008881
2405	16200390	1340	1343	GeneOrGeneProduct	TPH	7166
2406	16200390	1345	1349	GeneOrGeneProduct	AADC	1644
2407	16200390	1354	1358	GeneOrGeneProduct	MAOA	4128
2408	16200390	1395	1403	DiseaseOrPhenotypicFeature	migraine	D008881
2409	16225977	0	11	ChemicalEntity	Amisulpride	D000077582
2410	16225977	20	37	DiseaseOrPhenotypicFeature	tic-like symptoms	-
2411	16225977	55	68	DiseaseOrPhenotypicFeature	schizophrenic	D012559
2412	16225977	70	83	DiseaseOrPhenotypicFeature	Tic disorders	D013981
2413	16225977	123	137	ChemicalEntity	antipsychotics	D014150
2414	16225977	146	157	ChemicalEntity	risperidone	D018967
2415	16225977	159	169	ChemicalEntity	olanzapine	D000077152
2416	16225977	174	185	ChemicalEntity	ziprasidone	C092292
2417	16225977	233	250	DiseaseOrPhenotypicFeature	tic-like symptoms	-
2418	16225977	321	331	ChemicalEntity	quetiapine	D000069348
2419	16225977	335	344	ChemicalEntity	clozapine	D003024
2420	16225977	376	389	DiseaseOrPhenotypicFeature	schizophrenic	D012559
2421	16225977	413	447	DiseaseOrPhenotypicFeature	involuntary eye-blinking movements	D020820
2422	16225977	466	477	ChemicalEntity	amisulpride	D000077582
2423	16225977	511	528	DiseaseOrPhenotypicFeature	tic-like symptoms	-
2424	16225977	578	589	ChemicalEntity	amisulpride	D000077582
2425	16225977	627	636	DiseaseOrPhenotypicFeature	psychosis	D011605
2426	16225977	726	736	ChemicalEntity	quetiapine	D000069348
2427	16225977	871	888	DiseaseOrPhenotypicFeature	tic-like symptoms	-
2428	16225977	976	983	OrganismTaxon	patient	9606
2429	16225977	998	1015	DiseaseOrPhenotypicFeature	tic-like symptoms	-
2430	16225977	1093	1107	ChemicalEntity	antipsychotics	D014150
2431	16225977	1116	1126	ChemicalEntity	quetiapine	D000069348
2432	16225977	1128	1137	ChemicalEntity	clozapine	D003024
2433	16225977	1142	1153	ChemicalEntity	amisulpride	D000077582
2434	16252083	25	40	GeneOrGeneProduct	mismatch repair	4436
2435	16252083	46	51	GeneOrGeneProduct	HMSH2	4436
2436	16252083	55	68	DiseaseOrPhenotypicFeature	breast cancer	D001943
2437	16252083	221	238	DiseaseOrPhenotypicFeature	cancer initiation	D009369
2438	16252083	326	340	DiseaseOrPhenotypicFeature	carcinogenesis	D063646
2439	16252083	401	416	GeneOrGeneProduct	mismatch repair	4436
2440	16252083	418	421	GeneOrGeneProduct	MMR	4436
2441	16252083	451	468	DiseaseOrPhenotypicFeature	colorectal cancer	D015179
2442	16252083	508	521	DiseaseOrPhenotypicFeature	breast cancer	D001943
2443	16252083	523	528	GeneOrGeneProduct	hMSH2	4436
2444	16252083	563	566	GeneOrGeneProduct	MMR	4436
2445	16252083	659	664	GeneOrGeneProduct	hMSH2	4436
2446	16252083	674	708	SequenceVariant	A --> G transition at 127 position	rs17217772
2447	16252083	722	759	SequenceVariant	Asn --> Ser substitution at codon 127	rs17217772
2448	16252083	765	774	SequenceVariant	Asn127Ser	rs17217772
2449	16252083	795	830	SequenceVariant	G --> A transition at 1032 position	rs4987188
2450	16252083	846	877	SequenceVariant	Gly --> Asp change at codon 322	rs4987188
2451	16252083	883	892	SequenceVariant	Gly322Asp	rs4987188
2452	16252083	911	924	DiseaseOrPhenotypicFeature	breast cancer	D001943
2453	16252083	934	940	DiseaseOrPhenotypicFeature	cancer	D009369
2454	16252083	1028	1041	DiseaseOrPhenotypicFeature	breast cancer	D001943
2455	16252083	1042	1050	OrganismTaxon	patients	9606
2456	16252083	1071	1076	OrganismTaxon	women	9606
2457	16252083	1226	1239	DiseaseOrPhenotypicFeature	breast cancer	D001943
2458	16252083	1282	1287	DiseaseOrPhenotypicFeature	tumor	D009369
2459	16252083	1352	1365	DiseaseOrPhenotypicFeature	breast cancer	D001943
2460	16252083	1410	1419	SequenceVariant	Gly322Asp	rs4987188
2461	16252083	1508	1511	GeneOrGeneProduct	MMR	4436
2462	16252083	1535	1556	DiseaseOrPhenotypicFeature	breast carcinogenesis	D001943
2463	16252083	1565	1574	SequenceVariant	Gly322Asp	rs4987188
2464	16252083	1595	1600	GeneOrGeneProduct	hMSH2	4436
2465	16252083	1649	1662	DiseaseOrPhenotypicFeature	breast cancer	D001943
2466	16277682	17	22	SequenceVariant	M404V	rs771966860
2467	16277682	39	42	GeneOrGeneProduct	p62	8878
2468	16277682	43	57	GeneOrGeneProduct	sequestosome 1	8878
2469	16277682	59	62	GeneOrGeneProduct	p62	8878
2470	16277682	63	69	GeneOrGeneProduct	SQSTM1	8878
2471	16277682	93	116	DiseaseOrPhenotypicFeature	Paget's disease of bone	C538098
2472	16277682	156	159	GeneOrGeneProduct	p62	8878
2473	16277682	160	174	GeneOrGeneProduct	Sequestosome 1	8878
2474	16277682	181	184	GeneOrGeneProduct	p62	8878
2475	16277682	185	191	GeneOrGeneProduct	SQSTM1	8878
2476	16277682	241	264	DiseaseOrPhenotypicFeature	Paget's disease of bone	C538098
2477	16277682	266	269	DiseaseOrPhenotypicFeature	PDB	C538098
2478	16277682	298	343	SequenceVariant	methionine-->valine substitution at codon 404	rs771966860
2479	16277682	345	350	SequenceVariant	M404V	rs771966860
2480	16277682	406	409	GeneOrGeneProduct	p62	8878
2481	16277682	410	416	GeneOrGeneProduct	SQSTM1	8878
2482	16277682	436	439	DiseaseOrPhenotypicFeature	PDB	C538098
2483	16277682	440	447	OrganismTaxon	patient	9606
2484	16277682	481	488	OrganismTaxon	patient	9606
2485	16277682	541	544	DiseaseOrPhenotypicFeature	PDB	C538098
2486	16277682	646	651	SequenceVariant	M404V	rs771966860
2487	16277682	682	685	DiseaseOrPhenotypicFeature	PDB	C538098
2488	16277682	854	857	DiseaseOrPhenotypicFeature	PDB	C538098
2489	16277682	858	866	OrganismTaxon	patients	9606
2490	16277682	991	996	SequenceVariant	M404V	rs771966860
2491	16277682	1044	1047	DiseaseOrPhenotypicFeature	PDB	C538098
2492	16277682	1060	1067	OrganismTaxon	patient	9606
2493	16277682	1134	1153	DiseaseOrPhenotypicFeature	polyostotic disease	D005357
2494	16277682	1317	1322	SequenceVariant	M404V	rs771966860
2495	16277682	1411	1431	ChemicalEntity	alkaline phosphatase	D000469
2496	16277682	1572	1577	SequenceVariant	M404V	rs771966860
2497	16277682	1594	1597	GeneOrGeneProduct	p62	8878
2498	16277682	1598	1604	GeneOrGeneProduct	SQSTM1	8878
2499	16277682	1636	1639	DiseaseOrPhenotypicFeature	PDB	C538098
2500	16277682	1683	1686	DiseaseOrPhenotypicFeature	PDB	C538098
2501	16277682	1899	1902	GeneOrGeneProduct	p62	8878
2502	16277682	1903	1909	GeneOrGeneProduct	SQSTM1	8878
2503	16277682	1963	1966	DiseaseOrPhenotypicFeature	PDB	C538098
2504	16288197	34	55	DiseaseOrPhenotypicFeature	congenital microcoria	C537550
2505	16288197	99	120	DiseaseOrPhenotypicFeature	Congenital microcoria	C537550
2506	16288197	131	184	DiseaseOrPhenotypicFeature	autosomal dominant developmental disorder of the iris	D007499
2507	16288197	201	207	DiseaseOrPhenotypicFeature	myopia	D009216
2508	16288197	212	240	DiseaseOrPhenotypicFeature	juvenile open angle glaucoma	D005902
2509	16288197	409	430	DiseaseOrPhenotypicFeature	congenital microcoria	C537550
2510	16288197	1014	1017	GeneOrGeneProduct	DCT	1638
2511	16288197	1182	1203	DiseaseOrPhenotypicFeature	congenital microcoria	C537550
2512	16288197	1286	1296	DiseaseOrPhenotypicFeature	microcoria	C537550
2513	16288197	1301	1309	DiseaseOrPhenotypicFeature	glaucoma	D005901
2514	16288197	1328	1336	DiseaseOrPhenotypicFeature	glaucoma	D005901
2515	16288197	1344	1352	GeneOrGeneProduct	myocilin	4653
2516	16288197	1354	1358	GeneOrGeneProduct	MYOC	4653
2517	16288197	1361	1371	GeneOrGeneProduct	optineurin	10133
2518	16288197	1373	1377	GeneOrGeneProduct	OPTN	10133
2519	16288197	1383	1389	GeneOrGeneProduct	CYP1B1	1545
2520	16288197	1433	1440	SequenceVariant	144 G>A	rs74315339
2521	16288197	1457	1461	SequenceVariant	Q48H	rs74315339
2522	16288197	1492	1496	GeneOrGeneProduct	MYOC	4653
2523	16288197	1536	1544	DiseaseOrPhenotypicFeature	glaucoma	D005901
2524	16288197	1545	1553	OrganismTaxon	patients	9606
2525	16288197	1675	1696	DiseaseOrPhenotypicFeature	congenital microcoria	C537550
2526	16288197	1704	1708	GeneOrGeneProduct	MCOR	8104
2527	16288197	1946	1950	GeneOrGeneProduct	MCOR	8104
2528	16288197	2010	2013	GeneOrGeneProduct	DCT	1638
2529	16288197	2037	2047	GeneOrGeneProduct	tyrosinase	7299
2530	16288197	2067	2079	DiseaseOrPhenotypicFeature	pigmentation	D010859
2531	16288197	2155	2176	DiseaseOrPhenotypicFeature	congenital microcoria	C537550
2532	16288197	2208	2216	DiseaseOrPhenotypicFeature	glaucoma	D005901
2533	16288197	2289	2293	GeneOrGeneProduct	MYOC	4653
2534	16288197	2294	2298	SequenceVariant	Q48H	rs74315339
2535	16288197	2354	2362	DiseaseOrPhenotypicFeature	glaucoma	D005901
2536	16288197	2462	2471	GeneOrGeneProduct	micocoria	8104
2537	16288197	2516	2526	DiseaseOrPhenotypicFeature	microcoria	C537550
2538	16288197	2531	2539	DiseaseOrPhenotypicFeature	glaucoma	D005901
2539	16288197	2576	2586	DiseaseOrPhenotypicFeature	microcoria	C537550
2540	16288197	2588	2596	DiseaseOrPhenotypicFeature	glaucoma	D005901
2541	16288197	2606	2610	GeneOrGeneProduct	MYOC	4653
2542	16288197	2611	2615	SequenceVariant	Q48H	rs74315339
2543	16288199	26	47	GeneOrGeneProduct	nitric oxide synthase	4843
2544	16288199	62	70	DiseaseOrPhenotypicFeature	glaucoma	D005901
2545	16288199	134	146	ChemicalEntity	Nitric oxide	D009569
2546	16288199	184	189	OrganismTaxon	human	9606
2547	16288199	346	389	DiseaseOrPhenotypicFeature	neurological and non-neurological disorders	D009422
2548	16288199	475	496	GeneOrGeneProduct	Nitric Oxide Synthase	4843
2549	16288199	498	502	GeneOrGeneProduct	iNOS	4843
2550	16288199	512	547	DiseaseOrPhenotypicFeature	neuropathological disorder glaucoma	D005901
2551	16288199	576	585	DiseaseOrPhenotypicFeature	blindness	D001766
2552	16288199	670	674	GeneOrGeneProduct	iNOS	4843
2553	16288199	679	706	DiseaseOrPhenotypicFeature	primary open angle glaucoma	D005902
2554	16288199	708	712	DiseaseOrPhenotypicFeature	POAG	D005902
2555	16288199	925	929	GeneOrGeneProduct	iNOS	4843
2556	16288199	952	956	DiseaseOrPhenotypicFeature	POAG	D005902
2557	16288199	957	965	OrganismTaxon	patients	9606
2558	16288199	1229	1237	OrganismTaxon	patients	9606
2559	16288199	1252	1261	SequenceVariant	(CCTTT)14	c|DUP||CCTTT|14
2560	16288199	1373	1377	DiseaseOrPhenotypicFeature	POAG	D005902
2561	16288199	1378	1386	OrganismTaxon	patients	9606
2562	16288199	1394	1403	SequenceVariant	(CCTTT)10	c|DUP||CCTTT|10
2563	16288199	1408	1417	SequenceVariant	(CCTTT)13	c|DUP||CCTTT|13
2564	16288199	1449	1458	SequenceVariant	(CCTTT)14	c|DUP||CCTTT|14
2565	16288199	1669	1673	GeneOrGeneProduct	iNOS	4843
2566	16288199	1679	1683	DiseaseOrPhenotypicFeature	POAG	D005902
2567	16309808	5	16	ChemicalEntity	domperidone	D004294
2568	16309808	28	39	ChemicalEntity	mirtazapine	D000078785
2569	16309808	51	73	DiseaseOrPhenotypicFeature	restless legs syndrome	D012148
2570	16309808	154	176	DiseaseOrPhenotypicFeature	restless legs syndrome	D012148
2571	16309808	178	181	DiseaseOrPhenotypicFeature	RLS	D012148
2572	16309808	213	216	DiseaseOrPhenotypicFeature	RLS	D012148
2573	16309808	249	257	ChemicalEntity	levodopa	D007980
2574	16309808	262	270	ChemicalEntity	dopamine	D004298
2575	16309808	297	329	ChemicalEntity	dopamine D2 receptor antagonists	D065127
2576	16309808	354	357	DiseaseOrPhenotypicFeature	RLS	D012148
2577	16309808	432	443	ChemicalEntity	domperidone	D004294
2578	16309808	458	478	GeneOrGeneProduct	dopamine D2 receptor	1813
2579	16309808	532	535	DiseaseOrPhenotypicFeature	RLS	D012148
2580	16309808	537	548	ChemicalEntity	Mirtazapine	D000078785
2581	16309808	560	614	ChemicalEntity	noradrenergic and specific serotonergic antidepressant	D000928
2582	16309808	616	621	ChemicalEntity	NaSSA	D000928
2583	16309808	649	652	DiseaseOrPhenotypicFeature	RLS	D012148
2584	16309808	711	720	DiseaseOrPhenotypicFeature	depressed	D003866
2585	16309808	721	728	OrganismTaxon	patient	9606
2586	16309808	743	765	DiseaseOrPhenotypicFeature	postprandial dyspepsia	D004415
2587	16309808	780	783	DiseaseOrPhenotypicFeature	RLS	D012148
2588	16309808	790	801	ChemicalEntity	mirtazapine	D000078785
2589	16309808	824	835	ChemicalEntity	domperidone	D004294
2590	16309808	849	856	OrganismTaxon	patient	9606
2591	16309808	885	888	DiseaseOrPhenotypicFeature	RLS	D012148
2592	16309808	925	936	ChemicalEntity	mirtazapine	D000078785
2593	16309808	946	949	DiseaseOrPhenotypicFeature	RLS	D012148
2594	16309808	1007	1018	ChemicalEntity	mirtazapine	D000078785
2595	16309808	1068	1079	ChemicalEntity	mirtazapine	D000078785
2596	16309808	1100	1103	DiseaseOrPhenotypicFeature	RLS	D012148
2597	16309808	1111	1118	OrganismTaxon	patient	9606
2598	16309808	1160	1170	ChemicalEntity	domperione	D004294
2599	16309808	1174	1185	ChemicalEntity	mirtazapine	D000078785
2600	16309808	1197	1200	DiseaseOrPhenotypicFeature	RLS	D012148
2601	16309808	1262	1273	ChemicalEntity	mirtazapine	D000078785
2602	16309808	1297	1300	DiseaseOrPhenotypicFeature	RLS	D012148
2603	16309808	1361	1393	ChemicalEntity	dopamine D2 receptor antagonists	D065127
2604	16364460	18	28	ChemicalEntity	ritanserin	D016713
2605	16364460	73	84	ChemicalEntity	scopolamine	D012601
2606	16364460	93	100	DiseaseOrPhenotypicFeature	amnesia	D000647
2607	16364460	115	119	OrganismTaxon	rats	10116
2608	16364460	135	145	ChemicalEntity	ritanserin	D016713
2609	16364460	147	152	GeneOrGeneProduct	5-HT2	29595
2610	16364460	168	179	ChemicalEntity	scopolamine	D012601
2611	16364460	181	203	GeneOrGeneProduct	muscarinic cholinergic	25229
2612	16364460	224	231	DiseaseOrPhenotypicFeature	amnesia	D000647
2613	16364460	277	281	OrganismTaxon	Rats	10116
2614	16364460	435	439	ChemicalEntity	DMSO	D004121
2615	16364460	448	452	ChemicalEntity	DMSO	D004121
2616	16364460	455	466	ChemicalEntity	scopolamine	D012601
2617	16364460	526	536	ChemicalEntity	ritanserin	D016713
2618	16364460	567	571	ChemicalEntity	DMSO	D004121
2619	16364460	606	617	ChemicalEntity	scopolamine	D012601
2620	16364460	654	664	ChemicalEntity	ritanserin	D016713
2621	16364460	676	686	ChemicalEntity	ritanserin	D016713
2622	16364460	708	712	ChemicalEntity	DMSO	D004121
2623	16364460	1129	1140	ChemicalEntity	scopolamine	D012601
2624	16364460	1184	1194	ChemicalEntity	Ritanserin	D016713
2625	16364460	1203	1207	OrganismTaxon	rats	10116
2626	16364460	1308	1312	ChemicalEntity	DMSO	D004121
2627	16364460	1337	1348	ChemicalEntity	scopolamine	D012601
2628	16364460	1353	1363	ChemicalEntity	ritanserin	D016713
2629	16364460	1479	1490	ChemicalEntity	scopolamine	D012601
2630	16364460	1499	1503	OrganismTaxon	rats	10116
2631	16364460	1546	1556	ChemicalEntity	ritanserin	D016713
2632	16364460	1609	1620	ChemicalEntity	scopolamine	D012601
2633	16364460	1629	1636	DiseaseOrPhenotypicFeature	amnesia	D000647
2634	16369751	0	14	ChemicalEntity	5-Fluorouracil	D005472
2635	16369751	15	29	DiseaseOrPhenotypicFeature	cardiotoxicity	D066126
2636	16369751	41	66	ChemicalEntity	alpha-fluoro-beta-alanine	C032348
2637	16369751	68	82	DiseaseOrPhenotypicFeature	Cardiotoxicity	D066126
2638	16369751	123	137	ChemicalEntity	5-fluorouracil	D005472
2639	16369751	139	143	ChemicalEntity	5-FU	D005472
2640	16369751	159	171	DiseaseOrPhenotypicFeature	malignancies	D009369
2641	16369751	216	219	OrganismTaxon	man	9606
2642	16369751	225	229	ChemicalEntity	5-FU	D005472
2643	16369751	238	252	DiseaseOrPhenotypicFeature	cardiotoxicity	D066126
2644	16369751	284	309	ChemicalEntity	alpha-fluoro-beta-alanine	C032348
2645	16369751	311	315	ChemicalEntity	FBAL	C032348
2646	16369751	335	342	OrganismTaxon	patient	9606
2647	16369751	365	377	DiseaseOrPhenotypicFeature	colon cancer	D003110
2648	16369751	378	388	DiseaseOrPhenotypicFeature	metastases	D009362
2649	16369751	525	532	OrganismTaxon	patient	9606
2650	16369751	579	583	ChemicalEntity	5-FU	D005472
2651	16369751	612	627	DiseaseOrPhenotypicFeature	precordial pain	D002637
2652	16369751	633	658	DiseaseOrPhenotypicFeature	right bundle branch block	D002037
2653	16369751	700	704	ChemicalEntity	FBAL	C032348
2654	16369751	743	758	DiseaseOrPhenotypicFeature	precordial pain	D002637
2655	16369751	851	855	ChemicalEntity	5-FU	D005472
2656	16369751	864	879	DiseaseOrPhenotypicFeature	precordial pain	D002637
2657	16369751	888	895	OrganismTaxon	patient	9606
2658	16369751	931	935	ChemicalEntity	5-FU	D005472
2659	16369751	944	958	DiseaseOrPhenotypicFeature	cardiotoxicity	D066126
2660	16369751	982	986	ChemicalEntity	5-FU	D005472
2661	16369751	1034	1037	ChemicalEntity	S-1	C079198
2662	16369751	1055	1059	ChemicalEntity	5-FU	D005472
2663	16369751	1114	1117	ChemicalEntity	S-1	C079198
2664	16369751	1152	1169	ChemicalEntity	dihydropyrimidine	-
2665	16369751	1220	1224	ChemicalEntity	5-FU	D005472
2666	16369751	1230	1234	ChemicalEntity	FBAL	C032348
2667	16369751	1246	1250	ChemicalEntity	FBAL	C032348
2668	16369751	1353	1356	ChemicalEntity	S-1	C079198
2669	16369751	1388	1404	DiseaseOrPhenotypicFeature	cardiac symptoms	D006331
2670	16369751	1424	1431	OrganismTaxon	patient	9606
2671	16369751	1497	1500	ChemicalEntity	S-1	C079198
2672	16369751	1597	1601	ChemicalEntity	FBAL	C032348
2673	16369751	1616	1620	ChemicalEntity	5-FU	D005472
2674	16369751	1629	1643	DiseaseOrPhenotypicFeature	cardiotoxicity	D066126
2675	16369751	1645	1648	ChemicalEntity	S-1	C079198
2676	16369751	1679	1687	OrganismTaxon	patients	9606
2677	16369751	1693	1697	ChemicalEntity	5-FU	D005472
2678	16369751	1706	1720	DiseaseOrPhenotypicFeature	cardiotoxicity	D066126
2679	16391785	50	55	GeneOrGeneProduct	DOCK8	81704
2680	16391785	64	69	OrganismTaxon	human	9606
2681	16391785	70	81	DiseaseOrPhenotypicFeature	lung cancer	D008175
2682	16391785	112	117	GeneOrGeneProduct	DOCK8	81704
2683	16391785	119	145	GeneOrGeneProduct	dedicator of cytokinesis 8	81704
2684	16391785	187	198	DiseaseOrPhenotypicFeature	lung cancer	D008175
2685	16391785	259	264	GeneOrGeneProduct	DOCK8	81704
2686	16391785	296	301	GeneOrGeneProduct	DOCK8	81704
2687	16391785	358	363	GeneOrGeneProduct	DOCK8	81704
2688	16391785	394	399	OrganismTaxon	human	9606
2689	16391785	574	585	DiseaseOrPhenotypicFeature	lung cancer	D008175
2690	16391785	593	598	GeneOrGeneProduct	DOCK8	81704
2691	16391785	645	657	DiseaseOrPhenotypicFeature	lung cancers	D008175
2692	16391785	760	771	DiseaseOrPhenotypicFeature	lung cancer	D008175
2693	16391785	773	796	ChemicalEntity	5-Aza-2'-deoxy-cytidine	D000077209
2694	16391785	804	818	ChemicalEntity	Trichostatin A	C012589
2695	16391785	838	843	GeneOrGeneProduct	DOCK8	81704
2696	16391785	858	869	DiseaseOrPhenotypicFeature	lung cancer	D008175
2697	16391785	894	899	GeneOrGeneProduct	DOCK8	81704
2698	16391785	1032	1037	GeneOrGeneProduct	DOCK8	81704
2699	16391785	1057	1068	DiseaseOrPhenotypicFeature	lung cancer	D008175
2700	16391785	1131	1136	GeneOrGeneProduct	DOCK8	81704
2701	16391785	1161	1174	DiseaseOrPhenotypicFeature	breast cancer	D001943
2702	16391785	1186	1190	GeneOrGeneProduct	DOCK	81704
2703	16391785	1385	1390	GeneOrGeneProduct	DOCK8	81704
2704	16391785	1444	1466	DiseaseOrPhenotypicFeature	lung and other cancers	D008175,D009369
2705	16410744	31	44	DiseaseOrPhenotypicFeature	glioblastomas	D005909
2706	16410744	99	112	DiseaseOrPhenotypicFeature	glioblastomas	D005909
2707	16410744	153	159	DiseaseOrPhenotypicFeature	tumors	D009369
2708	16410744	182	190	OrganismTaxon	patients	9606
2709	16410744	330	343	DiseaseOrPhenotypicFeature	glioblastomas	D005909
2710	16410744	356	364	OrganismTaxon	patients	9606
2711	16410744	407	411	GeneOrGeneProduct	TP53	7157
2712	16410744	440	453	DiseaseOrPhenotypicFeature	glioblastomas	D005909
2713	16410744	458	462	GeneOrGeneProduct	PTEN	5728
2714	16410744	546	550	GeneOrGeneProduct	EGFR	1956
2715	16410744	593	596	GeneOrGeneProduct	p16	1029
2716	16410744	714	727	DiseaseOrPhenotypicFeature	glioblastomas	D005909
2717	16410744	817	830	DiseaseOrPhenotypicFeature	glioblastomas	D005909
2718	16410744	898	911	DiseaseOrPhenotypicFeature	glioblastomas	D005909
2719	16410744	964	968	GeneOrGeneProduct	EGFR	1956
2720	16410744	987	990	GeneOrGeneProduct	p16	1029
2721	16410744	1060	1064	GeneOrGeneProduct	TP53	7157
2722	16410744	1079	1082	GeneOrGeneProduct	p16	1029
2723	16410744	1105	1118	DiseaseOrPhenotypicFeature	glioblastomas	D005909
2724	16410744	1228	1240	DiseaseOrPhenotypicFeature	glioblastoma	D005909
2725	16410744	1241	1249	OrganismTaxon	patients	9606
2726	16410744	1335	1339	GeneOrGeneProduct	EGFR	1956
2727	16410744	1383	1396	DiseaseOrPhenotypicFeature	glioblastomas	D005909
2728	16410744	1426	1439	DiseaseOrPhenotypicFeature	glioblastomas	D005909
2729	16410744	1499	1516	SequenceVariant	codon 787 CAG/CAA	p|SUB|Q|787|Q
2730	16410744	1518	1525	SequenceVariant	Gln/Gln	p|SUB|Q||Q
2731	16410744	1530	1543	DiseaseOrPhenotypicFeature	glioblastomas	D005909
2732	16410744	1675	1688	DiseaseOrPhenotypicFeature	glioblastomas	D005909
2733	16410744	1833	1846	DiseaseOrPhenotypicFeature	glioblastomas	D005909
2734	16410744	2068	2072	GeneOrGeneProduct	EGFR	1956
2735	16412238	0	49	GeneOrGeneProduct	Peroxisomal proliferator activated receptor-gamma	5468
2736	16412238	88	125	DiseaseOrPhenotypicFeature	familial partial lipodystrophy type 3	D052496
2737	16412238	127	132	DiseaseOrPhenotypicFeature	FPLD3	D052496
2738	16412238	147	195	DiseaseOrPhenotypicFeature	Familial partial lipodystrophy (Dunnigan) type 3	D052496
2739	16412238	197	202	DiseaseOrPhenotypicFeature	FPLD3	D052496
2740	16412238	204	245	DiseaseOrPhenotypicFeature	Mendelian Inheritance in Man [MIM] 604367	D052496
2741	16412238	286	291	GeneOrGeneProduct	PPARG	5468
2742	16412238	301	350	GeneOrGeneProduct	peroxisomal proliferator-activated receptor-gamma	5468
2743	16412238	480	485	DiseaseOrPhenotypicFeature	FPLD3	D052496
2744	16412238	638	656	DiseaseOrPhenotypicFeature	insulin resistance	D007333
2745	16412238	658	666	DiseaseOrPhenotypicFeature	diabetes	D003920
2746	16412238	675	695	DiseaseOrPhenotypicFeature	hypertriglyceridemia	D015228
2747	16412238	710	722	DiseaseOrPhenotypicFeature	pancreatitis	D010195
2748	16412238	805	818	ChemicalEntity	triglycerides	D014280
2749	16412238	823	832	ChemicalEntity	C-peptide	D002096
2750	16412238	847	883	ChemicalEntity	high-density lipoprotein cholesterol	D008076
2751	16412238	945	950	GeneOrGeneProduct	PPARG	5468
2752	16412238	969	974	SequenceVariant	Y355X	p|SUB|Y|355|X
2753	16412238	1222	1227	OrganismTaxon	human	9606
2754	16412238	1228	1233	GeneOrGeneProduct	PPARG	5468
2755	16412238	1273	1283	GeneOrGeneProduct	PPAR-gamma	5468
2756	16412238	1465	1470	DiseaseOrPhenotypicFeature	FPLD3	D052496
2757	16418600	29	35	GeneOrGeneProduct	TSPYL1	7259
2758	16418600	44	72	DiseaseOrPhenotypicFeature	sudden infant death syndrome	D013398
2759	16418600	86	114	DiseaseOrPhenotypicFeature	Sudden infant death syndrome	D013398
2760	16418600	116	120	DiseaseOrPhenotypicFeature	SIDS	D013398
2761	16418600	161	166	DiseaseOrPhenotypicFeature	death	D003643
2762	16418600	253	311	DiseaseOrPhenotypicFeature	sudden infant death with dysgenesis of the testes syndrome	C563856
2763	16418600	313	318	DiseaseOrPhenotypicFeature	SIDDT	C563856
2764	16418600	385	391	GeneOrGeneProduct	TSPYL1	7259
2765	16418600	460	466	GeneOrGeneProduct	TSPYL1	7259
2766	16418600	470	474	DiseaseOrPhenotypicFeature	SIDS	D013398
2767	16418600	504	508	DiseaseOrPhenotypicFeature	SIDS	D013398
2768	16418600	737	745	OrganismTaxon	patients	9606
2769	16418600	806	813	OrganismTaxon	patient	9606
2770	16418600	816	823	SequenceVariant	p.F366L	rs140756663
2771	16418600	1045	1050	DiseaseOrPhenotypicFeature	SIDDT	C563856
2772	16418600	1079	1085	GeneOrGeneProduct	TSPYL1	7259
2773	16418600	1150	1162	DiseaseOrPhenotypicFeature	sudden death	D003645
2774	16418600	1216	1221	DiseaseOrPhenotypicFeature	SIDDT	C563856
2775	16418600	1223	1234	SequenceVariant	457_458insG	c|INS|457_458|G
2776	16418600	1327	1333	GeneOrGeneProduct	TSPYL1	7259
2777	16418600	1343	1347	DiseaseOrPhenotypicFeature	SIDS	D013398
2778	16418600	1403	1409	GeneOrGeneProduct	TSPYL1	7259
2779	16418600	1479	1483	DiseaseOrPhenotypicFeature	SIDS	D013398
2780	16418600	1492	1516	DiseaseOrPhenotypicFeature	dysgenesis of the testes	D013733
2781	16506214	25	30	GeneOrGeneProduct	COX-2	4513
2782	16506214	61	76	DiseaseOrPhenotypicFeature	prostate cancer	D011471
2783	16506214	83	88	GeneOrGeneProduct	COX-2	4513
2784	16506214	126	142	ChemicalEntity	arachidonic acid	D016718
2785	16506214	146	160	ChemicalEntity	prostaglandins	D011453
2786	16506214	166	180	ChemicalEntity	prostaglandins	D011453
2787	16506214	193	198	GeneOrGeneProduct	COX-2	4513
2788	16506214	215	227	DiseaseOrPhenotypicFeature	inflammation	D007249
2789	16506214	232	236	DiseaseOrPhenotypicFeature	pain	D010146
2790	16506214	406	411	GeneOrGeneProduct	COX-2	4513
2791	16506214	428	433	OrganismTaxon	human	9606
2792	16506214	434	448	DiseaseOrPhenotypicFeature	carcinogenesis	D009369
2793	16506214	473	488	DiseaseOrPhenotypicFeature	prostate cancer	D011471
2794	16506214	542	547	GeneOrGeneProduct	COX-2	4513
2795	16506214	573	588	DiseaseOrPhenotypicFeature	prostate cancer	D011471
2796	16506214	652	667	DiseaseOrPhenotypicFeature	cancer prostate	D011471
2797	16506214	804	809	GeneOrGeneProduct	COX-2	4513
2798	16506214	968	976	OrganismTaxon	patients	9606
2799	16506214	1163	1172	SequenceVariant	+3100 T/G	c|SUB|T|+3100|G
2800	16506214	1177	1186	SequenceVariant	+8365 C/T	c|SUB|C|+8365|T
2801	16506214	1354	1363	SequenceVariant	+3100 T/G	c|SUB|T|+3100|G
2802	16506214	1368	1377	SequenceVariant	+8365 C/T	c|SUB|C|+8365|T
2803	16506214	1471	1486	DiseaseOrPhenotypicFeature	prostate cancer	D011471
2804	16506214	1570	1582	DiseaseOrPhenotypicFeature	inflammation	D007249
2805	16506214	1598	1621	DiseaseOrPhenotypicFeature	prostate carcinogenesis	D011471
2806	16506214	1661	1666	GeneOrGeneProduct	COX-2	4513
2807	16506214	1694	1709	DiseaseOrPhenotypicFeature	prostate cancer	D011471
2808	16526029	14	18	GeneOrGeneProduct	RGS4	5999
2809	16526029	43	56	DiseaseOrPhenotypicFeature	schizophrenia	D012559
2810	16526029	98	132	GeneOrGeneProduct	regulator of G-protein signaling 4	5999
2811	16526029	134	138	GeneOrGeneProduct	RGS4	5999
2812	16526029	194	207	DiseaseOrPhenotypicFeature	schizophrenia	D012559
2813	16526029	328	332	GeneOrGeneProduct	RGS4	5999
2814	16526029	545	558	DiseaseOrPhenotypicFeature	schizophrenia	D012559
2815	16526029	712	725	DiseaseOrPhenotypicFeature	schizophrenia	D012559
2816	16526029	876	889	DiseaseOrPhenotypicFeature	schizophrenia	D012559
2817	16526029	923	927	GeneOrGeneProduct	RGS4	5999
2818	16526029	952	965	DiseaseOrPhenotypicFeature	schizophrenia	D012559
2819	16541406	44	48	GeneOrGeneProduct	MLH1	4292
2820	16541406	53	57	GeneOrGeneProduct	MSH2	4436
2821	16541406	128	142	DiseaseOrPhenotypicFeature	Lynch syndrome	D003123
2822	16541406	144	149	DiseaseOrPhenotypicFeature	HNPCC	D003123
2823	16541406	219	223	GeneOrGeneProduct	MLH1	4292
2824	16541406	228	232	GeneOrGeneProduct	MSH2	4436
2825	16541406	257	271	DiseaseOrPhenotypicFeature	Lynch Syndrome	D003123
2826	16541406	273	278	DiseaseOrPhenotypicFeature	HNPCC	D003123
2827	16541406	280	288	OrganismTaxon	patients	9606
2828	16541406	448	452	GeneOrGeneProduct	MLH1	4292
2829	16541406	466	470	GeneOrGeneProduct	MSH2	4436
2830	16541406	547	551	GeneOrGeneProduct	MSH2	4436
2831	16541406	690	694	GeneOrGeneProduct	MLH1	4292
2832	16541406	990	994	GeneOrGeneProduct	MSH2	4436
2833	16541406	1014	1018	GeneOrGeneProduct	MLH1	4292
2834	16541406	1303	1307	GeneOrGeneProduct	MLH1	4292
2835	16541406	1312	1316	GeneOrGeneProduct	MSH2	4436
2836	16574712	0	4	ChemicalEntity	MDMA	D018817
2837	16574712	85	134	DiseaseOrPhenotypicFeature	impaired social and emotional judgement processes	D003072
2838	16574712	160	175	DiseaseOrPhenotypicFeature	memory deficits	D008569
2839	16574712	207	211	ChemicalEntity	MDMA	D018817
2840	16574712	213	246	ChemicalEntity	3,4-methylenedioxymethamphetamine	D018817
2841	16574712	248	255	ChemicalEntity	ecstasy	D018817
2842	16574712	306	310	ChemicalEntity	MDMA	D018817
2843	16574712	501	508	ChemicalEntity	ecstasy	D018817
2844	16574712	535	542	ChemicalEntity	ecstasy	D018817
2845	16574712	865	869	ChemicalEntity	MDMA	D018817
2846	16574712	894	898	ChemicalEntity	MDMA	D018817
2847	16574712	1246	1253	ChemicalEntity	ecstasy	D018817
2848	16574713	20	41	GeneOrGeneProduct	serotonin transporter	6532
2849	16574713	72	79	ChemicalEntity	ecstasy	D018817
2850	16574713	81	85	ChemicalEntity	MDMA	D018817
2851	16574713	103	136	ChemicalEntity	3,4-methylenedioxymethamphetamine	D018817
2852	16574713	138	142	ChemicalEntity	MDMA	D018817
2853	16574713	146	153	ChemicalEntity	ecstasy	D018817
2854	16574713	186	195	ChemicalEntity	serotonin	D012701
2855	16574713	197	201	ChemicalEntity	5-HT	D012701
2856	16574713	235	241	OrganismTaxon	humans	9606
2857	16574713	295	299	ChemicalEntity	MDMA	D018817
2858	16574713	308	312	ChemicalEntity	5-HT	D012701
2859	16574713	313	331	DiseaseOrPhenotypicFeature	neurotoxic lesions	D020258
2860	16574713	354	358	ChemicalEntity	5-HT	D012701
2861	16574713	408	412	ChemicalEntity	5-HT	D012701
2862	16574713	475	479	ChemicalEntity	5-HT	D012701
2863	16574713	585	622	GeneOrGeneProduct	5-HT transporter promoter gene region	6532
2864	16574713	624	632	GeneOrGeneProduct	5-HTTLPR	6532
2865	16574713	663	667	ChemicalEntity	MDMA	D018817
2866	16574713	776	780	ChemicalEntity	MDMA	D018817
2867	16574713	860	864	ChemicalEntity	MDMA	D018817
2868	16574713	892	900	GeneOrGeneProduct	5-HTTLPR	6532
2869	16574713	1014	1018	ChemicalEntity	MDMA	D018817
2870	16574713	1058	1062	ChemicalEntity	MDMA	D018817
2871	16574713	1100	1104	ChemicalEntity	MDMA	D018817
2872	16574713	1269	1277	GeneOrGeneProduct	5-HTTLPR	6532
2873	16574713	1505	1509	ChemicalEntity	MDMA	D018817
2874	16574713	1607	1624	DiseaseOrPhenotypicFeature	memory impairment	D008569
2875	16574713	1650	1654	ChemicalEntity	MDMA	D018817
2876	16574713	1687	1695	GeneOrGeneProduct	5-HTTLPR	6532
2877	16574713	1737	1741	ChemicalEntity	MDMA	D018817
2878	16574713	1813	1840	DiseaseOrPhenotypicFeature	impaired memory functioning	D008569
2879	16574713	1855	1859	ChemicalEntity	MDMA	D018817
2880	16574713	1889	1907	DiseaseOrPhenotypicFeature	memory impairments	D008569
2881	16574713	1922	1930	GeneOrGeneProduct	5-HTTLPR	6532
2882	16574713	1963	1967	ChemicalEntity	MDMA	D018817
2883	16575011	0	5	DiseaseOrPhenotypicFeature	Tumor	D009369
2884	16575011	6	26	GeneOrGeneProduct	thymidylate synthase	7298
2885	16575011	27	35	SequenceVariant	1494del6	c|DEL|1494|6
2886	16575011	71	88	DiseaseOrPhenotypicFeature	colorectal cancer	D015179
2887	16575011	89	97	OrganismTaxon	patients	9606
2888	16575011	108	120	ChemicalEntity	fluorouracil	D005472
2889	16575011	223	228	DiseaseOrPhenotypicFeature	tumor	D009369
2890	16575011	229	249	GeneOrGeneProduct	thymidylate synthase	7298
2891	16575011	251	253	GeneOrGeneProduct	TS	7298
2892	16575011	304	321	DiseaseOrPhenotypicFeature	colorectal cancer	D015179
2893	16575011	322	330	OrganismTaxon	patients	9606
2894	16575011	350	362	ChemicalEntity	fluorouracil	D005472
2895	16575011	364	366	ChemicalEntity	FU	D005472
2896	16575011	386	394	OrganismTaxon	PATIENTS	9606
2897	16575011	432	449	DiseaseOrPhenotypicFeature	colorectal cancer	D015179
2898	16575011	450	458	OrganismTaxon	patients	9606
2899	16575011	486	488	ChemicalEntity	FU	D005472
2900	16575011	494	504	ChemicalEntity	levamisole	D007978
2901	16575011	508	518	ChemicalEntity	leucovorin	D002955
2902	16575011	558	560	GeneOrGeneProduct	TS	7298
2903	16575011	581	586	SequenceVariant	G > C	c|SUB|G||C
2904	16575011	629	631	GeneOrGeneProduct	TS	7298
2905	16575011	632	640	SequenceVariant	1494del6	c|DEL|1494|6
2906	16575011	708	713	DiseaseOrPhenotypicFeature	tumor	D009369
2907	16575011	738	740	GeneOrGeneProduct	TS	7298
2908	16575011	792	798	DiseaseOrPhenotypicFeature	tumors	D009369
2909	16575011	832	842	DiseaseOrPhenotypicFeature	metastases	D009362
2910	16575011	844	846	GeneOrGeneProduct	TS	7298
2911	16575011	912	918	DiseaseOrPhenotypicFeature	tumors	D009369
2912	16575011	1009	1014	DiseaseOrPhenotypicFeature	Tumor	D009369
2913	16575011	1214	1219	SequenceVariant	G > C	c|SUB|G||C
2914	16575011	1271	1276	DiseaseOrPhenotypicFeature	Tumor	D009369
2915	16575011	1277	1279	GeneOrGeneProduct	TS	7298
2916	16575011	1280	1288	SequenceVariant	1494del6	c|DEL|1494|6
2917	16575011	1717	1719	GeneOrGeneProduct	TS	7298
2918	16575011	1759	1765	DiseaseOrPhenotypicFeature	tumors	D009369
2919	16575011	1769	1779	DiseaseOrPhenotypicFeature	metastases	D009362
2920	16575011	1781	1783	GeneOrGeneProduct	TS	7298
2921	16575011	1886	1891	DiseaseOrPhenotypicFeature	Tumor	D009369
2922	16575011	1892	1894	GeneOrGeneProduct	TS	7298
2923	16575011	1895	1903	SequenceVariant	1494del6	c|DEL|1494|6
2924	16575011	1943	1945	ChemicalEntity	FU	D005472
2925	16575011	1974	1991	DiseaseOrPhenotypicFeature	colorectal cancer	D015179
2926	16575011	1992	2000	OrganismTaxon	patients	9606
2927	16596970	0	11	ChemicalEntity	Pilocarpine	D010862
2928	16596970	12	20	DiseaseOrPhenotypicFeature	seizures	D012640
2929	16596970	41	87	DiseaseOrPhenotypicFeature	impairment in auditory location discrimination	D001308
2930	16596970	107	125	DiseaseOrPhenotypicFeature	status epilepticus	D013226
2931	16596970	163	171	DiseaseOrPhenotypicFeature	seizures	D012640
2932	16596970	276	294	DiseaseOrPhenotypicFeature	status epilepticus	D013226
2933	16596970	302	337	DiseaseOrPhenotypicFeature	deficits in auditory discrimination	D001308
2934	16596970	465	483	DiseaseOrPhenotypicFeature	status epilepticus	D013226
2935	16596970	505	509	OrganismTaxon	rats	10116
2936	16596970	585	596	ChemicalEntity	pilocarpine	D010862
2937	16596970	612	623	ChemicalEntity	Pilocarpine	D010862
2938	16596970	646	664	DiseaseOrPhenotypicFeature	status epilepticus	D013226
2939	16596970	666	684	DiseaseOrPhenotypicFeature	status epilepticus	D013226
2940	16596970	704	707	CellLine	CA3	10090
2941	16596970	734	742	DiseaseOrPhenotypicFeature	seizures	D012640
2942	16596970	756	760	OrganismTaxon	rats	10116
2943	16596970	793	801	DiseaseOrPhenotypicFeature	seizures	D012640
2944	16596970	810	814	OrganismTaxon	rats	10116
2945	16596970	911	915	OrganismTaxon	rats	10116
2946	16596970	962	980	DiseaseOrPhenotypicFeature	status epilepticus	D013226
2947	16596970	987	991	OrganismTaxon	rats	10116
2948	16596970	1074	1092	DiseaseOrPhenotypicFeature	Status epilepticus	D013226
2949	16596970	1099	1103	OrganismTaxon	rats	10116
2950	16596970	1185	1203	DiseaseOrPhenotypicFeature	Status epilepticus	D013226
2951	16596970	1207	1210	OrganismTaxon	rat	10116
2952	16596970	1246	1283	DiseaseOrPhenotypicFeature	impairment in auditory discrimination	D001308
2953	16596970	1326	1367	DiseaseOrPhenotypicFeature	impaired auditory location discrimination	D001308
2954	16596970	1371	1377	OrganismTaxon	humans	9606
2955	16611040	17	32	DiseaseOrPhenotypicFeature	cystic fibrosis	D003550
2956	16611040	79	94	DiseaseOrPhenotypicFeature	Cystic fibrosis	D003550
2957	16611040	96	98	DiseaseOrPhenotypicFeature	CF	D003550
2958	16611040	121	140	DiseaseOrPhenotypicFeature	inherited disorders	D030342
2959	16611040	291	309	DiseaseOrPhenotypicFeature	inherited diseases	D030342
2960	16611040	347	398	GeneOrGeneProduct	cystic fibrosis transmembrane conductance regulator	1080
2961	16611040	462	464	DiseaseOrPhenotypicFeature	CF	D003550
2962	16611040	626	628	DiseaseOrPhenotypicFeature	CF	D003550
2963	16611040	740	759	DiseaseOrPhenotypicFeature	inherited disorders	D030342
2964	16611040	829	831	DiseaseOrPhenotypicFeature	CF	D003550
2965	16611040	1054	1056	DiseaseOrPhenotypicFeature	CF	D003550
2966	16611040	1089	1091	DiseaseOrPhenotypicFeature	CF	D003550
2967	16611040	1280	1282	DiseaseOrPhenotypicFeature	CF	D003550
2968	16611040	1577	1579	DiseaseOrPhenotypicFeature	CF	D003550
2969	16611040	1580	1588	OrganismTaxon	patients	9606
2970	16720068	9	39	DiseaseOrPhenotypicFeature	neuroleptic malignant syndrome	D009459
2971	16720068	78	88	ChemicalEntity	paroxetine	D017374
2972	16720068	93	103	ChemicalEntity	alprazolam	D000525
2973	16720068	119	122	OrganismTaxon	man	9606
2974	16720068	128	147	DiseaseOrPhenotypicFeature	depressive symptoms	D003866
2975	16720068	166	177	DiseaseOrPhenotypicFeature	psychiatric	D001523
2976	16720068	194	202	DiseaseOrPhenotypicFeature	insomnia	D007319
2977	16720068	204	220	DiseaseOrPhenotypicFeature	loss of appetite	D001068
2978	16720068	238	247	DiseaseOrPhenotypicFeature	agitation	D011595
2979	16720068	306	316	ChemicalEntity	paroxetine	D017374
2980	16720068	328	338	ChemicalEntity	alprazolam	D000525
2981	16720068	359	369	ChemicalEntity	paroxetine	D017374
2982	16720068	374	384	ChemicalEntity	alprazolam	D000525
2983	16720068	400	407	OrganismTaxon	patient	9606
2984	16720068	425	448	DiseaseOrPhenotypicFeature	psychomotor retardation	D011596
2985	16720068	477	492	DiseaseOrPhenotypicFeature	muscle rigidity	D009127
2986	16720068	498	505	DiseaseOrPhenotypicFeature	tremors	D014202
2987	16720068	511	518	OrganismTaxon	patient	9606
2988	16720068	525	530	DiseaseOrPhenotypicFeature	fever	D005334
2989	16720068	625	648	DiseaseOrPhenotypicFeature	extrapyramidal symptoms	D001480
2990	16720068	690	712	ChemicalEntity	creatine phosphokinase	D003402
2991	16720068	726	752	ChemicalEntity	aspartate aminotransferase	D001219
2992	16720068	765	789	ChemicalEntity	alanine aminotransferase	D000410
2993	16720068	834	841	OrganismTaxon	patient	9606
2994	16720068	851	864	ChemicalEntity	bromocriptine	D001971
2995	16720068	869	877	ChemicalEntity	diazepam	D003975
2996	16720068	919	924	DiseaseOrPhenotypicFeature	fever	D005334
2997	16720068	945	952	OrganismTaxon	patient	9606
2998	16720068	961	964	ChemicalEntity	CPK	D003402
2999	16720068	1005	1012	OrganismTaxon	patient	9606
3000	16720068	1040	1070	DiseaseOrPhenotypicFeature	neuroleptic malignant syndrome	D009459
3001	16720068	1072	1075	DiseaseOrPhenotypicFeature	NMS	D009459
3002	16720068	1102	1105	DiseaseOrPhenotypicFeature	NMS	D009459
3003	16720068	1145	1155	ChemicalEntity	paroxetine	D017374
3004	16720068	1160	1170	ChemicalEntity	alprazolam	D000525
3005	16720068	1314	1321	OrganismTaxon	patient	9606
3006	16720068	1324	1327	DiseaseOrPhenotypicFeature	NMS	D009459
3007	16720068	1470	1477	OrganismTaxon	patient	9606
3008	16720068	1518	1521	DiseaseOrPhenotypicFeature	NMS	D009459
3009	16720068	1549	1559	DiseaseOrPhenotypicFeature	depressive	D003866
3010	16720068	1560	1568	OrganismTaxon	patients	9606
3011	16720068	1598	1609	DiseaseOrPhenotypicFeature	dehydration	D003681
3012	16720068	1611	1620	DiseaseOrPhenotypicFeature	agitation	D011595
3013	16720068	1622	1634	DiseaseOrPhenotypicFeature	malnutrition	D044342
3014	16720068	1725	1733	OrganismTaxon	patients	9606
3015	16720068	1750	1760	DiseaseOrPhenotypicFeature	depression	D003866
3016	16781314	0	44	DiseaseOrPhenotypicFeature	Ectodermal dysplasia-skin fragility syndrome	C536183
3017	16781314	87	94	SequenceVariant	888delC	c|DEL888|C
3018	16781314	122	135	GeneOrGeneProduct	plakophilin 1	5317
3019	16781314	169	187	DiseaseOrPhenotypicFeature	inherited disorder	D030342
3020	16781314	214	227	GeneOrGeneProduct	plakophilin 1	5317
3021	16781314	242	286	DiseaseOrPhenotypicFeature	ectodermal dysplasia-skin fragility syndrome	C536183
3022	16781314	365	379	DiseaseOrPhenotypicFeature	skin fragility	C536183
3023	16781314	393	412	DiseaseOrPhenotypicFeature	plantar keratoderma	D017499
3024	16781314	414	428	DiseaseOrPhenotypicFeature	nail dystrophy	D009260
3025	16781314	434	442	DiseaseOrPhenotypicFeature	alopecia	D000505
3026	16781314	597	610	GeneOrGeneProduct	plakophilin 1	5317
3027	16781314	616	620	GeneOrGeneProduct	PKP1	5317
3028	16781314	643	674	SequenceVariant	deletion of C at nucleotide 888	c|DEL888|C
3029	16781314	721	725	GeneOrGeneProduct	PKP1	5317
3030	16781314	803	817	DiseaseOrPhenotypicFeature	genodermatosis	D012873
3031	16781314	912	925	GeneOrGeneProduct	plakophilin 1	5317
3032	16801510	13	29	DiseaseOrPhenotypicFeature	long QT syndrome	D008133
3033	16801510	64	73	ChemicalEntity	methadone	D008691
3034	16801510	106	114	OrganismTaxon	patients	9606
3035	16801510	158	174	DiseaseOrPhenotypicFeature	long QT syndrome	D008133
3036	16801510	211	220	ChemicalEntity	Methadone	D008691
3037	16801510	290	299	OrganismTaxon	inpatient	9606
3038	16801510	326	350	DiseaseOrPhenotypicFeature	QT interval prolongation	D008133
3039	16801510	356	365	ChemicalEntity	methadone	D008691
3040	16801510	593	602	ChemicalEntity	methadone	D008691
3041	16801510	627	636	ChemicalEntity	methadone	D008691
3042	16801510	647	655	OrganismTaxon	patients	9606
3043	16801510	734	742	OrganismTaxon	patients	9606
3044	16801510	753	762	ChemicalEntity	methadone	D008691
3045	16801510	876	885	ChemicalEntity	methadone	D008691
3046	16801510	902	911	ChemicalEntity	methadone	D008691
3047	16801510	1022	1037	DiseaseOrPhenotypicFeature	QT prolongation	D008133
3048	16801510	1058	1067	ChemicalEntity	methadone	D008691
3049	16801510	1080	1088	OrganismTaxon	patients	9606
3050	16801510	1108	1124	DiseaseOrPhenotypicFeature	QTc prolongation	D008133
3051	16801510	1212	1220	OrganismTaxon	patients	9606
3052	16801510	1235	1244	ChemicalEntity	methadone	D008691
3053	16801510	1261	1280	DiseaseOrPhenotypicFeature	torsades de pointes	D016171
3054	16801510	1338	1347	ChemicalEntity	methadone	D008691
3055	16801510	1497	1506	ChemicalEntity	methadone	D008691
3056	16801510	1513	1533	GeneOrGeneProduct	cytochrome P-450 3A4	1576
3057	16801510	1558	1569	DiseaseOrPhenotypicFeature	hypokalemia	D007008
3058	16801510	1612	1636	DiseaseOrPhenotypicFeature	QT interval prolongation	D008133
3059	16801510	1640	1649	ChemicalEntity	methadone	D008691
3060	16801510	1662	1670	OrganismTaxon	patients	9606
3061	16801510	1733	1742	ChemicalEntity	Methadone	D008691
3062	16801510	1761	1792	ChemicalEntity	cytochrome P-450 3A4 inhibitors	D065692
3063	16801510	1794	1803	ChemicalEntity	potassium	D011188
3064	16801510	1844	1859	DiseaseOrPhenotypicFeature	QT prolongation	D008133
3065	16801510	1861	1877	DiseaseOrPhenotypicFeature	Long QT syndrome	D008133
3066	16801510	1906	1915	ChemicalEntity	methadone	D008691
3067	16810074	14	26	DiseaseOrPhenotypicFeature	hypertension	D006973
3068	16810074	38	50	ChemicalEntity	nitric oxide	D009569
3069	16810074	52	54	ChemicalEntity	NO	D009569
3070	16810074	127	139	ChemicalEntity	nitric oxide	D009569
3071	16810074	141	143	ChemicalEntity	NO	D009569
3072	16810074	148	160	DiseaseOrPhenotypicFeature	hypertension	D006973
3073	16810074	178	198	DiseaseOrPhenotypicFeature	arterial dysfunction	D018754
3074	16810074	213	225	DiseaseOrPhenotypicFeature	hypertension	D006973
3075	16810074	252	254	ChemicalEntity	NO	D009569
3076	16810074	365	377	GeneOrGeneProduct	endothelin-1	24323
3077	16810074	379	383	GeneOrGeneProduct	ET-1	24323
3078	16810074	564	587	ChemicalEntity	Nomega-nitro-L-arginine	D019335
3079	16810074	589	593	ChemicalEntity	LNNA	D019335
3080	16810074	595	607	DiseaseOrPhenotypicFeature	hypertension	D006973
3081	16810074	634	638	OrganismTaxon	Rats	10116
3082	16810074	661	672	GeneOrGeneProduct	NO synthase	24598
3083	16810074	683	687	ChemicalEntity	LNNA	D019335
3084	16810074	765	769	OrganismTaxon	rats	10116
3085	16810074	824	828	ChemicalEntity	LNNA	D019335
3086	16810074	829	833	OrganismTaxon	rats	10116
3087	16810074	953	967	ChemicalEntity	norepinephrine	D009638
3088	16810074	1006	1010	ChemicalEntity	LNNA	D019335
3089	16810074	1033	1037	OrganismTaxon	rats	10116
3090	16810074	1073	1077	GeneOrGeneProduct	ET-1	24323
3091	16810074	1155	1169	ChemicalEntity	norepinephrine	D009638
3092	16810074	1230	1234	GeneOrGeneProduct	ET-1	24323
3093	16810074	1342	1346	ChemicalEntity	LNNA	D019335
3094	16810074	1347	1359	DiseaseOrPhenotypicFeature	hypertension	D006973
3095	16810074	1382	1386	ChemicalEntity	LNNA	D019335
3096	16810074	1392	1402	ChemicalEntity	superoxide	D013481
3097	16810074	1413	1419	ChemicalEntity	tempol	C001803
3098	16810074	1503	1507	OrganismTaxon	rats	10116
3099	16810074	1548	1552	ChemicalEntity	LNNA	D019335
3100	16810074	1553	1557	OrganismTaxon	rats	10116
3101	16810074	1641	1654	ChemicalEntity	hexamethonium	D018738
3102	16810074	1694	1698	ChemicalEntity	LNNA	D019335
3103	16810074	1699	1711	DiseaseOrPhenotypicFeature	hypertensive	D006973
3104	16810074	1712	1716	OrganismTaxon	rats	10116
3105	16810074	1756	1760	OrganismTaxon	rats	10116
3106	16810074	1838	1842	ChemicalEntity	LNNA	D019335
3107	16810074	1843	1847	OrganismTaxon	rats	10116
3108	16810074	1875	1885	ChemicalEntity	superoxide	D013481
3109	16810074	1919	1923	OrganismTaxon	rats	10116
3110	16810074	1955	1957	ChemicalEntity	NO	D009569
3111	16810074	2129	2141	DiseaseOrPhenotypicFeature	hypertension	D006973
3112	16820346	0	12	ChemicalEntity	Atorvastatin	D000069059
3113	16820346	36	49	ChemicalEntity	dexamethasone	D003907
3114	16820346	58	70	DiseaseOrPhenotypicFeature	hypertension	D006973
3115	16820346	78	81	OrganismTaxon	rat	10116
3116	16820346	97	108	ChemicalEntity	antioxidant	D000975
3117	16820346	120	132	ChemicalEntity	atorvastatin	D000069059
3118	16820346	134	140	ChemicalEntity	atorva	D000069059
3119	16820346	145	158	ChemicalEntity	dexamethasone	D003907
3120	16820346	160	163	ChemicalEntity	dex	D003907
3121	16820346	173	185	DiseaseOrPhenotypicFeature	hypertension	D006973
3122	16820346	210	214	OrganismTaxon	rats	10116
3123	16820346	233	239	ChemicalEntity	atorva	D000069059
3124	16820346	279	282	ChemicalEntity	Dex	D003907
3125	16820346	371	381	ChemicalEntity	superoxide	D013481
3126	16820346	426	429	ChemicalEntity	dex	D003907
3127	16820346	480	486	ChemicalEntity	atorva	D000069059
3128	16820346	489	492	ChemicalEntity	dex	D003907
3129	16820346	596	599	ChemicalEntity	dex	D003907
3130	16820346	624	630	ChemicalEntity	Atorva	D000069059
3131	16820346	640	643	ChemicalEntity	dex	D003907
3132	16820346	652	664	DiseaseOrPhenotypicFeature	hypertension	D006973
3133	16820346	737	747	ChemicalEntity	superoxide	D013481
3134	16820346	764	767	ChemicalEntity	dex	D003907
3135	16820346	784	790	ChemicalEntity	atorva	D000069059
3136	16820346	793	796	ChemicalEntity	dex	D003907
3137	16820346	818	825	ChemicalEntity	nitrate	D009566
3138	16820346	826	833	ChemicalEntity	nitrite	D009573
3139	16820346	835	838	ChemicalEntity	NOx	D009589
3140	16820346	857	860	ChemicalEntity	dex	D003907
3141	16820346	869	873	OrganismTaxon	rats	10116
3142	16820346	901	905	OrganismTaxon	rats	10116
3143	16820346	976	982	ChemicalEntity	Atorva	D000069059
3144	16820346	1007	1010	ChemicalEntity	NOx	D009589
3145	16820346	1036	1048	ChemicalEntity	atorvastatin	D000069059
3146	16820346	1072	1085	ChemicalEntity	dexamethasone	D003907
3147	16820346	1094	1106	DiseaseOrPhenotypicFeature	hypertension	D006973
3148	16820346	1114	1117	OrganismTaxon	rat	10116
3149	16838170	39	48	GeneOrGeneProduct	HNF4alpha	3172
3150	16838170	92	116	DiseaseOrPhenotypicFeature	type 2 diabetes mellitus	D003924
3151	16838170	140	172	GeneOrGeneProduct	Hepatocyte nuclear factor 4alpha	3172
3152	16838170	174	183	GeneOrGeneProduct	HNF4alpha	3172
3153	16838170	254	259	OrganismTaxon	human	9606
3154	16838170	355	360	GeneOrGeneProduct	HNF4A	3172
3155	16838170	371	380	GeneOrGeneProduct	HNF4alpha	3172
3156	16838170	413	439	DiseaseOrPhenotypicFeature	impaired glucose tolerance	D018149
3157	16838170	441	444	DiseaseOrPhenotypicFeature	IGT	D018149
3158	16838170	449	473	DiseaseOrPhenotypicFeature	type 2 diabetes mellitus	D003924
3159	16838170	556	564	ChemicalEntity	acarbose	D020909
3160	16838170	606	630	DiseaseOrPhenotypicFeature	type 2 diabetes mellitus	D003924
3161	16838170	704	709	GeneOrGeneProduct	HNF4A	3172
3162	16838170	828	837	SequenceVariant	rs4810424	rs4810424
3163	16838170	839	848	SequenceVariant	rs1884614	rs1884614
3164	16838170	854	863	SequenceVariant	rs2144908	rs2144908
3165	16838170	944	953	SequenceVariant	rs4810424	rs4810424
3166	16838170	1037	1046	SequenceVariant	rs4810424	rs4810424
3167	16838170	1148	1156	DiseaseOrPhenotypicFeature	diabetes	D003920
3168	16838170	1169	1174	OrganismTaxon	women	9606
3169	16838170	1258	1266	ChemicalEntity	acarbose	D020909
3170	16838170	1345	1348	OrganismTaxon	men	9606
3171	16838170	1390	1399	SequenceVariant	rs4810424	rs4810424
3172	16838170	1401	1410	SequenceVariant	rs2071197	rs2071197
3173	16838170	1416	1425	SequenceVariant	rs3818247	rs3818247
3174	16838170	1531	1555	DiseaseOrPhenotypicFeature	type 2 diabetes mellitus	D003924
3175	16838170	1627	1632	OrganismTaxon	women	9606
3176	16838170	1667	1672	GeneOrGeneProduct	HNF4A	3172
3177	16838170	1708	1732	DiseaseOrPhenotypicFeature	type 2 diabetes mellitus	D003924
3178	16840830	27	31	GeneOrGeneProduct	MEN1	4221
3179	16840830	54	84	DiseaseOrPhenotypicFeature	multiple endocrine neoplasia-1	D018761
3180	16840830	86	121	DiseaseOrPhenotypicFeature	Multiple endocrine neoplasia type 1	D018761
3181	16840830	123	127	DiseaseOrPhenotypicFeature	MEN1	D018761
3182	16840830	162	211	DiseaseOrPhenotypicFeature	enteropancreatic endocrine and pituitary adenomas	C535650,D010911
3183	16840830	248	252	GeneOrGeneProduct	MEN1	4221
3184	16840830	287	291	GeneOrGeneProduct	MEN1	4221
3185	16840830	320	324	GeneOrGeneProduct	MEN1	4221
3186	16840830	379	386	OrganismTaxon	patient	9606
3187	16840830	391	418	DiseaseOrPhenotypicFeature	primary hyperparathyroidism	D049950
3188	16840830	420	424	DiseaseOrPhenotypicFeature	PHPT	D049950
3189	16840830	433	445	DiseaseOrPhenotypicFeature	prolactinoma	D015175
3190	16840830	467	471	DiseaseOrPhenotypicFeature	PHPT	D049950
3191	16840830	488	495	OrganismTaxon	patient	9606
3192	16840830	533	538	OrganismTaxon	woman	9606
3193	16840830	580	587	OrganismTaxon	patient	9606
3194	16840830	629	633	DiseaseOrPhenotypicFeature	pain	D010146
3195	16840830	645	653	DiseaseOrPhenotypicFeature	diarrhea	D003967
3196	16840830	742	769	DiseaseOrPhenotypicFeature	pancreatic islet cell tumor	D007516
3197	16840830	807	819	DiseaseOrPhenotypicFeature	prolactinoma	D015175
3198	16840830	846	850	GeneOrGeneProduct	MEN1	4221
3199	16840830	945	952	OrganismTaxon	patient	9606
3200	16840830	1003	1045	SequenceVariant	A to G transition at codon 557 (AAG-->GAG)	p|SUB|K|557|E
3201	16840830	1060	1064	GeneOrGeneProduct	MEN1	4221
3202	16840830	1098	1121	SequenceVariant	lysine by glutamic acid	p|SUB|K||E
3203	16840830	1141	1148	OrganismTaxon	patient	9606
3204	16840830	1192	1235	SequenceVariant	mutation at codon 418 of exon 9 (GAC-->TAT)	p|SUB|D|418|Y
3205	16840830	1270	1295	SequenceVariant	aspartic acid by tyrosine	p|SUB|D||Y
3206	16840830	1365	1369	GeneOrGeneProduct	MEN1	4221
3207	16843501	25	39	DiseaseOrPhenotypicFeature	gastric cancer	D013274
3208	16843501	64	69	GeneOrGeneProduct	hOGG1	4968
3209	16843501	74	79	GeneOrGeneProduct	RAD51	5888
3210	16843501	195	201	DiseaseOrPhenotypicFeature	cancer	D009369
3211	16843501	381	386	GeneOrGeneProduct	hOGG1	4968
3212	16843501	440	445	GeneOrGeneProduct	RAD51	5888
3213	16843501	591	605	DiseaseOrPhenotypicFeature	stomach cancer	D013274
3214	16843501	738	755	ChemicalEntity	hydrogen peroxide	D006861
3215	16843501	794	808	DiseaseOrPhenotypicFeature	gastric cancer	D013274
3216	16843501	809	817	OrganismTaxon	patients	9606
3217	16843501	957	962	GeneOrGeneProduct	hOGG1	4968
3218	16843501	967	972	GeneOrGeneProduct	RAD51	5888
3219	16843501	982	1017	SequenceVariant	G-->C transversion at 1245 position	rs1052133
3220	16843501	1025	1030	GeneOrGeneProduct	hOGG1	4968
3221	16843501	1048	1087	SequenceVariant	Ser-->Cys substitution at the codon 326	rs1052133
3222	16843501	1093	1102	SequenceVariant	Ser326Cys	rs1052133
3223	16843501	1123	1157	SequenceVariant	G-->C substitution at position 135	g|SUB|G|135|C
3224	16843501	1190	1195	GeneOrGeneProduct	RAD51	5888
3225	16843501	1206	1211	SequenceVariant	G135C	g|SUB|G|135|C
3226	16843501	1354	1370	GeneOrGeneProduct	endonuclease III	4913
3227	16843501	1372	1375	GeneOrGeneProduct	Nth	4913
3228	16843501	1381	1416	GeneOrGeneProduct	formamidopyrimidine-DNA glycosylase	79661
3229	16843501	1418	1421	GeneOrGeneProduct	Fpg	79661
3230	16843501	1611	1625	DiseaseOrPhenotypicFeature	gastric cancer	D013274
3231	16843501	1661	1666	OrganismTaxon	human	9606
3232	16843501	1687	1690	SequenceVariant	G/C	g|SUB|G||C
3233	16843501	1707	1712	SequenceVariant	G135C	g|SUB|G|135|C
3234	16843501	1733	1738	GeneOrGeneProduct	RAD51	5888
3235	16843501	1812	1826	DiseaseOrPhenotypicFeature	stomach cancer	D013274
3236	16843501	1941	1951	SequenceVariant	Ser1245Cys	rs1052133
3237	16843501	1972	1977	GeneOrGeneProduct	hOGG1	4968
3238	16843501	1987	2001	DiseaseOrPhenotypicFeature	gastric cancer	D013274
3239	16843501	2142	2147	SequenceVariant	G135C	g|SUB|G|135|C
3240	16843501	2168	2173	GeneOrGeneProduct	RAD51	5888
3241	16843501	2198	2212	DiseaseOrPhenotypicFeature	gastric cancer	D013274
3242	16849419	26	33	GeneOrGeneProduct	SLC34A3	142680
3243	16849419	45	100	DiseaseOrPhenotypicFeature	hereditary hypophosphatemic rickets with hypercalciuria	C562793
3244	16849419	111	166	DiseaseOrPhenotypicFeature	Hereditary hypophosphatemic rickets with hypercalciuria	C562793
3245	16849419	168	172	DiseaseOrPhenotypicFeature	HHRH	C562793
3246	16849419	184	202	DiseaseOrPhenotypicFeature	metabolic disorder	D008659
3247	16849419	221	237	DiseaseOrPhenotypicFeature	hypophosphatemia	D017674
3248	16849419	242	249	DiseaseOrPhenotypicFeature	rickets	D012279
3249	16849419	250	262	DiseaseOrPhenotypicFeature	osteomalacia	D010018
3250	16849419	284	307	ChemicalEntity	1,25-dihydroxyvitamin D	C097949
3251	16849419	309	322	ChemicalEntity	1,25-(OH)(2)D	C097949
3252	16849419	337	351	DiseaseOrPhenotypicFeature	hypercalciuria	D053565
3253	16849419	420	427	GeneOrGeneProduct	SLC34A3	142680
3254	16849419	448	487	GeneOrGeneProduct	sodium-phosphate cotransporter type IIc	142680
3255	16849419	527	531	DiseaseOrPhenotypicFeature	HHRH	C562793
3256	16849419	608	615	GeneOrGeneProduct	SLC34A3	142680
3257	16849419	690	698	OrganismTaxon	PATIENTS	9606
3258	16849419	761	765	DiseaseOrPhenotypicFeature	HHRH	C562793
3259	16849419	860	875	SequenceVariant	101-bp deletion	c|DEL||101
3260	16849419	915	922	GeneOrGeneProduct	SLC34A3	142680
3261	16849419	1031	1035	DiseaseOrPhenotypicFeature	HHRH	C562793
3262	16849419	1071	1085	SequenceVariant	85-bp deletion	c|DEL||85
3263	16849419	1105	1111	SequenceVariant	G-to-A	c|SUB|G||A
3264	16849419	1391	1395	DiseaseOrPhenotypicFeature	HHRH	C562793
3265	16849419	1436	1443	GeneOrGeneProduct	SLC34A3	142680
3266	16849419	1619	1626	GeneOrGeneProduct	SLC34A3	142680
3267	16867021	0	13	ChemicalEntity	Antipsychotic	D014150
3268	16867021	30	42	ChemicalEntity	thioperamide	C052075
3269	16867021	56	67	GeneOrGeneProduct	H3-receptor	99296
3270	16867021	82	86	OrganismTaxon	mice	10090
3271	16867021	195	208	DiseaseOrPhenotypicFeature	schizophrenia	D012559
3272	16867021	264	287	GeneOrGeneProduct	histamine H(3)-receptor	99296
3273	16867021	299	310	ChemicalEntity	neuroleptic	D014150
3274	16867021	319	328	DiseaseOrPhenotypicFeature	catalepsy	D002375
3275	16867021	330	341	ChemicalEntity	apomorphine	D001058
3276	16867021	372	383	ChemicalEntity	amphetamine	D000661
3277	16867021	416	420	OrganismTaxon	mice	10090
3278	16867021	422	431	DiseaseOrPhenotypicFeature	Catalepsy	D002375
3279	16867021	447	458	ChemicalEntity	haloperidol	D006220
3280	16867021	481	492	ChemicalEntity	apomorphine	D001058
3281	16867021	514	525	ChemicalEntity	amphetamine	D000661
3282	16867021	622	647	ChemicalEntity	(R)-alpha-methylhistamine	C069357
3283	16867021	649	653	ChemicalEntity	RAMH	C069357
3284	16867021	677	689	ChemicalEntity	thioperamide	C052075
3285	16867021	691	694	ChemicalEntity	THP	C052075
3286	16867021	734	743	DiseaseOrPhenotypicFeature	catalepsy	D002375
3287	16867021	763	766	ChemicalEntity	THP	C052075
3288	16867021	810	821	ChemicalEntity	haloperidol	D006220
3289	16867021	867	876	DiseaseOrPhenotypicFeature	catalepsy	D002375
3290	16867021	922	926	ChemicalEntity	RAMH	C069357
3291	16867021	968	971	ChemicalEntity	THP	C052075
3292	16867021	989	993	ChemicalEntity	RAMH	C069357
3293	16867021	1089	1092	ChemicalEntity	THP	C052075
3294	16867021	1154	1165	ChemicalEntity	amphetamine	D000661
3295	16867021	1174	1187	DiseaseOrPhenotypicFeature	hyperactivity	D006948
3296	16867021	1189	1192	ChemicalEntity	THP	C052075
3297	16867021	1309	1313	ChemicalEntity	RAMH	C069357
3298	16867021	1372	1375	ChemicalEntity	THP	C052075
3299	16867021	1424	1435	ChemicalEntity	apomorphine	D001058
3300	16867021	1472	1475	ChemicalEntity	THP	C052075
3301	16867021	1530	1534	ChemicalEntity	RAMH	C069357
3302	16867021	1536	1539	ChemicalEntity	THP	C052075
3303	16867021	1553	1566	ChemicalEntity	antipsychotic	D014150
3304	16867021	1596	1607	ChemicalEntity	haloperidol	D006220
3305	16867021	1616	1625	DiseaseOrPhenotypicFeature	catalepsy	D002375
3306	16867021	1636	1647	ChemicalEntity	amphetamine	D000661
3307	16867021	1656	1669	DiseaseOrPhenotypicFeature	hyperactivity	D006948
3308	16867021	1683	1694	ChemicalEntity	apomorphine	D001058
3309	16867021	1715	1719	OrganismTaxon	mice	10090
3310	16867021	1737	1740	ChemicalEntity	THP	C052075
3311	16867021	1758	1762	ChemicalEntity	RAMH	C069357
3312	16867021	1793	1817	GeneOrGeneProduct	histamine H(3)-receptors	99296
3313	16867021	1852	1877	ChemicalEntity	H(3)-receptor antagonists	D054828
3314	16867021	1915	1928	DiseaseOrPhenotypicFeature	schizophrenia	D012559
3315	16867246	15	19	GeneOrGeneProduct	DRD2	1813
3316	16867246	38	52	ChemicalEntity	chlorpromazine	D002746
3317	16867246	61	84	DiseaseOrPhenotypicFeature	extrapyramidal syndrome	D001480
3318	16867246	96	109	DiseaseOrPhenotypicFeature	schizophrenic	D012559
3319	16867246	110	118	OrganismTaxon	patients	9606
3320	16867246	125	148	DiseaseOrPhenotypicFeature	Extrapyramidal syndrome	D001480
3321	16867246	150	153	DiseaseOrPhenotypicFeature	EPS	D001480
3322	16867246	192	211	ChemicalEntity	antipsychotic drugs	D014150
3323	16867246	247	258	GeneOrGeneProduct	D2 receptor	1813
3324	16867246	372	376	GeneOrGeneProduct	DRD2	1813
3325	16867246	414	427	DiseaseOrPhenotypicFeature	schizophrenia	D012559
3326	16867246	428	436	OrganismTaxon	patients	9606
3327	16867246	562	566	GeneOrGeneProduct	DRD2	1813
3328	16867246	576	590	ChemicalEntity	chlorpromazine	D002746
3329	16867246	599	602	DiseaseOrPhenotypicFeature	EPS	D001480
3330	16867246	606	619	DiseaseOrPhenotypicFeature	schizophrenic	D012559
3331	16867246	620	628	OrganismTaxon	patients	9606
3332	16867246	696	708	SequenceVariant	-141Cins>del	c|INDEL|0141|C
3333	16867246	724	733	SequenceVariant	Ser311Cys	c|SUB|S|311|C
3334	16867246	735	741	SequenceVariant	rs6275	rs6275
3335	16867246	743	749	SequenceVariant	rs6277	rs6277
3336	16867246	768	772	GeneOrGeneProduct	DRD2	1813
3337	16867246	785	798	DiseaseOrPhenotypicFeature	schizophrenic	D012559
3338	16867246	799	809	OrganismTaxon	inpatients	9606
3339	16867246	819	822	DiseaseOrPhenotypicFeature	EPS	D001480
3340	16867246	838	841	DiseaseOrPhenotypicFeature	EPS	D001480
3341	16867246	893	907	ChemicalEntity	chlorpromazine	D002746
3342	16867246	1029	1038	SequenceVariant	Ser311Cys	c|SUB|S|311|C
3343	16867246	1043	1049	SequenceVariant	rs6277	rs6277
3344	16867246	1189	1201	SequenceVariant	-141Cins>del	c|INDEL|0141|C
3345	16867246	1210	1216	SequenceVariant	rs6275	rs6275
3346	16867246	1281	1287	SequenceVariant	rs6275	rs6275
3347	16867246	1447	1451	GeneOrGeneProduct	DRD2	1813
3348	16867246	1531	1545	ChemicalEntity	chlorpromazine	D002746
3349	16867246	1567	1575	OrganismTaxon	patients	9606
3350	16867246	1581	1594	DiseaseOrPhenotypicFeature	schizophrenia	D012559
3351	16867246	1663	1667	GeneOrGeneProduct	DRD2	1813
3352	16867246	1672	1675	DiseaseOrPhenotypicFeature	EPS	D001480
3353	16920333	25	48	ChemicalEntity	eslicarbazepine acetate	C416835
3354	16920333	50	59	ChemicalEntity	BIA 2-093	C416835
3355	16920333	64	72	DiseaseOrPhenotypicFeature	seizures	D012640
3356	16920333	102	112	ChemicalEntity	picrotoxin	D010852
3357	16920333	149	153	OrganismTaxon	rats	10116
3358	16920333	155	178	ChemicalEntity	Eslicarbazepine acetate	C416835
3359	16920333	180	189	ChemicalEntity	BIA 2-093	C416835
3360	16920333	191	258	ChemicalEntity	S-(-)-10-acetoxy-10,11-dihydro-5H-dibenzo/b,f/azepine-5-carboxamide	C416835
3361	16920333	271	289	ChemicalEntity	antiepileptic drug	D000927
3362	16920333	430	443	ChemicalEntity	carbamazepine	D002220
3363	16920333	445	448	ChemicalEntity	CBZ	D002220
3364	16920333	454	467	ChemicalEntity	oxcarbazepine	C036006
3365	16920333	469	472	ChemicalEntity	OXC	C036006
3366	16920333	526	549	ChemicalEntity	eslicarbazepine acetate	C416835
3367	16920333	591	599	DiseaseOrPhenotypicFeature	seizures	D012640
3368	16920333	677	684	DiseaseOrPhenotypicFeature	seizure	D012640
3369	16920333	742	752	ChemicalEntity	picrotoxin	D010852
3370	16920333	776	784	DiseaseOrPhenotypicFeature	seizures	D012640
3371	16920333	812	819	DiseaseOrPhenotypicFeature	seizure	D012640
3372	16920333	894	904	ChemicalEntity	picrotoxin	D010852
3373	16920333	930	938	DiseaseOrPhenotypicFeature	seizures	D012640
3374	16920333	957	961	OrganismTaxon	rats	10116
3375	16920333	1008	1016	DiseaseOrPhenotypicFeature	seizures	D012640
3376	16920333	1086	1094	DiseaseOrPhenotypicFeature	seizures	D012640
3377	16920333	1122	1129	DiseaseOrPhenotypicFeature	seizure	D012640
3378	16920333	1184	1207	ChemicalEntity	eslicarbazepine acetate	C416835
3379	17003357	34	40	GeneOrGeneProduct	PTPN22	26191
3380	17003357	50	65	DiseaseOrPhenotypicFeature	type 1 diabetes	D003922
3381	17003357	117	132	DiseaseOrPhenotypicFeature	type 1 diabetes	D003922
3382	17003357	150	156	GeneOrGeneProduct	PTPN22	26191
3383	17003357	173	202	GeneOrGeneProduct	lymphoid-specific phosphatase	26191
3384	17003357	204	207	GeneOrGeneProduct	Lyp	26191
3385	17003357	250	256	GeneOrGeneProduct	PTPN22	26191
3386	17003357	260	275	DiseaseOrPhenotypicFeature	type 1 diabetes	D003922
3387	17003357	359	366	SequenceVariant	1858C/T	rs2476601
3388	17003357	421	427	GeneOrGeneProduct	PTPN22	26191
3389	17003357	510	525	DiseaseOrPhenotypicFeature	type 1 diabetes	D003922
3390	17003357	553	558	SequenceVariant	1858T	rs2476601
3391	17003357	641	656	DiseaseOrPhenotypicFeature	type 1 diabetes	D003922
3392	17003357	791	806	DiseaseOrPhenotypicFeature	type 1 diabetes	D003922
3393	17003357	854	860	GeneOrGeneProduct	PTPN22	26191
3394	17003357	907	914	SequenceVariant	2250G/C	rs56048322
3395	17003357	992	998	GeneOrGeneProduct	PTPN22	26191
3396	17003357	1216	1223	SequenceVariant	1858C/T	rs2476601
3397	17003357	1261	1276	DiseaseOrPhenotypicFeature	type 1 diabetes	D003922
3398	17003357	1284	1290	GeneOrGeneProduct	PTPN22	26191
3399	17003357	1361	1367	GeneOrGeneProduct	PTPN22	26191
3400	17003357	1391	1406	DiseaseOrPhenotypicFeature	type 1 diabetes	D003922
3401	17006606	18	44	SequenceVariant	C-to-T substitution at -31	rs1143627
3402	17006606	45	49	GeneOrGeneProduct	IL1B	3553
3403	17006606	90	112	DiseaseOrPhenotypicFeature	gastric adenocarcinoma	D013274
3404	17006606	139	163	GeneOrGeneProduct	Proinflammatory cytokine	3553
3405	17006606	224	238	DiseaseOrPhenotypicFeature	gastric cancer	D013274
3406	17006606	254	258	GeneOrGeneProduct	IL1B	3553
3407	17006606	258	264	SequenceVariant	-31T/C	rs1143627
3408	17006606	269	276	SequenceVariant	-511C/T	rs1143634
3409	17006606	360	364	GeneOrGeneProduct	IL1B	3553
3410	17006606	416	434	GeneOrGeneProduct	interleukin 1 beta	3553
3411	17006606	436	443	GeneOrGeneProduct	IL1beta	3553
3412	17006606	462	487	GeneOrGeneProduct	nuclear factor of kappa B	4790
3413	17006606	489	497	GeneOrGeneProduct	NFkappaB	4790
3414	17006606	520	526	DiseaseOrPhenotypicFeature	cancer	D009369
3415	17006606	584	625	GeneOrGeneProduct	FS-7 cell-associated cell surface antigen	355
3416	17006606	627	630	GeneOrGeneProduct	FAS	355
3417	17006606	727	735	GeneOrGeneProduct	NFkappaB	4790
3418	17006606	749	755	DiseaseOrPhenotypicFeature	cancer	D009369
3419	17006606	804	818	DiseaseOrPhenotypicFeature	gastric cancer	D013274
3420	17006606	819	827	OrganismTaxon	patients	9606
3421	17006606	849	853	GeneOrGeneProduct	IL1B	3553
3422	17006606	867	870	GeneOrGeneProduct	FAS	355
3423	17006606	937	959	DiseaseOrPhenotypicFeature	gastric adenocarcinoma	D013274
3424	17006606	960	968	OrganismTaxon	patients	9606
3425	17006606	1090	1106	SequenceVariant	T allele at -511	rs1143634
3426	17006606	1115	1130	SequenceVariant	C allele at -31	rs1143627
3427	17006606	1147	1163	SequenceVariant	C allele at -511	rs1143634
3428	17006606	1172	1187	SequenceVariant	T allele at -31	rs1143627
3429	17006606	1191	1195	GeneOrGeneProduct	IL1B	3553
3430	17006606	1249	1253	GeneOrGeneProduct	IL1B	3553
3431	17006606	1267	1270	GeneOrGeneProduct	FAS	355
3432	17006606	1329	1351	DiseaseOrPhenotypicFeature	gastric adenocarcinoma	D013274
3433	17006606	1360	1363	GeneOrGeneProduct	FAS	355
3434	17006606	1455	1459	GeneOrGeneProduct	IL1B	3553
3435	17006606	1459	1464	SequenceVariant	-31TT	rs1143627
3436	17006606	1469	1473	GeneOrGeneProduct	IL1B	3553
3437	17006606	1473	1479	SequenceVariant	-511CC	rs1143634
3438	17006606	1617	1621	GeneOrGeneProduct	IL1B	3553
3439	17006606	1621	1626	SequenceVariant	-31TT	rs1143627
3440	17006606	1631	1635	GeneOrGeneProduct	IL1B	3553
3441	17006606	1635	1641	SequenceVariant	-511CC	rs1143634
3442	17006606	1716	1720	GeneOrGeneProduct	IL1B	3553
3443	17006606	1720	1725	SequenceVariant	-31TT	rs1143627
3444	17006606	1730	1734	GeneOrGeneProduct	IL1B	3553
3445	17006606	1734	1740	SequenceVariant	-511CC	rs1143634
3446	17033686	32	37	GeneOrGeneProduct	PQBP1	10084
3447	17033686	62	76	DiseaseOrPhenotypicFeature	microphthalmia	D008850
3448	17033686	78	90	DiseaseOrPhenotypicFeature	microcephaly	D008831
3449	17033686	96	114	DiseaseOrPhenotypicFeature	mental retardation	D008607
3450	17033686	116	143	DiseaseOrPhenotypicFeature	X-linked mental retardation	D038901
3451	17033686	193	197	DiseaseOrPhenotypicFeature	XLMR	D038901
3452	17033686	227	231	DiseaseOrPhenotypicFeature	XLMR	D038901
3453	17033686	344	349	GeneOrGeneProduct	PQBP1	10084
3454	17033686	363	367	DiseaseOrPhenotypicFeature	XLMR	D038901
3455	17033686	382	386	DiseaseOrPhenotypicFeature	XLMR	D038901
3456	17033686	444	484	DiseaseOrPhenotypicFeature	X-linked phenotype of mental retardation	D038901
3457	17033686	486	488	DiseaseOrPhenotypicFeature	MR	D008607
3458	17033686	491	505	DiseaseOrPhenotypicFeature	microphthalmia	D008850
3459	17033686	507	523	DiseaseOrPhenotypicFeature	choroid coloboma	D003103
3460	17033686	525	537	DiseaseOrPhenotypicFeature	microcephaly	D008831
3461	17033686	539	555	DiseaseOrPhenotypicFeature	renal hypoplasia	D007674
3462	17033686	561	579	DiseaseOrPhenotypicFeature	spastic paraplegia	D010264
3463	17033686	745	749	GeneOrGeneProduct	BCOR	54880
3464	17033686	779	783	GeneOrGeneProduct	BCOR	54880
3465	17033686	815	843	DiseaseOrPhenotypicFeature	Lenz microphthalmia syndrome	C537464
3466	17033686	966	970	GeneOrGeneProduct	BCOR	54880
3467	17033686	994	1002	OrganismTaxon	patients	9606
3468	17033686	1036	1041	GeneOrGeneProduct	PQBP1	10084
3469	17033686	1128	1142	SequenceVariant	c.461_462delAG	rs606231195
3470	17033686	1230	1265	DiseaseOrPhenotypicFeature	Hamel cerebropalatocardiac syndrome	C537761
3471	17033686	1285	1289	DiseaseOrPhenotypicFeature	XLMR	D038901
3472	17033686	1493	1498	GeneOrGeneProduct	PQBP1	10084
3473	17033686	1524	1528	DiseaseOrPhenotypicFeature	XLMR	D038901
3474	17033686	1549	1563	DiseaseOrPhenotypicFeature	microphthalmia	D008850
3475	17033686	1643	1648	GeneOrGeneProduct	PQBP1	10084
3476	17035713	0	18	ChemicalEntity	Chloroacetaldehyde	C004656
3477	17035713	24	42	ChemicalEntity	sulfhydryl reagent	D013439
3478	17035713	65	70	ChemicalEntity	thiol	D013438
3479	17035713	81	91	ChemicalEntity	ifosfamide	D007069
3480	17035713	92	103	DiseaseOrPhenotypicFeature	nephropathy	D007674
3481	17035713	105	123	ChemicalEntity	Chloroacetaldehyde	C004656
3482	17035713	125	128	ChemicalEntity	CAA	C004656
3483	17035713	153	169	ChemicalEntity	alkylating agent	D000477
3484	17035713	170	180	ChemicalEntity	ifosfamide	D007069
3485	17035713	182	185	ChemicalEntity	IFO	D007069
3486	17035713	218	230	DiseaseOrPhenotypicFeature	renal damage	D007674
3487	17035713	246	251	DiseaseOrPhenotypicFeature	tumor	D009369
3488	17035713	265	268	ChemicalEntity	IFO	D007069
3489	17035713	283	293	ChemicalEntity	sulfhydryl	D013439
3490	17035713	295	297	ChemicalEntity	SH	D013439
3491	17035713	399	402	ChemicalEntity	CAA	C004656
3492	17035713	406	411	OrganismTaxon	human	9606
3493	17035713	454	460	CellLine	hRPTEC	9606
3494	17035713	480	488	DiseaseOrPhenotypicFeature	Toxicity	D064420
3495	17035713	492	495	ChemicalEntity	CAA	C004656
3496	17035713	544	547	ChemicalEntity	LDH	D007770
3497	17035713	557	568	ChemicalEntity	trypan blue	D014343
3498	17035713	589	598	GeneOrGeneProduct	caspase-3	836
3499	17035713	614	620	ChemicalEntity	thiols	D013438
3500	17035713	660	663	ChemicalEntity	CAA	C004656
3501	17035713	672	678	CellLine	hRPTEC	9606
3502	17035713	741	747	ChemicalEntity	thiols	D013438
3503	17035713	767	775	DiseaseOrPhenotypicFeature	necrosis	D009336
3504	17035713	785	788	ChemicalEntity	CAA	C004656
3505	17035713	797	805	ChemicalEntity	acrolein	D000171
3506	17035713	820	838	GeneOrGeneProduct	cysteine proteases	1508,836,841
3507	17035713	839	848	GeneOrGeneProduct	caspase-3	836
3508	17035713	850	859	GeneOrGeneProduct	caspase-8	841
3509	17035713	864	875	GeneOrGeneProduct	cathepsin B	1508
3510	17035713	877	884	GeneOrGeneProduct	Caspase	836,841
3511	17035713	899	908	ChemicalEntity	cisplatin	D002945
3512	17035713	926	929	ChemicalEntity	CAA	C004656
3513	17035713	991	994	ChemicalEntity	CAA	C004656
3514	17035713	1071	1074	ChemicalEntity	CAA	C004656
3515	17035713	1078	1095	GeneOrGeneProduct	cysteine protease	1508,836,841
3516	17035713	1111	1117	ChemicalEntity	thiols	D013438
3517	17035713	1198	1201	ChemicalEntity	CAA	C004656
3518	17035713	1207	1212	ChemicalEntity	thiol	D013438
3519	17035713	1253	1256	ChemicalEntity	CAA	C004656
3520	17035713	1260	1268	DiseaseOrPhenotypicFeature	necrosis	D009336
3521	17035713	1278	1283	ChemicalEntity	thiol	D013438
3522	17035713	1298	1315	GeneOrGeneProduct	cysteine protease	1508,836,841
3523	17035713	1350	1353	ChemicalEntity	CAA	C004656
3524	17035713	1408	1414	ChemicalEntity	thiols	D013438
3525	17035713	1430	1438	DiseaseOrPhenotypicFeature	toxicity	D064420
3526	17035713	1442	1448	CellLine	hRPTEC	9606
3527	17035713	1558	1561	ChemicalEntity	IFO	D007069
3528	17035713	1562	1573	DiseaseOrPhenotypicFeature	nephropathy	D007674
3529	17035713	1577	1585	OrganismTaxon	patients	9606
3530	17059986	29	36	GeneOrGeneProduct	SLC12A3	6559
3531	17059986	53	70	DiseaseOrPhenotypicFeature	Gitelman syndrome	D053579
3532	17059986	75	111	DiseaseOrPhenotypicFeature	idiopathic intracranial hypertension	D011559
3533	17059986	133	150	DiseaseOrPhenotypicFeature	Gitelman syndrome	D053579
3534	17059986	152	154	DiseaseOrPhenotypicFeature	GS	D053579
3535	17059986	214	226	DiseaseOrPhenotypicFeature	growth delay	D006130
3536	17059986	228	247	DiseaseOrPhenotypicFeature	metabolic alkalosis	D000471
3537	17059986	249	263	DiseaseOrPhenotypicFeature	hypomagnesemia	C537153
3538	17059986	268	279	DiseaseOrPhenotypicFeature	hypokalemia	D007008
3539	17059986	315	351	DiseaseOrPhenotypicFeature	idiopathic intracranial hypertension	D011559
3540	17059986	357	378	DiseaseOrPhenotypicFeature	bilateral papilledema	D010211
3541	17059986	380	399	DiseaseOrPhenotypicFeature	pseudotumor cerebri	D011559
3542	17059986	406	413	OrganismTaxon	patient	9606
3543	17059986	467	499	DiseaseOrPhenotypicFeature	cerebral cavernous malformations	D002543
3544	17059986	546	562	DiseaseOrPhenotypicFeature	Bartter syndrome	D001477
3545	17059986	681	688	GeneOrGeneProduct	SLC12A3	6559
3546	17059986	708	752	SequenceVariant	serine by leucine at amino acid position 555	rs148038173
3547	17059986	754	765	SequenceVariant	p.Ser555Leu	rs148038173
3548	17059986	779	798	SequenceVariant	guanine to cytosine	c|SUB|G||C
3549	17059986	846	857	SequenceVariant	c.2633+1G>C	c|SUB|G|2633+1|C
3550	17059986	897	899	DiseaseOrPhenotypicFeature	GS	D053579
3551	17059986	1074	1085	SequenceVariant	c.2633+1G>C	c|SUB|G|2633+1|C
3552	17059986	1183	1197	SequenceVariant	r.2521_2634del	r|DEL|2521_2634|
3553	17059986	1221	1230	ChemicalEntity	potassium	D011188
3554	17059986	1235	1244	ChemicalEntity	magnesium	D008274
3555	17059986	1365	1381	DiseaseOrPhenotypicFeature	Bartter syndrome	D001477
3556	17059986	1382	1384	DiseaseOrPhenotypicFeature	GS	D053579
3557	17059986	1390	1409	DiseaseOrPhenotypicFeature	pseudotumor cerebri	D011559
3558	17059986	1456	1481	DiseaseOrPhenotypicFeature	electrolyte abnormalities	D014883
3559	17059986	1486	1509	DiseaseOrPhenotypicFeature	secondary aldosteronism	D001477
3560	17059986	1529	1565	DiseaseOrPhenotypicFeature	idiopathic intracranial hypertension	D011559
3561	17059986	1642	1644	DiseaseOrPhenotypicFeature	GS	D053579
3562	17059986	1750	1773	DiseaseOrPhenotypicFeature	familial cavernomatosis	D006392
3563	17059986	1778	1780	DiseaseOrPhenotypicFeature	GS	D053579
3564	17065198	12	23	DiseaseOrPhenotypicFeature	skin cancer	D012878
3565	17065198	74	82	OrganismTaxon	patients	9606
3566	17065198	123	131	SequenceVariant	CC to TT	c|SUB|C||T
3567	17065198	149	152	GeneOrGeneProduct	p53	7157
3568	17065198	230	255	DiseaseOrPhenotypicFeature	non-melanoma skin cancers	D012878
3569	17065198	257	262	DiseaseOrPhenotypicFeature	NMSCs	D012878
3570	17065198	279	303	DiseaseOrPhenotypicFeature	squamous cell carcinomas	D002294
3571	17065198	305	309	DiseaseOrPhenotypicFeature	SCCs	D002294
3572	17065198	329	341	DiseaseOrPhenotypicFeature	skin lesions	D012871
3573	17065198	368	374	DiseaseOrPhenotypicFeature	tumors	D009369
3574	17065198	379	382	GeneOrGeneProduct	p53	7157
3575	17065198	419	441	OrganismTaxon	Human Papillomas Virus	10566
3576	17065198	443	446	OrganismTaxon	HPV	10566
3577	17065198	471	474	GeneOrGeneProduct	p53	7157
3578	17065198	518	521	GeneOrGeneProduct	XPD	2068
3579	17065198	550	553	GeneOrGeneProduct	p53	7157
3580	17065198	579	584	DiseaseOrPhenotypicFeature	NMSCs	D012878
3581	17065198	661	667	SequenceVariant	C to T	c|SUB|C||T
3582	17065198	774	782	SequenceVariant	CC to TT	c|SUB|C||T
3583	17065198	872	885	ChemicalEntity	cyclosporin A	D016572
3584	17065198	887	890	ChemicalEntity	CsA	D016572
3585	17065198	904	907	GeneOrGeneProduct	p53	7157
3586	17065198	932	944	DiseaseOrPhenotypicFeature	precancerous	D011230
3587	17065198	945	962	DiseaseOrPhenotypicFeature	actinic keratosis	D055623
3588	17065198	964	966	DiseaseOrPhenotypicFeature	AK	D055623
3589	17065198	985	988	GeneOrGeneProduct	p53	7157
3590	17065198	1023	1042	DiseaseOrPhenotypicFeature	skin carcinogenesis	D012878
3591	17065198	1106	1109	GeneOrGeneProduct	p53	7157
3592	17065198	1138	1141	OrganismTaxon	HPV	10566
3593	17065198	1169	1181	DiseaseOrPhenotypicFeature	skin lesions	D012871
3594	17065198	1187	1208	DiseaseOrPhenotypicFeature	Basal Cell Carcinomas	D002280
3595	17065198	1213	1215	DiseaseOrPhenotypicFeature	AK	D055623
3596	17065198	1224	1228	DiseaseOrPhenotypicFeature	SCCs	D002294
3597	17065198	1281	1291	DiseaseOrPhenotypicFeature	infections	D007239
3598	17065198	1295	1299	OrganismTaxon	HPVs	10566
3599	17065198	1315	1346	DiseaseOrPhenotypicFeature	epidermodysplasia verruciformis	D004819
3600	17065198	1377	1388	DiseaseOrPhenotypicFeature	skin cancer	D012878
3601	17065198	1434	1437	OrganismTaxon	HPV	10566
3602	17065198	1449	1452	GeneOrGeneProduct	p53	7157
3603	17065198	1473	1476	GeneOrGeneProduct	p53	7157
3604	17065198	1510	1513	GeneOrGeneProduct	XPD	2068
3605	17065198	1577	1580	GeneOrGeneProduct	p53	7157
3606	17065198	1627	1635	SequenceVariant	CC to TT	c|SUB|C||T
3607	17065198	1799	1818	DiseaseOrPhenotypicFeature	skin carcinogenesis	D012878
3608	17074608	0	9	ChemicalEntity	Valproate	D014635
3609	17074608	18	24	DiseaseOrPhenotypicFeature	chorea	D002819
3610	17074608	29	43	DiseaseOrPhenotypicFeature	encephalopathy	D001927
3611	17074608	56	82	DiseaseOrPhenotypicFeature	nonketotic hyperglycinemia	D020158
3612	17074608	84	110	DiseaseOrPhenotypicFeature	Nonketotic hyperglycinemia	D020158
3613	17074608	116	149	DiseaseOrPhenotypicFeature	disorder of amino acid metabolism	D000592
3614	17074608	175	182	ChemicalEntity	glycine	D005998
3615	17074608	227	234	ChemicalEntity	glycine	D005998
3616	17074608	323	328	DiseaseOrPhenotypicFeature	apnea	D001049
3617	17074608	342	350	DiseaseOrPhenotypicFeature	seizures	D012640
3618	17074608	356	365	DiseaseOrPhenotypicFeature	hypotonia	D009123
3619	17074608	391	414	DiseaseOrPhenotypicFeature	psychomotor retardation	D011596
3620	17074608	453	479	DiseaseOrPhenotypicFeature	nonketotic hyperglycinemia	D020158
3621	17074608	565	572	OrganismTaxon	patient	9606
3622	17074608	583	597	DiseaseOrPhenotypicFeature	language delay	D007805
3623	17074608	602	620	DiseaseOrPhenotypicFeature	mental retardation	D008607
3624	17074608	644	670	DiseaseOrPhenotypicFeature	nonketotic hyperglycinemia	D020158
3625	17074608	709	723	DiseaseOrPhenotypicFeature	encephalopathy	D001927
3626	17074608	728	734	DiseaseOrPhenotypicFeature	chorea	D002819
3627	17074608	763	772	ChemicalEntity	valproate	D014635
3628	17083016	46	67	GeneOrGeneProduct	surfactant protein-A2	729238
3629	17083016	96	117	DiseaseOrPhenotypicFeature	meningococcal disease	D008589
3630	17083016	131	152	DiseaseOrPhenotypicFeature	Meningococcal disease	D008589
3631	17083016	203	225	DiseaseOrPhenotypicFeature	Neisseria meningitidis	D006069
3632	17083016	227	252	GeneOrGeneProduct	Surfactant protein (SP)-A	653509,729238
3633	17083016	257	261	GeneOrGeneProduct	SP-D	6441
3634	17083016	335	347	DiseaseOrPhenotypicFeature	inflammatory	D007249
3635	17083016	399	405	ChemicalEntity	sugars	D000073893
3636	17083016	544	549	GeneOrGeneProduct	SP-A1	653509
3637	17083016	551	556	GeneOrGeneProduct	SP-A2	729238
3638	17083016	562	566	GeneOrGeneProduct	SP-D	6441
3639	17083016	619	627	OrganismTaxon	patients	9606
3640	17083016	658	679	DiseaseOrPhenotypicFeature	meningococcal disease	D008589
3641	17083016	694	702	OrganismTaxon	patients	9606
3642	17083016	707	711	DiseaseOrPhenotypicFeature	died	D003643
3643	17083016	786	791	GeneOrGeneProduct	SP-A2	729238
3644	17083016	814	835	DiseaseOrPhenotypicFeature	meningococcal disease	D008589
3645	17083016	1025	1029	GeneOrGeneProduct	SP-A	653509,729238
3646	17083016	1082	1146	SequenceVariant	lysine (in 1A1) rather than glutamine (in 1A5) at amino acid 223	c|SUB|Q|223|K
3647	17083016	1154	1166	ChemicalEntity	carbohydrate	D002241
3648	17083016	1227	1248	DiseaseOrPhenotypicFeature	meningococcal disease	D008589
3649	17083016	1307	1328	SequenceVariant	lysine at residue 223	c|Allele|K|223
3650	17083016	1349	1357	OrganismTaxon	patients	9606
3651	17083016	1362	1366	DiseaseOrPhenotypicFeature	died	D003643
3652	17083016	1474	1479	GeneOrGeneProduct	SP-A1	653509
3653	17083016	1484	1488	GeneOrGeneProduct	SP-D	6441
3654	17083016	1513	1534	DiseaseOrPhenotypicFeature	meningococcal disease	D008589
3655	17083016	1600	1636	SequenceVariant	glutamine with lysine at residue 223	c|SUB|Q|223|K
3656	17083016	1644	1656	ChemicalEntity	carbohydrate	D002241
3657	17083016	1679	1684	GeneOrGeneProduct	SP-A2	729238
3658	17083016	1713	1734	DiseaseOrPhenotypicFeature	meningococcal disease	D008589
3659	17083016	1759	1764	DiseaseOrPhenotypicFeature	death	D003643
3660	17151160	25	35	ChemicalEntity	olanzapine	C076029
3661	17151160	43	54	ChemicalEntity	risperidone	D018967
3662	17151160	90	103	DiseaseOrPhenotypicFeature	schizophrenia	D012559
3663	17151160	186	196	ChemicalEntity	olanzapine	C076029
3664	17151160	204	215	ChemicalEntity	risperidone	D018967
3665	17151160	247	260	DiseaseOrPhenotypicFeature	schizophrenia	D012559
3666	17151160	379	392	DiseaseOrPhenotypicFeature	schizophrenia	D012559
3667	17151160	400	425	DiseaseOrPhenotypicFeature	schizophreniform disorder	D011618
3668	17151160	436	460	DiseaseOrPhenotypicFeature	schizoaffective disorder	D011618
3669	17151160	507	517	ChemicalEntity	olanzapine	C076029
3670	17151160	537	548	ChemicalEntity	risperidone	D018967
3671	17151160	624	634	ChemicalEntity	olanzapine	C076029
3672	17151160	667	678	ChemicalEntity	risperidone	D018967
3673	17151160	766	776	ChemicalEntity	olanzapine	C076029
3674	17151160	823	834	ChemicalEntity	risperidone	D018967
3675	17151160	962	974	DiseaseOrPhenotypicFeature	parkinsonism	D010302
3676	17151160	979	988	DiseaseOrPhenotypicFeature	akathisia	D017109
3677	17151160	1025	1047	DiseaseOrPhenotypicFeature	Extrapyramidal symptom	D001480
3678	17151160	1095	1106	ChemicalEntity	risperidone	D018967
3679	17151160	1137	1147	ChemicalEntity	olanzapine	C076029
3680	17151160	1168	1179	DiseaseOrPhenotypicFeature	weight gain	D015430
3681	17151160	1194	1204	ChemicalEntity	olanzapine	C076029
3682	17151160	1215	1226	ChemicalEntity	risperidone	D018967
3683	17151160	1327	1337	ChemicalEntity	olanzapine	C076029
3684	17151160	1373	1384	ChemicalEntity	risperidone	D018967
3685	17151160	1494	1504	ChemicalEntity	olanzapine	C076029
3686	17151160	1569	1580	ChemicalEntity	risperidone	D018967
3687	17151160	1618	1629	ChemicalEntity	risperidone	D018967
3688	17151160	1655	1665	ChemicalEntity	olanzapine	C076029
3689	17151160	1700	1710	ChemicalEntity	Olanzapine	C076029
3690	17151160	1799	1810	DiseaseOrPhenotypicFeature	weight gain	D015430
3691	17151160	1816	1827	DiseaseOrPhenotypicFeature	weight gain	D015430
3692	17151160	1845	1855	ChemicalEntity	olanzapine	C076029
3693	17166870	23	31	GeneOrGeneProduct	endoglin	2022
3694	17166870	54	72	DiseaseOrPhenotypicFeature	systemic sclerosis	D012595
3695	17166870	81	112	DiseaseOrPhenotypicFeature	pulmonary arterial hypertension	D000081029
3696	17166870	114	132	DiseaseOrPhenotypicFeature	Systemic sclerosis	D012595
3697	17166870	134	137	DiseaseOrPhenotypicFeature	SSc	D012595
3698	17166870	206	221	DiseaseOrPhenotypicFeature	microangiopathy	D057049
3699	17166870	251	259	GeneOrGeneProduct	Endoglin	2022
3700	17166870	266	269	GeneOrGeneProduct	ENG	2022
3701	17166870	295	307	GeneOrGeneProduct	glycoprotein	351
3702	17166870	352	383	GeneOrGeneProduct	transforming growth factor-beta	7040
3703	17166870	385	393	GeneOrGeneProduct	TGF-beta	7040
3704	17166870	461	477	SequenceVariant	6-base insertion	c|INS||6
3705	17166870	491	496	SequenceVariant	6bINS	c|INS||6
3706	17166870	501	504	GeneOrGeneProduct	ENG	2022
3707	17166870	642	647	SequenceVariant	6bINS	c|INS||6
3708	17166870	656	677	DiseaseOrPhenotypicFeature	vascular complication	D014652
3709	17166870	678	709	DiseaseOrPhenotypicFeature	pulmonary arterial hypertension	D000081029
3710	17166870	711	714	DiseaseOrPhenotypicFeature	PAH	D000081029
3711	17166870	719	722	DiseaseOrPhenotypicFeature	SSc	D012595
3712	17166870	785	788	DiseaseOrPhenotypicFeature	SSc	D012595
3713	17166870	820	823	DiseaseOrPhenotypicFeature	PAH	D000081029
3714	17166870	872	880	OrganismTaxon	patients	9606
3715	17166870	886	900	DiseaseOrPhenotypicFeature	osteoarthritis	D010003
3716	17166870	1119	1124	SequenceVariant	6bINS	c|INS||6
3717	17166870	1135	1138	DiseaseOrPhenotypicFeature	SSc	D012595
3718	17166870	1139	1147	OrganismTaxon	patients	9606
3719	17166870	1164	1167	DiseaseOrPhenotypicFeature	PAH	D000081029
3720	17166870	1311	1314	DiseaseOrPhenotypicFeature	SSc	D012595
3721	17166870	1315	1323	OrganismTaxon	patients	9606
3722	17166870	1332	1335	DiseaseOrPhenotypicFeature	PAH	D000081029
3723	17166870	1418	1423	SequenceVariant	6bINS	c|INS||6
3724	17166870	1451	1454	DiseaseOrPhenotypicFeature	SSc	D012595
3725	17166870	1455	1463	OrganismTaxon	patients	9606
3726	17166870	1469	1472	DiseaseOrPhenotypicFeature	PAH	D000081029
3727	17166870	1552	1557	SequenceVariant	6bINS	c|INS||6
3728	17166870	1574	1577	DiseaseOrPhenotypicFeature	SSc	D012595
3729	17166870	1578	1586	OrganismTaxon	patients	9606
3730	17166870	1603	1606	DiseaseOrPhenotypicFeature	PAH	D000081029
3731	17166870	1638	1641	GeneOrGeneProduct	ENG	2022
3732	17166870	1662	1683	DiseaseOrPhenotypicFeature	vascular complication	D014652
3733	17166870	1687	1690	DiseaseOrPhenotypicFeature	SSc	D012595
3734	17177139	18	23	SequenceVariant	E333D	p|SUB|E|333|D
3735	17177139	32	61	GeneOrGeneProduct	thyroid hormone beta receptor	6955
3736	17177139	70	108	DiseaseOrPhenotypicFeature	resistance to thyroid hormone syndrome	D018382
3737	17177139	110	139	DiseaseOrPhenotypicFeature	Resistance to thyroid hormone	D018382
3738	17177139	141	144	DiseaseOrPhenotypicFeature	RTH	D018382
3739	17177139	203	219	ChemicalEntity	thyroid hormones	D013963
3740	17177139	221	223	ChemicalEntity	TH	D013963
3741	17177139	256	283	GeneOrGeneProduct	thyroid stimulating hormone	1081
3742	17177139	285	288	GeneOrGeneProduct	TSH	1081
3743	17177139	350	352	ChemicalEntity	TH	D013963
3744	17177139	411	440	GeneOrGeneProduct	thyroid hormone beta receptor	6955
3745	17177139	442	448	GeneOrGeneProduct	TRbeta	6955
3746	17177139	483	486	DiseaseOrPhenotypicFeature	RTH	D018382
3747	17177139	497	502	SequenceVariant	E333D	p|SUB|E|333|D
3748	17177139	567	573	GeneOrGeneProduct	TRbeta	6955
3749	17177139	627	632	OrganismTaxon	woman	9606
3750	17177139	686	696	DiseaseOrPhenotypicFeature	overweight	D050177
3751	17177139	737	746	ChemicalEntity	thyroxine	D013974
3752	17177139	748	750	ChemicalEntity	T4	D013974
3753	17177139	785	801	ChemicalEntity	triiodothyronine	D014284
3754	17177139	803	805	ChemicalEntity	T3	D014284
3755	17177139	895	898	GeneOrGeneProduct	TSH	1081
3756	17177139	1030	1033	DiseaseOrPhenotypicFeature	RTH	D018382
3757	17177139	1060	1066	GeneOrGeneProduct	TRbeta	6955
3758	17177139	1107	1114	SequenceVariant	1284A>C	c|SUB|A|1284|C
3759	17177139	1154	1188	SequenceVariant	glutamic acid 333 by aspartic acid	p|SUB|E|333|D
3760	17177139	1198	1203	SequenceVariant	E333D	p|SUB|E|333|D
3761	17177139	1247	1253	GeneOrGeneProduct	TRbeta	6955
3762	17177139	1295	1300	SequenceVariant	E333D	p|SUB|E|333|D
3763	17177139	1374	1376	ChemicalEntity	T3	D014284
3764	17177139	1417	1436	GeneOrGeneProduct	retinoid X receptor	6256
3765	17177139	1438	1441	GeneOrGeneProduct	RXR	6256
3766	17177139	1509	1514	SequenceVariant	E333D	p|SUB|E|333|D
3767	17177139	1515	1521	GeneOrGeneProduct	TRbeta	6955
3768	17177139	1696	1701	OrganismTaxon	human	9606
3769	17177139	1702	1710	GeneOrGeneProduct	TSHalpha	1081
3770	17177139	1770	1776	GeneOrGeneProduct	TRbeta	6955
3771	17177139	1871	1879	GeneOrGeneProduct	TSHalpha	1081
3772	17177139	1931	1936	SequenceVariant	E333D	p|SUB|E|333|D
3773	17177139	1937	1943	GeneOrGeneProduct	TRbeta	6955
3774	17177139	1976	1979	DiseaseOrPhenotypicFeature	RTH	D018382
3775	17185386	33	38	GeneOrGeneProduct	DISC1	27185
3776	17185386	61	74	DiseaseOrPhenotypicFeature	schizophrenia	D012559
3777	17185386	128	132	GeneOrGeneProduct	NDE1	54820
3778	17185386	216	244	GeneOrGeneProduct	Disrupted in Schizophrenia 1	27185
3779	17185386	247	252	GeneOrGeneProduct	DISC1	27185
3780	17185386	258	271	DiseaseOrPhenotypicFeature	schizophrenia	D012559
3781	17185386	310	323	DiseaseOrPhenotypicFeature	schizophrenia	D012559
3782	17185386	348	353	GeneOrGeneProduct	DISC1	27185
3783	17185386	445	450	GeneOrGeneProduct	DISC1	27185
3784	17185386	466	479	DiseaseOrPhenotypicFeature	schizophrenia	D012559
3785	17185386	691	696	GeneOrGeneProduct	DISC1	27185
3786	17185386	915	919	GeneOrGeneProduct	NDE1	54820
3787	17185386	972	977	GeneOrGeneProduct	DISC1	27185
3788	17185386	1110	1114	GeneOrGeneProduct	NDE1	54820
3789	17185386	1167	1180	DiseaseOrPhenotypicFeature	schizophrenia	D012559
3790	17185386	1547	1552	GeneOrGeneProduct	DISC1	27185
3791	17185386	1600	1613	DiseaseOrPhenotypicFeature	schizophrenia	D012559
3792	17192049	0	18	GeneOrGeneProduct	Cytochrome p4501A1	1543
3793	17192049	62	77	DiseaseOrPhenotypicFeature	prostate cancer	D011471
3794	17192049	79	85	GeneOrGeneProduct	CYP1A1	1543
3795	17192049	232	247	DiseaseOrPhenotypicFeature	prostate cancer	D011471
3796	17192049	339	345	SequenceVariant	A to G	rs1048943
3797	17192049	401	410	SequenceVariant	Ile462Val	rs1048943
3798	17192049	415	421	SequenceVariant	T3801C	g|SUB|T|3801|C
3799	17192049	435	441	GeneOrGeneProduct	CYP1A1	1543
3800	17192049	450	465	DiseaseOrPhenotypicFeature	prostate cancer	D011471
3801	17192049	650	656	GeneOrGeneProduct	CYP1A1	1543
3802	17192049	714	720	GeneOrGeneProduct	CYP1A1	1543
3803	17192049	721	728	SequenceVariant	Ile/Val	rs1048943
3804	17192049	809	824	DiseaseOrPhenotypicFeature	prostate cancer	D011471
3805	17192049	924	929	DiseaseOrPhenotypicFeature	tumor	D009369
3806	17192049	1033	1038	DiseaseOrPhenotypicFeature	tumor	D009369
3807	17192049	1280	1295	DiseaseOrPhenotypicFeature	prostate cancer	D011471
3808	17194457	31	58	ChemicalEntity	anabolic androgenic steroid	D045165
3809	17194457	76	80	OrganismTaxon	rats	10116
3810	17194457	90	99	ChemicalEntity	serotonin	D012701
3811	17194457	173	200	ChemicalEntity	anabolic androgenic steroid	D045165
3812	17194457	202	205	ChemicalEntity	AAS	D045165
3813	17194457	226	235	ChemicalEntity	serotonin	D012701
3814	17194457	237	256	ChemicalEntity	5-hydroxytryptamine	D012701
3815	17194457	258	262	ChemicalEntity	5-HT	D012701
3816	17194457	303	307	OrganismTaxon	rats	10116
3817	17194457	309	318	ChemicalEntity	Serotonin	D012701
3818	17194457	367	390	ChemicalEntity	parachlorophenylalanine	D010134
3819	17194457	392	396	ChemicalEntity	PCPA	D010134
3820	17194457	479	483	ChemicalEntity	PCPA	D010134
3821	17194457	492	496	OrganismTaxon	rats	10116
3822	17194457	525	529	OrganismTaxon	rats	10116
3823	17194457	551	563	ChemicalEntity	testosterone	D013739
3824	17194457	565	566	ChemicalEntity	T	D013739
3825	17194457	632	644	DiseaseOrPhenotypicFeature	irritability	D001523
3826	17194457	682	692	DiseaseOrPhenotypicFeature	aggression	D001523
3827	17194457	718	728	DiseaseOrPhenotypicFeature	aggression	D001523
3828	17194457	827	831	ChemicalEntity	5-HT	D012701
3829	17194457	852	878	ChemicalEntity	5-hydroxyindoleacetic acid	D006897
3830	17194457	880	886	ChemicalEntity	5-HIAA	D006897
3831	17194457	917	921	ChemicalEntity	PCPA	D010134
3832	17194457	963	967	ChemicalEntity	5-HT	D012701
3833	17194457	972	978	ChemicalEntity	5-HIAA	D006897
3834	17194457	1018	1019	ChemicalEntity	T	D013739
3835	17194457	1054	1058	ChemicalEntity	5-HT	D012701
3836	17194457	1063	1069	ChemicalEntity	5-HIAA	D006897
3837	17194457	1127	1131	ChemicalEntity	PCPA	D010134
3838	17194457	1153	1157	ChemicalEntity	PCPA	D010134
3839	17194457	1221	1233	DiseaseOrPhenotypicFeature	irritability	D001523
3840	17194457	1295	1305	DiseaseOrPhenotypicFeature	aggression	D001523
3841	17194457	1307	1308	ChemicalEntity	T	D013739
3842	17194457	1344	1356	DiseaseOrPhenotypicFeature	irritability	D001523
3843	17194457	1414	1424	DiseaseOrPhenotypicFeature	aggression	D001523
3844	17194457	1464	1465	ChemicalEntity	T	D013739
3845	17194457	1466	1470	ChemicalEntity	PCPA	D010134
3846	17194457	1679	1682	ChemicalEntity	AAS	D045165
3847	17194457	1706	1710	ChemicalEntity	5-HT	D012701
3848	17194457	1746	1765	DiseaseOrPhenotypicFeature	aggressive behavior	D001523
3849	17221831	4	8	SequenceVariant	G51S	rs1049564
3850	17221831	9	40	GeneOrGeneProduct	purine nucleoside phosphorylase	4860
3851	17221831	73	90	DiseaseOrPhenotypicFeature	cognitive decline	D003072
3852	17221831	94	113	DiseaseOrPhenotypicFeature	Alzheimer's disease	D000544
3853	17221831	114	122	OrganismTaxon	patients	9606
3854	17221831	124	143	DiseaseOrPhenotypicFeature	Alzheimer's disease	D000544
3855	17221831	145	147	DiseaseOrPhenotypicFeature	AD	D000544
3856	17221831	522	534	DiseaseOrPhenotypicFeature	inflammatory	D007249
3857	17221831	653	655	DiseaseOrPhenotypicFeature	AD	D000544
3858	17221831	703	706	SequenceVariant	G/A	rs1049564
3859	17221831	747	778	GeneOrGeneProduct	purine nucleoside phosphorylase	4860
3860	17221831	780	783	GeneOrGeneProduct	PNP	4860
3861	17221831	832	864	SequenceVariant	serine to glycine at position 51	rs1049564
3862	17221831	866	870	SequenceVariant	G51S	rs1049564
3863	17221831	915	917	DiseaseOrPhenotypicFeature	AD	D000544
3864	17221831	918	926	OrganismTaxon	patients	9606
3865	17221831	973	976	GeneOrGeneProduct	PNP	4860
3866	17221831	1029	1037	OrganismTaxon	patients	9606
3867	17221831	1103	1105	DiseaseOrPhenotypicFeature	AD	D000544
3868	17221831	1106	1114	OrganismTaxon	patients	9606
3869	17221831	1172	1189	DiseaseOrPhenotypicFeature	cognitive decline	D003072
3870	17221831	1252	1255	GeneOrGeneProduct	PNP	4860
3871	17221831	1284	1286	DiseaseOrPhenotypicFeature	AD	D000544
3872	17221831	1287	1295	OrganismTaxon	patients	9606
3873	17221831	1306	1329	DiseaseOrPhenotypicFeature	cognitive deterioration	D003072
3874	17221831	1359	1367	OrganismTaxon	patients	9606
3875	17221831	1428	1432	SequenceVariant	G51S	rs1049564
3876	17221831	1433	1436	GeneOrGeneProduct	PNP	4860
3877	17221831	1486	1503	DiseaseOrPhenotypicFeature	cognitive decline	D003072
3878	17221831	1507	1509	DiseaseOrPhenotypicFeature	AD	D000544
3879	17221831	1510	1518	OrganismTaxon	patients	9606
3880	17221831	1600	1626	DiseaseOrPhenotypicFeature	neurodegenerative disorder	D019636
3881	17255138	22	38	ChemicalEntity	COX-2 inhibitors	D052246
3882	17255138	56	62	ChemicalEntity	NSAIDs	D000894
3883	17255138	188	215	DiseaseOrPhenotypicFeature	acute myocardial infarction	D009203
3884	17255138	217	220	DiseaseOrPhenotypicFeature	AMI	D009203
3885	17255138	227	243	ChemicalEntity	COX-2 inhibitors	D052246
3886	17255138	324	361	ChemicalEntity	non-steroidal anti-inflammatory drugs	D000894
3887	17255138	363	369	ChemicalEntity	NSAIDs	D000894
3888	17255138	425	428	DiseaseOrPhenotypicFeature	AMI	D009203
3889	17255138	433	444	DiseaseOrPhenotypicFeature	GI bleeding	D006471
3890	17255138	474	490	ChemicalEntity	COX-2 inhibitors	D052246
3891	17255138	495	501	ChemicalEntity	NSAIDs	D000894
3892	17255138	506	519	ChemicalEntity	acetaminophen	D000082
3893	17255138	662	667	ChemicalEntity	NSAID	D000894
3894	17255138	671	684	ChemicalEntity	acetaminophen	D000082
3895	17255138	838	845	ChemicalEntity	aspirin	D001241
3896	17255138	862	875	ChemicalEntity	acetaminophen	D000082
3897	17255138	887	896	ChemicalEntity	rofecoxib	C116926
3898	17255138	907	916	ChemicalEntity	celecoxib	C105934
3899	17255138	935	941	ChemicalEntity	NSAIDs	D000894
3900	17255138	958	965	ChemicalEntity	aspirin	D001241
3901	17255138	988	997	ChemicalEntity	rofecoxib	C116926
3902	17255138	1009	1018	ChemicalEntity	celecoxib	C105934
3903	17255138	1032	1038	ChemicalEntity	NSAIDs	D000894
3904	17255138	1053	1066	ChemicalEntity	acetaminophen	D000082
3905	17255138	1087	1094	ChemicalEntity	aspirin	D001241
3906	17255138	1172	1175	DiseaseOrPhenotypicFeature	AMI	D009203
3907	17255138	1186	1199	ChemicalEntity	acetaminophen	D000082
3908	17255138	1209	1216	ChemicalEntity	aspirin	D001241
3909	17255138	1230	1239	ChemicalEntity	rofecoxib	C116926
3910	17255138	1259	1268	ChemicalEntity	celecoxib	C105934
3911	17255138	1288	1296	ChemicalEntity	naproxen	D009288
3912	17255138	1316	1326	ChemicalEntity	diclofenac	D004008
3913	17255138	1349	1358	ChemicalEntity	ibuprofen	D007052
3914	17255138	1393	1400	ChemicalEntity	aspirin	D001241
3915	17255138	1413	1422	ChemicalEntity	rofecoxib	C116926
3916	17255138	1442	1451	ChemicalEntity	celecoxib	C105934
3917	17255138	1471	1480	ChemicalEntity	ibuprofen	D007052
3918	17255138	1500	1510	ChemicalEntity	diclofenac	D004008
3919	17255138	1530	1538	ChemicalEntity	naproxen	D009288
3920	17255138	1561	1574	ChemicalEntity	acetaminophen	D000082
3921	17255138	1625	1632	ChemicalEntity	aspirin	D001241
3922	17255138	1634	1642	ChemicalEntity	naproxen	D009288
3923	17255138	1680	1683	DiseaseOrPhenotypicFeature	AMI	D009203
3924	17255138	1684	1695	DiseaseOrPhenotypicFeature	GI bleeding	D006471
3925	17255138	1701	1704	DiseaseOrPhenotypicFeature	AMI	D009203
3926	17255138	1705	1716	DiseaseOrPhenotypicFeature	GI toxicity	D005767
3927	17255138	1720	1729	ChemicalEntity	celecoxib	C105934
3928	17255138	1753	1766	ChemicalEntity	acetaminophen	D000082
3929	17255138	1805	1814	ChemicalEntity	rofecoxib	C116926
3930	17255138	1822	1828	ChemicalEntity	NSAIDs	D000894
3931	17255138	1845	1852	ChemicalEntity	aspirin	D001241
3932	17255138	1859	1868	ChemicalEntity	celecoxib	C105934
3933	17255138	1873	1881	ChemicalEntity	naproxen	D009288
3934	17277899	94	97	GeneOrGeneProduct	ACE	1636
3935	17277899	99	104	GeneOrGeneProduct	TPA25	-
3936	17277899	106	110	GeneOrGeneProduct	PV92	-
3937	17277899	112	115	GeneOrGeneProduct	APO	84909
3938	17277899	117	123	GeneOrGeneProduct	FXIIIB	2165
3939	17277899	125	127	GeneOrGeneProduct	D1	-
3940	17277899	129	132	GeneOrGeneProduct	A25	28936
3941	17277899	137	140	GeneOrGeneProduct	B65	-
3942	17297207	0	7	ChemicalEntity	Quinine	D011803
3943	17297207	16	26	DiseaseOrPhenotypicFeature	arrhythmia	D001145
3944	17297207	45	59	DiseaseOrPhenotypicFeature	severe malaria	D016778
3945	17297207	102	116	DiseaseOrPhenotypicFeature	severe malaria	D016778
3946	17297207	130	138	DiseaseOrPhenotypicFeature	jaundice	D007565
3947	17297207	158	168	DiseaseOrPhenotypicFeature	arrhythmia	D001145
3948	17297207	170	203	DiseaseOrPhenotypicFeature	premature ventricular contraction	D018879
3949	17297207	219	226	ChemicalEntity	quinine	D011803
3950	17297207	306	311	DiseaseOrPhenotypicFeature	fever	D005334
3951	17297207	313	318	DiseaseOrPhenotypicFeature	chill	D023341
3952	17297207	320	328	DiseaseOrPhenotypicFeature	vomiting	D014839
3953	17297207	330	338	DiseaseOrPhenotypicFeature	jaundice	D007565
3954	17297207	479	500	OrganismTaxon	Plasmodium falciparum	5833
3955	17297207	515	524	ChemicalEntity	bilirubin	D001663
3956	17297207	548	557	ChemicalEntity	bilirubin	D001663
3957	17297207	583	592	ChemicalEntity	bilirubin	D001663
3958	17297207	605	614	ChemicalEntity	potassium	D011188
3959	17297207	651	665	DiseaseOrPhenotypicFeature	severe malaria	D016778
3960	17297207	671	679	DiseaseOrPhenotypicFeature	jaundice	D007565
3961	17297207	688	695	ChemicalEntity	quinine	D011803
3962	17297207	708	716	ChemicalEntity	dextrose	D005947
3963	17297207	769	776	DiseaseOrPhenotypicFeature	vomitus	D014839
3964	17297207	778	786	DiseaseOrPhenotypicFeature	diarrhea	D003967
3965	17297207	788	796	DiseaseOrPhenotypicFeature	tinnitus	D014012
3966	17297207	798	813	DiseaseOrPhenotypicFeature	loss of hearing	D034381
3967	17297207	833	840	ChemicalEntity	quinine	D011803
3968	17297207	867	878	DiseaseOrPhenotypicFeature	palpitation	D006331
3969	17297207	926	959	DiseaseOrPhenotypicFeature	premature ventricular contraction	D018879
3970	17297207	961	964	DiseaseOrPhenotypicFeature	PVC	D018879
3971	17297207	1006	1022	DiseaseOrPhenotypicFeature	sinoatrial block	D012848
3972	17297207	1061	1070	ChemicalEntity	lidocaine	D008012
3973	17297207	1123	1131	ChemicalEntity	dextrose	D005947
3974	17297207	1147	1166	ChemicalEntity	potassium aspartate	D001224
3975	17297207	1175	1182	ChemicalEntity	Quinine	D011803
3976	17297207	1234	1241	ChemicalEntity	quinine	D011803
3977	17297207	1311	1314	DiseaseOrPhenotypicFeature	PVC	D018879
3978	17297207	1378	1387	ChemicalEntity	potassium	D011188
3979	17297207	1458	1465	ChemicalEntity	Quinine	D011803
3980	17297207	1472	1481	ChemicalEntity	quinidine	D011802
3981	17297207	1488	1505	ChemicalEntity	chincona alkaloid	-
3982	17297207	1520	1530	DiseaseOrPhenotypicFeature	arrhythmic	D001145
3983	17297207	1562	1572	DiseaseOrPhenotypicFeature	arrhythmic	D001145
3984	17297207	1596	1607	DiseaseOrPhenotypicFeature	arrhythmias	D001145
3985	17297207	1626	1636	DiseaseOrPhenotypicFeature	arrhythmia	D001145
3986	17297207	1654	1657	DiseaseOrPhenotypicFeature	PVC	D018879
3987	17297207	1688	1695	ChemicalEntity	quinine	D011803
3988	17297207	1764	1774	DiseaseOrPhenotypicFeature	arrhythmic	D001145
3989	17297207	1821	1835	DiseaseOrPhenotypicFeature	heart diseases	D006331
3990	17297207	1853	1873	DiseaseOrPhenotypicFeature	electrolyte disorder	D014883
3991	17297207	1875	1886	DiseaseOrPhenotypicFeature	hypokalemia	D007008
3992	17297207	1919	1927	DiseaseOrPhenotypicFeature	vomiting	D014839
3993	17297207	1935	1943	DiseaseOrPhenotypicFeature	diarrhea	D003967
3994	17297207	1947	1954	DiseaseOrPhenotypicFeature	malaria	D008288
3995	17304550	16	29	GeneOrGeneProduct	synaptotagmin	255928
3996	17304550	31	36	GeneOrGeneProduct	SYT14	255928
3997	17304550	54	86	DiseaseOrPhenotypicFeature	neurodevelopmental abnormalities	D009421
3998	17304550	247	263	DiseaseOrPhenotypicFeature	cerebral atrophy	D001927
3999	17304550	265	277	DiseaseOrPhenotypicFeature	macrocephaly	D058627
4000	17304550	278	286	DiseaseOrPhenotypicFeature	seizures	D012640
4001	17304550	292	311	DiseaseOrPhenotypicFeature	developmental delay	D002658
4002	17304550	428	441	GeneOrGeneProduct	synaptotagmin	255928
4003	17304550	448	453	GeneOrGeneProduct	SYT14	255928
4004	17304550	493	498	GeneOrGeneProduct	SYT14	255928
4005	17304550	502	507	OrganismTaxon	human	9606
4006	17304550	576	589	GeneOrGeneProduct	synaptotagmin	255928
4007	17304550	650	657	ChemicalEntity	calcium	D002118
4008	17304550	761	766	GeneOrGeneProduct	SYT14	255928
4009	17304550	899	904	GeneOrGeneProduct	SYT14	255928
4010	17304550	1021	1026	GeneOrGeneProduct	SYT14	255928
4011	17344330	0	7	DiseaseOrPhenotypicFeature	Syncope	D013575
4012	17344330	12	27	DiseaseOrPhenotypicFeature	QT prolongation	D008133
4013	17344330	34	42	OrganismTaxon	patients	9606
4014	17344330	56	65	ChemicalEntity	methadone	D008691
4015	17344330	70	87	DiseaseOrPhenotypicFeature	heroin dependence	D006556
4016	17344330	127	136	ChemicalEntity	Methadone	D008691
4017	17344330	154	168	DiseaseOrPhenotypicFeature	heroin addicts	D006556
4018	17344330	189	195	ChemicalEntity	opioid	D000701
4019	17344330	201	232	DiseaseOrPhenotypicFeature	Prolongation of the QT interval	D008133
4020	17344330	247	255	OrganismTaxon	patients	9606
4021	17344330	261	279	DiseaseOrPhenotypicFeature	torsade de pointes	D016171
4022	17344330	281	284	DiseaseOrPhenotypicFeature	TdP	D016171
4023	17344330	307	316	ChemicalEntity	methadone	D008691
4024	17344330	327	341	DiseaseOrPhenotypicFeature	heroin addicts	D006556
4025	17344330	430	437	DiseaseOrPhenotypicFeature	syncope	D013575
4026	17344330	501	504	DiseaseOrPhenotypicFeature	TdP	D016171
4027	17344330	630	639	ChemicalEntity	methadone	D008691
4028	17344330	754	768	DiseaseOrPhenotypicFeature	heroin addicts	D006556
4029	17344330	782	791	ChemicalEntity	methadone	D008691
4030	17344330	795	808	ChemicalEntity	buprenorphine	D002047
4031	17344330	834	842	OrganismTaxon	patients	9606
4032	17344330	1051	1058	DiseaseOrPhenotypicFeature	syncope	D013575
4033	17344330	1084	1090	ChemicalEntity	opioid	D000701
4034	17344330	1108	1117	ChemicalEntity	methadone	D008691
4035	17344330	1140	1147	DiseaseOrPhenotypicFeature	syncope	D013575
4036	17344330	1246	1255	ChemicalEntity	Methadone	D008691
4037	17344330	1281	1299	DiseaseOrPhenotypicFeature	longer QT interval	D008133
4038	17344330	1351	1364	ChemicalEntity	buprenorphine	D002047
4039	17344330	1416	1425	ChemicalEntity	methadone	D008691
4040	17344330	1431	1434	OrganismTaxon	men	9606
4041	17344330	1443	1448	OrganismTaxon	women	9606
4042	17344330	1453	1475	DiseaseOrPhenotypicFeature	prolonged QTc interval	D008133
4043	17344330	1511	1524	ChemicalEntity	buprenorphine	D002047
4044	17344330	1574	1583	ChemicalEntity	methadone	D008691
4045	17344330	1657	1664	DiseaseOrPhenotypicFeature	syncope	D013575
4046	17344330	1679	1688	ChemicalEntity	Methadone	D008691
4047	17344330	1708	1723	DiseaseOrPhenotypicFeature	QT prolongation	D008133
4048	17344330	1748	1755	DiseaseOrPhenotypicFeature	syncope	D013575
4049	17344330	1775	1789	DiseaseOrPhenotypicFeature	heroin addicts	D006556
4050	17345627	19	23	GeneOrGeneProduct	BMP4	652
4051	17345627	28	32	GeneOrGeneProduct	BMP5	653
4052	17345627	49	77	DiseaseOrPhenotypicFeature	axial skeletal malformations	D001848
4053	17345627	82	106	DiseaseOrPhenotypicFeature	heterotopic ossification	D009999
4054	17345627	124	151	GeneOrGeneProduct	Bone morphogenetic proteins	649,650,652,653
4055	17345627	153	157	GeneOrGeneProduct	BMPs	649,650,652,653
4056	17345627	223	259	DiseaseOrPhenotypicFeature	ectopic cartilage and bone formation	D001847,D002357
4057	17345627	296	324	GeneOrGeneProduct	bone morphogenetic protein 4	652
4058	17345627	326	330	GeneOrGeneProduct	BMP4	652
4059	17345627	357	365	OrganismTaxon	patients	9606
4060	17345627	375	412	DiseaseOrPhenotypicFeature	fibrodysplasia ossificans progressiva	D009221
4061	17345627	414	417	DiseaseOrPhenotypicFeature	FOP	D009221
4062	17345627	442	486	DiseaseOrPhenotypicFeature	axial and appendicular skeletal malformation	D001848
4063	17345627	503	527	DiseaseOrPhenotypicFeature	heterotopic ossification	D009999
4064	17345627	563	591	GeneOrGeneProduct	bone morphogenetic protein 5	653
4065	17345627	593	597	GeneOrGeneProduct	bmp5	653
4066	17345627	635	639	GeneOrGeneProduct	BMP5	653
4067	17345627	650	656	OrganismTaxon	murine	10090
4068	17345627	657	675	DiseaseOrPhenotypicFeature	short ear syndrome	D004427
4069	17345627	736	764	DiseaseOrPhenotypicFeature	axial skeletal malformations	D001848
4070	17345627	818	823	OrganismTaxon	mouse	10090
4071	17345627	828	831	DiseaseOrPhenotypicFeature	FOP	D009221
4072	17345627	848	871	DiseaseOrPhenotypicFeature	malformed external ears	D004426
4073	17345627	873	917	DiseaseOrPhenotypicFeature	multiple malformations of the axial skeleton	D001848
4074	17345627	935	959	DiseaseOrPhenotypicFeature	heterotopic ossification	D009999
4075	17345627	994	997	GeneOrGeneProduct	BMP	649,650,652,653
4076	17345627	1153	1157	GeneOrGeneProduct	BMP4	652
4077	17345627	1162	1166	GeneOrGeneProduct	BMP5	653
4078	17345627	1205	1212	OrganismTaxon	patient	9606
4079	17345627	1237	1241	GeneOrGeneProduct	BMP2	650
4080	17345627	1312	1316	GeneOrGeneProduct	BMP4	652
4081	17345627	1321	1325	GeneOrGeneProduct	BMP5	653
4082	17345627	1363	1368	OrganismTaxon	human	9606
4083	17345627	1369	1397	DiseaseOrPhenotypicFeature	axial skeletal abnormalities	D001848
4084	17345627	1423	1428	OrganismTaxon	mouse	10090
4085	17345627	1433	1436	DiseaseOrPhenotypicFeature	FOP	D009221
4086	17395743	18	22	GeneOrGeneProduct	PVT1	5820
4087	17395743	47	70	DiseaseOrPhenotypicFeature	end-stage renal disease	D007676
4088	17395743	74	89	DiseaseOrPhenotypicFeature	type 2 diabetes	D003924
4089	17395743	219	242	DiseaseOrPhenotypicFeature	end-stage renal disease	D007676
4090	17395743	244	248	DiseaseOrPhenotypicFeature	ESRD	D007676
4091	17395743	253	268	DiseaseOrPhenotypicFeature	type 2 diabetes	D003924
4092	17395743	401	405	DiseaseOrPhenotypicFeature	ESRD	D007676
4093	17395743	454	469	DiseaseOrPhenotypicFeature	type 2 diabetes	D003924
4094	17395743	822	831	SequenceVariant	rs2720709	rs2720709
4095	17395743	948	952	GeneOrGeneProduct	PVT1	5820
4096	17395743	1022	1026	GeneOrGeneProduct	PVT1	5820
4097	17395743	1265	1274	SequenceVariant	rs2720709	rs2720709
4098	17395743	1338	1342	DiseaseOrPhenotypicFeature	ESRD	D007676
4099	17395743	1409	1418	SequenceVariant	rs2648875	rs2648875
4100	17395743	1480	1484	GeneOrGeneProduct	PVT1	5820
4101	17395743	1523	1527	GeneOrGeneProduct	PVT1	5820
4102	17395743	1546	1550	DiseaseOrPhenotypicFeature	ESRD	D007676
4103	17395743	1569	1577	DiseaseOrPhenotypicFeature	diabetes	D003920
4104	17491223	79	89	ChemicalEntity	dobutamine	D004280
4105	17491223	98	117	DiseaseOrPhenotypicFeature	myocardial ischemia	D017202
4106	17491223	191	201	ChemicalEntity	dobutamine	D004280
4107	17491223	210	229	DiseaseOrPhenotypicFeature	myocardial ischemia	D017202
4108	17491223	429	439	ChemicalEntity	dobutamine	D004280
4109	17491223	448	467	DiseaseOrPhenotypicFeature	myocardial ischemia	D017202
4110	17491223	606	614	DiseaseOrPhenotypicFeature	ischemia	D007511
4111	17491223	654	662	OrganismTaxon	patients	9606
4112	17491223	690	700	ChemicalEntity	dobutamine	D004280
4113	17491223	799	809	ChemicalEntity	dobutamine	D004280
4114	17491223	833	841	OrganismTaxon	patients	9606
4115	17491223	876	884	DiseaseOrPhenotypicFeature	ischemia	D007511
4116	17491223	953	963	ChemicalEntity	dobutamine	D004280
4117	17491223	1562	1581	DiseaseOrPhenotypicFeature	myocardial ischemia	D017202
4118	17491223	1597	1605	OrganismTaxon	patients	9606
4119	17549393	8	12	GeneOrGeneProduct	IRF6	3664
4120	17549393	32	36	SequenceVariant	Y67X	p|SUB|Y|67|X
4121	17549393	62	84	DiseaseOrPhenotypicFeature	Van der Woude syndrome	C536528
4122	17549393	86	108	DiseaseOrPhenotypicFeature	Van der Woude syndrome	C536528
4123	17549393	110	113	DiseaseOrPhenotypicFeature	VWS	C536528
4124	17549393	142	167	DiseaseOrPhenotypicFeature	syndromic orofacial cleft	D002972
4125	17549393	212	232	DiseaseOrPhenotypicFeature	cleft lip and palate	D002971,D002972
4126	17549393	293	301	DiseaseOrPhenotypicFeature	lip pits	C536528
4127	17549393	303	312	DiseaseOrPhenotypicFeature	cleft lip	D002971
4128	17549393	317	329	DiseaseOrPhenotypicFeature	cleft palate	D002972
4129	17549393	335	345	DiseaseOrPhenotypicFeature	hypodontia	D000848
4130	17549393	347	350	DiseaseOrPhenotypicFeature	VWS	C536528
4131	17549393	406	436	GeneOrGeneProduct	interferon regulatory factor 6	3664
4132	17549393	438	442	GeneOrGeneProduct	IRF6	3664
4133	17549393	586	590	GeneOrGeneProduct	IRF6	3664
4134	17549393	628	631	DiseaseOrPhenotypicFeature	VWS	C536528
4135	17549393	632	640	OrganismTaxon	patients	9606
4136	17549393	752	756	GeneOrGeneProduct	IRF6	3664
4137	17549393	904	908	GeneOrGeneProduct	IRF6	3664
4138	17549393	921	929	OrganismTaxon	patients	9606
4139	17549393	972	980	SequenceVariant	c.201C>A	c|SUB|C|201|A
4140	17549393	994	1046	SequenceVariant	tyrosine codon at amino acid position 67 into a stop	p|SUB|Y|67|X
4141	17549393	1054	1060	SequenceVariant	p.Y67X	p|SUB|Y|67|X
4142	17549393	1196	1200	GeneOrGeneProduct	Smad	4086
4143	17549393	1201	1229	GeneOrGeneProduct	interferon regulatory factor	3664
4144	17549393	1290	1294	GeneOrGeneProduct	Smad	4086
4145	17595233	97	105	OrganismTaxon	patients	9606
4146	17595233	111	137	DiseaseOrPhenotypicFeature	inflammatory bowel disease	D015212
4147	17595233	253	268	DiseaseOrPhenotypicFeature	Crohn's disease	D003424
4148	17595233	343	351	OrganismTaxon	bacteria	2
4149	17595233	367	382	DiseaseOrPhenotypicFeature	Crohn's disease	D003424
4150	17595233	446	454	OrganismTaxon	bacteria	2
4151	17595233	701	723	GeneOrGeneProduct	innate immune receptor	10333,10392,22900,64127,7096,7097,7099
4152	17595233	731	772	GeneOrGeneProduct	nucleotide oligomerisation domain (NOD) 2	64127
4153	17595233	773	809	GeneOrGeneProduct	caspase recruitment domain (CARD) 15	64127
4154	17595233	811	815	GeneOrGeneProduct	NOD1	10392
4155	17595233	816	821	GeneOrGeneProduct	CARD4	10392
4156	17595233	823	828	GeneOrGeneProduct	TUCAN	22900
4157	17595233	829	837	GeneOrGeneProduct	CARDINAL	22900
4158	17595233	838	843	GeneOrGeneProduct	CARD8	22900
4159	17595233	845	871	GeneOrGeneProduct	Toll-like receptor (TLR) 4	7099
4160	17595233	873	877	GeneOrGeneProduct	TLR2	7097
4161	17595233	879	883	GeneOrGeneProduct	TLR1	7096
4162	17595233	888	892	GeneOrGeneProduct	TLR6	10333
4163	17595233	959	985	DiseaseOrPhenotypicFeature	inflammatory bowel disease	D015212
4164	17595233	987	990	DiseaseOrPhenotypicFeature	IBD	D015212
4165	17595233	1043	1051	OrganismTaxon	patients	9606
4166	17595233	1057	1060	DiseaseOrPhenotypicFeature	IBD	D015212
4167	17595233	1066	1081	DiseaseOrPhenotypicFeature	Crohn's disease	D003424
4168	17595233	1087	1105	DiseaseOrPhenotypicFeature	ulcerative colitis	D003093
4169	17595233	1124	1131	DiseaseOrPhenotypicFeature	colitis	D003092
4170	17595233	1173	1197	OrganismTaxon	Saccharomyces cerevisiae	4932
4171	17595233	1417	1421	GeneOrGeneProduct	NOD2	64127
4172	17595233	1422	1428	GeneOrGeneProduct	CARD15	64127
4173	17595233	1430	1435	GeneOrGeneProduct	TUCAN	22900
4174	17595233	1436	1444	GeneOrGeneProduct	CARDINAL	22900
4175	17595233	1445	1450	GeneOrGeneProduct	CARD8	22900
4176	17595233	1452	1456	GeneOrGeneProduct	NOD1	10392
4177	17595233	1457	1462	GeneOrGeneProduct	CARD4	10392
4178	17595233	1464	1468	GeneOrGeneProduct	TLR4	7099
4179	17595233	1470	1474	GeneOrGeneProduct	TLR1	7096
4180	17595233	1476	1480	GeneOrGeneProduct	TLR2	7097
4181	17595233	1485	1489	GeneOrGeneProduct	TLR6	10333
4182	17595233	1519	1534	DiseaseOrPhenotypicFeature	Crohn's disease	D003424
4183	17595233	1535	1543	OrganismTaxon	patients	9606
4184	17595233	1552	1558	GeneOrGeneProduct	CARD15	64127
4185	17595233	1599	1605	GeneOrGeneProduct	CARD15	64127
4186	17595233	1617	1632	DiseaseOrPhenotypicFeature	Crohn's disease	D003424
4187	17595233	1633	1641	OrganismTaxon	patients	9606
4188	17595233	1937	1945	OrganismTaxon	patients	9606
4189	17595233	1973	1979	GeneOrGeneProduct	CARD15	64127
4190	17595233	2042	2057	DiseaseOrPhenotypicFeature	Crohn's disease	D003424
4191	17595233	2058	2066	OrganismTaxon	patients	9606
4192	17595233	2076	2080	GeneOrGeneProduct	NOD1	10392
4193	17595233	2081	2086	GeneOrGeneProduct	CARD4	10392
4194	17595233	2152	2160	OrganismTaxon	patients	9606
4195	17595233	2266	2270	GeneOrGeneProduct	TLR4	7099
4196	17595233	2271	2276	SequenceVariant	D299G	rs4986790
4197	17595233	2281	2285	GeneOrGeneProduct	TLR2	7097
4198	17595233	2286	2291	SequenceVariant	P631H	p|SUB|P|631|H
4199	17595233	2465	2487	GeneOrGeneProduct	innate immune receptor	10333,10392,22900,64127,7096,7097,7099
4200	17595233	2626	2632	GeneOrGeneProduct	CARD15	64127
4201	17595233	2637	2641	GeneOrGeneProduct	TLR4	7099
4202	17595233	2766	2769	DiseaseOrPhenotypicFeature	IBD	D015212
4203	17600377	18	38	ChemicalEntity	maltolyl p-coumarate	C524754
4204	17600377	51	69	DiseaseOrPhenotypicFeature	cognitive deficits	D003072
4205	17600377	125	133	DiseaseOrPhenotypicFeature	dementia	D003704
4206	17600377	260	280	ChemicalEntity	maltolyl p-coumarate	C524754
4207	17600377	306	312	ChemicalEntity	maltol	C008316
4208	17600377	317	332	ChemicalEntity	p-coumaric acid	C495469
4209	17600377	380	400	ChemicalEntity	maltolyl p-coumarate	C524754
4210	17600377	415	432	DiseaseOrPhenotypicFeature	cognitive decline	D003072
4211	17600377	436	447	ChemicalEntity	scopolamine	D012601
4212	17600377	457	461	OrganismTaxon	rats	10116
4213	17600377	469	495	ChemicalEntity	amyloid beta peptide(1-42)	C544092
4214	17600377	504	508	OrganismTaxon	rats	10116
4215	17600377	510	530	ChemicalEntity	Maltolyl p-coumarate	C524754
4216	17600377	554	572	DiseaseOrPhenotypicFeature	cognitive deficits	D003072
4217	17600377	581	584	OrganismTaxon	rat	10116
4218	17600377	691	717	ChemicalEntity	amyloid beta peptide(1-42)	C544092
4219	17600377	726	730	OrganismTaxon	rats	10116
4220	17600377	780	800	ChemicalEntity	maltolyl p-coumarate	C524754
4221	17600377	816	823	CellLine	SH-SY5Y	9606
4222	17600377	858	878	ChemicalEntity	maltolyl p-coumarate	C524754
4223	17600377	898	924	ChemicalEntity	amyloid beta peptide(1-42)	C544092
4224	17600377	926	935	ChemicalEntity	glutamate	D018698
4225	17600377	939	943	ChemicalEntity	H2O2	D006861
4226	17600377	959	979	ChemicalEntity	maltolyl p-coumarate	C524754
4227	17600377	1037	1060	ChemicalEntity	reactive oxygen species	D017382
4228	17600377	1062	1074	ChemicalEntity	cytochrome c	D045304
4229	17600377	1088	1097	GeneOrGeneProduct	caspase 3	25402
4230	17600377	1186	1206	ChemicalEntity	maltolyl p-coumarate	C524754
4231	17600377	1252	1271	DiseaseOrPhenotypicFeature	Alzheimer's disease	D000544
4232	17600377	1309	1323	DiseaseOrPhenotypicFeature	neuronal death	D009410
4233	17600377	1340	1369	DiseaseOrPhenotypicFeature	decline of cognitive function	D003072
4234	17628794	0	30	GeneOrGeneProduct	Manganese superoxide dismutase	6648
4235	17628794	32	38	GeneOrGeneProduct	Mn-SOD	6648
4236	17628794	62	74	DiseaseOrPhenotypicFeature	urolithiasis	D052878
4237	17628794	92	122	GeneOrGeneProduct	manganese superoxide dismutase	6648
4238	17628794	129	135	GeneOrGeneProduct	Mn-SOD	6648
4239	17628794	197	209	DiseaseOrPhenotypicFeature	urolithiasis	D052878
4240	17628794	266	281	DiseaseOrPhenotypicFeature	stone formation	D002137
4241	17628794	303	308	GeneOrGeneProduct	MnSOD	6648
4242	17628794	402	461	SequenceVariant	valine (Val) to alanine (Ala) substitution at amino acid 16	p|SUB|V|16|A
4243	17628794	520	525	GeneOrGeneProduct	MnSOD	6648
4244	17628794	572	584	DiseaseOrPhenotypicFeature	urolithiasis	D052878
4245	17628794	650	655	GeneOrGeneProduct	MnSOD	6648
4246	17628794	691	703	DiseaseOrPhenotypicFeature	urolithiasis	D052878
4247	17628794	725	730	GeneOrGeneProduct	MnSOD	6648
4248	17628794	737	750	DiseaseOrPhenotypicFeature	stone-forming	D002137
4249	17628794	938	945	ChemicalEntity	agarose	D012685
4250	17628794	1079	1087	OrganismTaxon	patients	9606
4251	17628794	1186	1193	OrganismTaxon	patient	9606
4252	17628794	1274	1281	OrganismTaxon	patient	9606
4253	17628794	1351	1356	GeneOrGeneProduct	MnSOD	6648
4254	17628794	1442	1454	DiseaseOrPhenotypicFeature	urolithiasis	D052878
4255	17628794	1520	1535	DiseaseOrPhenotypicFeature	stone formation	D002137
4256	17634480	95	108	DiseaseOrPhenotypicFeature	breast cancer	D001943
4257	17634480	136	149	DiseaseOrPhenotypicFeature	breast cancer	D001943
4258	17634480	315	338	ChemicalEntity	reactive oxygen species	D017382
4259	17634480	340	343	ChemicalEntity	ROS	D017382
4260	17634480	353	356	ChemicalEntity	ROS	D017382
4261	17634480	427	433	DiseaseOrPhenotypicFeature	cancer	D009369
4262	17634480	435	443	OrganismTaxon	PATIENTS	9606
4263	17634480	623	626	GeneOrGeneProduct	CAT	847
4264	17634480	628	632	GeneOrGeneProduct	SOD1	6647
4265	17634480	634	638	GeneOrGeneProduct	SOD2	6648
4266	17634480	640	644	GeneOrGeneProduct	GPX1	2876
4267	17634480	646	650	GeneOrGeneProduct	GPX4	2879
4268	17634480	652	655	GeneOrGeneProduct	GSR	2936
4269	17634480	657	660	GeneOrGeneProduct	TXN	7295
4270	17634480	662	666	GeneOrGeneProduct	TXN2	25828
4271	17634480	668	674	GeneOrGeneProduct	TXNRD1	7296
4272	17634480	680	686	GeneOrGeneProduct	TXNRD2	10587
4273	17634480	710	715	OrganismTaxon	women	9606
4274	17634480	721	734	DiseaseOrPhenotypicFeature	breast cancer	D001943
4275	17634480	791	795	GeneOrGeneProduct	GPX4	2879
4276	17634480	797	805	SequenceVariant	rs713041	rs713041
4277	17634480	810	818	SequenceVariant	rs757229	rs757229
4278	17634480	1005	1009	GeneOrGeneProduct	GPX4	2879
4279	17634480	1010	1018	SequenceVariant	rs713041	rs713041
4280	17634480	1039	1053	ChemicalEntity	selenocysteine	D017279
4281	17634480	1088	1092	GeneOrGeneProduct	GPX4	2879
4282	17634480	1189	1194	DiseaseOrPhenotypicFeature	death	D003643
4283	17634480	1324	1329	DiseaseOrPhenotypicFeature	tumor	D009369
4284	17634480	1347	1364	GeneOrGeneProduct	estrogen receptor	2099
4285	17634480	1475	1488	DiseaseOrPhenotypicFeature	breast tumors	D001943
4286	17634480	1569	1573	GeneOrGeneProduct	GPX4	2879
4287	17634480	1687	1691	GeneOrGeneProduct	GPX4	2879
4288	17634480	1742	1755	DiseaseOrPhenotypicFeature	breast cancer	D001943
4289	17671735	66	74	OrganismTaxon	patients	9606
4290	17671735	93	97	GeneOrGeneProduct	GJB2	2706
4291	17671735	154	186	DiseaseOrPhenotypicFeature	sensorineural hearing impairment	D034381
4292	17671735	405	423	DiseaseOrPhenotypicFeature	hearing impairment	D034381
4293	17671735	461	465	GeneOrGeneProduct	GJB2	2706
4294	17671735	516	520	GeneOrGeneProduct	GJB2	2706
4295	17671735	527	535	OrganismTaxon	patients	9606
4296	17671735	541	559	DiseaseOrPhenotypicFeature	hearing impairment	D034381
4297	17671735	607	611	GeneOrGeneProduct	GJB6	10804
4298	17671735	616	620	GeneOrGeneProduct	GJB3	2707
4299	17671735	657	661	GeneOrGeneProduct	GJB2	2706
4300	17671735	707	711	GeneOrGeneProduct	GJB2	2706
4301	17671735	725	733	OrganismTaxon	patients	9606
4302	17671735	776	784	SequenceVariant	-3170G>A	c|SUB|G|-3170|A
4303	17671735	808	812	GeneOrGeneProduct	GJB2	2706
4304	17671735	834	842	OrganismTaxon	patients	9606
4305	17671735	861	869	SequenceVariant	-3170G>A	c|SUB|G|-3170|A
4306	17671735	899	906	SequenceVariant	p.R127H	rs111033196
4307	17671735	920	924	GeneOrGeneProduct	GJB2	2706
4308	17671735	967	971	GeneOrGeneProduct	GJB6	10804
4309	17671735	979	983	GeneOrGeneProduct	GJB6	10804
4310	17671735	1047	1051	GeneOrGeneProduct	GJB3	2707
4311	17671735	1053	1061	SequenceVariant	c.357C>T	rs41310442
4312	17671735	1063	1071	SequenceVariant	c.798C>T	rs35983826
4313	17671735	1076	1083	SequenceVariant	c.94C>T	rs1805063
4314	17671735	1085	1091	SequenceVariant	p.R32W	rs1805063
4315	17671735	1210	1218	SequenceVariant	-3170G>A	c|SUB|G|-3170|A
4316	17671735	1244	1252	SequenceVariant	c.35delG	rs80338939
4317	17671735	1257	1265	OrganismTaxon	patients	9606
4318	17671735	1271	1289	DiseaseOrPhenotypicFeature	hearing impairment	D034381
4319	17683901	63	68	GeneOrGeneProduct	FGFR3	2261
4320	17683901	69	74	SequenceVariant	G380R	rs28931614
4321	17683901	100	114	DiseaseOrPhenotypicFeature	achondroplasia	D000130
4322	17683901	116	130	DiseaseOrPhenotypicFeature	Achondroplasia	D000130
4323	17683901	158	166	DiseaseOrPhenotypicFeature	dwarfism	D004392
4324	17683901	273	330	SequenceVariant	G to A or G to C substitution at nucleotide position 1138	rs28931614
4325	17683901	332	339	SequenceVariant	p.G380R	rs28931614
4326	17683901	348	383	GeneOrGeneProduct	fibroblast growth factor receptor 3	2261
4327	17683901	385	390	GeneOrGeneProduct	FGFR3	2261
4328	17683901	482	491	SequenceVariant	c.1138G>A	rs28931614
4329	17683901	496	505	SequenceVariant	c.1138G>C	rs28931614
4330	17683901	606	615	SequenceVariant	c.1138G>A	rs28931614
4331	17683901	811	819	OrganismTaxon	patients	9606
4332	17683901	825	839	DiseaseOrPhenotypicFeature	achondroplasia	D000130
4333	17683901	883	897	DiseaseOrPhenotypicFeature	achondroplasia	D000130
4334	17683901	962	971	SequenceVariant	c.1138G>A	rs28931614
4335	17683901	1127	1132	GeneOrGeneProduct	FGFR3	2261
4336	17683901	1133	1140	SequenceVariant	p.G380R	rs28931614
4337	17854040	26	36	ChemicalEntity	lamivudine	D019259
4338	17854040	66	98	DiseaseOrPhenotypicFeature	hepatitis B virus (HBV) infected	D006509
4339	17854040	125	141	DiseaseOrPhenotypicFeature	HIV co-infection	D015658
4340	17854040	186	209	DiseaseOrPhenotypicFeature	HBV and HIV co-infected	D006509,D015658
4341	17854040	279	289	ChemicalEntity	lamivudine	D019259
4342	17854040	300	317	OrganismTaxon	hepatitis B virus	10407
4343	17854040	319	322	OrganismTaxon	HBV	10407
4344	17854040	344	354	ChemicalEntity	lamivudine	D019259
4345	17854040	362	365	OrganismTaxon	HBV	10407
4346	17854040	392	439	DiseaseOrPhenotypicFeature	human immunodeficiency virus (HIV) co-infection	D015658
4347	17854040	479	489	ChemicalEntity	lamivudine	D019259
4348	17854040	497	509	DiseaseOrPhenotypicFeature	HBV infected	D006509
4349	17854040	535	551	DiseaseOrPhenotypicFeature	HIV co-infection	D015658
4350	17854040	577	594	DiseaseOrPhenotypicFeature	HBV mono-infected	D006509
4351	17854040	611	630	DiseaseOrPhenotypicFeature	HBV-HIV co-infected	D006509,D015658
4352	17854040	697	700	OrganismTaxon	HBV	10407
4353	17854040	702	707	ChemicalEntity	HBsAg	D006514
4354	17854040	730	733	OrganismTaxon	HBV	10407
4355	17854040	735	740	ChemicalEntity	HBsAg	D006514
4356	17854040	762	767	ChemicalEntity	HBsAg	D006514
4357	17854040	798	805	OrganismTaxon	HIV 1/2	11676,11709
4358	17854040	950	953	OrganismTaxon	HBV	10407
4359	17854040	1137	1140	OrganismTaxon	HBV	10407
4360	17854040	1152	1155	OrganismTaxon	HBV	10407
4361	17854040	1195	1198	OrganismTaxon	HBV	10407
4362	17854040	1257	1260	OrganismTaxon	HBV	10407
4363	17854040	1261	1271	ChemicalEntity	lamivudine	D019259
4364	17854040	1337	1348	DiseaseOrPhenotypicFeature	hepatitis B	D006509
4365	17854040	1371	1390	DiseaseOrPhenotypicFeature	HBV-HIV co-infected	D006509,D015658
4366	17854040	1468	1471	OrganismTaxon	HBV	10407
4367	17854040	1472	1482	ChemicalEntity	lamivudine	D019259
4368	17854040	1519	1538	DiseaseOrPhenotypicFeature	HBV-HIV co-infected	D006509,D015658
4369	17854040	1553	1556	OrganismTaxon	HBV	10407
4370	17854040	1811	1814	OrganismTaxon	HBV	10407
4371	17854040	1838	1848	ChemicalEntity	lamivudine	D019259
4372	17854040	2031	2050	DiseaseOrPhenotypicFeature	HBV-HIV co-infected	D006509,D015658
4373	17879945	0	8	ChemicalEntity	Estrogen	D004967
4374	17879945	18	35	ChemicalEntity	cholesteryl ester	D002788
4375	17879945	79	91	GeneOrGeneProduct	HIV protease	-
4376	17879945	102	111	ChemicalEntity	ritonavir	D019438
4377	17879945	130	133	OrganismTaxon	HIV	11676
4378	17879945	224	233	ChemicalEntity	ritonavir	D019438
4379	17879945	307	332	DiseaseOrPhenotypicFeature	premature atherosclerosis	D050197
4380	17879945	371	380	ChemicalEntity	ritonavir	D019438
4381	17879945	401	423	DiseaseOrPhenotypicFeature	atherosclerotic lesion	D050197
4382	17879945	442	446	OrganismTaxon	mice	10090
4383	17879945	482	486	OrganismTaxon	mice	10090
4384	17879945	542	551	ChemicalEntity	ritonavir	D019438
4385	17879945	577	594	ChemicalEntity	cholesteryl ester	D002788
4386	17879945	712	723	ChemicalEntity	cholesterol	D002784
4387	17879945	769	781	GeneOrGeneProduct	HIV protease	-
4388	17879945	792	801	ChemicalEntity	ritonavir	D019438
4389	17879945	824	829	OrganismTaxon	human	9606
4390	17879945	850	855	CellLine	THP-1	9606
4391	17879945	1026	1042	ChemicalEntity	17beta-estradiol	D004958
4392	17879945	1044	1046	ChemicalEntity	E2	D004958
4393	17879945	1056	1068	ChemicalEntity	progesterone	D011374
4394	17879945	1087	1094	ChemicalEntity	ethanol	D000431
4395	17879945	1135	1144	ChemicalEntity	ritonavir	D019438
4396	17879945	1234	1239	ChemicalEntity	lipid	D008055
4397	17879945	1267	1269	ChemicalEntity	E2	D004958
4398	17879945	1300	1318	ChemicalEntity	cholesteryl esters	D002788
4399	17879945	1344	1353	ChemicalEntity	ritonavir	D019438
4400	17879945	1365	1374	ChemicalEntity	Ritonavir	D019438
4401	17879945	1427	1431	GeneOrGeneProduct	CD36	948
4402	17879945	1487	1496	ChemicalEntity	ritonavir	D019438
4403	17879945	1552	1561	GeneOrGeneProduct	PPARgamma	5468
4404	17879945	1625	1629	GeneOrGeneProduct	CD36	948
4405	17879945	1662	1664	ChemicalEntity	E2	D004958
4406	17879945	1728	1730	ChemicalEntity	E2	D004958
4407	17879945	1768	1772	GeneOrGeneProduct	CD36	948
4408	17879945	1860	1862	ChemicalEntity	E2	D004958
4409	17879945	1890	1894	GeneOrGeneProduct	CD36	948
4410	17879945	1983	2000	ChemicalEntity	cholesteryl ester	D002788
4411	17879945	2024	2033	ChemicalEntity	ritonavir	D019438
4412	17910065	50	55	OrganismTaxon	human	9606
4413	17910065	56	60	GeneOrGeneProduct	PAX9	5083
4414	17910065	68	79	DiseaseOrPhenotypicFeature	oligodontia	C538049
4415	17910065	81	85	GeneOrGeneProduct	PAX9	5083
4416	17910065	90	94	GeneOrGeneProduct	MSX1	4487
4417	17910065	188	194	OrganismTaxon	humans	9606
4418	17910065	240	278	DiseaseOrPhenotypicFeature	nonsyndromic and syndromic oligodontia	C538049
4419	17910065	322	346	DiseaseOrPhenotypicFeature	nonsyndromic oligodontia	C538049
4420	17910065	364	368	GeneOrGeneProduct	PAX9	5083
4421	17910065	373	377	GeneOrGeneProduct	MSX1	4487
4422	17910065	484	489	SequenceVariant	C139T	rs121917720
4423	17910065	504	508	GeneOrGeneProduct	PAX9	5083
4424	17910065	614	618	GeneOrGeneProduct	MSX1	4487
4425	17910065	624	629	SequenceVariant	C139T	rs121917720
4426	17910065	686	710	SequenceVariant	arginine by a tryptophan	rs121917720
4427	17910065	712	716	SequenceVariant	R47W	rs121917720
4428	17910065	782	786	GeneOrGeneProduct	PAX9	5083
4429	17910065	850	871	DiseaseOrPhenotypicFeature	oligodontia phenotype	C538049
4430	17910065	945	949	GeneOrGeneProduct	PAX9	5083
4431	17910065	1008	1012	SequenceVariant	R47W	rs121917720
4432	17951029	0	23	DiseaseOrPhenotypicFeature	Focal dermal hypoplasia	D005489
4433	17951029	64	71	SequenceVariant	p.E300X	p|SUB|E|300|X
4434	17951029	80	85	GeneOrGeneProduct	PORCN	64840
4435	17951029	104	127	DiseaseOrPhenotypicFeature	Focal dermal hypoplasia	D005489
4436	17951029	129	132	DiseaseOrPhenotypicFeature	FDH	D005489
4437	17951029	135	146	DiseaseOrPhenotypicFeature	OMIM 305600	D005489
4438	17951029	154	180	DiseaseOrPhenotypicFeature	X-linked dominant disorder	D040181
4439	17951029	227	241	DiseaseOrPhenotypicFeature	Goltz syndrome	D005489
4440	17951029	243	246	DiseaseOrPhenotypicFeature	FDH	D005489
4441	17951029	294	312	DiseaseOrPhenotypicFeature	hypoplastic dermis	D005489
4442	17951029	408	411	DiseaseOrPhenotypicFeature	FDH	D005489
4443	17951029	438	443	GeneOrGeneProduct	PORCN	64840
4444	17951029	633	636	DiseaseOrPhenotypicFeature	FDH	D005489
4445	17951029	691	700	DiseaseOrPhenotypicFeature	depressed	D003866
4446	17951029	814	827	DiseaseOrPhenotypicFeature	dental caries	D003731
4447	17951029	997	1002	GeneOrGeneProduct	PORCN	64840
4448	17951029	1058	1094	SequenceVariant	G>T substitution at nucleotide c.898	c|SUB|G|898|T
4449	17951029	1138	1204	SequenceVariant	glutamic acid residue (GAA) to a premature termination codon (TAA)	p|SUB|E||X
4450	17951029	1232	1239	SequenceVariant	p.E300X	p|SUB|E|300|X
4451	17951029	1406	1409	DiseaseOrPhenotypicFeature	FDH	D005489
4452	17951029	1466	1471	GeneOrGeneProduct	PORCN	64840
4453	17959715	12	16	GeneOrGeneProduct	MLH1	4292
4454	17959715	29	35	DiseaseOrPhenotypicFeature	cancer	D009369
4455	17959715	71	87	DiseaseOrPhenotypicFeature	Hodgkin lymphoma	D006689
4456	17959715	172	188	DiseaseOrPhenotypicFeature	Hodgkin lymphoma	D006689
4457	17959715	248	255	DiseaseOrPhenotypicFeature	cancers	D009369
4458	17959715	257	269	DiseaseOrPhenotypicFeature	Cytotoxicity	D064420
4459	17959715	363	367	GeneOrGeneProduct	MLH1	4292
4460	17959715	427	436	DiseaseOrPhenotypicFeature	cytotoxic	D064420
4461	17959715	614	618	GeneOrGeneProduct	MLH1	4292
4462	17959715	634	643	SequenceVariant	rs1800734	rs1800734
4463	17959715	666	672	DiseaseOrPhenotypicFeature	cancer	D009369
4464	17959715	718	726	OrganismTaxon	patients	9606
4465	17959715	741	747	DiseaseOrPhenotypicFeature	cancer	D009369
4466	17959715	806	814	OrganismTaxon	patients	9606
4467	17959715	838	855	DiseaseOrPhenotypicFeature	myeloid leukaemia	D007938
4468	17959715	861	869	OrganismTaxon	patients	9606
4469	17959715	885	909	DiseaseOrPhenotypicFeature	primary Hodgkin lymphoma	D006689
4470	17959715	960	964	GeneOrGeneProduct	MLH1	4292
4471	17959715	1137	1143	DiseaseOrPhenotypicFeature	cancer	D009369
4472	17959715	1152	1156	GeneOrGeneProduct	MLH1	4292
4473	17959715	1338	1342	GeneOrGeneProduct	MLH1	4292
4474	17959715	1369	1377	OrganismTaxon	patients	9606
4475	17959715	1408	1431	DiseaseOrPhenotypicFeature	acute myeloid leukaemia	D015470
4476	17959715	1435	1438	DiseaseOrPhenotypicFeature	AML	D015470
4477	17959715	1459	1472	DiseaseOrPhenotypicFeature	breast cancer	D001943
4478	17959715	1524	1540	DiseaseOrPhenotypicFeature	Hodgkin lymphoma	D006689
4479	17959715	1553	1561	OrganismTaxon	patients	9606
4480	17959715	1603	1606	DiseaseOrPhenotypicFeature	AML	D015470
4481	17959715	1623	1636	DiseaseOrPhenotypicFeature	breast cancer	D001943
4482	17959715	1637	1645	OrganismTaxon	patients	9606
4483	17959715	1667	1671	GeneOrGeneProduct	MLH1	4292
4484	17959715	1722	1725	DiseaseOrPhenotypicFeature	AML	D015470
4485	17959715	1757	1760	DiseaseOrPhenotypicFeature	AML	D015470
4486	17959715	1894	1897	DiseaseOrPhenotypicFeature	AML	D015470
4487	17959715	1968	1976	OrganismTaxon	patients	9606
4488	17959715	2138	2142	GeneOrGeneProduct	MLH1	4292
4489	17959715	2188	2194	DiseaseOrPhenotypicFeature	cancer	D009369
4490	17959715	2230	2246	DiseaseOrPhenotypicFeature	Hodgkin lymphoma	D006689
4491	17965424	33	43	ChemicalEntity	etoricoxib	D000077613
4492	17965424	47	67	DiseaseOrPhenotypicFeature	rheumatoid arthritis	D001172
4493	17965424	68	76	OrganismTaxon	patients	9606
4494	17965424	93	103	ChemicalEntity	etoricoxib	D000077613
4495	17965424	107	124	ChemicalEntity	diclofenac sodium	D004008
4496	17965424	308	318	ChemicalEntity	etoricoxib	D000077613
4497	17965424	323	333	ChemicalEntity	diclofenac	D004008
4498	17965424	337	345	OrganismTaxon	patients	9606
4499	17965424	351	371	DiseaseOrPhenotypicFeature	rheumatoid arthritis	D001172
4500	17965424	373	375	DiseaseOrPhenotypicFeature	RA	D001172
4501	17965424	378	386	OrganismTaxon	PATIENTS	9606
4502	17965424	416	424	OrganismTaxon	patients	9606
4503	17965424	462	464	DiseaseOrPhenotypicFeature	RA	D001172
4504	17965424	492	502	ChemicalEntity	etoricoxib	D000077613
4505	17965424	529	539	ChemicalEntity	diclofenac	D004008
4506	17965424	614	621	ChemicalEntity	aspirin	D001241
4507	17965424	706	713	OrganismTaxon	patient	9606
4508	17965424	762	784	DiseaseOrPhenotypicFeature	GI adverse experiences	D005767
4509	17965424	848	873	DiseaseOrPhenotypicFeature	thrombotic cardiovascular	D002318
4510	17965424	919	926	OrganismTaxon	Patient	9606
4511	17965424	1097	1107	ChemicalEntity	etoricoxib	D000077613
4512	17965424	1112	1122	ChemicalEntity	diclofenac	D004008
4513	17965424	1188	1194	DiseaseOrPhenotypicFeature	GI AEs	D005767
4514	17965424	1224	1234	ChemicalEntity	etoricoxib	D000077613
4515	17965424	1240	1250	ChemicalEntity	diclofenac	D004008
4516	17965424	1278	1285	OrganismTaxon	patient	9606
4517	17965424	1398	1410	DiseaseOrPhenotypicFeature	hypertension	D006973
4518	17965424	1423	1429	DiseaseOrPhenotypicFeature	oedema	D004487
4519	17965424	1473	1483	ChemicalEntity	etoricoxib	D000077613
4520	17965424	1527	1537	ChemicalEntity	diclofenac	D004008
4521	17965424	1579	1591	DiseaseOrPhenotypicFeature	hypertension	D006973
4522	17965424	1607	1613	DiseaseOrPhenotypicFeature	oedema	D004487
4523	17965424	1616	1626	ChemicalEntity	Etoricoxib	D000077613
4524	17965424	1631	1641	ChemicalEntity	diclofenac	D004008
4525	17965424	1759	1769	ChemicalEntity	Etoricoxib	D000077613
4526	17965424	1851	1857	DiseaseOrPhenotypicFeature	GI AEs	D005767
4527	17965424	1872	1882	ChemicalEntity	diclofenac	D004008
4528	17965424	1979	1985	DiseaseOrPhenotypicFeature	GI AEs	D005767
4529	17965424	2018	2028	ChemicalEntity	etoricoxib	D000077613
4530	17975693	0	10	DiseaseOrPhenotypicFeature	Anxiogenic	D001008
4531	17975693	24	37	ChemicalEntity	ciprofloxacin	D002939
4532	17975693	42	53	ChemicalEntity	norfloxacin	D009643
4533	17975693	57	61	OrganismTaxon	rats	10116
4534	17975693	90	100	DiseaseOrPhenotypicFeature	anxiogenic	D001008
4535	17975693	112	128	ChemicalEntity	fluoroquinolones	D024841
4536	17975693	137	150	ChemicalEntity	ciprofloxacin	D002939
4537	17975693	155	166	ChemicalEntity	norfloxacin	D009643
4538	17975693	217	221	OrganismTaxon	rats	10116
4539	17975693	595	608	ChemicalEntity	ciprofloxacin	D002939
4540	17975693	614	625	ChemicalEntity	norfloxacin	D009643
4541	17975693	634	638	OrganismTaxon	rats	10116
4542	17975693	646	663	DiseaseOrPhenotypicFeature	anxious behaviour	D001008
4543	17975693	689	693	OrganismTaxon	rats	10116
4544	17975693	734	747	ChemicalEntity	ciprofloxacin	D002939
4545	17975693	753	764	ChemicalEntity	norfloxacin	D009643
4546	17975693	773	777	OrganismTaxon	rats	10116
4547	17975693	941	951	DiseaseOrPhenotypicFeature	anxiogenic	D001008
4548	17975693	965	978	ChemicalEntity	ciprofloxacin	D002939
4549	17975693	983	994	ChemicalEntity	norfloxacin	D009643
4550	18046082	18	34	GeneOrGeneProduct	apolipoprotein E	348
4551	18046082	46	66	SequenceVariant	arginine 150 proline	p|SUB|R|150|P
4552	18046082	99	125	DiseaseOrPhenotypicFeature	lipoprotein glomerulopathy	C567089
4553	18046082	144	170	DiseaseOrPhenotypicFeature	Lipoprotein glomerulopathy	C567089
4554	18046082	172	175	DiseaseOrPhenotypicFeature	LPG	C567089
4555	18046082	212	220	DiseaseOrPhenotypicFeature	thrombus	D013927
4556	18046082	249	279	DiseaseOrPhenotypicFeature	dilated glomerular capillaries	D007674
4557	18046082	310	326	GeneOrGeneProduct	apolipoprotein E	348
4558	18046082	328	332	GeneOrGeneProduct	apoE	348
4559	18046082	389	393	GeneOrGeneProduct	apoE	348
4560	18046082	432	435	DiseaseOrPhenotypicFeature	LPG	C567089
4561	18046082	441	444	DiseaseOrPhenotypicFeature	LPG	C567089
4562	18046082	466	470	GeneOrGeneProduct	apoE	348
4563	18046082	497	505	OrganismTaxon	patients	9606
4564	18046082	567	571	GeneOrGeneProduct	apoE	348
4565	18046082	577	580	DiseaseOrPhenotypicFeature	LPG	C567089
4566	18046082	615	619	GeneOrGeneProduct	apoE	348
4567	18046082	644	647	DiseaseOrPhenotypicFeature	LPG	C567089
4568	18046082	648	656	OrganismTaxon	patients	9606
4569	18046082	730	734	GeneOrGeneProduct	apoE	348
4570	18046082	843	847	GeneOrGeneProduct	apoE	348
4571	18046082	877	880	DiseaseOrPhenotypicFeature	LPG	C567089
4572	18046082	881	889	OrganismTaxon	patients	9606
4573	18046082	965	1007	SequenceVariant	G to C point mutation in exon 4 (base 308)	c|SUB|G|308|C
4574	18046082	1015	1019	GeneOrGeneProduct	apoE	348
4575	18046082	1032	1040	OrganismTaxon	patients	9606
4576	18046082	1139	1191	SequenceVariant	proline residue for arginine residue at position 150	p|SUB|R|150|P
4577	18046082	1195	1199	GeneOrGeneProduct	apoE	348
4578	18046082	1207	1215	OrganismTaxon	patients	9606
4579	18046082	1244	1248	GeneOrGeneProduct	apoE	348
4580	18046082	1309	1313	GeneOrGeneProduct	apoE	348
4581	18046082	1350	1361	DiseaseOrPhenotypicFeature	proteinuria	D011507
4582	18046082	1414	1418	GeneOrGeneProduct	apoE	348
4583	18046082	1420	1440	SequenceVariant	arginine 150 proline	p|SUB|R|150|P
4584	18046082	1453	1457	GeneOrGeneProduct	apoE	348
4585	18046082	1496	1499	DiseaseOrPhenotypicFeature	LPG	C567089
4586	18046082	1515	1519	GeneOrGeneProduct	apoE	348
4587	18046082	1589	1593	GeneOrGeneProduct	apoE	348
4588	18046082	1633	1639	ChemicalEntity	lipids	D008055
4589	18050247	64	92	DiseaseOrPhenotypicFeature	systemic lupus erythematosus	D008180
4590	18050247	179	207	DiseaseOrPhenotypicFeature	systemic lupus erythematosus	D008180
4591	18050247	209	212	DiseaseOrPhenotypicFeature	SLE	D008180
4592	18050247	244	252	OrganismTaxon	patients	9606
4593	18050247	354	357	DiseaseOrPhenotypicFeature	SLE	D008180
4594	18050247	450	458	OrganismTaxon	patients	9606
4595	18050247	480	483	DiseaseOrPhenotypicFeature	SLE	D008180
4596	18050247	839	842	DiseaseOrPhenotypicFeature	SLE	D008180
4597	18050247	1018	1021	DiseaseOrPhenotypicFeature	SLE	D008180
4598	18050247	1029	1034	SequenceVariant	N673S	rs3917815
4599	18050247	1055	1065	GeneOrGeneProduct	P-selectin	6403
4600	18050247	1072	1076	GeneOrGeneProduct	SELP	6403
4601	18050247	1104	1109	SequenceVariant	C203S	rs10127175
4602	18050247	1130	1172	GeneOrGeneProduct	interleukin-1 receptor-associated kinase 1	3654
4603	18050247	1179	1184	GeneOrGeneProduct	IRAK1	3654
4604	18050247	1430	1433	DiseaseOrPhenotypicFeature	SLE	D008180
4605	18050247	1522	1529	GeneOrGeneProduct	TNFRSF6	355
4606	18050247	1531	1534	GeneOrGeneProduct	Fas	355
4607	18050247	1540	1544	GeneOrGeneProduct	IRF5	3663
4608	18050247	1601	1604	DiseaseOrPhenotypicFeature	SLE	D008180
4609	18050247	1631	1635	GeneOrGeneProduct	SELP	6403
4610	18050247	1640	1645	GeneOrGeneProduct	IRAK1	3654
4611	18050247	1671	1674	DiseaseOrPhenotypicFeature	SLE	D008180
4612	18050247	1791	1794	DiseaseOrPhenotypicFeature	SLE	D008180
4613	18165598	28	39	ChemicalEntity	bupivacaine	D002045
4614	18165598	44	53	ChemicalEntity	lidocaine	D008012
4615	18165598	57	73	GeneOrGeneProduct	prostaglandin E2	5732
4616	18165598	83	97	GeneOrGeneProduct	cyclooxygenase	4512,4513
4617	18165598	118	122	DiseaseOrPhenotypicFeature	pain	D010146
4618	18165598	137	141	DiseaseOrPhenotypicFeature	pain	D010146
4619	18165598	278	290	DiseaseOrPhenotypicFeature	inflammation	D007249
4620	18165598	357	368	ChemicalEntity	bupivacaine	D002045
4621	18165598	378	394	GeneOrGeneProduct	prostaglandin E2	5732
4622	18165598	396	400	GeneOrGeneProduct	PGE2	5732
4623	18165598	417	431	GeneOrGeneProduct	cyclooxygenase	4512,4513
4624	18165598	433	436	GeneOrGeneProduct	COX	4512,4513
4625	18165598	469	487	DiseaseOrPhenotypicFeature	postoperative pain	D010149
4626	18165598	491	496	OrganismTaxon	human	9606
4627	18165598	601	610	ChemicalEntity	lidocaine	D008012
4628	18165598	619	630	ChemicalEntity	bupivacaine	D002045
4629	18165598	657	666	ChemicalEntity	rofecoxib	C116926
4630	18165598	889	893	GeneOrGeneProduct	PGE2	5732
4631	18165598	898	912	ChemicalEntity	thromboxane B2	D013929
4632	18165598	914	918	ChemicalEntity	TXB2	D013929
4633	18165598	947	958	ChemicalEntity	bupivacaine	D002045
4634	18165598	959	968	ChemicalEntity	rofecoxib	C116926
4635	18165598	1003	1007	DiseaseOrPhenotypicFeature	pain	D010146
4636	18165598	1127	1138	ChemicalEntity	bupivacaine	D002045
4637	18165598	1181	1185	DiseaseOrPhenotypicFeature	pain	D010146
4638	18165598	1198	1202	GeneOrGeneProduct	PGE2	5732
4639	18165598	1306	1317	ChemicalEntity	bupivacaine	D002045
4640	18165598	1342	1347	GeneOrGeneProduct	COX-2	4513
4641	18165598	1393	1402	ChemicalEntity	lidocaine	D008012
4642	18165598	1418	1429	ChemicalEntity	Thromboxane	D013931
4643	18165598	1563	1568	GeneOrGeneProduct	COX-2	4513
4644	18165598	1578	1583	GeneOrGeneProduct	COX-1	4512
4645	18165598	1625	1636	ChemicalEntity	bupivacaine	D002045
4646	18165598	1648	1653	GeneOrGeneProduct	COX-2	4513
4647	18165598	1676	1689	DiseaseOrPhenotypicFeature	tissue injury	D017695
4648	18165598	1723	1727	GeneOrGeneProduct	PGE2	5732
4649	18165598	1743	1747	DiseaseOrPhenotypicFeature	pain	D010146
4650	18166824	47	52	OrganismTaxon	women	9606
4651	18166824	58	83	DiseaseOrPhenotypicFeature	premature ovarian failure	D016649
4652	18166824	204	208	GeneOrGeneProduct	DMC1	11144
4653	18166824	211	215	GeneOrGeneProduct	MutS	850545
4654	18166824	225	229	GeneOrGeneProduct	MSH4	4438
4655	18166824	232	236	GeneOrGeneProduct	MSH5	4439
4656	18166824	242	255	OrganismTaxon	S. cerevisiae	4932
4657	18166824	265	270	GeneOrGeneProduct	SPO11	856364
4658	18166824	294	319	DiseaseOrPhenotypicFeature	premature ovarian failure	D016649
4659	18166824	321	324	DiseaseOrPhenotypicFeature	POF	D016649
4660	18166824	464	472	OrganismTaxon	patients	9606
4661	18166824	578	583	OrganismTaxon	women	9606
4662	18166824	589	592	DiseaseOrPhenotypicFeature	POF	D016649
4663	18166824	608	613	OrganismTaxon	women	9606
4664	18166824	694	725	SequenceVariant	cytosine residue with thymidine	rs2075789
4665	18166824	739	743	GeneOrGeneProduct	MSH5	4439
4666	18166824	772	777	OrganismTaxon	women	9606
4667	18166824	786	789	DiseaseOrPhenotypicFeature	POF	D016649
4668	18166824	891	948	SequenceVariant	(proline) with a polar amino acid (serine) at position 29	rs2075789
4669	18166824	950	954	SequenceVariant	P29S	rs2075789
4670	18166824	976	981	OrganismTaxon	women	9606
4671	18166824	995	1003	OrganismTaxon	patients	9606
4672	18166824	1009	1012	DiseaseOrPhenotypicFeature	POF	D016649
4673	18166824	1058	1061	DiseaseOrPhenotypicFeature	POF	D016649
4674	18166824	1062	1069	OrganismTaxon	patient	9606
4675	18166824	1142	1146	GeneOrGeneProduct	DMC1	11144
4676	18166824	1224	1229	SequenceVariant	M200V	rs2227914
4677	18166824	1261	1272	DiseaseOrPhenotypicFeature	infertility	D007247
4678	18166824	1289	1293	GeneOrGeneProduct	DMC1	11144
4679	18166824	1334	1342	OrganismTaxon	patients	9606
4680	18166824	1393	1397	GeneOrGeneProduct	MSH5	4439
4681	18166824	1523	1527	GeneOrGeneProduct	MSH5	4439
4682	18166824	1532	1536	GeneOrGeneProduct	DMC1	11144
4683	18166824	1574	1577	DiseaseOrPhenotypicFeature	POF	D016649
4684	18179903	21	27	GeneOrGeneProduct	CHRNA1	1134
4685	18179903	29	35	GeneOrGeneProduct	CHRNB1	1140
4686	18179903	37	42	GeneOrGeneProduct	CHRND	1144
4687	18179903	48	53	GeneOrGeneProduct	RAPSN	5913
4688	18179903	63	90	DiseaseOrPhenotypicFeature	multiple pterygium syndrome	C537377
4689	18179903	91	105	DiseaseOrPhenotypicFeature	fetal akinesia	C536647
4690	18179903	106	114	OrganismTaxon	patients	9606
4691	18179903	116	144	DiseaseOrPhenotypicFeature	Multiple pterygium syndromes	C537377
4692	18179903	146	149	DiseaseOrPhenotypicFeature	MPS	C537377
4693	18179903	180	208	DiseaseOrPhenotypicFeature	congenital anomaly disorders	D000013
4694	18179903	283	301	DiseaseOrPhenotypicFeature	joint contractures	D003286
4695	18179903	303	317	DiseaseOrPhenotypicFeature	arthrogryposis	D001176
4696	18179903	320	323	DiseaseOrPhenotypicFeature	MPS	C537377
4697	18179903	524	566	GeneOrGeneProduct	embryonal acetylcholine receptor g subunit	1146
4698	18179903	568	573	GeneOrGeneProduct	CHRNG	1146
4699	18179903	611	614	DiseaseOrPhenotypicFeature	MPS	C537377
4700	18179903	663	677	DiseaseOrPhenotypicFeature	fetal akinesia	C536647
4701	18179903	773	776	DiseaseOrPhenotypicFeature	MPS	C537377
4702	18179903	777	791	DiseaseOrPhenotypicFeature	fetal akinesia	C536647
4703	18179903	840	843	DiseaseOrPhenotypicFeature	MPS	C537377
4704	18179903	844	858	DiseaseOrPhenotypicFeature	fetal akinesia	C536647
4705	18179903	867	872	GeneOrGeneProduct	CHRNG	1146
4706	18179903	904	910	GeneOrGeneProduct	CHRNA1	1134
4707	18179903	912	918	GeneOrGeneProduct	CHRNB1	1140
4708	18179903	920	925	GeneOrGeneProduct	CHRND	1144
4709	18179903	931	937	GeneOrGeneProduct	rapsyn	5913
4710	18179903	939	944	GeneOrGeneProduct	RAPSN	5913
4711	18179903	956	962	GeneOrGeneProduct	CHRNA1	1134
4712	18179903	964	970	GeneOrGeneProduct	CHRNB1	1140
4713	18179903	975	980	GeneOrGeneProduct	CHRND	1144
4714	18179903	1023	1028	GeneOrGeneProduct	RAPSN	5913
4715	18179903	1050	1066	SequenceVariant	c.1177-1178delAA	c|DEL|1177_1178|AA
4716	18179903	1136	1159	DiseaseOrPhenotypicFeature	fetal akinesia sequence	C536647
4717	18179903	1173	1178	GeneOrGeneProduct	RAPSN	5913
4718	18179903	1211	1232	DiseaseOrPhenotypicFeature	congenital myasthenia	D020294
4719	18179903	1321	1327	GeneOrGeneProduct	rapsyn	5913
4720	18179903	1347	1368	DiseaseOrPhenotypicFeature	congenital myasthenia	D020294
4721	18179903	1422	1436	DiseaseOrPhenotypicFeature	fetal akinesia	C536647
4722	18189233	0	6	GeneOrGeneProduct	RNASEL	6041
4723	18189233	11	17	GeneOrGeneProduct	RNASEL	6041
4724	18189233	42	57	DiseaseOrPhenotypicFeature	prostate cancer	D011471
4725	18189233	154	169	DiseaseOrPhenotypicFeature	prostate cancer	D011471
4726	18189233	193	208	DiseaseOrPhenotypicFeature	prostate cancer	D011471
4727	18189233	329	343	GeneOrGeneProduct	ribonuclease L	6041
4728	18189233	345	351	GeneOrGeneProduct	RNASEL	6041
4729	18189233	428	443	DiseaseOrPhenotypicFeature	prostate cancer	D011471
4730	18189233	462	468	GeneOrGeneProduct	RNASEL	6041
4731	18189233	516	531	DiseaseOrPhenotypicFeature	prostate cancer	D011471
4732	18189233	647	653	GeneOrGeneProduct	RNASEL	6041
4733	18189233	660	675	DiseaseOrPhenotypicFeature	prostate cancer	D011471
4734	18189233	720	725	SequenceVariant	R462Q	rs486907
4735	18189233	730	735	SequenceVariant	D541E	rs627928
4736	18189233	757	772	DiseaseOrPhenotypicFeature	prostate cancer	D011471
4737	18189233	831	837	GeneOrGeneProduct	RNASEL	6041
4738	18189233	839	844	GeneOrGeneProduct	ABCE1	6059
4739	18189233	876	891	DiseaseOrPhenotypicFeature	prostate cancer	D011471
4740	18189233	951	956	SequenceVariant	R462Q	rs486907
4741	18189233	961	966	SequenceVariant	D541E	rs627928
4742	18189233	985	1000	DiseaseOrPhenotypicFeature	prostate cancer	D011471
4743	18189233	1053	1058	SequenceVariant	K294E	rs143544690
4744	18189233	1116	1131	DiseaseOrPhenotypicFeature	prostate cancer	D011471
4745	18189233	1152	1231	SequenceVariant	20 bp insertion/deletion polymorphism 1,109 bp upstream of the initiation codon	c|INDEL|1109|20
4746	18189233	1274	1289	DiseaseOrPhenotypicFeature	prostate cancer	D011471
4747	18189233	1347	1352	GeneOrGeneProduct	ABCE1	6059
4748	18189233	1418	1442	SequenceVariant	A/G transition -1,071 bp	c|SUB|A|-1071|G
4749	18189233	1536	1551	DiseaseOrPhenotypicFeature	prostate cancer	D011471
4750	18189233	1624	1639	DiseaseOrPhenotypicFeature	prostate cancer	D011471
4751	18189233	1661	1667	GeneOrGeneProduct	RNASEL	6041
4752	18189233	1723	1738	DiseaseOrPhenotypicFeature	prostate cancer	D011471
4753	18310445	0	28	GeneOrGeneProduct	Bone morphogenetic protein-4	652
4754	18310445	44	51	GeneOrGeneProduct	activin	3624,83729
4755	18310445	56	60	GeneOrGeneProduct	GnRH	14714
4756	18310445	73	86	GeneOrGeneProduct	gonadotrophin	12640,14308
4757	18310445	100	107	CellLine	LbetaT2	10090
4758	18310445	156	161	OrganismTaxon	sheep	9940
4759	18310445	187	222	GeneOrGeneProduct	bone morphogenetic proteins (BMP)-4	443502
4760	18310445	232	239	GeneOrGeneProduct	FSHbeta	443387
4761	18310445	260	263	GeneOrGeneProduct	FSH	443387,443538
4762	18310445	289	294	OrganismTaxon	mouse	10090
4763	18310445	295	302	CellLine	LbetaT2	10090
4764	18310445	359	363	GeneOrGeneProduct	BMPs	652
4765	18310445	376	383	GeneOrGeneProduct	activin	16323
4766	18310445	395	402	GeneOrGeneProduct	FSHbeta	14308
4767	18310445	493	500	CellLine	LbetaT2	10090
4768	18310445	537	542	GeneOrGeneProduct	BMP-4	652
4769	18310445	546	559	GeneOrGeneProduct	gonadotrophin	12640,14308
4770	18310445	592	599	GeneOrGeneProduct	activin	16323
4771	18310445	604	608	GeneOrGeneProduct	GnRH	14714
4772	18310445	610	615	GeneOrGeneProduct	BMP-4	652
4773	18310445	639	642	GeneOrGeneProduct	FSH	443387,443538
4774	18310445	672	679	GeneOrGeneProduct	activin	16323
4775	18310445	680	684	GeneOrGeneProduct	GnRH	14714
4776	18310445	708	715	GeneOrGeneProduct	FSHbeta	14308
4777	18310445	725	728	GeneOrGeneProduct	FSH	443387,443538
4778	18310445	762	773	GeneOrGeneProduct	follistatin	14313
4779	18310445	780	785	GeneOrGeneProduct	BMP-4	652
4780	18310445	794	800	GeneOrGeneProduct	LHbeta	16866
4781	18310445	835	839	GeneOrGeneProduct	GnRH	14714
4782	18310445	844	851	GeneOrGeneProduct	activin	16323
4783	18310445	867	880	GeneOrGeneProduct	GnRH receptor	14715
4784	18310445	912	915	GeneOrGeneProduct	FSH	443387,443538
4785	18310445	929	931	GeneOrGeneProduct	LH	12640,16866
4786	18310445	973	978	OrganismTaxon	sheep	9940
4787	18310445	1022	1068	GeneOrGeneProduct	BMP receptor types IA (BMPRIA) and II (BMPRII)	101103793,101112282
4788	18310445	1070	1077	CellLine	LbetaT2	10090
4789	18310445	1097	1103	GeneOrGeneProduct	BMPRIB	12167
4790	18310445	1105	1112	GeneOrGeneProduct	Smad1/5	17125,17129
4791	18310445	1140	1145	GeneOrGeneProduct	BMP-4	652
4792	18310445	1172	1175	GeneOrGeneProduct	BMP	12159
4793	18310445	1209	1214	GeneOrGeneProduct	BMP-4	652
4794	18310445	1247	1254	GeneOrGeneProduct	activin	16323
4795	18310445	1257	1261	GeneOrGeneProduct	GnRH	14714
4796	18310445	1284	1291	GeneOrGeneProduct	activin	16323
4797	18310445	1299	1303	GeneOrGeneProduct	GnRH	14714
4798	18310445	1333	1338	GeneOrGeneProduct	BMP-4	652
4799	18310445	1356	1363	GeneOrGeneProduct	activin	16323
4800	18310445	1394	1401	GeneOrGeneProduct	Smad2/3	17126,17127
4801	18310445	1410	1414	GeneOrGeneProduct	GnRH	14714
4802	18310445	1423	1429	GeneOrGeneProduct	ERK1/2	26413,26417
4803	18310445	1433	1462	GeneOrGeneProduct	cAMP response element-binding	12912
4804	18310445	1507	1511	GeneOrGeneProduct	GnRH	14714
4805	18310445	1534	1542	GeneOrGeneProduct	p38 MAPK	26416
4806	18310445	1560	1565	GeneOrGeneProduct	BMP-4	652
4807	18310445	1602	1609	GeneOrGeneProduct	FSHbeta	14308
4808	18310445	1626	1629	GeneOrGeneProduct	FSH	443387,443538
4809	18310445	1655	1661	GeneOrGeneProduct	LHbeta	16866
4810	18310445	1700	1704	GeneOrGeneProduct	BMPs	652
4811	18310445	1732	1739	GeneOrGeneProduct	activin	16323
4812	18310445	1747	1751	GeneOrGeneProduct	GnRH	14714
4813	18310445	1763	1776	GeneOrGeneProduct	gonadotrophin	12640,14308
4814	18310445	1891	1903	GeneOrGeneProduct	BMP receptor	101103793,101112282,12167
4815	18356633	17	25	ChemicalEntity	amikacin	D000583
4816	18356633	26	40	DiseaseOrPhenotypicFeature	nephrotoxicity	D007674
4817	18356633	80	88	ChemicalEntity	Amikacin	D000583
4818	18356633	95	109	ChemicalEntity	aminoglycoside	D000617
4819	18356633	180	199	DiseaseOrPhenotypicFeature	febrile neutropenia	D009503
4820	18356633	220	230	DiseaseOrPhenotypicFeature	infections	D007239
4821	18356633	460	468	ChemicalEntity	amikacin	D000583
4822	18356633	480	494	DiseaseOrPhenotypicFeature	nephrotoxicity	D007674
4823	18356633	646	654	OrganismTaxon	patients	9606
4824	18356633	690	720	DiseaseOrPhenotypicFeature	hematologic/oncologic disorder	D006402,D009369
4825	18356633	753	767	ChemicalEntity	aminoglycoside	D000617
4826	18356633	828	836	ChemicalEntity	amikacin	D000583
4827	18356633	856	870	DiseaseOrPhenotypicFeature	nephrotoxicity	D007674
4828	18356633	904	914	ChemicalEntity	creatinine	D003404
4829	18356633	946	954	ChemicalEntity	amikacin	D000583
4830	18356633	1035	1049	DiseaseOrPhenotypicFeature	nephrotoxicity	D007674
4831	18356633	1161	1169	OrganismTaxon	patients	9606
4832	18356633	1301	1315	DiseaseOrPhenotypicFeature	nephrotoxicity	D007674
4833	18366737	4	6	GeneOrGeneProduct	FH	2271
4834	18366737	48	66	GeneOrGeneProduct	fumarate hydratase	2271
4835	18366737	93	97	DiseaseOrPhenotypicFeature	MCUL	C535516
4836	18366737	99	104	DiseaseOrPhenotypicFeature	HLRCC	C535516
4837	18366737	106	120	DiseaseOrPhenotypicFeature	tumor syndrome	D009369
4838	18366737	136	155	DiseaseOrPhenotypicFeature	fumarase deficiency	C538191
4839	18366737	169	187	GeneOrGeneProduct	Fumarate hydratase	2271
4840	18366737	217	219	GeneOrGeneProduct	FH	2271
4841	18366737	236	244	GeneOrGeneProduct	fumarase	2271
4842	18366737	266	284	ChemicalEntity	tricarboxylic acid	D014233
4843	18366737	286	289	ChemicalEntity	TCA	D014233
4844	18366737	389	405	DiseaseOrPhenotypicFeature	deficiency of FH	C538191
4845	18366737	437	451	DiseaseOrPhenotypicFeature	encephalopathy	D001927
4846	18366737	475	484	DiseaseOrPhenotypicFeature	Leiomyoma	D007889
4847	18366737	542	544	GeneOrGeneProduct	FH	2271
4848	18366737	548	556	OrganismTaxon	patients	9606
4849	18366737	562	603	DiseaseOrPhenotypicFeature	multiple cutaneous and uterine leiomyomas	C535516
4850	18366737	606	610	DiseaseOrPhenotypicFeature	MCUL	C535516
4851	18366737	612	623	DiseaseOrPhenotypicFeature	OMIM 150800	C535516
4852	18366737	643	660	DiseaseOrPhenotypicFeature	renal cell cancer	D002292
4853	18366737	733	780	DiseaseOrPhenotypicFeature	hereditary leiomyomatosis and renal cell cancer	C535516
4854	18366737	782	787	DiseaseOrPhenotypicFeature	HLRCC	C535516
4855	18366737	789	800	DiseaseOrPhenotypicFeature	OMIM 605839	C535516
4856	18366737	825	827	GeneOrGeneProduct	FH	2271
4857	18366737	833	838	DiseaseOrPhenotypicFeature	tumor	D009369
4858	18366737	1060	1073	DiseaseOrPhenotypicFeature	tumorigenesis	D009369
4859	18366737	1092	1094	GeneOrGeneProduct	FH	2271
4860	18366737	1130	1133	ChemicalEntity	TCA	D014233
4861	18366737	1444	1446	GeneOrGeneProduct	FH	2271
4862	18366737	1655	1657	GeneOrGeneProduct	FH	2271
4863	18366737	1723	1736	DiseaseOrPhenotypicFeature	FH deficiency	C538191
4864	18366737	1737	1745	OrganismTaxon	patients	9606
4865	18366737	1750	1758	OrganismTaxon	patients	9606
4866	18366737	1764	1768	DiseaseOrPhenotypicFeature	MCUL	C535516
4867	18366737	1769	1774	DiseaseOrPhenotypicFeature	HLRRC	C535516
4868	18366737	2052	2054	GeneOrGeneProduct	FH	2271
4869	18366737	2090	2092	GeneOrGeneProduct	FH	2271
4870	18366737	2176	2178	GeneOrGeneProduct	FH	2271
4871	18366737	2291	2299	OrganismTaxon	patients	9606
4872	18366737	2447	2449	GeneOrGeneProduct	FH	2271
4873	18385794	63	67	GeneOrGeneProduct	SOX2	6657
4874	18385794	72	77	GeneOrGeneProduct	CHX10	338917
4875	18385794	87	95	OrganismTaxon	patients	9606
4876	18385794	101	113	DiseaseOrPhenotypicFeature	anophthalmia	D000853
4877	18385794	114	128	DiseaseOrPhenotypicFeature	microphthalmia	D008850
4878	18385794	156	160	GeneOrGeneProduct	SOX2	6657
4879	18385794	165	170	GeneOrGeneProduct	CHX10	338917
4880	18385794	199	207	OrganismTaxon	patients	9606
4881	18385794	213	225	DiseaseOrPhenotypicFeature	anophthalmia	D000853
4882	18385794	233	247	DiseaseOrPhenotypicFeature	microphthalmia	D008850
4883	18385794	280	292	DiseaseOrPhenotypicFeature	anophthalmic	D000853
4884	18385794	293	307	DiseaseOrPhenotypicFeature	microphthalmic	D008850
4885	18385794	308	315	OrganismTaxon	patient	9606
4886	18385794	399	403	GeneOrGeneProduct	SOX2	6657
4887	18385794	408	413	GeneOrGeneProduct	CHX10	338917
4888	18385794	501	505	GeneOrGeneProduct	SOX2	6657
4889	18385794	510	515	GeneOrGeneProduct	CHX10	338917
4890	18385794	634	641	OrganismTaxon	Patient	9606
4891	18385794	734	738	GeneOrGeneProduct	SOX2	6657
4892	18385794	743	748	GeneOrGeneProduct	CHX10	338917
4893	18385794	797	804	OrganismTaxon	patient	9606
4894	18385794	897	901	GeneOrGeneProduct	SOX2	6657
4895	18385794	943	952	SequenceVariant	c.310 G>T	c|SUB|G|310|T
4896	18385794	954	964	SequenceVariant	p. Glu104X	p|SUB|E|104|X
4897	18385794	980	987	OrganismTaxon	patient	9606
4898	18385794	1095	1124	SequenceVariant	glutamic acid to a stop codon	p|SUB|E||X
4899	18385794	1212	1221	SequenceVariant	c.549delC	rs587776776
4900	18385794	1223	1240	SequenceVariant	p. Pro184ArgfsX19	rs587776776
4901	18385794	1476	1485	SequenceVariant	c.*557G>A	rs77677339
4902	18385794	1538	1545	OrganismTaxon	patient	9606
4903	18385794	1677	1688	SequenceVariant	c. *469 C>A	rs11915160
4904	18385794	1694	1704	SequenceVariant	rs11915160	rs11915160
4905	18385794	1739	1747	OrganismTaxon	patients	9606
4906	18385794	1762	1767	GeneOrGeneProduct	CHX10	338917
4907	18385794	1813	1822	SequenceVariant	c.471 C>T	rs35435463
4908	18385794	1824	1835	SequenceVariant	p.Ser157Ser	rs35435463
4909	18385794	1837	1847	SequenceVariant	rs35435463	rs35435463
4910	18385794	1853	1862	SequenceVariant	c.579 G>A	rs182972044
4911	18385794	1864	1876	SequenceVariant	p. Gln193Gln	rs182972044
4912	18385794	1931	1940	SequenceVariant	c.871 G>A	rs75395981
4913	18385794	1942	1954	SequenceVariant	p. Asp291Asn	rs75395981
4914	18385794	2111	2115	GeneOrGeneProduct	SOX2	6657
4915	18385794	2147	2151	GeneOrGeneProduct	SOX2	6657
4916	18385794	2179	2195	DiseaseOrPhenotypicFeature	eye malformation	D005124
4917	18385794	2197	2202	GeneOrGeneProduct	CHX10	338917
4918	18385794	2227	2241	DiseaseOrPhenotypicFeature	microphthalmia	D008850
4919	18385794	2242	2254	DiseaseOrPhenotypicFeature	anophthalmia	D000853
4920	18385794	2262	2269	OrganismTaxon	patient	9606
4921	18410548	0	45	GeneOrGeneProduct	Aryl hydrocarbon receptor interacting protein	9049
4922	18410548	47	50	GeneOrGeneProduct	AIP	9049
4923	18410548	117	135	DiseaseOrPhenotypicFeature	pituitary adenomas	D010911
4924	18410548	148	166	DiseaseOrPhenotypicFeature	Pituitary adenomas	D010911
4925	18410548	210	227	DiseaseOrPhenotypicFeature	Pituitary adenoma	D010911
4926	18410548	309	354	GeneOrGeneProduct	aryl hydrocarbon receptor interacting protein	9049
4927	18410548	356	359	GeneOrGeneProduct	AIP	9049
4928	18410548	430	433	GeneOrGeneProduct	AIP	9049
4929	18410548	478	496	DiseaseOrPhenotypicFeature	pituitary adenomas	D010911
4930	18410548	552	555	GeneOrGeneProduct	AIP	9049
4931	18410548	606	614	OrganismTaxon	PATIENTS	9606
4932	18410548	690	707	DiseaseOrPhenotypicFeature	pituitary adenoma	D010911
4933	18410548	708	716	OrganismTaxon	patients	9606
4934	18410548	787	795	OrganismTaxon	Patients	9606
4935	18410548	872	879	DiseaseOrPhenotypicFeature	adenoma	D000236
4936	18410548	962	969	SequenceVariant	Y248del	rs267606574
4937	18410548	971	986	SequenceVariant	c.742_744delTAC	rs267606574
4938	18410548	1010	1030	DiseaseOrPhenotypicFeature	GH-secreting adenoma	D049912
4939	18410548	1031	1038	OrganismTaxon	patient	9606
4940	18410548	1081	1087	DiseaseOrPhenotypicFeature	tumour	D009369
4941	18410548	1256	1276	DiseaseOrPhenotypicFeature	GH-secreting adenoma	D049912
4942	18410548	1277	1285	OrganismTaxon	patients	9606
4943	18410548	1296	1299	GeneOrGeneProduct	AIP	9049
4944	18410548	1356	1376	DiseaseOrPhenotypicFeature	GH-secreting tumours	D049912
4945	18410548	1447	1450	GeneOrGeneProduct	AIP	9049
4946	18410548	1480	1488	OrganismTaxon	patients	9606
4947	18410548	1592	1595	GeneOrGeneProduct	AIP	9049
4948	18410548	1610	1628	DiseaseOrPhenotypicFeature	pituitary adenomas	D010911
4949	18439317	51	55	GeneOrGeneProduct	MMP1	4312
4950	18439317	60	79	DiseaseOrPhenotypicFeature	lumbar disc disease	C535531
4951	18439317	113	138	GeneOrGeneProduct	Matrix metalloproteinases	4312
4952	18439317	140	144	GeneOrGeneProduct	MMPs	4312
4953	18439317	244	309	SequenceVariant	guanine insertion/deletion (G/D), the -1607 promoter polymorphism	c|DEL|-1607|G
4954	18439317	318	322	GeneOrGeneProduct	MMP1	4312
4955	18439317	471	474	DiseaseOrPhenotypicFeature	DDD	D055959
4956	18439317	573	576	DiseaseOrPhenotypicFeature	DDD	D055959
4957	18439317	969	973	GeneOrGeneProduct	MMP1	4312
4958	18439317	978	981	DiseaseOrPhenotypicFeature	DDD	D055959
4959	18439317	1060	1063	DiseaseOrPhenotypicFeature	DDD	D055959
4960	18439317	1220	1223	DiseaseOrPhenotypicFeature	DDD	D055959
4961	18439317	1706	1728	SequenceVariant	D allele for the -1607	c|Allele|D|-1607
4962	18439317	1754	1758	GeneOrGeneProduct	MMP1	4312
4963	18439317	1807	1810	DiseaseOrPhenotypicFeature	DDD	D055959
4964	18439803	17	42	ChemicalEntity	N-(2-propylpentanoyl)urea	C108761
4965	18439803	90	101	ChemicalEntity	pilocarpine	D010862
4966	18439803	110	117	DiseaseOrPhenotypicFeature	seizure	D012640
4967	18439803	121	125	OrganismTaxon	rats	10116
4968	18439803	275	284	ChemicalEntity	glutamate	D018698
4969	18439803	286	295	ChemicalEntity	aspartate	D001224
4970	18439803	297	304	ChemicalEntity	glycine	D005998
4971	18439803	309	313	ChemicalEntity	GABA	D005680
4972	18439803	318	343	ChemicalEntity	N-(2-propylpentanoyl)urea	C108761
4973	18439803	345	348	ChemicalEntity	VPU	C108761
4974	18439803	388	401	ChemicalEntity	valproic acid	D014635
4975	18439803	403	406	ChemicalEntity	VPA	D014635
4976	18439803	409	412	ChemicalEntity	VPU	C108761
4977	18439803	434	437	ChemicalEntity	VPA	D014635
4978	18439803	511	515	OrganismTaxon	rats	10116
4979	18439803	524	535	ChemicalEntity	pilocarpine	D010862
4980	18439803	544	551	DiseaseOrPhenotypicFeature	seizure	D012640
4981	18439803	588	591	ChemicalEntity	VPA	D014635
4982	18439803	684	695	ChemicalEntity	pilocarpine	D010862
4983	18439803	742	751	ChemicalEntity	glutamate	D018698
4984	18439803	756	765	ChemicalEntity	aspartate	D001224
4985	18439803	825	832	ChemicalEntity	glycine	D005998
4986	18439803	837	841	ChemicalEntity	GABA	D005680
4987	18439803	868	871	ChemicalEntity	VPU	C108761
4988	18439803	894	897	ChemicalEntity	VPA	D014635
4989	18439803	939	950	ChemicalEntity	pilocarpine	D010862
4990	18439803	985	994	ChemicalEntity	glutamate	D018698
4991	18439803	999	1008	ChemicalEntity	aspartate	D001224
4992	18439803	1095	1099	ChemicalEntity	GABA	D005680
4993	18439803	1104	1111	ChemicalEntity	glycine	D005998
4994	18439803	1149	1158	ChemicalEntity	glutamate	D018698
4995	18439803	1163	1172	ChemicalEntity	aspartate	D001224
4996	18439803	1206	1209	ChemicalEntity	VPU	C108761
4997	18439803	1214	1217	ChemicalEntity	VPA	D014635
4998	18439803	1252	1263	ChemicalEntity	pilocarpine	D010862
4999	18439803	1272	1279	DiseaseOrPhenotypicFeature	seizure	D012640
5000	18439803	1422	1431	ChemicalEntity	glutamate	D018698
5001	18439803	1436	1445	ChemicalEntity	aspartate	D001224
5002	18439803	1463	1466	ChemicalEntity	VPA	D014635
5003	18439803	1485	1488	ChemicalEntity	VPU	C108761
5004	18439803	1514	1525	ChemicalEntity	pilocarpine	D010862
5005	18439803	1547	1556	ChemicalEntity	glutamate	D018698
5006	18439803	1561	1570	ChemicalEntity	aspartate	D001224
5007	18439803	1648	1659	ChemicalEntity	pilocarpine	D010862
5008	18439803	1668	1675	DiseaseOrPhenotypicFeature	seizure	D012640
5009	18457324	29	49	GeneOrGeneProduct	carbonyl reductase 3	874
5010	18457324	55	59	GeneOrGeneProduct	CBR3	874
5011	18457324	68	100	GeneOrGeneProduct	NAD(P)H:quinone oxidoreductase 1	1728
5012	18457324	106	110	GeneOrGeneProduct	NQO1	1728
5013	18457324	114	122	OrganismTaxon	patients	9606
5014	18457324	137	150	ChemicalEntity	anthracycline	D018943
5015	18457324	159	183	DiseaseOrPhenotypicFeature	congestive heart failure	D006333
5016	18457324	200	206	DiseaseOrPhenotypicFeature	cancer	D009369
5017	18457324	232	246	ChemicalEntity	anthracyclines	D018943
5018	18457324	258	264	DiseaseOrPhenotypicFeature	cancer	D009369
5019	18457324	317	341	DiseaseOrPhenotypicFeature	congestive heart failure	D006333
5020	18457324	343	346	DiseaseOrPhenotypicFeature	CHF	D006333
5021	18457324	395	408	ChemicalEntity	anthracycline	D018943
5022	18457324	417	420	DiseaseOrPhenotypicFeature	CHF	D006333
5023	18457324	570	584	ChemicalEntity	anthracyclines	D018943
5024	18457324	605	673	GeneOrGeneProduct	nicotinamide adenine dinucleotide phosphate:quinone oxidoreductase 1	1728
5025	18457324	679	683	GeneOrGeneProduct	NQO1	1728
5026	18457324	692	712	GeneOrGeneProduct	carbonyl reductase 3	874
5027	18457324	718	722	GeneOrGeneProduct	CBR3	874
5028	18457324	753	766	ChemicalEntity	anthracycline	D018943
5029	18457324	775	778	DiseaseOrPhenotypicFeature	CHF	D006333
5030	18457324	855	863	OrganismTaxon	patients	9606
5031	18457324	940	954	ChemicalEntity	anthracyclines	D018943
5032	18457324	985	993	OrganismTaxon	patients	9606
5033	18457324	999	1002	DiseaseOrPhenotypicFeature	CHF	D006333
5034	18457324	1072	1076	GeneOrGeneProduct	NQO1	1728
5035	18457324	1078	1082	GeneOrGeneProduct	NQO1	1728
5036	18457324	1090	1094	GeneOrGeneProduct	CBR3	874
5037	18457324	1100	1104	GeneOrGeneProduct	CBR3	874
5038	18457324	1105	1162	SequenceVariant	valine [V] to methionine [M] substitution at position 244	rs1056892
5039	18457324	1164	1169	SequenceVariant	V244M	rs1056892
5040	18457324	1213	1217	GeneOrGeneProduct	CBR3	874
5041	18457324	1228	1232	GeneOrGeneProduct	CBR3	874
5042	18457324	1233	1237	SequenceVariant	V244	rs1056892
5043	18457324	1242	1246	GeneOrGeneProduct	CBR3	874
5044	18457324	1247	1251	SequenceVariant	M244	rs1056892
5045	18457324	1261	1274	ChemicalEntity	anthracycline	D018943
5046	18457324	1285	1296	ChemicalEntity	doxorubicin	D004317
5047	18457324	1351	1355	GeneOrGeneProduct	CBR3	874
5048	18457324	1356	1361	SequenceVariant	V244M	rs1056892
5049	18457324	1535	1539	GeneOrGeneProduct	NQO1	1728
5050	18457324	1546	1550	GeneOrGeneProduct	CBR3	874
5051	18457324	1551	1556	SequenceVariant	V244M	rs1056892
5052	18457324	1574	1577	DiseaseOrPhenotypicFeature	CHF	D006333
5053	18457324	1625	1629	GeneOrGeneProduct	NQO1	1728
5054	18457324	1661	1674	ChemicalEntity	anthracycline	D018943
5055	18457324	1683	1686	DiseaseOrPhenotypicFeature	CHF	D006333
5056	18457324	1771	1775	GeneOrGeneProduct	CBR3	874
5057	18457324	1776	1781	SequenceVariant	V244M	rs1056892
5058	18457324	1811	1814	DiseaseOrPhenotypicFeature	CHF	D006333
5059	18457324	1904	1908	GeneOrGeneProduct	CBR3	874
5060	18457324	1909	1913	SequenceVariant	V244	rs1056892
5061	18457324	1951	1962	DiseaseOrPhenotypicFeature	cardiotoxic	D066126
5062	18457324	1963	1976	ChemicalEntity	doxorubicinol	C010013
5063	18457324	1999	2003	GeneOrGeneProduct	CBR3	874
5064	18457324	2004	2008	SequenceVariant	M244	rs1056892
5065	18457324	2020	2024	GeneOrGeneProduct	CBR3	874
5066	18457324	2025	2029	SequenceVariant	V244	rs1056892
5067	18457324	2060	2064	GeneOrGeneProduct	CBR3	874
5068	18457324	2065	2069	SequenceVariant	M244	rs1056892
5069	18457324	2134	2138	GeneOrGeneProduct	CBR3	874
5070	18457324	2139	2144	SequenceVariant	V244M	rs1056892
5071	18457324	2192	2205	ChemicalEntity	anthracycline	D018943
5072	18457324	2214	2217	DiseaseOrPhenotypicFeature	CHF	D006333
5073	18457324	2234	2240	DiseaseOrPhenotypicFeature	cancer	D009369
5074	18457324	2295	2306	DiseaseOrPhenotypicFeature	cardiotoxic	D066126
5075	18457324	2307	2328	ChemicalEntity	anthracycline alcohol	D000438,D018943
5076	18470323	25	57	DiseaseOrPhenotypicFeature	lattice corneal dystrophy type I	C537881
5077	18470323	63	68	SequenceVariant	R124C	rs121909210
5078	18470323	85	90	GeneOrGeneProduct	TGFBI	7045
5079	18470323	92	97	GeneOrGeneProduct	BIGH3	7045
5080	18470323	182	214	DiseaseOrPhenotypicFeature	lattice corneal dystrophy type I	C537881
5081	18470323	216	220	DiseaseOrPhenotypicFeature	LCDI	C537881
5082	18470323	513	545	DiseaseOrPhenotypicFeature	lattice corneal dystrophy type I	C537881
5083	18470323	561	600	GeneOrGeneProduct	transforming growth factor-induced gene	7045
5084	18470323	602	607	GeneOrGeneProduct	TGFBI	7045
5085	18470323	654	659	SequenceVariant	R124C	rs121909210
5086	18470323	868	872	GeneOrGeneProduct	PstI	6690
5087	18470323	1065	1090	DiseaseOrPhenotypicFeature	lattice corneal dystrophy	C537881
5088	18470323	1122	1126	DiseaseOrPhenotypicFeature	LCD1	C537881
5089	18470323	1408	1416	OrganismTaxon	patients	9606
5090	18470323	1566	1571	GeneOrGeneProduct	TGFBI	7045
5091	18470323	1641	1646	SequenceVariant	C417T	rs121909210
5092	18470323	1684	1689	SequenceVariant	R124C	rs121909210
5093	18470323	1706	1725	GeneOrGeneProduct	TGF-induced protein	7045
5094	18470323	1872	1877	SequenceVariant	R124C	rs121909210
5095	18470323	1890	1895	GeneOrGeneProduct	TGFBI	7045
5096	18470323	1914	1924	DiseaseOrPhenotypicFeature	LCD type I	C537881
5097	18470323	2005	2015	DiseaseOrPhenotypicFeature	LCD type I	C537881
5098	18470323	2027	2035	OrganismTaxon	patients	9606
5099	18483878	26	38	DiseaseOrPhenotypicFeature	inflammatory	D007249
5100	18483878	52	85	GeneOrGeneProduct	vasoactive intestinal polypeptide	22353
5101	18483878	96	99	GeneOrGeneProduct	VIP	22353
5102	18483878	104	108	OrganismTaxon	mice	10090
5103	18483878	114	130	ChemicalEntity	cyclophosphamide	D003520
5104	18483878	132	135	ChemicalEntity	CYP	D003520
5105	18483878	145	153	DiseaseOrPhenotypicFeature	cystitis	D003556
5106	18483878	155	188	GeneOrGeneProduct	Vasoactive intestinal polypeptide	22353
5107	18483878	190	193	GeneOrGeneProduct	VIP	22353
5108	18483878	268	271	GeneOrGeneProduct	VIP	22353
5109	18483878	277	281	OrganismTaxon	mice	10090
5110	18483878	374	390	ChemicalEntity	cyclophosphamide	D003520
5111	18483878	392	395	ChemicalEntity	CYP	D003520
5112	18483878	405	413	DiseaseOrPhenotypicFeature	cystitis	D003556
5113	18483878	421	424	GeneOrGeneProduct	VIP	22353
5114	18483878	443	455	DiseaseOrPhenotypicFeature	inflammatory	D007249
5115	18483878	487	490	GeneOrGeneProduct	VIP	22353
5116	18483878	496	500	OrganismTaxon	mice	10090
5117	18483878	524	536	DiseaseOrPhenotypicFeature	inflammatory	D007249
5118	18483878	563	571	DiseaseOrPhenotypicFeature	cystitis	D003556
5119	18483878	575	580	OrganismTaxon	mouse	10090
5120	18483878	581	593	DiseaseOrPhenotypicFeature	inflammatory	D007249
5121	18483878	724	727	GeneOrGeneProduct	VIP	22353
5122	18483878	733	737	OrganismTaxon	mice	10090
5123	18483878	754	757	ChemicalEntity	CYP	D003520
5124	18483878	766	774	DiseaseOrPhenotypicFeature	cystitis	D003556
5125	18483878	853	856	ChemicalEntity	CYP	D003520
5126	18483878	875	878	GeneOrGeneProduct	VIP	22353
5127	18483878	899	902	ChemicalEntity	CYP	D003520
5128	18483878	939	942	GeneOrGeneProduct	VIP	22353
5129	18483878	969	972	ChemicalEntity	CYP	D003520
5130	18483878	997	1000	GeneOrGeneProduct	VIP	22353
5131	18483878	1011	1014	ChemicalEntity	CYP	D003520
5132	18483878	1267	1275	GeneOrGeneProduct	IL-1beta	16176
5133	18483878	1280	1285	GeneOrGeneProduct	CXCL1	14825
5134	18483878	1287	1290	ChemicalEntity	CYP	D003520
5135	18483878	1356	1361	GeneOrGeneProduct	CXCL1	14825
5136	18483878	1366	1374	GeneOrGeneProduct	IL-1beta	16176
5137	18483878	1408	1411	GeneOrGeneProduct	VIP	22353
5138	18483878	1417	1421	OrganismTaxon	mice	10090
5139	18483878	1441	1444	GeneOrGeneProduct	VIP	22353
5140	18483878	1450	1454	OrganismTaxon	mice	10090
5141	18483878	1460	1463	ChemicalEntity	CYP	D003520
5142	18483878	1637	1640	GeneOrGeneProduct	VIP	22353
5143	18483878	1646	1650	OrganismTaxon	mice	10090
5144	18483878	1656	1676	DiseaseOrPhenotypicFeature	bladder inflammation	D003556
5145	18483878	1678	1690	DiseaseOrPhenotypicFeature	inflammatory	D007249
5146	18483878	1746	1749	ChemicalEntity	CYP	D003520
5147	18483878	1801	1820	DiseaseOrPhenotypicFeature	bladder dysfunction	D001745
5148	18483878	1824	1827	GeneOrGeneProduct	VIP	22353
5149	18483878	1833	1837	OrganismTaxon	mice	10090
5150	18483878	1843	1863	DiseaseOrPhenotypicFeature	bladder inflammation	D003556
5151	18503483	12	22	ChemicalEntity	tacrolimus	D016559
5152	18503483	34	51	DiseaseOrPhenotypicFeature	brachial neuritis	D020968
5153	18503483	72	82	ChemicalEntity	everolimus	D000068338
5154	18503483	168	171	ChemicalEntity	TAC	D016559
5155	18503483	273	286	DiseaseOrPhenotypicFeature	Neurotoxicity	D020258
5156	18503483	349	363	DiseaseOrPhenotypicFeature	encephalopathy	D001927
5157	18503483	365	374	DiseaseOrPhenotypicFeature	headaches	D006261
5158	18503483	376	384	DiseaseOrPhenotypicFeature	seizures	D012640
5159	18503483	389	410	DiseaseOrPhenotypicFeature	neurological deficits	D009461
5160	18503483	617	625	DiseaseOrPhenotypicFeature	myelitis	D009187
5161	18503483	636	653	DiseaseOrPhenotypicFeature	brachial plexitis	D020968
5162	18503483	699	702	ChemicalEntity	TAC	D016559
5163	18503483	760	778	ChemicalEntity	methylprednisolone	D008775
5164	18503483	855	858	ChemicalEntity	TAC	D016559
5165	18503483	916	926	ChemicalEntity	everolimus	D000068338
5166	18507837	76	89	DiseaseOrPhenotypicFeature	breast cancer	D001943
5167	18507837	208	221	DiseaseOrPhenotypicFeature	breast cancer	D001943
5168	18507837	537	542	GeneOrGeneProduct	CCND1	595
5169	18507837	544	549	GeneOrGeneProduct	CCND2	894
5170	18507837	551	556	GeneOrGeneProduct	CCND3	896
5171	18507837	558	563	GeneOrGeneProduct	CCNE1	898
5172	18507837	565	575	GeneOrGeneProduct	CDK2 [p33]	1017
5173	18507837	577	581	GeneOrGeneProduct	CDK4	1019
5174	18507837	583	587	GeneOrGeneProduct	CDK6	1021
5175	18507837	589	595	GeneOrGeneProduct	CDKN1A	1026
5176	18507837	597	600	GeneOrGeneProduct	p21	1026
5177	18507837	602	606	GeneOrGeneProduct	Cip1	1026
5178	18507837	609	615	GeneOrGeneProduct	CDKN1B	1027
5179	18507837	617	626	GeneOrGeneProduct	p27, Kip1	1027
5180	18507837	629	635	GeneOrGeneProduct	CDKN2A	1029
5181	18507837	637	640	GeneOrGeneProduct	p16	1029
5182	18507837	643	649	GeneOrGeneProduct	CDKN2B	1030
5183	18507837	651	654	GeneOrGeneProduct	p15	1030
5184	18507837	657	663	GeneOrGeneProduct	CDKN2C	1031
5185	18507837	665	668	GeneOrGeneProduct	p18	1031
5186	18507837	675	681	GeneOrGeneProduct	CDKN2D	1032
5187	18507837	683	686	GeneOrGeneProduct	p19	1029
5188	18507837	708	713	OrganismTaxon	women	9606
5189	18507837	729	751	DiseaseOrPhenotypicFeature	invasive breast cancer	D001943
5190	18507837	842	855	DiseaseOrPhenotypicFeature	breast cancer	D001943
5191	18507837	884	889	OrganismTaxon	women	9606
5192	18507837	1199	1208	SequenceVariant	rs2479717	rs2479717
5193	18507837	1249	1254	DiseaseOrPhenotypicFeature	death	D003643
5194	18507837	1398	1404	DiseaseOrPhenotypicFeature	tumour	D009369
5195	18507837	1507	1512	GeneOrGeneProduct	CCND3	896
5196	18507837	1514	1518	GeneOrGeneProduct	BYSL	705
5197	18507837	1520	1524	GeneOrGeneProduct	TRFP	55031
5198	18507837	1526	1531	GeneOrGeneProduct	USP49	25862
5199	18507837	1533	1540	GeneOrGeneProduct	C6ofr49	29964
5200	18507837	1542	1546	GeneOrGeneProduct	FRS3	10817
5201	18507837	1552	1555	GeneOrGeneProduct	PGC	5225
5202	18507837	1639	1653	DiseaseOrPhenotypicFeature	breast tumours	D001943
5203	18507837	1745	1752	GeneOrGeneProduct	C6orf49	29964
5204	18507837	1784	1797	DiseaseOrPhenotypicFeature	breast cancer	D001943
5205	18507837	1883	1888	GeneOrGeneProduct	CCND3	896
5206	18507837	1889	1898	SequenceVariant	rs2479717	rs2479717
5207	18507837	1978	1991	DiseaseOrPhenotypicFeature	breast cancer	D001943
5208	18541230	22	34	ChemicalEntity	antithrombin	D000991
5209	18541230	38	63	ChemicalEntity	puromycin aminonucleoside	D011692
5210	18541230	64	73	DiseaseOrPhenotypicFeature	nephrosis	D009401
5211	18541230	77	81	OrganismTaxon	rats	10116
5212	18541230	114	126	ChemicalEntity	antithrombin	D000991
5213	18541230	174	178	OrganismTaxon	rats	10116
5214	18541230	184	209	ChemicalEntity	puromycin aminonucleoside	D011692
5215	18541230	218	227	DiseaseOrPhenotypicFeature	nephrosis	D009401
5216	18541230	263	268	OrganismTaxon	human	9606
5217	18541230	269	287	DiseaseOrPhenotypicFeature	nephrotic syndrome	D009404
5218	18541230	289	301	ChemicalEntity	Antithrombin	D000991
5219	18541230	345	349	OrganismTaxon	rats	10116
5220	18541230	408	433	ChemicalEntity	puromycin aminonucleoside	D011692
5221	18541230	466	478	ChemicalEntity	antithrombin	D000991
5222	18541230	494	519	ChemicalEntity	puromycin aminonucleoside	D011692
5223	18541230	528	555	DiseaseOrPhenotypicFeature	hematological abnormalities	D006402
5224	18541230	557	582	ChemicalEntity	Puromycin aminonucleoside	D011692
5225	18541230	591	608	DiseaseOrPhenotypicFeature	renal dysfunction	D007674
5226	18541230	613	627	DiseaseOrPhenotypicFeature	hyperlipidemia	D006949
5227	18541230	696	708	DiseaseOrPhenotypicFeature	renal damage	D007674
5228	18541230	794	798	OrganismTaxon	rats	10116
5229	18541230	847	859	ChemicalEntity	antithrombin	D000991
5230	18541230	868	872	OrganismTaxon	rats	10116
5231	18541230	887	899	ChemicalEntity	antithrombin	D000991
5232	18541230	930	955	ChemicalEntity	puromycin aminonucleoside	D011692
5233	18541230	1022	1047	ChemicalEntity	puromycin aminonucleoside	D011692
5234	18541230	1141	1149	GeneOrGeneProduct	thrombin	29251
5235	18541230	1197	1222	ChemicalEntity	puromycin aminonucleoside	D011692
5236	18541230	1231	1249	DiseaseOrPhenotypicFeature	nephrotic syndrome	D009404
5237	18541230	1266	1278	ChemicalEntity	antithrombin	D000991
5238	18541230	1310	1318	OrganismTaxon	patients	9606
5239	18541230	1324	1342	DiseaseOrPhenotypicFeature	nephrotic syndrome	D009404
5240	18544179	9	17	ChemicalEntity	fentanyl	D005283
5241	18544179	26	32	DiseaseOrPhenotypicFeature	nausea	D009325
5242	18544179	37	45	DiseaseOrPhenotypicFeature	vomiting	D014839
5243	18544179	66	70	DiseaseOrPhenotypicFeature	pain	D010146
5244	18544179	78	89	ChemicalEntity	sevoflurane	C009250
5245	18544179	201	212	ChemicalEntity	sevoflurane	C009250
5246	18544179	214	247	DiseaseOrPhenotypicFeature	postoperative nausea and vomiting	D020250
5247	18544179	267	275	ChemicalEntity	Fentanyl	D005283
5248	18544179	447	489	DiseaseOrPhenotypicFeature	postoperative nausea and vomiting and pain	D010149,D020250
5249	18544179	514	525	ChemicalEntity	sevoflurane	C009250
5250	18544179	643	651	ChemicalEntity	fentanyl	D005283
5251	18544179	682	695	ChemicalEntity	dexamethasone	D003907
5252	18544179	711	719	ChemicalEntity	fentanyl	D005283
5253	18544179	742	750	ChemicalEntity	fentanyl	D005283
5254	18544179	791	824	DiseaseOrPhenotypicFeature	postoperative nausea and vomiting	D020250
5255	18544179	858	866	DiseaseOrPhenotypicFeature	vomiting	D014839
5256	18544179	893	899	DiseaseOrPhenotypicFeature	nausea	D009325
5257	18544179	941	949	ChemicalEntity	fentanyl	D005283
5258	18544179	954	962	ChemicalEntity	fentanyl	D005283
5259	18544179	963	976	ChemicalEntity	dexamethasone	D003907
5260	18544179	1085	1098	ChemicalEntity	Dexamethasone	D003907
5261	18544179	1157	1190	DiseaseOrPhenotypicFeature	postoperative nausea and vomiting	D020250
5262	18544179	1210	1218	ChemicalEntity	fentanyl	D005283
5263	18544179	1304	1337	DiseaseOrPhenotypicFeature	postoperative nausea and vomiting	D020250
5264	18544179	1342	1348	DiseaseOrPhenotypicFeature	nausea	D009325
5265	18544179	1447	1453	DiseaseOrPhenotypicFeature	nausea	D009325
5266	18544179	1515	1519	DiseaseOrPhenotypicFeature	Pain	D010146
5267	18544179	1591	1599	ChemicalEntity	fentanyl	D005283
5268	18544179	1601	1609	ChemicalEntity	Fentanyl	D005283
5269	18544179	1662	1673	ChemicalEntity	sevoflurane	C009250
5270	18544179	1703	1725	DiseaseOrPhenotypicFeature	respiratory depression	D012131
5271	18544179	1727	1738	DiseaseOrPhenotypicFeature	hypotension	D007022
5272	18544179	1743	1754	DiseaseOrPhenotypicFeature	bradycardia	D001919
5273	18544179	1771	1779	ChemicalEntity	fentanyl	D005283
5274	18544179	1792	1825	DiseaseOrPhenotypicFeature	postoperative nausea and vomiting	D020250
5275	18544179	1852	1870	DiseaseOrPhenotypicFeature	postoperative pain	D010149
5276	18544179	1990	2001	ChemicalEntity	sevoflurane	C009250
5277	18593936	0	8	ChemicalEntity	Curcumin	D003474
5278	18593936	19	38	GeneOrGeneProduct	specificity protein	6667,6670,6671
5279	18593936	53	67	DiseaseOrPhenotypicFeature	bladder cancer	D001749
5280	18593936	75	83	ChemicalEntity	Curcumin	D003474
5281	18593936	286	294	ChemicalEntity	curcumin	D003474
5282	18593936	305	312	CellLine	253JB-V	9606
5283	18593936	317	320	CellLine	KU7	9606
5284	18593936	321	335	DiseaseOrPhenotypicFeature	bladder cancer	D001749
5285	18593936	432	452	GeneOrGeneProduct	proapoptotic protein	332
5286	18593936	453	461	GeneOrGeneProduct	survivin	332
5287	18593936	470	489	GeneOrGeneProduct	angiogenic proteins	2321,7422
5288	18593936	490	524	GeneOrGeneProduct	vascular endothelial growth factor	7422
5289	18593936	526	530	GeneOrGeneProduct	VEGF	7422
5290	18593936	536	551	GeneOrGeneProduct	VEGF receptor 1	2321
5291	18593936	553	559	GeneOrGeneProduct	VEGFR1	2321
5292	18593936	584	592	GeneOrGeneProduct	survivin	332
5293	18593936	594	598	GeneOrGeneProduct	VEGF	7422
5294	18593936	604	610	GeneOrGeneProduct	VEGFR1	2321
5295	18593936	628	674	GeneOrGeneProduct	specificity protein (Sp) transcription factors	6667,6670,6671
5296	18593936	712	720	ChemicalEntity	curcumin	D003474
5297	18593936	724	726	GeneOrGeneProduct	Sp	6667,6670,6671
5298	18593936	859	867	ChemicalEntity	curcumin	D003474
5299	18593936	876	886	GeneOrGeneProduct	proteasome	5698
5300	18593936	916	919	GeneOrGeneProduct	Sp1	6667
5301	18593936	921	924	GeneOrGeneProduct	Sp3	6670
5302	18593936	930	933	GeneOrGeneProduct	Sp4	6671
5303	18593936	937	944	CellLine	253JB-V	9606
5304	18593936	949	952	CellLine	KU7	9606
5305	18593936	1024	1027	GeneOrGeneProduct	Sp1	6667
5306	18593936	1029	1032	GeneOrGeneProduct	Sp3	6670
5307	18593936	1038	1041	GeneOrGeneProduct	Sp4	6671
5308	18593936	1060	1068	ChemicalEntity	curcumin	D003474
5309	18593936	1093	1114	GeneOrGeneProduct	nuclear factor kappaB	4790
5310	18593936	1116	1125	GeneOrGeneProduct	NF-kappaB	4790
5311	18593936	1152	1157	GeneOrGeneProduct	bcl-2	596
5312	18593936	1159	1167	GeneOrGeneProduct	survivin	332
5313	18593936	1173	1182	GeneOrGeneProduct	cyclin D1	595
5314	18593936	1218	1220	GeneOrGeneProduct	Sp	6667,6670,6671
5315	18593936	1231	1239	ChemicalEntity	Curcumin	D003474
5316	18593936	1255	1268	DiseaseOrPhenotypicFeature	bladder tumor	D001749
5317	18593936	1292	1296	OrganismTaxon	mice	10090
5318	18593936	1305	1308	CellLine	KU7	9606
5319	18593936	1367	1370	GeneOrGeneProduct	Sp1	20683
5320	18593936	1372	1375	GeneOrGeneProduct	Sp3	20687
5321	18593936	1381	1384	GeneOrGeneProduct	Sp4	20688
5322	18593936	1403	1409	DiseaseOrPhenotypicFeature	tumors	D009369
5323	18593936	1500	1508	ChemicalEntity	curcumin	D003474
5324	18593936	1514	1520	DiseaseOrPhenotypicFeature	cancer	D009369
5325	18593936	1588	1612	GeneOrGeneProduct	Sp transcription factors	6667,6670,6671
5326	18593936	1616	1630	DiseaseOrPhenotypicFeature	bladder cancer	D001749
5327	18657397	38	48	ChemicalEntity	penicillin	D010406
5328	18657397	57	78	DiseaseOrPhenotypicFeature	epileptiform activity	D004827
5329	18657397	95	99	OrganismTaxon	rats	10116
5330	18657397	101	111	ChemicalEntity	Penicillin	D010406
5331	18657397	158	166	DiseaseOrPhenotypicFeature	epilepsy	D004827
5332	18657397	250	260	ChemicalEntity	penicillin	D010406
5333	18657397	269	290	DiseaseOrPhenotypicFeature	epileptiform activity	D004827
5334	18657397	354	358	OrganismTaxon	rats	10116
5335	18657397	372	376	OrganismTaxon	rats	10116
5336	18657397	405	413	ChemicalEntity	urethane	D014520
5337	18657397	510	519	DiseaseOrPhenotypicFeature	epileptic	D004827
5338	18657397	566	588	ChemicalEntity	penicillin-G potassium	D010400
5339	18657397	714	724	ChemicalEntity	penicillin	D010406
5340	18657397	733	754	DiseaseOrPhenotypicFeature	epileptiform activity	D004827
5341	18657397	1138	1159	DiseaseOrPhenotypicFeature	epileptiform activity	D004827
5342	18657397	1296	1317	DiseaseOrPhenotypicFeature	epileptiform activity	D004827
5343	18657397	1566	1576	DiseaseOrPhenotypicFeature	epilepsies	D004827
5344	18672102	0	5	GeneOrGeneProduct	GATA4	2626
5345	18672102	31	39	OrganismTaxon	patients	9606
5346	18672102	45	69	DiseaseOrPhenotypicFeature	congenital heart disease	D006331
5347	18672102	122	127	GeneOrGeneProduct	GATA4	2626
5348	18672102	150	174	DiseaseOrPhenotypicFeature	congenital heart disease	D006331
5349	18672102	176	179	DiseaseOrPhenotypicFeature	CHD	D006331
5350	18672102	209	214	GeneOrGeneProduct	GATA4	2626
5351	18672102	228	231	DiseaseOrPhenotypicFeature	CHD	D006331
5352	18672102	264	269	GeneOrGeneProduct	GATA4	2626
5353	18672102	283	286	DiseaseOrPhenotypicFeature	CHD	D006331
5354	18672102	424	429	GeneOrGeneProduct	GATA4	2626
5355	18672102	442	445	DiseaseOrPhenotypicFeature	CHD	D006331
5356	18672102	446	454	OrganismTaxon	patients	9606
5357	18672102	623	629	SequenceVariant	46delS	|DEL|46|S
5358	18672102	663	674	SequenceVariant	118-119insA	|INS|118_119|A
5359	18672102	679	691	SequenceVariant	125-126insAA	|INS|125_126|AA
5360	18672102	728	731	SequenceVariant	A6V	rs199922907
5361	18672102	733	738	SequenceVariant	P163S	rs387906769
5362	18672102	740	745	SequenceVariant	E359K	rs368489876
5363	18672102	747	752	SequenceVariant	P407Q	rs115099192
5364	18672102	754	759	SequenceVariant	S429T	p|SUB|S|429|T
5365	18672102	764	769	SequenceVariant	A442V	rs146017816
5366	18672102	804	812	OrganismTaxon	patients	9606
5367	18672102	824	849	DiseaseOrPhenotypicFeature	ventricular septal defect	D006345
5368	18672102	860	879	DiseaseOrPhenotypicFeature	Tetralogy of Fallot	D013771
5369	18672102	894	920	DiseaseOrPhenotypicFeature	endocardial cushion defect	D004694
5370	18672102	936	944	OrganismTaxon	patients	9606
5371	18672102	954	959	SequenceVariant	E359K	rs368489876
5372	18672102	1014	1039	DiseaseOrPhenotypicFeature	ventricular septal defect	D006345
5373	18672102	1041	1044	DiseaseOrPhenotypicFeature	VSD	D006345
5374	18672102	1088	1101	SequenceVariant	c.1146+25insA	c|INS|1146+25|A
5375	18672102	1133	1136	DiseaseOrPhenotypicFeature	VSD	D006345
5376	18672102	1137	1145	OrganismTaxon	patients	9606
5377	18672102	1246	1251	GeneOrGeneProduct	GATA4	2626
5378	18672102	1294	1299	GeneOrGeneProduct	GATA4	2626
5379	18672102	1317	1320	DiseaseOrPhenotypicFeature	CHD	D006331
5380	18672102	1342	1350	OrganismTaxon	patients	9606
5381	18674790	5	8	ChemicalEntity	fat	D004041
5382	18674790	18	23	DiseaseOrPhenotypicFeature	obese	D009765
5383	18674790	24	28	OrganismTaxon	rats	10116
5384	18674790	53	64	ChemicalEntity	doxorubicin	D004317
5385	18674790	73	87	DiseaseOrPhenotypicFeature	cardiotoxicity	D066126
5386	18674790	112	123	ChemicalEntity	doxorubicin	D004317
5387	18674790	125	135	ChemicalEntity	Adriamycin	D004317
5388	18674790	172	186	DiseaseOrPhenotypicFeature	cardiotoxicity	D066126
5389	18674790	306	317	ChemicalEntity	doxorubicin	D004317
5390	18674790	326	340	DiseaseOrPhenotypicFeature	cardiotoxicity	D066126
5391	18674790	421	434	ChemicalEntity	triglycerides	D014280
5392	18674790	457	467	ChemicalEntity	fatty-acid	D005227
5393	18674790	479	482	ChemicalEntity	ATP	D000255
5394	18674790	510	513	GeneOrGeneProduct	JAK	84598
5395	18674790	514	519	GeneOrGeneProduct	STAT3	25125
5396	18674790	624	627	ChemicalEntity	fat	D004041
5397	18674790	654	661	DiseaseOrPhenotypicFeature	obesity	D009765
5398	18674790	685	689	OrganismTaxon	rats	10116
5399	18674790	717	728	ChemicalEntity	doxorubicin	D004317
5400	18674790	737	751	DiseaseOrPhenotypicFeature	cardiotoxicity	D066126
5401	18674790	773	784	ChemicalEntity	doxorubicin	D004317
5402	18674790	857	871	DiseaseOrPhenotypicFeature	cardiotoxicity	D066126
5403	18674790	873	892	DiseaseOrPhenotypicFeature	cardiac dysfunction	D006331
5404	18674790	894	899	ChemicalEntity	lipid	D008055
5405	18674790	939	944	DiseaseOrPhenotypicFeature	obese	D009765
5406	18674790	946	948	DiseaseOrPhenotypicFeature	OB	D009765
5407	18674790	950	954	OrganismTaxon	rats	10116
5408	18674790	989	1014	DiseaseOrPhenotypicFeature	renal or hepatic toxicity	D007674,D056486
5409	18674790	1016	1027	ChemicalEntity	Doxorubicin	D004317
5410	18674790	1089	1100	ChemicalEntity	doxorubicin	D004317
5411	18674790	1105	1118	ChemicalEntity	doxorubicinol	C010013
5412	18674790	1170	1172	DiseaseOrPhenotypicFeature	OB	D009765
5413	18674790	1215	1217	DiseaseOrPhenotypicFeature	OB	D009765
5414	18674790	1218	1222	OrganismTaxon	rats	10116
5415	18674790	1302	1329	GeneOrGeneProduct	uncoupling proteins 2 and 3	25708,54315
5416	18674790	1361	1410	GeneOrGeneProduct	peroxisome proliferators activated receptor-alpha	25747
5417	18674790	1433	1444	GeneOrGeneProduct	adiponectin	246253
5418	18674790	1475	1485	ChemicalEntity	fatty-acid	D005227
5419	18674790	1573	1575	DiseaseOrPhenotypicFeature	OB	D009765
5420	18674790	1606	1631	GeneOrGeneProduct	AMP-alpha2 protein kinase	65248
5421	18674790	1661	1664	ChemicalEntity	ATP	D000255
5422	18674790	1697	1700	ChemicalEntity	ATP	D000255
5423	18674790	1701	1704	ChemicalEntity	ADP	D000244
5424	18674790	1717	1728	ChemicalEntity	doxorubicin	D004317
5425	18674790	1763	1777	GeneOrGeneProduct	erythropoietin	24335
5426	18674790	1792	1797	GeneOrGeneProduct	SOCS3	89829
5427	18674790	1841	1844	GeneOrGeneProduct	JAK	84598
5428	18674790	1845	1850	GeneOrGeneProduct	STAT3	25125
5429	18674790	1887	1892	DiseaseOrPhenotypicFeature	obese	D009765
5430	18674790	1893	1897	OrganismTaxon	rats	10116
5431	18674790	1923	1934	ChemicalEntity	doxorubicin	D004317
5432	18674790	1943	1957	DiseaseOrPhenotypicFeature	cardiotoxicity	D066126
5433	18674790	2012	2015	ChemicalEntity	ATP	D000255
5434	18674790	2079	2082	GeneOrGeneProduct	JAK	84598
5435	18674790	2083	2088	GeneOrGeneProduct	STAT3	25125
5436	18681856	31	61	DiseaseOrPhenotypicFeature	non-autoimmune hyperthyroidism	C563786
5437	18681856	102	109	SequenceVariant	p.M453T	rs121908864
5438	18681856	118	138	GeneOrGeneProduct	thyrotropin receptor	7253
5439	18681856	220	250	DiseaseOrPhenotypicFeature	non-autoimmune hyperthyroidism	C563786
5440	18681856	252	255	DiseaseOrPhenotypicFeature	NAH	C563786
5441	18681856	306	326	GeneOrGeneProduct	thyrotropin receptor	7253
5442	18681856	328	332	GeneOrGeneProduct	TSHR	7253
5443	18681856	340	348	OrganismTaxon	PATIENTS	9606
5444	18681856	638	642	GeneOrGeneProduct	TSHR	7253
5445	18681856	756	762	SequenceVariant	T to C	rs121908864
5446	18681856	792	796	GeneOrGeneProduct	TSHR	7253
5447	18681856	803	814	SequenceVariant	c.1358T-->C	rs121908864
5448	18681856	849	897	SequenceVariant	methionine (ATG) by threonine (ACG) at codon 453	rs121908864
5449	18681856	899	906	SequenceVariant	p.M453T	rs121908864
5450	18681856	1049	1064	DiseaseOrPhenotypicFeature	hyperthyroidism	D006980
5451	18681856	1066	1082	DiseaseOrPhenotypicFeature	ventriculomegaly	D006849
5452	18681856	1250	1266	DiseaseOrPhenotypicFeature	Ventriculomegaly	D006849
5453	18681856	1404	1407	DiseaseOrPhenotypicFeature	NAH	C563786
5454	18681856	1433	1437	GeneOrGeneProduct	TSHR	7253
5455	18779591	53	71	GeneOrGeneProduct	prolactin receptor	5618
5456	18779591	75	80	OrganismTaxon	women	9606
5457	18779591	86	106	DiseaseOrPhenotypicFeature	benign breast tumors	D001943
5458	18779591	136	151	DiseaseOrPhenotypicFeature	genetic disease	D030342
5459	18779591	162	171	GeneOrGeneProduct	prolactin	5617
5460	18779591	173	176	GeneOrGeneProduct	Prl	5617
5461	18779591	195	199	GeneOrGeneProduct	PrlR	5618
5462	18779591	204	210	OrganismTaxon	humans	9606
5463	18779591	321	324	GeneOrGeneProduct	Prl	5617
5464	18779591	325	329	GeneOrGeneProduct	PrlR	5618
5465	18779591	372	387	DiseaseOrPhenotypicFeature	breast diseases	D001941
5466	18779591	423	445	DiseaseOrPhenotypicFeature	Multiple fibroadenomas	D018226
5467	18779591	447	450	DiseaseOrPhenotypicFeature	MFA	D018226
5468	18779591	456	476	DiseaseOrPhenotypicFeature	benign breast tumors	D001943
5469	18779591	515	520	OrganismTaxon	women	9606
5470	18779591	549	552	GeneOrGeneProduct	Prl	5617
5471	18779591	646	649	DiseaseOrPhenotypicFeature	MFA	D018226
5472	18779591	650	658	OrganismTaxon	patients	9606
5473	18779591	704	712	OrganismTaxon	patients	9606
5474	18779591	786	790	GeneOrGeneProduct	PrlR	5618
5475	18779591	806	820	SequenceVariant	Ile(146)-->Leu	rs72478580
5476	18779591	958	962	GeneOrGeneProduct	PrlR	19116
5477	18779591	963	968	SequenceVariant	I146L	rs72478580
5478	18779591	1020	1025	CellLine	Ba/F3	10090
5479	18779591	1027	1033	CellLine	HEK293	9606
5480	18779591	1038	1043	CellLine	MCF-7	9606
5481	18779591	1054	1057	GeneOrGeneProduct	Prl	5617
5482	18779591	1074	1078	GeneOrGeneProduct	PrlR	5618
5483	18779591	1124	1174	GeneOrGeneProduct	signal transducer and activator of transcription 5	6776
5484	18779591	1176	1181	GeneOrGeneProduct	STAT5	6776
5485	18779591	1234	1237	GeneOrGeneProduct	Prl	5617
5486	18779591	1349	1353	GeneOrGeneProduct	PrlR	5618
5487	18779591	1354	1359	SequenceVariant	I146L	rs72478580
5488	18779591	1389	1396	OrganismTaxon	patient	9606
5489	18779591	1424	1429	GeneOrGeneProduct	STAT5	6776
5490	18779591	1502	1506	GeneOrGeneProduct	PrlR	5618
5491	18779591	1525	1530	OrganismTaxon	human	9606
5492	18779591	1607	1622	ChemicalEntity	PrlR antagonist	-
5493	18779591	1673	1676	DiseaseOrPhenotypicFeature	MFA	D018226
5494	18808529	0	13	ChemicalEntity	Isoproterenol	D007545
5495	18808529	38	48	GeneOrGeneProduct	dystrophin	24907
5496	18808529	52	55	OrganismTaxon	rat	10116
5497	18808529	81	98	DiseaseOrPhenotypicFeature	myocardial injury	D009202
5498	18808529	117	130	ChemicalEntity	isoproterenol	D007545
5499	18808529	139	156	DiseaseOrPhenotypicFeature	myocardial damage	D009202
5500	18808529	187	193	ChemicalEntity	oxygen	D010100
5501	18808529	231	242	DiseaseOrPhenotypicFeature	hypotension	D007022
5502	18808529	247	271	DiseaseOrPhenotypicFeature	myocardial hyperactivity	D009202
5503	18808529	470	483	ChemicalEntity	isoproterenol	D007545
5504	18808529	557	567	GeneOrGeneProduct	dystrophin	24907
5505	18808529	568	580	GeneOrGeneProduct	glycoprotein	11820
5506	18808529	609	614	GeneOrGeneProduct	actin	60
5507	18808529	619	626	GeneOrGeneProduct	laminin	309368
5508	18808529	732	745	ChemicalEntity	isoproterenol	D007545
5509	18808529	876	889	ChemicalEntity	isoproterenol	D007545
5510	18808529	960	970	GeneOrGeneProduct	dystrophin	24907
5511	18808529	1029	1034	GeneOrGeneProduct	actin	60
5512	18808529	1114	1119	GeneOrGeneProduct	actin	60
5513	18808529	1172	1182	GeneOrGeneProduct	dystrophin	24907
5514	18808529	1227	1244	GeneOrGeneProduct	gamma-sarcoglycan	305941
5515	18808529	1246	1263	GeneOrGeneProduct	beta-dystroglycan	114489
5516	18808529	1265	1279	GeneOrGeneProduct	beta1-integrin	24511
5517	18808529	1285	1300	GeneOrGeneProduct	laminin alpha-2	309368
5518	18808529	1433	1446	ChemicalEntity	isoproterenol	D007545
5519	18808529	1450	1454	OrganismTaxon	rats	10116
5520	18808529	1482	1492	GeneOrGeneProduct	dystrophin	24907
5521	18808529	1665	1681	DiseaseOrPhenotypicFeature	ischaemic injury	D007511
5522	18808529	1830	1843	ChemicalEntity	isoproterenol	D007545
5523	18945288	0	5	SequenceVariant	R58fs	p|FS|R|58||
5524	18945288	22	25	GeneOrGeneProduct	HGD	3081
5525	18945288	48	60	DiseaseOrPhenotypicFeature	alkaptonuria	D000474
5526	18945288	129	141	DiseaseOrPhenotypicFeature	alkaptonuria	D000474
5527	18945288	436	453	ChemicalEntity	homogentisic acid	D006713
5528	18945288	698	701	GeneOrGeneProduct	HGD	3081
5529	18945288	864	881	ChemicalEntity	homogentisic acid	D006713
5530	18945288	986	989	ChemicalEntity	HGA	D006713
5531	18945288	1109	1119	DiseaseOrPhenotypicFeature	joint pain	D018771
5532	18945288	1234	1243	SequenceVariant	c.342delA	c|DEL|342|A
5533	18945288	1322	1331	SequenceVariant	p.Arg58fs	p|FS|R|58||
5534	18945288	1335	1342	SequenceVariant	p.R58fs	p|FS|R|58||
5535	18945288	1345	1357	DiseaseOrPhenotypicFeature	Alkaptonuria	D000474
5536	18945288	1479	1484	SequenceVariant	R58fs	p|FS|R|58||
5537	19037252	13	38	GeneOrGeneProduct	phospholipase C epsilon 1	51196
5538	19037252	67	94	DiseaseOrPhenotypicFeature	diffuse mesangial sclerosis	C537346
5539	19037252	96	123	DiseaseOrPhenotypicFeature	Diffuse mesangial sclerosis	C537346
5540	19037252	209	234	GeneOrGeneProduct	phospholipase C epsilon 1	51196
5541	19037252	236	241	GeneOrGeneProduct	PLCE1	51196
5542	19037252	410	437	DiseaseOrPhenotypicFeature	diffuse mesangial sclerosis	C537346
5543	19037252	457	499	DiseaseOrPhenotypicFeature	congenital or infantile nephrotic syndrome	C535761
5544	19037252	525	530	GeneOrGeneProduct	PLCE1	51196
5545	19037252	546	554	GeneOrGeneProduct	KIAA1516	51196
5546	19037252	556	560	GeneOrGeneProduct	PLCE	51196
5547	19037252	565	570	GeneOrGeneProduct	NPHS3	51196
5548	19037252	698	720	SequenceVariant	four-basepair deletion	c|DEL||4
5549	19037252	1014	1019	GeneOrGeneProduct	PLCE1	51196
5550	19037252	1054	1081	DiseaseOrPhenotypicFeature	diffuse mesangial sclerosis	C537346
5551	19048115	0	15	GeneOrGeneProduct	Neurofibromin 1	4763
5552	19048115	17	20	GeneOrGeneProduct	NF1	4763
5553	19048115	44	49	OrganismTaxon	human	9606
5554	19048115	50	75	DiseaseOrPhenotypicFeature	ovarian serous carcinomas	D010051
5555	19048115	94	98	GeneOrGeneProduct	TP53	7157
5556	19048115	110	134	DiseaseOrPhenotypicFeature	Ovarian serous carcinoma	D010051
5557	19048115	136	139	DiseaseOrPhenotypicFeature	OSC	D010051
5558	19048115	190	219	DiseaseOrPhenotypicFeature	ovarian epithelial malignancy	D002277
5559	19048115	234	238	GeneOrGeneProduct	TP53	7157
5560	19048115	262	267	GeneOrGeneProduct	Brca1	672
5561	19048115	275	280	GeneOrGeneProduct	Brca2	675
5562	19048115	281	286	DiseaseOrPhenotypicFeature	tumor	D009369
5563	19048115	381	385	DiseaseOrPhenotypicFeature	OSCs	D010051
5564	19048115	444	449	DiseaseOrPhenotypicFeature	tumor	D009369
5565	19048115	565	569	DiseaseOrPhenotypicFeature	OSCs	D010051
5566	19048115	589	595	DiseaseOrPhenotypicFeature	tumors	D009369
5567	19048115	638	641	GeneOrGeneProduct	NF1	4763
5568	19048115	665	682	DiseaseOrPhenotypicFeature	ovarian carcinoma	D010051
5569	19048115	717	721	DiseaseOrPhenotypicFeature	OSCs	D010051
5570	19048115	741	744	GeneOrGeneProduct	NF1	4763
5571	19048115	799	802	GeneOrGeneProduct	Nf1	4763
5572	19048115	929	932	GeneOrGeneProduct	NF1	4763
5573	19048115	1002	1005	GeneOrGeneProduct	NF1	4763
5574	19048115	1070	1073	GeneOrGeneProduct	NF1	4763
5575	19048115	1097	1100	GeneOrGeneProduct	NF1	4763
5576	19048115	1208	1212	DiseaseOrPhenotypicFeature	OSCs	D010051
5577	19048115	1227	1233	DiseaseOrPhenotypicFeature	tumors	D009369
5578	19048115	1254	1257	GeneOrGeneProduct	NF1	4763
5579	19048115	1286	1290	GeneOrGeneProduct	KRAS	3845
5580	19048115	1294	1298	GeneOrGeneProduct	BRAF	673
5581	19048115	1310	1313	GeneOrGeneProduct	Ras	3845
5582	19048115	1390	1394	GeneOrGeneProduct	MAPK	5594
5583	19048115	1404	1410	DiseaseOrPhenotypicFeature	tumors	D009369
5584	19048115	1435	1438	ChemicalEntity	GTP	D006160
5585	19048115	1445	1448	GeneOrGeneProduct	Ras	3845
5586	19048115	1467	1471	GeneOrGeneProduct	TP53	7157
5587	19048115	1472	1477	DiseaseOrPhenotypicFeature	tumor	D009369
5588	19048115	1513	1517	DiseaseOrPhenotypicFeature	OSCs	D010051
5589	19048115	1534	1537	GeneOrGeneProduct	NF1	4763
5590	19048115	1600	1605	DiseaseOrPhenotypicFeature	tumor	D009369
5591	19048115	1664	1682	DiseaseOrPhenotypicFeature	ovarian carcinomas	D010051
5592	19067809	105	110	GeneOrGeneProduct	renin	5972
5593	19067809	111	122	GeneOrGeneProduct	angiotensin	183
5594	19067809	127	136	ChemicalEntity	serotonin	D012701
5595	19067809	195	200	GeneOrGeneProduct	renin	5972
5596	19067809	201	212	GeneOrGeneProduct	angiotensin	183
5597	19067809	224	245	GeneOrGeneProduct	serotonin transporter	6532
5598	19067809	366	374	OrganismTaxon	patients	9606
5599	19067809	380	397	DiseaseOrPhenotypicFeature	vasovagal syncope	D019462
5600	19067809	435	443	OrganismTaxon	patients	9606
5601	19067809	472	475	OrganismTaxon	men	9606
5602	19067809	481	486	OrganismTaxon	women	9606
5603	19067809	554	583	GeneOrGeneProduct	angiotensin-converting enzyme	1636
5604	19067809	621	624	GeneOrGeneProduct	ACE	1636
5605	19067809	627	642	GeneOrGeneProduct	angiotensinogen	183
5606	19067809	662	667	SequenceVariant	M 235	p|Allele|M|235
5607	19067809	670	700	GeneOrGeneProduct	angiotensin II receptor type 1	185
5608	19067809	702	706	GeneOrGeneProduct	ATR1	185
5609	19067809	722	730	SequenceVariant	A 11666C	rs5186
5610	19067809	753	774	GeneOrGeneProduct	serotonin transporter	6532
5611	19067809	781	788	GeneOrGeneProduct	5HTTLPR	6532
5612	19067809	1023	1030	SequenceVariant	A 1166C	rs5186
5613	19067809	1531	1538	DiseaseOrPhenotypicFeature	syncope	D013575
5614	19067809	1636	1643	SequenceVariant	A 1166C	rs5186
5615	19067809	1664	1668	GeneOrGeneProduct	ATR1	185
5616	19067809	1697	1708	DiseaseOrPhenotypicFeature	hypotension	D007022
5617	19067809	1791	1808	DiseaseOrPhenotypicFeature	vasovagal syncope	D019462
5618	19082493	70	90	GeneOrGeneProduct	thymidylate synthase	7298
5619	19082493	118	132	ChemicalEntity	5 fluorouracil	D005472
5620	19082493	141	158	DiseaseOrPhenotypicFeature	colorectal cancer	D015179
5621	19082493	159	167	OrganismTaxon	patients	9606
5622	19082493	243	245	GeneOrGeneProduct	TS	7298
5623	19082493	296	313	DiseaseOrPhenotypicFeature	colorectal cancer	D015179
5624	19082493	315	318	DiseaseOrPhenotypicFeature	CRC	D015179
5625	19082493	320	328	OrganismTaxon	patients	9606
5626	19082493	342	345	ChemicalEntity	5FU	D005472
5627	19082493	362	401	SequenceVariant	28 bp variable number of tandem repeats	c|DUP||28
5628	19082493	412	415	SequenceVariant	G/C	c|SUB|G||C
5629	19082493	460	493	SequenceVariant	deletion of 6 bp at position 1494	c|DEL|194|6
5630	19082493	591	599	OrganismTaxon	patients	9606
5631	19082493	661	669	ChemicalEntity	paraffin	D010232
5632	19082493	697	705	OrganismTaxon	patients	9606
5633	19082493	728	731	DiseaseOrPhenotypicFeature	CRC	D015179
5634	19082493	733	735	GeneOrGeneProduct	TS	7298
5635	19082493	886	898	SequenceVariant	ins/del 6 bp	c|INDEL||6
5636	19082493	932	934	GeneOrGeneProduct	TS	7298
5637	19082493	1040	1052	SequenceVariant	ins/del 6 bp	c|INDEL||6
5638	19082493	1119	1131	SequenceVariant	ins/del 6 bp	c|INDEL||6
5639	19082493	1154	1160	DiseaseOrPhenotypicFeature	tumour	D009369
5640	19082493	1216	1223	DiseaseOrPhenotypicFeature	tumours	D009369
5641	19082493	1268	1282	DiseaseOrPhenotypicFeature	rectal cancers	D012004
5642	19082493	1362	1370	OrganismTaxon	patients	9606
5643	19082493	1388	1395	DiseaseOrPhenotypicFeature	tumours	D009369
5644	19082493	1498	1505	DiseaseOrPhenotypicFeature	tumours	D009369
5645	19082493	1964	1971	DiseaseOrPhenotypicFeature	tumours	D009369
5646	19082493	2008	2016	OrganismTaxon	patients	9606
5647	19082493	2097	2099	GeneOrGeneProduct	TS	7298
5648	19082493	2168	2171	DiseaseOrPhenotypicFeature	CRC	D015179
5649	19082493	2172	2180	OrganismTaxon	patients	9606
5650	19082493	2194	2197	ChemicalEntity	5FU	D005472
5651	19101703	33	67	DiseaseOrPhenotypicFeature	oculopharyngeal muscular dystrophy	D039141
5652	19101703	81	115	DiseaseOrPhenotypicFeature	Oculopharyngeal muscular dystrophy	D039141
5653	19101703	117	121	DiseaseOrPhenotypicFeature	OPMD	D039141
5654	19101703	139	173	DiseaseOrPhenotypicFeature	autosomal dominant muscle disorder	D030342
5655	19101703	175	179	DiseaseOrPhenotypicFeature	OPMD	D039141
5656	19101703	253	264	ChemicalEntity	polyalanine	C019529
5657	19101703	278	317	GeneOrGeneProduct	polyadenylate binding-protein nuclear 1	8106
5658	19101703	319	325	GeneOrGeneProduct	PABPN1	8106
5659	19101703	367	373	GeneOrGeneProduct	PABPN1	8106
5660	19101703	410	414	DiseaseOrPhenotypicFeature	OPMD	D039141
5661	19101703	516	520	DiseaseOrPhenotypicFeature	OPMD	D039141
5662	19101703	556	562	GeneOrGeneProduct	PABPN1	8106
5663	19101703	641	645	DiseaseOrPhenotypicFeature	OPMD	D039141
5664	19101703	741	747	GeneOrGeneProduct	PABPN1	8106
5665	19101703	765	832	SequenceVariant	(GCG)6(GCA)3GCG sequence was replaced by (GCG)6(GCA)(GCG)4(GCA)3GCG	c|SUB|(GCG)6(GCA)3GCG||(GCG)6(GCA)(GCG)4(GCA)3GCG
5666	19101703	843	865	SequenceVariant	insertion of (GCG)4GCA	c|INS|(GCG)4GCA
5667	19101703	906	910	DiseaseOrPhenotypicFeature	OPMD	D039141
5668	19101703	983	987	DiseaseOrPhenotypicFeature	OPMD	D039141
5669	19101703	988	996	OrganismTaxon	patients	9606
5670	19101703	1019	1041	SequenceVariant	insertion of (GCG)4GCA	c|INS|(GCG)4GCA
5671	19101703	1049	1055	GeneOrGeneProduct	PABPN1	8106
5672	19101703	1088	1092	DiseaseOrPhenotypicFeature	OPMD	D039141
5673	19101703	1211	1217	GeneOrGeneProduct	PABPN1	8106
5674	19108278	52	63	ChemicalEntity	propranolol	D011433
5675	19108278	85	104	DiseaseOrPhenotypicFeature	cardiac arrhythmias	D001145
5676	19108278	132	143	ChemicalEntity	propranolol	D011433
5677	19108278	285	297	ChemicalEntity	isoprenaline	D007545
5678	19108278	303	314	ChemicalEntity	propranolol	D011433
5679	19108278	362	373	ChemicalEntity	propranolol	D011433
5680	19108278	397	408	ChemicalEntity	propranolol	D011433
5681	19108278	443	455	ChemicalEntity	isoprenaline	D007545
5682	19108278	568	580	ChemicalEntity	isoprenaline	D007545
5683	19108278	584	588	OrganismTaxon	dogs	9615
5684	19108278	617	624	ChemicalEntity	glucose	D005947
5685	19108278	626	633	ChemicalEntity	lactate	D019344
5686	19108278	643	654	ChemicalEntity	fatty acids	D005227
5687	19108278	680	691	ChemicalEntity	propranolol	D011433
5688	19108278	697	708	ChemicalEntity	Propranolol	D011433
5689	19108278	726	736	ChemicalEntity	fatty acid	D005227
5690	19108278	799	806	ChemicalEntity	lactate	D019344
5691	19108278	811	818	ChemicalEntity	glucose	D005947
5692	19108278	838	849	ChemicalEntity	propranolol	D011433
5693	19108278	924	935	OrganismTaxon	guinea-pigs	10141
5694	19108278	954	965	ChemicalEntity	propranolol	D011433
5695	19108278	1095	1103	ChemicalEntity	procaine	D011343
5696	19108278	1194	1205	ChemicalEntity	propranolol	D011433
5697	19108278	1233	1243	ChemicalEntity	adrenaline	D004837
5698	19108278	1252	1271	DiseaseOrPhenotypicFeature	cardiac arrhythmias	D001145
5699	19108278	1275	1279	OrganismTaxon	cats	9685
5700	19108278	1299	1308	ChemicalEntity	halothane	D006221
5701	19108278	1335	1346	ChemicalEntity	propranolol	D011433
5702	19108278	1389	1400	ChemicalEntity	propranolol	D011433
5703	19108278	1457	1468	ChemicalEntity	propranolol	D011433
5704	19108278	1563	1574	DiseaseOrPhenotypicFeature	arrhythmias	D001145
5705	19108278	1636	1646	ChemicalEntity	adrenaline	D004837
5706	19108278	1666	1677	ChemicalEntity	propranolol	D011433
5707	19108278	1709	1732	DiseaseOrPhenotypicFeature	ventricular tachycardia	D017180
5708	19108278	1743	1750	ChemicalEntity	ouabain	D010042
5709	19108278	1768	1772	OrganismTaxon	cats	9685
5710	19108278	1777	1781	OrganismTaxon	dogs	9615
5711	19108278	1799	1810	ChemicalEntity	propranolol	D011433
5712	19108278	1854	1865	ChemicalEntity	propranolol	D011433
5713	19160446	0	5	GeneOrGeneProduct	P2RX7	5027
5714	19160446	9	38	DiseaseOrPhenotypicFeature	bipolar and unipolar disorder	D001714,D003866
5715	19160446	157	173	DiseaseOrPhenotypicFeature	bipolar disorder	D001714
5716	19160446	178	200	DiseaseOrPhenotypicFeature	unipolar mood disorder	D003866,D019964
5717	19160446	253	269	DiseaseOrPhenotypicFeature	bipolar disorder	D001714
5718	19160446	274	290	DiseaseOrPhenotypicFeature	Darier's disease	D007644
5719	19160446	338	343	GeneOrGeneProduct	P2RX7	5027
5720	19160446	442	458	DiseaseOrPhenotypicFeature	bipolar disorder	D001714
5721	19160446	463	482	DiseaseOrPhenotypicFeature	unipolar depression	D003866
5722	19160446	507	516	SequenceVariant	rs2230912	rs2230912
5723	19160446	555	560	SequenceVariant	Q460R	rs2230912
5724	19160446	716	734	DiseaseOrPhenotypicFeature	bipolar I disorder	D001714
5725	19160446	744	779	DiseaseOrPhenotypicFeature	unipolar recurrent major depression	D003865
5726	19160446	820	829	SequenceVariant	rs2230912	rs2230912
5727	19160446	871	876	GeneOrGeneProduct	P2RX7	5027
5728	19160446	909	922	DiseaseOrPhenotypicFeature	mood disorder	D019964
5729	19160446	957	985	DiseaseOrPhenotypicFeature	bipolar or unipolar disorder	D001714,D003866
5730	19160446	1102	1107	GeneOrGeneProduct	P2RX7	5027
5731	19160446	1176	1185	SequenceVariant	rs2230912	rs2230912
5732	19160446	1232	1237	GeneOrGeneProduct	P2RX7	5027
5733	19160446	1281	1295	DiseaseOrPhenotypicFeature	mood disorders	D019964
5734	19207031	0	14	GeneOrGeneProduct	Growth hormone	2688
5735	19207031	23	47	DiseaseOrPhenotypicFeature	growth hormone-deficient	D004393
5736	19207031	78	83	GeneOrGeneProduct	IGF-1	3479
5737	19207031	197	202	GeneOrGeneProduct	IGF-1	3479
5738	19207031	261	266	GeneOrGeneProduct	IGF-1	3479
5739	19207031	301	306	GeneOrGeneProduct	IGF-1	3479
5740	19207031	381	395	GeneOrGeneProduct	growth hormone	2688
5741	19207031	397	399	GeneOrGeneProduct	GH	2688
5742	19207031	457	459	GeneOrGeneProduct	GH	2688
5743	19207031	469	481	DiseaseOrPhenotypicFeature	GH-deficient	D004393
5744	19207031	482	490	OrganismTaxon	patients	9606
5745	19207031	533	538	GeneOrGeneProduct	IGF-1	3479
5746	19207031	582	584	GeneOrGeneProduct	GH	2688
5747	19207031	593	605	DiseaseOrPhenotypicFeature	GH-deficient	D004393
5748	19207031	776	784	OrganismTaxon	patients	9606
5749	19207031	789	792	OrganismTaxon	men	9606
5750	19207031	797	802	OrganismTaxon	women	9606
5751	19207031	878	891	DiseaseOrPhenotypicFeature	GH-deficiency	D004393
5752	19207031	893	896	DiseaseOrPhenotypicFeature	GHD	D004393
5753	19207031	1016	1024	OrganismTaxon	Patients	9606
5754	19207031	1034	1036	GeneOrGeneProduct	GH	2688
5755	19207031	1093	1095	GeneOrGeneProduct	GH	2688
5756	19207031	1112	1117	GeneOrGeneProduct	IGF-1	3479
5757	19207031	1132	1134	GeneOrGeneProduct	GH	2688
5758	19207031	1167	1172	GeneOrGeneProduct	IGF-1	3479
5759	19207031	1189	1194	GeneOrGeneProduct	IGF-1	3479
5760	19207031	1231	1236	GeneOrGeneProduct	IGF-1	3479
5761	19207031	1237	1239	GeneOrGeneProduct	GH	2688
5762	19207031	1317	1326	SequenceVariant	rs1019731	rs1019731
5763	19207031	1369	1374	GeneOrGeneProduct	IGF-1	3479
5764	19207031	1454	1456	GeneOrGeneProduct	GH	2688
5765	19207031	1464	1469	GeneOrGeneProduct	IGF-1	3479
5766	19207031	1486	1491	GeneOrGeneProduct	IGF-1	3479
5767	19207031	1500	1505	GeneOrGeneProduct	IGF-1	3479
5768	19207031	1506	1508	GeneOrGeneProduct	GH	2688
5769	19207031	1594	1599	GeneOrGeneProduct	IGF-1	3479
5770	19207031	1676	1678	GeneOrGeneProduct	GH	2688
5771	19207031	1682	1685	DiseaseOrPhenotypicFeature	GHD	D004393
5772	19207031	1724	1729	GeneOrGeneProduct	IGF-1	3479
5773	19207031	1783	1785	GeneOrGeneProduct	GH	2688
5774	19207031	1786	1789	GeneOrGeneProduct	IGF	3479
5775	19207031	1834	1836	GeneOrGeneProduct	GH	2688
5776	19208385	0	32	DiseaseOrPhenotypicFeature	Osteogenesis imperfecta type III	C536044
5777	19208385	38	61	DiseaseOrPhenotypicFeature	intracranial hemorrhage	D020300
5778	19208385	66	79	DiseaseOrPhenotypicFeature	brachydactyly	D059327
5779	19208385	120	126	GeneOrGeneProduct	COL1A2	1278
5780	19208385	128	151	DiseaseOrPhenotypicFeature	Osteogenesis imperfecta	D010013
5781	19208385	153	155	DiseaseOrPhenotypicFeature	OI	D010013
5782	19208385	172	185	DiseaseOrPhenotypicFeature	bone disorder	D001847
5783	19208385	203	212	DiseaseOrPhenotypicFeature	fractures	D050723
5784	19208385	226	232	DiseaseOrPhenotypicFeature	trauma	D014947
5785	19208385	234	257	DiseaseOrPhenotypicFeature	Intracranial hemorrhage	D020300
5786	19208385	297	299	DiseaseOrPhenotypicFeature	OI	D010013
5787	19208385	300	308	OrganismTaxon	patients	9606
5788	19208385	333	341	OrganismTaxon	patients	9606
5789	19208385	406	417	DiseaseOrPhenotypicFeature	OI type III	C536044
5790	19208385	431	454	DiseaseOrPhenotypicFeature	intracranial hemorrhage	D020300
5791	19208385	475	488	DiseaseOrPhenotypicFeature	brachydactyly	D059327
5792	19208385	493	508	DiseaseOrPhenotypicFeature	nail hypoplasia	D009260
5793	19208385	526	534	OrganismTaxon	patients	9606
5794	19208385	536	538	DiseaseOrPhenotypicFeature	OI	D010013
5795	19208385	596	602	GeneOrGeneProduct	COL1A2	1278
5796	19208385	692	715	GeneOrGeneProduct	collagen type I alpha 2	1278
5797	19208385	787	810	GeneOrGeneProduct	collagen type I alpha 2	1278
5798	19208385	838	863	DiseaseOrPhenotypicFeature	abnormal limb development	D009140
5799	19208385	868	889	DiseaseOrPhenotypicFeature	intracranial bleeding	D020300
5800	19234905	77	107	DiseaseOrPhenotypicFeature	idiopathic Parkinson's disease	D010300
5801	19234905	254	284	DiseaseOrPhenotypicFeature	idiopathic Parkinson's disease	D010300
5802	19234905	286	288	DiseaseOrPhenotypicFeature	PD	D010300
5803	19234905	352	360	OrganismTaxon	patients	9606
5804	19234905	394	397	OrganismTaxon	men	9606
5805	19234905	401	406	OrganismTaxon	women	9606
5806	19234905	581	589	ChemicalEntity	levodopa	D007980
5807	19234905	598	609	DiseaseOrPhenotypicFeature	dyskinesias	D004409
5808	19234905	629	637	OrganismTaxon	patients	9606
5809	19234905	671	679	ChemicalEntity	levodopa	D007980
5810	19234905	717	725	OrganismTaxon	patients	9606
5811	19234905	875	894	DiseaseOrPhenotypicFeature	Parkinson's Disease	D010300
5812	19234905	1145	1157	DiseaseOrPhenotypicFeature	parkinsonian	D010300
5813	19234905	1177	1185	OrganismTaxon	patients	9606
5814	19234905	1209	1217	ChemicalEntity	Levodopa	D007980
5815	19234905	1462	1470	OrganismTaxon	patients	9606
5816	19234905	1487	1509	DiseaseOrPhenotypicFeature	homonymous hemianopsia	D006423
5817	19234905	1653	1662	ChemicalEntity	Valproate	D014635
5818	19234905	1790	1798	OrganismTaxon	patients	9606
5819	19234905	1813	1815	DiseaseOrPhenotypicFeature	PD	D010300
5820	19276632	21	26	GeneOrGeneProduct	FOXF2	2295
5821	19276632	30	38	OrganismTaxon	patients	9606
5822	19276632	44	72	DiseaseOrPhenotypicFeature	disorders of sex development	D012734
5823	19276632	74	77	DiseaseOrPhenotypicFeature	DSD	D012734
5824	19276632	99	111	DiseaseOrPhenotypicFeature	cleft palate	D002972
5825	19276632	128	163	DiseaseOrPhenotypicFeature	disorders of sexual differentiation	D012734
5826	19276632	182	190	ChemicalEntity	androgen	D000728
5827	19276632	215	223	ChemicalEntity	androgen	D000728
5828	19276632	327	333	OrganismTaxon	humans	9606
5829	19276632	395	400	GeneOrGeneProduct	FOXF2	2295
5830	19276632	424	429	OrganismTaxon	human	9606
5831	19276632	450	455	GeneOrGeneProduct	Foxf2	14238
5832	19276632	465	469	OrganismTaxon	mice	10090
5833	19276632	483	495	DiseaseOrPhenotypicFeature	cleft palate	D002972
5834	19276632	516	550	DiseaseOrPhenotypicFeature	hypoplasia of the genital tubercle	C537540
5835	19276632	573	579	OrganismTaxon	humans	9606
5836	19276632	585	613	DiseaseOrPhenotypicFeature	disorders of sex development	D012734
5837	19276632	615	618	DiseaseOrPhenotypicFeature	DSD	D012734
5838	19276632	640	652	DiseaseOrPhenotypicFeature	cleft palate	D002972
5839	19276632	681	686	GeneOrGeneProduct	FOXF2	2295
5840	19276632	716	719	DiseaseOrPhenotypicFeature	DSD	D012734
5841	19276632	724	736	DiseaseOrPhenotypicFeature	cleft palate	D002972
5842	19276632	767	770	DiseaseOrPhenotypicFeature	DSD	D012734
5843	19276632	840	845	GeneOrGeneProduct	FOXF2	2295
5844	19276632	1018	1025	OrganismTaxon	patient	9606
5845	19276632	1072	1090	SequenceVariant	duplication of GCC	c|DUP||GCC|
5846	19276632	1092	1107	SequenceVariant	c.97GCC[9]+[10]	c|DUP|97|GCC|9-10
5847	19276632	1159	1165	SequenceVariant	25*G>A	c|SUB|G|*25|A
5848	19276632	1214	1222	OrganismTaxon	patients	9606
5849	19276632	1233	1241	SequenceVariant	c.262G>A	rs72667003
5850	19276632	1279	1287	SequenceVariant	Ala88Thr	rs72667003
5851	19276632	1365	1374	SequenceVariant	c.1272C>T	rs61753348
5852	19276632	1376	1385	SequenceVariant	Ser424Ser	rs61753348
5853	19276632	1391	1400	SequenceVariant	c.1284T>C	rs2293783
5854	19276632	1402	1411	SequenceVariant	Tyr428Tyr	rs2293783
5855	19276632	1483	1491	OrganismTaxon	patients	9606
5856	19276632	1729	1734	GeneOrGeneProduct	FOXF2	2295
5857	19306381	0	17	GeneOrGeneProduct	Neuregulin-1 beta	3084
5858	19306381	22	40	GeneOrGeneProduct	neuregulin-1 alpha	3084
5859	19306381	93	132	DiseaseOrPhenotypicFeature	malignant peripheral nerve sheath tumor	D018319
5860	19306381	140	180	DiseaseOrPhenotypicFeature	Malignant peripheral nerve sheath tumors	D018319
5861	19306381	182	188	DiseaseOrPhenotypicFeature	MPNSTs	D018319
5862	19306381	210	220	DiseaseOrPhenotypicFeature	malignancy	D009369
5863	19306381	237	261	GeneOrGeneProduct	neurofibromatosis Type 1	4763
5864	19306381	263	266	GeneOrGeneProduct	NF1	4763
5865	19306381	304	312	DiseaseOrPhenotypicFeature	sarcomas	D012509
5866	19306381	502	508	DiseaseOrPhenotypicFeature	MPNSTs	D018319
5867	19306381	517	542	GeneOrGeneProduct	neuregulin-1 (NRG-1) beta	3084
5868	19306381	614	625	GeneOrGeneProduct	NRG-1 alpha	3084
5869	19306381	709	719	GeneOrGeneProduct	NRG-1 beta	3084
5870	19306381	727	738	GeneOrGeneProduct	NRG-1 alpha	3084
5871	19306381	747	752	DiseaseOrPhenotypicFeature	MPNST	D018319
5872	19306381	777	787	GeneOrGeneProduct	NRG-1 beta	3084
5873	19306381	797	802	DiseaseOrPhenotypicFeature	MPNST	D018319
5874	19306381	877	884	GeneOrGeneProduct	laminin	16777
5875	19306381	896	911	GeneOrGeneProduct	collagen type I	1277,1278
5876	19306381	915	926	GeneOrGeneProduct	fibronectin	2335
5877	19306381	932	937	GeneOrGeneProduct	NRG-1	3084
5878	19306381	948	953	GeneOrGeneProduct	erbB3	13867,2065
5879	19306381	958	963	GeneOrGeneProduct	erbB4	13869,2066
5880	19306381	980	985	DiseaseOrPhenotypicFeature	MPNST	D018319
5881	19306381	1057	1078	GeneOrGeneProduct	focal adhesion kinase	5747
5882	19306381	1087	1103	GeneOrGeneProduct	laminin receptor	3688
5883	19306381	1104	1120	GeneOrGeneProduct	beta(1)-integrin	3688
5884	19306381	1151	1167	GeneOrGeneProduct	beta(1)-integrin	3688
5885	19306381	1169	1179	GeneOrGeneProduct	NRG-1 beta	3084
5886	19306381	1191	1196	OrganismTaxon	human	9606
5887	19306381	1201	1207	OrganismTaxon	murine	10090
5888	19306381	1208	1213	DiseaseOrPhenotypicFeature	MPNST	D018319
5889	19306381	1367	1377	GeneOrGeneProduct	NRG-1 beta	3084
5890	19306381	1401	1405	GeneOrGeneProduct	erbB	13867,13869,2065,2066
5891	19306381	1443	1450	GeneOrGeneProduct	MEK 1/2	26395,26396,5604,5605
5892	19306381	1452	1456	GeneOrGeneProduct	SAPK	26419,5599
5893	19306381	1457	1460	GeneOrGeneProduct	JNK	26419,5599
5894	19306381	1462	1473	GeneOrGeneProduct	PI-3 kinase	30955,5290
5895	19306381	1475	1493	GeneOrGeneProduct	Src family kinases	20779,6714
5896	19306381	1498	1507	GeneOrGeneProduct	ROCK-I/II	19877,19878,6093,9475
5897	19306381	1522	1533	GeneOrGeneProduct	NRG-1 alpha	3084
5898	19306381	1586	1591	DiseaseOrPhenotypicFeature	MPNST	D018319
5899	19306381	1643	1653	GeneOrGeneProduct	NRG-1 beta	3084
5900	19306381	1690	1697	GeneOrGeneProduct	Erk 1/2	26413,26417,5594,5595
5901	19306381	1699	1703	GeneOrGeneProduct	SAPK	26419,5599
5902	19306381	1704	1707	GeneOrGeneProduct	JNK	26419,5599
5903	19306381	1709	1712	GeneOrGeneProduct	Akt	11651,207
5904	19306381	1717	1735	GeneOrGeneProduct	Src family kinases	20779,6714
5905	19306381	1737	1748	GeneOrGeneProduct	NRG-1 alpha	3084
5906	19306381	1766	1769	GeneOrGeneProduct	Akt	11651,207
5907	19306381	1849	1859	GeneOrGeneProduct	NRG-1 beta	3084
5908	19306381	1906	1916	GeneOrGeneProduct	NRG-1 beta	3084
5909	19306381	1926	1931	DiseaseOrPhenotypicFeature	MPNST	D018319
5910	19306381	1951	1961	GeneOrGeneProduct	NRG-1 beta	3084
5911	19306381	1966	1977	GeneOrGeneProduct	NRG-1 alpha	3084
5912	19319147	42	52	DiseaseOrPhenotypicFeature	hemorrhage	D006470
5913	19319147	65	70	OrganismTaxon	mouse	10090
5914	19319147	80	88	ChemicalEntity	warfarin	D014859
5915	19319147	100	124	DiseaseOrPhenotypicFeature	intracerebral hemorrhage	D002543
5916	19319147	126	134	ChemicalEntity	Warfarin	D014859
5917	19319147	146	170	DiseaseOrPhenotypicFeature	intracerebral hemorrhage	D002543
5918	19319147	172	173	ChemicalEntity	W	D014859
5919	19319147	174	177	DiseaseOrPhenotypicFeature	ICH	D002543
5920	19319147	199	205	DiseaseOrPhenotypicFeature	stroke	D020521
5921	19319147	258	259	ChemicalEntity	W	D014859
5922	19319147	260	263	DiseaseOrPhenotypicFeature	ICH	D002543
5923	19319147	273	278	OrganismTaxon	mouse	10090
5924	19319147	348	353	OrganismTaxon	human	9606
5925	19319147	354	385	ChemicalEntity	prothrombin complex concentrate	C025667
5926	19319147	387	390	ChemicalEntity	PCC	C025667
5927	19319147	439	443	OrganismTaxon	mice	10090
5928	19319147	462	470	ChemicalEntity	warfarin	D014859
5929	19319147	622	627	OrganismTaxon	human	9606
5930	19319147	628	631	ChemicalEntity	PCC	C025667
5931	19319147	668	672	OrganismTaxon	mice	10090
5932	19319147	710	721	ChemicalEntity	collagenase	D017364
5933	19319147	749	759	DiseaseOrPhenotypicFeature	hemorrhage	D006470
5934	19319147	848	851	ChemicalEntity	PCC	C025667
5935	19319147	920	930	DiseaseOrPhenotypicFeature	hemorrhage	D006470
5936	19319147	1069	1072	ChemicalEntity	PCC	C025667
5937	19319147	1201	1205	OrganismTaxon	mice	10090
5938	19319147	1222	1231	DiseaseOrPhenotypicFeature	hematomas	D006406
5939	19319147	1312	1315	ChemicalEntity	PCC	C025667
5940	19319147	1363	1366	ChemicalEntity	PCC	C025667
5941	19319147	1406	1407	ChemicalEntity	W	D014859
5942	19319147	1408	1411	DiseaseOrPhenotypicFeature	ICH	D002543
5943	19319147	1551	1556	OrganismTaxon	human	9606
5944	19319147	1557	1558	ChemicalEntity	W	D014859
5945	19319147	1559	1562	DiseaseOrPhenotypicFeature	ICH	D002543
5946	19346865	11	37	DiseaseOrPhenotypicFeature	inferior colliculus lesion	D001927
5947	19346865	41	54	ChemicalEntity	metronidazole	D008795
5948	19346865	63	77	DiseaseOrPhenotypicFeature	encephalopathy	D001927
5949	19346865	219	246	DiseaseOrPhenotypicFeature	inferior colliculus lesions	D001927
5950	19346865	250	263	ChemicalEntity	metronidazole	D008795
5951	19346865	272	286	DiseaseOrPhenotypicFeature	encephalopathy	D001927
5952	19346865	457	465	OrganismTaxon	patients	9606
5953	19346865	469	472	OrganismTaxon	men	9606
5954	19346865	479	484	OrganismTaxon	women	9606
5955	19346865	511	524	ChemicalEntity	metronidazole	D008795
5956	19346865	533	547	DiseaseOrPhenotypicFeature	encephalopathy	D001927
5957	19346865	595	608	ChemicalEntity	metronidazole	D008795
5958	19346865	678	687	DiseaseOrPhenotypicFeature	infection	D007239
5959	19346865	941	949	OrganismTaxon	patients	9606
5960	19346865	999	1012	ChemicalEntity	metronidazole	D008795
5961	19346865	1603	1610	OrganismTaxon	patient	9606
5962	19346865	1826	1834	OrganismTaxon	patients	9606
5963	19346865	1845	1852	OrganismTaxon	patient	9606
5964	19346865	1869	1884	DiseaseOrPhenotypicFeature	callosal lesion	D001927
5965	19346865	1920	1947	DiseaseOrPhenotypicFeature	inferior colliculus lesions	D001927
5966	19346865	1994	2007	ChemicalEntity	metronidazole	D008795
5967	19346865	2016	2030	DiseaseOrPhenotypicFeature	encephalopathy	D001927
5968	19365571	0	25	DiseaseOrPhenotypicFeature	Macular corneal dystrophy	D003317
5969	19365571	78	83	GeneOrGeneProduct	CHST6	4166
5970	19365571	123	157	GeneOrGeneProduct	carbohydrate sulfotransferase gene	4166
5971	19365571	159	164	GeneOrGeneProduct	CHST6	4166
5972	19365571	192	217	DiseaseOrPhenotypicFeature	macular corneal dystrophy	D003317
5973	19365571	219	222	DiseaseOrPhenotypicFeature	MCD	D003317
5974	19365571	649	654	GeneOrGeneProduct	CHST6	4166
5975	19365571	846	850	ChemicalEntity	iron	D007501
5976	19365571	1117	1125	SequenceVariant	c.892C>T	c|SUB|C|892|T
5977	19365571	1130	1139	SequenceVariant	c.1072T>C	c|SUB|T|1072|C
5978	19365571	1170	1175	GeneOrGeneProduct	CHST6	4166
5979	19365571	1185	1193	OrganismTaxon	patients	9606
5980	19365571	1251	1288	SequenceVariant	stop codon for glutamine at codon 298	p|SUB|Q|298|X
5981	19365571	1290	1297	SequenceVariant	p.Q298X	p|SUB|Q|298|X
5982	19365571	1326	1358	SequenceVariant	codon 358, tyrosine to histidine	p|SUB|Y|358|H
5983	19365571	1360	1367	SequenceVariant	p.Y358H	p|SUB|Y|358|H
5984	19365571	1625	1630	GeneOrGeneProduct	CHST6	4166
5985	19365571	1682	1697	ChemicalEntity	keratan sulfate	D007632
5986	19365571	1699	1701	ChemicalEntity	KS	D007632
5987	19365571	1825	1833	GeneOrGeneProduct	collagen	1277
5988	19370764	76	134	GeneOrGeneProduct	UDP-N-acetylglucosamine-1-phosphotransferase gamma subunit	84572
5989	19370764	136	141	GeneOrGeneProduct	GNPTG	84572
5990	19370764	151	159	OrganismTaxon	patients	9606
5991	19370764	165	188	DiseaseOrPhenotypicFeature	mucolipidosis III gamma	C565367
5992	19370764	190	212	DiseaseOrPhenotypicFeature	Mucolipidosis type III	D009081
5993	19370764	214	219	DiseaseOrPhenotypicFeature	MLIII	D009081
5994	19370764	227	255	DiseaseOrPhenotypicFeature	autosomal recessive disorder	D030342
5995	19370764	316	324	OrganismTaxon	patients	9606
5996	19370764	398	403	DiseaseOrPhenotypicFeature	MLIII	D009081
5997	19370764	415	420	GeneOrGeneProduct	GNPTG	84572
5998	19370764	478	485	SequenceVariant	p.T286M	rs193302860
5999	19370764	501	508	SequenceVariant	p.W111X	rs137852884
6000	19370764	553	568	SequenceVariant	AG-dinucleotide	rs193302855
6001	19370764	607	617	SequenceVariant	c.610-2A>G	rs193302855
6002	19370764	677	686	SequenceVariant	c.611delG	rs193302856
6003	19370764	691	705	SequenceVariant	c.640_667del28	rs193302859
6004	19370764	758	776	SequenceVariant	c.609+28_610-16del	c|DEL|609+28_610-16|
6005	19370764	839	849	SequenceVariant	c.610-2A>G	rs193302855
6006	19370764	1005	1019	SequenceVariant	p.G204_K247del	p|DEL|204_247|
6007	19370764	1058	1070	SequenceVariant	p.G204VfsX28	p|FS|G|204|V|28
6008	19370764	1105	1112	OrganismTaxon	patient	9606
6009	19370764	1151	1169	SequenceVariant	c.609+28_610-16del	c|DEL|609+28_610-16|
6010	19370764	1193	1198	GeneOrGeneProduct	GNPTG	84572
6011	19370764	1237	1255	SequenceVariant	c.609+28_610-16del	c|DEL|609+28_610-16|
6012	19370764	1335	1342	OrganismTaxon	patient	9606
6013	19370764	1407	1417	ChemicalEntity	anisomycin	D000841
6014	19370764	1512	1534	SequenceVariant	33-bp genomic deletion	g|DEL||33
6015	19370764	1584	1589	GeneOrGeneProduct	GNPTG	84572
6016	19370764	1656	1668	SequenceVariant	p.G204VfsX17	p|FS|G|204|V|17
6017	19370764	1721	1726	GeneOrGeneProduct	GNPTG	84572
6018	19370764	2083	2088	GeneOrGeneProduct	GNPTG	84572
6019	19394258	18	23	GeneOrGeneProduct	DGUOK	1716
6020	19394258	49	100	DiseaseOrPhenotypicFeature	hepatocerebral mitochondrial DNA depletion syndrome	C580039
6021	19394258	102	140	DiseaseOrPhenotypicFeature	Deoxyguanosine kinase (dGK) deficiency	C580039
6022	19394258	164	191	DiseaseOrPhenotypicFeature	mitochondrial DNA depletion	C580039
6023	19394258	297	302	GeneOrGeneProduct	DGUOK	1716
6024	19394258	368	373	GeneOrGeneProduct	DGUOK	1716
6025	19394258	374	382	OrganismTaxon	patients	9606
6026	19394258	393	398	GeneOrGeneProduct	DGUOK	1716
6027	19394258	420	431	SequenceVariant	c.444-62C>A	c|SUB|C|444-62|A
6028	19394258	457	465	OrganismTaxon	patients	9606
6029	19394258	527	557	DiseaseOrPhenotypicFeature	respiratory chain deficiencies	D028361
6030	19394258	562	589	DiseaseOrPhenotypicFeature	mitochondrial DNA depletion	C580039
6031	19394258	629	634	GeneOrGeneProduct	DGUOK	1716
6032	19394258	635	643	OrganismTaxon	patients	9606
6033	19394258	687	720	DiseaseOrPhenotypicFeature	subtentorial abnormal myelination	-
6034	19394258	725	748	DiseaseOrPhenotypicFeature	moderate hyperintensity	D006973
6035	19394258	781	789	OrganismTaxon	patients	9606
6036	19394258	1116	1119	GeneOrGeneProduct	dGK	1716
6037	19394258	1179	1199	ChemicalEntity	deoxyribonucleosides	D003853
6038	19394258	1406	1411	GeneOrGeneProduct	DGUOK	1716
6039	19394258	1450	1455	GeneOrGeneProduct	DGUOK	1716
6040	19394258	1530	1533	GeneOrGeneProduct	dGK	1716
6041	19445921	27	45	ChemicalEntity	salvianolic acid A	C066201
6042	19445921	49	62	ChemicalEntity	isoproterenol	D007545
6043	19445921	71	92	DiseaseOrPhenotypicFeature	myocardial infarction	D009203
6044	19445921	96	100	OrganismTaxon	rats	10116
6045	19445921	179	197	ChemicalEntity	salvianolic acid A	C066201
6046	19445921	201	214	ChemicalEntity	isoproterenol	D007545
6047	19445921	223	244	DiseaseOrPhenotypicFeature	myocardial infarction	D009203
6048	19445921	248	252	OrganismTaxon	rats	10116
6049	19445921	556	569	ChemicalEntity	Isoproterenol	D007545
6050	19445921	578	582	OrganismTaxon	rats	10116
6051	19445921	629	650	GeneOrGeneProduct	lactate dehydrogenase	24533
6052	19445921	652	674	GeneOrGeneProduct	aspartate transaminase	25721
6053	19445921	676	691	GeneOrGeneProduct	creatine kinase	24264
6054	19445921	696	711	ChemicalEntity	malondialdehyde	D008315
6055	19445921	759	779	GeneOrGeneProduct	superoxide dismutase	24786
6056	19445921	781	789	GeneOrGeneProduct	catalase	24248
6057	19445921	794	816	GeneOrGeneProduct	glutathione peroxidase	24404
6058	19445921	843	847	OrganismTaxon	rats	10116
6059	19445921	1059	1096	DiseaseOrPhenotypicFeature	mitochondrial respiratory dysfunction	D028361
6060	19445921	1154	1157	ChemicalEntity	ADP	D000244
6061	19445921	1176	1189	ChemicalEntity	isoproterenol	D007545
6062	19445921	1198	1202	OrganismTaxon	rats	10116
6063	19445921	1222	1240	ChemicalEntity	salvianolic acid A	C066201
6064	19445921	1289	1302	ChemicalEntity	isoproterenol	D007545
6065	19445921	1311	1330	DiseaseOrPhenotypicFeature	cardiac dysfunction	D006331
6066	19445921	1335	1352	DiseaseOrPhenotypicFeature	myocardial injury	D009202
6067	19445921	1425	1443	ChemicalEntity	salvianolic acid A	C066201
6068	19445921	1452	1465	ChemicalEntity	isoproterenol	D007545
6069	19445921	1474	1491	DiseaseOrPhenotypicFeature	myocardial damage	D009202
6070	19445921	1586	1604	ChemicalEntity	salvianolic acid A	C066201
6071	19445921	1681	1694	ChemicalEntity	isoproterenol	D007545
6072	19445921	1703	1724	DiseaseOrPhenotypicFeature	myocardial infarction	D009203
6073	19463742	0	23	GeneOrGeneProduct	Melanocortin-4 receptor	17202,25635,4160
6074	19463742	44	67	GeneOrGeneProduct	c-Jun N-terminal kinase	116554,26419,5599
6075	19463742	90	97	GeneOrGeneProduct	insulin	16333,24505,3630
6076	19463742	113	125	GeneOrGeneProduct	melanocortin	5443
6077	19463742	185	213	GeneOrGeneProduct	melanocortin receptor type 4	4160
6078	19463742	215	219	GeneOrGeneProduct	MC4R	4160
6079	19463742	231	238	GeneOrGeneProduct	insulin	3630
6080	19463742	264	287	GeneOrGeneProduct	c-Jun N-terminal kinase	5599
6081	19463742	289	292	GeneOrGeneProduct	JNK	5599
6082	19463742	299	311	GeneOrGeneProduct	melanocortin	5443
6083	19463742	320	327	ChemicalEntity	NDP-MSH	C027756
6084	19463742	355	358	GeneOrGeneProduct	JNK	5599
6085	19463742	371	377	CellLine	HEK293	9606
6086	19463742	406	411	OrganismTaxon	human	9606
6087	19463742	412	416	GeneOrGeneProduct	MC4R	4160
6088	19463742	443	464	GeneOrGeneProduct	melanocortin receptor	4160
6089	19463742	477	484	ChemicalEntity	NDP-MSH	C027756
6090	19463742	522	527	GeneOrGeneProduct	IRS-1	3667
6091	19463742	528	534	SequenceVariant	ser307	p|Allele|S|307
6092	19463742	589	610	GeneOrGeneProduct	melanocortin receptor	4160
6093	19463742	623	630	ChemicalEntity	NDP-MSH	C027756
6094	19463742	641	648	GeneOrGeneProduct	insulin	3630
6095	19463742	660	663	GeneOrGeneProduct	AKT	207
6096	19463742	694	706	GeneOrGeneProduct	melanocortin	5443
6097	19463742	715	727	ChemicalEntity	melanotan II	C079282
6098	19463742	738	745	GeneOrGeneProduct	insulin	24505
6099	19463742	757	760	GeneOrGeneProduct	AKT	24185
6100	19463742	784	787	OrganismTaxon	rat	10116
6101	19463742	810	817	ChemicalEntity	NDP-MSH	C027756
6102	19463742	828	835	GeneOrGeneProduct	insulin	16333
6103	19463742	847	854	ChemicalEntity	glucose	D005947
6104	19463742	878	883	CellLine	GT1-1	10090
6105	19463742	964	971	GeneOrGeneProduct	insulin	16333,24505,3630
6106	19463742	1003	1006	GeneOrGeneProduct	JNK	116554,26419,5599
6107	19484664	0	29	GeneOrGeneProduct	Angiotensin converting enzyme	1636
6108	19484664	59	68	DiseaseOrPhenotypicFeature	asthmatic	D001249
6109	19484664	69	77	OrganismTaxon	patients	9606
6110	19484664	79	85	DiseaseOrPhenotypicFeature	Asthma	D001249
6111	19484664	99	119	DiseaseOrPhenotypicFeature	inflammatory disease	D007249
6112	19484664	226	232	DiseaseOrPhenotypicFeature	asthma	D001249
6113	19484664	248	277	GeneOrGeneProduct	angiotensin converting enzyme	1636
6114	19484664	279	282	GeneOrGeneProduct	ACE	1636
6115	19484664	334	337	GeneOrGeneProduct	ACE	1636
6116	19484664	367	376	DiseaseOrPhenotypicFeature	asthmatic	D001249
6117	19484664	377	385	OrganismTaxon	patients	9606
6118	19484664	472	481	DiseaseOrPhenotypicFeature	asthmatic	D001249
6119	19484664	482	490	OrganismTaxon	patients	9606
6120	19484664	721	727	DiseaseOrPhenotypicFeature	asthma	D001249
6121	19484664	749	756	DiseaseOrPhenotypicFeature	atopism	C566404
6122	19484664	795	803	OrganismTaxon	patients	9606
6123	19484664	855	858	GeneOrGeneProduct	ACE	1636
6124	19484664	908	918	DiseaseOrPhenotypicFeature	asthmatics	D001249
6125	19484664	947	957	DiseaseOrPhenotypicFeature	asthmatics	D001249
6126	19484664	1184	1187	GeneOrGeneProduct	ACE	1636
6127	19484664	1232	1242	DiseaseOrPhenotypicFeature	asthmatics	D001249
6128	19484664	1279	1289	DiseaseOrPhenotypicFeature	Asthmatics	D001249
6129	19484664	1302	1305	GeneOrGeneProduct	ACE	1636
6130	19484664	1344	1358	DiseaseOrPhenotypicFeature	drug allergies	D004342
6131	19484664	1420	1430	DiseaseOrPhenotypicFeature	Asthmatics	D001249
6132	19484664	1491	1500	DiseaseOrPhenotypicFeature	asthmatic	D001249
6133	19484664	1530	1546	DiseaseOrPhenotypicFeature	viral infections	D001102
6134	19484664	1609	1617	OrganismTaxon	Patients	9606
6135	19484664	1647	1653	DiseaseOrPhenotypicFeature	asthma	D001249
6136	19484664	1733	1736	GeneOrGeneProduct	ACE	1636
6137	19484664	1765	1774	DiseaseOrPhenotypicFeature	asthmatic	D001249
6138	19484664	1775	1783	OrganismTaxon	patients	9606
6139	19484664	1802	1812	DiseaseOrPhenotypicFeature	asthmatics	D001249
6140	19484664	1835	1838	GeneOrGeneProduct	ACE	1636
6141	19484664	1882	1888	DiseaseOrPhenotypicFeature	asthma	D001249
6142	19508969	25	33	GeneOrGeneProduct	meckelin	91147
6143	19508969	35	39	GeneOrGeneProduct	MKS3	91147
6144	19508969	40	46	GeneOrGeneProduct	TMEM67	91147
6145	19508969	54	90	DiseaseOrPhenotypicFeature	nephronophthisis with liver fibrosis	OMIM:613550
6146	19508969	92	98	DiseaseOrPhenotypicFeature	NPHP11	OMIM:613550
6147	19508969	113	129	DiseaseOrPhenotypicFeature	Nephronophthisis	C537699
6148	19508969	131	135	DiseaseOrPhenotypicFeature	NPHP	C537699
6149	19508969	155	176	DiseaseOrPhenotypicFeature	cystic kidney disease	D052177
6150	19508969	216	237	DiseaseOrPhenotypicFeature	chronic renal failure	D007676
6151	19508969	293	300	GeneOrGeneProduct	NPHP1-9	23322,261734,27031,27130,284086,4867,80184,84662,9657
6152	19508969	324	328	DiseaseOrPhenotypicFeature	NPHP	C537699
6153	19508969	352	372	DiseaseOrPhenotypicFeature	retinal degeneration	D012162
6154	19508969	374	395	DiseaseOrPhenotypicFeature	Senior-Loken syndrome	C537580
6155	19508969	412	432	DiseaseOrPhenotypicFeature	cerebellar anomalies	D002526
6156	19508969	434	450	DiseaseOrPhenotypicFeature	Joubert syndrome	C536293
6157	19508969	456	470	DiseaseOrPhenotypicFeature	liver fibrosis	D008103
6158	19508969	528	536	OrganismTaxon	patients	9606
6159	19508969	553	567	DiseaseOrPhenotypicFeature	liver fibrosis	D008103
6160	19508969	667	675	OrganismTaxon	patients	9606
6161	19508969	915	919	GeneOrGeneProduct	MKS3	91147
6162	19508969	920	926	GeneOrGeneProduct	TMEM67	91147
6163	19508969	980	988	OrganismTaxon	patients	9606
6164	19508969	994	998	DiseaseOrPhenotypicFeature	NPHP	C537699
6165	19508969	1014	1028	DiseaseOrPhenotypicFeature	liver fibrosis	D008103
6166	19508969	1076	1083	SequenceVariant	p.W290L	rs267607117
6167	19508969	1085	1092	SequenceVariant	p.C615R	rs201893408
6168	19508969	1094	1101	SequenceVariant	p.G821S	rs267607116
6169	19508969	1107	1114	SequenceVariant	p.G821R	rs267607116
6170	19508969	1146	1150	GeneOrGeneProduct	MKS3	91147
6171	19508969	1151	1157	GeneOrGeneProduct	TMEM67	91147
6172	19508969	1177	1212	DiseaseOrPhenotypicFeature	Meckel-Gruber syndrome (MKS) type 3	C536132
6173	19508969	1217	1247	DiseaseOrPhenotypicFeature	Joubert syndrome (JBTS) type 6	C537689
6174	19508969	1333	1341	OrganismTaxon	patients	9606
6175	19508969	1347	1351	DiseaseOrPhenotypicFeature	NPHP	C537699
6176	19508969	1367	1381	DiseaseOrPhenotypicFeature	liver fibrosis	D008103
6177	19508969	1537	1540	DiseaseOrPhenotypicFeature	MKS	C536133
6178	19508969	1544	1548	DiseaseOrPhenotypicFeature	JBTS	C536293
6179	19508969	1596	1600	GeneOrGeneProduct	MKS3	91147
6180	19508969	1601	1607	GeneOrGeneProduct	TMEM67	91147
6181	19508969	1615	1623	OrganismTaxon	patients	9606
6182	19508969	1629	1633	DiseaseOrPhenotypicFeature	JBTS	C536293
6183	19508969	1689	1697	OrganismTaxon	patients	9606
6184	19508969	1743	1757	DiseaseOrPhenotypicFeature	liver fibrosis	D008103
6185	19508969	1784	1788	GeneOrGeneProduct	MKS3	91147
6186	19508969	1789	1795	GeneOrGeneProduct	TMEM67	91147
6187	19508969	1812	1836	DiseaseOrPhenotypicFeature	NPHP with liver fibrosis	OMIM:613550
6188	19508969	1838	1844	DiseaseOrPhenotypicFeature	NPHP11	OMIM:613550
6189	19508969	1875	1879	GeneOrGeneProduct	MKS3	91147
6190	19508969	1893	1901	OrganismTaxon	patients	9606
6191	19508969	1964	1968	DiseaseOrPhenotypicFeature	NPHP	C537699
6192	19508969	1970	1974	DiseaseOrPhenotypicFeature	JBTS	C536293
6193	19508969	1980	1983	DiseaseOrPhenotypicFeature	MKS	C536133
6194	19508969	1994	2011	DiseaseOrPhenotypicFeature	allelic disorders	D030342
6195	19536134	0	4	GeneOrGeneProduct	TAK1	26409
6196	19536134	34	37	GeneOrGeneProduct	BMP	12159
6197	19536134	63	89	GeneOrGeneProduct	TGFbeta activated kinase 1	26409
6198	19536134	91	95	GeneOrGeneProduct	TAK1	26409
6199	19536134	114	120	GeneOrGeneProduct	MAPKKK	26409
6200	19536134	288	292	GeneOrGeneProduct	TAK1	26409
6201	19536134	320	324	OrganismTaxon	mice	10090
6202	19536134	356	360	GeneOrGeneProduct	Tak1	26409
6203	19536134	375	385	GeneOrGeneProduct	collagen 2	12824
6204	19536134	396	400	GeneOrGeneProduct	Tak1	26409
6205	19536134	401	405	GeneOrGeneProduct	col2	12824
6206	19536134	407	411	OrganismTaxon	mice	10090
6207	19536134	429	445	DiseaseOrPhenotypicFeature	chondrodysplasia	D010009
6208	19536134	521	540	DiseaseOrPhenotypicFeature	joint abnormalities	D007592
6209	19536134	551	568	DiseaseOrPhenotypicFeature	elbow dislocation	D004204
6210	19536134	573	586	DiseaseOrPhenotypicFeature	tarsal fusion	D000070604
6211	19536134	621	664	GeneOrGeneProduct	bone morphogenetic protein receptor (BMPR)1	12166
6212	19536134	669	673	GeneOrGeneProduct	Gdf5	14563
6213	19536134	684	688	OrganismTaxon	mice	10090
6214	19536134	690	694	GeneOrGeneProduct	BMPR	12166
6215	19536134	731	735	GeneOrGeneProduct	TAK1	26409
6216	19536134	803	806	GeneOrGeneProduct	BMP	12159
6217	19536134	858	867	GeneOrGeneProduct	Smad1/5/8	17125,17129,55994
6218	19536134	872	875	GeneOrGeneProduct	p38	26416
6219	19536134	876	879	GeneOrGeneProduct	Jnk	26419
6220	19536134	880	883	GeneOrGeneProduct	Erk	26413
6221	19536134	884	895	GeneOrGeneProduct	MAP kinases	26413,26416,26419
6222	19536134	897	901	GeneOrGeneProduct	TAK1	26409
6223	19536134	911	916	GeneOrGeneProduct	Smad1	17125
6224	19536134	1041	1045	GeneOrGeneProduct	TAK1	26409
6225	19536134	1062	1065	GeneOrGeneProduct	BMP	12159
6226	19536134	1128	1137	GeneOrGeneProduct	Smad1/5/8	17125,17129,55994
6227	19536134	1182	1192	GeneOrGeneProduct	MAP kinase	26413,26416,26419
6228	19536134	1248	1252	GeneOrGeneProduct	TAK1	26409
6229	19549709	12	22	ChemicalEntity	everolimus	D000068338
6230	19549709	24	30	ChemicalEntity	RAD001	D000068338
6231	19549709	35	43	OrganismTaxon	patients	9606
6232	19549709	58	63	DiseaseOrPhenotypicFeature	NSCLC	D002289
6233	19549709	132	136	GeneOrGeneProduct	EGFR	1956
6234	19549709	213	239	DiseaseOrPhenotypicFeature	non-small-cell lung cancer	D002289
6235	19549709	241	246	DiseaseOrPhenotypicFeature	NSCLC	D002289
6236	19549709	248	256	OrganismTaxon	patients	9606
6237	19549709	258	264	ChemicalEntity	RAD001	D000068338
6238	19549709	291	320	GeneOrGeneProduct	mammalian target of rapamycin	2475
6239	19549709	322	326	GeneOrGeneProduct	mTOR	2475
6240	19549709	359	364	DiseaseOrPhenotypicFeature	NSCLC	D002289
6241	19549709	392	397	DiseaseOrPhenotypicFeature	NSCLC	D002289
6242	19549709	398	406	OrganismTaxon	patients	9606
6243	19549709	459	467	ChemicalEntity	platinum	D010984
6244	19549709	511	559	GeneOrGeneProduct	epidermal growth factor receptor tyrosine kinase	1956
6245	19549709	593	599	ChemicalEntity	RAD001	D000068338
6246	19549709	644	652	DiseaseOrPhenotypicFeature	toxicity	D064420
6247	19549709	745	749	GeneOrGeneProduct	mTOR	2475
6248	19549709	787	792	DiseaseOrPhenotypicFeature	tumor	D009369
6249	19549709	895	903	OrganismTaxon	patients	9606
6250	19549709	1164	1171	DiseaseOrPhenotypicFeature	fatigue	D005221
6251	19549709	1173	1180	DiseaseOrPhenotypicFeature	dyspnea	D004417
6252	19549709	1182	1192	DiseaseOrPhenotypicFeature	stomatitis	D013280
6253	19549709	1194	1200	DiseaseOrPhenotypicFeature	anemia	D000740
6254	19549709	1206	1222	DiseaseOrPhenotypicFeature	thrombocytopenia	D013921
6255	19549709	1224	1235	DiseaseOrPhenotypicFeature	Pneumonitis	D011014
6256	19549709	1364	1367	GeneOrGeneProduct	AKT	207
6257	19549709	1369	1373	GeneOrGeneProduct	pAKT	207
6258	19549709	1442	1448	ChemicalEntity	RAD001	D000068338
6259	19549709	1526	1531	DiseaseOrPhenotypicFeature	NSCLC	D002289
6260	19549709	1547	1553	ChemicalEntity	RAD001	D000068338
6261	19549709	1591	1596	DiseaseOrPhenotypicFeature	NSCLC	D002289
6262	19565319	0	24	GeneOrGeneProduct	Adenosine A(2A) receptor	135
6263	19565319	31	38	GeneOrGeneProduct	ADORA2A	135
6264	19565319	62	79	DiseaseOrPhenotypicFeature	autistic symptoms	D001321
6265	19565319	84	91	DiseaseOrPhenotypicFeature	anxiety	D001008
6266	19565319	95	119	DiseaseOrPhenotypicFeature	autism spectrum disorder	D000067877
6267	19565319	121	146	DiseaseOrPhenotypicFeature	Autism spectrum disorders	D000067877
6268	19565319	148	152	DiseaseOrPhenotypicFeature	ASDs	D000067877
6269	19565319	217	224	DiseaseOrPhenotypicFeature	anxiety	D001008
6270	19565319	230	254	GeneOrGeneProduct	adenosine A(2A) receptor	135
6271	19565319	261	268	GeneOrGeneProduct	ADORA2A	135
6272	19565319	289	303	DiseaseOrPhenotypicFeature	panic disorder	D016584
6273	19565319	365	389	GeneOrGeneProduct	adenosine A(2A) receptor	135
6274	19565319	463	466	DiseaseOrPhenotypicFeature	ASD	D000067877
6275	19565319	471	488	DiseaseOrPhenotypicFeature	autistic symptoms	D001321
6276	19565319	523	548	DiseaseOrPhenotypicFeature	22q11.2 deletion syndrome	D004062
6277	19565319	560	577	DiseaseOrPhenotypicFeature	22q11.2 deletions	D004062
6278	19565319	617	620	DiseaseOrPhenotypicFeature	ASD	D000067877
6279	19565319	669	672	DiseaseOrPhenotypicFeature	ASD	D000067877
6280	19565319	761	768	GeneOrGeneProduct	ADORA2A	135
6281	19565319	825	834	SequenceVariant	rs2236624	rs2236624
6282	19565319	869	872	DiseaseOrPhenotypicFeature	ASD	D000067877
6283	19565319	900	909	SequenceVariant	rs3761422	rs3761422
6284	19565319	911	920	SequenceVariant	rs5751876	rs5751876
6285	19565319	925	935	SequenceVariant	rs35320474	rs35320474
6286	19565319	965	972	GeneOrGeneProduct	ADORA2A	135
6287	19565319	987	994	DiseaseOrPhenotypicFeature	anxiety	D001008
6288	19565319	1031	1034	DiseaseOrPhenotypicFeature	ASD	D000067877
6289	19565319	1087	1094	GeneOrGeneProduct	ADORA2A	135
6290	19565319	1132	1135	DiseaseOrPhenotypicFeature	ASD	D000067877
6291	19624920	32	58	OrganismTaxon	Mycobacterium tuberculosis	1773
6292	19624920	100	132	DiseaseOrPhenotypicFeature	multidrug-resistant tuberculosis	D018088
6293	19624920	134	140	DiseaseOrPhenotypicFeature	MDR TB	D018088
6294	19624920	207	213	DiseaseOrPhenotypicFeature	MDR TB	D018088
6295	19624920	347	353	DiseaseOrPhenotypicFeature	MDR TB	D018088
6296	19624920	482	488	DiseaseOrPhenotypicFeature	MDR TB	D018088
6297	19631624	0	28	DiseaseOrPhenotypicFeature	Learning and memory deficits	D007859,D008569
6298	19631624	32	39	ChemicalEntity	ecstasy	D018817
6299	19631624	139	146	ChemicalEntity	ecstasy	D018817
6300	19631624	161	195	DiseaseOrPhenotypicFeature	impairments in learning and memory	D007859,D008569
6301	19631624	251	258	ChemicalEntity	ecstasy	D018817
6302	19631624	616	623	ChemicalEntity	ecstasy	D018817
6303	19631624	693	701	ChemicalEntity	cannabis	D002188
6304	19631624	713	720	ChemicalEntity	ecstasy	D018817
6305	19631624	782	790	ChemicalEntity	cannabis	D002188
6306	19631624	854	885	DiseaseOrPhenotypicFeature	Deficits in learning and memory	D007859,D008569
6307	19631624	903	916	DiseaseOrPhenotypicFeature	hyperactivity	D006948
6308	19631624	952	960	ChemicalEntity	cannabis	D002188
6309	19631624	995	1002	ChemicalEntity	Ecstasy	D018817
6310	19631624	1087	1095	ChemicalEntity	cannabis	D002188
6311	19631624	1179	1186	ChemicalEntity	ecstasy	D018817
6312	19631624	1196	1209	DiseaseOrPhenotypicFeature	hyperactivity	D006948
6313	19631624	1330	1337	ChemicalEntity	Ecstasy	D018817
6314	19631624	1471	1478	ChemicalEntity	ecstasy	D018817
6315	19631624	1483	1491	ChemicalEntity	cannabis	D002188
6316	19631624	1665	1672	ChemicalEntity	ecstasy	D018817
6317	19631624	1733	1741	ChemicalEntity	cannabis	D002188
6318	19631624	1753	1760	ChemicalEntity	ecstasy	D018817
6319	19631624	1861	1871	DiseaseOrPhenotypicFeature	neurotoxic	D020258
6320	19631624	1883	1890	ChemicalEntity	ecstasy	D018817
6321	19672862	0	22	GeneOrGeneProduct	Protein kinase C alpha	5578
6322	19672862	52	70	DiseaseOrPhenotypicFeature	endometrial cancer	D016889
6323	19672862	87	100	DiseaseOrPhenotypicFeature	tumorigenesis	D009369
6324	19672862	102	120	DiseaseOrPhenotypicFeature	Endometrial cancer	D016889
6325	19672862	149	171	DiseaseOrPhenotypicFeature	gynecologic malignancy	D005833
6326	19672862	340	356	GeneOrGeneProduct	protein kinase C	5578
6327	19672862	358	361	GeneOrGeneProduct	PKC	5578
6328	19672862	372	380	GeneOrGeneProduct	PKCalpha	5578
6329	19672862	414	440	DiseaseOrPhenotypicFeature	endometrial adenocarcinoma	D016889
6330	19672862	442	450	CellLine	Ishikawa	9606
6331	19672862	469	477	GeneOrGeneProduct	PKCalpha	5578
6332	19672862	593	598	DiseaseOrPhenotypicFeature	tumor	D009369
6333	19672862	617	621	OrganismTaxon	mice	10090
6334	19672862	656	664	GeneOrGeneProduct	PKCalpha	5578
6335	19672862	699	722	GeneOrGeneProduct	cyclin-dependent kinase	983
6336	19672862	724	727	GeneOrGeneProduct	CDK	983
6337	19672862	740	743	GeneOrGeneProduct	p21	1026
6338	19672862	744	748	GeneOrGeneProduct	Cip1	1026
6339	19672862	749	753	GeneOrGeneProduct	WAF1	1026
6340	19672862	756	759	GeneOrGeneProduct	p21	1026
6341	19672862	765	768	GeneOrGeneProduct	p27	1027
6342	19672862	769	773	GeneOrGeneProduct	Kip1	1027
6343	19672862	776	779	GeneOrGeneProduct	p27	1027
6344	19672862	816	846	GeneOrGeneProduct	phosphatase and tensin homolog	5728
6345	19672862	848	852	GeneOrGeneProduct	PTEN	5728
6346	19672862	865	873	CellLine	Ishikawa	9606
6347	19672862	881	889	GeneOrGeneProduct	PKCalpha	5578
6348	19672862	908	911	GeneOrGeneProduct	Akt	207
6349	19672862	931	941	SequenceVariant	serine 473	p|Allele|S|473
6350	19672862	993	996	GeneOrGeneProduct	Akt	207
6351	19672862	1005	1035	GeneOrGeneProduct	glycogen synthase kinase-3beta	2932
6352	19672862	1037	1046	GeneOrGeneProduct	GSK-3beta	2932
6353	19672862	1049	1057	GeneOrGeneProduct	PKCalpha	5578
6354	19672862	1101	1104	GeneOrGeneProduct	ERK	5594
6355	19672862	1136	1139	GeneOrGeneProduct	ERK	5594
6356	19672862	1161	1164	GeneOrGeneProduct	EGF	1950
6357	19672862	1178	1181	GeneOrGeneProduct	p21	1026
6358	19672862	1186	1189	GeneOrGeneProduct	p27	1027
6359	19672862	1235	1243	CellLine	Ishikawa	9606
6360	19672862	1255	1258	GeneOrGeneProduct	ERK	5594
6361	19672862	1263	1266	GeneOrGeneProduct	Akt	207
6362	19672862	1295	1303	GeneOrGeneProduct	PKCalpha	5578
6363	19672862	1314	1317	GeneOrGeneProduct	CDK	983
6364	19672862	1346	1349	GeneOrGeneProduct	Akt	207
6365	19672862	1354	1357	GeneOrGeneProduct	ERK	5594
6366	19672862	1399	1426	DiseaseOrPhenotypicFeature	endometrioid adenocarcinoma	D016889
6367	19672862	1445	1453	GeneOrGeneProduct	PKCalpha	5578
6368	19672862	1488	1496	GeneOrGeneProduct	PKCalpha	5578
6369	19672862	1589	1597	GeneOrGeneProduct	PKCalpha	5578
6370	19672862	1623	1636	DiseaseOrPhenotypicFeature	tumorigenesis	D009369
6371	19672862	1665	1668	GeneOrGeneProduct	CDK	983
6372	19672862	1680	1683	GeneOrGeneProduct	p21	1026
6373	19672862	1688	1691	GeneOrGeneProduct	p27	1027
6374	19672862	1710	1713	GeneOrGeneProduct	Akt	207
6375	19672862	1718	1721	GeneOrGeneProduct	ERK	5594
6376	19672862	1772	1780	GeneOrGeneProduct	PKCalpha	5578
6377	19672862	1822	1840	DiseaseOrPhenotypicFeature	endometrial tumors	D016889
6378	19681452	10	56	DiseaseOrPhenotypicFeature	haemorrhagic infarction of the globus pallidus	D002543,D020520
6379	19681452	63	70	ChemicalEntity	cocaine	D003042
6380	19681452	75	82	ChemicalEntity	alcohol	D000431
6381	19681452	97	104	ChemicalEntity	Cocaine	D003042
6382	19681452	131	163	DiseaseOrPhenotypicFeature	ischemic and haemorrhagic stroke	D002544,D020521
6383	19681452	202	205	OrganismTaxon	man	9606
6384	19681452	221	252	DiseaseOrPhenotypicFeature	ischemia of the globus pallidus	D002545
6385	19681452	269	276	ChemicalEntity	alcohol	D000431
6386	19681452	292	299	ChemicalEntity	cocaine	D003042
6387	19681452	318	345	DiseaseOrPhenotypicFeature	globus pallidus infarctions	D020520
6388	19681452	377	383	ChemicalEntity	heroin	D003932
6389	19681452	395	417	DiseaseOrPhenotypicFeature	basal ganglia infarcts	D020520
6390	19681452	435	442	ChemicalEntity	cocaine	D003042
6391	19681452	463	469	ChemicalEntity	heroin	D003932
6392	19681452	508	515	OrganismTaxon	patient	9606
6393	19681452	527	545	DiseaseOrPhenotypicFeature	cardiac arrhythmia	D001145
6394	19681452	549	572	DiseaseOrPhenotypicFeature	respiratory dysfunction	D012131
6395	19681452	584	591	ChemicalEntity	cocaine	D003042
6396	19681452	599	606	ChemicalEntity	ethanol	D000431
6397	19681452	642	664	DiseaseOrPhenotypicFeature	cerebral hypoperfusion	D002545
6398	19707748	0	8	DiseaseOrPhenotypicFeature	Seizures	D012640
6399	19707748	25	37	ChemicalEntity	levofloxacin	D064704
6400	19707748	112	119	OrganismTaxon	patient	9606
6401	19707748	134	142	DiseaseOrPhenotypicFeature	seizures	D012640
6402	19707748	183	195	ChemicalEntity	levofloxacin	D064704
6403	19707748	277	302	GeneOrGeneProduct	cytochrome P450 (CYP) 1A2	1544
6404	19707748	347	359	ChemicalEntity	levofloxacin	D064704
6405	19707748	368	376	DiseaseOrPhenotypicFeature	seizures	D012640
6406	19707748	520	532	ChemicalEntity	levofloxacin	D064704
6407	19707748	612	624	ChemicalEntity	levofloxacin	D064704
6408	19707748	633	641	DiseaseOrPhenotypicFeature	seizures	D012640
6409	19707748	732	738	GeneOrGeneProduct	CYP1A2	1544
6410	19707748	742	754	ChemicalEntity	levofloxacin	D064704
6411	19707748	891	903	ChemicalEntity	levofloxacin	D064704
6412	19707748	915	923	OrganismTaxon	patients	9606
6413	19707748	982	988	GeneOrGeneProduct	CYP1A2	1544
6414	19721134	59	70	ChemicalEntity	pilocarpine	D010862
6415	19721134	140	151	ChemicalEntity	pilocarpine	D010862
6416	19721134	207	216	ChemicalEntity	aconitine	D000157
6417	19721134	225	228	OrganismTaxon	rat	10116
6418	19721134	233	240	ChemicalEntity	ouabain	D010042
6419	19721134	249	259	OrganismTaxon	guinea pig	10141
6420	19721134	260	270	DiseaseOrPhenotypicFeature	arrhythmia	D001145
6421	19721134	338	345	ChemicalEntity	calcium	D002118
6422	19721134	363	369	ChemicalEntity	Ca(2+)	D002118
6423	19721134	426	437	ChemicalEntity	pilocarpine	D010862
6424	19721134	469	480	DiseaseOrPhenotypicFeature	arrhythmias	D001145
6425	19721134	511	551	DiseaseOrPhenotypicFeature	ventricular tachycardia and fibrillation	D017180|D014693
6426	19721134	561	571	DiseaseOrPhenotypicFeature	arrhythmia	D001145
6427	19721134	614	624	DiseaseOrPhenotypicFeature	arrhythmic	D001145
6428	19721134	625	629	OrganismTaxon	rats	10116
6429	19721134	634	645	OrganismTaxon	guinea pigs	10141
6430	19721134	648	654	ChemicalEntity	Ca(2+)	D002118
6431	19721134	679	688	ChemicalEntity	aconitine	D000157
6432	19721134	692	699	ChemicalEntity	ouabain	D010042
6433	19721134	749	760	ChemicalEntity	pilocarpine	D010862
6434	19721134	772	810	GeneOrGeneProduct	M(3)-muscarinic acetylcholine receptor	100379235,24260
6435	19721134	812	817	GeneOrGeneProduct	mAChR	100379235,24260
6436	19721134	830	836	ChemicalEntity	4-DAMP	C042375
6437	19721134	838	885	ChemicalEntity	4-diphenylacetoxy-N-methylpiperidine-methiodide	C042375
6438	19721134	933	944	ChemicalEntity	pilocarpine	D010862
6439	19721134	970	981	ChemicalEntity	pilocarpine	D010862
6440	19721134	1017	1027	DiseaseOrPhenotypicFeature	arrhythmic	D001145
6441	19721134	1028	1031	OrganismTaxon	rat	10116
6442	19721134	1036	1046	OrganismTaxon	guinea pig	10141
6443	19721134	1065	1074	ChemicalEntity	aconitine	D000157
6444	19721134	1078	1085	ChemicalEntity	ouabain	D010042
6445	19721134	1114	1124	GeneOrGeneProduct	M(3)-mAChR	100379235,24260
6446	19721134	1177	1183	ChemicalEntity	Ca(2+)	D002118
6447	19759529	4	25	GeneOrGeneProduct	glycine transporter-1	14664
6448	19759529	36	45	ChemicalEntity	SSR103800	-1
6449	19759529	132	136	OrganismTaxon	mice	10090
6450	19759529	138	151	DiseaseOrPhenotypicFeature	Schizophrenia	D012559
6451	19759529	202	210	ChemicalEntity	dopamine	D004298
6452	19759529	279	325	GeneOrGeneProduct	glutamate N-methyl-D-aspartate (NMDA) receptor	14810
6453	19759529	334	347	DiseaseOrPhenotypicFeature	schizophrenic	D012559
6454	19759529	365	371	OrganismTaxon	humans	9606
6455	19759529	448	461	GeneOrGeneProduct	NMDA receptor	14810
6456	19759529	667	680	GeneOrGeneProduct	NMDA receptor	14810
6457	19759529	697	718	GeneOrGeneProduct	glycine transporter-1	14664
6458	19759529	720	725	GeneOrGeneProduct	GlyT1	14664
6459	19759529	746	755	ChemicalEntity	SSR103800	-1
6460	19759529	782	795	GeneOrGeneProduct	NMDA receptor	14810
6461	19759529	823	830	ChemicalEntity	glycine	D005998
6462	19759529	853	866	GeneOrGeneProduct	NMDA receptor	14810
6463	19759529	972	981	ChemicalEntity	SSR103800	-1
6464	19759529	1020	1033	DiseaseOrPhenotypicFeature	hyperactivity	D006948
6465	19759529	1072	1083	ChemicalEntity	amphetamine	D000661
6466	19759529	1088	1094	ChemicalEntity	MK-801	D016291
6467	19759529	1110	1114	OrganismTaxon	mice	10090
6468	19759529	1120	1128	GeneOrGeneProduct	NMDA Nr1	14810
6469	19759529	1141	1144	GeneOrGeneProduct	DAT	13162
6470	19759529	1172	1181	ChemicalEntity	SSR103800	-1
6471	19759529	1209	1222	DiseaseOrPhenotypicFeature	hyperactivity	D006948
6472	19759529	1254	1267	GeneOrGeneProduct	NMDA receptor	14810
6473	19759529	1280	1286	ChemicalEntity	MK-801	D016291
6474	19759529	1322	1335	DiseaseOrPhenotypicFeature	hyperactivity	D006948
6475	19759529	1339	1347	GeneOrGeneProduct	NMDA Nr1	14810
6476	19759529	1356	1360	OrganismTaxon	mice	10090
6477	19759529	1375	1384	ChemicalEntity	SSR103800	-1
6478	19759529	1402	1415	DiseaseOrPhenotypicFeature	hyperactivity	D006948
6479	19759529	1427	1438	ChemicalEntity	amphetamine	D000661
6480	19759529	1464	1484	GeneOrGeneProduct	dopamine transporter	13162
6481	19759529	1486	1489	GeneOrGeneProduct	DAT	13162
6482	19759529	1505	1509	OrganismTaxon	mice	10090
6483	19759529	1559	1570	ChemicalEntity	haloperidol	D006220
6484	19759529	1586	1596	ChemicalEntity	olanzapine	C076029
6485	19759529	1598	1607	ChemicalEntity	clozapine	D003024
6486	19759529	1612	1624	ChemicalEntity	aripiprazole	C094645
6487	19759529	1679	1692	DiseaseOrPhenotypicFeature	hyperactivity	D006948
6488	19759529	1724	1733	ChemicalEntity	SSR103800	-1
6489	19759529	1750	1759	DiseaseOrPhenotypicFeature	catalepsy	D002375
6490	19759529	1846	1851	GeneOrGeneProduct	GlyT1	14664
6491	19759529	1863	1872	ChemicalEntity	SSR103800	-1
6492	19759529	1983	1995	ChemicalEntity	dopaminergic	D004298
6493	19779499	6	13	GeneOrGeneProduct	CACNA1S	779
6494	19779499	49	79	DiseaseOrPhenotypicFeature	hypokalemic periodic paralysis	D020514
6495	19779499	108	139	DiseaseOrPhenotypicFeature	Hypokalaemic periodic paralysis	D020514
6496	19779499	141	147	DiseaseOrPhenotypicFeature	HypoPP	D020514
6497	19779499	155	182	DiseaseOrPhenotypicFeature	autosomal dominant disorder	D030342
6498	19779499	230	245	DiseaseOrPhenotypicFeature	muscle weakness	D018908
6499	19779499	286	295	ChemicalEntity	potassium	D011188
6500	19779499	336	342	DiseaseOrPhenotypicFeature	HypoPP	D020514
6501	19779499	366	373	GeneOrGeneProduct	CACNA1S	779
6502	19779499	393	438	GeneOrGeneProduct	skeletal muscle calcium channel alpha-subunit	779
6503	19779499	538	545	GeneOrGeneProduct	CACNA1S	779
6504	19779499	570	576	DiseaseOrPhenotypicFeature	HypoPP	D020514
6505	19779499	577	585	OrganismTaxon	patients	9606
6506	19779499	668	675	GeneOrGeneProduct	CACNA1S	779
6507	19779499	809	815	DiseaseOrPhenotypicFeature	HypoPP	D020514
6508	19779499	853	858	SequenceVariant	V876E	rs267606698
6509	19779499	875	881	DiseaseOrPhenotypicFeature	HypoPP	D020514
6510	19779499	882	890	OrganismTaxon	patients	9606
6511	19779499	1004	1009	SequenceVariant	V876E	rs267606698
6512	19779499	1146	1151	DiseaseOrPhenotypicFeature	death	D003643
6513	19779499	1194	1201	GeneOrGeneProduct	CACNA1S	779
6514	19779499	1229	1236	GeneOrGeneProduct	CACNA1S	779
6515	19779499	1263	1269	DiseaseOrPhenotypicFeature	HypoPP	D020514
6516	19789368	0	18	GeneOrGeneProduct	Vitamin D receptor	7421
6517	19789368	49	55	GeneOrGeneProduct	PIK3CA	5290
6518	19789368	60	64	GeneOrGeneProduct	KRAS	3845
6519	19789368	78	95	DiseaseOrPhenotypicFeature	colorectal cancer	D015179
6520	19789368	97	106	ChemicalEntity	Vitamin D	D014807
6521	19789368	153	160	DiseaseOrPhenotypicFeature	cancers	D009369
6522	19789368	172	184	DiseaseOrPhenotypicFeature	colon cancer	D015179
6523	19789368	190	208	GeneOrGeneProduct	vitamin D receptor	7421
6524	19789368	210	213	GeneOrGeneProduct	VDR	7421
6525	19789368	348	351	GeneOrGeneProduct	VDR	7421
6526	19789368	360	363	GeneOrGeneProduct	RAS	3845
6527	19789368	364	396	GeneOrGeneProduct	mitogen-activated protein kinase	1432
6528	19789368	398	402	GeneOrGeneProduct	MAPK	1432
6529	19789368	407	436	GeneOrGeneProduct	phosphatidylinositol 3-kinase	5290
6530	19789368	438	442	GeneOrGeneProduct	PI3K	5290
6531	19789368	444	447	GeneOrGeneProduct	AKT	207
6532	19789368	508	511	GeneOrGeneProduct	VDR	7421
6533	19789368	548	554	GeneOrGeneProduct	PIK3CA	5290
6534	19789368	558	562	GeneOrGeneProduct	KRAS	3845
6535	19789368	601	619	DiseaseOrPhenotypicFeature	colorectal cancers	D015179
6536	19789368	665	671	DiseaseOrPhenotypicFeature	tumors	D009369
6537	19789368	679	682	GeneOrGeneProduct	VDR	7421
6538	19789368	739	745	GeneOrGeneProduct	PIK3CA	5290
6539	19789368	750	754	GeneOrGeneProduct	KRAS	3845
6540	19789368	950	957	GeneOrGeneProduct	CACNA1G	8913
6541	19789368	959	965	GeneOrGeneProduct	CDKN2A	1029
6542	19789368	967	970	GeneOrGeneProduct	p16	1029
6543	19789368	973	979	GeneOrGeneProduct	CRABP1	1381
6544	19789368	981	985	GeneOrGeneProduct	IGF2	3481
6545	19789368	987	991	GeneOrGeneProduct	MLH1	4292
6546	19789368	993	1000	GeneOrGeneProduct	NEUROG1	4762
6547	19789368	1002	1007	GeneOrGeneProduct	RUNX3	864
6548	19789368	1013	1018	GeneOrGeneProduct	SOCS1	8651
6549	19789368	1051	1054	GeneOrGeneProduct	VDR	7421
6550	19789368	1104	1108	GeneOrGeneProduct	KRAS	3845
6551	19789368	1177	1183	GeneOrGeneProduct	PIK3CA	5290
6552	19789368	1319	1322	GeneOrGeneProduct	VDR	7421
6553	19789368	1396	1413	DiseaseOrPhenotypicFeature	colorectal cancer	D015179
6554	19789368	1415	1420	DiseaseOrPhenotypicFeature	tumor	D009369
6555	19789368	1460	1465	DiseaseOrPhenotypicFeature	tumor	D009369
6556	19789368	1527	1531	GeneOrGeneProduct	BRAF	673
6557	19789368	1533	1536	GeneOrGeneProduct	p53	7157
6558	19789368	1538	1541	GeneOrGeneProduct	p21	1026
6559	19789368	1543	1555	GeneOrGeneProduct	beta-catenin	1499
6560	19789368	1560	1576	GeneOrGeneProduct	cyclooxygenase-2	5743
6561	19789368	1578	1581	GeneOrGeneProduct	VDR	7421
6562	19789368	1628	1635	OrganismTaxon	patient	9606
6563	19789368	1693	1696	GeneOrGeneProduct	VDR	7421
6564	19789368	1715	1732	DiseaseOrPhenotypicFeature	colorectal cancer	D015179
6565	19789368	1766	1772	GeneOrGeneProduct	PIK3CA	5290
6566	19789368	1777	1781	GeneOrGeneProduct	KRAS	3845
6567	19789368	1845	1848	GeneOrGeneProduct	VDR	7421
6568	19789368	1850	1853	GeneOrGeneProduct	RAS	3845
6569	19789368	1854	1858	GeneOrGeneProduct	MAPK	1432
6570	19789368	1863	1867	GeneOrGeneProduct	PI3K	5290
6571	19789368	1868	1871	GeneOrGeneProduct	AKT	207
6572	19789368	1908	1912	GeneOrGeneProduct	KRAS	3845
6573	19789368	1916	1922	GeneOrGeneProduct	PIK3CA	5290
6574	19789368	1972	1975	GeneOrGeneProduct	VDR	7421
6575	19825989	0	21	GeneOrGeneProduct	H3 histamine receptor	11255
6576	19825989	45	66	GeneOrGeneProduct	protein kinase Calpha	5578
6577	19825989	90	108	DiseaseOrPhenotypicFeature	cholangiocarcinoma	D018281
6578	19825989	131	140	ChemicalEntity	Histamine	D006632
6579	19825989	181	185	GeneOrGeneProduct	HRH1	3269
6580	19825989	187	191	GeneOrGeneProduct	HRH2	3274
6581	19825989	193	197	GeneOrGeneProduct	HRH3	11255
6582	19825989	203	207	GeneOrGeneProduct	HRH4	59340
6583	19825989	214	248	ChemicalEntity	d-myo-inositol 1,4,5-trisphosphate	D015544
6584	19825989	250	255	ChemicalEntity	IP(3)	D015544
6585	19825989	257	263	ChemicalEntity	Ca(2+)	D002118
6586	19825989	264	280	GeneOrGeneProduct	protein kinase C	5578
6587	19825989	282	285	GeneOrGeneProduct	PKC	5578
6588	19825989	287	319	GeneOrGeneProduct	mitogen-activated protein kinase	5594,5595
6589	19825989	338	356	DiseaseOrPhenotypicFeature	cholangiocarcinoma	D018281
6590	19825989	390	394	GeneOrGeneProduct	HRH3	11255
6591	19825989	416	434	DiseaseOrPhenotypicFeature	cholangiocarcinoma	D018281
6592	19825989	457	461	GeneOrGeneProduct	HRH3	11255
6593	19825989	534	539	OrganismTaxon	human	9606
6594	19825989	571	579	CellLine	Mz-ChA-1	9606
6595	19825989	602	648	ChemicalEntity	(R)-(alpha)-(-)-methylhistamine dihydrobromide	C069357
6596	19825989	650	654	ChemicalEntity	RAMH	C069357
6597	19825989	690	695	ChemicalEntity	IP(3)	D015544
6598	19825989	700	710	ChemicalEntity	cyclic AMP	D000242
6599	19825989	746	749	GeneOrGeneProduct	PKC	5578
6600	19825989	754	786	GeneOrGeneProduct	mitogen-activated protein kinase	5594,5595
6601	19825989	813	821	GeneOrGeneProduct	PKCalpha	5578
6602	19825989	897	905	GeneOrGeneProduct	PKCalpha	5578
6603	19825989	964	972	GeneOrGeneProduct	PKCalpha	5578
6604	19825989	974	982	CellLine	Mz-ChA-1	9606
6605	19825989	1010	1014	ChemicalEntity	RAMH	C069357
6606	19825989	1049	1096	GeneOrGeneProduct	extracellular signal-regulated kinase (ERK)-1/2	5595;5594
6607	19825989	1147	1153	CellLine	BALB/c	10090
6608	19825989	1159	1163	OrganismTaxon	mice	10090
6609	19825989	1165	1169	OrganismTaxon	Mice	10090
6610	19825989	1198	1202	ChemicalEntity	RAMH	C069357
6611	19825989	1219	1224	DiseaseOrPhenotypicFeature	tumor	D009369
6612	19825989	1246	1252	DiseaseOrPhenotypicFeature	Tumors	D009369
6613	19825989	1328	1336	GeneOrGeneProduct	PKCalpha	5578
6614	19825989	1338	1381	GeneOrGeneProduct	vascular endothelial growth factor (VEGF)-A	7422
6615	19825989	1383	1389	GeneOrGeneProduct	VEGF-C	7424
6616	19825989	1391	1406	GeneOrGeneProduct	VEGF receptor 2	3791
6617	19825989	1412	1427	GeneOrGeneProduct	VEGF receptor 3	2324
6618	19825989	1429	1433	GeneOrGeneProduct	HRH3	11255
6619	19825989	1469	1473	ChemicalEntity	RAMH	C069357
6620	19825989	1498	1516	DiseaseOrPhenotypicFeature	cholangiocarcinoma	D018281
6621	19825989	1524	1528	ChemicalEntity	RAMH	C069357
6622	19825989	1539	1544	ChemicalEntity	IP(3)	D015544
6623	19825989	1556	1564	GeneOrGeneProduct	PKCalpha	5578
6624	19825989	1595	1601	GeneOrGeneProduct	ERK1/2	5595;5594
6625	19825989	1619	1623	ChemicalEntity	RAMH	C069357
6626	19825989	1663	1671	GeneOrGeneProduct	PKCalpha	5578
6627	19825989	1737	1745	CellLine	Mz-ChA-1	9606
6628	19825989	1766	1774	GeneOrGeneProduct	PKCalpha	5578
6629	19825989	1785	1789	ChemicalEntity	RAMH	C069357
6630	19825989	1804	1812	CellLine	Mz-ChA-1	9606
6631	19825989	1837	1841	ChemicalEntity	RAMH	C069357
6632	19825989	1853	1859	GeneOrGeneProduct	ERK1/2	5595;5594
6633	19825989	1886	1890	ChemicalEntity	RAMH	C069357
6634	19825989	1901	1906	DiseaseOrPhenotypicFeature	tumor	D009369
6635	19825989	1932	1936	GeneOrGeneProduct	VEGF	7422;7424
6636	19825989	1956	1964	GeneOrGeneProduct	PKCalpha	5578
6637	19825989	1991	1995	ChemicalEntity	RAMH	C069357
6638	19825989	2005	2023	DiseaseOrPhenotypicFeature	cholangiocarcinoma	D018281
6639	19825989	2034	2042	GeneOrGeneProduct	PKCalpha	5578
6640	19825989	2053	2059	GeneOrGeneProduct	ERK1/2	5595;5594
6641	19825989	2093	2101	GeneOrGeneProduct	PKCalpha	5578
6642	19825989	2105	2124	GeneOrGeneProduct	histamine receptors	11255,3269,3274,59340
6643	19825989	2156	2174	DiseaseOrPhenotypicFeature	cholangiocarcinoma	D018281
6644	19841052	11	24	ChemicalEntity	crack cocaine	D016578
6645	19841052	46	59	DiseaseOrPhenotypicFeature	HIV infection	D015658
6646	19841052	163	176	ChemicalEntity	crack cocaine	D016578
6647	19841052	201	214	DiseaseOrPhenotypicFeature	HIV infection	D015658
6648	19841052	244	257	ChemicalEntity	crack cocaine	D016578
6649	19841052	342	355	DiseaseOrPhenotypicFeature	HIV infection	D015658
6650	19841052	577	580	DiseaseOrPhenotypicFeature	HIV	D015658
6651	19841052	684	702	DiseaseOrPhenotypicFeature	HIV seroconversion	D006679
6652	19841052	726	739	ChemicalEntity	crack cocaine	D016578
6653	19841052	1065	1078	DiseaseOrPhenotypicFeature	HIV infection	D015658
6654	19841052	1163	1176	ChemicalEntity	crack cocaine	D016578
6655	19841052	1301	1319	DiseaseOrPhenotypicFeature	HIV seroconversion	D006679
6656	19841052	1365	1378	ChemicalEntity	crack cocaine	D016578
6657	19841052	1580	1593	ChemicalEntity	crack cocaine	D016578
6658	19841052	1641	1659	DiseaseOrPhenotypicFeature	HIV seroconversion	D006679
6659	19841052	1817	1830	ChemicalEntity	crack cocaine	D016578
6660	19880293	21	26	GeneOrGeneProduct	FOXP3	50943
6661	19880293	47	56	DiseaseOrPhenotypicFeature	psoriasis	D011565
6662	19880293	57	65	OrganismTaxon	patients	9606
6663	19880293	79	88	DiseaseOrPhenotypicFeature	Psoriasis	D011565
6664	19880293	101	124	DiseaseOrPhenotypicFeature	dermatological disorder	D012871
6665	19880293	173	176	GeneOrGeneProduct	CD4	920
6666	19880293	179	183	GeneOrGeneProduct	CD25	3559
6667	19880293	278	297	DiseaseOrPhenotypicFeature	autoimmune diseases	D001327
6668	19880293	363	368	GeneOrGeneProduct	FOXP3	50943
6669	19880293	521	526	GeneOrGeneProduct	FOXP3	50943
6670	19880293	569	589	DiseaseOrPhenotypicFeature	autoimmune disorders	D001327
6671	19880293	618	623	GeneOrGeneProduct	FOXP3	50943
6672	19880293	632	641	DiseaseOrPhenotypicFeature	psoriasis	D011565
6673	19880293	710	715	GeneOrGeneProduct	FOXP3	50943
6674	19880293	748	757	DiseaseOrPhenotypicFeature	psoriasis	D011565
6675	19880293	840	848	OrganismTaxon	patients	9606
6676	19880293	854	863	DiseaseOrPhenotypicFeature	psoriasis	D011565
6677	19880293	872	881	DiseaseOrPhenotypicFeature	psoriasis	D011565
6678	19880293	973	978	GeneOrGeneProduct	FOXP3	50943
6679	19880293	985	1004	SequenceVariant	-6054, deletion/ATT	c|DEL|-6054|ATT
6680	19880293	1006	1016	SequenceVariant	-3279, A/C	c|SUB|A|-3279|C
6681	19880293	1018	1027	SequenceVariant	-924, A/G	c|SUB|A|-924|G
6682	19880293	1029	1042	SequenceVariant	IVS9+459, A/G	c|SUB|A|IVS9+459|G
6683	19880293	1047	1056	DiseaseOrPhenotypicFeature	psoriatic	D011565
6684	19880293	1057	1065	OrganismTaxon	patients	9606
6685	19880293	1115	1124	DiseaseOrPhenotypicFeature	psoriatic	D011565
6686	19880293	1125	1133	OrganismTaxon	patients	9606
6687	19880293	1404	1413	DiseaseOrPhenotypicFeature	psoriasis	D011565
6688	19880293	1438	1443	GeneOrGeneProduct	FOXP3	50943
6689	19880293	1444	1452	SequenceVariant	-3279 AC	c|Allele|AC|-3297
6690	19880293	1591	1599	SequenceVariant	-3279 CC	c|Allele|CC|-3279
6691	19880293	1650	1659	DiseaseOrPhenotypicFeature	psoriasis	D011565
6692	19880293	1684	1689	GeneOrGeneProduct	FOXP3	50943
6693	19880293	1690	1701	SequenceVariant	IVS9+459 GG	c|Allele|GG|IVS9+459
6694	19880293	1869	1880	SequenceVariant	IVS9+459 AA	c|Allele|AA|IVS9+459
6695	19880293	1954	1959	GeneOrGeneProduct	FOXP3	50943
6696	19880293	1959	1977	SequenceVariant	-6054 deletion/ATT	c|DEL|-6054|ATT
6697	19880293	1981	1986	GeneOrGeneProduct	FOXP3	50943
6698	19880293	1986	1994	SequenceVariant	-924 A/G	c|SUB|A|-924|G
6699	19880293	2040	2045	GeneOrGeneProduct	FOXP3	50943
6700	19880293	2045	2056	SequenceVariant	-3279 AC+AA	c|Allele|AC|-3279
6701	19880293	2153	2162	DiseaseOrPhenotypicFeature	psoriasis	D011565
6702	19880293	2163	2171	OrganismTaxon	patients	9606
6703	19880293	2241	2246	GeneOrGeneProduct	FOXP3	50943
6704	19880293	2247	2261	SequenceVariant	IVS9+459 GA+GG	c|Allele|GA|IVS9+459
6705	19880293	2303	2312	DiseaseOrPhenotypicFeature	psoriasis	D011565
6706	19880293	2313	2321	OrganismTaxon	patients	9606
6707	19880293	2373	2378	GeneOrGeneProduct	FOXP3	50943
6708	19880293	2429	2438	DiseaseOrPhenotypicFeature	psoriasis	D011565
6709	19881468	0	5	GeneOrGeneProduct	hOGG1	4968
6710	19881468	6	15	SequenceVariant	Ser326Cys	rs1052133
6711	19881468	41	52	DiseaseOrPhenotypicFeature	lung cancer	D008175
6712	19881468	75	80	OrganismTaxon	Human	9606
6713	19881468	81	111	GeneOrGeneProduct	8-oxoguanine DNA glycosylase 1	4968
6714	19881468	113	118	GeneOrGeneProduct	hOGG1	4968
6715	19881468	154	170	ChemicalEntity	8-hydroxyguanine	C024829
6716	19881468	230	239	SequenceVariant	rs1052133	rs1052133
6717	19881468	296	315	SequenceVariant	326 from Ser to Cys	rs1052133
6718	19881468	387	392	GeneOrGeneProduct	hOGG1	4968
6719	19881468	393	399	SequenceVariant	Cys326	rs1052133
6720	19881468	468	477	SequenceVariant	rs1052133	rs1052133
6721	19881468	482	493	DiseaseOrPhenotypicFeature	lung cancer	D008175
6722	19881468	538	549	DiseaseOrPhenotypicFeature	lung cancer	D008175
6723	19881468	652	663	DiseaseOrPhenotypicFeature	lung cancer	D008175
6724	19881468	717	723	DiseaseOrPhenotypicFeature	cancer	D009369
6725	19881468	855	866	DiseaseOrPhenotypicFeature	lung cancer	D008175
6726	19881468	1068	1088	DiseaseOrPhenotypicFeature	small-cell carcinoma	D018288
6727	19881468	1161	1175	DiseaseOrPhenotypicFeature	adenocarcinoma	D000230
6728	19881468	1317	1331	DiseaseOrPhenotypicFeature	adenocarcinoma	D000230
6729	19881468	1386	1423	DiseaseOrPhenotypicFeature	squamous- and small-cell lung cancers	D002289,D055752
6730	19881468	1453	1462	SequenceVariant	rs1052133	rs1052133
6731	19881468	1490	1512	DiseaseOrPhenotypicFeature	adenocarcinoma of lung	D000077192
6732	19889778	47	52	SequenceVariant	G145R	p|SUB|G|145|R
6733	19889778	57	62	SequenceVariant	P120T	c|SUB|P|120|T
6734	19889778	85	95	ChemicalEntity	lamivudine	D019259
6735	19889778	106	133	ChemicalEntity	hepatitis B virus e antigen	D006513
6736	19889778	196	213	OrganismTaxon	hepatitis B virus	10407
6737	19889778	215	218	OrganismTaxon	HBV	10407
6738	19889778	314	317	OrganismTaxon	HBV	10407
6739	19889778	622	627	SequenceVariant	G145R	p|SUB|G|145|R
6740	19889778	633	638	SequenceVariant	P120T	c|SUB|P|120|T
6741	19889778	774	784	ChemicalEntity	lamivudine	D019259
6742	19889778	786	789	ChemicalEntity	LAM	D019259
6743	19889778	798	803	ChemicalEntity	HBeAg	D006513
6744	19889778	838	841	OrganismTaxon	HBV	10407
6745	19889778	856	861	SequenceVariant	G145R	p|SUB|G|145|R
6746	19889778	866	871	SequenceVariant	P120T	c|SUB|P|120|T
6747	19889778	876	879	ChemicalEntity	LAM	D019259
6748	19889778	894	899	SequenceVariant	M204I	p|SUB|M|204|I
6749	19889778	905	910	SequenceVariant	L180M	p|SUB|L|180|M
6750	19889778	913	918	SequenceVariant	M204V	p|SUB|M|204|V
6751	19889778	941	946	ChemicalEntity	HBeAg	D006513
6752	19889778	963	968	ChemicalEntity	HBeAg	D006513
6753	19889778	994	1001	GeneOrGeneProduct	precore	944568
6754	19889778	1003	1005	GeneOrGeneProduct	PC	944568
6755	19889778	1051	1056	SequenceVariant	G145R	p|SUB|G|145|R
6756	19889778	1083	1088	ChemicalEntity	HBsAg	D006514
6757	19889778	1154	1157	ChemicalEntity	LAM	D019259
6758	19889778	1168	1171	OrganismTaxon	HBV	10407
6759	19889778	1207	1210	OrganismTaxon	HBV	10407
6760	19889778	1216	1218	GeneOrGeneProduct	PC	944568
6761	19889778	1286	1291	SequenceVariant	P120T	c|SUB|P|120|T
6762	19889778	1319	1324	ChemicalEntity	HBsAg	D006514
6763	19889778	1374	1377	ChemicalEntity	LAM	D019259
6764	19889778	1435	1440	ChemicalEntity	HBeAg	D006513
6765	19889778	1453	1455	GeneOrGeneProduct	PC	944568
6766	19889778	1463	1468	SequenceVariant	P120T	c|SUB|P|120|T
6767	19889778	1474	1477	ChemicalEntity	LAM	D019259
6768	19889778	1555	1558	OrganismTaxon	HBV	10407
6769	19889778	1606	1609	ChemicalEntity	LAM	D019259
6770	19889778	1657	1665	ChemicalEntity	adefovir	C053001
6771	19889778	1670	1679	ChemicalEntity	tenofovir	D000068698
6772	19889778	1868	1871	OrganismTaxon	HBV	10407
6773	19891556	0	11	ChemicalEntity	Clopidogrel	D000077144
6774	19891556	123	134	ChemicalEntity	clopidogrel	D000077144
6775	19891556	171	194	DiseaseOrPhenotypicFeature	coronary artery disease	D003324
6776	19891556	195	203	OrganismTaxon	patients	9606
6777	19891556	283	291	OrganismTaxon	patients	9606
6778	19891556	343	354	ChemicalEntity	Clopidogrel	D000077144
6779	19891556	412	419	GeneOrGeneProduct	CYP2C19	1557
6780	19891556	521	528	GeneOrGeneProduct	CYP2C19	1557
6781	19891556	606	617	ChemicalEntity	clopidogrel	D000077144
6782	19891556	805	816	ChemicalEntity	clopidogrel	D000077144
6783	19891556	870	877	GeneOrGeneProduct	CYP2C19	1557
6784	19891556	890	901	ChemicalEntity	clopidogrel	D000077144
6785	19891556	1053	1060	GeneOrGeneProduct	CYP2C19	1557
6786	19891556	1119	1130	ChemicalEntity	clopidogrel	D000077144
6787	19914299	0	10	ChemicalEntity	Fluoxetine	D005473
6788	19914299	24	39	DiseaseOrPhenotypicFeature	memory deficits	D008569
6789	19914299	73	87	ChemicalEntity	5-fluorouracil	D005472
6790	19914299	89	95	DiseaseOrPhenotypicFeature	Cancer	D009369
6791	19914299	258	272	ChemicalEntity	5-fluorouracil	D005472
6792	19914299	274	278	ChemicalEntity	5-FU	D005472
6793	19914299	592	596	ChemicalEntity	SSRI	D017367
6794	19914299	612	622	ChemicalEntity	Fluoxetine	D005473
6795	19914299	707	711	ChemicalEntity	5-FU	D005472
6796	19914299	735	745	ChemicalEntity	Fluoxetine	D005473
6797	19914299	787	791	ChemicalEntity	5-FU	D005472
6798	19914299	827	831	OrganismTaxon	rats	10116
6799	19914299	972	976	ChemicalEntity	5-FU	D005472
6800	19914299	1212	1216	ChemicalEntity	5-FU	D005472
6801	19914299	1313	1323	ChemicalEntity	Fluoxetine	D005473
6802	19914299	1352	1356	ChemicalEntity	5-FU	D005472
6803	19914299	1541	1551	ChemicalEntity	Fluoxetine	D005473
6804	19914299	1577	1581	ChemicalEntity	5-FU	D005472
6805	19914299	1583	1593	ChemicalEntity	Fluoxetine	D005473
6806	19914299	1690	1694	ChemicalEntity	5-FU	D005472
6807	19914299	1879	1889	ChemicalEntity	Fluoxetine	D005473
6808	19957053	0	13	ChemicalEntity	Phenylephrine	D010656
6809	19957053	22	31	ChemicalEntity	ephedrine	D004809
6810	19957053	94	105	DiseaseOrPhenotypicFeature	hypotension	D007022
6811	19957053	177	188	DiseaseOrPhenotypicFeature	hypotension	D007022
6812	19957053	216	229	ChemicalEntity	phenylephrine	D010656
6813	19957053	234	243	ChemicalEntity	ephedrine	D004809
6814	19957053	312	323	DiseaseOrPhenotypicFeature	hypotension	D007022
6815	19957053	371	379	ChemicalEntity	fentanyl	D005283
6816	19957053	401	409	ChemicalEntity	propofol	D015742
6817	19957053	430	438	OrganismTaxon	patients	9606
6818	19957053	448	461	ChemicalEntity	phenylephrine	D010656
6819	19957053	481	489	OrganismTaxon	patients	9606
6820	19957053	499	508	ChemicalEntity	ephedrine	D004809
6821	19957053	583	589	DiseaseOrPhenotypicFeature	stroke	D020521
6822	19957053	831	844	ChemicalEntity	phenylephrine	D010656
6823	19957053	1085	1094	ChemicalEntity	ephedrine	D004809
6824	19957053	1276	1289	ChemicalEntity	phenylephrine	D010656
6825	19957053	1301	1312	DiseaseOrPhenotypicFeature	hypotension	D007022
6826	19957053	1375	1384	ChemicalEntity	ephedrine	D004809
6827	19996135	10	25	ChemicalEntity	tranexamic Acid	D014148
6828	19996135	66	74	DiseaseOrPhenotypicFeature	seizures	D012640
6829	19996135	95	103	OrganismTaxon	patients	9606
6830	19996135	205	224	DiseaseOrPhenotypicFeature	convulsive seizures	D012640
6831	19996135	246	254	OrganismTaxon	patients	9606
6832	19996135	381	396	ChemicalEntity	tranexamic acid	D014148
6833	19996135	398	401	ChemicalEntity	TXA	D014148
6834	19996135	585	588	ChemicalEntity	TXA	D014148
6835	19996135	599	607	DiseaseOrPhenotypicFeature	seizures	D012640
6836	19996135	690	698	OrganismTaxon	patients	9606
6837	19996135	727	735	DiseaseOrPhenotypicFeature	seizures	D012640
6838	19996135	798	806	OrganismTaxon	patients	9606
6839	19996135	816	824	OrganismTaxon	patients	9606
6840	19996135	919	927	OrganismTaxon	patients	9606
6841	19996135	957	981	DiseaseOrPhenotypicFeature	cerebral ischemic injury	D001930
6842	19996135	987	995	DiseaseOrPhenotypicFeature	seizures	D012640
6843	19996135	1015	1036	DiseaseOrPhenotypicFeature	ischemic brain injury	D001930
6844	19996135	1042	1050	OrganismTaxon	patients	9606
6845	19996135	1056	1064	OrganismTaxon	patients	9606
6846	19996135	1070	1078	DiseaseOrPhenotypicFeature	seizures	D012640
6847	19996135	1102	1128	DiseaseOrPhenotypicFeature	neurological abnormalities	D009422
6848	19996135	1137	1145	OrganismTaxon	patients	9606
6849	19996135	1151	1159	DiseaseOrPhenotypicFeature	seizures	D012640
6850	19996135	1183	1186	ChemicalEntity	TXA	D014148
6851	19996135	1356	1363	OrganismTaxon	patient	9606
6852	19996135	1422	1436	DiseaseOrPhenotypicFeature	brain ischemic	D002546
6853	19996135	1452	1464	DiseaseOrPhenotypicFeature	hyperthermia	D005334
6854	19996135	1490	1498	DiseaseOrPhenotypicFeature	seizures	D012640
6855	19996135	1567	1570	ChemicalEntity	TXA	D014148
6856	19996135	1580	1588	OrganismTaxon	patients	9606
6857	19996135	1693	1701	DiseaseOrPhenotypicFeature	seizures	D012640
6858	19996135	1717	1725	OrganismTaxon	patients	9606
6859	20005218	77	83	GeneOrGeneProduct	Klotho	9365
6860	20005218	112	134	DiseaseOrPhenotypicFeature	essential hypertension	D000075222
6861	20005218	178	182	OrganismTaxon	Mice	10090
6862	20005218	203	209	GeneOrGeneProduct	Klotho	16591
6863	20005218	259	275	DiseaseOrPhenotypicFeature	arteriosclerosis	D001161
6864	20005218	302	308	SequenceVariant	G-395A	rs1207568
6865	20005218	352	357	OrganismTaxon	human	9606
6866	20005218	358	364	GeneOrGeneProduct	Klotho	9365
6867	20005218	406	428	DiseaseOrPhenotypicFeature	Essential Hypertension	D000075222
6868	20005218	430	432	DiseaseOrPhenotypicFeature	EH	D000075222
6869	20005218	471	477	SequenceVariant	G-395A	rs1207568
6870	20005218	494	500	GeneOrGeneProduct	Klotho	9365
6871	20005218	520	522	DiseaseOrPhenotypicFeature	EH	D000075222
6872	20005218	557	565	OrganismTaxon	patients	9606
6873	20005218	571	573	DiseaseOrPhenotypicFeature	EH	D000075222
6874	20005218	586	598	DiseaseOrPhenotypicFeature	hypertensive	D006973
6875	20005218	634	637	SequenceVariant	G/A	rs1207568
6876	20005218	658	664	SequenceVariant	G-395A	rs1207568
6877	20005218	814	820	SequenceVariant	G-395A	rs1207568
6878	20005218	846	848	DiseaseOrPhenotypicFeature	EH	D000075222
6879	20005218	857	869	DiseaseOrPhenotypicFeature	hypertension	D006973
6880	20005218	1009	1015	SequenceVariant	G-395A	rs1207568
6881	20005218	1034	1036	DiseaseOrPhenotypicFeature	EH	D000075222
6882	20005218	1042	1048	SequenceVariant	G-395A	rs1207568
6883	20005218	1095	1097	DiseaseOrPhenotypicFeature	EH	D000075222
6884	20005218	1232	1234	DiseaseOrPhenotypicFeature	EH	D000075222
6885	20005218	1242	1247	SequenceVariant	-395A	rs1207568
6886	20005218	1426	1431	SequenceVariant	-395A	rs1207568
6887	20005218	1481	1487	SequenceVariant	G-395A	rs1207568
6888	20005218	1510	1516	GeneOrGeneProduct	Klotho	9365
6889	20005218	1571	1576	SequenceVariant	-395G	rs1207568
6890	20005218	1603	1609	SequenceVariant	G-395A	rs1207568
6891	20005218	1630	1635	OrganismTaxon	human	9606
6892	20005218	1636	1642	GeneOrGeneProduct	Klotho	9365
6893	20005218	1667	1669	DiseaseOrPhenotypicFeature	EH	D000075222
6894	20034406	10	14	GeneOrGeneProduct	CCL2	24770
6895	20034406	32	36	GeneOrGeneProduct	CCR2	60463
6896	20034406	80	91	ChemicalEntity	pilocarpine	D010862
6897	20034406	100	118	DiseaseOrPhenotypicFeature	status epilepticus	D013226
6898	20034406	132	149	DiseaseOrPhenotypicFeature	Neuroinflammation	D007249
6899	20034406	163	171	DiseaseOrPhenotypicFeature	seizures	D012640
6900	20034406	210	214	GeneOrGeneProduct	CCR2	60463
6901	20034406	220	238	GeneOrGeneProduct	chemokine receptor	60463
6902	20034406	243	247	GeneOrGeneProduct	CCL2	24770
6903	20034406	308	325	DiseaseOrPhenotypicFeature	neuroinflammatory	D007249
6904	20034406	389	393	GeneOrGeneProduct	CCR2	60463
6905	20034406	398	402	GeneOrGeneProduct	CCL2	24770
6906	20034406	438	456	DiseaseOrPhenotypicFeature	status epilepticus	D013226
6907	20034406	458	460	DiseaseOrPhenotypicFeature	SE	D013226
6908	20034406	473	484	ChemicalEntity	pilocarpine	D010862
6909	20034406	505	507	DiseaseOrPhenotypicFeature	SE	D013226
6910	20034406	523	534	ChemicalEntity	pilocarpine	D010862
6911	20034406	554	558	OrganismTaxon	rats	10116
6912	20034406	596	607	ChemicalEntity	pilocarpine	D010862
6913	20034406	625	627	DiseaseOrPhenotypicFeature	SE	D013226
6914	20034406	629	633	GeneOrGeneProduct	CCR2	60463
6915	20034406	732	736	GeneOrGeneProduct	CCR2	60463
6916	20034406	811	815	GeneOrGeneProduct	CCL2	24770
6917	20034406	898	902	GeneOrGeneProduct	CCR2	60463
6918	20034406	941	943	DiseaseOrPhenotypicFeature	SE	D013226
6919	20034406	945	953	DiseaseOrPhenotypicFeature	Seizures	D012640
6920	20034406	1012	1016	GeneOrGeneProduct	CCR2	60463
6921	20034406	1062	1066	GeneOrGeneProduct	CCR2	60463
6922	20034406	1090	1092	DiseaseOrPhenotypicFeature	SE	D013226
6923	20034406	1144	1148	GeneOrGeneProduct	CCR2	60463
6924	20034406	1166	1168	DiseaseOrPhenotypicFeature	SE	D013226
6925	20034406	1169	1173	OrganismTaxon	rats	10116
6926	20034406	1188	1192	OrganismTaxon	rats	10116
6927	20034406	1210	1212	DiseaseOrPhenotypicFeature	SE	D013226
6928	20034406	1223	1227	GeneOrGeneProduct	CCR2	60463
6929	20034406	1324	1328	GeneOrGeneProduct	CCR2	60463
6930	20034406	1371	1375	OrganismTaxon	rats	10116
6931	20034406	1392	1396	GeneOrGeneProduct	CCL2	24770
6932	20034406	1465	1467	DiseaseOrPhenotypicFeature	SE	D013226
6933	20034406	1500	1504	GeneOrGeneProduct	CCR2	60463
6934	20034406	1509	1513	GeneOrGeneProduct	CCL2	24770
6935	20034406	1556	1567	ChemicalEntity	pilocarpine	D010862
6936	20034406	1576	1578	DiseaseOrPhenotypicFeature	SE	D013226
6937	20034406	1580	1588	DiseaseOrPhenotypicFeature	Seizures	D012640
6938	20034406	1615	1619	GeneOrGeneProduct	CCR2	60463
6939	20034406	1734	1751	DiseaseOrPhenotypicFeature	neuroinflammatory	D007249
6940	20034406	1781	1789	DiseaseOrPhenotypicFeature	seizures	D012640
6941	20046642	0	15	ChemicalEntity	Metallothionein	D008668
6942	20046642	34	43	GeneOrGeneProduct	caspase-3	25402
6943	20046642	57	65	GeneOrGeneProduct	TNFalpha	24835
6944	20046642	147	157	ChemicalEntity	carmustine	D002330
6945	20046642	166	170	OrganismTaxon	rats	10116
6946	20046642	264	279	ChemicalEntity	metallothionein	D008668
6947	20046642	281	283	ChemicalEntity	MT	D008668
6948	20046642	288	295	ChemicalEntity	ZnSO(4)	D019287
6949	20046642	398	400	ChemicalEntity	MT	D008668
6950	20046642	414	424	ChemicalEntity	carmustine	D002330
6951	20046642	426	430	ChemicalEntity	BCNU	D002330
6952	20046642	452	473	DiseaseOrPhenotypicFeature	cognitive dysfunction	D003072
6953	20046642	477	481	OrganismTaxon	rats	10116
6954	20046642	516	520	OrganismTaxon	rats	10116
6955	20046642	665	669	ChemicalEntity	BCNU	D002330
6956	20046642	715	722	ChemicalEntity	ZnSO(4)	D019287
6957	20046642	780	784	ChemicalEntity	BCNU	D002330
6958	20046642	832	836	ChemicalEntity	BCNU	D002330
6959	20046642	947	954	ChemicalEntity	ZnSO(4)	D019287
6960	20046642	1006	1010	ChemicalEntity	BCNU	D002330
6961	20046642	1077	1081	ChemicalEntity	BCNU	D002330
6962	20046642	1109	1156	DiseaseOrPhenotypicFeature	deterioration of learning and short-term memory	D007859,D008569
6963	20046642	1247	1268	GeneOrGeneProduct	glutathione reductase	116686
6964	20046642	1270	1272	GeneOrGeneProduct	GR	116686
6965	20046642	1295	1306	ChemicalEntity	glutathione	D005978
6966	20046642	1308	1311	ChemicalEntity	GSH	D005978
6967	20046642	1328	1332	ChemicalEntity	BCNU	D002330
6968	20046642	1364	1391	GeneOrGeneProduct	tumor necrosis factor-alpha	24835
6969	20046642	1393	1401	GeneOrGeneProduct	TNFalpha	24835
6970	20046642	1416	1418	ChemicalEntity	MT	D008668
6971	20046642	1423	1438	ChemicalEntity	malondialdehyde	D008315
6972	20046642	1440	1443	ChemicalEntity	MDA	D008315
6973	20046642	1465	1474	GeneOrGeneProduct	caspase-3	25402
6974	20046642	1525	1532	ChemicalEntity	ZnSO(4)	D019287
6975	20046642	1559	1563	ChemicalEntity	BCNU	D002330
6976	20046642	1586	1588	GeneOrGeneProduct	GR	116686
6977	20046642	1606	1609	ChemicalEntity	GSH	D005978
6978	20046642	1665	1668	ChemicalEntity	MDA	D008315
6979	20046642	1673	1681	GeneOrGeneProduct	TNFalpha	24835
6980	20046642	1709	1718	GeneOrGeneProduct	caspase-3	25402
6981	20046642	1778	1782	OrganismTaxon	rats	10116
6982	20046642	1796	1803	ChemicalEntity	ZnSO(4)	D019287
6983	20046642	1806	1810	ChemicalEntity	BCNU	D002330
6984	20046642	1828	1832	ChemicalEntity	BCNU	D002330
6985	20046642	1865	1867	ChemicalEntity	MT	D008668
6986	20046642	1884	1888	ChemicalEntity	BCNU	D002330
6987	20046642	1909	1917	DiseaseOrPhenotypicFeature	toxicity	D064420
6988	20046642	1934	1936	GeneOrGeneProduct	GR	116686
6989	20046642	1952	1955	ChemicalEntity	GSH	D005978
6990	20046642	2007	2015	GeneOrGeneProduct	TNFalpha	24835
6991	20046642	2017	2020	ChemicalEntity	MDA	D008315
6992	20046642	2025	2034	GeneOrGeneProduct	caspase-3	25402
6993	20080916	35	39	GeneOrGeneProduct	IRF5	3663
6994	20080916	89	117	DiseaseOrPhenotypicFeature	systemic lupus erythematosus	D008180
6995	20080916	321	325	GeneOrGeneProduct	IRF5	3663
6996	20080916	336	364	DiseaseOrPhenotypicFeature	systemic lupus erythematosus	D008180
6997	20080916	366	369	DiseaseOrPhenotypicFeature	SLE	D008180
6998	20080916	451	455	GeneOrGeneProduct	IRF5	3663
6999	20080916	493	496	DiseaseOrPhenotypicFeature	SLE	D008180
7000	20080916	497	505	OrganismTaxon	patients	9606
7001	20080916	674	683	SequenceVariant	rs2070197	rs2070197
7002	20080916	756	765	SequenceVariant	rs2004640	rs2004640
7003	20080916	770	780	SequenceVariant	rs10954213	rs10954213
7004	20080916	821	831	SequenceVariant	rs10954213	rs10954213
7005	20080916	866	870	GeneOrGeneProduct	IRF5	3663
7006	20080916	961	964	DiseaseOrPhenotypicFeature	SLE	D008180
7007	20080916	1010	1020	SequenceVariant	rs10954213	rs10954213
7008	20080916	1088	1092	GeneOrGeneProduct	IRF5	3663
7009	20105310	36	39	GeneOrGeneProduct	ASP	718
7010	20105310	129	134	DiseaseOrPhenotypicFeature	obese	D009765
7011	20105310	171	178	DiseaseOrPhenotypicFeature	obesity	D009765
7012	20105310	227	232	DiseaseOrPhenotypicFeature	obese	D009765
7013	20105310	252	270	DiseaseOrPhenotypicFeature	insulin resistance	D007333
7014	20105310	272	281	GeneOrGeneProduct	adipokine	9370
7015	20105310	347	352	DiseaseOrPhenotypicFeature	obese	D009765
7016	20105310	382	411	GeneOrGeneProduct	Acylation Stimulating protein	718
7017	20105310	413	416	GeneOrGeneProduct	ASP	718
7018	20105310	422	434	ChemicalEntity	Triglyceride	D014280
7019	20105310	436	438	ChemicalEntity	TG	D014280
7020	20105310	454	457	GeneOrGeneProduct	ASP	718
7021	20105310	462	464	ChemicalEntity	TG	D014280
7022	20105310	586	591	ChemicalEntity	lipid	D008055
7023	20105310	607	619	DiseaseOrPhenotypicFeature	inflammation	D007249
7024	20105310	697	704	DiseaseOrPhenotypicFeature	obesity	D009765
7025	20105310	706	713	GeneOrGeneProduct	insulin	3630
7026	20105310	719	726	ChemicalEntity	glucose	D005947
7027	20105310	758	765	GeneOrGeneProduct	insulin	3630
7028	20105310	781	785	GeneOrGeneProduct	InsR	3643
7029	20105310	787	792	GeneOrGeneProduct	IRS-1	3667
7030	20105310	795	798	GeneOrGeneProduct	ASP	718
7031	20105310	874	882	GeneOrGeneProduct	factor B	629
7032	20105310	884	891	GeneOrGeneProduct	adipsin	1675
7033	20105310	893	906	GeneOrGeneProduct	complement C3	718
7034	20105310	1047	1051	GeneOrGeneProduct	C5L2	27202
7035	20105310	1067	1079	GeneOrGeneProduct	ASP receptor	27202
7036	20105310	1112	1115	GeneOrGeneProduct	ASP	718
7037	20105310	1151	1153	ChemicalEntity	TG	D014280
7038	20105310	1214	1219	ChemicalEntity	lipid	D008055
7039	20105310	1247	1251	GeneOrGeneProduct	CD36	948
7040	20105310	1253	1258	GeneOrGeneProduct	DGAT1	8694
7041	20105310	1260	1265	GeneOrGeneProduct	DGAT2	84649
7042	20105310	1267	1271	GeneOrGeneProduct	SCD1	6319
7043	20105310	1273	1277	GeneOrGeneProduct	FASN	2194
7044	20105310	1283	1286	GeneOrGeneProduct	LPL	4023
7045	20105310	1300	1303	GeneOrGeneProduct	HSL	3991
7046	20105310	1305	1309	GeneOrGeneProduct	CES1	1066
7047	20105310	1311	1320	GeneOrGeneProduct	perilipin	5346
7048	20105310	1323	1350	GeneOrGeneProduct	fatty acid binding proteins	2168,2170
7049	20105310	1352	1357	GeneOrGeneProduct	FABP1	2168
7050	20105310	1359	1364	GeneOrGeneProduct	FABP3	2170
7051	20105310	1405	1414	GeneOrGeneProduct	CEBPalpha	1050
7052	20105310	1416	1424	GeneOrGeneProduct	CEBPbeta	1051
7053	20105310	1426	1435	GeneOrGeneProduct	PPARgamma	5468
7054	20105310	1491	1495	GeneOrGeneProduct	AMPK	5562
7055	20105310	1497	1501	GeneOrGeneProduct	UCP1	7350
7056	20105310	1503	1507	GeneOrGeneProduct	CPT1	1374
7057	20105310	1509	1514	GeneOrGeneProduct	FABP7	2173
7058	20105310	1549	1561	DiseaseOrPhenotypicFeature	inflammatory	D007249
7059	20105310	1568	1573	GeneOrGeneProduct	TGFB1	7040
7060	20105310	1575	1580	GeneOrGeneProduct	TIMP1	7076
7061	20105310	1582	1587	GeneOrGeneProduct	TIMP3	7078
7062	20105310	1593	1598	GeneOrGeneProduct	TIMP4	7079
7063	20105310	1605	1620	DiseaseOrPhenotypicFeature	proinflammatory	D007249
7064	20105310	1621	1625	GeneOrGeneProduct	PIG7	9516
7065	20105310	1630	1634	GeneOrGeneProduct	MMP2	4313
7066	20105310	1735	1739	GeneOrGeneProduct	C5L2	27202
7067	20105310	1750	1753	GeneOrGeneProduct	ASP	718
7068	20105310	1824	1829	DiseaseOrPhenotypicFeature	obese	D009765
7069	20105310	1913	1916	GeneOrGeneProduct	ASP	718
7070	20105310	1921	1923	ChemicalEntity	TG	D014280
7071	20126413	0	5	CellLine	U87MG	9606
7072	20126413	66	71	OrganismTaxon	human	9606
7073	20126413	72	78	DiseaseOrPhenotypicFeature	cancer	D009369
7074	20126413	90	95	CellLine	U87MG	9606
7075	20126413	118	133	DiseaseOrPhenotypicFeature	grade IV glioma	D005909
7076	20126413	320	326	DiseaseOrPhenotypicFeature	cancer	D009369
7077	20126413	1068	1072	GeneOrGeneProduct	PTEN	5728
7078	20126413	1498	1504	DiseaseOrPhenotypicFeature	cancer	D009369
7079	20126413	1941	1947	DiseaseOrPhenotypicFeature	cancer	D009369
7080	20126413	2028	2033	CellLine	U87MG	9606
7081	20129423	6	19	ChemicalEntity	carbamazepine	D002220
7082	20129423	52	68	DiseaseOrPhenotypicFeature	hypersensitivity	D006967
7083	20129423	70	81	DiseaseOrPhenotypicFeature	myocarditis	D009205
7084	20129423	167	188	DiseaseOrPhenotypicFeature	drug hypersensitivity	D004342
7085	20129423	254	267	ChemicalEntity	carbamazepine	D002220
7086	20129423	419	432	ChemicalEntity	carbamazepine	D002220
7087	20129423	462	478	DiseaseOrPhenotypicFeature	hypersensitivity	D006967
7088	20129423	480	491	DiseaseOrPhenotypicFeature	myocarditis	D009205
7089	20129423	513	529	DiseaseOrPhenotypicFeature	hypersensitivity	D006967
7090	20129423	530	541	DiseaseOrPhenotypicFeature	myocarditis	D009205
7091	20129423	573	586	ChemicalEntity	carbamazepine	D002220
7092	20129423	594	610	DiseaseOrPhenotypicFeature	hypersensitivity	D006967
7093	20129423	611	622	DiseaseOrPhenotypicFeature	myocarditis	D009205
7094	20129423	815	820	DiseaseOrPhenotypicFeature	death	D003643
7095	20129423	832	849	DiseaseOrPhenotypicFeature	cardiogenic shock	D012770
7096	20129423	909	922	ChemicalEntity	carbamazepine	D002220
7097	20129423	931	942	DiseaseOrPhenotypicFeature	myocarditis	D009205
7098	20143913	39	54	GeneOrGeneProduct	arylsulfatase B	411
7099	20143913	94	123	DiseaseOrPhenotypicFeature	mucopolysaccharidosis type VI	D009087
7100	20143913	124	131	OrganismTaxon	patient	9606
7101	20143913	172	179	SequenceVariant	p.R315X	p|SUB|R|315|X
7102	20143913	205	220	GeneOrGeneProduct	arylsulfatase B	411
7103	20143913	222	226	GeneOrGeneProduct	ARSB	411
7104	20143913	238	267	DiseaseOrPhenotypicFeature	mucopolysaccharidosis type VI	D009087
7105	20143913	268	275	OrganismTaxon	patient	9606
7106	20143913	343	350	OrganismTaxon	Patient	9606
7107	20143913	404	408	GeneOrGeneProduct	ARSB	411
7108	20143913	463	476	SequenceVariant	c.899-1142del	c|DEL|899_1142|
7109	20143913	660	664	GeneOrGeneProduct	ARSB	411
7110	20143913	742	759	SequenceVariant	g.99367-102002del	g|DEL|99367_102002|
7111	20226780	0	9	OrganismTaxon	Zebrafish	7955
7112	20226780	10	22	GeneOrGeneProduct	chordin-like	563085
7113	20226780	27	34	GeneOrGeneProduct	chordin	30161
7114	20226780	113	120	GeneOrGeneProduct	Chordin	30161
7115	20226780	152	192	GeneOrGeneProduct	cysteine-rich domain-containing proteins	25884,30161,373985,419054,563085,69121,83453,91851
7116	20226780	237	244	GeneOrGeneProduct	TGFbeta	359834
7117	20226780	259	279	GeneOrGeneProduct	Chordin-like 1 and 2	373985,83453,91851;25884,419054,69121
7118	20226780	281	291	GeneOrGeneProduct	CHL1 and 2	373985,83453,91851;25884,419054,69121
7119	20226780	351	356	OrganismTaxon	human	9606
7120	20226780	358	363	OrganismTaxon	mouse	10090
7121	20226780	369	374	OrganismTaxon	chick	9031
7122	20226780	403	413	GeneOrGeneProduct	CHL1 and 2	373985,83453,91851;25884,419054,69121
7123	20226780	523	532	OrganismTaxon	zebrafish	7955
7124	20226780	534	545	OrganismTaxon	Danio rerio	7955
7125	20226780	547	550	GeneOrGeneProduct	CHL	563085
7126	20226780	552	555	GeneOrGeneProduct	Chl	563085
7127	20226780	562	565	GeneOrGeneProduct	chl	563085
7128	20226780	629	635	OrganismTaxon	murine	10090
7129	20226780	661	665	GeneOrGeneProduct	CHL2	69121
7130	20226780	705	714	OrganismTaxon	zebrafish	7955
7131	20226780	751	755	GeneOrGeneProduct	CHL1	91851
7132	20226780	775	778	GeneOrGeneProduct	Chl	563085
7133	20226780	798	807	OrganismTaxon	zebrafish	7955
7134	20226780	828	832	GeneOrGeneProduct	CHL1	91851
7135	20226780	837	841	GeneOrGeneProduct	CHL2	25884
7136	20226780	860	863	GeneOrGeneProduct	Chl	563085
7137	20226780	1022	1031	OrganismTaxon	zebrafish	7955
7138	20226780	1032	1039	GeneOrGeneProduct	chordin	30161
7139	20226780	1041	1044	GeneOrGeneProduct	Chd	30161
7140	20226780	1140	1143	GeneOrGeneProduct	Chl	563085
7141	20226780	1150	1153	GeneOrGeneProduct	Chd	30161
7142	20226780	1212	1216	GeneOrGeneProduct	BMP1	30204
7143	20226780	1297	1300	GeneOrGeneProduct	Chl	563085
7144	20226780	1313	1316	GeneOrGeneProduct	BMP	30204
7145	20226780	1388	1391	GeneOrGeneProduct	Chd	30161
7146	20331935	46	57	ChemicalEntity	risperidone	D018967
7147	20331935	62	101	ChemicalEntity	selective serotonin reuptake inhibitors	D017367
7148	20331935	208	219	ChemicalEntity	risperidone	D018967
7149	20331935	228	246	DiseaseOrPhenotypicFeature	hyperprolactinemia	D006966
7150	20331935	420	431	ChemicalEntity	risperidone	D018967
7151	20331935	503	513	OrganismTaxon	outpatient	9606
7152	20331935	957	975	DiseaseOrPhenotypicFeature	Hyperprolactinemia	D006966
7153	20331935	1028	1039	ChemicalEntity	risperidone	D018967
7154	20331935	1071	1083	ChemicalEntity	testosterone	D013739
7155	20331935	1153	1171	DiseaseOrPhenotypicFeature	hyperprolactinemia	D006966
7156	20331935	1334	1343	GeneOrGeneProduct	prolactin	5617
7157	20331935	1504	1543	ChemicalEntity	selective serotonin reuptake inhibitors	D017367
7158	20331935	1545	1550	ChemicalEntity	SSRIs	D017367
7159	20331935	1755	1763	OrganismTaxon	patients	9606
7160	20331935	1782	1791	DiseaseOrPhenotypicFeature	fractures	D050723
7161	20331935	1810	1821	ChemicalEntity	risperidone	D018967
7162	20331935	1826	1831	ChemicalEntity	SSRIs	D017367
7163	20331935	1867	1875	OrganismTaxon	patients	9606
7164	20331935	1881	1899	DiseaseOrPhenotypicFeature	hyperprolactinemia	D006966
7165	20331935	1946	1957	ChemicalEntity	risperidone	D018967
7166	20331935	1966	1984	DiseaseOrPhenotypicFeature	hyperprolactinemia	D006966
7167	20331935	1989	1993	ChemicalEntity	SSRI	D017367
7168	20331935	2181	2189	DiseaseOrPhenotypicFeature	fracture	D050723
7169	20335448	42	47	OrganismTaxon	human	9606
7170	20335448	48	71	GeneOrGeneProduct	glucocorticoid receptor	2908
7171	20335448	91	116	DiseaseOrPhenotypicFeature	glucocorticoid resistance	C564221
7172	20335448	196	221	DiseaseOrPhenotypicFeature	glucocorticoid resistance	C564221
7173	20335448	314	329	ChemicalEntity	glucocorticoids	D005938
7174	20335448	358	381	GeneOrGeneProduct	glucocorticoid receptor	2908
7175	20335448	383	385	GeneOrGeneProduct	GR	2908
7176	20335448	471	488	ChemicalEntity	mineralocorticoid	D008901
7177	20335448	504	512	ChemicalEntity	androgen	D000728
7178	20335448	601	608	OrganismTaxon	PATIENT	9606
7179	20335448	666	691	DiseaseOrPhenotypicFeature	glucocorticoid resistance	C564221
7180	20335448	706	713	OrganismTaxon	patient	9606
7181	20335448	748	755	DiseaseOrPhenotypicFeature	seizure	D012640
7182	20335448	772	784	DiseaseOrPhenotypicFeature	hypoglycemia	D007003
7183	20335448	789	800	DiseaseOrPhenotypicFeature	hypokalemia	D007008
7184	20335448	815	827	DiseaseOrPhenotypicFeature	hypertension	D006973
7185	20335448	832	850	DiseaseOrPhenotypicFeature	premature pubarche	C567552
7186	20335448	860	873	ChemicalEntity	dexamethasone	D003907
7187	20335448	941	948	OrganismTaxon	patient	9606
7188	20335448	951	953	GeneOrGeneProduct	GR	2908
7189	20335448	988	1023	SequenceVariant	(G-->A) at nucleotide position 2141	c|SUB|G|2141|A
7190	20335448	1068	1116	SequenceVariant	arginine by glutamine at amino acid position 714	c|SUB|R|714|Q
7191	20335448	1159	1167	GeneOrGeneProduct	GR alpha	2908
7192	20335448	1417	1450	GeneOrGeneProduct	p160 nuclear receptor coactivator	8648
7193	20335448	1516	1553	SequenceVariant	arginine by glutamine at position 714	c|SUB|R|714|Q
7194	20335448	1740	1753	ChemicalEntity	Dexamethasone	D003907
7195	20335448	1796	1814	DiseaseOrPhenotypicFeature	premature pubarche	C567552
7196	20335448	1816	1828	DiseaseOrPhenotypicFeature	hypoglycemia	D007003
7197	20335448	1830	1842	DiseaseOrPhenotypicFeature	hypertension	D006973
7198	20335448	1848	1859	DiseaseOrPhenotypicFeature	hypokalemia	D007008
7199	20335448	1888	1900	SequenceVariant	arginine 714	c|Allele|R|714
7200	20335448	1999	2007	GeneOrGeneProduct	GR alpha	2908
7201	20401977	4	9	OrganismTaxon	human	9606
7202	20401977	10	13	GeneOrGeneProduct	AHR	196
7203	20401977	121	156	ChemicalEntity	2,3,7,8-tetrachlorodibenzo-p-dioxin	D000072317
7204	20401977	169	175	ChemicalEntity	dioxin	D004147
7205	20401977	258	283	GeneOrGeneProduct	aryl hydrocarbon receptor	196
7206	20401977	285	288	GeneOrGeneProduct	AHR	196
7207	20401977	295	300	OrganismTaxon	human	9606
7208	20401977	301	304	GeneOrGeneProduct	AHR	196
7209	20401977	502	509	ChemicalEntity	dioxins	D004147
7210	20401977	616	619	GeneOrGeneProduct	AHR	196
7211	20401977	684	689	OrganismTaxon	human	9606
7212	20401977	690	693	GeneOrGeneProduct	AHR	196
7213	20401977	817	820	GeneOrGeneProduct	AHR	196
7214	20401977	1158	1161	GeneOrGeneProduct	AHR	196
7215	20401977	1367	1372	OrganismTaxon	human	9606
7216	20401977	1373	1376	GeneOrGeneProduct	AHR	196
7217	20401977	1536	1541	OrganismTaxon	human	9606
7218	20401977	1542	1545	GeneOrGeneProduct	AHR	196
7219	20401977	1642	1647	OrganismTaxon	human	9606
7220	20415560	0	9	ChemicalEntity	Vitamin E	D014810
7221	20415560	18	40	DiseaseOrPhenotypicFeature	cardiovascular disease	D002318
7222	20415560	61	78	DiseaseOrPhenotypicFeature	diabetes mellitus	D003920
7223	20415560	87	98	GeneOrGeneProduct	haptoglobin	3240
7224	20415560	141	158	DiseaseOrPhenotypicFeature	diabetes mellitus	D003920
7225	20415560	160	162	DiseaseOrPhenotypicFeature	DM	D003920
7226	20415560	172	183	GeneOrGeneProduct	Haptoglobin	3240
7227	20415560	185	187	GeneOrGeneProduct	Hp	3240
7228	20415560	227	249	DiseaseOrPhenotypicFeature	cardiovascular disease	D002318
7229	20415560	286	288	GeneOrGeneProduct	Hp	3240
7230	20415560	368	379	ChemicalEntity	antioxidant	D000975
7231	20415560	380	389	ChemicalEntity	vitamin E	D014810
7232	20415560	449	451	GeneOrGeneProduct	Hp	3240
7233	20415560	456	458	DiseaseOrPhenotypicFeature	DM	D003920
7234	20415560	511	513	GeneOrGeneProduct	Hp	3240
7235	20415560	526	528	DiseaseOrPhenotypicFeature	DM	D003920
7236	20415560	602	611	ChemicalEntity	vitamin E	D014810
7237	20415560	615	617	GeneOrGeneProduct	Hp	3240
7238	20415560	682	688	DiseaseOrPhenotypicFeature	stroke	D020521
7239	20415560	690	711	DiseaseOrPhenotypicFeature	myocardial infarction	D009203
7240	20415560	716	736	DiseaseOrPhenotypicFeature	cardiovascular death	D002318
7241	20415560	1100	1102	GeneOrGeneProduct	Hp	3240
7242	20415560	1107	1109	DiseaseOrPhenotypicFeature	DM	D003920
7243	20415560	1127	1136	ChemicalEntity	vitamin E	D014810
7244	20415560	1249	1251	GeneOrGeneProduct	Hp	3240
7245	20415560	1265	1274	ChemicalEntity	vitamin E	D014810
7246	20415560	1320	1322	GeneOrGeneProduct	Hp	3240
7247	20415560	1336	1338	DiseaseOrPhenotypicFeature	DM	D003920
7248	20415560	1379	1381	GeneOrGeneProduct	Hp	3240
7249	20415560	1391	1400	ChemicalEntity	vitamin E	D014810
7250	20415560	1415	1433	DiseaseOrPhenotypicFeature	myocardial infarct	D009203
7251	20415560	1435	1441	DiseaseOrPhenotypicFeature	stroke	D020521
7252	20415560	1445	1465	DiseaseOrPhenotypicFeature	cardiovascular death	D002318
7253	20415560	1494	1503	ChemicalEntity	vitamin E	D014810
7254	20415560	1507	1509	GeneOrGeneProduct	Hp	3240
7255	20415560	1514	1516	DiseaseOrPhenotypicFeature	DM	D003920
7256	20415560	1655	1657	DiseaseOrPhenotypicFeature	DM	D003920
7257	20415560	1678	1680	GeneOrGeneProduct	Hp	3240
7258	20415560	1714	1716	GeneOrGeneProduct	Hp	3240
7259	20415560	1726	1735	ChemicalEntity	vitamin E	D014810
7260	20428796	28	37	GeneOrGeneProduct	TGF-beta1	4052
7261	20428796	51	67	ChemicalEntity	oligonucleotides	D009841
7262	20428796	89	135	GeneOrGeneProduct	TGF-beta-isoforms and their receptors I and II	7046,7048
7263	20428796	165	177	DiseaseOrPhenotypicFeature	keloid scars	D007627
7264	20428796	343	349	DiseaseOrPhenotypicFeature	keloid	D007627
7265	20428796	377	391	DiseaseOrPhenotypicFeature	Keloid disease	D007627
7266	20428796	438	443	DiseaseOrPhenotypicFeature	tumor	D009369
7267	20428796	462	468	OrganismTaxon	humans	9606
7268	20428796	470	478	GeneOrGeneProduct	TGF-beta	7040,7042,7043
7269	20428796	593	602	GeneOrGeneProduct	TGF-beta1	4052
7270	20428796	607	616	GeneOrGeneProduct	TGF-beta2	7042
7271	20428796	654	663	GeneOrGeneProduct	TGF-beta3	7043
7272	20428796	697	705	GeneOrGeneProduct	TGF-beta	7040,7042,7043
7273	20428796	741	778	GeneOrGeneProduct	type I and type II TGF-beta receptors	7046,7048
7274	20428796	916	925	GeneOrGeneProduct	TGF-beta1	4052
7275	20428796	949	965	ChemicalEntity	oligonucleotides	D009841
7276	20428796	1013	1021	GeneOrGeneProduct	TGF-beta	7040,7042,7043
7277	20428796	1054	1060	DiseaseOrPhenotypicFeature	keloid	D007627
7278	20428796	1172	1192	GeneOrGeneProduct	TGF-beta1 and -beta2	4052,7042
7279	20428796	1224	1230	DiseaseOrPhenotypicFeature	keloid	D007627
7280	20428796	1270	1279	GeneOrGeneProduct	TGF-beta3	7043
7281	20428796	1287	1298	GeneOrGeneProduct	TGF-betaRII	7048
7282	20428796	1366	1375	GeneOrGeneProduct	TGF-beta1	4052
7283	20428796	1409	1429	GeneOrGeneProduct	TGF-beta1 and -beta2	4052,7042
7284	20428796	1454	1463	GeneOrGeneProduct	TGF-beta2	7042
7285	20428796	1496	1505	GeneOrGeneProduct	TGF-beta3	7043
7286	20428796	1560	1568	OrganismTaxon	patients	9606
7287	20428796	1589	1599	GeneOrGeneProduct	TGF-betaRI	7046
7288	20428796	1653	1664	GeneOrGeneProduct	TGF-betaRII	7048
7289	20428796	1788	1797	GeneOrGeneProduct	TGF-beta1	4052
7290	20428796	1901	1909	GeneOrGeneProduct	TGF-beta	7040,7042,7043
7291	20428796	2135	2143	GeneOrGeneProduct	TGF-beta	7040,7042,7043
7292	20428796	2147	2161	DiseaseOrPhenotypicFeature	keloid disease	D007627
7293	20428796	2253	2267	DiseaseOrPhenotypicFeature	keloid disease	D007627
7294	20431083	0	19	ChemicalEntity	Antithrombotic drug	D005343
7295	20431083	25	45	DiseaseOrPhenotypicFeature	cerebral microbleeds	D002543
7296	20431083	51	75	DiseaseOrPhenotypicFeature	intracerebral hemorrhage	D002543
7297	20431083	159	179	DiseaseOrPhenotypicFeature	Cerebral microbleeds	D002543
7298	20431083	181	183	DiseaseOrPhenotypicFeature	MB	D002543
7299	20431083	216	240	DiseaseOrPhenotypicFeature	intracerebral hemorrhage	D002543
7300	20431083	242	245	DiseaseOrPhenotypicFeature	ICH	D002543
7301	20431083	306	326	ChemicalEntity	antithrombotic drugs	D005343
7302	20431083	372	374	DiseaseOrPhenotypicFeature	MB	D002543
7303	20431083	434	437	DiseaseOrPhenotypicFeature	ICH	D002543
7304	20431083	442	457	DiseaseOrPhenotypicFeature	ischemic stroke	D002544
7305	20431083	459	461	DiseaseOrPhenotypicFeature	IS	D002544
7306	20431083	463	488	DiseaseOrPhenotypicFeature	transient ischemic attack	D002546
7307	20431083	490	493	DiseaseOrPhenotypicFeature	TIA	D002546
7308	20431083	590	596	DiseaseOrPhenotypicFeature	stroke	D020521
7309	20431083	600	603	DiseaseOrPhenotypicFeature	TIA	D002546
7310	20431083	631	633	DiseaseOrPhenotypicFeature	MB	D002543
7311	20431083	695	698	DiseaseOrPhenotypicFeature	ICH	D002543
7312	20431083	742	744	DiseaseOrPhenotypicFeature	IS	D002544
7313	20431083	745	748	DiseaseOrPhenotypicFeature	TIA	D002546
7314	20431083	758	761	DiseaseOrPhenotypicFeature	ICH	D002543
7315	20431083	765	773	DiseaseOrPhenotypicFeature	ischemic	D007511
7316	20431083	898	901	DiseaseOrPhenotypicFeature	ICH	D002543
7317	20431083	931	933	DiseaseOrPhenotypicFeature	MB	D002543
7318	20431083	973	976	DiseaseOrPhenotypicFeature	ICH	D002543
7319	20431083	986	988	DiseaseOrPhenotypicFeature	IS	D002544
7320	20431083	989	992	DiseaseOrPhenotypicFeature	TIA	D002546
7321	20431083	994	996	DiseaseOrPhenotypicFeature	MB	D002543
7322	20431083	1019	1022	DiseaseOrPhenotypicFeature	ICH	D002543
7323	20431083	1026	1028	DiseaseOrPhenotypicFeature	IS	D002544
7324	20431083	1029	1032	DiseaseOrPhenotypicFeature	TIA	D002546
7325	20431083	1223	1231	ChemicalEntity	warfarin	D014859
7326	20431083	1287	1289	DiseaseOrPhenotypicFeature	MB	D002543
7327	20431083	1293	1301	ChemicalEntity	warfarin	D014859
7328	20431083	1325	1328	DiseaseOrPhenotypicFeature	ICH	D002543
7329	20431083	1377	1385	ChemicalEntity	warfarin	D014859
7330	20431083	1397	1399	DiseaseOrPhenotypicFeature	IS	D002544
7331	20431083	1400	1403	DiseaseOrPhenotypicFeature	TIA	D002546
7332	20431083	1489	1491	DiseaseOrPhenotypicFeature	MB	D002543
7333	20431083	1531	1534	DiseaseOrPhenotypicFeature	ICH	D002543
7334	20431083	1626	1628	DiseaseOrPhenotypicFeature	IS	D002544
7335	20431083	1629	1632	DiseaseOrPhenotypicFeature	TIA	D002546
7336	20431083	1756	1758	DiseaseOrPhenotypicFeature	MB	D002543
7337	20431083	1836	1839	DiseaseOrPhenotypicFeature	ICH	D002543
7338	20431083	1906	1908	DiseaseOrPhenotypicFeature	MB	D002543
7339	20431083	1912	1920	ChemicalEntity	warfarin	D014859
7340	20431083	1932	1935	DiseaseOrPhenotypicFeature	ICH	D002543
7341	20431083	1975	1977	DiseaseOrPhenotypicFeature	MB	D002543
7342	20431083	1999	2007	ChemicalEntity	warfarin	D014859
7343	20431083	2019	2022	DiseaseOrPhenotypicFeature	ICH	D002543
7344	20477932	0	7	ChemicalEntity	Cocaine	D003042
7345	20477932	15	46	DiseaseOrPhenotypicFeature	memory and learning impairments	D007859,D008569
7346	20477932	50	54	OrganismTaxon	rats	10116
7347	20477932	71	93	GeneOrGeneProduct	nuclear factor kappa B	81736
7348	20477932	134	144	ChemicalEntity	topiramate	D000077236
7349	20477932	191	198	ChemicalEntity	cocaine	D003042
7350	20477932	199	207	DiseaseOrPhenotypicFeature	toxicity	D064420
7351	20477932	312	319	ChemicalEntity	cocaine	D003042
7352	20477932	360	382	GeneOrGeneProduct	Nuclear factor kappa B	81736
7353	20477932	384	392	GeneOrGeneProduct	NFkappaB	81736
7354	20477932	494	502	DiseaseOrPhenotypicFeature	toxicity	D064420
7355	20477932	539	547	GeneOrGeneProduct	NFkappaB	81736
7356	20477932	576	606	GeneOrGeneProduct	neuronal nitric oxide synthase	24598
7357	20477932	608	612	GeneOrGeneProduct	nNOS	24598
7358	20477932	677	687	ChemicalEntity	topiramate	D000077236
7359	20477932	723	740	DiseaseOrPhenotypicFeature	cocaine addiction	D019970
7360	20477932	785	792	ChemicalEntity	cocaine	D003042
7361	20477932	811	815	OrganismTaxon	rats	10116
7362	20477932	817	825	GeneOrGeneProduct	NFkappaB	81736
7363	20477932	874	881	ChemicalEntity	cocaine	D003042
7364	20477932	890	894	OrganismTaxon	rats	10116
7365	20477932	907	910	ChemicalEntity	GSH	D005978
7366	20477932	929	940	ChemicalEntity	glutathione	D005978
7367	20477932	989	993	GeneOrGeneProduct	nNOS	24598
7368	20477932	1087	1094	ChemicalEntity	cocaine	D003042
7369	20477932	1154	1162	GeneOrGeneProduct	NFkappaB	81736
7370	20477932	1279	1283	GeneOrGeneProduct	nNOS	24598
7371	20477932	1313	1324	ChemicalEntity	glutathione	D005978
7372	20477932	1440	1448	GeneOrGeneProduct	NFkappaB	81736
7373	20477932	1479	1486	ChemicalEntity	cocaine	D003042
7374	20477932	1488	1498	ChemicalEntity	Topiramate	D000077236
7375	20510337	0	12	ChemicalEntity	Coenzyme Q10	C024989
7376	20510337	41	50	ChemicalEntity	cisplatin	D002945
7377	20510337	51	65	DiseaseOrPhenotypicFeature	nephrotoxicity	D007674
7378	20510337	69	73	OrganismTaxon	mice	10090
7379	20510337	106	118	ChemicalEntity	coenzyme Q10	C024989
7380	20510337	139	143	OrganismTaxon	mice	10090
7381	20510337	149	167	DiseaseOrPhenotypicFeature	acute renal injury	D058186
7382	20510337	206	215	ChemicalEntity	cisplatin	D002945
7383	20510337	227	239	ChemicalEntity	Coenzyme Q10	C024989
7384	20510337	329	338	ChemicalEntity	cisplatin	D002945
7385	20510337	355	367	ChemicalEntity	Coenzyme Q10	C024989
7386	20510337	390	409	ChemicalEntity	blood urea nitrogen	D001806
7387	20510337	420	430	ChemicalEntity	creatinine	D003404
7388	20510337	462	471	ChemicalEntity	cisplatin	D002945
7389	20510337	473	485	ChemicalEntity	Coenzyme Q10	C024989
7390	20510337	568	579	ChemicalEntity	glutathione	D005978
7391	20510337	590	610	GeneOrGeneProduct	superoxide dismutase	20655
7392	20510337	633	638	ChemicalEntity	lipid	D008055
7393	20510337	681	708	GeneOrGeneProduct	tumor necrosis factor-alpha	21926
7394	20510337	710	722	ChemicalEntity	nitric oxide	D009569
7395	20510337	727	735	ChemicalEntity	platinum	D010984
7396	20510337	788	796	ChemicalEntity	selenium	D012643
7397	20510337	801	805	ChemicalEntity	zinc	D015032
7398	20510337	841	850	ChemicalEntity	cisplatin	D002945
7399	20510337	891	910	DiseaseOrPhenotypicFeature	renal tissue damage	D007674
7400	20510337	923	932	ChemicalEntity	cisplatin	D002945
7401	20510337	952	964	ChemicalEntity	coenzyme Q10	C024989
7402	20510337	1019	1031	ChemicalEntity	coenzyme Q10	C024989
7403	20510337	1060	1069	ChemicalEntity	cisplatin	D002945
7404	20510337	1106	1127	GeneOrGeneProduct	nitric oxide synthase	18125
7405	20510337	1129	1150	GeneOrGeneProduct	nuclear factor-kappaB	18033
7406	20510337	1152	1161	GeneOrGeneProduct	caspase-3	12367
7407	20510337	1166	1169	GeneOrGeneProduct	p53	22060
7408	20510337	1209	1221	ChemicalEntity	coenzyme Q10	C024989
7409	20510337	1289	1298	ChemicalEntity	cisplatin	D002945
7410	20510337	1299	1313	DiseaseOrPhenotypicFeature	nephrotoxicity	D007674
7411	20523265	21	40	GeneOrGeneProduct	complement factor H	3075
7412	20523265	42	44	GeneOrGeneProduct	C2	717
7413	20523265	46	49	GeneOrGeneProduct	CFB	629
7414	20523265	55	57	GeneOrGeneProduct	C3	718
7415	20523265	62	94	DiseaseOrPhenotypicFeature	age-related macular degeneration	D008268
7416	20523265	176	195	GeneOrGeneProduct	complement factor H	3075
7417	20523265	197	200	GeneOrGeneProduct	CFH	3075
7418	20523265	203	208	GeneOrGeneProduct	C2/BF	629,717
7419	20523265	214	216	GeneOrGeneProduct	C3	718
7420	20523265	259	291	DiseaseOrPhenotypicFeature	age-related macular degeneration	D008268
7421	20523265	293	296	DiseaseOrPhenotypicFeature	AMD	D008268
7422	20523265	500	508	OrganismTaxon	patients	9606
7423	20523265	518	521	DiseaseOrPhenotypicFeature	AMD	D008268
7424	20523265	526	534	OrganismTaxon	patients	9606
7425	20523265	545	551	DiseaseOrPhenotypicFeature	drusen	D005128
7426	20523265	652	655	GeneOrGeneProduct	CFH	3075
7427	20523265	672	674	GeneOrGeneProduct	C2	717
7428	20523265	676	679	GeneOrGeneProduct	CFB	629
7429	20523265	686	688	GeneOrGeneProduct	C3	718
7430	20523265	780	785	GeneOrGeneProduct	CFHR1	3078
7431	20523265	790	795	GeneOrGeneProduct	CFHR3	10878
7432	20523265	906	915	SequenceVariant	rs3753394	rs3753394
7433	20523265	930	938	SequenceVariant	rs800292	rs800292
7434	20523265	953	962	SequenceVariant	rs1061170	rs1061170
7435	20523265	982	991	SequenceVariant	rs1329428	rs1329428
7436	20523265	1009	1012	GeneOrGeneProduct	CFH	3075
7437	20523265	1055	1058	DiseaseOrPhenotypicFeature	AMD	D008268
7438	20523265	1176	1179	DiseaseOrPhenotypicFeature	AMD	D008268
7439	20523265	1298	1307	SequenceVariant	rs2274700	rs2274700
7440	20523265	1312	1321	SequenceVariant	rs1410996	rs1410996
7441	20523265	1366	1369	DiseaseOrPhenotypicFeature	AMD	D008268
7442	20523265	1431	1434	GeneOrGeneProduct	CFH	3075
7443	20523265	1473	1479	DiseaseOrPhenotypicFeature	drusen	D005128
7444	20523265	1505	1508	GeneOrGeneProduct	CFH	3075
7445	20523265	1510	1512	GeneOrGeneProduct	C2	717
7446	20523265	1514	1517	GeneOrGeneProduct	CFB	629
7447	20523265	1523	1525	GeneOrGeneProduct	C3	718
7448	20523265	1575	1578	DiseaseOrPhenotypicFeature	AMD	D008268
7449	20523265	1582	1588	DiseaseOrPhenotypicFeature	drusen	D005128
7450	20523265	1622	1627	GeneOrGeneProduct	CFHR1	3078
7451	20523265	1632	1637	GeneOrGeneProduct	CFHR3	10878
7452	20523265	1725	1728	DiseaseOrPhenotypicFeature	AMD	D008268
7453	20523265	1732	1738	DiseaseOrPhenotypicFeature	drusen	D005128
7454	20523265	1780	1789	SequenceVariant	rs3753394	rs3753394
7455	20523265	1804	1812	SequenceVariant	rs800292	rs800292
7456	20523265	1827	1836	SequenceVariant	rs1061170	rs1061170
7457	20523265	1856	1865	SequenceVariant	rs1329428	rs1329428
7458	20523265	1888	1897	SequenceVariant	rs7535263	rs7535263
7459	20523265	1899	1908	SequenceVariant	rs1410996	rs1410996
7460	20523265	1913	1922	SequenceVariant	rs2274700	rs2274700
7461	20523265	1927	1930	GeneOrGeneProduct	CFH	3075
7462	20523265	1970	1973	DiseaseOrPhenotypicFeature	AMD	D008268
7463	20523265	2035	2038	GeneOrGeneProduct	CFH	3075
7464	20523265	2061	2064	DiseaseOrPhenotypicFeature	AMD	D008268
7465	20523265	2127	2132	GeneOrGeneProduct	CFHR1	3078
7466	20523265	2137	2142	GeneOrGeneProduct	CFHR3	10878
7467	20523265	2262	2265	DiseaseOrPhenotypicFeature	AMD	D008268
7468	20523265	2291	2293	GeneOrGeneProduct	C2	717
7469	20523265	2295	2298	GeneOrGeneProduct	CFB	629
7470	20523265	2304	2306	GeneOrGeneProduct	C3	718
7471	20523265	2351	2354	DiseaseOrPhenotypicFeature	AMD	D008268
7472	20534142	15	22	DiseaseOrPhenotypicFeature	obesity	D009765
7473	20534142	36	41	GeneOrGeneProduct	PCSK1	5122
7474	20534142	47	54	GeneOrGeneProduct	insulin	3630
7475	20534142	71	81	ChemicalEntity	proinsulin	D011384
7476	20534142	106	129	GeneOrGeneProduct	Prohormone convertase 1	5122
7477	20534142	192	197	GeneOrGeneProduct	PCSK1	5122
7478	20534142	237	244	DiseaseOrPhenotypicFeature	obesity	D009765
7479	20534142	249	277	DiseaseOrPhenotypicFeature	abnormal glucose homeostasis	D044882
7480	20534142	292	302	ChemicalEntity	proinsulin	D011384
7481	20534142	383	389	SequenceVariant	rs6232	rs6232
7482	20534142	394	400	SequenceVariant	rs6235	rs6235
7483	20534142	422	429	DiseaseOrPhenotypicFeature	obesity	D009765
7484	20534142	494	512	DiseaseOrPhenotypicFeature	insulin resistance	D007333
7485	20534142	514	535	DiseaseOrPhenotypicFeature	beta-cell dysfunction	-
7486	20534142	540	559	DiseaseOrPhenotypicFeature	glucose intolerance	D018149
7487	20534142	613	619	SequenceVariant	rs6232	rs6232
7488	20534142	624	630	SequenceVariant	rs6235	rs6235
7489	20534142	638	643	GeneOrGeneProduct	PCSK1	5122
7490	20534142	699	706	ChemicalEntity	glucose	D005947
7491	20534142	727	734	ChemicalEntity	glucose	D005947
7492	20534142	736	743	GeneOrGeneProduct	insulin	3630
7493	20534142	745	755	ChemicalEntity	proinsulin	D011384
7494	20534142	761	770	ChemicalEntity	C-peptide	D002096
7495	20534142	824	851	DiseaseOrPhenotypicFeature	hyperinsulinemic-euglycemic	D044903
7496	20534142	916	922	SequenceVariant	rs6235	rs6235
7497	20534142	936	942	SequenceVariant	rs6232	rs6232
7498	20534142	1010	1016	SequenceVariant	rs6235	rs6235
7499	20534142	1021	1027	SequenceVariant	rs6232	rs6232
7500	20534142	1138	1145	GeneOrGeneProduct	insulin	3630
7501	20534142	1191	1201	ChemicalEntity	proinsulin	D011384
7502	20534142	1209	1219	ChemicalEntity	proinsulin	D011384
7503	20534142	1223	1230	GeneOrGeneProduct	insulin	3630
7504	20534142	1232	1238	SequenceVariant	rs6235	rs6235
7505	20534142	1289	1295	SequenceVariant	rs6232	rs6232
7506	20534142	1346	1353	GeneOrGeneProduct	Insulin	3630
7507	20534142	1472	1478	SequenceVariant	rs6232	rs6232
7508	20534142	1565	1572	GeneOrGeneProduct	insulin	3630
7509	20534142	1660	1667	ChemicalEntity	glucose	D005947
7510	20534142	1709	1719	ChemicalEntity	proinsulin	D011384
7511	20534142	1736	1742	SequenceVariant	rs6235	rs6235
7512	20534142	1837	1842	GeneOrGeneProduct	PCSK1	5122
7513	20534142	1886	1893	ChemicalEntity	glucose	D005947
7514	20534142	1905	1915	ChemicalEntity	proinsulin	D011384
7515	20534142	1936	1943	GeneOrGeneProduct	insulin	3630
7516	20534142	1968	1974	SequenceVariant	rs6232	rs6232
7517	20534142	2009	2014	SequenceVariant	N221D	rs6232
7518	20534142	2027	2034	GeneOrGeneProduct	insulin	3630
7519	20534142	2051	2058	ChemicalEntity	glucose	D005947
7520	20534762	27	35	GeneOrGeneProduct	TSH-beta	7252
7521	20534762	60	93	DiseaseOrPhenotypicFeature	congenital central hypothyroidism	D003409
7522	20534762	119	122	GeneOrGeneProduct	TSH	7252
7523	20534762	143	151	OrganismTaxon	Patients	9606
7524	20534762	157	165	GeneOrGeneProduct	TSH-beta	7252
7525	20534762	186	211	DiseaseOrPhenotypicFeature	congenital hypothyroidism	D003409
7526	20534762	226	229	GeneOrGeneProduct	TSH	7252
7527	20534762	395	403	GeneOrGeneProduct	TSH-beta	7252
7528	20534762	430	438	OrganismTaxon	patients	9606
7529	20534762	444	477	DiseaseOrPhenotypicFeature	congenital central hypothyroidism	D003409
7530	20534762	515	521	DiseaseOrPhenotypicFeature	anemia	D000740
7531	20534762	532	539	OrganismTaxon	Patient	9606
7532	20534762	559	565	SequenceVariant	G to A	c|SUB|G||A
7533	20534762	978	985	OrganismTaxon	patient	9606
7534	20534762	1066	1073	SequenceVariant	313delT	c|DEL|313|T
7535	20534762	1075	1086	SequenceVariant	C105Vfs114X	p|FS|C|105|V|114
7536	20534762	1153	1192	SequenceVariant	G for A at cDNA nucleotide position 323	c|SUB|G|323|A
7537	20534762	1209	1213	SequenceVariant	C88Y	p|SUB|C|88|Y
7538	20534762	1299	1333	GeneOrGeneProduct	glycoprotein hormone-beta subunits	122876
7539	20534762	1383	1387	SequenceVariant	C88Y	p|SUB|C|88|Y
7540	20534762	1519	1523	SequenceVariant	C88Y	p|SUB|C|88|Y
7541	20534762	1580	1594	DiseaseOrPhenotypicFeature	TSH deficiency	D007037
7542	20534762	1656	1685	DiseaseOrPhenotypicFeature	isolated pituitary deficiency	C566321
7543	20534762	1760	1782	DiseaseOrPhenotypicFeature	central hypothyroidism	D007037
7544	20534762	1833	1839	DiseaseOrPhenotypicFeature	anemia	D000740
7545	20540798	35	55	GeneOrGeneProduct	phosphodiesterase 4D	5144
7546	20540798	57	62	GeneOrGeneProduct	PDE4D	5144
7547	20540798	67	90	DiseaseOrPhenotypicFeature	carotid atherosclerosis	D002340
7548	20540798	108	128	GeneOrGeneProduct	phosphodiesterase 4D	5144
7549	20540798	130	135	GeneOrGeneProduct	PDE4D	5144
7550	20540798	183	189	DiseaseOrPhenotypicFeature	stroke	D020521
7551	20540798	260	271	DiseaseOrPhenotypicFeature	atherogenic	D050197
7552	20540798	460	475	DiseaseOrPhenotypicFeature	atherosclerosis	D050197
7553	20540798	532	538	DiseaseOrPhenotypicFeature	stroke	D020521
7554	20540798	629	632	OrganismTaxon	men	9606
7555	20540798	983	986	OrganismTaxon	men	9606
7556	20540798	991	996	OrganismTaxon	women	9606
7557	20540798	1078	1086	SequenceVariant	Rs702553	rs702553
7558	20540798	1094	1099	GeneOrGeneProduct	PDE4D	5144
7559	20540798	1156	1162	DiseaseOrPhenotypicFeature	stroke	D020521
7560	20540798	1202	1208	DiseaseOrPhenotypicFeature	stroke	D020521
7561	20540798	1421	1429	SequenceVariant	rs702553	rs702553
7562	20540798	1568	1571	OrganismTaxon	men	9606
7563	20540798	1583	1588	OrganismTaxon	women	9606
7564	20540798	1770	1773	OrganismTaxon	men	9606
7565	20540798	1909	1914	OrganismTaxon	women	9606
7566	20540798	1965	1973	SequenceVariant	rs702553	rs702553
7567	20540798	1990	1998	SequenceVariant	rs702553	rs702553
7568	20540798	2029	2035	DiseaseOrPhenotypicFeature	stroke	D020521
7569	20540798	2036	2039	OrganismTaxon	men	9606
7570	20540798	2073	2078	OrganismTaxon	women	9606
7571	20540798	2164	2169	GeneOrGeneProduct	PDE4D	5144
7572	20540798	2195	2201	DiseaseOrPhenotypicFeature	stroke	D020521
7573	20540798	2256	2269	DiseaseOrPhenotypicFeature	atherogenesis	D050197
7574	20558148	44	58	GeneOrGeneProduct	NMDA receptors	24408
7575	20558148	99	110	ChemicalEntity	haloperidol	D006220
7576	20558148	119	128	DiseaseOrPhenotypicFeature	catalepsy	D002375
7577	20558148	742	751	DiseaseOrPhenotypicFeature	catalepsy	D002375
7578	20558148	767	784	GeneOrGeneProduct	dopamine receptor	24316
7579	20558148	793	804	ChemicalEntity	haloperidol	D006220
7580	20558148	851	855	OrganismTaxon	rats	10116
7581	20558148	857	868	ChemicalEntity	Haloperidol	D006220
7582	20558148	877	886	DiseaseOrPhenotypicFeature	catalepsy	D002375
7583	20558148	948	971	GeneOrGeneProduct	glutamate NMDA receptor	24408
7584	20558148	985	991	ChemicalEntity	MK-801	D016291
7585	20558148	1023	1026	ChemicalEntity	AP7	C031231
7586	20558148	1065	1078	GeneOrGeneProduct	NMDA receptor	24408
7587	20558148	1087	1107	ChemicalEntity	N-methyl-d-aspartate	D016202
7588	20558148	1109	1113	ChemicalEntity	NMDA	D016202
7589	20558148	1200	1206	ChemicalEntity	MK-801	D016291
7590	20558148	1211	1214	ChemicalEntity	AP7	C031231
7591	20558148	1250	1261	ChemicalEntity	haloperidol	D006220
7592	20558148	1291	1300	DiseaseOrPhenotypicFeature	catalepsy	D002375
7593	20558148	1419	1423	ChemicalEntity	NMDA	D016202
7594	20558148	1496	1505	ChemicalEntity	glutamate	D018698
7595	20558148	1575	1586	ChemicalEntity	haloperidol	D006220
7596	20558148	1595	1604	DiseaseOrPhenotypicFeature	catalepsy	D002375
7597	20583543	23	32	DiseaseOrPhenotypicFeature	46,XY DSD	D058490
7598	20583543	63	84	SequenceVariant	8 nucleotide deletion	c|DEL||8
7599	20583543	102	108	GeneOrGeneProduct	SRD5A2	6716
7600	20583543	142	151	DiseaseOrPhenotypicFeature	46,XY DSD	D058490
7601	20583543	407	424	GeneOrGeneProduct	androgen receptor	367
7602	20583543	426	428	GeneOrGeneProduct	AR	367
7603	20583543	434	440	GeneOrGeneProduct	SRD5A2	6716
7604	20583543	467	475	OrganismTaxon	patients	9606
7605	20583543	481	490	DiseaseOrPhenotypicFeature	46,XY DSD	D058490
7606	20583543	610	618	OrganismTaxon	patients	9606
7607	20583543	733	739	GeneOrGeneProduct	SRD5A2	6716
7608	20583543	754	762	OrganismTaxon	patients	9606
7609	20583543	763	770	SequenceVariant	p.R246Q	rs9332967
7610	20583543	868	887	SequenceVariant	g.80_87delT CGCGAAG	g|DEL|80_87|TCGCGAAG
7611	20583543	889	900	SequenceVariant	p.A27fsX132	p|FS|A|27||132
7612	20583543	906	913	SequenceVariant	p.R246Q	rs9332967
7613	20583543	923	930	OrganismTaxon	patient	9606
7614	20583543	936	955	DiseaseOrPhenotypicFeature	isolated micropenis	C536649
7615	20583543	980	987	SequenceVariant	p.G196S	rs121434250
7616	20583543	1010	1012	GeneOrGeneProduct	AR	367
7617	20583543	1080	1087	SequenceVariant	p.R246Q	rs9332967
7618	20583543	1115	1123	OrganismTaxon	patients	9606
7619	20583543	1129	1135	GeneOrGeneProduct	SRD5A2	6716
7620	20583543	1230	1236	GeneOrGeneProduct	SRD5A2	6716
7621	20583543	1247	1254	OrganismTaxon	patient	9606
7622	20583543	1267	1278	DiseaseOrPhenotypicFeature	hypospadias	D007021
7623	20588063	109	134	ChemicalEntity	puromycin aminonucleoside	D011692
7624	20588063	135	144	DiseaseOrPhenotypicFeature	nephrosis	D009401
7625	20588063	219	230	DiseaseOrPhenotypicFeature	proteinuria	D011507
7626	20588063	245	270	ChemicalEntity	puromycin aminonucleoside	D011692
7627	20588063	271	280	DiseaseOrPhenotypicFeature	nephrosis	D009401
7628	20588063	282	285	DiseaseOrPhenotypicFeature	PAN	D009401
7629	20588063	287	291	OrganismTaxon	rats	10116
7630	20588063	418	425	GeneOrGeneProduct	nephrin	64563
7631	20588063	427	436	GeneOrGeneProduct	a-actinin	81634
7632	20588063	438	445	GeneOrGeneProduct	dendrin	25113
7633	20588063	451	458	GeneOrGeneProduct	plekhh2	313866
7634	20588063	725	728	GeneOrGeneProduct	ACE	24310
7635	20588063	816	827	DiseaseOrPhenotypicFeature	proteinuria	D011507
7636	20588063	853	860	GeneOrGeneProduct	nephrin	64563
7637	20588063	1036	1047	DiseaseOrPhenotypicFeature	proteinuria	D011507
7638	20588063	1104	1111	GeneOrGeneProduct	Nephrin	64563
7639	20588063	1137	1144	GeneOrGeneProduct	dendrin	25113
7640	20588063	1149	1156	GeneOrGeneProduct	plekhh2	313866
7641	20588063	1176	1185	GeneOrGeneProduct	a-actinin	81634
7642	20588063	1206	1209	GeneOrGeneProduct	ACE	24310
7643	20588063	1272	1275	DiseaseOrPhenotypicFeature	PAN	D009401
7644	20588063	1357	1368	DiseaseOrPhenotypicFeature	proteinuria	D011507
7645	20588063	1399	1406	GeneOrGeneProduct	nephrin	64563
7646	20588063	1490	1497	GeneOrGeneProduct	dendrin	25113
7647	20588063	1502	1509	GeneOrGeneProduct	plekhh2	313866
7648	20588063	1549	1552	DiseaseOrPhenotypicFeature	PAN	D009401
7649	20588063	1562	1571	GeneOrGeneProduct	a-actinin	81634
7650	20606392	9	34	DiseaseOrPhenotypicFeature	GH insensitivity syndrome	D046150
7651	20606392	46	85	DiseaseOrPhenotypicFeature	insulin-like growth factor-I deficiency	C563867
7652	20606392	140	151	GeneOrGeneProduct	GH receptor	2690
7653	20606392	244	260	DiseaseOrPhenotypicFeature	GH insensitivity	D046150
7654	20606392	265	279	DiseaseOrPhenotypicFeature	IGF deficiency	C563867
7655	20606392	315	326	GeneOrGeneProduct	GH receptor	2690
7656	20606392	328	331	GeneOrGeneProduct	GHR	2690
7657	20606392	377	391	DiseaseOrPhenotypicFeature	growth failure	D006130
7658	20606392	427	445	GeneOrGeneProduct	GH-binding protein	2690
7659	20606392	447	451	GeneOrGeneProduct	GHBP	2690
7660	20606392	479	495	DiseaseOrPhenotypicFeature	GH insensitivity	D046150
7661	20606392	632	634	GeneOrGeneProduct	GH	2688
7662	20606392	672	677	GeneOrGeneProduct	IGF-I	3479
7663	20606392	682	689	GeneOrGeneProduct	IGFBP-3	3486
7664	20606392	716	720	GeneOrGeneProduct	GHBP	2690
7665	20606392	800	803	GeneOrGeneProduct	GHR	2690
7666	20606392	837	842	SequenceVariant	R211H	p|SUB|R|211|H
7667	20606392	903	910	SequenceVariant	899dupC	c|DUP|899|C|
7668	20606392	1017	1022	GeneOrGeneProduct	IGF-I	3479
7669	20606392	1120	1123	GeneOrGeneProduct	GHR	2690
7670	20606392	1138	1154	DiseaseOrPhenotypicFeature	GH insensitivity	D046150
7671	20606392	1159	1173	DiseaseOrPhenotypicFeature	IGF deficiency	C563867
7672	20606392	1214	1218	GeneOrGeneProduct	GHBP	2690
7673	20606392	1273	1275	GeneOrGeneProduct	GH	2688
7674	20606392	1351	1354	GeneOrGeneProduct	GHR	2690
7675	20606392	1393	1397	GeneOrGeneProduct	GHBP	2690
7676	20621845	13	19	GeneOrGeneProduct	ADAM10	29650
7677	20621845	21	27	GeneOrGeneProduct	ADAM17	57027
7678	20621845	29	34	GeneOrGeneProduct	MMP-2	81686
7679	20621845	39	44	GeneOrGeneProduct	MMP-9	81687
7680	20621845	89	94	ChemicalEntity	CaCl2	D002122
7681	20621845	103	127	DiseaseOrPhenotypicFeature	thoracic aortic aneurysm	D017545
7682	20621845	133	136	OrganismTaxon	rat	10116
7683	20621845	192	195	OrganismTaxon	rat	10116
7684	20621845	205	229	DiseaseOrPhenotypicFeature	thoracic aortic aneurysm	D017545
7685	20621845	231	234	DiseaseOrPhenotypicFeature	TAA	D017545
7686	20621845	239	255	ChemicalEntity	calcium chloride	D002122
7687	20621845	257	264	ChemicalEntity	CaCl(2)	D002122
7688	20621845	274	289	DiseaseOrPhenotypicFeature	arterial injury	D014652
7689	20621845	327	362	GeneOrGeneProduct	a disintegrin and metalloproteinase	29650,57027
7690	20621845	364	368	GeneOrGeneProduct	ADAM	29650,57027
7691	20621845	371	396	GeneOrGeneProduct	matrix metalloproteinases	81686;81687
7692	20621845	398	402	GeneOrGeneProduct	MMPs	81686;81687
7693	20621845	447	450	DiseaseOrPhenotypicFeature	TAA	D017545
7694	20621845	509	513	OrganismTaxon	rats	10116
7695	20621845	534	541	ChemicalEntity	CaCl(2)	D002122
7696	20621845	560	564	ChemicalEntity	NaCl	D012965
7697	20621845	611	618	ChemicalEntity	CaCl(2)	D002122
7698	20621845	628	635	ChemicalEntity	CaCl(2)	D002122
7699	20621845	657	661	ChemicalEntity	NaCl	D012965
7700	20621845	752	755	GeneOrGeneProduct	MMP	81686;81687
7701	20621845	756	760	GeneOrGeneProduct	TIMP	116510
7702	20621845	765	769	GeneOrGeneProduct	ADAM	29650,57027
7703	20621845	925	932	ChemicalEntity	CaCl(2)	D002122
7704	20621845	946	953	ChemicalEntity	CaCl(2)	D002122
7705	20621845	966	970	ChemicalEntity	NaCl	D012965
7706	20621845	1167	1174	ChemicalEntity	CaCl(2)	D002122
7707	20621845	1193	1198	GeneOrGeneProduct	MMP-2	81686
7708	20621845	1200	1205	GeneOrGeneProduct	MMP-9	81687
7709	20621845	1207	1214	GeneOrGeneProduct	ADAM-10	29650
7710	20621845	1219	1226	GeneOrGeneProduct	ADAM-17	57027
7711	20621845	1257	1264	ChemicalEntity	CaCl(2)	D002122
7712	20621845	1324	1331	ChemicalEntity	CaCl(2)	D002122
7713	20621845	1369	1373	ChemicalEntity	NaCl	D012965
7714	20621845	1462	1467	GeneOrGeneProduct	MMP-2	81686
7715	20621845	1469	1474	GeneOrGeneProduct	MMP-9	81687
7716	20621845	1476	1483	GeneOrGeneProduct	ADAM-10	29650
7717	20621845	1488	1495	GeneOrGeneProduct	ADAM-17	57027
7718	20621845	1533	1540	ChemicalEntity	CaCl(2)	D002122
7719	20621845	1559	1563	GeneOrGeneProduct	TIMP	116510
7720	20621845	1682	1685	DiseaseOrPhenotypicFeature	TAA	D017545
7721	20621845	1708	1715	ChemicalEntity	CaCl(2)	D002122
7722	20621845	1728	1732	OrganismTaxon	rats	10116
7723	20621845	1792	1797	GeneOrGeneProduct	MMP-2	81686
7724	20621845	1799	1804	GeneOrGeneProduct	MMP-9	81687
7725	20621845	1806	1812	GeneOrGeneProduct	ADAM10	29650
7726	20621845	1817	1823	GeneOrGeneProduct	ADAM17	57027
7727	20651814	28	34	GeneOrGeneProduct	ADRA2B	151
7728	20651814	34	63	SequenceVariant	-4825 gene insertion/deletion	c|INDEL|-4825||
7729	20651814	81	89	DiseaseOrPhenotypicFeature	migraine	D008881
7730	20651814	206	214	DiseaseOrPhenotypicFeature	migraine	D008881
7731	20651814	223	263	SequenceVariant	12-nucleotide insertion/deletion (indel)	c|INDEL||12
7732	20651814	299	328	GeneOrGeneProduct	alpha(2B)-adrenergic receptor	151
7733	20651814	335	341	GeneOrGeneProduct	ADRA2B	151
7734	20651814	440	448	DiseaseOrPhenotypicFeature	migraine	D008881
7735	20651814	623	631	DiseaseOrPhenotypicFeature	migraine	D008881
7736	20651814	773	781	DiseaseOrPhenotypicFeature	migraine	D008881
7737	20651814	898	904	GeneOrGeneProduct	ADRA2B	151
7738	20651814	905	941	SequenceVariant	indel polymorphism at position -4825	c|INDEL|-4825||
7739	20651814	1028	1036	DiseaseOrPhenotypicFeature	migraine	D008881
7740	20682662	23	47	GeneOrGeneProduct	C-C chemokine receptor 5	1234
7741	20682662	48	61	SequenceVariant	DD32 deletion	c|DEL||32
7742	20682662	74	94	DiseaseOrPhenotypicFeature	rheumatoid arthritis	D001172
7743	20682662	96	124	DiseaseOrPhenotypicFeature	systemic lupus erythematosus	D008180
7744	20682662	126	141	DiseaseOrPhenotypicFeature	lupus nephritis	D008181
7745	20682662	176	200	GeneOrGeneProduct	C-C chemokine receptor 5	1234
7746	20682662	202	206	GeneOrGeneProduct	CCR5	1234
7747	20682662	235	247	DiseaseOrPhenotypicFeature	inflammation	D007249
7748	20682662	251	279	SequenceVariant	32 base-pair (DD32) deletion	c|DEL||32
7749	20682662	287	291	GeneOrGeneProduct	CCR5	1234
7750	20682662	438	457	DiseaseOrPhenotypicFeature	autoimmune diseases	D001327
7751	20682662	487	500	SequenceVariant	DD32 deletion	c|DEL||32
7752	20682662	562	570	OrganismTaxon	patients	9606
7753	20682662	576	596	DiseaseOrPhenotypicFeature	rheumatoid arthritis	D001172
7754	20682662	598	600	DiseaseOrPhenotypicFeature	RA	D001172
7755	20682662	603	631	DiseaseOrPhenotypicFeature	systemic lupus erythematosus	D008180
7756	20682662	633	636	DiseaseOrPhenotypicFeature	SLE	D008180
7757	20682662	643	658	DiseaseOrPhenotypicFeature	lupus nephritis	D008181
7758	20682662	660	662	DiseaseOrPhenotypicFeature	LN	D008181
7759	20682662	747	749	DiseaseOrPhenotypicFeature	RA	D001172
7760	20682662	750	758	OrganismTaxon	patients	9606
7761	20682662	763	766	DiseaseOrPhenotypicFeature	SLE	D008180
7762	20682662	767	775	OrganismTaxon	patients	9606
7763	20682662	781	783	DiseaseOrPhenotypicFeature	LN	D008181
7764	20682662	784	792	OrganismTaxon	patients	9606
7765	20682662	842	846	GeneOrGeneProduct	CCR5	1234
7766	20682662	847	860	SequenceVariant	DD32 deletion	c|DEL||32
7767	20682662	918	926	OrganismTaxon	patients	9606
7768	20682662	1110	1118	OrganismTaxon	patients	9606
7769	20682662	1163	1167	GeneOrGeneProduct	CCR5	1234
7770	20682662	1168	1172	SequenceVariant	DD32	c|DEL||32
7771	20682662	1174	1178	SequenceVariant	DD32	c|DEL||32
7772	20682662	1179	1183	SequenceVariant	DD32	c|DEL||32
7773	20682662	1185	1187	DiseaseOrPhenotypicFeature	RA	D001172
7774	20682662	1218	1221	DiseaseOrPhenotypicFeature	SLE	D008180
7775	20682662	1238	1240	DiseaseOrPhenotypicFeature	LN	D008181
7776	20682662	1320	1333	SequenceVariant	DD32 deletion	c|DEL||32
7777	20682662	1354	1356	DiseaseOrPhenotypicFeature	LN	D008181
7778	20682662	1357	1365	OrganismTaxon	patients	9606
7779	20682662	1448	1452	GeneOrGeneProduct	CCR5	1234
7780	20682662	1484	1486	DiseaseOrPhenotypicFeature	RA	D001172
7781	20682662	1488	1491	DiseaseOrPhenotypicFeature	SLE	D008180
7782	20682662	1496	1498	DiseaseOrPhenotypicFeature	LN	D008181
7783	20682662	1541	1543	DiseaseOrPhenotypicFeature	LN	D008181
7784	20682662	1568	1572	GeneOrGeneProduct	CCR5	1234
7785	20682662	1573	1586	SequenceVariant	DD32 deletion	c|DEL||32
7786	20682662	1645	1647	DiseaseOrPhenotypicFeature	RA	D001172
7787	20682662	1649	1652	DiseaseOrPhenotypicFeature	SLE	D008180
7788	20682662	1657	1659	DiseaseOrPhenotypicFeature	LN	D008181
7789	20682662	1690	1703	SequenceVariant	DD32 deletion	c|DEL||32
7790	20705401	0	20	GeneOrGeneProduct	Serotonin 6 receptor	3362
7791	20705401	45	60	ChemicalEntity	methamphetamine	D008694
7792	20705401	69	78	DiseaseOrPhenotypicFeature	psychosis	D011605
7793	20705401	208	227	DiseaseOrPhenotypicFeature	psychotic disorders	D011605
7794	20705401	236	249	DiseaseOrPhenotypicFeature	schizophrenia	D012559
7795	20705401	255	283	GeneOrGeneProduct	serotonin 6 (5-HT6) receptor	3362
7796	20705401	341	355	ChemicalEntity	antipsychotics	D014150
7797	20705401	365	374	ChemicalEntity	clozapine	D003024
7798	20705401	379	389	ChemicalEntity	olanzapine	D000077152
7799	20705401	395	408	ChemicalEntity	d-amphetamine	D003913
7800	20705401	417	430	DiseaseOrPhenotypicFeature	hyperactivity	D006948
7801	20705401	434	438	OrganismTaxon	rats	10116
7802	20705401	480	505	ChemicalEntity	5-HT6 receptor antagonist	D012702
7803	20705401	565	578	ChemicalEntity	d-amphetamine	D003913
7804	20705401	582	595	ChemicalEntity	phencyclidine	D010622
7805	20705401	612	637	ChemicalEntity	5-HT6 receptor antagonist	D012702
7806	20705401	663	667	OrganismTaxon	rats	10116
7807	20705401	741	754	DiseaseOrPhenotypicFeature	schizophrenia	D012559
7808	20705401	801	816	GeneOrGeneProduct	5-HT6 receptors	3362
7809	20705401	856	875	DiseaseOrPhenotypicFeature	psychotic disorders	D011605
7810	20705401	893	908	ChemicalEntity	methamphetamine	D008694
7811	20705401	910	914	ChemicalEntity	METH	D008694
7812	20705401	924	933	DiseaseOrPhenotypicFeature	psychosis	D011605
7813	20705401	958	985	DiseaseOrPhenotypicFeature	paranoid type schizophrenia	D012563
7814	20705401	1049	1054	GeneOrGeneProduct	5-HT6	3362
7815	20705401	1061	1065	GeneOrGeneProduct	HTR6	3362
7816	20705401	1072	1076	ChemicalEntity	METH	D008694
7817	20705401	1085	1094	DiseaseOrPhenotypicFeature	psychosis	D011605
7818	20705401	1129	1138	SequenceVariant	rs6693503	rs6693503
7819	20705401	1140	1149	SequenceVariant	rs1805054	rs1805054
7820	20705401	1151	1160	SequenceVariant	rs4912138	rs4912138
7821	20705401	1162	1171	SequenceVariant	rs3790757	rs3790757
7822	20705401	1176	1185	SequenceVariant	rs9659997	rs9659997
7823	20705401	1261	1265	ChemicalEntity	METH	D008694
7824	20705401	1274	1283	DiseaseOrPhenotypicFeature	psychosis	D011605
7825	20705401	1284	1292	OrganismTaxon	patients	9606
7826	20705401	1412	1427	ChemicalEntity	methamphetamine	D008694
7827	20705401	1439	1447	OrganismTaxon	patients	9606
7828	20705401	1458	1467	SequenceVariant	rs6693503	rs6693503
7829	20705401	1488	1492	ChemicalEntity	METH	D008694
7830	20705401	1501	1510	DiseaseOrPhenotypicFeature	psychosis	D011605
7831	20705401	1511	1519	OrganismTaxon	patients	9606
7832	20705401	1715	1724	SequenceVariant	rs6693503	rs6693503
7833	20705401	1729	1738	SequenceVariant	rs1805054	rs1805054
7834	20705401	1759	1768	SequenceVariant	rs6693503	rs6693503
7835	20705401	1770	1779	SequenceVariant	rs1805054	rs1805054
7836	20705401	1784	1793	SequenceVariant	rs4912138	rs4912138
7837	20705401	1798	1802	GeneOrGeneProduct	HTR6	3362
7838	20705401	1807	1811	ChemicalEntity	METH	D008694
7839	20705401	1820	1829	DiseaseOrPhenotypicFeature	psychosis	D011605
7840	20705401	1830	1838	OrganismTaxon	patients	9606
7841	20705401	1866	1870	GeneOrGeneProduct	HTR6	3362
7842	20705401	1924	1928	ChemicalEntity	METH	D008694
7843	20705401	1937	1946	DiseaseOrPhenotypicFeature	psychosis	D011605
7844	20708777	44	51	GeneOrGeneProduct	CYP11B2	1585
7845	20708777	52	59	GeneOrGeneProduct	CYP11B1	1584
7846	20708777	84	96	DiseaseOrPhenotypicFeature	hypertension	D006973
7847	20708777	109	117	OrganismTaxon	patients	9606
7848	20708777	123	153	DiseaseOrPhenotypicFeature	aldosterone-producing adenomas	D000236
7849	20708777	167	179	DiseaseOrPhenotypicFeature	Hypertension	D006973
7850	20708777	292	304	DiseaseOrPhenotypicFeature	hypertension	D006973
7851	20708777	480	503	GeneOrGeneProduct	steroid synthesis genes	1584,1585
7852	20708777	505	512	GeneOrGeneProduct	CYP11B2	1585
7853	20708777	514	521	GeneOrGeneProduct	CYP11B1	1584
7854	20708777	559	571	DiseaseOrPhenotypicFeature	hypertension	D006973
7855	20708777	583	591	OrganismTaxon	patients	9606
7856	20708777	621	651	DiseaseOrPhenotypicFeature	aldosterone-producing adenomas	D000236
7857	20708777	653	656	DiseaseOrPhenotypicFeature	APA	D000236
7858	20708777	681	689	OrganismTaxon	patients	9606
7859	20708777	695	698	DiseaseOrPhenotypicFeature	APA	D000236
7860	20708777	745	757	DiseaseOrPhenotypicFeature	hypertension	D006973
7861	20708777	763	771	OrganismTaxon	patients	9606
7862	20708777	791	800	SequenceVariant	rs1799998	rs1799998
7863	20708777	802	809	SequenceVariant	C-344 T	rs1799998
7864	20708777	833	839	SequenceVariant	rs4539	rs4539
7865	20708777	841	847	SequenceVariant	A2718G	rs4539
7866	20708777	856	863	GeneOrGeneProduct	CYP11B2	1585
7867	20708777	868	874	SequenceVariant	rs6410	rs6410
7868	20708777	876	882	SequenceVariant	G22 5A	rs6410
7869	20708777	885	891	SequenceVariant	rs6387	rs6387
7870	20708777	893	899	SequenceVariant	A2803G	rs6387
7871	20708777	908	915	GeneOrGeneProduct	CYP11B1	1584
7872	20708777	942	950	GeneOrGeneProduct	CYPB11B2	1585
7873	20708777	951	958	GeneOrGeneProduct	CYP11B1	1584
7874	20708777	1002	1014	DiseaseOrPhenotypicFeature	hypertension	D006973
7875	20708777	1064	1071	GeneOrGeneProduct	CYP11B2	1585
7876	20708777	1072	1079	GeneOrGeneProduct	CYP11B1	1584
7877	20708777	1135	1147	DiseaseOrPhenotypicFeature	hypertension	D006973
7878	20708777	1159	1167	OrganismTaxon	patients	9606
7879	20708777	1198	1201	DiseaseOrPhenotypicFeature	APA	D000236
7880	20708777	1232	1238	SequenceVariant	rs4539	rs4539
7881	20708777	1302	1314	DiseaseOrPhenotypicFeature	hypertension	D006973
7882	20708777	1480	1492	DiseaseOrPhenotypicFeature	hypertension	D006973
7883	20708777	1595	1607	DiseaseOrPhenotypicFeature	hypertension	D006973
7884	20708777	1629	1641	DiseaseOrPhenotypicFeature	hypertension	D006973
7885	20708777	1672	1684	DiseaseOrPhenotypicFeature	hypertension	D006973
7886	20708777	1763	1769	SequenceVariant	rs4539	rs4539
7887	20708777	1847	1859	DiseaseOrPhenotypicFeature	hypertension	D006973
7888	20708777	1872	1880	OrganismTaxon	patients	9606
7889	20708777	1911	1914	DiseaseOrPhenotypicFeature	APA	D000236
7890	20708777	1937	1947	GeneOrGeneProduct	CYP11B2/B1	1584,1585
7891	20708777	1997	2009	DiseaseOrPhenotypicFeature	hypertension	D006973
7892	20708777	2013	2021	OrganismTaxon	patients	9606
7893	20708777	2027	2030	DiseaseOrPhenotypicFeature	APA	D000236
7894	20709368	4	20	GeneOrGeneProduct	fibrinogen gamma	2266
7895	20709368	21	29	SequenceVariant	10034C>T	rs2066865
7896	20709368	66	93	DiseaseOrPhenotypicFeature	Peripheral Arterial Disease	D058729
7897	20709368	109	119	GeneOrGeneProduct	fibrinogen	2243,2244,2266
7898	20709368	123	129	GeneOrGeneProduct	fibrin	2243,2244,2266
7899	20709368	204	210	GeneOrGeneProduct	fibrin	2243,2244,2266
7900	20709368	217	227	GeneOrGeneProduct	Fibrinogen	2243,2244,2266
7901	20709368	317	333	GeneOrGeneProduct	fibrinogen alpha	2243
7902	20709368	335	338	GeneOrGeneProduct	FGA	2243
7903	20709368	341	356	GeneOrGeneProduct	fibrinogen beta	2244
7904	20709368	358	361	GeneOrGeneProduct	FGB	2244
7905	20709368	367	383	GeneOrGeneProduct	fibrinogen gamma	2266
7906	20709368	385	388	GeneOrGeneProduct	FGG	2266
7907	20709368	479	482	GeneOrGeneProduct	FGG	2266
7908	20709368	489	492	GeneOrGeneProduct	FGG	2266
7909	20709368	493	501	SequenceVariant	10034C>T	rs2066865
7910	20709368	503	512	SequenceVariant	rs2066865	rs2066865
7911	20709368	539	561	DiseaseOrPhenotypicFeature	deep venous thrombosis	D020246
7912	20709368	566	587	DiseaseOrPhenotypicFeature	myocardial infarction	D009203
7913	20709368	662	689	DiseaseOrPhenotypicFeature	peripheral arterial disease	D058729
7914	20709368	691	694	DiseaseOrPhenotypicFeature	PAD	D058729
7915	20709368	756	764	OrganismTaxon	patients	9606
7916	20709368	781	784	DiseaseOrPhenotypicFeature	PAD	D058729
7917	20709368	811	814	GeneOrGeneProduct	FGG	2266
7918	20709368	873	876	GeneOrGeneProduct	FGG	2266
7919	20709368	939	942	DiseaseOrPhenotypicFeature	PAD	D058729
7920	20709368	943	951	OrganismTaxon	patients	9606
7921	20709368	1123	1131	DiseaseOrPhenotypicFeature	diabetes	D003920
7922	20709368	1142	1154	DiseaseOrPhenotypicFeature	hypertension	D006973
7923	20709368	1159	1179	DiseaseOrPhenotypicFeature	hypercholesterolemia	D006937
7924	20709368	1185	1188	GeneOrGeneProduct	FGG	2266
7925	20709368	1189	1196	SequenceVariant	10034 T	rs2066865
7926	20709368	1259	1262	DiseaseOrPhenotypicFeature	PAD	D058729
7927	20709368	1333	1336	GeneOrGeneProduct	FGG	2266
7928	20709368	1337	1345	SequenceVariant	10034C>T	rs2066865
7929	20709368	1411	1414	DiseaseOrPhenotypicFeature	PAD	D058729
7930	20709368	1451	1454	GeneOrGeneProduct	FGG	2266
7931	20709368	1455	1462	SequenceVariant	10034 T	rs2066865
7932	20709368	1529	1532	DiseaseOrPhenotypicFeature	PAD	D058729
7933	20722491	10	22	ChemicalEntity	capecitabine	D000069287
7934	20722491	59	76	ChemicalEntity	Fluoropyrimidines	-
7935	20722491	92	106	ChemicalEntity	5-fluorouracil	D005472
7936	20722491	108	112	ChemicalEntity	5-FU	D005472
7937	20722491	169	175	DiseaseOrPhenotypicFeature	tumors	D009369
7938	20722491	187	231	DiseaseOrPhenotypicFeature	colorectal, breast and head and neck cancers	D001943,D006258,D015179
7939	20722491	333	345	ChemicalEntity	capecitabine	D000069287
7940	20722491	467	479	ChemicalEntity	capecitabine	D000069287
7941	20722491	511	519	OrganismTaxon	patients	9606
7942	20722491	539	563	DiseaseOrPhenotypicFeature	renal and kidney disease	D007674
7943	20722491	615	627	ChemicalEntity	capecitabine	D000069287
7944	20722491	663	675	ChemicalEntity	Capecitabine	D000069287
7945	20722491	698	702	ChemicalEntity	5-FU	D005472
7946	20722491	913	998	DiseaseOrPhenotypicFeature	colorectal, breast, pancreaticobiliary, gastric, renal cell and head and neck cancers	D001943,D002292,D006258,D010190,D013274,D015179
7947	20722491	1044	1056	ChemicalEntity	capecitabine	D000069287
7948	20722491	1061	1069	DiseaseOrPhenotypicFeature	diarrhea	D003967
7949	20722491	1071	1077	DiseaseOrPhenotypicFeature	nausea	D009325
7950	20722491	1079	1087	DiseaseOrPhenotypicFeature	vomiting	D014839
7951	20722491	1089	1099	DiseaseOrPhenotypicFeature	stomatitis	D013280
7952	20722491	1104	1122	DiseaseOrPhenotypicFeature	hand-foot syndrome	D060831
7953	20722491	1124	1136	ChemicalEntity	Capecitabine	D000069287
7954	20722491	1202	1210	OrganismTaxon	patients	9606
7955	20722491	1230	1260	DiseaseOrPhenotypicFeature	hepatic and renal dysfunctions	D007674,D008107
7956	20801104	61	65	GeneOrGeneProduct	DRD4	1815
7957	20801104	71	84	DiseaseOrPhenotypicFeature	schizophrenia	D012559
7958	20801104	86	96	DiseaseOrPhenotypicFeature	depression	D003866
7959	20801104	102	118	DiseaseOrPhenotypicFeature	heroin addiction	D006556
7960	20801104	238	258	GeneOrGeneProduct	dopamine D4 receptor	1815
7961	20801104	260	264	GeneOrGeneProduct	DRD4	1815
7962	20801104	275	288	DiseaseOrPhenotypicFeature	schizophrenia	D012559
7963	20801104	290	300	DiseaseOrPhenotypicFeature	depression	D003866
7964	20801104	306	322	DiseaseOrPhenotypicFeature	heroin addiction	D006556
7965	20801104	399	407	OrganismTaxon	patients	9606
7966	20801104	413	426	DiseaseOrPhenotypicFeature	schizophrenia	D012559
7967	20801104	432	440	OrganismTaxon	patients	9606
7968	20801104	446	456	DiseaseOrPhenotypicFeature	depression	D003866
7969	20801104	462	470	OrganismTaxon	patients	9606
7970	20801104	476	492	DiseaseOrPhenotypicFeature	heroin addiction	D006556
7971	20801104	573	577	GeneOrGeneProduct	DRD4	1815
7972	20801104	579	598	SequenceVariant	-120 bp duplication	c|DUP|-120||
7973	20801104	600	607	SequenceVariant	-616C/G	rs747302
7974	20801104	613	620	SequenceVariant	-521C/T	rs1800955
7975	20801104	824	843	SequenceVariant	-120 bp duplication	c|DUP|-120||
7976	20801104	868	881	DiseaseOrPhenotypicFeature	schizophrenia	D012559
7977	20801104	914	923	SequenceVariant	-1240 L/S	p|SUB|L|-1240|S
7978	20801104	932	954	DiseaseOrPhenotypicFeature	paranoid schizophrenia	D012563
7979	20801104	1014	1022	SequenceVariant	-521 C/T	rs1800955
7980	20801104	1047	1064	DiseaseOrPhenotypicFeature	heroin dependence	D006556
7981	20801104	1122	1141	SequenceVariant	-120-bp duplication	c|DUP|-120||
7982	20801104	1158	1162	GeneOrGeneProduct	DRD4	1815
7983	20801104	1182	1195	DiseaseOrPhenotypicFeature	schizophrenia	D012559
7984	20801104	1209	1217	SequenceVariant	-521 C/T	rs1800955
7985	20801104	1250	1266	DiseaseOrPhenotypicFeature	heroin addiction	D006556
7986	20801540	22	26	ChemicalEntity	iron	D007501
7987	20801540	50	61	ChemicalEntity	deferasirox	D000077588
7988	20801540	65	83	DiseaseOrPhenotypicFeature	aceruloplasminemia	C536004
7989	20801540	137	155	DiseaseOrPhenotypicFeature	Aceruloplasminemia	C536004
7990	20801540	166	211	DiseaseOrPhenotypicFeature	autosomal recessive neurodegenerative disease	D020271
7991	20801540	244	248	ChemicalEntity	iron	D007501
7992	20801540	292	310	DiseaseOrPhenotypicFeature	movement disorders	D009069
7993	20801540	312	332	DiseaseOrPhenotypicFeature	retinal degeneration	D012162
7994	20801540	338	355	DiseaseOrPhenotypicFeature	diabetes mellitus	D003920
7995	20801540	357	370	GeneOrGeneProduct	Ceruloplasmin	1356
7996	20801540	389	400	ChemicalEntity	ferroxidase	-
7997	20801540	455	459	ChemicalEntity	iron	D007501
7998	20801540	471	475	ChemicalEntity	iron	D007501
7999	20801540	487	498	GeneOrGeneProduct	transferrin	7018
8000	20801540	528	541	GeneOrGeneProduct	ceruloplasmin	1356
8001	20801540	557	568	SequenceVariant	c.2554+1G>T	c|SUB|G|2554+1|T
8002	20801540	601	619	DiseaseOrPhenotypicFeature	aceruloplasminemia	C536004
8003	20801540	676	694	DiseaseOrPhenotypicFeature	movement disorders	D009069
8004	20801540	699	707	DiseaseOrPhenotypicFeature	diabetes	D003920
8005	20801540	795	826	SequenceVariant	deletion of amino acids 809-852	c|DEL|809_852|
8006	20801540	924	932	OrganismTaxon	patients	9606
8007	20801540	988	1006	DiseaseOrPhenotypicFeature	Aceruloplasminemia	C536004
8008	20801540	1050	1063	DiseaseOrPhenotypicFeature	iron overload	D019190
8009	20801540	1102	1106	ChemicalEntity	iron	D007501
8010	20801540	1115	1123	GeneOrGeneProduct	hepcidin	57817
8011	20801540	1170	1183	DiseaseOrPhenotypicFeature	iron overload	D019190
8012	20801540	1193	1197	ChemicalEntity	iron	D007501
8013	20801540	1246	1250	ChemicalEntity	iron	D007501
8014	20801540	1274	1285	ChemicalEntity	deferasirox	D000077588
8015	20801540	1326	1333	GeneOrGeneProduct	insulin	3630
8016	20801540	1446	1459	DiseaseOrPhenotypicFeature	iron overload	D019190
8017	20801540	1474	1492	DiseaseOrPhenotypicFeature	Aceruloplasminemia	C536004
8018	20801540	1570	1574	ChemicalEntity	iron	D007501
8019	20801540	1619	1623	ChemicalEntity	Iron	D007501
8020	20801540	1640	1658	DiseaseOrPhenotypicFeature	aceruloplasminemia	C536004
8021	20801540	1693	1697	ChemicalEntity	iron	D007501
8022	20801540	1712	1720	GeneOrGeneProduct	hepcidin	57817
8023	20801540	1765	1778	DiseaseOrPhenotypicFeature	iron overload	D019190
8024	20801540	1780	1784	ChemicalEntity	Iron	D007501
8025	20801540	1800	1811	ChemicalEntity	deferasirox	D000077588
8026	20801540	1848	1852	ChemicalEntity	iron	D007501
8027	20801540	1880	1884	ChemicalEntity	iron	D007501
8028	20828385	42	54	ChemicalEntity	temsirolimus	C401859
8029	20828385	69	89	DiseaseOrPhenotypicFeature	mantle cell lymphoma	D020522
8030	20828385	91	111	DiseaseOrPhenotypicFeature	Mantle cell lymphoma	D020522
8031	20828385	113	116	DiseaseOrPhenotypicFeature	MCL	D020522
8032	20828385	151	180	DiseaseOrPhenotypicFeature	B-cell non-Hodgkin's lymphoma	D008228
8033	20828385	182	190	OrganismTaxon	Patients	9606
8034	20828385	353	356	DiseaseOrPhenotypicFeature	MCL	D020522
8035	20828385	370	382	ChemicalEntity	temsirolimus	C401859
8036	20828385	386	390	GeneOrGeneProduct	mTOR	2475
8037	20828385	459	462	DiseaseOrPhenotypicFeature	MCL	D020522
8038	20828385	471	476	DiseaseOrPhenotypicFeature	tumor	D009369
8039	20828385	505	517	ChemicalEntity	temsirolimus	C401859
8040	20828385	652	664	ChemicalEntity	temsirolimus	C401859
8041	20828385	717	729	ChemicalEntity	temsirolimus	C401859
8042	20828385	740	745	DiseaseOrPhenotypicFeature	tumor	D009369
8043	20828385	849	854	DiseaseOrPhenotypicFeature	tumor	D009369
8044	20828385	897	909	ChemicalEntity	temsirolimus	C401859
8045	20828385	956	961	DiseaseOrPhenotypicFeature	tumor	D009369
8046	20828385	989	993	GeneOrGeneProduct	VEGF	7422
8047	20828385	1083	1091	DiseaseOrPhenotypicFeature	necrotic	D009336
8048	20828385	1132	1144	ChemicalEntity	temsirolimus	C401859
8049	20828385	1160	1172	ChemicalEntity	temsirolimus	C401859
8050	20828385	1181	1186	DiseaseOrPhenotypicFeature	tumor	D009369
8051	20828385	1272	1284	ChemicalEntity	temsirolimus	C401859
8052	20828385	1288	1293	DiseaseOrPhenotypicFeature	tumor	D009369
8053	20828385	1368	1371	DiseaseOrPhenotypicFeature	MCL	D020522
8054	20846357	24	35	GeneOrGeneProduct	connexin 26	2706
8055	20846357	42	46	GeneOrGeneProduct	GJB2	2706
8056	20846357	102	146	DiseaseOrPhenotypicFeature	keratitis-ichthyosis-deafness (KID) syndrome	C536168
8057	20846357	160	204	DiseaseOrPhenotypicFeature	Keratitis-ichthyosis-deafness (KID) syndrome	C536168
8058	20846357	215	245	DiseaseOrPhenotypicFeature	congenital ectodermal disorder	D004476
8059	20846357	291	295	GeneOrGeneProduct	GJB2	2706
8060	20846357	331	342	GeneOrGeneProduct	connexin 26	2706
8061	20846357	374	384	SequenceVariant	p.Asp50Asn	rs28931594
8062	20846357	611	623	DiseaseOrPhenotypicFeature	KID syndrome	C536168
8063	20846357	720	724	GeneOrGeneProduct	GJB2	2706
8064	20846357	821	839	DiseaseOrPhenotypicFeature	hearing impairment	D034381
8065	20846357	841	867	DiseaseOrPhenotypicFeature	ichthyosiform erythroderma	D016113
8066	20846357	897	921	DiseaseOrPhenotypicFeature	palmoplantar keratoderma	D007645
8067	20846357	923	958	DiseaseOrPhenotypicFeature	alopecia of the scalp and eyelashes	D000505
8068	20846357	1068	1080	DiseaseOrPhenotypicFeature	KID syndrome	C536168
8069	20846357	1090	1100	DiseaseOrPhenotypicFeature	acanthosis	D000052
8070	20846357	1105	1119	DiseaseOrPhenotypicFeature	papillomatosis	D010212
8071	20846357	1155	1169	DiseaseOrPhenotypicFeature	hyperkeratosis	D017488
8072	20846357	1231	1240	ChemicalEntity	acitretin	D017255
8073	20846357	1270	1316	DiseaseOrPhenotypicFeature	intraventricular and intracerebral haemorrhage	D000074042,D002543
8074	20846357	1329	1342	DiseaseOrPhenotypicFeature	hydrocephalus	D006849
8075	20846357	1385	1396	DiseaseOrPhenotypicFeature	septicaemia	D018805
8076	20846357	1401	1411	DiseaseOrPhenotypicFeature	meningitis	D008581
8077	20846357	1422	1431	DiseaseOrPhenotypicFeature	infection	D007239
8078	20846357	1480	1501	DiseaseOrPhenotypicFeature	Klebsiella pneumoniae	D007710
8079	20846357	1510	1529	DiseaseOrPhenotypicFeature	respiratory failure	D012131
8080	20846357	1632	1636	GeneOrGeneProduct	GJB2	2706
8081	20846357	1712	1720	SequenceVariant	c.263C>T	c|SUB|C|263|T
8082	20846357	1762	1795	SequenceVariant	alanine for valine at position 88	p|SUB|A|88|V
8083	20846357	1797	1807	SequenceVariant	p.Ala88Val	p|SUB|A|88|V
8084	20846357	1892	1896	GeneOrGeneProduct	Cx26	2706
8085	20846357	1903	1911	SequenceVariant	c.263C>T	c|SUB|C|263|T
8086	20846357	1913	1923	SequenceVariant	p.Ala88Val	p|SUB|A|88|V
8087	20846357	1936	1948	DiseaseOrPhenotypicFeature	KID syndrome	C536168
8088	20854438	0	6	GeneOrGeneProduct	SLURP1	57152
8089	20854438	60	73	DiseaseOrPhenotypicFeature	mal de Meleda	D007645
8090	20854438	87	100	DiseaseOrPhenotypicFeature	Mal de Meleda	D007645
8091	20854438	102	105	DiseaseOrPhenotypicFeature	MDM	D007645
8092	20854438	110	141	DiseaseOrPhenotypicFeature	palmoplantar erythrokeratoderma	C563781
8093	20854438	231	238	GeneOrGeneProduct	SLURP-1	57152
8094	20854438	240	260	GeneOrGeneProduct	lymphocyte antigen 6	57152
8095	20854438	261	324	GeneOrGeneProduct	urokinase-type plasminogen activator receptor related protein-1	57152
8096	20854438	327	334	GeneOrGeneProduct	SLURP-1	57152
8097	20854438	367	399	GeneOrGeneProduct	nicotinic acetylcholine receptor	1137
8098	20854438	401	406	GeneOrGeneProduct	nAchR	1137
8099	20854438	461	467	OrganismTaxon	murine	10090
8100	20854438	492	497	GeneOrGeneProduct	nAchR	11441
8101	20854438	587	595	OrganismTaxon	patients	9606
8102	20854438	616	622	GeneOrGeneProduct	SLURP1	57152
8103	20854438	683	691	DiseaseOrPhenotypicFeature	melanoma	D008545
8104	20854438	696	711	DiseaseOrPhenotypicFeature	viral infection	D014777
8105	20854438	860	866	GeneOrGeneProduct	SLURP1	57152
8106	20854438	931	934	DiseaseOrPhenotypicFeature	MDM	D007645
8107	20854438	949	956	GeneOrGeneProduct	SLURP-1	57152
8108	20854438	1002	1007	OrganismTaxon	Human	9606
8109	20854438	1082	1085	DiseaseOrPhenotypicFeature	MDM	D007645
8110	20854438	1105	1142	SequenceVariant	G to A substitution in nucleotide 256	rs28937888
8111	20854438	1150	1156	GeneOrGeneProduct	SLURP1	57152
8112	20854438	1182	1231	SequenceVariant	glycine to arginine substitution at amino acid 86	rs28937888
8113	20854438	1233	1237	SequenceVariant	G86R	rs28937888
8114	20854438	1246	1253	GeneOrGeneProduct	SLURP-1	57152
8115	20854438	1335	1338	GeneOrGeneProduct	CD3	915
8116	20854438	1344	1348	GeneOrGeneProduct	CD28	940
8117	20854438	1488	1495	GeneOrGeneProduct	SLURP-1	57152
8118	20854438	1496	1500	SequenceVariant	G86R	rs28937888
8119	20854438	1606	1611	OrganismTaxon	human	9606
8120	20854438	1612	1619	GeneOrGeneProduct	SLURP-1	57152
8121	20854438	1642	1650	OrganismTaxon	Patients	9606
8122	20854438	1656	1659	DiseaseOrPhenotypicFeature	MDM	D007645
8123	20854438	1680	1687	GeneOrGeneProduct	SLURP-1	57152
8124	20854438	1688	1692	SequenceVariant	G86R	rs28937888
8125	20854438	1768	1775	GeneOrGeneProduct	SLURP-1	57152
8126	20859899	0	7	DiseaseOrPhenotypicFeature	Syncope	D013575
8127	20859899	18	30	DiseaseOrPhenotypicFeature	hyperkalemia	D006947
8128	20859899	73	112	ChemicalEntity	angiotensin-converting enzyme inhibitor	D000806
8129	20859899	117	131	ChemicalEntity	spironolactone	D013148
8130	20859899	147	152	OrganismTaxon	woman	9606
8131	20859899	213	234	DiseaseOrPhenotypicFeature	myocardial infarction	D009203
8132	20859899	278	299	DiseaseOrPhenotypicFeature	loss of consciousness	D014474
8133	20859899	314	325	DiseaseOrPhenotypicFeature	bradycardia	D001919
8134	20859899	336	348	DiseaseOrPhenotypicFeature	hyperkalemia	D006947
8135	20859899	377	386	ChemicalEntity	potassium	D011188
8136	20859899	464	473	ChemicalEntity	potassium	D011188
8137	20859899	494	506	DiseaseOrPhenotypicFeature	hyperkalemia	D006947
8138	20859899	545	559	ChemicalEntity	spiranolactone	D013148
8139	20859899	564	575	ChemicalEntity	aldosterone	D000450
8140	20859899	627	635	ChemicalEntity	ramipril	D017257
8141	20859899	640	643	GeneOrGeneProduct	ACE	1636
8142	20859899	804	816	DiseaseOrPhenotypicFeature	hyperkalemia	D006947
8143	20859899	840	848	OrganismTaxon	patients	9606
8144	20859899	855	858	GeneOrGeneProduct	ACE	1636
8145	20859899	859	862	ChemicalEntity	ARB	D057911
8146	20859899	883	892	ChemicalEntity	potassium	D011188
8147	20859899	926	943	DiseaseOrPhenotypicFeature	renal disturbance	D007674
8148	20949073	531	546	DiseaseOrPhenotypicFeature	cystic fibrosis	D003550
8149	20949073	547	555	OrganismTaxon	patients	9606
8150	20949073	575	580	SequenceVariant	E831X	rs397508387
8151	20949073	591	598	SequenceVariant	2623G>T	rs397508387
8152	20949073	607	611	GeneOrGeneProduct	CFTR	1080
8153	20959502	45	55	ChemicalEntity	daptomycin	D017576
8154	20959502	69	90	OrganismTaxon	Staphylococcus aureus	1280
8155	20959502	91	101	DiseaseOrPhenotypicFeature	meningitis	D008581
8156	20959502	134	145	ChemicalEntity	methicillin	D008712
8157	20959502	156	177	OrganismTaxon	Staphylococcus aureus	1280
8158	20959502	185	195	DiseaseOrPhenotypicFeature	bacteremia	D016470
8159	20959502	216	226	DiseaseOrPhenotypicFeature	meningitis	D008581
8160	20959502	250	260	ChemicalEntity	daptomycin	D017576
8161	20959502	426	434	DiseaseOrPhenotypicFeature	weakness	D018908
8162	20959502	471	480	DiseaseOrPhenotypicFeature	pneumonia	D011014
8163	20959502	549	559	ChemicalEntity	vancomycin	D014640
8164	20959502	561	573	ChemicalEntity	levofloxacin	D064704
8165	20959502	579	602	ChemicalEntity	piperacillin/tazobactam	D000077725
8166	20959502	628	637	OrganismTaxon	S. aureus	1280
8167	20959502	653	662	ChemicalEntity	oxacillin	D010068
8168	20959502	672	682	ChemicalEntity	antibiotic	D000900
8169	20959502	709	718	ChemicalEntity	nafcillin	D009254
8170	20959502	743	750	OrganismTaxon	patient	9606
8171	20959502	761	780	DiseaseOrPhenotypicFeature	acute renal failure	D058186
8172	20959502	788	798	ChemicalEntity	creatinine	D003404
8173	20959502	885	892	OrganismTaxon	patient	9606
8174	20959502	903	907	DiseaseOrPhenotypicFeature	Coma	D003128
8175	20959502	1021	1035	DiseaseOrPhenotypicFeature	cardiac arrest	D006323
8176	20959502	1051	1058	OrganismTaxon	patient	9606
8177	20959502	1086	1096	DiseaseOrPhenotypicFeature	bacteremia	D016470
8178	20959502	1138	1176	DiseaseOrPhenotypicFeature	central nervous system (CNS) infection	D002494
8179	20959502	1178	1187	ChemicalEntity	Nafcillin	D009254
8180	20959502	1209	1219	ChemicalEntity	daptomycin	D017576
8181	20959502	1262	1272	DiseaseOrPhenotypicFeature	meningitis	D008581
8182	20959502	1301	1308	OrganismTaxon	patient	9606
8183	20959502	1311	1316	DiseaseOrPhenotypicFeature	death	D003643
8184	20959502	1328	1338	ChemicalEntity	Daptomycin	D017576
8185	20959502	1543	1558	GeneOrGeneProduct	Creatine kinase	1152
8186	20959502	1587	1597	ChemicalEntity	daptomycin	D017576
8187	20959502	1643	1653	ChemicalEntity	Daptomycin	D017576
8188	20959502	1675	1682	OrganismTaxon	patient	9606
8189	20959502	1705	1714	ChemicalEntity	nafcillin	D009254
8190	20959502	1729	1751	DiseaseOrPhenotypicFeature	interstitial nephritis	D009395
8191	20959502	1766	1776	DiseaseOrPhenotypicFeature	bacteremia	D016470
8192	20959502	1928	1938	ChemicalEntity	daptomycin	D017576
8193	20959502	1977	1987	DiseaseOrPhenotypicFeature	bacteremia	D016470
8194	20959502	2020	2028	OrganismTaxon	patients	9606
8195	20959502	2113	2121	OrganismTaxon	patients	9606
8196	20959502	2137	2147	DiseaseOrPhenotypicFeature	meningitis	D008581
8197	20973483	35	71	ChemicalEntity	adenosine A2A/A1 receptor antagonist	D058915
8198	20973483	92	111	DiseaseOrPhenotypicFeature	Parkinson's disease	D010300
8199	20973483	152	192	ChemicalEntity	adenosine A(2A)/A(1) receptor antagonist	D058915
8200	20973483	221	240	DiseaseOrPhenotypicFeature	Parkinson's disease	D010300
8201	20973483	441	471	ChemicalEntity	A(2A)/A(1) receptor antagonist	D058915
8202	20973483	616	635	DiseaseOrPhenotypicFeature	Parkinson's disease	D010300
8203	20973483	646	651	OrganismTaxon	mouse	10090
8204	20973483	656	659	OrganismTaxon	rat	10116
8205	20973483	670	681	ChemicalEntity	haloperidol	D006220
8206	20973483	690	699	DiseaseOrPhenotypicFeature	catalepsy	D002375
8207	20973483	701	706	OrganismTaxon	mouse	10090
8208	20973483	716	725	ChemicalEntity	reserpine	D012110
8209	20973483	734	742	DiseaseOrPhenotypicFeature	akinesia	D004409
8210	20973483	744	747	OrganismTaxon	rat	10116
8211	20973483	748	765	ChemicalEntity	6-hydroxydopamine	D016627
8212	20973483	767	773	ChemicalEntity	6-OHDA	D016627
8213	20973483	818	822	ChemicalEntity	MPTP	D015632
8214	20973483	835	840	OrganismTaxon	human	9606
8215	21042587	9	32	GeneOrGeneProduct	glucocorticoid receptor	2908
8216	21042587	86	105	DiseaseOrPhenotypicFeature	adrenal hyperplasia	D000312
8217	21042587	110	143	DiseaseOrPhenotypicFeature	apparent mineralocorticoid excess	C537422
8218	21042587	153	178	DiseaseOrPhenotypicFeature	glucocorticoid resistance	C564221
8219	21042587	180	191	DiseaseOrPhenotypicFeature	OMIM 138040	OMIM:138040
8220	21042587	203	221	DiseaseOrPhenotypicFeature	hereditary disease	D030342
8221	21042587	273	287	ChemicalEntity	glucocorticoid	D005938
8222	21042587	330	353	GeneOrGeneProduct	glucocorticoid receptor	2908
8223	21042587	355	357	GeneOrGeneProduct	GR	2908
8224	21042587	377	399	DiseaseOrPhenotypicFeature	adrenal incidentalomas	C538238
8225	21042587	499	518	DiseaseOrPhenotypicFeature	cortisol resistance	C535280
8226	21042587	520	549	DiseaseOrPhenotypicFeature	bilateral adrenal hyperplasia	D000312
8227	21042587	560	572	DiseaseOrPhenotypicFeature	hypertension	D006973
8228	21042587	577	588	DiseaseOrPhenotypicFeature	hypokalemia	D007008
8229	21042587	687	698	SequenceVariant	p.R469[R,X]	p|SUB|R|469|X
8230	21042587	724	726	GeneOrGeneProduct	GR	2908
8231	21042587	741	789	SequenceVariant	arginine (CGA) by a stop (TGA) at amino-acid 469	p|SUB|R|469|X
8232	21042587	911	913	GeneOrGeneProduct	GR	2908
8233	21042587	1183	1185	GeneOrGeneProduct	GR	2908
8234	21042587	1239	1241	GeneOrGeneProduct	GR	2908
8235	21042587	1279	1281	GeneOrGeneProduct	GR	2908
8236	21042587	1344	1358	ChemicalEntity	glucocorticoid	D005938
8237	21042587	1381	1386	GeneOrGeneProduct	FKBP5	2289
8238	21042587	1452	1466	ChemicalEntity	glucocorticoid	D005938
8239	21042587	1498	1500	GeneOrGeneProduct	GR	2908
8240	21042587	1568	1570	GeneOrGeneProduct	GR	2908
8241	21042587	1658	1665	ChemicalEntity	emetine	D004640
8242	21042587	1699	1701	GeneOrGeneProduct	GR	2908
8243	21042587	1730	1742	DiseaseOrPhenotypicFeature	hypertension	D006973
8244	21042587	1778	1804	GeneOrGeneProduct	mineralocorticoid receptor	4306
8245	21042587	1817	1825	ChemicalEntity	cortisol	D006854
8246	21042587	1851	1868	ChemicalEntity	mineralocorticoid	D008901
8247	21042587	1900	1925	DiseaseOrPhenotypicFeature	glucocorticoid resistance	C564221
8248	21042587	1935	1968	DiseaseOrPhenotypicFeature	apparent mineralocorticoid excess	C537422
8249	21042587	2011	2030	ChemicalEntity	tetrahydrocortisone	D013761
8250	21042587	2031	2049	ChemicalEntity	tetrahydrocortisol	D013760
8251	21042587	2068	2076	OrganismTaxon	patients	9606
8252	21042587	2096	2110	ChemicalEntity	glucocorticoid	D005938
8253	21042587	2148	2187	GeneOrGeneProduct	11b-hydroxysteroid dehydrogenase type 2	3291
8254	21042587	2191	2193	GeneOrGeneProduct	GR	2908
8255	21042587	2231	2233	GeneOrGeneProduct	GR	2908
8256	21042587	2265	2279	ChemicalEntity	glucocorticoid	D005938
8257	21042587	2347	2363	DiseaseOrPhenotypicFeature	hypercortisolism	D003480
8258	21042587	2387	2416	DiseaseOrPhenotypicFeature	bilateral adrenal hyperplasia	D000312
8259	21042587	2421	2438	ChemicalEntity	mineralocorticoid	D008901
8260	21042587	2451	2463	DiseaseOrPhenotypicFeature	hypertension	D006973
8261	21054465	23	29	GeneOrGeneProduct	CYP2C8	1558
8262	21054465	33	45	DiseaseOrPhenotypicFeature	hypertensive	D006973
8263	21054465	46	54	OrganismTaxon	patients	9606
8264	21054465	141	147	GeneOrGeneProduct	CYP2C8	1558
8265	21054465	167	200	GeneOrGeneProduct	cytochrome P450 (CYP) epoxygenase	1558
8266	21054465	210	226	ChemicalEntity	Arachidonic acid	D016718
8267	21054465	247	274	ChemicalEntity	epoxyeicosatrienenoic acids	-
8268	21054465	279	307	ChemicalEntity	hydroxyeicosatetrenoic acids	-
8269	21054465	337	349	DiseaseOrPhenotypicFeature	hypertension	D006973
8270	21054465	451	457	GeneOrGeneProduct	CYP2C8	1558
8271	21054465	563	575	DiseaseOrPhenotypicFeature	hypertensive	D006973
8272	21054465	576	584	OrganismTaxon	patients	9606
8273	21054465	633	639	GeneOrGeneProduct	CYP2C8	1558
8274	21054465	690	696	GeneOrGeneProduct	CYP2C8	1558
8275	21054465	730	738	OrganismTaxon	patients	9606
8276	21054465	744	756	DiseaseOrPhenotypicFeature	hypertension	D006973
8277	21054465	842	860	SequenceVariant	T deletion at 5063	c|DEL|5063|T
8278	21054465	881	896	SequenceVariant	C to T at 33468	c|SUB|C|33468|T
8279	21054465	982	994	DiseaseOrPhenotypicFeature	hypertensive	D006973
8280	21054465	995	1003	OrganismTaxon	patients	9606
8281	21054465	1058	1065	SequenceVariant	C35322C	c|SUB|C|35322|C
8282	21054465	1082	1090	OrganismTaxon	patients	9606
8283	21054465	1182	1189	SequenceVariant	C35322C	c|SUB|C|35322|C
8284	21054465	1223	1235	DiseaseOrPhenotypicFeature	hypertension	D006973
8285	21054465	1411	1418	SequenceVariant	C35322T	c|SUB|C|35322|T
8286	21054465	1442	1454	DiseaseOrPhenotypicFeature	hypertensive	D006973
8287	21054465	1455	1463	OrganismTaxon	patients	9606
8288	21070631	4	26	GeneOrGeneProduct	dopamine b-hydroxylase	1621
8289	21070631	27	35	SequenceVariant	-1021C/T	rs1611115
8290	21070631	80	99	DiseaseOrPhenotypicFeature	Alzheimer's disease	D000544
8291	21070631	218	237	DiseaseOrPhenotypicFeature	Alzheimer's disease	D000544
8292	21070631	239	241	DiseaseOrPhenotypicFeature	AD	D000544
8293	21070631	244	266	GeneOrGeneProduct	Dopamine b-hydroxylase	1621
8294	21070631	268	271	GeneOrGeneProduct	DBH	1621
8295	21070631	301	309	ChemicalEntity	dopamine	D004298
8296	21070631	313	326	ChemicalEntity	noradrenaline	D009638
8297	21070631	385	391	SequenceVariant	-1021T	rs1611115
8298	21070631	400	409	SequenceVariant	rs1611115	rs1611115
8299	21070631	414	417	GeneOrGeneProduct	DBH	1621
8300	21070631	447	459	DiseaseOrPhenotypicFeature	inflammatory	D007249
8301	21070631	476	480	GeneOrGeneProduct	IL1A	3552
8302	21070631	485	488	GeneOrGeneProduct	IL6	3569
8303	21070631	518	520	DiseaseOrPhenotypicFeature	AD	D000544
8304	21070631	566	568	DiseaseOrPhenotypicFeature	AD	D000544
8305	21070631	576	579	GeneOrGeneProduct	DBH	1621
8306	21070631	580	586	SequenceVariant	-1021T	rs1611115
8307	21070631	669	671	DiseaseOrPhenotypicFeature	AD	D000544
8308	21070631	786	789	GeneOrGeneProduct	DBH	1621
8309	21070631	791	795	GeneOrGeneProduct	IL1A	3552
8310	21070631	800	803	GeneOrGeneProduct	IL6	3569
8311	21070631	924	926	DiseaseOrPhenotypicFeature	AD	D000544
8312	21070631	971	977	SequenceVariant	-1021T	rs1611115
8313	21070631	1005	1007	DiseaseOrPhenotypicFeature	AD	D000544
8314	21070631	1116	1119	OrganismTaxon	men	9606
8315	21070631	1225	1228	GeneOrGeneProduct	DBH	1621
8316	21070631	1229	1235	SequenceVariant	-1021T	rs1611115
8317	21070631	1244	1250	SequenceVariant	-889TT	rs1800587
8318	21070631	1261	1270	SequenceVariant	rs1800587	rs1800587
8319	21070631	1275	1279	GeneOrGeneProduct	IL1A	3552
8320	21070631	1482	1495	ChemicalEntity	noradrenaline	D009638
8321	21070631	1514	1526	DiseaseOrPhenotypicFeature	inflammation	D007249
8322	21070631	1551	1557	SequenceVariant	-1021T	rs1611115
8323	21070631	1632	1644	DiseaseOrPhenotypicFeature	inflammation	D007249
8324	21070631	1685	1687	DiseaseOrPhenotypicFeature	AD	D000544
8325	21080147	6	12	GeneOrGeneProduct	CRELD1	78987
8326	21080147	31	39	OrganismTaxon	patients	9606
8327	21080147	45	75	DiseaseOrPhenotypicFeature	atrioventricular septal defect	C562831
8328	21080147	89	120	DiseaseOrPhenotypicFeature	Atrioventricular septal defects	C562831
8329	21080147	122	127	DiseaseOrPhenotypicFeature	AVSDs	C562831
8330	21080147	190	216	DiseaseOrPhenotypicFeature	autosomal dominant defects	D030342
8331	21080147	248	261	DiseaseOrPhenotypicFeature	malformations	D000013
8332	21080147	394	398	DiseaseOrPhenotypicFeature	AVSD	C562831
8333	21080147	400	406	GeneOrGeneProduct	CRELD1	78987
8334	21080147	469	473	DiseaseOrPhenotypicFeature	AVSD	C562831
8335	21080147	508	516	OrganismTaxon	patients	9606
8336	21080147	522	526	DiseaseOrPhenotypicFeature	AVSD	C562831
8337	21080147	644	650	GeneOrGeneProduct	CRELD1	78987
8338	21080147	779	787	OrganismTaxon	patients	9606
8339	21080147	816	823	OrganismTaxon	patient	9606
8340	21080147	827	877	SequenceVariant	C-to-G transition was identified at nucleotide 857	c|SUB|C|857|G
8341	21080147	923	960	SequenceVariant	alanine for proline at amino acid 286	p|SUB|A|286|P
8342	21080147	974	981	ChemicalEntity	calcium	D002118
8343	21080147	990	993	GeneOrGeneProduct	EGF	1950
8344	21080147	1007	1014	OrganismTaxon	patient	9606
8345	21080147	1039	1043	DiseaseOrPhenotypicFeature	AVSD	C562831
8346	21080147	1127	1134	OrganismTaxon	patient	9606
8347	21080147	1150	1154	DiseaseOrPhenotypicFeature	AVSD	C562831
8348	21080147	1171	1184	DiseaseOrPhenotypicFeature	Down syndrome	D004314
8349	21080147	1203	1211	SequenceVariant	c.973G>A	rs755981922
8350	21080147	1263	1305	SequenceVariant	lysine for glutamic acid at amino acid 325	rs755981922
8351	21080147	1307	1312	SequenceVariant	E325K	rs755981922
8352	21080147	1328	1335	ChemicalEntity	calcium	D002118
8353	21080147	1344	1347	GeneOrGeneProduct	EGF	1950
8354	21080147	1379	1385	GeneOrGeneProduct	CRELD1	78987
8355	21080147	1419	1426	ChemicalEntity	calcium	D002118
8356	21080147	1435	1438	GeneOrGeneProduct	EGF	1950
8357	21080147	1449	1457	OrganismTaxon	patients	9606
8358	21080147	1463	1467	DiseaseOrPhenotypicFeature	AVSD	C562831
8359	21080147	1469	1475	GeneOrGeneProduct	CRELD1	78987
8360	21080147	1495	1499	DiseaseOrPhenotypicFeature	AVSD	C562831
8361	21080147	1524	1530	GeneOrGeneProduct	CRELD1	78987
8362	21080147	1579	1591	DiseaseOrPhenotypicFeature	heart defect	D006331
8363	21126715	21	57	DiseaseOrPhenotypicFeature	congenital generalized lipodystrophy	D052497
8364	21126715	79	87	SequenceVariant	Ile262fs	p|FS|I|262||
8365	21126715	104	109	GeneOrGeneProduct	BSCL2	26580
8366	21126715	116	152	DiseaseOrPhenotypicFeature	Congenital generalized lipodystrophy	D052497
8367	21126715	154	157	DiseaseOrPhenotypicFeature	CGL	D052497
8368	21126715	169	196	DiseaseOrPhenotypicFeature	autosomal recessive disease	D030342
8369	21126715	310	315	GeneOrGeneProduct	BSCL2	26580
8370	21126715	344	348	DiseaseOrPhenotypicFeature	CGL2	D052497
8371	21126715	379	383	DiseaseOrPhenotypicFeature	CGL1	D052497
8372	21126715	466	489	DiseaseOrPhenotypicFeature	intellectual impairment	D008607
8373	21126715	507	521	DiseaseOrPhenotypicFeature	cardiomyopathy	D009202
8374	21126715	653	671	DiseaseOrPhenotypicFeature	eruptive xanthomas	D014973
8375	21126715	685	705	DiseaseOrPhenotypicFeature	hypertriglyceridemia	D015228
8376	21126715	817	829	DiseaseOrPhenotypicFeature	Hepatomegaly	D006529
8377	21126715	916	933	DiseaseOrPhenotypicFeature	hepatic steatosis	D005234
8378	21126715	949	957	DiseaseOrPhenotypicFeature	necrosis	D009336
8379	21126715	1006	1020	DiseaseOrPhenotypicFeature	cardiomyopathy	D009202
8380	21126715	1047	1070	DiseaseOrPhenotypicFeature	intellectual impairment	D008607
8381	21126715	1163	1185	DiseaseOrPhenotypicFeature	enlargement of kidneys	D007674
8382	21126715	1234	1241	SequenceVariant	783insG	c|INS|783|G
8383	21126715	1243	1251	SequenceVariant	Ile262fs	p|FS|I|262||
8384	21126715	1280	1285	GeneOrGeneProduct	BSCL2	26580
8385	21126715	1320	1323	DiseaseOrPhenotypicFeature	CGL	D052497
8386	21126715	1382	1387	GeneOrGeneProduct	BSCL2	26580
8387	21126715	1418	1421	DiseaseOrPhenotypicFeature	CGL	D052497
8388	21130517	13	17	GeneOrGeneProduct	EGFR	1956
8389	21130517	47	58	DiseaseOrPhenotypicFeature	lung cancer	D008175
8390	21130517	59	67	OrganismTaxon	patients	9606
8391	21130517	117	122	DiseaseOrPhenotypicFeature	tumor	D009369
8392	21130517	123	127	GeneOrGeneProduct	EGFR	1956
8393	21130517	151	155	GeneOrGeneProduct	EGFR	1956
8394	21130517	174	178	GeneOrGeneProduct	EGFR	1956
8395	21130517	219	223	GeneOrGeneProduct	EGFR	1956
8396	21130517	244	255	DiseaseOrPhenotypicFeature	lung cancer	D008175
8397	21130517	275	279	GeneOrGeneProduct	EGFR	1956
8398	21130517	327	332	DiseaseOrPhenotypicFeature	tumor	D009369
8399	21130517	512	516	GeneOrGeneProduct	EGFR	1956
8400	21130517	551	559	OrganismTaxon	patients	9606
8401	21130517	565	576	DiseaseOrPhenotypicFeature	lung cancer	D008175
8402	21130517	637	645	OrganismTaxon	patients	9606
8403	21130517	679	683	GeneOrGeneProduct	EGFR	1956
8404	21130517	705	709	GeneOrGeneProduct	EGFR	1956
8405	21130517	710	715	SequenceVariant	L858R	rs121434568
8406	21130517	775	779	GeneOrGeneProduct	EGFR	1956
8407	21130517	808	813	DiseaseOrPhenotypicFeature	tumor	D009369
8408	21130517	825	829	GeneOrGeneProduct	EGFR	1956
8409	21130517	859	863	GeneOrGeneProduct	EGFR	1956
8410	21130517	883	888	DiseaseOrPhenotypicFeature	tumor	D009369
8411	21130517	958	962	GeneOrGeneProduct	EGFR	1956
8412	21130517	1022	1027	DiseaseOrPhenotypicFeature	tumor	D009369
8413	21130517	1038	1046	OrganismTaxon	patients	9606
8414	21130517	1151	1155	GeneOrGeneProduct	EGFR	1956
8415	21130517	1182	1186	GeneOrGeneProduct	EGFR	1956
8416	21130517	1187	1192	SequenceVariant	L858R	rs121434568
8417	21130517	1239	1245	DiseaseOrPhenotypicFeature	tumors	D009369
8418	21130517	1311	1316	DiseaseOrPhenotypicFeature	tumor	D009369
8419	21130517	1381	1389	OrganismTaxon	patients	9606
8420	21130517	1403	1412	ChemicalEntity	erlotinib	D000069347
8421	21130517	1467	1471	GeneOrGeneProduct	EGFR	1956
8422	21130517	1498	1503	DiseaseOrPhenotypicFeature	tumor	D009369
8423	21130517	1535	1543	OrganismTaxon	patients	9606
8424	21130517	1643	1647	GeneOrGeneProduct	EGFR	1956
8425	21130517	1747	1751	GeneOrGeneProduct	EGFR	1956
8426	21130517	1805	1810	DiseaseOrPhenotypicFeature	tumor	D009369
8427	21130517	1811	1815	GeneOrGeneProduct	EGFR	1956
8428	21130517	1860	1864	GeneOrGeneProduct	EGFR	1956
8429	21130517	1945	1953	OrganismTaxon	patients	9606
8430	21130517	1987	1992	DiseaseOrPhenotypicFeature	tumor	D009369
8431	21135151	10	14	GeneOrGeneProduct	CCR5	1234
8432	21135151	14	21	SequenceVariant	delta32	c|DEL||32
8433	21135151	73	78	OrganismTaxon	HIV-1	11676
8434	21135151	206	235	GeneOrGeneProduct	C-C chemokine receptor type 5	1234
8435	21135151	237	241	GeneOrGeneProduct	CCR5	1234
8436	21135151	303	308	OrganismTaxon	HIV-1	11676
8437	21135151	933	937	GeneOrGeneProduct	CCR5	1234
8438	21135151	1028	1033	GeneOrGeneProduct	gp120	3700
8439	21135151	1065	1070	OrganismTaxon	HIV-1	11676
8440	21135151	1130	1139	DiseaseOrPhenotypicFeature	infection	D007239
8441	21135151	1160	1174	DiseaseOrPhenotypicFeature	HIV-1-infected	D015658
8442	21135151	1205	1209	GeneOrGeneProduct	CCR5	1234
8443	21135151	1216	1221	OrganismTaxon	HIV-1	11676
8444	21135151	1276	1280	GeneOrGeneProduct	CCR5	1234
8445	21135151	1284	1288	SequenceVariant	DD32	c|DEL||32
8446	21135151	1352	1361	DiseaseOrPhenotypicFeature	infection	D007239
8447	21135151	1489	1496	OrganismTaxon	patient	9606
8448	21135151	1839	1846	OrganismTaxon	patient	9606
8449	21135151	1975	1979	GeneOrGeneProduct	CCR5	1234
8450	21135151	2063	2070	OrganismTaxon	patient	9606
8451	21135151	2096	2100	DiseaseOrPhenotypicFeature	AIDS	D000163
8452	21163864	4	9	SequenceVariant	M235T	rs699
8453	21163864	30	45	GeneOrGeneProduct	angiotensinogen	183
8454	21163864	67	75	OrganismTaxon	patients	9606
8455	21163864	79	106	DiseaseOrPhenotypicFeature	hypertrophic cardiomyopathy	D002312
8456	21163864	122	149	DiseaseOrPhenotypicFeature	Hypertrophic cardiomyopathy	D002312
8457	21163864	151	154	DiseaseOrPhenotypicFeature	HCM	D002312
8458	21163864	206	221	DiseaseOrPhenotypicFeature	cardiac disease	D006331
8459	21163864	327	332	SequenceVariant	T704C	rs699
8460	21163864	363	378	GeneOrGeneProduct	angiotensinogen	183
8461	21163864	380	383	GeneOrGeneProduct	AGT	183
8462	21163864	395	398	DiseaseOrPhenotypicFeature	HCM	D002312
8463	21163864	493	496	DiseaseOrPhenotypicFeature	HCM	D002312
8464	21163864	501	537	DiseaseOrPhenotypicFeature	sporadic hypertrophic cardiomyopathy	D002312
8465	21163864	539	543	DiseaseOrPhenotypicFeature	SHCM	D002312
8466	21163864	552	588	DiseaseOrPhenotypicFeature	familial hypertrophic cardiomyopathy	D024741
8467	21163864	590	594	DiseaseOrPhenotypicFeature	FHCM	D024741
8468	21163864	597	605	OrganismTaxon	patients	9606
8469	21163864	673	685	DiseaseOrPhenotypicFeature	hypertension	D006973
8470	21163864	690	718	DiseaseOrPhenotypicFeature	left ventricular hypertrophy	D017379
8471	21163864	825	828	GeneOrGeneProduct	AGT	183
8472	21163864	862	911	SequenceVariant	methionine to threonine substitution at codon 235	rs699
8473	21163864	913	918	SequenceVariant	M235T	rs699
8474	21163864	1054	1059	ChemicalEntity	SfaNI	-
8475	21163864	1202	1206	DiseaseOrPhenotypicFeature	SHCM	D002312
8476	21163864	1207	1215	OrganismTaxon	patients	9606
8477	21163864	1281	1285	DiseaseOrPhenotypicFeature	FHCM	D024741
8478	21163864	1344	1347	GeneOrGeneProduct	AGT	183
8479	21163864	1386	1390	DiseaseOrPhenotypicFeature	SHCM	D002312
8480	21163864	1516	1520	DiseaseOrPhenotypicFeature	FHCM	D024741
8481	21219851	38	75	DiseaseOrPhenotypicFeature	Ehlers-Danlos Syndrome, vascular type	D004535
8482	21219851	183	220	DiseaseOrPhenotypicFeature	Ehlers-Danlos syndrome, vascular type	D004535
8483	21219851	222	226	DiseaseOrPhenotypicFeature	vEDS	D004535
8484	21219851	229	240	DiseaseOrPhenotypicFeature	MIM #130050	D004535
8485	21219851	248	275	DiseaseOrPhenotypicFeature	autosomal dominant disorder	D030342
8486	21219851	286	306	GeneOrGeneProduct	type III procollagen	1281
8487	21219851	313	319	GeneOrGeneProduct	COL3A1	1281
8488	21219851	337	343	GeneOrGeneProduct	COL3A1	1281
8489	21219851	391	398	OrganismTaxon	patient	9606
8490	21219851	719	725	GeneOrGeneProduct	COL3A1	1281
8491	21219851	777	783	GeneOrGeneProduct	COL3A1	1281
8492	21219851	971	975	DiseaseOrPhenotypicFeature	vEDS	D004535
8493	21219851	976	984	OrganismTaxon	patients	9606
8494	21219851	1017	1023	GeneOrGeneProduct	COL3A1	1281
8495	21219851	1139	1145	GeneOrGeneProduct	COL3A1	1281
8496	21219851	1181	1191	SequenceVariant	c.2187delA	c|DEL|2187|A
8497	21219851	1220	1229	SequenceVariant	c.2992C>T	c|SUB|C|2992|T
8498	21219851	1422	1431	SequenceVariant	rs1800255	rs1800255
8499	21219851	1432	1435	SequenceVariant	G>A	rs1800255
8500	21219851	1437	1446	SequenceVariant	rs1801184	rs1801184
8501	21219851	1447	1450	SequenceVariant	T>C	rs1801184
8502	21219851	1456	1465	SequenceVariant	rs2271683	rs2271683
8503	21219851	1466	1469	SequenceVariant	A>G	rs2271683
8504	21219851	1474	1480	GeneOrGeneProduct	COL3A1	1281
8505	21219851	1612	1618	GeneOrGeneProduct	COL3A1	1281
8506	21219851	1731	1737	GeneOrGeneProduct	COL3A1	1281
8507	21238926	0	4	GeneOrGeneProduct	Brat	35197
8508	21238926	88	91	GeneOrGeneProduct	BMP	33432
8509	21238926	103	113	OrganismTaxon	Drosophila	7227
8510	21238926	167	170	GeneOrGeneProduct	Dpp	33432
8511	21238926	189	196	GeneOrGeneProduct	Pumilio	41094
8512	21238926	198	201	GeneOrGeneProduct	Pum	41094
8513	21238926	207	212	GeneOrGeneProduct	Nanos	42297
8514	21238926	214	217	GeneOrGeneProduct	Nos	42297
8515	21238926	260	263	GeneOrGeneProduct	Dpp	33432
8516	21238926	295	298	GeneOrGeneProduct	Nos	42297
8517	21238926	430	433	GeneOrGeneProduct	Pum	41094
8518	21238926	434	437	GeneOrGeneProduct	Nos	42297
8519	21238926	495	498	GeneOrGeneProduct	Dpp	33432
8520	21238926	529	540	GeneOrGeneProduct	Brain Tumor	35197
8521	21238926	542	546	GeneOrGeneProduct	Brat	35197
8522	21238926	597	600	GeneOrGeneProduct	Pum	41094
8523	21238926	601	604	GeneOrGeneProduct	Nos	42297
8524	21238926	617	621	GeneOrGeneProduct	Brat	35197
8525	21238926	647	650	GeneOrGeneProduct	Pum	41094
8526	21238926	651	654	GeneOrGeneProduct	Nos	42297
8527	21238926	674	677	GeneOrGeneProduct	Pum	41094
8528	21238926	744	747	GeneOrGeneProduct	Mad	33529
8529	21238926	752	756	GeneOrGeneProduct	dMyc	31310
8530	21238926	840	843	GeneOrGeneProduct	Dpp	33432
8531	21238926	986	990	GeneOrGeneProduct	Brat	35197
8532	21238926	1066	1070	GeneOrGeneProduct	Brat	35197
8533	21238926	1094	1097	GeneOrGeneProduct	Dpp	33432
8534	21325775	8	24	GeneOrGeneProduct	apolipoprotein E	348
8535	21325775	35	39	GeneOrGeneProduct	ApoE	348
8536	21325775	47	57	SequenceVariant	Arg158 Pro	p|SUB|R|158|P
8537	21325775	65	77	DiseaseOrPhenotypicFeature	dyslipidemic	D050171
8538	21325775	78	85	OrganismTaxon	patient	9606
8539	21325775	91	117	DiseaseOrPhenotypicFeature	lipoprotein glomerulopathy	C567089
8540	21325775	119	145	DiseaseOrPhenotypicFeature	Lipoprotein glomerulopathy	C567089
8541	21325775	147	150	DiseaseOrPhenotypicFeature	LPG	C567089
8542	21325775	317	333	GeneOrGeneProduct	apolipoprotein E	348
8543	21325775	335	339	GeneOrGeneProduct	apoE	348
8544	21325775	374	378	GeneOrGeneProduct	apoE	348
8545	21325775	420	423	DiseaseOrPhenotypicFeature	LPG	C567089
8546	21325775	460	463	DiseaseOrPhenotypicFeature	LPG	C567089
8547	21325775	464	471	OrganismTaxon	patient	9606
8548	21325775	485	489	GeneOrGeneProduct	apoE	348
8549	21325775	500	504	GeneOrGeneProduct	apoE	348
8550	21325775	516	523	OrganismTaxon	patient	9606
8551	21325775	542	545	OrganismTaxon	man	9606
8552	21325775	574	592	DiseaseOrPhenotypicFeature	nephrotic syndrome	D009404
8553	21325775	696	699	DiseaseOrPhenotypicFeature	LPG	C567089
8554	21325775	711	728	DiseaseOrPhenotypicFeature	lamellate thrombi	D013927
8555	21325775	781	785	GeneOrGeneProduct	apoE	348
8556	21325775	800	807	GeneOrGeneProduct	apoE3/2	348
8557	21325775	824	836	DiseaseOrPhenotypicFeature	dyslipidemia	D050171
8558	21325775	856	870	ChemicalEntity	polyacrylamide	-
8559	21325775	924	928	GeneOrGeneProduct	apoE	348
8560	21325775	995	999	GeneOrGeneProduct	apoE	348
8561	21325775	1078	1082	GeneOrGeneProduct	ApoE	348
8562	21325775	1133	1152	SequenceVariant	G to C at codon 158	c|SUB|G|CODON158|C
8563	21325775	1216	1272	SequenceVariant	arginine residue for the proline residue at position 158	p|SUB|R|158|P
8564	21325775	1276	1280	GeneOrGeneProduct	apoE	348
8565	21325775	1437	1441	GeneOrGeneProduct	apoE	348
8566	21325775	1491	1495	GeneOrGeneProduct	apoE	348
8567	21325775	1549	1553	GeneOrGeneProduct	apoE	348
8568	21325775	1656	1659	DiseaseOrPhenotypicFeature	LPG	C567089
8569	21325775	1673	1677	GeneOrGeneProduct	apoE	348
8570	21405999	26	32	GeneOrGeneProduct	GUCA1B	2979
8571	21405999	41	49	OrganismTaxon	patients	9606
8572	21405999	74	101	DiseaseOrPhenotypicFeature	cone and cone rod dystrophy	D000071700,D000077765
8573	21405999	141	147	GeneOrGeneProduct	GUCA1A	2978
8574	21405999	224	238	DiseaseOrPhenotypicFeature	cone dystrophy	D000077765
8575	21405999	240	258	DiseaseOrPhenotypicFeature	cone rod dystrophy	D000071700
8576	21405999	263	280	DiseaseOrPhenotypicFeature	macular dystrophy	D008268
8577	21405999	303	309	GeneOrGeneProduct	GUCA1B	2979
8578	21405999	338	353	DiseaseOrPhenotypicFeature	retinal disease	D012164
8579	21405999	428	434	GeneOrGeneProduct	GUCA1B	2979
8580	21405999	484	492	OrganismTaxon	patients	9606
8581	21405999	580	594	DiseaseOrPhenotypicFeature	cone dystrophy	D000077765
8582	21405999	599	617	DiseaseOrPhenotypicFeature	cone rod dystrophy	D000071700
8583	21405999	663	671	OrganismTaxon	patients	9606
8584	21405999	687	701	DiseaseOrPhenotypicFeature	cone dystrophy	D000077765
8585	21405999	705	723	DiseaseOrPhenotypicFeature	cone rod dystrophy	D000071700
8586	21405999	918	924	GeneOrGeneProduct	GUCA1B	2979
8587	21405999	1077	1085	SequenceVariant	c.-17T>C	rs1474867
8588	21405999	1087	1095	SequenceVariant	c.171T>C	rs3749921
8589	21405999	1097	1105	SequenceVariant	c.465G>T	rs139923590
8590	21405999	1144	1152	SequenceVariant	c.465G>T	rs139923590
8591	21405999	1201	1212	SequenceVariant	p.Glu155Asp	rs139923590
8592	21405999	1240	1247	ChemicalEntity	calcium	D002118
8593	21405999	1264	1269	GeneOrGeneProduct	GCAP2	2979
8594	21405999	1419	1426	OrganismTaxon	patient	9606
8595	21405999	1451	1457	GeneOrGeneProduct	GUCA1B	2979
8596	21405999	1484	1505	DiseaseOrPhenotypicFeature	retinal degenerations	D012162
8597	21615796	0	15	GeneOrGeneProduct	Interleukin-17F	112744
8598	21615796	37	45	OrganismTaxon	patients	9606
8599	21615796	51	82	DiseaseOrPhenotypicFeature	chronic immune thrombocytopenia	D016553
8600	21615796	98	104	GeneOrGeneProduct	IL-17F	112744
8601	21615796	116	137	GeneOrGeneProduct	inflammatory cytokine	112744
8602	21615796	174	193	DiseaseOrPhenotypicFeature	autoimmune diseases	D001327
8603	21615796	235	246	DiseaseOrPhenotypicFeature	chronic ITP	D016553
8604	21615796	303	311	SequenceVariant	rs763780	rs763780
8605	21615796	313	320	SequenceVariant	7488T/C	rs763780
8606	21615796	338	379	SequenceVariant	His-to-Arg substitution at amino acid 161	rs763780
8607	21615796	381	389	OrganismTaxon	PATIENTS	9606
8608	21615796	419	427	OrganismTaxon	patients	9606
8609	21615796	429	432	OrganismTaxon	men	9606
8610	21615796	433	438	OrganismTaxon	women	9606
8611	21615796	478	489	DiseaseOrPhenotypicFeature	chronic ITP	D016553
8612	21615796	516	519	OrganismTaxon	men	9606
8613	21615796	520	525	OrganismTaxon	women	9606
8614	21615796	716	724	OrganismTaxon	patients	9606
8615	21615796	730	741	DiseaseOrPhenotypicFeature	chronic ITP	D016553
8616	21615796	785	791	GeneOrGeneProduct	IL-17F	112744
8617	21615796	792	798	SequenceVariant	7488CC	rs763780
8618	21615796	845	851	GeneOrGeneProduct	IL-17F	112744
8619	21615796	852	857	SequenceVariant	7488C	rs763780
8620	21615796	876	884	OrganismTaxon	patients	9606
8621	21615796	890	901	DiseaseOrPhenotypicFeature	chronic ITP	D016553
8622	21615796	1022	1030	OrganismTaxon	patients	9606
8623	21615796	1040	1046	GeneOrGeneProduct	IL-17F	112744
8624	21615796	1047	1053	SequenceVariant	7488TT	rs763780
8625	21615796	1079	1095	DiseaseOrPhenotypicFeature	thrombocytopenic	D011696
8626	21615796	1164	1170	GeneOrGeneProduct	IL-17F	112744
8627	21615796	1171	1177	SequenceVariant	7488TC	rs763780
8628	21615796	1255	1261	GeneOrGeneProduct	IL-17F	112744
8629	21615796	1262	1268	SequenceVariant	7488 T	rs763780
8630	21615796	1328	1339	DiseaseOrPhenotypicFeature	chronic ITP	D016553
8631	21615796	1363	1369	GeneOrGeneProduct	IL-17F	112744
8632	21615796	1393	1404	DiseaseOrPhenotypicFeature	chronic ITP	D016553
8633	21666969	9	15	SequenceVariant	G1359A	rs1049353
8634	21666969	36	56	GeneOrGeneProduct	cannabinoid receptor	1268
8635	21666969	63	67	GeneOrGeneProduct	CNR1	1268
8636	21666969	72	83	DiseaseOrPhenotypicFeature	weight loss	D015431
8637	21666969	178	186	SequenceVariant	1359 G/A	rs1049353
8638	21666969	195	198	GeneOrGeneProduct	CB1	1268
8639	21666969	241	275	SequenceVariant	G to A at nucleotide position 1359	rs1049353
8640	21666969	279	294	SequenceVariant	codon 435 (Thr)	rs1049353
8641	21666969	495	501	SequenceVariant	G1359A	rs1049353
8642	21666969	506	518	GeneOrGeneProduct	CB1 receptor	1268
8643	21666969	555	566	DiseaseOrPhenotypicFeature	weight loss	D015431
8644	21666969	654	659	DiseaseOrPhenotypicFeature	obese	D009765
8645	21666969	660	668	OrganismTaxon	patients	9606
8646	21666969	697	705	OrganismTaxon	patients	9606
8647	21666969	711	718	DiseaseOrPhenotypicFeature	obesity	D009765
8648	21666969	947	953	SequenceVariant	G1359A	rs1049353
8649	21666969	958	964	SequenceVariant	A1359A	rs1049353
8650	21666969	990	996	SequenceVariant	G1359G	rs1049353
8651	21666969	1058	1066	OrganismTaxon	patients	9606
8652	21666969	1090	1096	SequenceVariant	G1359G	rs1049353
8653	21666969	1128	1136	OrganismTaxon	patients	9606
8654	21666969	1137	1143	SequenceVariant	G1359A	rs1049353
8655	21666969	1148	1156	OrganismTaxon	patients	9606
8656	21666969	1168	1174	SequenceVariant	A1359A	rs1049353
8657	21666969	1178	1186	OrganismTaxon	patients	9606
8658	21666969	1380	1388	GeneOrGeneProduct	resistin	56729
8659	21666969	1436	1442	GeneOrGeneProduct	leptin	3952
8660	21666969	1490	1494	GeneOrGeneProduct	IL-6	3569
8661	21666969	1667	1672	SequenceVariant	A1359	rs1049353
8662	21666969	1693	1701	GeneOrGeneProduct	resistin	56729
8663	21666969	1703	1709	GeneOrGeneProduct	leptin	3952
8664	21666969	1714	1727	GeneOrGeneProduct	interleukin-6	3569
8665	21666969	1741	1752	DiseaseOrPhenotypicFeature	weight loss	D015431
8666	21682595	0	5	GeneOrGeneProduct	XRCC1	7515
8667	21682595	6	15	SequenceVariant	Arg399Gln	rs25487
8668	21682595	50	78	DiseaseOrPhenotypicFeature	systemic lupus erythematosus	D008180
8669	21682595	153	161	OrganismTaxon	patients	9606
8670	21682595	167	195	DiseaseOrPhenotypicFeature	systemic lupus erythematosus	D008180
8671	21682595	197	200	DiseaseOrPhenotypicFeature	SLE	D008180
8672	21682595	215	247	GeneOrGeneProduct	X-ray repair cross-complementing	7515
8673	21682595	249	254	GeneOrGeneProduct	XRCC1	7515
8674	21682595	256	265	SequenceVariant	Arg399Gln	rs25487
8675	21682595	267	274	SequenceVariant	rs25487	rs25487
8676	21682595	353	358	GeneOrGeneProduct	XRCC1	7515
8677	21682595	359	368	SequenceVariant	Arg399Gln	rs25487
8678	21682595	385	393	OrganismTaxon	patients	9606
8679	21682595	399	402	DiseaseOrPhenotypicFeature	SLE	D008180
8680	21682595	494	497	DiseaseOrPhenotypicFeature	SLE	D008180
8681	21682595	498	506	OrganismTaxon	patients	9606
8682	21682595	736	743	SequenceVariant	399 Gln	rs25487
8683	21682595	754	762	OrganismTaxon	patients	9606
8684	21682595	768	771	DiseaseOrPhenotypicFeature	SLE	D008180
8685	21682595	911	916	GeneOrGeneProduct	XRCC1	7515
8686	21682595	917	926	SequenceVariant	Arg399Gln	rs25487
8687	21682595	1078	1088	DiseaseOrPhenotypicFeature	malar rash	D005076
8688	21682595	1127	1130	DiseaseOrPhenotypicFeature	SLE	D008180
8689	21682595	1347	1350	DiseaseOrPhenotypicFeature	SLE	D008180
8690	21682595	1553	1558	GeneOrGeneProduct	XRCC1	7515
8691	21682595	1559	1568	SequenceVariant	Arg399Gln	rs25487
8692	21682595	1620	1623	DiseaseOrPhenotypicFeature	SLE	D008180
8693	21682595	1651	1654	DiseaseOrPhenotypicFeature	SLE	D008180
8694	21684788	35	59	DiseaseOrPhenotypicFeature	Sjogren-Larsson syndrome	D016111
8695	21684788	61	85	DiseaseOrPhenotypicFeature	Sjogren-Larsson syndrome	D016111
8696	21684788	87	90	DiseaseOrPhenotypicFeature	SLS	D016111
8697	21684788	98	126	DiseaseOrPhenotypicFeature	autosomal recessive disorder	D030342
8698	21684788	144	154	DiseaseOrPhenotypicFeature	ichthyosis	D007057
8699	21684788	156	174	DiseaseOrPhenotypicFeature	mental retardation	D008607
8700	21684788	176	186	DiseaseOrPhenotypicFeature	spasticity	D009128
8701	21684788	208	215	GeneOrGeneProduct	ALDH3A2	224
8702	21684788	225	253	GeneOrGeneProduct	fatty aldehyde dehydrogenase	224
8703	21684788	297	311	ChemicalEntity	fatty aldehyde	C001634
8704	21684788	315	325	ChemicalEntity	fatty acid	D005227
8705	21684788	374	377	DiseaseOrPhenotypicFeature	SLS	D016111
8706	21684788	378	386	OrganismTaxon	patients	9606
8707	21684788	516	519	DiseaseOrPhenotypicFeature	SLS	D016111
8708	21684788	520	528	OrganismTaxon	patients	9606
8709	21684788	595	602	GeneOrGeneProduct	ALDH3A2	224
8710	21684788	750	753	DiseaseOrPhenotypicFeature	SLS	D016111
8711	21684788	782	797	SequenceVariant	352-kb deletion	c|DEL||352K
8712	21684788	808	821	GeneOrGeneProduct	ALDH3A2 and 4	223,224
8713	21684788	849	856	GeneOrGeneProduct	ALDH3A1	218
8714	21684788	928	943	DiseaseOrPhenotypicFeature	corneal disease	D003316
8715	21684788	975	978	DiseaseOrPhenotypicFeature	SLS	D016111
8716	21684788	1084	1091	OrganismTaxon	patient	9606
8717	21684788	1126	1158	SequenceVariant	1.44-Mb contiguous gene deletion	c|DEL||1.44M
8718	21684788	1184	1192	SequenceVariant	c.407C>T	c|SUB|C|407|T
8719	21684788	1194	1199	SequenceVariant	P136L	p|SUB|P|136|L
8720	21684788	1204	1211	GeneOrGeneProduct	ALDH3A2	224
8721	21684788	1311	1314	DiseaseOrPhenotypicFeature	SLS	D016111
8722	21684788	1410	1418	OrganismTaxon	patients	9606
8723	21684788	1424	1427	DiseaseOrPhenotypicFeature	SLS	D016111
8724	21684788	1438	1465	DiseaseOrPhenotypicFeature	inborn errors of metabolism	D008661
8725	21695597	0	3	GeneOrGeneProduct	MHC	3123,720
8726	21695597	23	51	DiseaseOrPhenotypicFeature	systemic lupus erythematosus	D008180
8727	21695597	72	77	OrganismTaxon	women	9606
8728	21695597	83	115	GeneOrGeneProduct	major histocompatibility complex	3123,720
8729	21695597	117	120	GeneOrGeneProduct	MHC	3123,720
8730	21695597	186	214	DiseaseOrPhenotypicFeature	systemic lupus erythematosus	D008180
8731	21695597	216	219	DiseaseOrPhenotypicFeature	SLE	D008180
8732	21695597	231	234	DiseaseOrPhenotypicFeature	SLE	D008180
8733	21695597	360	363	GeneOrGeneProduct	MHC	3123,720
8734	21695597	390	393	DiseaseOrPhenotypicFeature	SLE	D008180
8735	21695597	448	451	GeneOrGeneProduct	MHC	3123,720
8736	21695597	532	535	GeneOrGeneProduct	C4A	720
8737	21695597	546	549	DiseaseOrPhenotypicFeature	SLE	D008180
8738	21695597	643	648	OrganismTaxon	Women	9606
8739	21695597	879	882	DiseaseOrPhenotypicFeature	SLE	D008180
8740	21695597	891	900	SequenceVariant	rs9271366	rs9271366
8741	21695597	950	958	GeneOrGeneProduct	HLA-DRB1	3123
8742	21695597	1023	1031	SequenceVariant	rs204890	rs204890
8743	21695597	1061	1070	SequenceVariant	rs2071349	rs2071349
8744	21695597	1104	1113	SequenceVariant	rs2844580	rs2844580
8745	21695597	1165	1168	DiseaseOrPhenotypicFeature	SLE	D008180
8746	21695597	1188	1197	SequenceVariant	rs9271366	rs9271366
8747	21695597	1242	1245	GeneOrGeneProduct	C4A	720
8748	21695597	1568	1577	SequenceVariant	rs9271366	rs9271366
8749	21695597	1623	1626	DiseaseOrPhenotypicFeature	SLE	D008180
8750	21695597	1746	1751	OrganismTaxon	women	9606
8751	21695597	1851	1854	DiseaseOrPhenotypicFeature	SLE	D008180
8752	21695597	1944	1947	GeneOrGeneProduct	MHC	3123,720
8753	21695597	1979	1982	DiseaseOrPhenotypicFeature	SLE	D008180
8754	21695597	2003	2008	OrganismTaxon	women	9606
8755	21750150	26	31	GeneOrGeneProduct	DACH1	1602
8756	21750150	42	47	DiseaseOrPhenotypicFeature	tumor	D009369
8757	21750150	71	77	DiseaseOrPhenotypicFeature	glioma	D005910
8758	21750150	118	123	DiseaseOrPhenotypicFeature	tumor	D009369
8759	21750150	156	169	DiseaseOrPhenotypicFeature	tumorigenesis	D009369
8760	21750150	323	335	DiseaseOrPhenotypicFeature	glioblastoma	D005909
8761	21750150	375	380	GeneOrGeneProduct	DACH1	1602
8762	21750150	451	457	DiseaseOrPhenotypicFeature	glioma	D005910
8763	21750150	493	498	GeneOrGeneProduct	DACH1	1602
8764	21750150	518	526	CellLine	U87TR-Da	9606
8765	21750150	527	533	DiseaseOrPhenotypicFeature	glioma	D005910
8766	21750150	547	552	GeneOrGeneProduct	DACH1	1602
8767	21750150	611	622	ChemicalEntity	doxycycline	D004318
8768	21750150	700	706	DiseaseOrPhenotypicFeature	tumors	D009369
8769	21750150	710	714	OrganismTaxon	mice	10090
8770	21750150	730	738	CellLine	U87TR-Da	9606
8771	21750150	750	755	GeneOrGeneProduct	DACH1	1602
8772	21750150	768	771	CellLine	U87	9606
8773	21750150	772	777	GeneOrGeneProduct	DACH1	1602
8774	21750150	799	804	GeneOrGeneProduct	DACH1	1602
8775	21750150	819	827	CellLine	U87TR-Da	9606
8776	21750150	835	838	CellLine	U87	9606
8777	21750150	839	844	GeneOrGeneProduct	DACH1	1602
8778	21750150	851	854	CellLine	U87	9606
8779	21750150	855	860	GeneOrGeneProduct	DACH1	1602
8780	21750150	891	896	GeneOrGeneProduct	CD133	8842
8781	21750150	901	907	GeneOrGeneProduct	Nestin	10763
8782	21750150	944	947	CellLine	U87	9606
8783	21750150	948	953	GeneOrGeneProduct	DACH1	1602
8784	21750150	1004	1007	CellLine	U87	9606
8785	21750150	1008	1013	GeneOrGeneProduct	DACH1	1602
8786	21750150	1034	1037	CellLine	U87	9606
8787	21750150	1038	1043	GeneOrGeneProduct	DACH1	1602
8788	21750150	1096	1101	GeneOrGeneProduct	DACH1	1602
8789	21750150	1126	1131	DiseaseOrPhenotypicFeature	tumor	D009369
8790	21750150	1227	1253	GeneOrGeneProduct	fibroblast growth factor 2	2247
8791	21750150	1255	1259	GeneOrGeneProduct	FGF2	2247
8792	21750150	1260	1264	GeneOrGeneProduct	bFGF	2247
8793	21750150	1300	1305	GeneOrGeneProduct	DACH1	1602
8794	21750150	1368	1372	GeneOrGeneProduct	bFGF	2247
8795	21750150	1433	1436	CellLine	U87	9606
8796	21750150	1437	1442	GeneOrGeneProduct	DACH1	1602
8797	21750150	1479	1484	GeneOrGeneProduct	DACH1	1602
8798	21750150	1509	1514	DiseaseOrPhenotypicFeature	tumor	D009369
8799	21750150	1570	1574	GeneOrGeneProduct	bFGF	2247
8800	21750150	1606	1611	GeneOrGeneProduct	DACH1	1602
8801	21750150	1629	1634	DiseaseOrPhenotypicFeature	tumor	D009369
8802	21750150	1686	1691	DiseaseOrPhenotypicFeature	tumor	D009369
8803	21750150	1717	1721	GeneOrGeneProduct	bFGF	2247
8804	21750150	1731	1736	DiseaseOrPhenotypicFeature	tumor	D009369
8805	21750150	1760	1766	DiseaseOrPhenotypicFeature	glioma	D005910
8806	21879313	9	18	SequenceVariant	rs8099917	rs8099917
8807	21879313	28	33	GeneOrGeneProduct	IL28B	282617
8808	21879313	108	125	OrganismTaxon	hepatitis C virus	11103
8809	21879313	152	172	GeneOrGeneProduct	apolipoprotein B-100	338
8810	21879313	190	209	DiseaseOrPhenotypicFeature	chronic hepatitis C	D019698
8811	21879313	233	250	OrganismTaxon	hepatitis C virus	11103
8812	21879313	252	255	OrganismTaxon	HCV	11103
8813	21879313	324	329	ChemicalEntity	lipid	D008055
8814	21879313	366	386	GeneOrGeneProduct	pegylated interferon	3439
8815	21879313	392	401	ChemicalEntity	ribavirin	D012254
8816	21879313	403	410	GeneOrGeneProduct	PEG-IFN	3439
8817	21879313	411	414	ChemicalEntity	RBV	D012254
8818	21879313	481	486	OrganismTaxon	human	9606
8819	21879313	487	502	GeneOrGeneProduct	interleukin 28B	282617
8820	21879313	504	509	GeneOrGeneProduct	IL28B	282617
8821	21879313	577	580	OrganismTaxon	HCV	11103
8822	21879313	626	633	GeneOrGeneProduct	PEG-IFN	3439
8823	21879313	634	637	ChemicalEntity	RBV	D012254
8824	21879313	649	666	DiseaseOrPhenotypicFeature	chronic hepatitis	D006521
8825	21879313	672	697	DiseaseOrPhenotypicFeature	HCV genotype 1b infection	D006526
8826	21879313	769	774	ChemicalEntity	lipid	D008055
8827	21879313	828	835	GeneOrGeneProduct	PEG-IFN	3439
8828	21879313	836	838	ChemicalEntity	RB	D012254
8829	21879313	871	891	GeneOrGeneProduct	apolipoprotein B-100	338
8830	21879313	893	901	GeneOrGeneProduct	apoB-100	338
8831	21879313	932	949	DiseaseOrPhenotypicFeature	HCV G1b infection	D006526
8832	21879313	1035	1038	OrganismTaxon	HCV	11103
8833	21879313	1047	1056	SequenceVariant	rs8099917	rs8099917
8834	21879313	1085	1090	GeneOrGeneProduct	IL28B	282617
8835	21879313	1137	1145	GeneOrGeneProduct	apoB-100	338
8836	21879313	1150	1191	ChemicalEntity	low-density lipoprotein (LDL) cholesterol	D008078
8837	21879313	1261	1269	GeneOrGeneProduct	apoB-100	338
8838	21879313	1291	1306	ChemicalEntity	LDL cholesterol	D008078
8839	21879313	1342	1347	SequenceVariant	Arg70	p|Allele|R|70
8840	21879313	1423	1432	SequenceVariant	rs8099917	rs8099917
8841	21879313	1476	1484	GeneOrGeneProduct	apoB-100	338
8842	21879313	1506	1521	ChemicalEntity	LDL cholesterol	D008078
8843	21879313	1565	1573	GeneOrGeneProduct	apoB-100	338
8844	21879313	1578	1593	ChemicalEntity	LDL cholesterol	D008078
8845	21879313	1694	1697	OrganismTaxon	HCV	11103
8846	21879313	1709	1722	DiseaseOrPhenotypicFeature	HCV infection	D006526
8847	21879313	1745	1753	GeneOrGeneProduct	apoB-100	338
8848	21879313	1822	1825	OrganismTaxon	HCV	11103
8849	21879313	1877	1885	OrganismTaxon	patients	9606
8850	21879313	1899	1908	SequenceVariant	rs8099917	rs8099917
8851	21903317	53	58	GeneOrGeneProduct	renin	5972
8852	21903317	77	83	DiseaseOrPhenotypicFeature	anemia	D000740
8853	21903317	85	98	DiseaseOrPhenotypicFeature	hyperuricemia	D033461
8854	21903317	104	107	DiseaseOrPhenotypicFeature	CKD	D051436
8855	21903317	158	163	GeneOrGeneProduct	renin	5972
8856	21903317	165	168	GeneOrGeneProduct	REN	5972
8857	21903317	176	200	DiseaseOrPhenotypicFeature	renal tubular dysgenesis	C537048
8858	21903317	228	233	DiseaseOrPhenotypicFeature	death	D003643
8859	21903317	250	264	DiseaseOrPhenotypicFeature	kidney failure	D051437
8860	21903317	269	289	DiseaseOrPhenotypicFeature	pulmonary hypoplasia	D008171
8861	21903317	319	328	DiseaseOrPhenotypicFeature	fetopathy	C576203
8862	21903317	339	378	ChemicalEntity	angiotensin-converting enzyme inhibitor	D000806
8863	21903317	382	410	ChemicalEntity	angiotensin receptor blocker	D057911
8864	21903317	459	462	GeneOrGeneProduct	REN	5972
8865	21903317	509	522	DiseaseOrPhenotypicFeature	hyperuricemia	D033461
8866	21903317	524	530	DiseaseOrPhenotypicFeature	anemia	D000740
8867	21903317	536	558	DiseaseOrPhenotypicFeature	chronic kidney disease	D051436
8868	21903317	560	563	DiseaseOrPhenotypicFeature	CKD	D051436
8869	21903317	605	608	GeneOrGeneProduct	REN	5972
8870	21903317	675	678	GeneOrGeneProduct	REN	5972
8871	21903317	704	717	DiseaseOrPhenotypicFeature	hyperuricemia	D033461
8872	21903317	722	725	DiseaseOrPhenotypicFeature	CKD	D051436
8873	21903317	778	782	GeneOrGeneProduct	UMOD	7369
8874	21903317	784	794	GeneOrGeneProduct	uromodulin	7369
8875	21903317	800	805	GeneOrGeneProduct	HNF1B	6928
8876	21903317	807	835	GeneOrGeneProduct	hepatocyte nuclear factor 1b	6928
8877	21903317	883	928	SequenceVariant	thymidine to cytosine mutation at position 28	c|SUB|T|28|C
8878	21903317	936	939	GeneOrGeneProduct	REN	5972
8879	21903317	978	1030	SequenceVariant	tryptophan to arginine substitution at amino acid 10	p|SUB|W|10|R
8880	21903317	1075	1082	SequenceVariant	c.28T>C	c|SUB|T|28|C
8881	21903317	1084	1090	SequenceVariant	p.W10R	p|SUB|W|10|R
8882	21903317	1125	1128	GeneOrGeneProduct	REN	5972
8883	21903317	1158	1166	OrganismTaxon	patients	9606
8884	21903317	1172	1175	DiseaseOrPhenotypicFeature	CKD	D051436
8885	21903317	1268	1271	GeneOrGeneProduct	REN	5972
8886	21903317	1319	1325	DiseaseOrPhenotypicFeature	anemia	D000740
8887	21903317	1327	1340	DiseaseOrPhenotypicFeature	hyperuricemia	D033461
8888	21903317	1346	1349	DiseaseOrPhenotypicFeature	CKD	D051436
8889	21903317	1351	1357	DiseaseOrPhenotypicFeature	Anemia	D000740
8890	21903317	1458	1461	GeneOrGeneProduct	REN	5972
8891	21903317	1552	1555	GeneOrGeneProduct	REN	5972
8892	21903317	1565	1573	OrganismTaxon	patients	9606
8893	21903317	1579	1582	DiseaseOrPhenotypicFeature	CKD	D051436
8894	21903317	1588	1601	DiseaseOrPhenotypicFeature	hyperuricemia	D033461
8895	21903317	1606	1612	DiseaseOrPhenotypicFeature	anemia	D000740
8896	21904390	27	31	GeneOrGeneProduct	PAX6	5080
8897	21904390	88	96	OrganismTaxon	patients	9606
8898	21904390	107	115	DiseaseOrPhenotypicFeature	Aniridia	D015783
8899	21904390	117	119	DiseaseOrPhenotypicFeature	AN	D015783
8900	21904390	131	160	DiseaseOrPhenotypicFeature	congenital panocular disorder	D000013
8901	21904390	192	218	GeneOrGeneProduct	paired box homeotic gene 6	5080
8902	21904390	219	223	GeneOrGeneProduct	PAX6	5080
8903	21904390	235	239	GeneOrGeneProduct	PAX6	5080
8904	21904390	271	301	DiseaseOrPhenotypicFeature	anterior segment malformations	C537775
8905	21904390	312	326	DiseaseOrPhenotypicFeature	Peters anomaly	C537884
8906	21904390	343	347	GeneOrGeneProduct	PAX6	5080
8907	21904390	443	445	DiseaseOrPhenotypicFeature	AN	D015783
8908	21904390	447	475	DiseaseOrPhenotypicFeature	coloboma of iris and choroid	D003103
8909	21904390	480	510	DiseaseOrPhenotypicFeature	anterior segment malformations	C537775
8910	21904390	512	520	OrganismTaxon	PATIENTS	9606
8911	21904390	573	581	OrganismTaxon	patients	9606
8912	21904390	753	757	GeneOrGeneProduct	PAX6	5080
8913	21904390	965	973	OrganismTaxon	patients	9606
8914	21904390	1038	1040	DiseaseOrPhenotypicFeature	AN	D015783
8915	21904390	1042	1071	DiseaseOrPhenotypicFeature	coloboma of iris and choroids	D003103
8916	21904390	1081	1111	DiseaseOrPhenotypicFeature	anterior segment malformations	C537775
8917	21904390	1122	1136	DiseaseOrPhenotypicFeature	peters anomaly	C537884
8918	21904390	1156	1160	GeneOrGeneProduct	PAX6	5080
8919	21904390	1249	1259	SequenceVariant	c.357-3C>G	c|SUB|C|357-3|G
8920	21904390	1261	1272	SequenceVariant	p.Ser119fsX	p|FS|S|119||
8921	21904390	1297	1305	OrganismTaxon	patients	9606
8922	21904390	1313	1315	DiseaseOrPhenotypicFeature	AN	D015783
8923	21904390	1349	1357	SequenceVariant	c.643T>C	c|SUB|T|643|C
8924	21904390	1359	1366	SequenceVariant	p.S216P	p|SUB|S|216|P
8925	21904390	1388	1417	DiseaseOrPhenotypicFeature	anterior segment malformation	C537775
8926	21904390	1438	1445	SequenceVariant	p.S216P	p|SUB|S|216|P
8927	21904390	1487	1491	GeneOrGeneProduct	PAX6	5080
8928	21904390	1516	1530	DiseaseOrPhenotypicFeature	Peters anomaly	C537884
8929	21904390	1631	1635	GeneOrGeneProduct	PAX6	5080
8930	21904390	1645	1659	GeneOrGeneProduct	DKFZ p686k1684	-
8931	21904390	1694	1701	OrganismTaxon	patient	9606
8932	21904390	1711	1713	DiseaseOrPhenotypicFeature	AN	D015783
8933	21904390	1801	1829	DiseaseOrPhenotypicFeature	coloboma of iris and choroid	D003103
8934	21904390	2043	2047	GeneOrGeneProduct	PAX6	5080
8935	21976953	26	30	GeneOrGeneProduct	FBN1	2200
8936	21976953	70	85	DiseaseOrPhenotypicFeature	Marfan syndrome	D008382
8937	21976953	128	139	GeneOrGeneProduct	fibrillin-1	2200
8938	21976953	146	150	GeneOrGeneProduct	FBN1	2200
8939	21976953	177	192	DiseaseOrPhenotypicFeature	Marfan syndrome	D008382
8940	21976953	194	197	DiseaseOrPhenotypicFeature	MFS	D008382
8941	21976953	209	217	OrganismTaxon	Patients	9606
8942	21976953	509	513	GeneOrGeneProduct	FBN1	2200
8943	21976953	1018	1027	SequenceVariant	c.3703T>C	c|SUB|T|3703|C
8944	21976953	1049	1053	GeneOrGeneProduct	FBN1	2200
8945	21976953	1121	1152	SequenceVariant	serine by proline at codon 1235	p|SUB|S|1235|P
8946	21976953	1154	1162	SequenceVariant	p.S1235P	p|SUB|S|1235|P
8947	21976953	1344	1351	ChemicalEntity	calcium	D002118
8948	21976953	1360	1383	GeneOrGeneProduct	epidermal growth factor	1956
8949	21976953	1540	1548	SequenceVariant	p.S1235P	p|SUB|S|1235|P
8950	21976953	1561	1565	GeneOrGeneProduct	FBN1	2200
8951	21976953	1603	1606	DiseaseOrPhenotypicFeature	MFS	D008382
8952	21976953	1667	1671	GeneOrGeneProduct	FBN1	2200
8953	21976953	1734	1749	DiseaseOrPhenotypicFeature	Marfan syndrome	D008382
8954	22051099	17	22	GeneOrGeneProduct	CXCR1	3577
8955	22051099	29	34	GeneOrGeneProduct	IL8RA	3577
8956	22051099	77	98	DiseaseOrPhenotypicFeature	chronic periodontitis	D055113
8957	22051099	116	143	GeneOrGeneProduct	chemokine receptor 1 CXCR-1	3577
8958	22051099	148	158	GeneOrGeneProduct	IL8R-alpha	3577
8959	22051099	191	204	GeneOrGeneProduct	interleukin 8	3576
8960	22051099	206	210	GeneOrGeneProduct	IL-8	3576
8961	22051099	287	299	DiseaseOrPhenotypicFeature	inflammatory	D007249
8962	22051099	327	336	SequenceVariant	rs2234671	rs2234671
8963	22051099	349	359	SequenceVariant	Ex2+860G>C	rs2234671
8964	22051099	367	372	GeneOrGeneProduct	CXCR1	3577
8965	22051099	425	430	SequenceVariant	S276T	rs2234671
8966	22051099	535	546	DiseaseOrPhenotypicFeature	lung cancer	D008175
8967	22051099	622	625	GeneOrGeneProduct	IL8	3576
8968	22051099	637	642	GeneOrGeneProduct	CXCR2	3579
8969	22051099	681	702	DiseaseOrPhenotypicFeature	chronic periodontitis	D055113
8970	22051099	751	760	SequenceVariant	rs2234671	rs2234671
8971	22051099	804	825	DiseaseOrPhenotypicFeature	chronic periodontitis	D055113
8972	22051099	972	981	SequenceVariant	rs2234671	rs2234671
8973	22051099	989	994	GeneOrGeneProduct	CXCR1	3577
8974	22051099	1046	1067	DiseaseOrPhenotypicFeature	chronic periodontitis	D055113
8975	22711886	0	24	GeneOrGeneProduct	TNFR-associated factor 2	22030
8976	22711886	68	96	DiseaseOrPhenotypicFeature	chronic lymphocytic leukemia	D015451
8977	22711886	97	123	DiseaseOrPhenotypicFeature	small lymphocytic lymphoma	D015451
8978	22711886	127	131	OrganismTaxon	mice	10090
8979	22711886	179	183	OrganismTaxon	mice	10090
8980	22711886	217	222	GeneOrGeneProduct	BCL-2	596
8981	22711886	229	253	GeneOrGeneProduct	TNFR-associated factor 2	22030
8982	22711886	255	260	GeneOrGeneProduct	TRAF2	22030
8983	22711886	351	377	DiseaseOrPhenotypicFeature	small lymphocytic lymphoma	D015451
8984	22711886	382	410	DiseaseOrPhenotypicFeature	chronic lymphocytic leukemia	D015451
8985	22711886	535	540	GeneOrGeneProduct	TRAF2	22030
8986	22711886	621	626	GeneOrGeneProduct	TRAF2	22030
8987	22711886	660	672	CellLine	Traf2DN-tg B	10090
8988	22711886	703	707	OrganismTaxon	mice	10090
8989	22711886	732	742	GeneOrGeneProduct	proteasome	16912
8990	22711886	808	813	GeneOrGeneProduct	TRAF2	22030
8991	22711886	866	871	GeneOrGeneProduct	Traf2	22030
8992	22711886	882	892	CellLine	Traf2DN-tg	10090
8993	22711886	893	897	OrganismTaxon	mice	10090
8994	22711886	966	981	GeneOrGeneProduct	p100 NF-kappaB2	18034
8995	22711886	1000	1005	GeneOrGeneProduct	TRAF3	22031
8996	22711886	1007	1038	GeneOrGeneProduct	X-linked inhibitor of apoptosis	11798
8997	22711886	1044	1052	GeneOrGeneProduct	Bcl-X(L)	12048
8998	22711886	1095	1135	GeneOrGeneProduct	cellular inhibitors of apoptosis 1 and 2	11796,11797
8999	22711886	1278	1283	GeneOrGeneProduct	TRAF2	22030
9000	22711886	1311	1314	GeneOrGeneProduct	JNK	26419
9001	22711886	1319	1322	GeneOrGeneProduct	ERK	26413
9002	22711886	1349	1353	GeneOrGeneProduct	CD40	21939
9003	22711886	1375	1380	GeneOrGeneProduct	TRAF2	22030
9004	22711886	1401	1404	GeneOrGeneProduct	BCR	12518
9005	22711886	1456	1461	GeneOrGeneProduct	TRAF2	22030
9006	22711886	1490	1494	GeneOrGeneProduct	CD40	21939
9007	22711886	1504	1512	GeneOrGeneProduct	p38 MAPK	26416
9008	22711886	1550	1553	GeneOrGeneProduct	BCR	12518
9009	22711886	1563	1566	GeneOrGeneProduct	p38	26416
9010	22711886	1612	1617	GeneOrGeneProduct	TRAF2	22030
9011	22711886	1635	1639	GeneOrGeneProduct	CD40	21939
9012	22711886	1713	1737	GeneOrGeneProduct	B cell activating factor	24099
9013	22711886	1789	1794	GeneOrGeneProduct	TRAF2	22030
9014	22711886	1822	1827	GeneOrGeneProduct	BCL-2	596
9015	22711886	1841	1869	DiseaseOrPhenotypicFeature	chronic lymphocytic leukemia	D015451
9016	22711886	1870	1896	DiseaseOrPhenotypicFeature	small lymphocytic lymphoma	D015451
9017	22711886	1900	1904	OrganismTaxon	mice	10090
9018	22711886	1987	2018	GeneOrGeneProduct	X-linked inhibitor of apoptosis	11798
9019	22711886	2068	2092	GeneOrGeneProduct	B cell activating factor	24099
9020	22808010	12	16	GeneOrGeneProduct	EPOR	13857
9021	22808010	77	87	GeneOrGeneProduct	Tnfr-sf13c	72049
9022	22808010	111	114	GeneOrGeneProduct	EPO	13856
9023	22808010	178	181	GeneOrGeneProduct	EPO	13856
9024	22808010	182	186	GeneOrGeneProduct	EPOR	13857
9025	22808010	241	246	GeneOrGeneProduct	Bcl-x	12048
9026	22808010	334	338	GeneOrGeneProduct	EPOR	13857
9027	22808010	365	373	GeneOrGeneProduct	p85/PI3K	18708
9028	22808010	411	423	DiseaseOrPhenotypicFeature	polycythemia	D011086
9029	22808010	429	433	GeneOrGeneProduct	Erk1	26417
9030	22808010	501	504	GeneOrGeneProduct	EPO	13856
9031	22808010	505	509	GeneOrGeneProduct	EPOR	13857
9032	22808010	592	595	GeneOrGeneProduct	EPO	13856
9033	22808010	596	600	GeneOrGeneProduct	EPOR	13857
9034	22808010	676	679	GeneOrGeneProduct	EPO	13856
9035	22808010	680	684	GeneOrGeneProduct	EPOR	13857
9036	22808010	765	768	GeneOrGeneProduct	EPO	13856
9037	22808010	805	809	GeneOrGeneProduct	Lyl1	17095
9038	22808010	811	815	GeneOrGeneProduct	Gas5	14455
9039	22808010	817	821	GeneOrGeneProduct	Pim3	223775
9040	22808010	823	827	GeneOrGeneProduct	Pim1	18712
9041	22808010	829	832	GeneOrGeneProduct	Bim	12125
9042	22808010	834	839	GeneOrGeneProduct	Trib3	228775
9043	22808010	844	854	GeneOrGeneProduct	Serpina 3g	20715
9044	22808010	856	859	GeneOrGeneProduct	EPO	13856
9045	22808010	860	864	GeneOrGeneProduct	EPOR	13857
9046	22808010	905	911	GeneOrGeneProduct	Cdc25a	12530
9047	22808010	913	917	GeneOrGeneProduct	Btg3	12228
9048	22808010	919	928	GeneOrGeneProduct	Cyclin-d2	12444
9049	22808010	930	938	GeneOrGeneProduct	p27-kip1	12576
9050	22808010	940	949	GeneOrGeneProduct	Cyclin-g2	12452
9051	22808010	954	967	GeneOrGeneProduct	CyclinB1-IP-1	239083
9052	22808010	969	972	GeneOrGeneProduct	EPO	13856
9053	22808010	1069	1074	GeneOrGeneProduct	Socs3	12702
9054	22808010	1080	1085	GeneOrGeneProduct	Socs2	216233
9055	22808010	1095	1101	GeneOrGeneProduct	Spred2	114716
9056	22808010	1103	1109	GeneOrGeneProduct	Spred1	114715
9057	22808010	1114	1118	GeneOrGeneProduct	Eaf1	74427
9058	22808010	1124	1127	GeneOrGeneProduct	EPO	13856
9059	22808010	1169	1174	GeneOrGeneProduct	Socs2	216233
9060	22808010	1237	1241	GeneOrGeneProduct	EPOR	13857
9061	22808010	1242	1246	GeneOrGeneProduct	Jak2	16452
9062	22808010	1247	1252	GeneOrGeneProduct	Stat5	20850
9063	22808010	1315	1321	DiseaseOrPhenotypicFeature	anemia	D000740
9064	22808010	1353	1365	GeneOrGeneProduct	TNF-receptor	72049
9065	22808010	1366	1376	GeneOrGeneProduct	Tnfr-sf13c	72049
9066	22808010	1408	1411	GeneOrGeneProduct	EPO	13856
9067	22808010	1427	1437	GeneOrGeneProduct	Tnfr-sf13c	72049
9068	22808010	1550	1554	GeneOrGeneProduct	EPOR	13857
9069	22808010	1634	1644	GeneOrGeneProduct	Tnfr-sf13c	72049
9070	22836123	11	35	DiseaseOrPhenotypicFeature	scleroderma renal crisis	D007674
9071	22836123	47	57	ChemicalEntity	tacrolimus	D016559
9072	22836123	62	74	ChemicalEntity	prednisolone	D011239
9073	22836123	91	115	DiseaseOrPhenotypicFeature	Scleroderma renal crisis	D007674
9074	22836123	117	120	DiseaseOrPhenotypicFeature	SRC	D007674
9075	22836123	148	166	DiseaseOrPhenotypicFeature	systemic sclerosis	D012595
9076	22836123	168	171	DiseaseOrPhenotypicFeature	SSc	D012595
9077	22836123	281	295	ChemicalEntity	corticosteroid	D000305
9078	22836123	341	344	DiseaseOrPhenotypicFeature	SRC	D007674
9079	22836123	386	412	DiseaseOrPhenotypicFeature	thrombotic microangiopathy	D057049
9080	22836123	429	441	ChemicalEntity	cyclosporine	D016572
9081	22836123	445	453	OrganismTaxon	patients	9606
9082	22836123	459	462	DiseaseOrPhenotypicFeature	SSc	D012595
9083	22836123	493	500	OrganismTaxon	patient	9606
9084	22836123	506	509	DiseaseOrPhenotypicFeature	SRC	D007674
9085	22836123	521	531	ChemicalEntity	tacrolimus	D016559
9086	22836123	536	551	ChemicalEntity	corticosteroids	D000305
9087	22836123	610	620	ChemicalEntity	tacrolimus	D016559
9088	22836123	628	636	OrganismTaxon	patients	9606
9089	22836123	642	645	DiseaseOrPhenotypicFeature	SSc	D012595
9090	22859398	13	17	GeneOrGeneProduct	IL10	3586
9091	22859398	87	102	DiseaseOrPhenotypicFeature	prostate cancer	D011471
9092	22859398	216	220	GeneOrGeneProduct	IL10	3586
9093	22859398	255	278	ChemicalEntity	reactive oxygen species	D017382
9094	22859398	367	382	DiseaseOrPhenotypicFeature	prostate cancer	D011471
9095	22859398	437	440	OrganismTaxon	men	9606
9096	22859398	630	638	ChemicalEntity	paraffin	D010232
9097	22859398	736	740	GeneOrGeneProduct	IL10	3586
9098	22859398	742	745	GeneOrGeneProduct	CRP	1401
9099	22859398	747	751	GeneOrGeneProduct	GPX1	2876
9100	22859398	753	756	GeneOrGeneProduct	GSR	2936
9101	22859398	758	763	GeneOrGeneProduct	GSTP1	2950
9102	22859398	765	770	GeneOrGeneProduct	hOGG1	4968
9103	22859398	772	776	GeneOrGeneProduct	IL1B	3553
9104	22859398	778	783	GeneOrGeneProduct	IL1RN	3557
9105	22859398	785	788	GeneOrGeneProduct	IL6	3569
9106	22859398	790	793	GeneOrGeneProduct	IL8	3576
9107	22859398	795	798	GeneOrGeneProduct	MPO	4353
9108	22859398	800	804	GeneOrGeneProduct	NOS2	4843
9109	22859398	806	810	GeneOrGeneProduct	NOS3	4846
9110	22859398	812	816	GeneOrGeneProduct	SOD1	6647
9111	22859398	818	822	GeneOrGeneProduct	SOD2	6648
9112	22859398	824	828	GeneOrGeneProduct	SOD3	6649
9113	22859398	830	834	GeneOrGeneProduct	TLR4	7099
9114	22859398	840	843	GeneOrGeneProduct	TNF	7124
9115	22859398	864	868	GeneOrGeneProduct	IL10	3586
9116	22859398	870	873	GeneOrGeneProduct	CRP	1401
9117	22859398	875	878	GeneOrGeneProduct	GSR	2936
9118	22859398	880	885	GeneOrGeneProduct	IL1RN	3557
9119	22859398	887	890	GeneOrGeneProduct	IL6	3569
9120	22859398	892	896	GeneOrGeneProduct	NOS2	4843
9121	22859398	902	906	GeneOrGeneProduct	NOS3	4846
9122	22859398	1031	1035	GeneOrGeneProduct	IL10	3586
9123	22859398	1036	1045	SequenceVariant	rs1800872	rs1800872
9124	22859398	1069	1083	GeneOrGeneProduct	interleukin-10	3586
9125	22859398	1085	1090	GeneOrGeneProduct	IL-10	3586
9126	22859398	1201	1210	SequenceVariant	rs1800896	rs1800896
9127	22859398	1234	1239	GeneOrGeneProduct	IL-10	3586
9128	22859398	1372	1375	GeneOrGeneProduct	CRP	1401
9129	22859398	1377	1382	GeneOrGeneProduct	GSTP1	2950
9130	22859398	1388	1392	GeneOrGeneProduct	IL1B	3553
9131	22859398	1403	1407	GeneOrGeneProduct	IL10	3586
9132	22859398	1431	1435	GeneOrGeneProduct	NOS2	4843
9133	22859398	1505	1509	GeneOrGeneProduct	IL10	3586
9134	22859398	1511	1514	GeneOrGeneProduct	CRP	1401
9135	22859398	1516	1521	GeneOrGeneProduct	GSTP1	2950
9136	22859398	1523	1527	GeneOrGeneProduct	IL1B	3553
9137	22859398	1533	1537	GeneOrGeneProduct	NOS2	4843
9138	22859398	1558	1573	DiseaseOrPhenotypicFeature	prostate cancer	D011471
9139	22859398	1725	1740	DiseaseOrPhenotypicFeature	prostate cancer	D011471
9140	23069675	17	37	GeneOrGeneProduct	neuronal pentraxin 1	18164
9141	23069675	63	95	DiseaseOrPhenotypicFeature	hypoxic-ischemic neuronal injury	D020925
9142	23069675	139	167	DiseaseOrPhenotypicFeature	hypoxic-ischemic (HI) injury	D020925
9143	23069675	186	211	DiseaseOrPhenotypicFeature	neurological disabilities	D009461
9144	23069675	289	309	GeneOrGeneProduct	neuronal pentraxin 1	266777
9145	23069675	311	314	GeneOrGeneProduct	NP1	266777
9146	23069675	378	396	DiseaseOrPhenotypicFeature	HI neuronal injury	D020925
9147	23069675	472	489	DiseaseOrPhenotypicFeature	HI neuronal death	D020925
9148	23069675	518	521	GeneOrGeneProduct	NP1	18164
9149	23069675	532	535	GeneOrGeneProduct	NP1	18164
9150	23069675	540	545	OrganismTaxon	mouse	10090
9151	23069675	607	613	ChemicalEntity	oxygen	D010100
9152	23069675	614	621	ChemicalEntity	glucose	D005947
9153	23069675	670	675	OrganismTaxon	mouse	10090
9154	23069675	685	700	DiseaseOrPhenotypicFeature	HI brain injury	D020925
9155	23069675	732	735	GeneOrGeneProduct	NP1	18164
9156	23069675	833	836	GeneOrGeneProduct	CA1	12346
9157	23069675	841	844	GeneOrGeneProduct	CA3	12350
9158	23069675	932	936	GeneOrGeneProduct	PTEN	19211
9159	23069675	1010	1013	GeneOrGeneProduct	Akt	11651
9160	23069675	1015	1021	SequenceVariant	Ser473	p|AellelS|473
9161	23069675	1027	1033	GeneOrGeneProduct	GSK-3b	56637
9162	23069675	1035	1039	SequenceVariant	Ser9	p|AellelS|9
9163	23069675	1110	1113	GeneOrGeneProduct	Bad	12015
9164	23069675	1115	1121	SequenceVariant	Ser136	p|AellelS|136
9165	23069675	1128	1131	GeneOrGeneProduct	Bax	12028
9166	23069675	1265	1268	GeneOrGeneProduct	Bad	12015
9167	23069675	1273	1276	GeneOrGeneProduct	Bax	12028
9168	23069675	1361	1366	GeneOrGeneProduct	Cyt C	13063
9169	23069675	1411	1420	GeneOrGeneProduct	caspase-3	12367
9170	23069675	1422	1425	GeneOrGeneProduct	NP1	18164
9171	23069675	1462	1465	GeneOrGeneProduct	Bad	12015
9172	23069675	1470	1473	GeneOrGeneProduct	Bax	12028
9173	23069675	1521	1524	GeneOrGeneProduct	NP1	18164
9174	23069675	1530	1533	GeneOrGeneProduct	Bad	12015
9175	23069675	1538	1541	GeneOrGeneProduct	Bax	12028
9176	23069675	1665	1668	GeneOrGeneProduct	NP1	18164
9177	23069675	1727	1739	GeneOrGeneProduct	cytochrome C	13063
9178	23069675	1741	1746	GeneOrGeneProduct	Cyt C	13063
9179	23069675	1780	1789	GeneOrGeneProduct	caspase-3	12367
9180	23069675	1875	1878	GeneOrGeneProduct	NP1	18164
9181	23069675	1920	1923	GeneOrGeneProduct	Bad	12015
9182	23069675	1928	1931	GeneOrGeneProduct	Bax	12028
9183	23069675	2007	2012	GeneOrGeneProduct	Cyt C	13063
9184	23069675	2025	2034	GeneOrGeneProduct	caspase-3	12367
9185	23069675	2101	2115	DiseaseOrPhenotypicFeature	neuronal death	D009410
9186	23069675	2159	2162	GeneOrGeneProduct	NP1	18164
9187	23069675	2166	2169	GeneOrGeneProduct	Bad	12015
9188	23069675	2170	2173	GeneOrGeneProduct	Bax	12028
9189	23069675	2209	2214	GeneOrGeneProduct	Cyt C	13063
9190	23069675	2219	2228	GeneOrGeneProduct	caspase-3	12367
9191	23069675	2302	2305	GeneOrGeneProduct	NP1	18164
9192	23069675	2371	2374	GeneOrGeneProduct	NP1	18164
9193	23069675	2417	2432	DiseaseOrPhenotypicFeature	HI brain injury	D020925
9194	23285048	39	51	GeneOrGeneProduct	Delta-like 4	54485
9195	23285048	99	111	GeneOrGeneProduct	Delta-like 4	54485
9196	23285048	113	117	GeneOrGeneProduct	Dll4	54485
9197	23285048	138	143	GeneOrGeneProduct	Notch	18128
9198	23285048	207	212	DiseaseOrPhenotypicFeature	tumor	D009369
9199	23285048	298	303	DiseaseOrPhenotypicFeature	tumor	D009369
9200	23285048	315	319	GeneOrGeneProduct	Dll4	54485
9201	23285048	445	449	GeneOrGeneProduct	Dll4	54485
9202	23285048	450	455	GeneOrGeneProduct	Notch	18128
9203	23285048	487	493	DiseaseOrPhenotypicFeature	tumors	D009369
9204	23285048	553	557	GeneOrGeneProduct	Dll4	54485
9205	23285048	628	632	GeneOrGeneProduct	Dll4	54485
9206	23285048	727	731	OrganismTaxon	mice	10090
9207	23285048	756	760	GeneOrGeneProduct	CD31	18613
9208	23285048	765	776	GeneOrGeneProduct	VE-Cadherin	12562
9209	23285048	784	789	GeneOrGeneProduct	c-kit	16590
9210	23285048	852	857	GeneOrGeneProduct	CD105	13805
9211	23285048	862	868	GeneOrGeneProduct	VEGFR3	14257
9212	23285048	873	876	GeneOrGeneProduct	SMA	11475
9213	23285048	884	890	GeneOrGeneProduct	lectin	-
9214	23285048	990	994	GeneOrGeneProduct	Dll4	54485
9215	23285048	1035	1041	GeneOrGeneProduct	IGFbp2	16008
9216	23285048	1043	1049	GeneOrGeneProduct	IGFbp3	16009
9217	23285048	1051	1057	GeneOrGeneProduct	Angpt2	11601
9218	23285048	1059	1063	GeneOrGeneProduct	Dll4	54485
9219	23285048	1065	1068	GeneOrGeneProduct	DHH	13363
9220	23285048	1073	1079	GeneOrGeneProduct	VEGF-A	22339
9221	23285048	1103	1107	GeneOrGeneProduct	FGF1	14164
9222	23285048	1112	1116	GeneOrGeneProduct	CSF2	12981
9223	23285048	1180	1184	GeneOrGeneProduct	Dll4	54485
9224	23285048	1193	1196	GeneOrGeneProduct	Akt	11651
9225	23285048	1249	1256	GeneOrGeneProduct	Erk 1/2	26413,26417
9226	23285048	1325	1329	GeneOrGeneProduct	Dll4	54485
9227	23285048	1400	1405	GeneOrGeneProduct	CD11b	16409
9228	23285048	1424	1428	GeneOrGeneProduct	B220	19264
9229	23285048	1440	1443	GeneOrGeneProduct	CD3	12501
9230	23285048	1479	1483	OrganismTaxon	mice	10090
9231	23285048	1560	1564	GeneOrGeneProduct	Dll4	54485
9232	23285048	1670	1676	GeneOrGeneProduct	Notch1	18128
9233	23285048	1692	1696	GeneOrGeneProduct	Dll4	54485
9234	23285048	1889	1893	GeneOrGeneProduct	Dll4	54485
9235	23791840	0	22	GeneOrGeneProduct	Superoxide dismutase 1	20655
9236	23791840	41	45	OrganismTaxon	mice	10090
9237	23791840	56	73	DiseaseOrPhenotypicFeature	maternal diabetes	D016640
9238	23791840	114	122	DiseaseOrPhenotypicFeature	diabetic	D003920
9239	23791840	123	134	DiseaseOrPhenotypicFeature	embryopathy	D005315
9240	23791840	235	243	DiseaseOrPhenotypicFeature	diabetic	D003920
9241	23791840	244	255	DiseaseOrPhenotypicFeature	embryopathy	D005315
9242	23791840	343	365	GeneOrGeneProduct	superoxide dismutase 1	20655
9243	23791840	367	371	GeneOrGeneProduct	SOD1	20655
9244	23791840	438	442	GeneOrGeneProduct	SOD1	20655
9245	23791840	463	471	DiseaseOrPhenotypicFeature	diabetic	D003920
9246	23791840	487	491	GeneOrGeneProduct	SOD1	20655
9247	23791840	545	569	GeneOrGeneProduct	C/EBP-homologous protein	13198
9248	23791840	571	575	GeneOrGeneProduct	CHOP	13198
9249	23791840	578	586	GeneOrGeneProduct	calnexin	12330
9250	23791840	588	619	GeneOrGeneProduct	eukaryotic initiation factor 2a	229317
9251	23791840	621	626	GeneOrGeneProduct	eIF2a	229317
9252	23791840	629	681	GeneOrGeneProduct	protein kinase ribonucleic acid (RNA)-like ER kinase	13666
9253	23791840	683	687	GeneOrGeneProduct	PERK	13666
9254	23791840	690	720	GeneOrGeneProduct	binding immunoglobulin protein	14828
9255	23791840	722	767	GeneOrGeneProduct	protein disulfide isomerase family A member 3	14827
9256	23791840	769	806	GeneOrGeneProduct	kinases inositol-requiring protein-1a	78943
9257	23791840	808	813	GeneOrGeneProduct	IRE1a	78943
9258	23791840	824	845	GeneOrGeneProduct	X-box binding protein	22433
9259	23791840	847	851	GeneOrGeneProduct	XBP1	22433
9260	23791840	893	910	DiseaseOrPhenotypicFeature	Maternal diabetes	D016640
9261	23791840	949	953	GeneOrGeneProduct	CHOP	13198
9262	23791840	955	963	GeneOrGeneProduct	calnexin	12330
9263	23791840	984	989	GeneOrGeneProduct	eIF2a	229317
9264	23791840	993	997	GeneOrGeneProduct	PERK	13666
9265	23791840	1005	1010	GeneOrGeneProduct	IRE1a	78943
9266	23791840	1022	1026	GeneOrGeneProduct	XBP1	22433
9267	23791840	1099	1103	GeneOrGeneProduct	SOD1	20655
9268	23791840	1133	1141	DiseaseOrPhenotypicFeature	diabetes	D003920
9269	23791840	1213	1217	GeneOrGeneProduct	SOD1	20655
9270	23791840	1240	1257	DiseaseOrPhenotypicFeature	maternal diabetes	D016640
9271	23864035	0	10	ChemicalEntity	Bortezomib	D000069286
9272	23864035	15	28	ChemicalEntity	dexamethasone	D003907
9273	23864035	51	59	OrganismTaxon	patients	9606
9274	23864035	85	101	DiseaseOrPhenotypicFeature	multiple myeloma	D009101
9275	23864035	144	154	ChemicalEntity	Bortezomib	D000069286
9276	23864035	156	160	ChemicalEntity	bort	D000069286
9277	23864035	162	175	ChemicalEntity	dexamethasone	D003907
9278	23864035	177	180	ChemicalEntity	dex	D003907
9279	23864035	236	252	DiseaseOrPhenotypicFeature	multiple myeloma	D009101
9280	23864035	254	256	DiseaseOrPhenotypicFeature	MM	D009101
9281	23864035	316	320	ChemicalEntity	bort	D000069286
9282	23864035	377	380	ChemicalEntity	dex	D003907
9283	23864035	420	424	ChemicalEntity	bort	D000069286
9284	23864035	453	461	OrganismTaxon	patients	9606
9285	23864035	471	473	DiseaseOrPhenotypicFeature	MM	D009101
9286	23864035	632	640	OrganismTaxon	patients	9606
9287	23864035	717	721	ChemicalEntity	bort	D000069286
9288	23864035	722	725	ChemicalEntity	dex	D003907
9289	23864035	748	752	ChemicalEntity	bort	D000069286
9290	23864035	753	756	ChemicalEntity	dex	D003907
9291	23864035	845	853	OrganismTaxon	patients	9606
9292	23864035	1122	1143	DiseaseOrPhenotypicFeature	peripheral neuropathy	D010523
9293	23864035	1175	1183	OrganismTaxon	patients	9606
9294	23864035	1469	1477	OrganismTaxon	patients	9606
9295	23864035	1505	1509	ChemicalEntity	bort	D000069286
9296	23864035	1510	1513	ChemicalEntity	dex	D003907
9297	23864035	1546	1550	ChemicalEntity	Bort	D000069286
9298	23864035	1551	1554	ChemicalEntity	dex	D003907
9299	23864035	1594	1596	DiseaseOrPhenotypicFeature	MM	D009101
9300	23864035	1597	1605	OrganismTaxon	patients	9606
9301	23949582	26	36	ChemicalEntity	ifosfamide	D007069
9302	23949582	38	43	ChemicalEntity	mesna	D015080
9303	23949582	81	87	OrganismTaxon	rabbit	9986
9304	23949582	140	150	ChemicalEntity	Ifosfamide	D007069
9305	23949582	152	155	ChemicalEntity	IFO	D007069
9306	23949582	163	190	ChemicalEntity	alkylating nitrogen mustard	D008357
9307	23949582	297	308	DiseaseOrPhenotypicFeature	hemorrhagic	D006470
9308	23949582	309	317	DiseaseOrPhenotypicFeature	cystitis	D003556
9309	23949582	339	342	ChemicalEntity	IFO	D007069
9310	23949582	397	429	ChemicalEntity	sodium 2-sulfanylethanesulfonate	D015080
9311	23949582	431	436	ChemicalEntity	Mesna	D015080
9312	23949582	479	482	ChemicalEntity	IFO	D007069
9313	23949582	487	492	ChemicalEntity	Mesna	D015080
9314	23949582	526	532	OrganismTaxon	rabbit	9986
9315	23949582	716	721	ChemicalEntity	Mesna	D015080
9316	23949582	752	755	ChemicalEntity	IFO	D007069
9317	23949582	840	843	ChemicalEntity	IFO	D007069
9318	23949582	916	921	ChemicalEntity	Mesna	D015080
9319	23949582	1002	1005	ChemicalEntity	IFO	D007069
9320	23949582	1059	1064	ChemicalEntity	Mesna	D015080
9321	23949582	1087	1090	ChemicalEntity	IFO	D007069
9322	23949582	1093	1105	DiseaseOrPhenotypicFeature	genotoxicity	D030342
9323	23952588	31	39	ChemicalEntity	levodopa	D007980
9324	23952588	48	58	DiseaseOrPhenotypicFeature	dyskinesia	D004409
9325	23952588	93	112	DiseaseOrPhenotypicFeature	Parkinson's disease	D010300
9326	23952588	132	140	ChemicalEntity	levodopa	D007980
9327	23952588	153	172	DiseaseOrPhenotypicFeature	Parkinson's disease	D010300
9328	23952588	174	176	DiseaseOrPhenotypicFeature	PD	D010300
9329	23952588	229	239	DiseaseOrPhenotypicFeature	dyskinesia	D004409
9330	23952588	285	293	ChemicalEntity	levodopa	D007980
9331	23952588	302	312	DiseaseOrPhenotypicFeature	dyskinesia	D004409
9332	23952588	341	349	OrganismTaxon	patients	9606
9333	23952588	355	357	DiseaseOrPhenotypicFeature	PD	D010300
9334	23952588	413	421	OrganismTaxon	patients	9606
9335	23952588	427	429	DiseaseOrPhenotypicFeature	PD	D010300
9336	23952588	447	455	ChemicalEntity	levodopa	D007980
9337	23952588	555	565	DiseaseOrPhenotypicFeature	dyskinesia	D004409
9338	23952588	761	771	DiseaseOrPhenotypicFeature	Dyskinesia	D004409
9339	23952588	812	820	ChemicalEntity	levodopa	D007980
9340	23952588	943	951	OrganismTaxon	patients	9606
9341	23952588	957	967	DiseaseOrPhenotypicFeature	dyskinesia	D004409
9342	23952588	995	1003	OrganismTaxon	Patients	9606
9343	23952588	1009	1019	DiseaseOrPhenotypicFeature	dyskinesia	D004409
9344	23952588	1073	1081	ChemicalEntity	levodopa	D007980
9345	23952588	1161	1169	ChemicalEntity	levodopa	D007980
9346	23952588	1237	1245	OrganismTaxon	patients	9606
9347	23952588	1254	1264	DiseaseOrPhenotypicFeature	dyskinesia	D004409
9348	23952588	1302	1312	DiseaseOrPhenotypicFeature	dyskinesia	D004409
9349	23952588	1330	1338	ChemicalEntity	levodopa	D007980
9350	23952588	1375	1383	ChemicalEntity	levodopa	D007980
9351	23952588	1421	1429	ChemicalEntity	levodopa	D007980
9352	23952588	1438	1448	DiseaseOrPhenotypicFeature	dyskinesia	D004409
9353	23952588	1456	1464	OrganismTaxon	patients	9606
9354	23952588	1523	1531	ChemicalEntity	levodopa	D007980
9355	23952588	1553	1561	ChemicalEntity	levodopa	D007980
9356	24014394	25	30	GeneOrGeneProduct	LYRM7	90624
9357	24014394	31	36	GeneOrGeneProduct	MZM1L	90624
9358	24014394	65	79	DiseaseOrPhenotypicFeature	encephalopathy	D001927
9359	24014394	81	96	DiseaseOrPhenotypicFeature	lactic acidosis	D000140
9360	24014394	109	147	DiseaseOrPhenotypicFeature	reduction of mitochondrial complex III	C565128
9361	24014394	201	250	DiseaseOrPhenotypicFeature	defective complex III (cIII) of the mitochondrial	C565128
9362	24014394	309	313	GeneOrGeneProduct	cIII	617
9363	24014394	381	385	GeneOrGeneProduct	cIII	617
9364	24014394	417	422	OrganismTaxon	human	9606
9365	24014394	423	428	GeneOrGeneProduct	LYRM7	90624
9366	24014394	429	434	GeneOrGeneProduct	MZM1L	90624
9367	24014394	452	457	OrganismTaxon	yeast	4932
9368	24014394	458	462	GeneOrGeneProduct	MZM1	852104
9369	24014394	513	517	GeneOrGeneProduct	cIII	617
9370	24014394	529	536	OrganismTaxon	patient	9606
9371	24014394	562	576	DiseaseOrPhenotypicFeature	encephalopathy	D001927
9372	24014394	578	593	DiseaseOrPhenotypicFeature	lactic acidosis	D000140
9373	24014394	617	632	DiseaseOrPhenotypicFeature	cIII deficiency	C565128
9374	24014394	710	717	SequenceVariant	c.73G>A	rs587777433
9375	24014394	722	727	GeneOrGeneProduct	LYRM7	90624
9376	24014394	728	733	GeneOrGeneProduct	MZM1L	90624
9377	24014394	805	815	SequenceVariant	p.Asp25Asn	rs587777433
9378	24014394	823	828	GeneOrGeneProduct	mzm1D	852104
9379	24014394	829	834	OrganismTaxon	yeast	4932
9380	24014394	863	867	GeneOrGeneProduct	mzm1	852104
9381	24014394	868	872	SequenceVariant	D25N	rs587777433
9382	24014394	917	942	DiseaseOrPhenotypicFeature	respiratory growth defect	D012131
9383	24014394	954	960	ChemicalEntity	oxygen	D010100
9384	24014394	1015	1034	GeneOrGeneProduct	Rieske Fe-S protein	856689
9385	24014394	1048	1059	GeneOrGeneProduct	complex III	617
9386	24014394	1081	1086	GeneOrGeneProduct	LYRM7	90624
9387	24014394	1087	1092	GeneOrGeneProduct	MZM1L	90624
9388	24014394	1126	1140	DiseaseOrPhenotypicFeature	cIII-defective	C565128
9389	24014394	1162	1190	DiseaseOrPhenotypicFeature	mitochondrial encephalopathy	C538525
9390	24036311	0	4	GeneOrGeneProduct	CTR9	22083
9391	24036311	5	10	GeneOrGeneProduct	PAF1c	22083,54624,76246
9392	24036311	49	59	GeneOrGeneProduct	histone H3	260423
9393	24036311	59	62	SequenceVariant	K36	c|Allele|K|36
9394	24036311	428	507	GeneOrGeneProduct	RNA polymerase II associated factor, homolog (Saccharomyces cerevisiae) complex	22083,54624,76246
9395	24036311	509	521	GeneOrGeneProduct	PAF1 complex	22083,54624,76246
9396	24036311	535	539	GeneOrGeneProduct	Ctr9	22083
9397	24036311	544	548	GeneOrGeneProduct	Rtf1	76246
9398	24036311	629	633	GeneOrGeneProduct	Ctr9	22083
9399	24036311	779	783	GeneOrGeneProduct	Ctr9	22083
9400	24036311	813	818	GeneOrGeneProduct	Eomes	13813
9401	24036311	820	824	GeneOrGeneProduct	Elf5	13711
9402	24036311	829	833	GeneOrGeneProduct	Sox2	20674
9403	24036311	879	883	GeneOrGeneProduct	Oct4	18999
9404	24036311	885	890	GeneOrGeneProduct	Nanog	71950
9405	24036311	892	897	GeneOrGeneProduct	Gata6	14465
9406	24036311	899	903	GeneOrGeneProduct	Fgf4	14175
9407	24036311	908	913	GeneOrGeneProduct	Sox17	20671
9408	24036311	959	963	GeneOrGeneProduct	Mest	17294
9409	24036311	965	969	GeneOrGeneProduct	Peg3	18616
9410	24036311	971	976	GeneOrGeneProduct	Snrpn	20646
9411	24036311	981	985	GeneOrGeneProduct	Meg3	17263
9412	24036311	1091	1101	GeneOrGeneProduct	histone H3	260423
9413	24036311	1102	1111	SequenceVariant	lysine 36	c|Allele|K|36
9414	24036311	1128	1130	GeneOrGeneProduct	H3	260423
9415	24036311	1130	1133	SequenceVariant	K36	c|Allele|K|36
9416	24036311	1141	1145	GeneOrGeneProduct	Ctr9	22083
9417	24036311	1201	1206	GeneOrGeneProduct	Setd2	235626
9418	24036311	1210	1214	GeneOrGeneProduct	Rtf1	76246
9419	24036311	1275	1287	GeneOrGeneProduct	PAF1 complex	22083,54624,76246
9420	24036311	1356	1358	GeneOrGeneProduct	H3	260423
9421	24036311	1358	1361	SequenceVariant	K36	c|Allele|K|36
9422	24036311	1410	1422	GeneOrGeneProduct	PAF1 complex	22083,54624,76246
9423	24036311	1428	1433	OrganismTaxon	yeast	4932
9424	24055495	15	24	ChemicalEntity	galactose	D005690
9425	24055495	44	62	DiseaseOrPhenotypicFeature	cognitive deficits	D003072
9426	24055495	78	82	OrganismTaxon	rats	10116
9427	24055495	122	136	ChemicalEntity	streptozotocin	D013311
9428	24055495	188	196	DiseaseOrPhenotypicFeature	dementia	D003704
9429	24055495	209	228	DiseaseOrPhenotypicFeature	Alzheimer's disease	D000544
9430	24055495	230	233	DiseaseOrPhenotypicFeature	sAD	D000544
9431	24055495	278	294	GeneOrGeneProduct	insulin-receptor	24954
9432	24055495	296	298	GeneOrGeneProduct	IR	24954
9433	24055495	329	336	ChemicalEntity	glucose	D005947
9434	24055495	351	358	ChemicalEntity	glucose	D005947
9435	24055495	371	376	GeneOrGeneProduct	GLUT4	25139
9436	24055495	391	398	ChemicalEntity	glucose	D005947
9437	24055495	461	472	ChemicalEntity	d-galactose	D005690
9438	24055495	492	501	ChemicalEntity	d-glucose	D005947
9439	24055495	542	549	GeneOrGeneProduct	insulin	24505
9440	24055495	562	567	GeneOrGeneProduct	GLUT3	25551
9441	24055495	613	620	ChemicalEntity	glucose	D005947
9442	24055495	688	697	ChemicalEntity	galactose	D005690
9443	24055495	705	725	DiseaseOrPhenotypicFeature	memory deterioration	D008569
9444	24055495	806	815	ChemicalEntity	galactose	D005690
9445	24055495	931	940	ChemicalEntity	galactose	D005690
9446	24055495	970	988	DiseaseOrPhenotypicFeature	cognitive deficits	D003072
9447	24055495	992	1006	ChemicalEntity	streptozotocin	D013311
9448	24055495	1016	1019	ChemicalEntity	STZ	D013311
9449	24055495	1025	1028	OrganismTaxon	rat	10116
9450	24055495	1038	1041	DiseaseOrPhenotypicFeature	sAD	D000544
9451	24055495	1131	1140	ChemicalEntity	galactose	D005690
9452	24055495	1183	1186	ChemicalEntity	STZ	D013311
9453	24055495	1249	1252	ChemicalEntity	STZ	D013311
9454	24055495	1265	1283	DiseaseOrPhenotypicFeature	cognitive deficits	D003072
9455	24055495	1311	1320	ChemicalEntity	galactose	D005690
9456	24055495	1344	1347	OrganismTaxon	rat	10116
9457	24055495	1363	1372	ChemicalEntity	galactose	D005690
9458	24055495	1432	1441	ChemicalEntity	galactose	D005690
9459	24055495	1482	1491	ChemicalEntity	galactose	D005690
9460	24055495	1522	1531	ChemicalEntity	galactose	D005690
9461	24055495	1657	1666	ChemicalEntity	galactose	D005690
9462	24055495	1678	1687	ChemicalEntity	galactose	D005690
9463	24055495	1810	1828	DiseaseOrPhenotypicFeature	cognitive deficits	D003072
9464	24055495	1845	1867	DiseaseOrPhenotypicFeature	glucose hypometabolism	D018149
9465	24055495	1871	1873	DiseaseOrPhenotypicFeature	AD	D000544
9466	24100257	0	18	DiseaseOrPhenotypicFeature	Takotsubo syndrome	D054549
9467	24100257	23	49	DiseaseOrPhenotypicFeature	apical ballooning syndrome	D054549
9468	24100257	64	76	ChemicalEntity	Zolmitriptan	C089750
9469	24100257	78	96	DiseaseOrPhenotypicFeature	Takotsubo syndrome	D054549
9470	24100257	98	100	DiseaseOrPhenotypicFeature	TS	D054549
9471	24100257	117	138	DiseaseOrPhenotypicFeature	broken heart syndrome	D054549
9472	24100257	276	299	DiseaseOrPhenotypicFeature	acute coronary syndrome	D054058
9473	24100257	403	408	OrganismTaxon	woman	9606
9474	24100257	433	454	DiseaseOrPhenotypicFeature	mitral valve prolapse	D008945
9475	24100257	459	468	DiseaseOrPhenotypicFeature	migraines	D008881
9476	24100257	518	528	DiseaseOrPhenotypicFeature	chest pain	D002637
9477	24100257	782	802	DiseaseOrPhenotypicFeature	motion abnormalities	D009041
9478	24100257	819	821	DiseaseOrPhenotypicFeature	TS	D054549
9479	24100257	883	890	OrganismTaxon	patient	9606
9480	24100257	896	908	ChemicalEntity	zolmitriptan	C089750
9481	24100257	937	946	DiseaseOrPhenotypicFeature	migraines	D008881
9482	24100257	986	998	ChemicalEntity	zolmitriptan	C089750
9483	24100257	1056	1073	DiseaseOrPhenotypicFeature	migraine headache	D008881
9484	24100257	1130	1136	OrganismTaxon	horses	9796
9485	24100257	1256	1274	DiseaseOrPhenotypicFeature	status migrainosus	D008881
9486	24100257	1331	1356	DiseaseOrPhenotypicFeature	coronary artery vasospasm	D003329
9487	24100257	1370	1382	ChemicalEntity	zolmitriptan	C089750
9488	24100257	1427	1429	DiseaseOrPhenotypicFeature	TS	D054549
9489	24309294	0	27	ChemicalEntity	Cholecystokinin-octapeptide	D012844
9490	24309294	37	45	ChemicalEntity	morphine	D009020
9491	24309294	103	107	OrganismTaxon	rats	10116
9492	24309294	109	136	ChemicalEntity	Cholecystokinin-octapeptide	D012844
9493	24309294	138	143	ChemicalEntity	CCK-8	D012844
9494	24309294	293	298	ChemicalEntity	CCK-8	D012844
9495	24309294	324	332	ChemicalEntity	morphine	D009020
9496	24309294	341	348	DiseaseOrPhenotypicFeature	amnesia	D000647
9497	24309294	426	434	ChemicalEntity	morphine	D009020
9498	24309294	489	494	ChemicalEntity	CCK-8	D012844
9499	24309294	587	590	OrganismTaxon	rat	10116
9500	24309294	629	637	ChemicalEntity	morphine	D009020
9501	24309294	646	650	OrganismTaxon	rats	10116
9502	24309294	759	767	ChemicalEntity	morphine	D009020
9503	24309294	839	844	ChemicalEntity	CCK-8	D012844
9504	24309294	911	919	ChemicalEntity	morphine	D009020
9505	24309294	962	967	ChemicalEntity	CCK-8	D012844
9506	24309294	1068	1072	OrganismTaxon	rats	10116
9507	24309294	1095	1108	GeneOrGeneProduct	CCK2 receptor	25706
9508	24309294	1120	1129	ChemicalEntity	L-365,260	C058121
9509	24309294	1168	1173	ChemicalEntity	CCK-8	D012844
9510	24309294	1183	1196	GeneOrGeneProduct	CCK1 receptor	24889
9511	24309294	1208	1217	ChemicalEntity	L-364,718	D020109
9512	24309294	1278	1283	ChemicalEntity	CCK-8	D012844
9513	24309294	1309	1317	ChemicalEntity	morphine	D009020
9514	24309294	1345	1359	GeneOrGeneProduct	CCK2 receptors	25706
9515	24309294	1400	1405	ChemicalEntity	CCK-8	D012844
9516	24309294	1409	1417	ChemicalEntity	morphine	D009020
9517	24309294	1426	1443	DiseaseOrPhenotypicFeature	memory impairment	D008569
9518	24442316	0	36	ChemicalEntity	Cultured mycelium Cordyceps sinensis	-
9519	24442316	90	103	DiseaseOrPhenotypicFeature	liver injured	D008107
9520	24442316	104	108	OrganismTaxon	mice	10090
9521	24442316	110	146	ChemicalEntity	Cultured mycelium Cordyceps sinensis	-
9522	24442316	148	152	ChemicalEntity	CMCS	-
9523	24442316	206	218	DiseaseOrPhenotypicFeature	liver injury	D008107
9524	24442316	284	288	ChemicalEntity	CMCS	-
9525	24442316	344	356	DiseaseOrPhenotypicFeature	injury liver	D008107
9526	24442316	392	396	OrganismTaxon	mice	10090
9527	24442316	434	452	ChemicalEntity	lipopolysaccharide	D008070
9528	24442316	454	457	ChemicalEntity	LPS	D008070
9529	24442316	463	478	ChemicalEntity	D-galactosamine	D005688
9530	24442316	480	486	ChemicalEntity	D-GalN	D005688
9531	24442316	497	503	CellLine	BABL/c	10090
9532	24442316	504	508	OrganismTaxon	mice	10090
9533	24442316	580	584	ChemicalEntity	CMCS	-
9534	24442316	599	618	ChemicalEntity	1,10-phenanthroline	C025205
9535	24442316	683	707	GeneOrGeneProduct	alanine aminotransferase	76282
9536	24442316	709	712	GeneOrGeneProduct	ALT	76282
9537	24442316	718	744	GeneOrGeneProduct	aspartate aminotransferase	14718
9538	24442316	746	749	GeneOrGeneProduct	AST	14718
9539	24442316	800	812	DiseaseOrPhenotypicFeature	inflammation	D007249
9540	24442316	1066	1099	GeneOrGeneProduct	intercellular adhesion molecule-1	15894
9541	24442316	1101	1107	GeneOrGeneProduct	ICAM-1	15894
9542	24442316	1113	1146	GeneOrGeneProduct	vascular cell adhesion molecule-1	22329
9543	24442316	1148	1154	GeneOrGeneProduct	VCAM-1	22329
9544	24442316	1216	1237	GeneOrGeneProduct	von Willebrand factor	22371
9545	24442316	1239	1242	GeneOrGeneProduct	vWF	22371
9546	24442316	1299	1304	ChemicalEntity	lipid	D008055
9547	24442316	1368	1389	ChemicalEntity	hydroxyl free radical	D017665
9548	24442316	1391	1394	ChemicalEntity	.OH	D017665
9549	24442316	1397	1417	GeneOrGeneProduct	superoxide dismutase	20655
9550	24442316	1419	1422	GeneOrGeneProduct	SOD	20655
9551	24442316	1425	1440	ChemicalEntity	malondialdehyde	D008315
9552	24442316	1445	1470	GeneOrGeneProduct	glutathione S-transferase	54486
9553	24442316	1472	1475	GeneOrGeneProduct	GST	14870
9554	24442316	1508	1540	GeneOrGeneProduct	matrix metalloproteinase-2 and 9	17390,17395
9555	24442316	1542	1549	GeneOrGeneProduct	MMP-2/9	17390,17395
9556	24442316	1668	1672	OrganismTaxon	mice	10090
9557	24442316	1705	1708	GeneOrGeneProduct	ALT	76282
9558	24442316	1713	1716	GeneOrGeneProduct	AST	14718
9559	24442316	1733	1737	OrganismTaxon	mice	10090
9560	24442316	1791	1809	DiseaseOrPhenotypicFeature	liver inflammation	D008107
9561	24442316	1850	1855	ChemicalEntity	lipid	D008055
9562	24442316	1906	1909	ChemicalEntity	.OH	D017665
9563	24442316	1914	1917	ChemicalEntity	MDA	D008315
9564	24442316	1933	1936	GeneOrGeneProduct	SOD	20655
9565	24442316	1941	1944	GeneOrGeneProduct	GST	54486
9566	24442316	1956	1963	GeneOrGeneProduct	MMP-2/9	17390,17395
9567	24442316	1979	1985	GeneOrGeneProduct	VCAM-1	22329
9568	24442316	1987	1993	GeneOrGeneProduct	ICAM-1	15894
9569	24442316	1998	2001	GeneOrGeneProduct	vWF	22371
9570	24442316	2038	2049	DiseaseOrPhenotypicFeature	LSEC injury	D008107
9571	24442316	2145	2149	ChemicalEntity	CMCS	-
9572	24442316	2154	2173	ChemicalEntity	1,10-phenanthroline	C025205
9573	24442316	2203	2206	GeneOrGeneProduct	ALT	76282
9574	24442316	2207	2210	GeneOrGeneProduct	AST	14718
9575	24442316	2223	2243	DiseaseOrPhenotypicFeature	hepatic inflammation	D008107
9576	24442316	2270	2285	DiseaseOrPhenotypicFeature	injury in liver	D008107
9577	24442316	2297	2304	GeneOrGeneProduct	MMP-2/9	17390,17395
9578	24442316	2413	2419	GeneOrGeneProduct	VCAM-1	22329
9579	24442316	2424	2430	GeneOrGeneProduct	ICAM-1	15894
9580	24442316	2432	2436	ChemicalEntity	CMCS	-
9581	24442316	2451	2468	DiseaseOrPhenotypicFeature	LSECs from injury	D008107
9582	24442316	2524	2537	DiseaseOrPhenotypicFeature	injured liver	D008107
9583	24442316	2541	2545	OrganismTaxon	mice	10090
9584	24442316	2557	2560	ChemicalEntity	LPS	D008070
9585	24442316	2561	2567	ChemicalEntity	D-GalN	D005688
9586	24442316	2633	2640	GeneOrGeneProduct	MMP-2/9	17390,17395
9587	24442316	2686	2699	DiseaseOrPhenotypicFeature	injured liver	D008107
9588	24477591	4	11	SequenceVariant	-930A>G	rs9932581
9589	24477591	32	36	GeneOrGeneProduct	CYBA	1535
9590	24477591	71	94	DiseaseOrPhenotypicFeature	coronary artery disease	D003324
9591	24477591	153	176	ChemicalEntity	Reactive oxygen species	D017382
9592	24477591	178	181	ChemicalEntity	ROS	D017382
9593	24477591	219	234	DiseaseOrPhenotypicFeature	atherosclerosis	D050197
9594	24477591	239	262	DiseaseOrPhenotypicFeature	coronary artery disease	D003324
9595	24477591	264	267	DiseaseOrPhenotypicFeature	CAD	D003324
9596	24477591	270	284	GeneOrGeneProduct	NADPH oxidases	1666
9597	24477591	308	311	ChemicalEntity	ROS	D017382
9598	24477591	332	339	GeneOrGeneProduct	p22phox	1535
9599	24477591	376	390	GeneOrGeneProduct	NADPH oxidases	1666
9600	24477591	413	417	GeneOrGeneProduct	CYBA	1535
9601	24477591	419	440	GeneOrGeneProduct	cytochrome b245 alpha	1535
9602	24477591	452	459	SequenceVariant	-930A>G	rs9932581
9603	24477591	460	464	GeneOrGeneProduct	CYBA	1535
9604	24477591	479	488	SequenceVariant	rs9932581	rs9932581
9605	24477591	489	492	SequenceVariant	A>G	rs9932581
9606	24477591	524	528	GeneOrGeneProduct	CYBA	1535
9607	24477591	554	558	GeneOrGeneProduct	CYBA	1535
9608	24477591	664	671	SequenceVariant	-930A>G	rs9932581
9609	24477591	689	692	DiseaseOrPhenotypicFeature	CAD	D003324
9610	24477591	786	794	OrganismTaxon	patients	9606
9611	24477591	810	813	DiseaseOrPhenotypicFeature	CAD	D003324
9612	24477591	857	864	SequenceVariant	-930A>G	rs9932581
9613	24477591	971	976	SequenceVariant	-930G	rs9932581
9614	24477591	1020	1023	DiseaseOrPhenotypicFeature	CAD	D003324
9615	24477591	1090	1095	SequenceVariant	-930G	rs9932581
9616	24477591	1108	1118	DiseaseOrPhenotypicFeature	overweight	D050177
9617	24477591	1119	1126	DiseaseOrPhenotypicFeature	obesity	D009765
9618	24477591	1185	1188	DiseaseOrPhenotypicFeature	CAD	D003324
9619	24477591	1215	1220	SequenceVariant	-930G	rs9932581
9620	24477591	1389	1394	SequenceVariant	-930G	rs9932581
9621	24477591	1403	1413	DiseaseOrPhenotypicFeature	Overweight	D050177
9622	24477591	1414	1421	DiseaseOrPhenotypicFeature	obesity	D009765
9623	24477591	1444	1447	DiseaseOrPhenotypicFeature	CAD	D003324
9624	24477591	1460	1465	SequenceVariant	-930G	rs9932581
9625	24477591	1552	1559	SequenceVariant	-930A>G	rs9932581
9626	24477591	1560	1564	GeneOrGeneProduct	CYBA	1535
9627	24477591	1597	1600	DiseaseOrPhenotypicFeature	CAD	D003324
9628	24477591	1631	1636	SequenceVariant	-930G	rs9932581
9629	24477591	1697	1704	DiseaseOrPhenotypicFeature	obesity	D009765
9630	24477591	1709	1716	OrganismTaxon	tobacco	4097
9631	24587916	0	11	ChemicalEntity	Antioxidant	D000975
9632	24587916	23	29	OrganismTaxon	bovine	9913
9633	24587916	30	41	GeneOrGeneProduct	lactoferrin	301034
9634	24587916	45	58	ChemicalEntity	dexamethasone	D003907
9635	24587916	67	79	DiseaseOrPhenotypicFeature	hypertension	D006973
9636	24587916	83	86	OrganismTaxon	rat	10116
9637	24587916	88	101	ChemicalEntity	Dexamethasone	D003907
9638	24587916	104	107	ChemicalEntity	Dex	D003907
9639	24587916	118	130	DiseaseOrPhenotypicFeature	hypertension	D006973
9640	24587916	177	188	GeneOrGeneProduct	Lactoferrin	301034
9641	24587916	190	192	GeneOrGeneProduct	LF	301034
9642	24587916	200	204	ChemicalEntity	iron	D007501
9643	24587916	213	225	GeneOrGeneProduct	glycoprotein	11820
9644	24587916	331	333	GeneOrGeneProduct	LF	301034
9645	24587916	358	370	DiseaseOrPhenotypicFeature	hypertension	D006973
9646	24587916	376	379	ChemicalEntity	Dex	D003907
9647	24587916	408	412	OrganismTaxon	rats	10116
9648	24587916	429	432	ChemicalEntity	Dex	D003907
9649	24587916	493	499	OrganismTaxon	bovine	9913
9650	24587916	500	502	GeneOrGeneProduct	LF	301034
9651	24587916	595	599	OrganismTaxon	rats	10116
9652	24587916	619	621	GeneOrGeneProduct	LF	301034
9653	24587916	644	647	ChemicalEntity	Dex	D003907
9654	24587916	791	805	ChemicalEntity	glucocorticoid	D005938
9655	24587916	823	840	ChemicalEntity	hydrogen peroxide	D006861
9656	24587916	842	846	ChemicalEntity	H2O2	D006861
9657	24587916	866	872	ChemicalEntity	ferric	D007501
9658	24587916	930	943	ChemicalEntity	Dexamethasone	D003907
9659	24587916	983	987	ChemicalEntity	H2O2	D006861
9660	24587916	1033	1035	GeneOrGeneProduct	LF	301034
9661	24587916	1098	1101	ChemicalEntity	Dex	D003907
9662	24587916	1110	1122	DiseaseOrPhenotypicFeature	hypertension	D006973
9663	24587916	1124	1126	GeneOrGeneProduct	LF	301034
9664	24587916	1142	1153	DiseaseOrPhenotypicFeature	weight loss	D015431
9665	24587916	1200	1204	ChemicalEntity	H2O2	D006861
9666	24587916	1258	1260	GeneOrGeneProduct	LF	301034
9667	24587916	1315	1318	ChemicalEntity	ROS	D017382
9668	24587916	1356	1359	ChemicalEntity	Dex	D003907
9669	24587916	1368	1380	DiseaseOrPhenotypicFeature	hypertension	D006973
9670	24587916	1487	1489	GeneOrGeneProduct	LF	301034
9671	24588023	24	39	ChemicalEntity	tranexamic acid	D014148
9672	24588023	44	63	DiseaseOrPhenotypicFeature	convulsive seizures	D012640
9673	24588023	121	129	OrganismTaxon	patients	9606
9674	24588023	180	188	DiseaseOrPhenotypicFeature	seizures	D012640
9675	24588023	294	302	OrganismTaxon	patients	9606
9676	24588023	381	399	DiseaseOrPhenotypicFeature	convulsive seizure	D012640
9677	24588023	480	516	DiseaseOrPhenotypicFeature	abnormal involuntary motor movements	D004409
9678	24588023	617	625	DiseaseOrPhenotypicFeature	seizures	D012640
9679	24588023	649	657	OrganismTaxon	patients	9606
9680	24588023	682	701	DiseaseOrPhenotypicFeature	convulsive seizures	D012640
9681	24588023	703	733	DiseaseOrPhenotypicFeature	Generalised and focal seizures	D012640
9682	24588023	763	771	OrganismTaxon	patients	9606
9683	24588023	840	847	DiseaseOrPhenotypicFeature	seizure	D012640
9684	24588023	981	989	OrganismTaxon	patients	9606
9685	24588023	1031	1039	DiseaseOrPhenotypicFeature	seizures	D012640
9686	24588023	1088	1120	DiseaseOrPhenotypicFeature	calcification of ascending aorta	D001018
9687	24588023	1122	1146	DiseaseOrPhenotypicFeature	congestive heart failure	D006333
9688	24588023	1153	1164	DiseaseOrPhenotypicFeature	hypothermic	D007035
9689	24588023	1220	1235	ChemicalEntity	tranexamic acid	D014148
9690	24588023	1288	1303	ChemicalEntity	tranexamic acid	D014148
9691	24588023	1342	1350	DiseaseOrPhenotypicFeature	seizures	D012640
9692	24588023	1390	1398	OrganismTaxon	Patients	9606
9693	24588023	1404	1423	DiseaseOrPhenotypicFeature	convulsive seizures	D012640
9694	24588023	1525	1533	OrganismTaxon	patients	9606
9695	24588023	1542	1561	DiseaseOrPhenotypicFeature	convulsive seizures	D012640
9696	24588023	1655	1663	OrganismTaxon	patients	9606
9697	24588023	1669	1688	DiseaseOrPhenotypicFeature	convulsive seizures	D012640
9698	24588023	1729	1737	OrganismTaxon	patients	9606
9699	24588023	1746	1754	DiseaseOrPhenotypicFeature	seizures	D012640
9700	24588023	1768	1787	DiseaseOrPhenotypicFeature	Convulsive seizures	D012640
9701	24588023	1802	1828	DiseaseOrPhenotypicFeature	postoperative complication	D011183
9702	24588023	1855	1870	ChemicalEntity	tranexamic acid	D014148
9703	24588023	2020	2028	DiseaseOrPhenotypicFeature	seizures	D012640
9704	24623966	12	27	GeneOrGeneProduct	NADPH oxidase 4	85431
9705	24623966	37	82	GeneOrGeneProduct	vascular endothelial growth factor receptor 2	25589
9706	24623966	128	131	OrganismTaxon	rat	10116
9707	24623966	141	167	DiseaseOrPhenotypicFeature	retinopathy of prematurity	D012178
9708	24623966	178	191	GeneOrGeneProduct	NADPH oxidase	114243,50507,66021,85431
9709	24623966	202	225	ChemicalEntity	reactive oxygen species	D017382
9710	24623966	227	230	ChemicalEntity	ROS	D017382
9711	24623966	276	289	GeneOrGeneProduct	NADPH oxidase	114243,50507,66021,85431
9712	24623966	290	294	GeneOrGeneProduct	NOX1	114243
9713	24623966	296	300	GeneOrGeneProduct	NOX2	66021
9714	24623966	306	310	GeneOrGeneProduct	NOX4	85431
9715	24623966	378	382	GeneOrGeneProduct	NOX1	114243
9716	24623966	387	391	GeneOrGeneProduct	NOX2	66021
9717	24623966	470	476	ChemicalEntity	oxygen	D010100
9718	24623966	485	496	DiseaseOrPhenotypicFeature	retinopathy	D012164
9719	24623966	498	501	DiseaseOrPhenotypicFeature	OIR	D012164
9720	24623966	568	572	GeneOrGeneProduct	NOX4	85431
9721	24623966	595	629	GeneOrGeneProduct	vascular endothelial growth factor	83785
9722	24623966	631	635	GeneOrGeneProduct	VEGF	83785
9723	24623966	689	702	GeneOrGeneProduct	NADPH oxidase	114243,50507,66021,85431
9724	24623966	765	770	OrganismTaxon	human	9606
9725	24623966	834	839	OrganismTaxon	human	9606
9726	24623966	901	904	OrganismTaxon	rat	10116
9727	24623966	939	942	DiseaseOrPhenotypicFeature	OIR	D012164
9728	24623966	961	967	ChemicalEntity	oxygen	D010100
9729	24623966	1090	1093	OrganismTaxon	rat	10116
9730	24623966	1094	1097	DiseaseOrPhenotypicFeature	OIR	D012164
9731	24623966	1106	1110	GeneOrGeneProduct	NOX4	85431
9732	24623966	1238	1243	GeneOrGeneProduct	STAT3	25125
9733	24623966	1301	1306	GeneOrGeneProduct	STAT3	25125
9734	24623966	1316	1321	GeneOrGeneProduct	STAT3	25125
9735	24623966	1403	1406	OrganismTaxon	rat	10116
9736	24623966	1407	1410	DiseaseOrPhenotypicFeature	OIR	D012164
9737	24623966	1471	1475	GeneOrGeneProduct	NOX4	85431
9738	24623966	1492	1498	GeneOrGeneProduct	lectin	-
9739	24623966	1593	1596	DiseaseOrPhenotypicFeature	OIR	D012164
9740	24623966	1635	1639	GeneOrGeneProduct	NOX4	50507
9741	24623966	1663	1667	GeneOrGeneProduct	VEGF	7422
9742	24623966	1683	1686	ChemicalEntity	ROS	D017382
9743	24623966	1721	1800	ChemicalEntity	5-(and-6)-chloromethyl-2',7'-dichlorodihydrofluorescein diacetate, acetyl ester	-
9744	24623966	1842	1857	GeneOrGeneProduct	VEGF receptor 2	3791
9745	24623966	1862	1867	GeneOrGeneProduct	STAT3	6774
9746	24623966	1879	1885	GeneOrGeneProduct	VEGFR2	3791
9747	24623966	1890	1895	GeneOrGeneProduct	STAT3	6774
9748	24623966	1936	1940	GeneOrGeneProduct	VEGF	7422
9749	24623966	2014	2018	GeneOrGeneProduct	NOX4	50507
9750	24623966	2028	2033	GeneOrGeneProduct	STAT3	6774
9751	24623966	2074	2078	GeneOrGeneProduct	NOX4	50507
9752	24623966	2113	2126	GeneOrGeneProduct	NADPH oxidase	114243,50507,66021,85431
9753	24623966	2144	2148	GeneOrGeneProduct	NOX4	85431
9754	24623966	2275	2279	GeneOrGeneProduct	NOX4	85431
9755	24623966	2305	2308	DiseaseOrPhenotypicFeature	OIR	D012164
9756	24623966	2356	2362	GeneOrGeneProduct	lectin	-
9757	24623966	2367	2371	GeneOrGeneProduct	NOX4	85431
9758	24623966	2457	2462	GeneOrGeneProduct	STAT3	25125
9759	24623966	2565	2569	GeneOrGeneProduct	NOX4	50507
9760	24623966	2602	2606	GeneOrGeneProduct	VEGF	7422
9761	24623966	2615	2618	ChemicalEntity	ROS	D017382
9762	24623966	2631	2635	GeneOrGeneProduct	VEGF	7422
9763	24623966	2685	2691	GeneOrGeneProduct	VEGFR2	3791
9764	24623966	2696	2700	GeneOrGeneProduct	NOX4	50507
9765	24623966	2715	2719	GeneOrGeneProduct	NOX4	50507
9766	24623966	2732	2738	GeneOrGeneProduct	VEGFR2	3791
9767	24623966	2790	2795	GeneOrGeneProduct	STAT3	6774
9768	24623966	2822	2826	GeneOrGeneProduct	VEGF	7422
9769	24623966	2848	2852	GeneOrGeneProduct	NOX4	50507
9770	24623966	2856	2861	GeneOrGeneProduct	STAT3	6774
9771	24623966	2872	2876	GeneOrGeneProduct	VEGF	7422
9772	24623966	2967	2972	OrganismTaxon	human	9606
9773	24623966	2973	2999	DiseaseOrPhenotypicFeature	retinopathy of prematurity	D012178
9774	24623966	3001	3005	GeneOrGeneProduct	NOX4	85431
9775	24623966	3057	3061	GeneOrGeneProduct	VEGF	7422
9776	24623966	3072	3076	GeneOrGeneProduct	NOX4	50507
9777	24623966	3107	3111	GeneOrGeneProduct	VEGF	7422
9778	24623966	3122	3128	GeneOrGeneProduct	VEGFR2	3791
9779	24623966	3133	3137	GeneOrGeneProduct	NOX4	50507
9780	24623966	3187	3192	GeneOrGeneProduct	STAT3	6774
9781	24623966	3231	3235	GeneOrGeneProduct	NOX4	85431
9782	24623966	3249	3255	GeneOrGeneProduct	VEGFR2	25589
9783	24623966	3288	3293	GeneOrGeneProduct	STAT3	25125
9784	24632946	57	66	GeneOrGeneProduct	b-catenin	12387
9785	24632946	84	107	DiseaseOrPhenotypicFeature	anorectal malformations	D000071056
9786	24632946	254	278	DiseaseOrPhenotypicFeature	congenital malformations	D000013
9787	24632946	288	311	DiseaseOrPhenotypicFeature	anorectal malformations	D000071056
9788	24632946	313	317	DiseaseOrPhenotypicFeature	ARMs	D000071056
9789	24632946	418	427	GeneOrGeneProduct	b-Catenin	12387
9790	24632946	465	468	GeneOrGeneProduct	Wnt	22408
9791	24632946	597	606	GeneOrGeneProduct	b-catenin	12387
9792	24632946	686	695	GeneOrGeneProduct	b-catenin	12387
9793	24632946	752	761	ChemicalEntity	tamoxifen	D013629
9794	24632946	789	792	GeneOrGeneProduct	Shh	20423
9795	24632946	809	818	GeneOrGeneProduct	b-catenin	12387
9796	24632946	921	932	DiseaseOrPhenotypicFeature	hypoplastic	D029502
9797	24632946	1050	1059	GeneOrGeneProduct	b-catenin	12387
9798	24632946	1260	1269	GeneOrGeneProduct	keratin 1	16678
9799	24632946	1274	1283	GeneOrGeneProduct	filaggrin	14246
9800	24632946	1330	1356	GeneOrGeneProduct	bone morphogenetic protein	12159,12162
9801	24632946	1358	1361	GeneOrGeneProduct	Bmp	12159,12162
9802	24632946	1378	1382	GeneOrGeneProduct	Bmp4	12159
9803	24632946	1387	1391	GeneOrGeneProduct	Bmp7	12162
9804	24632946	1457	1466	GeneOrGeneProduct	b-catenin	12387
9805	24632946	1502	1506	GeneOrGeneProduct	Msx2	17702
9806	24632946	1531	1540	GeneOrGeneProduct	Smad1/5/8	17125,17129,55994
9807	24632946	1563	1566	GeneOrGeneProduct	Bmp	12159,12162
9808	24632946	1666	1678	GeneOrGeneProduct	Bmp receptor	12166
9809	24632946	1685	1691	GeneOrGeneProduct	BmprIA	12166
9810	24632946	1697	1700	GeneOrGeneProduct	Shh	20423
9811	24632946	1713	1722	GeneOrGeneProduct	b-catenin	12387
9812	24632946	1737	1743	GeneOrGeneProduct	BmprIA	12166
9813	24632946	1826	1835	GeneOrGeneProduct	b-catenin	12387
9814	24632946	1882	1885	DiseaseOrPhenotypicFeature	ARM	D000071056
9815	24632946	1904	1913	GeneOrGeneProduct	b-catenin	12387
9816	24632946	1950	1953	GeneOrGeneProduct	Bmp	12159,12162
9817	24632946	2028	2037	GeneOrGeneProduct	b-catenin	12387
9818	24632946	2055	2058	DiseaseOrPhenotypicFeature	ARM	D000071056
9819	24632946	2146	2151	OrganismTaxon	human	9606
9820	24632946	2152	2156	DiseaseOrPhenotypicFeature	ARMs	D000071056
9821	24671324	0	21	DiseaseOrPhenotypicFeature	Necrotising fasciitis	D019115
9822	24671324	28	38	ChemicalEntity	bortezomib	D000069286
9823	24671324	43	56	ChemicalEntity	dexamethasone	D003907
9824	24671324	90	97	OrganismTaxon	patient	9606
9825	24671324	101	131	DiseaseOrPhenotypicFeature	Waldenstrom macroglobulinaemia	D008258
9826	24671324	133	143	ChemicalEntity	Bortezomib	D000069286
9827	24671324	158	171	ChemicalEntity	dexamethasone	D003907
9828	24671324	249	269	DiseaseOrPhenotypicFeature	bacterial infections	D001424
9829	24671324	273	281	OrganismTaxon	patients	9606
9830	24671324	294	306	DiseaseOrPhenotypicFeature	malignancies	D009369
9831	24671324	388	396	OrganismTaxon	patients	9606
9832	24671324	432	435	OrganismTaxon	man	9606
9833	24671324	441	471	DiseaseOrPhenotypicFeature	Waldenstrom macroglobulinaemia	D008258
9834	24671324	485	506	DiseaseOrPhenotypicFeature	necrotising fasciitis	D019115
9835	24671324	515	526	DiseaseOrPhenotypicFeature	neutropenia	D009503
9836	24671324	564	574	ChemicalEntity	bortezomib	D000069286
9837	24671324	586	599	ChemicalEntity	dexamethasone	D003907
9838	24671324	604	613	ChemicalEntity	rituximab	D000069283
9839	24671324	756	776	DiseaseOrPhenotypicFeature	bacterial infections	D001424
9840	24671324	788	798	ChemicalEntity	bortezomib	D000069286
9841	24671324	814	827	ChemicalEntity	dexamethasone	D003907
9842	24671324	839	847	OrganismTaxon	patients	9606
9843	24709919	11	23	ChemicalEntity	ginsenosides	D036145
9844	24709919	27	33	ChemicalEntity	opioid	D000701
9845	24709919	42	54	DiseaseOrPhenotypicFeature	hyperalgesia	D006930
9846	24709919	58	62	OrganismTaxon	mice	10090
9847	24709919	64	70	ChemicalEntity	Opioid	D000701
9848	24709919	79	91	DiseaseOrPhenotypicFeature	hyperalgesia	D006930
9849	24709919	93	96	DiseaseOrPhenotypicFeature	OIH	D006930
9850	24709919	179	185	ChemicalEntity	opioid	D000701
9851	24709919	191	194	DiseaseOrPhenotypicFeature	OIH	D006930
9852	24709919	225	231	ChemicalEntity	opioid	D000701
9853	24709919	274	290	DiseaseOrPhenotypicFeature	opioid addiction	D009293
9854	24709919	338	367	ChemicalEntity	Re, Rg1, and Rb1 ginsenosides	C035054,C049864,C442759
9855	24709919	397	404	OrganismTaxon	ginseng	4054
9856	24709919	409	412	DiseaseOrPhenotypicFeature	OIH	D006930
9857	24709919	414	417	DiseaseOrPhenotypicFeature	OIH	D006930
9858	24709919	434	438	OrganismTaxon	mice	10090
9859	24709919	476	484	ChemicalEntity	morphine	D009020
9860	24709919	569	573	OrganismTaxon	mice	10090
9861	24709919	592	594	ChemicalEntity	Re	C049864
9862	24709919	596	599	ChemicalEntity	Rg1	C035054
9863	24709919	604	607	ChemicalEntity	Rb1	C442759
9864	24709919	670	674	OrganismTaxon	mice	10090
9865	24709919	730	741	ChemicalEntity	acetic acid	D019342
9866	24709919	765	767	ChemicalEntity	Re	C049864
9867	24709919	790	793	DiseaseOrPhenotypicFeature	OIH	D006930
9868	24709919	839	850	ChemicalEntity	acetic acid	D019342
9869	24709919	887	911	ChemicalEntity	Rg1 and Rb1 ginsenosides	C035054,C442759
9870	24709919	930	933	DiseaseOrPhenotypicFeature	OIH	D006930
9871	24709919	963	966	ChemicalEntity	Rg1	C035054
9872	24709919	998	1001	DiseaseOrPhenotypicFeature	OIH	D006930
9873	24709919	1009	1020	ChemicalEntity	acetic acid	D019342
9874	24709919	1072	1086	ChemicalEntity	ginsenoside Re	C049864
9875	24709919	1096	1099	ChemicalEntity	Rg1	C035054
9876	24709919	1103	1106	ChemicalEntity	Rb1	C442759
9877	24709919	1142	1145	DiseaseOrPhenotypicFeature	OIH	D006930
9878	24742750	16	21	OrganismTaxon	human	9606
9879	24742750	111	126	DiseaseOrPhenotypicFeature	QT prolongation	D008133
9880	24742750	162	167	OrganismTaxon	human	9606
9881	24742750	331	370	ChemicalEntity	K(+) channel and Ca(2+) channel blocker	D002121,D026902
9882	24742750	509	524	DiseaseOrPhenotypicFeature	QT prolongation	D008133
9883	24742750	623	638	DiseaseOrPhenotypicFeature	QT prolongation	D008133
9884	24742750	907	930	ChemicalEntity	Ca(2+) channel blockers	D002121
9885	24742750	1005	1015	ChemicalEntity	Amiodarone	D000638
9886	24742750	1017	1027	ChemicalEntity	Paroxetine	D017374
9887	24742750	1029	1040	ChemicalEntity	Terfenadine	D016593
9888	24742750	1045	1055	ChemicalEntity	Citalopram	D015283
9889	24742750	1135	1146	ChemicalEntity	Terfenadine	D016593
9890	24742750	1151	1161	ChemicalEntity	Citalopram	D015283
9891	24742750	1191	1209	DiseaseOrPhenotypicFeature	Torsade de Pointes	D016171
9892	24742750	1211	1214	DiseaseOrPhenotypicFeature	TdP	D016171
9893	24742750	1447	1450	DiseaseOrPhenotypicFeature	TdP	D016171
9894	24743235	0	4	GeneOrGeneProduct	IL-3	16187
9895	24743235	9	14	GeneOrGeneProduct	CSF-1	12977
9896	24743235	49	54	GeneOrGeneProduct	CD11c	16411
9897	24743235	56	61	GeneOrGeneProduct	IL-10	16153
9898	24743235	195	199	GeneOrGeneProduct	IL-3	16187
9899	24743235	263	268	GeneOrGeneProduct	CSF-1	12977
9900	24743235	377	382	GeneOrGeneProduct	CSF-1	12977
9901	24743235	386	390	GeneOrGeneProduct	IL-3	16187
9902	24743235	415	420	GeneOrGeneProduct	CSF-1	12977
9903	24743235	444	448	GeneOrGeneProduct	IL-3	16187
9904	24743235	456	461	GeneOrGeneProduct	CD11c	16411
9905	24743235	530	537	CellLine	C57BL/6	10090
9906	24743235	586	591	GeneOrGeneProduct	CSF-1	12977
9907	24743235	592	598	GeneOrGeneProduct	CSF-1R	12978
9908	24743235	633	637	GeneOrGeneProduct	IL-3	16187
9909	24743235	646	651	GeneOrGeneProduct	CD11c	16411
9910	24743235	687	692	GeneOrGeneProduct	c-Fos	14281
9911	24743235	717	722	GeneOrGeneProduct	CD11c	16411
9912	24743235	741	745	GeneOrGeneProduct	IL-3	16187
9913	24743235	749	753	GeneOrGeneProduct	IL-3	16187
9914	24743235	754	759	GeneOrGeneProduct	CSF-1	12977
9915	24743235	820	824	GeneOrGeneProduct	IL-3	16187
9916	24743235	829	833	GeneOrGeneProduct	IL-3	16187
9917	24743235	834	839	GeneOrGeneProduct	CSF-1	12977
9918	24743235	972	977	GeneOrGeneProduct	IL-10	16153
9919	24743235	994	998	GeneOrGeneProduct	IL-1	111343
9920	24743235	1000	1004	GeneOrGeneProduct	IL-6	16193
9921	24743235	1009	1013	GeneOrGeneProduct	TNFa	21926
9922	24743235	1030	1033	ChemicalEntity	LPS	D008070
9923	24743235	1127	1132	GeneOrGeneProduct	CSF-1	12977
9924	24743235	1150	1154	GeneOrGeneProduct	IL-3	16187
9925	24743235	1227	1232	GeneOrGeneProduct	CD11c	16411
9926	24840785	0	9	ChemicalEntity	Aconitine	D000157
9927	24840785	18	22	ChemicalEntity	Ca2+	D002118
9928	24840785	39	49	DiseaseOrPhenotypicFeature	arrhythmia	D001145
9929	24840785	81	89	GeneOrGeneProduct	p38 MAPK	81649
9930	24840785	111	115	OrganismTaxon	rats	10116
9931	24840785	117	126	ChemicalEntity	Aconitine	D000157
9932	24840785	148	168	ChemicalEntity	diterpenoid alkaloid	-
9933	24840785	275	280	ChemicalEntity	Na(+)	D012964
9934	24840785	316	330	DiseaseOrPhenotypicFeature	cardiotoxicity	D066126
9935	24840785	334	343	ChemicalEntity	aconitine	D000157
9936	24840785	394	400	ChemicalEntity	Ca(2+)	D002118
9937	24840785	404	413	ChemicalEntity	aconitine	D000157
9938	24840785	414	423	DiseaseOrPhenotypicFeature	poisoning	D011041
9939	24840785	483	489	ChemicalEntity	Ca(2+)	D002118
9940	24840785	503	512	ChemicalEntity	aconitine	D000157
9941	24840785	513	522	DiseaseOrPhenotypicFeature	poisoning	D011041
9942	24840785	559	565	ChemicalEntity	Ca(2+)	D002118
9943	24840785	619	622	OrganismTaxon	rat	10116
9944	24840785	655	665	DiseaseOrPhenotypicFeature	arrhythmia	D001145
9945	24840785	693	697	OrganismTaxon	rats	10116
9946	24840785	725	734	ChemicalEntity	aconitine	D000157
9947	24840785	738	755	DiseaseOrPhenotypicFeature	myocardial injury	D009202
9948	24840785	770	782	DiseaseOrPhenotypicFeature	cytotoxicity	D064420
9949	24840785	801	804	OrganismTaxon	rat	10116
9950	24840785	855	876	GeneOrGeneProduct	lactate dehydrogenase	24533
9951	24840785	957	961	OrganismTaxon	rats	10116
9952	24840785	987	996	ChemicalEntity	aconitine	D000157
9953	24840785	1009	1026	DiseaseOrPhenotypicFeature	myocardial injury	D009202
9954	24840785	1254	1258	ChemicalEntity	dUTP	-1
9955	24840785	1259	1265	ChemicalEntity	biotin	D001710
9956	24840785	1315	1324	ChemicalEntity	aconitine	D000157
9957	24840785	1391	1397	ChemicalEntity	Ca(2+)	D002118
9958	24840785	1434	1443	ChemicalEntity	aconitine	D000157
9959	24840785	1453	1459	ChemicalEntity	Ca(2+)	D002118
9960	24840785	1506	1512	ChemicalEntity	Ca(2+)	D002118
9961	24840785	1677	1682	GeneOrGeneProduct	BCL-2	24224
9962	24840785	1755	1759	GeneOrGeneProduct	MAPK	81649
9963	24840785	1793	1796	GeneOrGeneProduct	P38	81649
9964	24840785	1797	1800	GeneOrGeneProduct	P38	81649
9965	24840785	1869	1878	ChemicalEntity	aconitine	D000157
9966	24840785	1904	1910	ChemicalEntity	Ca(2+)	D002118
9967	24840785	1931	1941	DiseaseOrPhenotypicFeature	arrhythmia	D001145
9968	24840785	2008	2044	GeneOrGeneProduct	P38 mitogen-activated protein kinase	81649
9969	24842192	23	32	ChemicalEntity	metformin	D008687
9970	24842192	44	64	GeneOrGeneProduct	toll-like receptor 4	29260
9971	24842192	90	118	DiseaseOrPhenotypicFeature	left ventricular dysfunction	D018487
9972	24842192	129	150	DiseaseOrPhenotypicFeature	myocardial infarction	D009203
9973	24842192	173	182	ChemicalEntity	metformin	D008687
9974	24842192	210	231	DiseaseOrPhenotypicFeature	myocardial infarction	D009203
9975	24842192	250	262	DiseaseOrPhenotypicFeature	inflammatory	D007249
9976	24842192	294	322	GeneOrGeneProduct	AMP-activated protein kinase	65248
9977	24842192	324	328	GeneOrGeneProduct	AMPK	65248
9978	24842192	394	403	ChemicalEntity	metformin	D008687
9979	24842192	407	426	DiseaseOrPhenotypicFeature	cardiac dysfunction	D006331
9980	24842192	431	451	GeneOrGeneProduct	toll-like receptor 4	29260
9981	24842192	453	457	GeneOrGeneProduct	TLR4	29260
9982	24842192	480	501	DiseaseOrPhenotypicFeature	myocardial infarction	D009203
9983	24842192	526	530	GeneOrGeneProduct	AMPK	65248
9984	24842192	558	562	OrganismTaxon	rats	10116
9985	24842192	652	665	ChemicalEntity	isoproterenol	D007545
9986	24842192	725	734	ChemicalEntity	metformin	D008687
9987	24842192	760	773	ChemicalEntity	Isoproterenol	D007545
9988	24842192	849	876	DiseaseOrPhenotypicFeature	acute myocardial infarction	D009203
9989	24842192	878	891	ChemicalEntity	Isoproterenol	D007545
9990	24842192	1014	1042	DiseaseOrPhenotypicFeature	left ventricular dysfunction	D018487
9991	24842192	1112	1121	ChemicalEntity	metformin	D008687
9992	24842192	1123	1132	ChemicalEntity	Metfromin	D008687
9993	24842192	1150	1163	ChemicalEntity	isoproterenol	D007545
9994	24842192	1199	1203	GeneOrGeneProduct	TLR4	29260
9995	24842192	1210	1244	GeneOrGeneProduct	myeloid differentiation protein 88	301059
9996	24842192	1246	1251	GeneOrGeneProduct	MyD88	301059
9997	24842192	1254	1281	GeneOrGeneProduct	tumor necrosis factor-alpha	24835
9998	24842192	1283	1288	GeneOrGeneProduct	TNF-a	24835
9999	24842192	1295	1308	GeneOrGeneProduct	interleukin 6	24498
10000	24842192	1310	1314	GeneOrGeneProduct	IL-6	24498
10001	24842192	1392	1397	GeneOrGeneProduct	TNF-a	24835
10002	24842192	1402	1406	GeneOrGeneProduct	IL-6	24498
10003	24842192	1501	1506	GeneOrGeneProduct	AMPKa	65248
10004	24842192	1510	1514	GeneOrGeneProduct	AMPK	65248
10005	24842192	1575	1584	ChemicalEntity	metformin	D008687
10006	24842192	1655	1664	ChemicalEntity	metformin	D008687
10007	24842192	1678	1699	DiseaseOrPhenotypicFeature	myocardial infarction	D009203
10008	24842192	1700	1719	DiseaseOrPhenotypicFeature	cardiac dysfunction	D006331
10009	24842192	1735	1747	DiseaseOrPhenotypicFeature	inflammatory	D007249
10010	24842192	1790	1794	GeneOrGeneProduct	TLR4	29260
10011	24842192	1863	1883	DiseaseOrPhenotypicFeature	infarcted myocardium	D009203
10012	24911645	40	44	OrganismTaxon	mice	10090
10013	24911645	61	80	ChemicalEntity	garcinielliptone FC	C573355
10014	24911645	84	95	ChemicalEntity	pilocarpine	D010862
10015	24911645	104	112	DiseaseOrPhenotypicFeature	seizures	D012640
10016	24911645	114	133	ChemicalEntity	Garcinielliptone FC	C573355
10017	24911645	135	138	ChemicalEntity	GFC	C573355
10018	24911645	195	217	OrganismTaxon	Platonia insignis Mart	198787
10019	24911645	263	276	DiseaseOrPhenotypicFeature	skin diseases	D012871
10020	24911645	285	291	OrganismTaxon	humans	9606
10021	24911645	357	366	DiseaseOrPhenotypicFeature	diarrheas	D003967
10022	24911645	371	392	DiseaseOrPhenotypicFeature	inflammatory diseases	D007249
10023	24911645	427	430	ChemicalEntity	GFC	C573355
10024	24911645	521	524	ChemicalEntity	GFC	C573355
10025	24911645	567	574	DiseaseOrPhenotypicFeature	seizure	D012640
10026	24911645	660	679	ChemicalEntity	r-aminobutyric acid	D005680
10027	24911645	681	685	ChemicalEntity	GABA	D005680
10028	24911645	688	697	ChemicalEntity	glutamine	D018698
10029	24911645	699	708	ChemicalEntity	aspartate	D001224
10030	24911645	713	724	ChemicalEntity	glutathione	D005978
10031	24911645	747	767	GeneOrGeneProduct	acetylcholinesterase	11423
10032	24911645	769	773	GeneOrGeneProduct	AChE	11423
10033	24911645	787	791	OrganismTaxon	mice	10090
10034	24911645	810	818	DiseaseOrPhenotypicFeature	seizures	D012640
10035	24911645	820	823	ChemicalEntity	GFC	C573355
10036	24911645	863	870	DiseaseOrPhenotypicFeature	seizure	D012640
10037	24911645	993	997	OrganismTaxon	mice	10090
10038	24911645	1012	1016	ChemicalEntity	GABA	D005680
10039	24911645	1028	1032	OrganismTaxon	mice	10090
10040	24911645	1058	1063	ChemicalEntity	GFC75	C573355
10041	24911645	1069	1073	ChemicalEntity	P400	D010862
10042	24911645	1129	1133	OrganismTaxon	mice	10090
10043	24911645	1138	1147	ChemicalEntity	aspartate	D001224
10044	24911645	1149	1158	ChemicalEntity	glutamine	D018698
10045	24911645	1163	1172	ChemicalEntity	glutamate	D018698
10046	24911645	1245	1249	OrganismTaxon	mice	10090
10047	24911645	1275	1280	ChemicalEntity	GFC75	C573355
10048	24911645	1286	1290	ChemicalEntity	P400	D010862
10049	24911645	1317	1321	OrganismTaxon	mice	10090
10050	24911645	1335	1339	OrganismTaxon	mice	10090
10051	24911645	1353	1358	ChemicalEntity	GFC75	C573355
10052	24911645	1364	1368	ChemicalEntity	P400	D010862
10053	24911645	1391	1395	GeneOrGeneProduct	AChE	11423
10054	24911645	1440	1444	OrganismTaxon	mice	10090
10055	24911645	1472	1475	ChemicalEntity	GFC	C573355
10056	24911645	1554	1565	ChemicalEntity	pilocarpine	D010862
10057	24911645	1574	1592	DiseaseOrPhenotypicFeature	status epilepticus	D013226
10058	24911645	1642	1649	DiseaseOrPhenotypicFeature	seizure	D012640
10059	24911645	1730	1733	ChemicalEntity	GFC	C573355
10060	24911645	1805	1816	ChemicalEntity	pilocarpine	D010862
10061	24911645	1841	1845	ChemicalEntity	GABA	D005680
10062	24911645	1850	1859	ChemicalEntity	glutamate	D018698
10063	24911645	1876	1880	GeneOrGeneProduct	AChE	11423
10064	24911645	1900	1904	OrganismTaxon	mice	10090
10065	24914936	0	26	GeneOrGeneProduct	Thyroid hormone receptor a	21833
10066	24914936	56	65	ChemicalEntity	thyroxine	D013974
10067	24914936	76	94	DiseaseOrPhenotypicFeature	skeletal dysplasia	D001848
10068	24914936	105	109	OrganismTaxon	mice	10090
10069	24914936	184	188	GeneOrGeneProduct	THRA	7067
10070	24914936	199	226	GeneOrGeneProduct	thyroid hormone receptor a1	7067
10071	24914936	228	232	GeneOrGeneProduct	TRa1	7067
10072	24914936	271	273	ChemicalEntity	T3	D014284
10073	24914936	274	276	ChemicalEntity	T4	D013974
10074	24914936	307	327	DiseaseOrPhenotypicFeature	intellectual deficit	D008607
10075	24914936	332	344	DiseaseOrPhenotypicFeature	constipation	D003248
10076	24914936	379	397	DiseaseOrPhenotypicFeature	skeletal dysplasia	D001848
10077	24914936	424	443	DiseaseOrPhenotypicFeature	developmental delay	D002658
10078	24914936	470	484	DiseaseOrPhenotypicFeature	hypothyroidism	D007037
10079	24914936	486	494	OrganismTaxon	patients	9606
10080	24914936	540	542	ChemicalEntity	T4	D013974
10081	24914936	599	604	GeneOrGeneProduct	Thra1	21833
10082	24914936	611	615	OrganismTaxon	mice	10090
10083	24914936	666	670	GeneOrGeneProduct	TRa1	21833
10084	24914936	764	769	GeneOrGeneProduct	Thra1	21833
10085	24914936	776	780	OrganismTaxon	mice	10090
10086	24914936	830	835	OrganismTaxon	human	9606
10087	24914936	836	840	GeneOrGeneProduct	THRA	7067
10088	24914936	927	929	ChemicalEntity	T4	D013974
10089	24914936	946	968	DiseaseOrPhenotypicFeature	skeletal abnormalities	D001847
10090	24914936	983	988	GeneOrGeneProduct	Thra1	21833
10091	24914936	995	999	OrganismTaxon	mice	10090
10092	24914936	1004	1017	DiseaseOrPhenotypicFeature	short stature	D006130
10093	24914936	1110	1112	ChemicalEntity	T4	D013974
10094	24914936	1134	1137	GeneOrGeneProduct	TSH	12640,22094
10095	24914936	1264	1293	DiseaseOrPhenotypicFeature	resistance to thyroid hormone	D018382
10096	24914936	1319	1321	ChemicalEntity	T4	D013974
10097	24914936	1481	1485	GeneOrGeneProduct	TRa1	7067
10098	24914936	1562	1570	OrganismTaxon	patients	9606
10099	24914936	1586	1590	GeneOrGeneProduct	THRA	7067
10100	24914936	1636	1638	ChemicalEntity	T4	D013974
10101	25006961	11	20	GeneOrGeneProduct	PKC-alpha	18750
10102	25006961	32	39	ChemicalEntity	lithium	D008094
10103	25006961	48	78	DiseaseOrPhenotypicFeature	nephrogenic diabetes insipidus	D018500
10104	25006961	80	87	ChemicalEntity	Lithium	D008094
10105	25006961	125	155	DiseaseOrPhenotypicFeature	nephrogenic diabetes insipidus	D018500
10106	25006961	157	160	DiseaseOrPhenotypicFeature	NDI	D018500
10107	25006961	173	181	OrganismTaxon	patients	9606
10108	25006961	244	251	ChemicalEntity	lithium	D008094
10109	25006961	275	279	ChemicalEntity	cAMP	D000242
10110	25006961	313	329	GeneOrGeneProduct	urea transporter	27411
10111	25006961	331	336	GeneOrGeneProduct	UT-A1	27411
10112	25006961	357	361	GeneOrGeneProduct	AQP2	11827
10113	25006961	448	451	GeneOrGeneProduct	PKC	18750
10114	25006961	511	518	ChemicalEntity	lithium	D008094
10115	25006961	527	535	DiseaseOrPhenotypicFeature	polyuria	D011141
10116	25006961	537	546	GeneOrGeneProduct	PKC-alpha	18750
10117	25006961	552	556	OrganismTaxon	mice	10090
10118	25006961	558	562	GeneOrGeneProduct	PKCa	18750
10119	25006961	628	635	ChemicalEntity	lithium	D008094
10120	25006961	659	663	OrganismTaxon	mice	10090
10121	25006961	760	764	GeneOrGeneProduct	PKCa	18750
10122	25006961	768	772	OrganismTaxon	mice	10090
10123	25006961	857	861	GeneOrGeneProduct	AQP2	11827
10124	25006961	931	935	OrganismTaxon	mice	10090
10125	25006961	946	950	GeneOrGeneProduct	AQP2	11827
10126	25006961	968	972	GeneOrGeneProduct	PKCa	18750
10127	25006961	1012	1017	GeneOrGeneProduct	UT-A1	27411
10128	25006961	1061	1068	ChemicalEntity	lithium	D008094
10129	25006961	1082	1089	ChemicalEntity	Lithium	D008094
10130	25006961	1101	1105	OrganismTaxon	mice	10090
10131	25006961	1157	1161	GeneOrGeneProduct	PKCa	18750
10132	25006961	1206	1210	GeneOrGeneProduct	AQP2	11827
10133	25006961	1215	1220	GeneOrGeneProduct	UT-A1	27411
10134	25006961	1254	1261	ChemicalEntity	lithium	D008094
10135	25006961	1300	1304	GeneOrGeneProduct	PKCa	18750
10136	25006961	1308	1312	OrganismTaxon	mice	10090
10137	25006961	1314	1318	GeneOrGeneProduct	AQP2	11827
10138	25006961	1350	1355	GeneOrGeneProduct	UT-A1	27411
10139	25006961	1391	1397	ChemicalEntity	sodium	D012964
10140	25006961	1399	1408	ChemicalEntity	potassium	D011188
10141	25006961	1413	1420	ChemicalEntity	calcium	D002118
10142	25006961	1438	1445	ChemicalEntity	lithium	D008094
10143	25006961	1464	1471	ChemicalEntity	lithium	D008094
10144	25006961	1476	1480	GeneOrGeneProduct	PKCa	18750
10145	25006961	1484	1488	OrganismTaxon	mice	10090
10146	25006961	1521	1525	GeneOrGeneProduct	PKCa	18750
10147	25006961	1536	1540	GeneOrGeneProduct	AQP2	11827
10148	25006961	1545	1550	GeneOrGeneProduct	UT-A1	27411
10149	25006961	1590	1597	ChemicalEntity	lithium	D008094
10150	25006961	1606	1609	DiseaseOrPhenotypicFeature	NDI	D018500
10151	25006961	1654	1662	DiseaseOrPhenotypicFeature	polyuria	D011141
10152	25006961	1679	1686	ChemicalEntity	lithium	D008094
10153	25054547	28	32	GeneOrGeneProduct	BCHE	590
10154	25054547	66	77	SequenceVariant	p.Val204Asp	p|SUB|V|204|D
10155	25054547	117	122	DiseaseOrPhenotypicFeature	apnea	D001049
10156	25054547	128	141	ChemicalEntity	suxamethonium	D013390
10157	25054547	143	175	DiseaseOrPhenotypicFeature	Butyrylcholinesterase deficiency	C537417
10158	25054547	206	211	DiseaseOrPhenotypicFeature	apnea	D001049
10159	25054547	229	245	ChemicalEntity	muscle relaxants	-
10160	25054547	247	260	ChemicalEntity	suxamethonium	D013390
10161	25054547	264	274	ChemicalEntity	mivacurium	D000077590
10162	25054547	279	287	OrganismTaxon	patients	9606
10163	25054547	314	318	GeneOrGeneProduct	BCHE	590
10164	25054547	361	380	DiseaseOrPhenotypicFeature	neuromuscular block	D055191
10165	25054547	405	418	ChemicalEntity	suxamethonium	D013390
10166	25054547	455	459	GeneOrGeneProduct	BCHE	590
10167	25054547	469	477	SequenceVariant	c.695T>A	c|SUB|T|695|A
10168	25054547	479	490	SequenceVariant	p.Val204Asp	p|SUB|V|204|D
10169	25054547	683	690	OrganismTaxon	patient	9606
10170	25054547	698	719	GeneOrGeneProduct	butyrylcholinesterase	590
10171	25054547	725	743	ChemicalEntity	butyrylthiocholine	D002092
10172	25054547	745	748	ChemicalEntity	BTC	D002092
10173	25054547	754	768	ChemicalEntity	benzoylcholine	D001588
10174	25054547	784	793	ChemicalEntity	dibucaine	D003992
10175	25054547	798	806	ChemicalEntity	fluoride	D005459
10176	25054547	898	902	GeneOrGeneProduct	BChE	590
10177	25054547	945	952	OrganismTaxon	patient	9606
10178	25054547	1032	1036	GeneOrGeneProduct	BChE	590
10179	25054547	1141	1152	SequenceVariant	p.Val204Asp	p|SUB|V|204|D
10180	25054547	1153	1163	SequenceVariant	p.Asp70Gly	rs1799807
10181	25054547	1164	1175	SequenceVariant	p.Ala539Thr	rs1803274
10182	25054547	1176	1180	GeneOrGeneProduct	BChE	590
10183	25054547	1222	1225	ChemicalEntity	BTC	D002092
10184	25054547	1286	1289	ChemicalEntity	BTC	D002092
10185	25054547	1409	1422	ChemicalEntity	suxamethonium	D013390
10186	25054547	1506	1517	SequenceVariant	p.Val204Asp	p|SUB|V|204|D
10187	25054547	1560	1566	SequenceVariant	Gln223	p|Allele|Q|223
10188	25054547	1571	1577	SequenceVariant	Glu441	p|Allele|E|2441
10189	25054547	1587	1593	SequenceVariant	Ser198	p|Allele|S|198
10190	25054547	1598	1604	SequenceVariant	His438	p|Allele|H|438
10191	25054547	1868	1879	SequenceVariant	p.Ala204Asp	p|SUB|A|204|D
10192	25054547	1880	1890	SequenceVariant	p.Asp70Gly	rs1799807
10193	25054547	1891	1902	SequenceVariant	p.Ala539Thr	rs1803274
10194	25119790	0	8	ChemicalEntity	Curcumin	D003474
10195	25119790	18	25	ChemicalEntity	maleate	C030272
10196	25119790	34	48	DiseaseOrPhenotypicFeature	nephrotoxicity	D007674
10197	25119790	119	125	ChemicalEntity	oxygen	D010100
10198	25119790	154	175	ChemicalEntity	respiratory complex I	D042967
10199	25119790	236	244	ChemicalEntity	curcumin	D003474
10200	25119790	284	296	DiseaseOrPhenotypicFeature	renal injury	D007674
10201	25119790	308	315	ChemicalEntity	maleate	C030272
10202	25119790	339	350	DiseaseOrPhenotypicFeature	proteinuria	D011507
10203	25119790	410	417	ChemicalEntity	maleate	C030272
10204	25119790	433	437	OrganismTaxon	rats	10116
10205	25119790	439	446	ChemicalEntity	Maleate	C030272
10206	25119790	455	467	DiseaseOrPhenotypicFeature	renal injury	D007674
10207	25119790	562	569	ChemicalEntity	glucose	D005947
10208	25119790	571	577	ChemicalEntity	sodium	D012964
10209	25119790	579	621	GeneOrGeneProduct	neutrophil gelatinase-associated lipocalin	170496
10210	25119790	623	627	GeneOrGeneProduct	NGAL	170496
10211	25119790	633	661	GeneOrGeneProduct	N-acetyl b-D-glucosaminidase	-
10212	25119790	663	666	GeneOrGeneProduct	NAG	-
10213	25119790	685	715	GeneOrGeneProduct	kidney injury molecule (KIM)-1	286934
10214	25119790	750	759	GeneOrGeneProduct	claudin-2	733684
10215	25119790	782	821	DiseaseOrPhenotypicFeature	necrosis and apoptosis of tubular cells	D007673
10216	25119790	893	899	ChemicalEntity	lipids	D008055
10217	25119790	937	941	GeneOrGeneProduct	Nrf2	83619
10218	25119790	998	1005	CellLine	LLC-PK1	9823
10219	25119790	1086	1093	ChemicalEntity	Maleate	C030272
10220	25119790	1118	1141	ChemicalEntity	reactive oxygen species	D017382
10221	25119790	1143	1146	ChemicalEntity	ROS	D017382
10222	25119790	1162	1169	CellLine	LLC-PK1	9823
10223	25119790	1201	1208	ChemicalEntity	maleate	C030272
10224	25119790	1227	1233	ChemicalEntity	oxygen	D010100
10225	25119790	1249	1252	ChemicalEntity	ADP	D000244
10226	25119790	1329	1335	ChemicalEntity	malate	C030298
10227	25119790	1336	1345	ChemicalEntity	glutamate	D018698
10228	25119790	1397	1406	GeneOrGeneProduct	aconitase	50655
10229	25119790	1483	1491	ChemicalEntity	curcumin	D003474
10230	25119790	1514	1522	ChemicalEntity	curcumin	D003474
10231	25119790	1552	1559	ChemicalEntity	maleate	C030272
10232	25119790	1568	1579	DiseaseOrPhenotypicFeature	nephropathy	D007674
10233	25119790	1716	1722	ChemicalEntity	oxygen	D010100
10234	25119790	1751	1772	ChemicalEntity	respiratory complex I	D042967
10235	25119790	1838	1841	ChemicalEntity	ROS	D017382
10236	25218136	0	6	DiseaseOrPhenotypicFeature	Sepsis	D018805
10237	25218136	26	49	GeneOrGeneProduct	amino acid transporters	246235,25648,29642,84551
10238	25218136	54	61	ChemicalEntity	leucine	D007930
10239	25218136	76	80	GeneOrGeneProduct	mTOR	56718
10240	25218136	146	152	DiseaseOrPhenotypicFeature	sepsis	D018805
10241	25218136	161	168	ChemicalEntity	leucine	D007930
10242	25218136	170	173	ChemicalEntity	Leu	D007930
10243	25218136	245	268	GeneOrGeneProduct	amino acid transporters	246235,25648,29642,84551
10244	25218136	293	296	ChemicalEntity	Leu	D007930
10245	25218136	343	346	ChemicalEntity	Leu	D007930
10246	25218136	357	361	GeneOrGeneProduct	mTOR	56718
10247	25218136	362	379	GeneOrGeneProduct	Ragulator complex	295234,308869
10248	25218136	381	387	DiseaseOrPhenotypicFeature	Sepsis	D018805
10249	25218136	402	406	OrganismTaxon	rats	10116
10250	25218136	490	494	GeneOrGeneProduct	mTOR	56718
10251	25218136	532	538	GeneOrGeneProduct	4E-BP1	116636
10252	25218136	543	547	GeneOrGeneProduct	S6K1	83840
10253	25218136	585	588	ChemicalEntity	Leu	D007930
10254	25218136	623	627	GeneOrGeneProduct	mTOR	56718
10255	25218136	670	676	DiseaseOrPhenotypicFeature	sepsis	D018805
10256	25218136	678	684	DiseaseOrPhenotypicFeature	Sepsis	D018805
10257	25218136	695	699	GeneOrGeneProduct	CAT1	25648
10258	25218136	701	705	GeneOrGeneProduct	LAT2	84551
10259	25218136	710	715	GeneOrGeneProduct	SNAT2	29642
10260	25218136	780	784	GeneOrGeneProduct	CAT1	25648
10261	25218136	837	843	DiseaseOrPhenotypicFeature	sepsis	D018805
10262	25218136	858	904	GeneOrGeneProduct	proton-assisted amino acid transporter (PAT)-2	246235
10263	25218136	954	958	GeneOrGeneProduct	PAT2	246235
10264	25218136	981	987	DiseaseOrPhenotypicFeature	sepsis	D018805
10265	25218136	991	994	ChemicalEntity	Leu	D007930
10266	25218136	1029	1035	GeneOrGeneProduct	RagA-D	117043,117044,297960,298514
10267	25218136	1037	1052	GeneOrGeneProduct	LAMTOR-1 and -2	295234,308869
10268	25218136	1054	1060	GeneOrGeneProduct	raptor	287871
10269	25218136	1062	1066	GeneOrGeneProduct	Rheb	26954
10270	25218136	1070	1074	GeneOrGeneProduct	mTOR	56718
10271	25218136	1101	1105	GeneOrGeneProduct	mTOR	56718
10272	25218136	1107	1113	GeneOrGeneProduct	PRAS40	292887
10273	25218136	1118	1122	GeneOrGeneProduct	RagC	298514
10274	25218136	1126	1132	GeneOrGeneProduct	raptor	287871
10275	25218136	1215	1218	ChemicalEntity	Leu	D007930
10276	25218136	1239	1245	GeneOrGeneProduct	PRAS40	292887
10277	25218136	1246	1252	GeneOrGeneProduct	raptor	287871
10278	25218136	1269	1273	GeneOrGeneProduct	RagC	298514
10279	25218136	1274	1280	GeneOrGeneProduct	raptor	287871
10280	25218136	1318	1324	DiseaseOrPhenotypicFeature	sepsis	D018805
10281	25218136	1344	1347	ChemicalEntity	Leu	D007930
10282	25218136	1441	1444	ChemicalEntity	Leu	D007930
10283	25218136	1481	1484	ChemicalEntity	Leu	D007930
10284	25218136	1536	1540	OrganismTaxon	rats	10116
10285	25218136	1577	1600	GeneOrGeneProduct	amino acid transporters	246235,25648,29642,84551
10286	25218136	1640	1646	DiseaseOrPhenotypicFeature	sepsis	D018805
10287	25218136	1655	1658	ChemicalEntity	Leu	D007930
10288	25218136	1675	1678	ChemicalEntity	Leu	D007930
10289	25218136	1701	1707	GeneOrGeneProduct	raptor	287871
10290	25218136	1713	1717	GeneOrGeneProduct	RagC	298514
10291	25218136	1741	1745	GeneOrGeneProduct	mTOR	56718
10292	25218136	1746	1752	GeneOrGeneProduct	raptor	287871
10293	25218136	1830	1833	ChemicalEntity	Leu	D007930
10294	25218136	1852	1856	GeneOrGeneProduct	mTOR	56718
10295	25277705	0	26	GeneOrGeneProduct	Leukemia inhibitory factor	16878,3976
10296	25277705	52	89	DiseaseOrPhenotypicFeature	respiratory syncytial viral infection	D018357
10297	25277705	103	130	OrganismTaxon	Respiratory syncytial virus	12814
10298	25277705	132	135	OrganismTaxon	RSV	12814
10299	25277705	271	288	DiseaseOrPhenotypicFeature	acute lung injury	D055371
10300	25277705	335	348	DiseaseOrPhenotypicFeature	RSV infection	D018357
10301	25277705	417	420	OrganismTaxon	RSV	12814
10302	25277705	447	456	DiseaseOrPhenotypicFeature	infection	D007239
10303	25277705	497	501	CellLine	A549	9606
10304	25277705	511	516	OrganismTaxon	human	9606
10305	25277705	542	545	CellLine	SAE	9606
10306	25277705	568	619	GeneOrGeneProduct	TIR-domain-containing adapter-inducing interferon-b	106759
10307	25277705	621	625	GeneOrGeneProduct	Trif	106759
10308	25277705	631	672	GeneOrGeneProduct	mitochondrial antiviral-signaling protein	228607
10309	25277705	674	678	GeneOrGeneProduct	Mavs	228607
10310	25277705	694	698	OrganismTaxon	mice	10090
10311	25277705	718	721	OrganismTaxon	RSV	12814
10312	25277705	820	846	GeneOrGeneProduct	leukemia inhibitory factor	3976
10313	25277705	848	851	GeneOrGeneProduct	LIF	3976
10314	25277705	930	943	DiseaseOrPhenotypicFeature	RSV infection	D018357
10315	25277705	969	981	DiseaseOrPhenotypicFeature	RSV-infected	D018357
10316	25277705	982	986	CellLine	A549	9606
10317	25277705	991	994	CellLine	SAE	9606
10318	25277705	1060	1063	OrganismTaxon	RSV	12814
10319	25277705	1084	1087	GeneOrGeneProduct	LIF	3976
10320	25277705	1089	1116	GeneOrGeneProduct	migration inhibitory factor	4282
10321	25277705	1118	1121	GeneOrGeneProduct	MIF	4282
10322	25277705	1124	1140	GeneOrGeneProduct	stem cell factor	4254
10323	25277705	1142	1145	GeneOrGeneProduct	SCF	4254
10324	25277705	1148	1153	GeneOrGeneProduct	CCL27	10850
10325	25277705	1155	1161	GeneOrGeneProduct	CXCL12	6387
10326	25277705	1166	1194	GeneOrGeneProduct	stem cell growth factor beta	6320
10327	25277705	1196	1202	GeneOrGeneProduct	SCGF-b	6320
10328	25277705	1211	1214	OrganismTaxon	RSV	12814
10329	25277705	1272	1276	OrganismTaxon	mice	10090
10330	25277705	1287	1296	DiseaseOrPhenotypicFeature	infection	D007239
10331	25277705	1328	1331	OrganismTaxon	RSV	12814
10332	25277705	1353	1357	GeneOrGeneProduct	Mavs	228607
10333	25277705	1362	1366	GeneOrGeneProduct	Trif	106759
10334	25277705	1404	1407	OrganismTaxon	RSV	12814
10335	25277705	1437	1442	GeneOrGeneProduct	IL-1b	16176
10336	25277705	1444	1448	GeneOrGeneProduct	IL-4	16189
10337	25277705	1450	1454	GeneOrGeneProduct	IL-5	16191
10338	25277705	1456	1460	GeneOrGeneProduct	IL-6	16193
10339	25277705	1462	1467	GeneOrGeneProduct	IL-12	16160
10340	25277705	1468	1471	GeneOrGeneProduct	p40	16160
10341	25277705	1474	1479	GeneOrGeneProduct	IFN-g	15978
10342	25277705	1481	1485	GeneOrGeneProduct	CCL2	20296
10343	25277705	1487	1491	GeneOrGeneProduct	CCL5	20304
10344	25277705	1493	1497	GeneOrGeneProduct	CCL3	20302
10345	25277705	1499	1504	GeneOrGeneProduct	CXCL1	14825
10346	25277705	1506	1511	GeneOrGeneProduct	IP-10	15945
10347	25277705	1512	1518	GeneOrGeneProduct	CXCL10	15945
10348	25277705	1520	1525	GeneOrGeneProduct	IL-22	50929
10349	25277705	1527	1530	GeneOrGeneProduct	MIG	17329
10350	25277705	1531	1536	GeneOrGeneProduct	CXCL9	17329
10351	25277705	1541	1544	GeneOrGeneProduct	MIF	17319
10352	25277705	1563	1567	GeneOrGeneProduct	Mavs	228607
10353	25277705	1582	1586	OrganismTaxon	mice	10090
10354	25277705	1596	1600	GeneOrGeneProduct	Trif	106759
10355	25277705	1615	1619	OrganismTaxon	mice	10090
10356	25277705	1632	1635	OrganismTaxon	RSV	12814
10357	25277705	1649	1654	GeneOrGeneProduct	IL-1b	16176
10358	25277705	1656	1660	GeneOrGeneProduct	IL-5	16191
10359	25277705	1662	1668	GeneOrGeneProduct	CXCL12	20315
10360	25277705	1670	1673	GeneOrGeneProduct	MIF	17319
10361	25277705	1675	1678	GeneOrGeneProduct	LIF	16878
10362	25277705	1680	1686	GeneOrGeneProduct	CXCL12	20315
10363	25277705	1691	1696	GeneOrGeneProduct	IFN-g	15978
10364	25277705	1711	1741	GeneOrGeneProduct	retinoic acid-inducible gene-1	23586
10365	25277705	1743	1748	GeneOrGeneProduct	RIG-I	23586
10366	25277705	1764	1768	CellLine	A549	9606
10367	25277705	1799	1802	OrganismTaxon	RSV	12814
10368	25277705	1828	1873	GeneOrGeneProduct	melanoma differentiation-associated protein 5	64135
10369	25277705	1875	1879	GeneOrGeneProduct	MDA5	64135
10370	25277705	1885	1924	GeneOrGeneProduct	laboratory of genetics and physiology 2	79132
10371	25277705	1926	1930	GeneOrGeneProduct	LGP2	79132
10372	25277705	1937	1941	GeneOrGeneProduct	Trif	148022
10373	25277705	1978	1981	GeneOrGeneProduct	LIF	16878
10374	25277705	2004	2017	DiseaseOrPhenotypicFeature	RSV infection	D018357
10375	25277705	2063	2066	GeneOrGeneProduct	LIF	16878
10376	25277705	2087	2090	OrganismTaxon	RSV	12814
10377	25277705	2240	2253	DiseaseOrPhenotypicFeature	RSV infection	D018357
10378	25277705	2319	2328	DiseaseOrPhenotypicFeature	infection	D007239
10379	25277705	2345	2350	GeneOrGeneProduct	RIG-I	23586
10380	25277705	2383	2386	GeneOrGeneProduct	LIF	16878,3976
10381	25277705	2410	2421	DiseaseOrPhenotypicFeature	lung injury	D055370
10382	25277705	2452	2465	DiseaseOrPhenotypicFeature	RSV infection	D018357
10383	25550469	4	21	GeneOrGeneProduct	androgen receptor	11835
10384	25550469	62	77	DiseaseOrPhenotypicFeature	atherosclerosis	D050197
10385	25550469	79	86	DiseaseOrPhenotypicFeature	obesity	D009765
10386	25550469	92	104	DiseaseOrPhenotypicFeature	dyslipidemia	D050171
10387	25550469	115	119	OrganismTaxon	mice	10090
10388	25550469	121	130	ChemicalEntity	Androgens	D000728
10389	25550469	257	274	GeneOrGeneProduct	androgen receptor	11835
10390	25550469	276	278	GeneOrGeneProduct	AR	11835
10391	25550469	301	310	ChemicalEntity	androgens	D000728
10392	25550469	314	327	DiseaseOrPhenotypicFeature	atherogenesis	D050197
10393	25550469	338	342	OrganismTaxon	mice	10090
10394	25550469	364	366	GeneOrGeneProduct	AR	11835
10395	25550469	377	379	GeneOrGeneProduct	AR	11835
10396	25550469	383	387	OrganismTaxon	mice	10090
10397	25550469	394	409	DiseaseOrPhenotypicFeature	atherosclerosis	D050197
10398	25550469	416	432	GeneOrGeneProduct	apolipoprotein E	11816
10399	25550469	434	438	GeneOrGeneProduct	apoE	11816
10400	25550469	527	542	DiseaseOrPhenotypicFeature	atherosclerosis	D050197
10401	25550469	569	571	GeneOrGeneProduct	AR	11835
10402	25550469	600	604	GeneOrGeneProduct	apoE	11816
10403	25550469	615	619	OrganismTaxon	mice	10090
10404	25550469	632	634	GeneOrGeneProduct	AR	11835
10405	25550469	732	744	GeneOrGeneProduct	triglyceride	100035834
10406	25550469	761	768	GeneOrGeneProduct	insulin	16334
10407	25550469	795	806	DiseaseOrPhenotypicFeature	atherogenic	D050197
10408	25550469	807	819	DiseaseOrPhenotypicFeature	dyslipidemia	D050171
10409	25550469	827	838	ChemicalEntity	cholesterol	D002784
10410	25550469	862	877	DiseaseOrPhenotypicFeature	atherosclerosis	D050197
10411	25550469	896	901	ChemicalEntity	lipid	D008055
10412	25550469	917	919	GeneOrGeneProduct	AR	11835
10413	25550469	934	938	OrganismTaxon	mice	10090
10414	25550469	957	961	OrganismTaxon	mice	10090
10415	25550469	1050	1059	ChemicalEntity	androgens	D000728
10416	25550469	1077	1079	GeneOrGeneProduct	AR	11835
10417	25550469	1098	1100	GeneOrGeneProduct	AR	11835
10418	25550469	1109	1128	ChemicalEntity	dihydrotestosterone	D013196
10419	25550469	1137	1152	DiseaseOrPhenotypicFeature	atherosclerosis	D050197
10420	25550469	1211	1222	ChemicalEntity	cholesterol	D002784
10421	25550469	1255	1259	OrganismTaxon	mice	10090
10422	25550469	1280	1285	ChemicalEntity	lipid	D008055
10423	25550469	1302	1310	DiseaseOrPhenotypicFeature	hepatoma	D006528
10424	25550469	1386	1391	ChemicalEntity	lipid	D008055
10425	25550469	1444	1446	GeneOrGeneProduct	AR	11835
10426	25550469	1477	1492	DiseaseOrPhenotypicFeature	atherosclerosis	D050197
10427	25550469	1503	1507	OrganismTaxon	mice	10090
10428	25550469	1580	1585	ChemicalEntity	lipid	D008055
10429	25589620	91	99	DiseaseOrPhenotypicFeature	Toxicity	D064420
10430	25589620	103	116	DiseaseOrPhenotypicFeature	Rectal Cancer	D012004
10431	25589620	117	125	OrganismTaxon	Patients	9606
10432	25589620	139	143	ChemicalEntity	5-FU	D005472
10433	25589620	216	221	GeneOrGeneProduct	GSTP1	2950
10434	25589620	223	227	GeneOrGeneProduct	COX2	4513
10435	25589620	229	233	GeneOrGeneProduct	IL10	3586
10436	25589620	235	239	GeneOrGeneProduct	EGFR	1956
10437	25589620	241	244	GeneOrGeneProduct	EGF	1950
10438	25589620	246	251	GeneOrGeneProduct	FGFR4	2264
10439	25589620	253	258	GeneOrGeneProduct	CCDN1	595
10440	25589620	260	266	GeneOrGeneProduct	VEGFR2	3791
10441	25589620	268	272	GeneOrGeneProduct	VEGF	7422
10442	25589620	274	279	GeneOrGeneProduct	CXCR2	3579
10443	25589620	281	284	GeneOrGeneProduct	IL8	3576
10444	25589620	286	290	GeneOrGeneProduct	MMP3	4314
10445	25589620	292	297	GeneOrGeneProduct	ICAM1	3383
10446	25589620	299	304	GeneOrGeneProduct	ERCC1	2067
10447	25589620	306	311	GeneOrGeneProduct	RAD51	5888
10448	25589620	317	322	GeneOrGeneProduct	XRCC3	7517
10449	25589620	394	402	DiseaseOrPhenotypicFeature	toxicity	D064420
10450	25589620	495	509	ChemicalEntity	5-fluorouracil	D005472
10451	25589620	511	515	ChemicalEntity	5-FU	D005472
10452	25589620	564	578	DiseaseOrPhenotypicFeature	rectal cancers	D012004
10453	25589620	605	609	ChemicalEntity	5-FU	D005472
10454	25589620	622	626	ChemicalEntity	5-FU	D005472
10455	25589620	719	723	ChemicalEntity	5-FU	D005472
10456	25589620	788	792	ChemicalEntity	5-FU	D005472
10457	25589620	866	874	OrganismTaxon	patients	9606
10458	25589620	990	998	ChemicalEntity	formalin	D005557
10459	25589620	1006	1014	ChemicalEntity	paraffin	D010232
10460	25589620	1031	1036	DiseaseOrPhenotypicFeature	tumor	D009369
10461	25589620	1196	1201	GeneOrGeneProduct	GSTP1	2950
10462	25589620	1202	1211	SequenceVariant	Ile105Val	rs1695
10463	25589620	1213	1219	SequenceVariant	rs1695	rs1695
10464	25589620	1423	1431	OrganismTaxon	patients	9606
10465	25589620	1443	1446	GeneOrGeneProduct	IL8	3576
10466	25589620	1446	1453	SequenceVariant	-251A/A	rs4073
10467	25589620	1464	1470	SequenceVariant	rs4073	rs4073
10468	25589620	1508	1518	DiseaseOrPhenotypicFeature	toxicities	D064420
10469	25589620	1535	1541	GeneOrGeneProduct	VEGFR2	3791
10470	25589620	1542	1547	SequenceVariant	H472Q	rs1870377
10471	25589620	1562	1571	SequenceVariant	rs1870377	rs1870377
10472	25589620	1666	1675	DiseaseOrPhenotypicFeature	mucositis	D052016
10473	25589620	1772	1781	DiseaseOrPhenotypicFeature	mucositis	D052016
10474	25589620	1807	1813	SequenceVariant	rs1695	rs1695
10475	25589620	1835	1843	OrganismTaxon	patients	9606
10476	25589620	1849	1862	DiseaseOrPhenotypicFeature	rectal cancer	D012004
10477	25589620	1890	1896	SequenceVariant	rs4073	rs4073
10478	25589620	1901	1910	SequenceVariant	rs1870377	rs1870377
10479	25589620	1951	1959	DiseaseOrPhenotypicFeature	toxicity	D064420
10480	25589620	1978	1982	ChemicalEntity	5-FU	D005472
10481	25622904	16	19	GeneOrGeneProduct	Sag	19823
10482	25622904	20	24	GeneOrGeneProduct	Rbx2	19823
10483	25622904	25	29	GeneOrGeneProduct	Roc2	19823
10484	25622904	30	49	GeneOrGeneProduct	e3 ubiquitin ligase	19823
10485	25622904	83	87	GeneOrGeneProduct	kras	16653
10486	25622904	142	145	GeneOrGeneProduct	SAG	19823
10487	25622904	146	150	GeneOrGeneProduct	RBX2	19823
10488	25622904	151	170	GeneOrGeneProduct	E3 ubiquitin ligase	19823
10489	25622904	238	242	GeneOrGeneProduct	NOXA	58801
10490	25622904	247	250	GeneOrGeneProduct	NF1	18015
10491	25622904	273	277	GeneOrGeneProduct	Kras	16653
10492	25622904	289	307	DiseaseOrPhenotypicFeature	lung tumorigenesis	D008175
10493	25622904	322	330	GeneOrGeneProduct	NFkappaB	18033
10494	25622904	335	339	GeneOrGeneProduct	mTOR	56717
10495	25622904	377	382	DiseaseOrPhenotypicFeature	tumor	D009369
10496	25622904	416	423	GeneOrGeneProduct	IkappaB	18033
10497	25622904	425	431	GeneOrGeneProduct	DEPTOR	97998
10498	25622904	433	436	GeneOrGeneProduct	p21	12575
10499	25622904	441	444	GeneOrGeneProduct	p27	12576
10500	25622904	479	482	GeneOrGeneProduct	Sag	19823
10501	25622904	483	487	GeneOrGeneProduct	Rbx2	19823
10502	25622904	488	497	GeneOrGeneProduct	E3 ligase	19823
10503	25622904	544	549	OrganismTaxon	mouse	10090
10504	25622904	595	598	GeneOrGeneProduct	Sag	19823
10505	25622904	645	649	GeneOrGeneProduct	Kras	16653
10506	25622904	650	654	SequenceVariant	G12D	rs121913529
10507	25622904	681	684	GeneOrGeneProduct	Sag	19823
10508	25622904	824	827	GeneOrGeneProduct	p16	12578
10509	25622904	837	840	GeneOrGeneProduct	p53	22059
10510	25622904	859	862	GeneOrGeneProduct	Sag	19823
10511	25622904	895	900	GeneOrGeneProduct	Jun-B	16477
10512	25622904	917	920	GeneOrGeneProduct	Sag	19823
10513	25622904	921	926	GeneOrGeneProduct	Fbxw7	50754
10514	25622904	927	936	GeneOrGeneProduct	E3 ligase	19823
10515	25622904	976	979	GeneOrGeneProduct	p16	12578
10516	25622904	1032	1035	GeneOrGeneProduct	Sag	19823
10517	25622904	1096	1102	GeneOrGeneProduct	Cdkn2a	12578
10518	25622904	1108	1111	GeneOrGeneProduct	p16	12578
10519	25622904	1168	1172	GeneOrGeneProduct	Kras	16653
10520	25622904	1173	1177	SequenceVariant	G12D	rs121913529
10521	25622904	1228	1231	GeneOrGeneProduct	Sag	19823
10522	25622904	1318	1324	GeneOrGeneProduct	Cdkn2a	12578
10523	25622904	1349	1352	GeneOrGeneProduct	Sag	19823
10524	25622904	1374	1378	GeneOrGeneProduct	Kras	16653
10525	25622904	1379	1383	SequenceVariant	G12D	rs121913529
10526	25622904	1408	1412	GeneOrGeneProduct	MAPK	26413
10527	25622904	1458	1461	GeneOrGeneProduct	p16	12578
10528	25622904	1531	1534	GeneOrGeneProduct	Sag	19823
10529	25622904	1540	1544	GeneOrGeneProduct	Kras	16653
10530	25622904	1545	1549	SequenceVariant	G12D	rs121913529
10531	25622904	1585	1589	GeneOrGeneProduct	Kras	16653
10532	25622904	1590	1594	SequenceVariant	G12D	rs121913529
10533	25622904	1654	1657	GeneOrGeneProduct	SAG	19823
10534	25622904	1658	1661	GeneOrGeneProduct	SCF	50754
10535	25622904	1662	1671	GeneOrGeneProduct	E3 ligase	19823
10536	25622904	1732	1738	DiseaseOrPhenotypicFeature	cancer	D009369
10537	25874935	26	37	GeneOrGeneProduct	neuroserpin	116459
10538	25874935	41	47	ChemicalEntity	oxygen	D010100
10539	25874935	48	55	ChemicalEntity	glucose	D005947
10540	25874935	95	98	OrganismTaxon	rat	10116
10541	25874935	120	131	GeneOrGeneProduct	Neuroserpin	116459,5274
10542	25874935	133	136	GeneOrGeneProduct	NSP	116459,5274
10543	25874935	183	200	DiseaseOrPhenotypicFeature	cerebral ischemic	D002545
10544	25874935	219	227	OrganismTaxon	patients	9606
10545	25874935	344	347	GeneOrGeneProduct	NSP	116459
10546	25874935	369	377	DiseaseOrPhenotypicFeature	ischemic	D007511
10547	25874935	452	456	OrganismTaxon	rats	10116
10548	25874935	475	481	ChemicalEntity	oxygen	D010100
10549	25874935	482	489	ChemicalEntity	glucose	D005947
10550	25874935	585	588	GeneOrGeneProduct	NSP	116459
10551	25874935	635	656	GeneOrGeneProduct	lactate dehydrogenase	24533
10552	25874935	658	661	GeneOrGeneProduct	LDH	24533
10553	25874935	747	756	GeneOrGeneProduct	Annexin V	25673
10554	25874935	803	806	GeneOrGeneProduct	NSP	116459
10555	25874935	823	835	ChemicalEntity	nitric oxide	D009569
10556	25874935	837	839	ChemicalEntity	NO	D009569
10557	25874935	845	854	GeneOrGeneProduct	TNF-alpha	24835
10558	25874935	866	869	GeneOrGeneProduct	NSP	116459
10559	25874935	965	974	GeneOrGeneProduct	NF-kappaB	309165
10560	25874935	976	982	GeneOrGeneProduct	ERK1/2	5594,5595
10561	25874935	988	992	GeneOrGeneProduct	PI3K	298947
10562	25874935	993	996	GeneOrGeneProduct	Akt	24185
10563	25874935	1121	1130	GeneOrGeneProduct	NF-kappaB	309165
10564	25874935	1142	1151	GeneOrGeneProduct	NF-kappaB	309165
10565	25874935	1170	1176	ChemicalEntity	sc3060	C118258
10566	25874935	1216	1219	GeneOrGeneProduct	NSP	116459
10567	25874935	1259	1262	GeneOrGeneProduct	NSP	116459
10568	25874935	1322	1325	GeneOrGeneProduct	LDH	24533
10569	25874935	1379	1381	ChemicalEntity	NO	D009569
10570	25874935	1382	1391	GeneOrGeneProduct	TNF-alpha	24835
10571	25874935	1454	1468	GeneOrGeneProduct	IKKBalpha/beta	309361,84351
10572	25874935	1473	1476	GeneOrGeneProduct	P65	309165
10573	25874935	1566	1569	GeneOrGeneProduct	NSP	116459
10574	25874935	1590	1593	GeneOrGeneProduct	NSP	116459
10575	25874935	1670	1679	GeneOrGeneProduct	NF-kappaB	309165
10576	25874935	1698	1704	ChemicalEntity	sc3060	C118258
10577	25874935	1732	1736	GeneOrGeneProduct	ERK1	50689
10578	25874935	1740	1744	GeneOrGeneProduct	ERK2	116590
10579	25874935	1752	1755	GeneOrGeneProduct	AKT	24185
10580	25874935	1837	1840	GeneOrGeneProduct	NSP	116459
10581	25874935	1914	1917	GeneOrGeneProduct	NSP	116459
10582	25874935	1921	1929	DiseaseOrPhenotypicFeature	ischemic	D007511
10583	25874935	2004	2006	ChemicalEntity	NO	D009569
10584	25874935	2007	2016	GeneOrGeneProduct	TNF-alpha	24835
10585	25874935	2039	2048	GeneOrGeneProduct	NF-kappaB	309165
10586	25874935	2098	2101	GeneOrGeneProduct	NSP	116459
10587	25874935	2130	2134	GeneOrGeneProduct	MAPK	116590,50689
10588	25874935	2139	2143	GeneOrGeneProduct	PI3K	298947
10589	25874935	2144	2147	GeneOrGeneProduct	Akt	24185
10590	25946186	0	5	GeneOrGeneProduct	TIPE2	79626
10591	25946186	15	26	DiseaseOrPhenotypicFeature	Lung Cancer	D008175
10592	25946186	149	154	GeneOrGeneProduct	TIPE2	79626
10593	25946186	171	177	DiseaseOrPhenotypicFeature	cancer	D009369
10594	25946186	222	227	GeneOrGeneProduct	TIPE2	79626
10595	25946186	231	242	DiseaseOrPhenotypicFeature	lung cancer	D008175
10596	25946186	282	287	GeneOrGeneProduct	TIPE2	79626
10597	25946186	291	310	DiseaseOrPhenotypicFeature	lung carcinogenesis	D008175
10598	25946186	342	347	GeneOrGeneProduct	TIPE2	79626
10599	25946186	351	371	DiseaseOrPhenotypicFeature	lung squamous cancer	D002289
10600	25946186	373	376	DiseaseOrPhenotypicFeature	LSC	D002289
10601	25946186	379	401	DiseaseOrPhenotypicFeature	small cell lung cancer	D055752
10602	25946186	406	425	DiseaseOrPhenotypicFeature	lung adenocarcinoma	D000077192
10603	25946186	427	430	DiseaseOrPhenotypicFeature	AdC	D000077192
10604	25946186	455	460	GeneOrGeneProduct	TIPE2	79626
10605	25946186	484	506	DiseaseOrPhenotypicFeature	small cell lung cancer	D055752
10606	25946186	535	540	DiseaseOrPhenotypicFeature	tumor	D009369
10607	25946186	568	573	GeneOrGeneProduct	TIPE2	79626
10608	25946186	612	623	DiseaseOrPhenotypicFeature	lung cancer	D008175
10609	25946186	629	633	CellLine	H446	9606
10610	25946186	663	668	DiseaseOrPhenotypicFeature	tumor	D009369
10611	25946186	718	723	GeneOrGeneProduct	TIPE2	79626
10612	25946186	761	765	CellLine	H446	9606
10613	25946186	770	775	GeneOrGeneProduct	TIPE2	79626
10614	25946186	799	808	GeneOrGeneProduct	caspase-3	836
10615	25946186	810	819	GeneOrGeneProduct	caspase-9	842
10616	25946186	825	828	GeneOrGeneProduct	Bax	581
10617	25946186	867	872	GeneOrGeneProduct	Bcl-2	596
10618	25946186	960	966	DiseaseOrPhenotypicFeature	tumors	D009369
10619	25946186	977	981	OrganismTaxon	mice	10090
10620	25946186	983	988	GeneOrGeneProduct	TIPE2	79626
10621	25946186	1022	1025	GeneOrGeneProduct	Akt	207
10622	25946186	1066	1069	GeneOrGeneProduct	P38	1432
10623	25946186	1092	1096	GeneOrGeneProduct	IkBa	4792
10624	25946186	1101	1104	GeneOrGeneProduct	ERK	5594
10625	25946186	1130	1135	GeneOrGeneProduct	TIPE2	79626
10626	25946186	1145	1156	DiseaseOrPhenotypicFeature	lung cancer	D008175
10627	25946186	1218	1227	GeneOrGeneProduct	caspase-3	836
10628	25946186	1229	1238	GeneOrGeneProduct	caspase-9	842
10629	25946186	1240	1245	GeneOrGeneProduct	Bcl-2	596
10630	25946186	1250	1253	GeneOrGeneProduct	Bax	581
10631	25946186	1279	1282	GeneOrGeneProduct	P38	1432
10632	25946186	1287	1290	GeneOrGeneProduct	Akt	207
10633	25946186	1317	1322	GeneOrGeneProduct	TIPE2	79626
10634	25946186	1351	1362	DiseaseOrPhenotypicFeature	lung cancer	D008175
10635	25979836	0	25	ChemicalEntity	Gastrointestinal hormones	D005768
10636	25979836	26	43	ChemicalEntity	neurotransmitters	D018377
10637	25979836	76	98	GeneOrGeneProduct	P21 activated kinase 2	29432
10638	25979836	147	169	GeneOrGeneProduct	P-21-activated kinases	292756,29431,29432,29433,296078,311450
10639	25979836	171	175	GeneOrGeneProduct	PAKs	292756,29431,29432,29433,296078,311450
10640	25979836	181	205	GeneOrGeneProduct	serine/threonine kinases	292756,29431,29432,29433,296078,311450
10641	25979836	262	268	GeneOrGeneProduct	PAK1-3	29431,29432,29433
10642	25979836	280	286	GeneOrGeneProduct	PAK4-6	292756,296078,311450
10643	25979836	453	457	GeneOrGeneProduct	PAKs	292756,29431,29432,29433,296078,311450
10644	25979836	485	515	ChemicalEntity	gastrointestinal (GI) hormones	D005768
10645	25979836	516	533	ChemicalEntity	neurotransmitters	D018377
10646	25979836	558	561	OrganismTaxon	rat	10116
10647	25979836	605	616	ChemicalEntity	GI-hormones	D005768
10648	25979836	617	634	ChemicalEntity	neurotransmitters	D018377
10649	25979836	662	674	GeneOrGeneProduct	Group-I-PAKs	29431,29432,29433
10650	25979836	717	721	GeneOrGeneProduct	PAK2	29432
10651	25979836	744	748	GeneOrGeneProduct	PAK2	29432
10652	25979836	771	796	GeneOrGeneProduct	pancreatic growth-factors	25266,25313,54250
10653	25979836	798	801	GeneOrGeneProduct	EGF	25313
10654	25979836	803	807	GeneOrGeneProduct	PDGF	25266
10655	25979836	809	813	GeneOrGeneProduct	bFGF	54250
10656	25979836	844	859	GeneOrGeneProduct	phospholipase-C	24655
10657	25979836	861	864	GeneOrGeneProduct	PLC	24655
10658	25979836	867	870	GeneOrGeneProduct	CCK	25298
10659	25979836	872	881	ChemicalEntity	carbachol	D002217
10660	25979836	883	891	ChemicalEntity	bombesin	D001839
10661	25979836	936	939	GeneOrGeneProduct	PKC	24681
10662	25979836	941	944	ChemicalEntity	TPA	D013755
10663	25979836	987	994	ChemicalEntity	calcium	D002118
10664	25979836	1009	1019	ChemicalEntity	cyclic AMP	D000242
10665	25979836	1021	1024	GeneOrGeneProduct	CCK	25298
10666	25979836	1039	1043	GeneOrGeneProduct	PAK2	29432
10667	25979836	1081	1094	GeneOrGeneProduct	CCK1-receptor	24889
10668	25979836	1141	1144	GeneOrGeneProduct	PKC	24681
10669	25979836	1149	1152	GeneOrGeneProduct	Src	83805
10670	25979836	1178	1182	GeneOrGeneProduct	PI3K	298947
10671	25979836	1195	1205	ChemicalEntity	wortmannin	D000077191
10672	25979836	1207	1215	ChemicalEntity	LY294002	C085911
10673	25979836	1220	1232	ChemicalEntity	thapsigargin	D019284
10674	25979836	1234	1239	ChemicalEntity	IPA-3	C541795
10675	25979836	1256	1260	GeneOrGeneProduct	PAK2	29432
10676	25979836	1272	1285	GeneOrGeneProduct	small-GTPases	363875,64465
10677	25979836	1306	1310	GeneOrGeneProduct	PAK2	29432
10678	25979836	1342	1345	GeneOrGeneProduct	CCK	25298
10679	25979836	1354	1360	GeneOrGeneProduct	ERK1/2	116590,50689
10680	25979836	1376	1383	GeneOrGeneProduct	amylase	24203
10681	25979836	1403	1406	GeneOrGeneProduct	CCK	25298
10682	25979836	1410	1418	ChemicalEntity	bombesin	D001839
10683	25979836	1479	1490	GeneOrGeneProduct	Group-I-PAK	29431,29432,29433
10684	25979836	1492	1496	GeneOrGeneProduct	PAK2	29432
10685	25979836	1498	1501	GeneOrGeneProduct	CCK	25298
10686	25979836	1512	1523	ChemicalEntity	GI-hormones	D005768
10687	25979836	1524	1541	ChemicalEntity	neurotransmitters	D018377
10688	25979836	1566	1570	GeneOrGeneProduct	PAK2	29432
10689	25979836	1575	1588	GeneOrGeneProduct	small GTPases	363875,64465
10690	25979836	1590	1595	GeneOrGeneProduct	CDC42	64465
10691	25979836	1596	1600	GeneOrGeneProduct	Rac1	363875
10692	25979836	1603	1606	GeneOrGeneProduct	PKC	24681
10693	25979836	1611	1614	GeneOrGeneProduct	SFK	83805
10694	25979836	1633	1640	ChemicalEntity	calcium	D002118
10695	25979836	1644	1648	GeneOrGeneProduct	PI3K	298947
10696	25979836	1650	1653	GeneOrGeneProduct	CCK	25298
10697	25979836	1668	1672	GeneOrGeneProduct	PAK2	29432
10698	25979836	1762	1765	GeneOrGeneProduct	PLC	24655
10699	25979836	1771	1774	GeneOrGeneProduct	PKC	24681
10700	25979836	1812	1824	GeneOrGeneProduct	small-GTPase	363875,64465
10701	25979836	1883	1887	GeneOrGeneProduct	PAK2	29432
10702	25979836	2113	2133	DiseaseOrPhenotypicFeature	pancreatic disorders	D010182
10703	25979836	2142	2154	DiseaseOrPhenotypicFeature	pancreatitis	D010195
10704	26102294	25	30	GeneOrGeneProduct	OCT4A	5460
10705	26102294	61	80	DiseaseOrPhenotypicFeature	embryonal carcinoma	D018236
10706	26102294	100	109	ChemicalEntity	etoposide	D005047
10707	26102294	326	332	DiseaseOrPhenotypicFeature	tumors	D009369
10708	26102294	421	430	ChemicalEntity	etoposide	D005047
10709	26102294	432	435	ChemicalEntity	ETO	D005047
10710	26102294	447	466	DiseaseOrPhenotypicFeature	embryonal carcinoma	D018236
10711	26102294	467	471	CellLine	PA-1	9606
10712	26102294	488	491	GeneOrGeneProduct	p53	7157
10713	26102294	518	523	GeneOrGeneProduct	OCT4A	5460
10714	26102294	528	535	GeneOrGeneProduct	p21Cip1	1026
10715	26102294	733	737	CellLine	PA-1	9606
10716	26102294	757	760	ChemicalEntity	ETO	D005047
10717	26102294	803	808	GeneOrGeneProduct	OCT4A	5460
10718	26102294	813	820	GeneOrGeneProduct	p21Cip1	1026
10719	26102294	873	878	GeneOrGeneProduct	OCT4A	5460
10720	26102294	890	897	GeneOrGeneProduct	p21Cip1	1026
10721	26102294	978	985	GeneOrGeneProduct	p21Cip1	1026
10722	26102294	1011	1016	GeneOrGeneProduct	OCT4A	5460
10723	26102294	1051	1055	GeneOrGeneProduct	SOX2	6657
10724	26102294	1060	1065	GeneOrGeneProduct	NANOG	79923
10725	26102294	1102	1105	ChemicalEntity	ETO	D005047
10726	26102294	1145	1150	GeneOrGeneProduct	OCT4A	5460
10727	26102294	1192	1195	ChemicalEntity	ETO	D005047
10728	26102294	1204	1209	GeneOrGeneProduct	OCT4A	5460
10729	26102294	1245	1249	GeneOrGeneProduct	AMPK	5562
10730	26102294	1313	1321	GeneOrGeneProduct	p16ink4a	1029
10731	26102294	1414	1417	ChemicalEntity	ETO	D005047
10732	26102294	1538	1546	GeneOrGeneProduct	p16ink4a	1029
10733	26102294	1635	1640	GeneOrGeneProduct	OCT4A	5460
10734	26102294	1675	1679	CellLine	PA-1	9606
10735	26102294	1778	1785	GeneOrGeneProduct	p21Cip1	1026
10736	26102294	1803	1807	GeneOrGeneProduct	AMPK	5562
10737	26115410	69	76	ChemicalEntity	Arsenic	D001151
10738	26115410	269	286	ChemicalEntity	inorganic arsenic	D001152
10739	26115410	288	291	ChemicalEntity	iAs	D001152
10740	26115410	318	330	ChemicalEntity	Inorganic As	D001152
10741	26115410	569	572	ChemicalEntity	iAs	D001152
10742	26115410	659	665	DiseaseOrPhenotypicFeature	cancer	D009369
10743	26115410	773	779	DiseaseOrPhenotypicFeature	cancer	D009369
10744	26115410	840	843	ChemicalEntity	iAs	D001152
10745	26115410	962	968	DiseaseOrPhenotypicFeature	cancer	D009369
10746	26115410	1058	1061	ChemicalEntity	iAs	D001152
10747	26115410	1086	1098	DiseaseOrPhenotypicFeature	carcinogenic	D009369
10748	26115410	1166	1169	ChemicalEntity	iAs	D001152
10749	26115410	1183	1189	DiseaseOrPhenotypicFeature	cancer	D009369
10750	26115410	1314	1319	OrganismTaxon	human	9606
10751	26270232	16	26	GeneOrGeneProduct	chemokines	3576,6347,6348,6351,6352,6374
10752	26270232	27	31	GeneOrGeneProduct	CCL4	6351
10753	26270232	36	40	GeneOrGeneProduct	CCL5	6352
10754	26270232	44	53	DiseaseOrPhenotypicFeature	cirrhotic	D008103
10755	26270232	54	62	OrganismTaxon	patients	9606
10756	26270232	88	112	DiseaseOrPhenotypicFeature	hepatocellular carcinoma	D006528
10757	26270232	131	156	DiseaseOrPhenotypicFeature	hepatocellular carcinomas	D006528
10758	26270232	158	162	DiseaseOrPhenotypicFeature	HCCs	D006528
10759	26270232	230	236	DiseaseOrPhenotypicFeature	tumour	D009369
10760	26270232	245	262	GeneOrGeneProduct	alpha-fetoprotein	174
10761	26270232	264	267	GeneOrGeneProduct	AFP	174
10762	26270232	273	302	GeneOrGeneProduct	des-gamma-carboxy prothrombin	2147
10763	26270232	304	307	GeneOrGeneProduct	DCP	2147
10764	26270232	417	429	DiseaseOrPhenotypicFeature	inflammatory	D007249
10765	26270232	443	452	DiseaseOrPhenotypicFeature	cirrhotic	D008103
10766	26270232	453	461	OrganismTaxon	patients	9606
10767	26270232	479	482	DiseaseOrPhenotypicFeature	HCC	D006528
10768	26270232	527	536	DiseaseOrPhenotypicFeature	cirrhotic	D008103
10769	26270232	564	572	OrganismTaxon	patients	9606
10770	26270232	603	606	DiseaseOrPhenotypicFeature	HCC	D006528
10771	26270232	684	687	GeneOrGeneProduct	CRP	1401
10772	26270232	689	698	ChemicalEntity	neopterin	D019798
10773	26270232	703	707	GeneOrGeneProduct	IL-6	3569
10774	26270232	722	734	DiseaseOrPhenotypicFeature	inflammation	D007249
10775	26270232	739	753	GeneOrGeneProduct	thrombopoietin	7066
10776	26270232	755	758	GeneOrGeneProduct	TPO	7066
10777	26270232	761	765	GeneOrGeneProduct	GCSF	1440
10778	26270232	767	776	GeneOrGeneProduct	FGF basic	2247
10779	26270232	781	785	GeneOrGeneProduct	VEGF	7422
10780	26270232	787	792	GeneOrGeneProduct	HMGB1	3146
10781	26270232	794	799	GeneOrGeneProduct	CK-18	3875
10782	26270232	810	814	GeneOrGeneProduct	CK18	3875
10783	26270232	845	871	GeneOrGeneProduct	proinflammatory chemokines	3576,6347,6348,6351,6352,6374
10784	26270232	873	877	GeneOrGeneProduct	CCL2	6347
10785	26270232	879	883	GeneOrGeneProduct	CCL3	6348
10786	26270232	885	889	GeneOrGeneProduct	CCL4	6351
10787	26270232	891	895	GeneOrGeneProduct	CCL5	6352
10788	26270232	897	902	GeneOrGeneProduct	CXCL5	6374
10789	26270232	907	911	GeneOrGeneProduct	IL-8	3576
10790	26270232	1068	1076	OrganismTaxon	Patients	9606
10791	26270232	1082	1085	DiseaseOrPhenotypicFeature	HCC	D006528
10792	26270232	1103	1106	GeneOrGeneProduct	TPO	7066
10793	26270232	1111	1121	GeneOrGeneProduct	chemokines	3576,6347,6348,6351,6352,6374
10794	26270232	1138	1141	GeneOrGeneProduct	TPO	7066
10795	26270232	1143	1147	GeneOrGeneProduct	CCL4	6351
10796	26270232	1149	1153	GeneOrGeneProduct	CCL5	6352
10797	26270232	1158	1163	GeneOrGeneProduct	CXCL5	6374
10798	26270232	1175	1179	GeneOrGeneProduct	CCL2	6347
10799	26270232	1202	1211	DiseaseOrPhenotypicFeature	cirrhotic	D008103
10800	26270232	1212	1220	OrganismTaxon	patients	9606
10801	26270232	1229	1232	DiseaseOrPhenotypicFeature	HCC	D006528
10802	26270232	1352	1356	GeneOrGeneProduct	CCL4	6351
10803	26270232	1361	1365	GeneOrGeneProduct	CCL5	6352
10804	26270232	1402	1405	DiseaseOrPhenotypicFeature	HCC	D006528
10805	26270232	1423	1426	GeneOrGeneProduct	TPO	7066
10806	26270232	1431	1441	GeneOrGeneProduct	chemokines	3576,6347,6348,6351,6352,6374
10807	26270232	1494	1503	DiseaseOrPhenotypicFeature	cirrhotic	D008103
10808	26270232	1504	1512	OrganismTaxon	patients	9606
10809	26270232	1560	1572	DiseaseOrPhenotypicFeature	inflammatory	D007249
10810	26270232	1573	1583	GeneOrGeneProduct	chemokines	3576,6347,6348,6351,6352,6374
10811	26270232	1592	1596	GeneOrGeneProduct	CCL4	6351
10812	26270232	1601	1605	GeneOrGeneProduct	CCL5	6352
10813	26270232	1622	1631	DiseaseOrPhenotypicFeature	cirrhotic	D008103
10814	26270232	1632	1640	OrganismTaxon	patients	9606
10815	26270232	1666	1669	DiseaseOrPhenotypicFeature	HCC	D006528
10816	26411452	9	24	DiseaseOrPhenotypicFeature	Prostate Cancer	D011471
10817	26411452	40	57	GeneOrGeneProduct	Androgen Receptor	367
10818	26411452	78	90	GeneOrGeneProduct	Melanophilin	79083
10819	26411452	135	152	GeneOrGeneProduct	Androgen Receptor	367
10820	26411452	288	303	DiseaseOrPhenotypicFeature	prostate cancer	D011471
10821	26411452	305	308	DiseaseOrPhenotypicFeature	PCa	D011471
10822	26411452	484	491	GeneOrGeneProduct	TMPRSS2	7113
10823	26411452	492	495	GeneOrGeneProduct	ERG	2078
10824	26411452	524	529	CellLine	DUCaP	9606
10825	26411452	550	553	DiseaseOrPhenotypicFeature	PCa	D011471
10826	26411452	640	657	GeneOrGeneProduct	androgen receptor	367
10827	26411452	673	675	GeneOrGeneProduct	AR	367
10828	26411452	763	765	GeneOrGeneProduct	AR	367
10829	26411452	780	790	SequenceVariant	rs11891426	rs11891426
10830	26411452	791	794	SequenceVariant	T>G	rs11891426
10831	26411452	815	827	GeneOrGeneProduct	melanophilin	79083
10832	26411452	834	838	GeneOrGeneProduct	MLPH	79083
10833	26411452	878	880	GeneOrGeneProduct	AR	367
10834	26411452	947	955	ChemicalEntity	androgen	D000728
10835	26411452	977	980	SequenceVariant	T>G	rs11891426
10836	26411452	1037	1039	GeneOrGeneProduct	AR	367
10837	26411452	1048	1050	GeneOrGeneProduct	AR	367
10838	26411452	1090	1094	GeneOrGeneProduct	MLPH	79083
10839	26411452	1106	1121	DiseaseOrPhenotypicFeature	prostate tumors	D011471
10840	26411452	1227	1229	GeneOrGeneProduct	AR	367
10841	26411452	1246	1258	GeneOrGeneProduct	melanophilin	79083
10842	26411452	1287	1295	OrganismTaxon	patients	9606
10843	26411452	1313	1316	DiseaseOrPhenotypicFeature	PCa	D011471
10844	26411452	1343	1348	DiseaseOrPhenotypicFeature	tumor	D009369
10845	26411452	1413	1415	GeneOrGeneProduct	AR	367
10846	26411452	1442	1445	DiseaseOrPhenotypicFeature	PCa	D011471
10847	26411452	1488	1496	ChemicalEntity	androgen	D000728
10848	26411452	1525	1529	GeneOrGeneProduct	MLPH	79083
10849	26449539	14	19	GeneOrGeneProduct	PPARa	5465
10850	26449539	66	71	OrganismTaxon	human	9606
10851	26449539	123	127	OrganismTaxon	mice	10090
10852	26449539	144	149	GeneOrGeneProduct	PPARa	19013
10853	26449539	179	184	ChemicalEntity	lipid	D008055
10854	26449539	326	331	GeneOrGeneProduct	PPARa	5465
10855	26449539	335	340	OrganismTaxon	human	9606
10856	26449539	398	403	GeneOrGeneProduct	PPARa	5465
10857	26449539	407	412	OrganismTaxon	human	9606
10858	26449539	467	472	OrganismTaxon	human	9606
10859	26449539	503	508	GeneOrGeneProduct	PPARa	5465
10860	26449539	517	524	ChemicalEntity	Wy14643	C006253
10861	26449539	567	572	GeneOrGeneProduct	PPARa	5465
10862	26449539	594	599	OrganismTaxon	human	9606
10863	26449539	610	615	OrganismTaxon	human	9606
10864	26449539	652	657	GeneOrGeneProduct	PPARa	5465
10865	26449539	666	671	GeneOrGeneProduct	PLIN2	123
10866	26449539	673	678	GeneOrGeneProduct	VLDLR	7436
10867	26449539	680	687	GeneOrGeneProduct	ANGPTL4	51129
10868	26449539	689	694	GeneOrGeneProduct	CPT1A	1374
10869	26449539	699	703	GeneOrGeneProduct	PDK4	5166
10870	26449539	728	733	GeneOrGeneProduct	PPARa	5465
10871	26449539	849	854	GeneOrGeneProduct	PPARa	5465
10872	26449539	906	911	GeneOrGeneProduct	PPARa	5465
10873	26449539	940	945	ChemicalEntity	lipid	D008055
10874	26449539	958	963	GeneOrGeneProduct	ACSL5	51703
10875	26449539	965	971	GeneOrGeneProduct	AGPAT9	84803
10876	26449539	973	978	GeneOrGeneProduct	FADS1	3992
10877	26449539	980	987	GeneOrGeneProduct	SLC27A4	10999
10878	26449539	1013	1016	GeneOrGeneProduct	POR	5447
10879	26449539	1018	1023	GeneOrGeneProduct	ABCC2	1244
10880	26449539	1025	1031	GeneOrGeneProduct	CYP3A5	1577
10881	26449539	1192	1197	GeneOrGeneProduct	PPARa	5465
10882	26449539	1222	1232	GeneOrGeneProduct	chemokines	4283,6355,6372,6376
10883	26449539	1239	1247	GeneOrGeneProduct	CXCL9-11	4283
10884	26449539	1249	1253	GeneOrGeneProduct	CCL8	6355
10885	26449539	1255	1261	GeneOrGeneProduct	CX3CL1	6376
10886	26449539	1263	1268	GeneOrGeneProduct	CXCL6	6372
10887	26449539	1271	1283	GeneOrGeneProduct	interferon g	3458
10888	26449539	1304	1310	GeneOrGeneProduct	IFITM1	8519
10889	26449539	1312	1317	GeneOrGeneProduct	IFIT1	3434
10890	26449539	1319	1324	GeneOrGeneProduct	IFIT2	3433
10891	26449539	1326	1331	GeneOrGeneProduct	IFIT3	3437
10892	26449539	1379	1383	GeneOrGeneProduct	TLR3	7098
10893	26449539	1385	1389	GeneOrGeneProduct	NOS2	4843
10894	26449539	1395	1399	GeneOrGeneProduct	LCN2	3934
10895	26449539	1445	1452	ChemicalEntity	Wy14643	C006253
10896	26449539	1461	1466	OrganismTaxon	human	9606
10897	26449539	1492	1497	OrganismTaxon	human	9606
10898	26449539	1560	1565	GeneOrGeneProduct	PPARa	5465
10899	26449539	1657	1662	GeneOrGeneProduct	PPARa	5465
10900	26449539	1703	1715	DiseaseOrPhenotypicFeature	inflammation	D007249
10901	26449539	1733	1738	OrganismTaxon	human	9606
10902	26449539	1830	1835	GeneOrGeneProduct	PPARa	5465
10903	26449539	1882	1887	GeneOrGeneProduct	PPARa	5465
10904	26449539	1910	1915	OrganismTaxon	human	9606
10905	26449539	1947	1951	GeneOrGeneProduct	TSKU	25987
10906	26449539	1953	1957	GeneOrGeneProduct	RHOF	54509
10907	26449539	1959	1963	GeneOrGeneProduct	CA12	771
10908	26449539	1968	1975	GeneOrGeneProduct	VSIG10L	147645
10909	26449539	2047	2052	OrganismTaxon	human	9606
10910	26449539	2127	2132	GeneOrGeneProduct	PPARa	5465
10911	26449539	2136	2141	OrganismTaxon	human	9606
10912	26449539	2187	2192	GeneOrGeneProduct	PPARa	5465
10913	26449539	2218	2223	ChemicalEntity	lipid	D008055
10914	26449539	2253	2258	OrganismTaxon	human	9606
10915	26449539	2309	2321	DiseaseOrPhenotypicFeature	inflammatory	D007249
10916	26449539	2332	2337	GeneOrGeneProduct	PPARa	5465
10917	26449539	2341	2346	OrganismTaxon	human	9606
10918	26449539	2401	2434	DiseaseOrPhenotypicFeature	non-alcoholic fatty liver disease	D065626
10919	26615423	16	38	GeneOrGeneProduct	centrosomal protein 55	55165
10920	26615423	84	89	DiseaseOrPhenotypicFeature	tumor	D009369
10921	26615423	102	130	DiseaseOrPhenotypicFeature	epithelial ovarian carcinoma	D000077216
10922	26615423	132	154	GeneOrGeneProduct	Centrosomal protein 55	55165
10923	26615423	156	161	GeneOrGeneProduct	CEP55	55165
10924	26615423	226	233	DiseaseOrPhenotypicFeature	cancers	D009369
10925	26615423	263	268	GeneOrGeneProduct	CEP55	55165
10926	26615423	336	341	OrganismTaxon	human	9606
10927	26615423	342	370	DiseaseOrPhenotypicFeature	epithelial ovarian carcinoma	D000077216
10928	26615423	372	375	DiseaseOrPhenotypicFeature	EOC	D000077216
10929	26615423	460	465	GeneOrGeneProduct	CEP55	55165
10930	26615423	469	477	OrganismTaxon	patients	9606
10931	26615423	483	486	DiseaseOrPhenotypicFeature	EOC	D000077216
10932	26615423	527	548	DiseaseOrPhenotypicFeature	metastasis of ovarian	D010051
10933	26615423	561	566	GeneOrGeneProduct	CEP55	55165
10934	26615423	733	738	GeneOrGeneProduct	CEP55	55165
10935	26615423	786	793	OrganismTaxon	patient	9606
10936	26615423	819	824	GeneOrGeneProduct	CEP55	55165
10937	26615423	981	986	GeneOrGeneProduct	CEP55	55165
10938	26615423	1020	1034	DiseaseOrPhenotypicFeature	ovarian cancer	D010051
10939	26615423	1139	1142	DiseaseOrPhenotypicFeature	EOC	D000077216
10940	26615423	1152	1157	GeneOrGeneProduct	CEP55	55165
10941	26615423	1233	1254	DiseaseOrPhenotypicFeature	lymph node metastasis	D008207
10942	26615423	1268	1294	DiseaseOrPhenotypicFeature	intraperitoneal metastasis	D009362
10943	26615423	1308	1313	DiseaseOrPhenotypicFeature	tumor	D009369
10944	26615423	1382	1387	DiseaseOrPhenotypicFeature	tumor	D009369
10945	26615423	1406	1413	DiseaseOrPhenotypicFeature	ascites	D001201
10946	26615423	1418	1423	DiseaseOrPhenotypicFeature	tumor	D009369
10947	26615423	1453	1458	GeneOrGeneProduct	CA153	4582
10948	26615423	1488	1496	OrganismTaxon	patients	9606
10949	26615423	1511	1516	GeneOrGeneProduct	CEP55	55165
10950	26615423	1725	1732	OrganismTaxon	patient	9606
10951	26615423	1766	1771	GeneOrGeneProduct	CA125	94025
10952	26615423	1773	1778	GeneOrGeneProduct	CA199	94025
10953	26615423	1780	1785	GeneOrGeneProduct	CA724	94025
10954	26615423	1787	1790	GeneOrGeneProduct	NSE	2026
10955	26615423	1792	1795	GeneOrGeneProduct	CEA	1084
10956	26615423	1801	1806	GeneOrGeneProduct	b-HCG	93659
10957	26615423	1815	1823	OrganismTaxon	Patients	9606
10958	26615423	1834	1839	GeneOrGeneProduct	CEP55	55165
10959	26615423	1943	1948	GeneOrGeneProduct	CEP55	55165
10960	26615423	1994	1999	GeneOrGeneProduct	CEP55	55165
10961	26615423	2043	2046	DiseaseOrPhenotypicFeature	EOC	D000077216
10962	26615423	2047	2055	OrganismTaxon	patients	9606
10963	26615423	2089	2094	GeneOrGeneProduct	CEP55	55165
10964	26615423	2098	2112	DiseaseOrPhenotypicFeature	ovarian cancer	D010051
10965	26615423	2181	2186	GeneOrGeneProduct	CEP55	55165
10966	26615423	2243	2246	DiseaseOrPhenotypicFeature	EOC	D000077216
10967	26615423	2247	2255	OrganismTaxon	patients	9606
10968	26615423	2309	2323	DiseaseOrPhenotypicFeature	ovarian cancer	D010051
10969	26615423	2337	2342	GeneOrGeneProduct	CEP55	55165
10970	26615423	2403	2406	DiseaseOrPhenotypicFeature	EOC	D000077216
10971	26684240	22	26	GeneOrGeneProduct	BRAF	673
10972	26684240	27	32	SequenceVariant	V600E	rs113488022
10973	26684240	45	89	DiseaseOrPhenotypicFeature	gastroenteropancreatic neuroendocrine tumors	C535650
10974	26684240	111	155	DiseaseOrPhenotypicFeature	gastroenteropancreatic neuroendocrine tumors	C535650
10975	26684240	157	165	DiseaseOrPhenotypicFeature	GEP-NETs	C535650
10976	26684240	334	342	DiseaseOrPhenotypicFeature	GEP-NETs	C535650
10977	26684240	348	356	OrganismTaxon	patients	9606
10978	26684240	433	442	ChemicalEntity	pazopanib	C516667
10979	26684240	536	550	DiseaseOrPhenotypicFeature	intestine NETs	D007414
10980	26684240	652	660	DiseaseOrPhenotypicFeature	GEP-NETs	C535650
10981	26684240	702	708	DiseaseOrPhenotypicFeature	cancer	D009369
10982	26684240	733	737	GeneOrGeneProduct	TP53	7157
10983	26684240	739	744	GeneOrGeneProduct	CNBD1	168975
10984	26684240	746	749	GeneOrGeneProduct	RB1	5925
10985	26684240	751	754	GeneOrGeneProduct	APC	324
10986	26684240	756	760	GeneOrGeneProduct	BCOR	54880
10987	26684240	762	766	GeneOrGeneProduct	BRAF	673
10988	26684240	768	774	GeneOrGeneProduct	CTNNB1	1499
10989	26684240	776	780	GeneOrGeneProduct	EGFR	1956
10990	26684240	782	787	GeneOrGeneProduct	EP300	2033
10991	26684240	789	794	GeneOrGeneProduct	ERBB3	2065
10992	26684240	796	801	GeneOrGeneProduct	KDM6A	7403
10993	26684240	803	807	GeneOrGeneProduct	KRAS	3845
10994	26684240	809	812	GeneOrGeneProduct	MGA	23269
10995	26684240	814	818	GeneOrGeneProduct	MLL3	58508
10996	26684240	820	824	GeneOrGeneProduct	PTEN	5728
10997	26684240	826	831	GeneOrGeneProduct	RASA1	5921
10998	26684240	833	840	GeneOrGeneProduct	SMARCB1	6598
10999	26684240	842	846	GeneOrGeneProduct	SPEN	23013
11000	26684240	848	855	GeneOrGeneProduct	TBC1D12	23232
11001	26684240	861	864	GeneOrGeneProduct	VHL	7428
11002	26684240	866	870	GeneOrGeneProduct	TP53	7157
11003	26684240	919	924	GeneOrGeneProduct	CNBD1	168975
11004	26684240	929	932	GeneOrGeneProduct	RB1	5925
11005	26684240	979	986	DiseaseOrPhenotypicFeature	GEP-NET	C535650
11006	26684240	987	995	OrganismTaxon	patients	9606
11007	26684240	1001	1005	GeneOrGeneProduct	TP53	7157
11008	26684240	1062	1088	DiseaseOrPhenotypicFeature	intestinal grade (G) 1 NET	D007414
11009	26684240	1089	1096	OrganismTaxon	patient	9606
11010	26684240	1102	1106	GeneOrGeneProduct	BRAF	673
11011	26684240	1107	1112	SequenceVariant	V600E	rs113488022
11012	26684240	1147	1156	ChemicalEntity	pazopanib	C516667
11013	26684240	1177	1181	GeneOrGeneProduct	BRAF	673
11014	26684240	1182	1187	SequenceVariant	V600E	rs113488022
11015	26684240	1192	1195	DiseaseOrPhenotypicFeature	NET	D018358
11016	26684240	1219	1223	DiseaseOrPhenotypicFeature	NETs	D018358
11017	26684240	1240	1244	GeneOrGeneProduct	BRAF	673
11018	26684240	1245	1250	SequenceVariant	G593S	p.G593S
11019	26684240	1255	1258	DiseaseOrPhenotypicFeature	NET	D018358
11020	26684240	1331	1339	DiseaseOrPhenotypicFeature	GEP-NETs	C535650
11021	26684240	1487	1492	DiseaseOrPhenotypicFeature	tumor	D009369
11022	26684240	1553	1557	GeneOrGeneProduct	BRAF	673
11023	26684240	1558	1563	SequenceVariant	V600E	rs113488022
11024	26684240	1610	1619	ChemicalEntity	pazopanib	C516667
11025	26684240	1681	1689	DiseaseOrPhenotypicFeature	GEP-NETs	C535650
11026	26684240	1690	1698	OrganismTaxon	patients	9606
11027	26847345	0	10	GeneOrGeneProduct	Transgelin	6876
11028	26847345	45	62	DiseaseOrPhenotypicFeature	colorectal cancer	D015179
11029	26847345	147	157	GeneOrGeneProduct	Transgelin	6876
11030	26847345	164	185	GeneOrGeneProduct	actin-binding protein	21345,6876
11031	26847345	247	257	GeneOrGeneProduct	transgelin	6876
11032	26847345	261	267	DiseaseOrPhenotypicFeature	cancer	D009369
11033	26847345	364	369	DiseaseOrPhenotypicFeature	tumor	D009369
11034	26847345	456	466	GeneOrGeneProduct	transgelin	6876
11035	26847345	533	543	GeneOrGeneProduct	transgelin	6876
11036	26847345	554	571	DiseaseOrPhenotypicFeature	colorectal cancer	D015179
11037	26847345	573	576	DiseaseOrPhenotypicFeature	CRC	D015179
11038	26847345	650	653	DiseaseOrPhenotypicFeature	CRC	D015179
11039	26847345	680	690	GeneOrGeneProduct	transgelin	6876
11040	26847345	776	781	OrganismTaxon	mouse	10090
11041	26847345	848	858	GeneOrGeneProduct	transgelin	6876
11042	26847345	977	987	GeneOrGeneProduct	transgelin	6876
11043	26847345	991	994	CellLine	RKO	9606
11044	26847345	1180	1195	DiseaseOrPhenotypicFeature	lung metastases	D008175
11045	26847345	1203	1208	OrganismTaxon	mouse	10090
11046	26847345	1262	1272	GeneOrGeneProduct	transgelin	6876
11047	26847345	1287	1293	CellLine	HCT116	9606
11048	26847345	1346	1356	DiseaseOrPhenotypicFeature	metastases	D009362
11049	26847345	1430	1440	GeneOrGeneProduct	transgelin	6876
11050	26847345	1573	1578	GeneOrGeneProduct	actin	60
11051	26847345	1588	1609	GeneOrGeneProduct	cytoskeletal proteins	51361,55740,6876,7145
11052	26847345	1641	1646	GeneOrGeneProduct	HOOK1	51361
11053	26847345	1648	1655	GeneOrGeneProduct	SDCCAG8	10806
11054	26847345	1657	1661	GeneOrGeneProduct	ENAH	55740
11055	26847345	1662	1666	GeneOrGeneProduct	Mena	55740
11056	26847345	1672	1676	GeneOrGeneProduct	TNS1	7145
11057	26847345	1694	1697	GeneOrGeneProduct	EMB	133418
11058	26847345	1699	1705	GeneOrGeneProduct	BCL11B	64919
11059	26847345	1711	1716	GeneOrGeneProduct	PTPRD	5789
11060	26847345	1757	1767	GeneOrGeneProduct	transgelin	6876
11061	26847345	1802	1807	DiseaseOrPhenotypicFeature	tumor	D009369
11062	26900322	0	3	GeneOrGeneProduct	CFI	3426
11063	26900322	4	13	SequenceVariant	rs7356506	rs7356506
11064	26900322	44	73	DiseaseOrPhenotypicFeature	Vogt-Koyanagi-Harada syndrome	D014607
11065	26900322	84	103	GeneOrGeneProduct	Complement factor I	3426
11066	26900322	105	108	GeneOrGeneProduct	CFI	3426
11067	26900322	210	217	DiseaseOrPhenotypicFeature	uveitis	D014605
11068	26900322	306	309	GeneOrGeneProduct	CFI	3426
11069	26900322	336	371	DiseaseOrPhenotypicFeature	Vogt-Koyanagi-Harada (VKH) syndrome	D014607
11070	26900322	397	405	OrganismTaxon	patients	9606
11071	26900322	421	433	DiseaseOrPhenotypicFeature	VKH syndrome	D014607
11072	26900322	575	578	GeneOrGeneProduct	CFI	3426
11073	26900322	579	588	SequenceVariant	rs7356506	rs7356506
11074	26900322	709	717	OrganismTaxon	patients	9606
11075	26900322	813	821	DiseaseOrPhenotypicFeature	cataract	D002386
11076	26900322	834	841	ChemicalEntity	steroid	D013256
11077	26900322	914	917	GeneOrGeneProduct	CFI	3426
11078	26900322	918	927	SequenceVariant	rs7356506	rs7356506
11079	26900322	946	958	DiseaseOrPhenotypicFeature	VKH syndrome	D014607
11080	26900322	969	977	OrganismTaxon	patients	9606
11081	26900322	993	1005	DiseaseOrPhenotypicFeature	VKH syndrome	D014607
11082	26900322	1067	1070	GeneOrGeneProduct	CFI	3426
11083	26900322	1071	1080	SequenceVariant	rs7356506	rs7356506
11084	26900322	1344	1347	GeneOrGeneProduct	CFI	3426
11085	26900322	1348	1357	SequenceVariant	rs7356506	rs7356506
11086	26900322	1361	1369	OrganismTaxon	patients	9606
11087	26900322	1375	1387	DiseaseOrPhenotypicFeature	VKH syndrome	D014607
11088	26900322	1405	1413	DiseaseOrPhenotypicFeature	cataract	D002386
11089	26900322	1579	1587	OrganismTaxon	patients	9606
11090	26900322	1593	1605	DiseaseOrPhenotypicFeature	VKH syndrome	D014607
11091	26900322	1609	1616	ChemicalEntity	steroid	D013256
11092	26900322	1653	1656	GeneOrGeneProduct	CFI	3426
11093	26900322	1657	1666	SequenceVariant	rs7356506	rs7356506
11094	26900322	1721	1724	GeneOrGeneProduct	CFI	3426
11095	26900322	1777	1789	DiseaseOrPhenotypicFeature	VKH syndrome	D014607
11096	26900322	1850	1853	GeneOrGeneProduct	CFI	3426
11097	26900322	1854	1861	SequenceVariant	7356506	rs7356506
11098	26900322	1867	1879	DiseaseOrPhenotypicFeature	VKH syndrome	D014607
11099	26900322	1937	1945	DiseaseOrPhenotypicFeature	cataract	D002386
11100	26900322	1968	1975	ChemicalEntity	steroid	D013256
11101	26937641	0	15	GeneOrGeneProduct	Serum Amyloid A	20208,20210,6288
11102	26937641	104	119	GeneOrGeneProduct	Serum amyloid A	20208,20210,6288
11103	26937641	121	124	GeneOrGeneProduct	SAA	20208,20210,6288
11104	26937641	250	279	DiseaseOrPhenotypicFeature	liver injury and fibrogenesis	D008107
11105	26937641	356	359	GeneOrGeneProduct	SAA	20208,20210,6288
11106	26937641	438	453	GeneOrGeneProduct	Serum amyloid A	20208,20210,6288
11107	26937641	473	487	GeneOrGeneProduct	IkappaB kinase	84351,9641
11108	26937641	489	512	GeneOrGeneProduct	c-Jun N-terminal kinase	116554,5599
11109	26937641	514	517	GeneOrGeneProduct	JNK	116554,5599
11110	26937641	520	523	GeneOrGeneProduct	Erk	116590,5594
11111	26937641	528	531	GeneOrGeneProduct	Akt	207,24185
11112	26937641	545	554	GeneOrGeneProduct	NF-kappaB	4790,81736
11113	26937641	596	601	OrganismTaxon	human	9606
11114	26937641	606	609	OrganismTaxon	rat	10116
11115	26937641	616	631	GeneOrGeneProduct	Serum amyloid A	20208,20210,6288
11116	26937641	661	666	GeneOrGeneProduct	MCP-1	24770,6347
11117	26937641	668	674	GeneOrGeneProduct	RANTES	6352,81780
11118	26937641	679	683	GeneOrGeneProduct	MMP9	4318,81687
11119	26937641	690	699	GeneOrGeneProduct	NF-kappaB	4790,81736
11120	26937641	705	708	GeneOrGeneProduct	JNK	116554,5599
11121	26937641	739	748	GeneOrGeneProduct	NF-kappaB	4790,81736
11122	26937641	758	767	DiseaseOrPhenotypicFeature	cytotoxic	D064420
11123	26937641	779	782	GeneOrGeneProduct	SAA	20208,20210,6288
11124	26937641	831	840	GeneOrGeneProduct	caspase 3	25402,836
11125	26937641	845	849	GeneOrGeneProduct	PARP	142,25591
11126	26937641	863	872	GeneOrGeneProduct	Annexin V	25673,308
11127	26937641	883	898	GeneOrGeneProduct	Serum amyloid A	20208,20210,6288
11128	26937641	944	947	GeneOrGeneProduct	JNK	116554,5599
11129	26937641	949	952	GeneOrGeneProduct	Erk	116590,5594
11130	26937641	957	960	GeneOrGeneProduct	Akt	207,24185
11131	26937641	995	998	GeneOrGeneProduct	SAA	20208,20210,6288
11132	26937641	1014	1026	GeneOrGeneProduct	MAP kinases,	116554,116590,207,24185,5594,5599
11133	26937641	1072	1081	GeneOrGeneProduct	NF-kappaB	4790,81736
11134	26937641	1111	1131	DiseaseOrPhenotypicFeature	hepatic fibrogenesis	D008107
11135	26937641	1133	1137	GeneOrGeneProduct	CCl4	6351
11136	26937641	1195	1199	GeneOrGeneProduct	SAA1	20208
11137	26937641	1204	1208	GeneOrGeneProduct	SAA3	20210
11138	26937641	1249	1252	GeneOrGeneProduct	SAA	20208,20210,6288
11139	26991973	0	4	GeneOrGeneProduct	MOL1	835209
11140	26991973	44	55	OrganismTaxon	Arabidopsis	3702
11141	26991973	276	287	GeneOrGeneProduct	CLE peptide	820713,821957,832170
11142	26991973	292	332	GeneOrGeneProduct	leucine-rich repeat receptor-like kinase	835209,836269
11143	26991973	334	341	GeneOrGeneProduct	LRR-RLK	835209,836269
11144	26991973	505	512	GeneOrGeneProduct	LRR-RLK	835209,836269
11145	26991973	513	517	GeneOrGeneProduct	MOL1	835209
11146	26991973	558	578	OrganismTaxon	Arabidopsis thaliana	3702
11147	26991973	633	637	GeneOrGeneProduct	MOL1	835209
11148	26991973	718	723	GeneOrGeneProduct	CLE41	822075
11149	26991973	724	727	GeneOrGeneProduct	PXY	836269
11150	26991973	774	778	GeneOrGeneProduct	MOL1	835209
11151	26991973	813	818	GeneOrGeneProduct	CLE41	822075
11152	26991973	819	822	GeneOrGeneProduct	PXY	836269
11153	26991973	871	875	GeneOrGeneProduct	MOL1	835209
11154	26991973	964	968	GeneOrGeneProduct	MOL1	835209
11155	26991973	973	976	GeneOrGeneProduct	PXY	836269
11156	26991973	983	991	GeneOrGeneProduct	LRR-RLKs	835209,836269
11157	26991973	1088	1092	GeneOrGeneProduct	MOL1	835209
11158	26991973	1101	1104	GeneOrGeneProduct	PXY	836269
11159	26991973	1123	1127	GeneOrGeneProduct	CLV1	843915
11160	26991973	1207	1211	GeneOrGeneProduct	mol1	835209
11161	26991973	1241	1245	GeneOrGeneProduct	MOL1	835209
11162	26991973	1293	1301	ChemicalEntity	ethylene	D005030
11163	26991973	1306	1319	ChemicalEntity	jasmonic acid	C011006
11164	26991973	1408	1419	OrganismTaxon	Arabidopsis	3702
11165	27084744	0	6	GeneOrGeneProduct	NOTCH1	4851
11166	27084744	11	16	GeneOrGeneProduct	SOX10	6663
11167	27084744	77	83	DiseaseOrPhenotypicFeature	Cancer	D009369
11168	27084744	103	127	DiseaseOrPhenotypicFeature	Adenoid Cystic Carcinoma	D003528
11169	27084744	164	170	DiseaseOrPhenotypicFeature	cancer	D009369
11170	27084744	191	215	DiseaseOrPhenotypicFeature	adenoid cystic carcinoma	D003528
11171	27084744	217	220	DiseaseOrPhenotypicFeature	ACC	D003528
11172	27084744	390	393	DiseaseOrPhenotypicFeature	ACC	D003528
11173	27084744	511	514	DiseaseOrPhenotypicFeature	ACC	D003528
11174	27084744	546	550	GeneOrGeneProduct	ROCK	6093
11175	27084744	707	710	DiseaseOrPhenotypicFeature	ACC	D003528
11176	27084744	711	716	GeneOrGeneProduct	CD133	8842
11177	27084744	745	751	GeneOrGeneProduct	NOTCH1	4851
11178	27084744	756	761	GeneOrGeneProduct	SOX10	6663
11179	27084744	795	801	DiseaseOrPhenotypicFeature	tumors	D009369
11180	27084744	810	814	OrganismTaxon	mice	10090
11181	27084744	816	821	GeneOrGeneProduct	CD133	8842
11182	27084744	824	827	DiseaseOrPhenotypicFeature	ACC	D003528
11183	27084744	853	859	GeneOrGeneProduct	NOTCH1	4851
11184	27084744	861	866	GeneOrGeneProduct	N1ICD	4851
11185	27084744	882	887	GeneOrGeneProduct	CD133	8842
11186	27084744	911	915	GeneOrGeneProduct	JAG1	182
11187	27084744	958	963	GeneOrGeneProduct	NR2F1	7025
11188	27084744	965	970	GeneOrGeneProduct	NR2F2	7026
11189	27084744	976	983	GeneOrGeneProduct	p27Kip1	1027
11190	27084744	999	1005	GeneOrGeneProduct	NOTCH1	4851
11191	27084744	1007	1012	GeneOrGeneProduct	SOX10	6663
11192	27084744	1040	1045	GeneOrGeneProduct	FABP7	2173
11193	27084744	1209	1214	GeneOrGeneProduct	FABP7	2173
11194	27084744	1366	1372	GeneOrGeneProduct	NOTCH1	4851
11195	27084744	1373	1378	GeneOrGeneProduct	FABP7	2173
11196	27084744	1402	1406	GeneOrGeneProduct	SKP2	6502
11197	27084744	1425	1432	GeneOrGeneProduct	p27Kip1	1027
11198	27084744	1436	1447	GeneOrGeneProduct	g-secretase	55851
11199	27084744	1459	1463	ChemicalEntity	DAPT	C419410
11200	27084744	1486	1491	GeneOrGeneProduct	CD133	8842
11201	27084744	1512	1517	GeneOrGeneProduct	N1ICD	4851
11202	27084744	1522	1526	GeneOrGeneProduct	SKP2	6502
11203	27084744	1536	1543	GeneOrGeneProduct	p27Kip1	1027
11204	27084744	1555	1558	DiseaseOrPhenotypicFeature	ACC	D003528
11205	27084744	1589	1594	GeneOrGeneProduct	CD133	8842
11206	27084744	1673	1676	DiseaseOrPhenotypicFeature	ACC	D003528
11207	27084744	1736	1741	GeneOrGeneProduct	CD133	8842
11208	27084744	1799	1804	GeneOrGeneProduct	SOX10	6663
11209	27084744	1806	1812	GeneOrGeneProduct	NOTCH1	4851
11210	27084744	1818	1823	GeneOrGeneProduct	FABP7	2173
11211	27084744	1855	1860	GeneOrGeneProduct	Notch	4851
11212	27084744	1896	1900	GeneOrGeneProduct	SKP2	6502
11213	27084744	1938	1941	DiseaseOrPhenotypicFeature	ACC	D003528
11214	27090298	12	31	GeneOrGeneProduct	Fatty Acid Synthase	2194
11215	27090298	44	49	OrganismTaxon	women	9606
11216	27090298	138	142	GeneOrGeneProduct	FASN	2194
11217	27090298	144	163	GeneOrGeneProduct	fatty acid synthase	2194
11218	27090298	193	205	DiseaseOrPhenotypicFeature	hypertension	D006973
11219	27090298	210	231	DiseaseOrPhenotypicFeature	metabolic dysfunction	D008659
11220	27090298	233	237	GeneOrGeneProduct	FASN	2194
11221	27090298	265	270	OrganismTaxon	human	9606
11222	27090298	334	338	GeneOrGeneProduct	FASN	2194
11223	27090298	427	432	OrganismTaxon	women	9606
11224	27090298	446	450	GeneOrGeneProduct	FASN	2194
11225	27090298	493	498	OrganismTaxon	women	9606
11226	27090298	547	556	ChemicalEntity	C-peptide	D002096
11227	27090298	566	573	ChemicalEntity	glucose	D005947
11228	27090298	578	585	GeneOrGeneProduct	insulin	3630
11229	27090298	597	604	ChemicalEntity	glucose	D005947
11230	27090298	605	611	ChemicalEntity	lipids	D008055
11231	27090298	613	616	GeneOrGeneProduct	HMW	57587
11232	27090298	617	628	GeneOrGeneProduct	adiponectin	9370
11233	27090298	753	757	GeneOrGeneProduct	FASN	2194
11234	27090298	834	838	GeneOrGeneProduct	FASN	2194
11235	27090298	954	961	ChemicalEntity	glucose	D005947
11236	27090298	966	973	GeneOrGeneProduct	insulin	3630
11237	27090298	985	992	ChemicalEntity	glucose	D005947
11238	27090298	994	999	GeneOrGeneProduct	HbAc1	3043
11239	27090298	1013	1022	ChemicalEntity	C-peptide	D002096
11240	27090298	1106	1110	GeneOrGeneProduct	FASN	2194
11241	27090298	1156	1160	GeneOrGeneProduct	FASN	2194
11242	27090298	1279	1283	GeneOrGeneProduct	FASN	2194
11243	27090298	1287	1292	OrganismTaxon	human	9606
11244	27090298	1352	1356	GeneOrGeneProduct	FASN	2194
11245	27090298	1494	1501	GeneOrGeneProduct	insulin	3630
11246	27103577	23	28	GeneOrGeneProduct	PPARa	19013
11247	27103577	59	66	DiseaseOrPhenotypicFeature	hypoxia	D000860
11248	27103577	101	108	DiseaseOrPhenotypicFeature	hypoxic	D000860
11249	27103577	129	173	GeneOrGeneProduct	peroxisome proliferator-activated receptor a	19013
11250	27103577	175	180	GeneOrGeneProduct	PPARa	19013
11251	27103577	237	244	DiseaseOrPhenotypicFeature	hypoxia	D000860
11252	27103577	274	278	OrganismTaxon	mice	10090
11253	27103577	294	301	DiseaseOrPhenotypicFeature	hypoxia	D000860
11254	27103577	501	511	ChemicalEntity	fatty acid	D005227
11255	27103577	543	547	ChemicalEntity	(3)H	D014316
11256	27103577	602	607	OrganismTaxon	mouse	10090
11257	27103577	615	622	DiseaseOrPhenotypicFeature	hypoxia	D000860
11258	27103577	633	638	GeneOrGeneProduct	PPARa	19013
11259	27103577	651	661	ChemicalEntity	fatty acid	D005227
11260	27103577	677	711	GeneOrGeneProduct	mitochondrial uncoupling protein 3	22229
11261	27103577	713	717	GeneOrGeneProduct	UCP3	22229
11262	27103577	795	798	ChemicalEntity	ATP	D000255
11263	27103577	816	819	ChemicalEntity	ATP	D000255
11264	27103577	889	894	GeneOrGeneProduct	PPARa	19013
11265	27103577	907	917	ChemicalEntity	fatty acid	D005227
11266	27103577	933	937	GeneOrGeneProduct	UCP3	22229
11267	27103577	972	979	DiseaseOrPhenotypicFeature	Hypoxia	D000860
11268	27103577	1009	1014	GeneOrGeneProduct	PPARa	19013
11269	27103577	1110	1113	ChemicalEntity	ATP	D000255
11270	27103577	1206	1213	DiseaseOrPhenotypicFeature	hypoxia	D000860
11271	27103577	1225	1230	OrganismTaxon	mouse	10090
11272	27103577	1277	1282	GeneOrGeneProduct	PPARa	19013
11273	27103577	1294	1299	GeneOrGeneProduct	PPARa	19013
11274	27103577	1306	1311	OrganismTaxon	mouse	10090
11275	27103577	1345	1352	DiseaseOrPhenotypicFeature	hypoxia	D000860
11276	27103577	1443	1448	GeneOrGeneProduct	PPARa	19013
11277	27103577	1510	1517	DiseaseOrPhenotypicFeature	hypoxia	D000860
11278	27103577	1875	1880	GeneOrGeneProduct	PPARa	19013
11279	27103577	1911	1918	DiseaseOrPhenotypicFeature	hypoxia	D000860
11280	27103577	1953	1960	DiseaseOrPhenotypicFeature	hypoxic	D000860
11281	27172902	0	9	ChemicalEntity	Cisplatin	D002945
11282	27172902	61	64	GeneOrGeneProduct	TLR	13982
11283	27172902	105	110	GeneOrGeneProduct	IL-10	16153
11284	27172902	203	212	ChemicalEntity	cisplatin	D002945
11285	27172902	214	242	ChemicalEntity	cis-diamminedichloroplatinum	D002945
11286	27172902	249	253	ChemicalEntity	CDDP	D002945
11287	27172902	277	283	DiseaseOrPhenotypicFeature	cancer	D009369
11288	27172902	323	332	ChemicalEntity	cisplatin	D002945
11289	27172902	462	471	ChemicalEntity	cisplatin	D002945
11290	27172902	553	571	GeneOrGeneProduct	toll-like receptor	13982
11291	27172902	573	576	GeneOrGeneProduct	TLR	13982
11292	27172902	591	600	ChemicalEntity	Cisplatin	D002945
11293	27172902	670	674	GeneOrGeneProduct	CD80	12519
11294	27172902	676	680	GeneOrGeneProduct	CD86	12524
11295	27172902	682	700	GeneOrGeneProduct	MHC class I and II	14961,14972
11296	27172902	796	799	GeneOrGeneProduct	TLR	13982
11297	27172902	810	819	ChemicalEntity	cisplatin	D002945
11298	27172902	858	863	GeneOrGeneProduct	IL-10	16153
11299	27172902	901	909	GeneOrGeneProduct	p38 MAPK	26416
11300	27172902	914	923	GeneOrGeneProduct	NF-kappaB	18033
11301	27172902	974	983	GeneOrGeneProduct	TNF-alpha	21926
11302	27172902	988	996	GeneOrGeneProduct	IL-12p70	16185
11303	27172902	1013	1022	ChemicalEntity	cisplatin	D002945
11304	27172902	1109	1114	GeneOrGeneProduct	IL-10	16153
11305	27172902	1154	1159	GeneOrGeneProduct	IL-10	16153
11306	27172902	1163	1167	OrganismTaxon	mice	10090
11307	27172902	1172	1177	GeneOrGeneProduct	IL-10	16153
11308	27172902	1266	1275	ChemicalEntity	cisplatin	D002945
11309	27172902	1280	1298	ChemicalEntity	lipopolysaccharide	D008070
11310	27172902	1300	1303	ChemicalEntity	LPS	D008070
11311	27172902	1562	1567	GeneOrGeneProduct	IL-10	16153
11312	27172902	1578	1581	GeneOrGeneProduct	CD3	12501
11313	27172902	1582	1585	GeneOrGeneProduct	CD4	12504
11314	27172902	1586	1591	GeneOrGeneProduct	LAG-3	16768
11315	27172902	1592	1597	GeneOrGeneProduct	CD49b	16398
11316	27172902	1598	1602	GeneOrGeneProduct	CD25	16184
11317	27172902	1603	1608	GeneOrGeneProduct	Foxp3	20371
11318	27172902	1675	1680	GeneOrGeneProduct	Foxp3	20371
11319	27172902	1753	1762	ChemicalEntity	cisplatin	D002945
11320	27172902	1809	1820	ChemicalEntity	TLR agonist	-
11321	27172902	1829	1841	DiseaseOrPhenotypicFeature	inflammatory	D007249
11322	27172902	1866	1871	GeneOrGeneProduct	IL-10	16153
11323	27172902	1981	1987	DiseaseOrPhenotypicFeature	cancer	D009369
11324	27184800	0	17	GeneOrGeneProduct	Metallothionein-1	4495
11325	27184800	64	88	DiseaseOrPhenotypicFeature	hepatocellular carcinoma	D006528
11326	27184800	106	115	ChemicalEntity	sorafenib	D000077157
11327	27184800	129	138	ChemicalEntity	Sorafenib	D000077157
11328	27184800	188	195	DiseaseOrPhenotypicFeature	tumours	D009369
11329	27184800	263	271	DiseaseOrPhenotypicFeature	necrosis	D009336
11330	27184800	281	287	DiseaseOrPhenotypicFeature	cancer	D009369
11331	27184800	355	364	ChemicalEntity	sorafenib	D000077157
11332	27184800	392	398	DiseaseOrPhenotypicFeature	cancer	D009369
11333	27184800	611	617	DiseaseOrPhenotypicFeature	cancer	D009369
11334	27184800	627	636	ChemicalEntity	sorafenib	D000077157
11335	27184800	638	644	DiseaseOrPhenotypicFeature	Tumour	D009369
11336	27184800	677	701	DiseaseOrPhenotypicFeature	hepatocellular carcinoma	D006528
11337	27184800	703	706	DiseaseOrPhenotypicFeature	HCC	D006528
11338	27184800	748	751	DiseaseOrPhenotypicFeature	HCC	D006528
11339	27184800	752	760	OrganismTaxon	patients	9606
11340	27184800	771	780	ChemicalEntity	sorafenib	D000077157
11341	27184800	836	853	GeneOrGeneProduct	metallothionein-1	4495
11342	27184800	855	858	GeneOrGeneProduct	MT1	4495
11343	27184800	886	889	DiseaseOrPhenotypicFeature	HCC	D006528
11344	27184800	900	904	CellLine	Huh7	9606
11345	27184800	916	925	ChemicalEntity	sorafenib	D000077157
11346	27184800	927	936	ChemicalEntity	Sorafenib	D000077157
11347	27184800	965	969	GeneOrGeneProduct	MT1G	4495
11348	27184800	989	994	OrganismTaxon	human	9606
11349	27184800	995	1001	DiseaseOrPhenotypicFeature	cancer	D009369
11350	27184800	1137	1141	GeneOrGeneProduct	MT1G	4495
11351	27184800	1180	1189	ChemicalEntity	sorafenib	D000077157
11352	27184800	1324	1328	GeneOrGeneProduct	NRF2	4780
11353	27184800	1330	1373	GeneOrGeneProduct	Nuclear factor erythroid 2-Related Factor 2	4780
11354	27184800	1458	1462	GeneOrGeneProduct	MT1G	4495
11355	27184800	1471	1477	DiseaseOrPhenotypicFeature	tumour	D009369
11356	27184800	1510	1513	DiseaseOrPhenotypicFeature	HCC	D006528
11357	27184800	1569	1572	GeneOrGeneProduct	MT1	4495
11358	27184800	1603	1606	DiseaseOrPhenotypicFeature	HCC	D006528
11359	27184800	1607	1615	OrganismTaxon	patients	9606
11360	27184800	1626	1635	ChemicalEntity	sorafenib	D000077157
11361	27184800	1734	1737	GeneOrGeneProduct	MT1	4495
11362	27184800	1797	1806	ChemicalEntity	sorafenib	D000077157
11363	27184800	1834	1840	DiseaseOrPhenotypicFeature	cancer	D009369
11364	27292643	23	45	DiseaseOrPhenotypicFeature	Chromosome Instability	D043171
11365	27292643	57	61	GeneOrGeneProduct	Mad2	56150
11366	27292643	83	96	DiseaseOrPhenotypicFeature	Breast Cancer	D001943
11367	27292643	144	166	DiseaseOrPhenotypicFeature	Chromosome instability	D043171
11368	27292643	168	171	DiseaseOrPhenotypicFeature	CIN	D043171
11369	27292643	245	257	DiseaseOrPhenotypicFeature	malignancies	D009369
11370	27292643	285	288	DiseaseOrPhenotypicFeature	CIN	D043171
11371	27292643	409	413	GeneOrGeneProduct	Mad2	56150
11372	27292643	419	423	GeneOrGeneProduct	Kras	16653
11373	27292643	424	428	GeneOrGeneProduct	G12D	16653
11374	27292643	433	437	GeneOrGeneProduct	Her2	13866
11375	27292643	465	469	OrganismTaxon	mice	10090
11376	27292643	530	535	DiseaseOrPhenotypicFeature	tumor	D009369
11377	27292643	619	624	DiseaseOrPhenotypicFeature	tumor	D009369
11378	27292643	713	717	GeneOrGeneProduct	Mad2	56150
11379	27292643	776	780	GeneOrGeneProduct	Kras	16653
11380	27292643	781	787	DiseaseOrPhenotypicFeature	tumors	D009369
11381	27292643	847	851	GeneOrGeneProduct	Mad2	56150
11382	27292643	861	867	DiseaseOrPhenotypicFeature	tumors	D009369
11383	27464336	50	57	ChemicalEntity	Alcohol	D000438
11384	27464336	103	107	GeneOrGeneProduct	S6K1	72508
11385	27464336	215	222	ChemicalEntity	alcohol	D000438
11386	27464336	320	333	DiseaseOrPhenotypicFeature	lipodystrophy	D008060
11387	27464336	435	442	ChemicalEntity	alcohol	D000438
11388	27464336	447	451	OrganismTaxon	mice	10090
11389	27464336	546	575	GeneOrGeneProduct	mammalian target of rapamycin	56717
11390	27464336	577	581	GeneOrGeneProduct	mTOR	56717
11391	27464336	604	608	OrganismTaxon	mice	10090
11392	27464336	626	633	ChemicalEntity	alcohol	D000438
11393	27464336	944	951	ChemicalEntity	alcohol	D000438
11394	27464336	1123	1127	GeneOrGeneProduct	mTOR	56717
11395	27464336	1129	1135	GeneOrGeneProduct	4E-BP1	13685
11396	27464336	1137	1140	GeneOrGeneProduct	Akt	11651
11397	27464336	1145	1151	GeneOrGeneProduct	PRAS40	67605
11398	27464336	1221	1225	GeneOrGeneProduct	S6K1	72508
11399	27464336	1257	1259	GeneOrGeneProduct	S6	20104
11400	27464336	1264	1269	GeneOrGeneProduct	eIF4B	75705
11401	27464336	1286	1293	ChemicalEntity	alcohol	D000438
11402	27464336	1298	1302	OrganismTaxon	mice	10090
11403	27464336	1304	1311	ChemicalEntity	Alcohol	D000438
11404	27464336	1327	1332	GeneOrGeneProduct	eEF2K	13631
11405	27464336	1363	1367	GeneOrGeneProduct	eEF2	13629
11406	27464336	1434	1441	ChemicalEntity	Alcohol	D000438
11407	27464336	1452	1459	GeneOrGeneProduct	Atg12-5	11793,67526
11408	27464336	1461	1475	GeneOrGeneProduct	LC3B-I and -II	67443
11409	27464336	1481	1485	GeneOrGeneProduct	ULK1	22241
11410	27464336	1486	1490	SequenceVariant	S555	p|Allele|S|555
11411	27464336	1576	1592	GeneOrGeneProduct	caspase-3 and -9	12367,12371
11412	27464336	1598	1602	GeneOrGeneProduct	PARP	11545
11413	27464336	1639	1643	GeneOrGeneProduct	ATGL	66853
11414	27464336	1648	1651	GeneOrGeneProduct	HSL	16890
11415	27464336	1710	1719	GeneOrGeneProduct	PPARgamma	19016
11416	27464336	1724	1734	GeneOrGeneProduct	C/EBPalpha	12606
11417	27464336	1762	1769	ChemicalEntity	alcohol	D000438
11418	27464336	1780	1787	ChemicalEntity	alcohol	D000438
11419	27464336	1798	1807	GeneOrGeneProduct	TNF-alpha	21926
11420	27464336	1809	1813	GeneOrGeneProduct	IL-6	16193
11421	27464336	1819	1827	GeneOrGeneProduct	IL-1beta	16176
11422	27464336	1869	1874	GeneOrGeneProduct	NLRP3	216799
11423	27464336	1889	1894	GeneOrGeneProduct	NLRP3	216799
11424	27464336	1896	1899	GeneOrGeneProduct	ACS	66824
11425	27464336	1913	1922	GeneOrGeneProduct	caspase-1	12362
11426	27464336	1948	1955	ChemicalEntity	alcohol	D000438
11427	27464336	1992	1999	GeneOrGeneProduct	insulin	16334
11428	27464336	2079	2086	ChemicalEntity	alcohol	D000438
11429	27464336	2273	2277	GeneOrGeneProduct	S6K1	72508
11430	27491646	0	8	ChemicalEntity	Gartanin	C000605798
11431	27491646	84	88	GeneOrGeneProduct	PI3K	5291
11432	27491646	89	92	GeneOrGeneProduct	Akt	207
11433	27491646	93	97	GeneOrGeneProduct	mTOR	2475
11434	27491646	102	106	GeneOrGeneProduct	MAPK	5594
11435	27491646	129	134	OrganismTaxon	human	9606
11436	27491646	135	141	DiseaseOrPhenotypicFeature	glioma	D005910
11437	27491646	176	182	DiseaseOrPhenotypicFeature	glioma	D005910
11438	27491646	202	222	DiseaseOrPhenotypicFeature	primary brain tumour	D001932
11439	27491646	315	323	ChemicalEntity	Gartanin	C000605798
11440	27491646	335	343	ChemicalEntity	xanthone	C009689
11441	27491646	347	357	OrganismTaxon	mangosteen	58228
11442	27491646	465	469	CellLine	T98G	9606
11443	27491646	470	476	DiseaseOrPhenotypicFeature	glioma	D005910
11444	27491646	494	499	OrganismTaxon	mouse	10090
11445	27491646	516	520	CellLine	HT22	10090
11446	27491646	528	536	ChemicalEntity	Gartanin	C000605798
11447	27491646	672	681	GeneOrGeneProduct	cyclin D1	595
11448	27491646	719	742	GeneOrGeneProduct	cyclin-dependent kinase	983
11449	27491646	753	760	GeneOrGeneProduct	p27Kip1	1027
11450	27491646	805	834	GeneOrGeneProduct	matrix metalloproteinases 2/9	4313,4318
11451	27491646	836	844	GeneOrGeneProduct	MMP-2/-9	4313,4318
11452	27491646	879	883	CellLine	T98G	9606
11453	27491646	903	911	ChemicalEntity	gartanin	C000605798
11454	27491646	949	982	GeneOrGeneProduct	mitogen-activated protein kinases	5594
11455	27491646	984	988	GeneOrGeneProduct	MAPK	5594
11456	27491646	1012	1016	CellLine	T98G	9606
11457	27491646	1017	1023	DiseaseOrPhenotypicFeature	glioma	D005910
11458	27491646	1041	1049	ChemicalEntity	gartanin	C000605798
11459	27491646	1085	1089	CellLine	T98G	9606
11460	27491646	1114	1117	GeneOrGeneProduct	LC3	84557
11461	27491646	1189	1197	GeneOrGeneProduct	Beclin 1	8678
11462	27491646	1202	1205	GeneOrGeneProduct	LC3	84557
11463	27491646	1247	1250	GeneOrGeneProduct	p62	8878
11464	27491646	1252	1260	ChemicalEntity	Gartanin	C000605798
11465	27491646	1305	1309	GeneOrGeneProduct	PI3K	5291
11466	27491646	1310	1313	GeneOrGeneProduct	Akt	207
11467	27491646	1314	1318	GeneOrGeneProduct	mTOR	2475
11468	27491646	1392	1400	ChemicalEntity	gartanin	C000605798
11469	27491646	1487	1502	ChemicalEntity	3-methyladenine	C025946
11470	27491646	1504	1508	ChemicalEntity	3-MA	C025946
11471	27491646	1514	1525	ChemicalEntity	chloroquine	D002738
11472	27491646	1527	1529	ChemicalEntity	CQ	D002738
11473	27491646	1589	1597	ChemicalEntity	gartanin	C000605798
11474	27491646	1601	1605	CellLine	T98G	9606
11475	27491646	1695	1699	GeneOrGeneProduct	PI3K	5291
11476	27491646	1700	1703	GeneOrGeneProduct	Akt	207
11477	27491646	1704	1708	GeneOrGeneProduct	mTOR	2475
11478	27491646	1791	1799	GeneOrGeneProduct	MMP-2/-9	4313,4318
11479	27491646	1830	1834	GeneOrGeneProduct	MAPK	5594
11480	27509880	19	38	GeneOrGeneProduct	histone deacetylase	3065
11481	27509880	49	61	ChemicalEntity	depsipeptide	D047630
11482	27509880	66	80	ChemicalEntity	5-fluorouracil	D005472
11483	27509880	93	134	GeneOrGeneProduct	major histocompatibility complex class II	3119
11484	27509880	139	142	GeneOrGeneProduct	p21	1026
11485	27509880	163	174	GeneOrGeneProduct	caspase-3/7	836,840
11486	27509880	178	183	OrganismTaxon	human	9606
11487	27509880	184	196	DiseaseOrPhenotypicFeature	colon cancer	D003110
11488	27509880	197	204	CellLine	HCT-116	9606
11489	27509880	248	267	GeneOrGeneProduct	histone deacetylase	3065
11490	27509880	269	273	GeneOrGeneProduct	HDAC	3065
11491	27509880	437	449	ChemicalEntity	depsipeptide	D047630
11492	27509880	454	458	GeneOrGeneProduct	HDAC	3065
11493	27509880	508	522	ChemicalEntity	5-fluorouracil	D005472
11494	27509880	524	528	ChemicalEntity	5-FU	D005472
11495	27509880	535	540	OrganismTaxon	human	9606
11496	27509880	541	553	DiseaseOrPhenotypicFeature	colon cancer	D003110
11497	27509880	571	578	CellLine	HCT-116	9606
11498	27509880	580	584	CellLine	HT29	9606
11499	27509880	590	594	CellLine	SW48	9606
11500	27509880	700	704	ChemicalEntity	5-FU	D005472
11501	27509880	724	736	ChemicalEntity	depsipeptide	D047630
11502	27509880	802	813	GeneOrGeneProduct	caspase-3/7	836,840
11503	27509880	821	825	ChemicalEntity	5-FU	D005472
11504	27509880	851	862	GeneOrGeneProduct	caspase-3/7	836,840
11505	27509880	939	943	ChemicalEntity	5-FU	D005472
11506	27509880	947	959	ChemicalEntity	depsipeptide	D047630
11507	27509880	996	1000	ChemicalEntity	5-FU	D005472
11508	27509880	1005	1017	ChemicalEntity	depsipeptide	D047630
11509	27509880	1139	1150	GeneOrGeneProduct	caspase-3/7	836,840
11510	27509880	1261	1275	ChemicalEntity	polysaccharide	D011134
11511	27509880	1288	1332	GeneOrGeneProduct	major histocompatibility complex (MHC) class	3123
11512	27509880	1350	1369	GeneOrGeneProduct	MHC protein complex	3123
11513	27509880	1458	1462	ChemicalEntity	5-FU	D005472
11514	27509880	1467	1479	ChemicalEntity	depsipeptide	D047630
11515	27509880	1538	1556	GeneOrGeneProduct	MHC class II genes	3119
11516	27509880	1569	1586	GeneOrGeneProduct	MHC class I genes	3106
11517	27509880	1708	1726	GeneOrGeneProduct	MHC class II genes	3119
11518	27509880	1764	1768	GeneOrGeneProduct	PCAF	8850
11519	27509880	1773	1778	GeneOrGeneProduct	CIITA	4261
11520	27509880	1804	1808	ChemicalEntity	5-FU	D005472
11521	27509880	1813	1825	ChemicalEntity	depsipeptide	D047630
11522	27509880	1897	1909	GeneOrGeneProduct	MHC class II	3119
11523	27509880	1974	1986	ChemicalEntity	depsipeptide	D047630
11524	27509880	1991	1995	ChemicalEntity	5-FU	D005472
11525	27509880	2085	2089	ChemicalEntity	5-FU	D005472
11526	27509880	2094	2106	ChemicalEntity	depsipeptide	D047630
11527	27509880	2115	2120	OrganismTaxon	human	9606
11528	27509880	2121	2133	DiseaseOrPhenotypicFeature	colon cancer	D003110
11529	27509880	2193	2205	GeneOrGeneProduct	MHC class II	3119
11530	27630165	11	14	GeneOrGeneProduct	CD4	12504
11531	27630165	15	20	GeneOrGeneProduct	IFN-g	15978
11532	27630165	54	57	GeneOrGeneProduct	CD4	12504
11533	27630165	58	63	GeneOrGeneProduct	IFN-g	15978
11534	27630165	64	69	GeneOrGeneProduct	IL-10	16153
11535	27630165	94	99	GeneOrGeneProduct	IL-10	16153
11536	27630165	168	185	DiseaseOrPhenotypicFeature	Malaria Infection	D008288
11537	27630165	187	190	GeneOrGeneProduct	CD4	12504
11538	27630165	215	220	GeneOrGeneProduct	IFN-g	15978
11539	27630165	255	260	GeneOrGeneProduct	IL-10	16153
11540	27630165	276	285	DiseaseOrPhenotypicFeature	infection	D007239
11541	27630165	368	371	GeneOrGeneProduct	CD4	12504
11542	27630165	374	379	GeneOrGeneProduct	IFN-g	15978
11543	27630165	382	387	GeneOrGeneProduct	IL-10	16153
11544	27630165	430	439	DiseaseOrPhenotypicFeature	infection	D007239
11545	27630165	565	570	GeneOrGeneProduct	IFN-g	15978
11546	27630165	608	613	GeneOrGeneProduct	IL-10	16153
11547	27630165	632	636	OrganismTaxon	mice	10090
11548	27630165	659	676	DiseaseOrPhenotypicFeature	malaria infection	D008288
11549	27630165	685	688	GeneOrGeneProduct	CD4	12504
11550	27630165	765	770	GeneOrGeneProduct	IL-10	16153
11551	27630165	828	831	GeneOrGeneProduct	CD4	12504
11552	27630165	904	907	GeneOrGeneProduct	CD4	12504
11553	27630165	1062	1066	GeneOrGeneProduct	PD-1	18566
11554	27630165	1068	1073	GeneOrGeneProduct	Lag-3	16768
11555	27630165	1079	1084	GeneOrGeneProduct	TIGIT	100043314
11556	27630165	1149	1152	GeneOrGeneProduct	CD4	12504
11557	27630165	1269	1278	DiseaseOrPhenotypicFeature	infection	D007239
11558	27630165	1293	1296	GeneOrGeneProduct	CD4	12504
11559	27630165	1366	1371	GeneOrGeneProduct	IL-10	16153
11560	27630165	1400	1409	DiseaseOrPhenotypicFeature	infection	D007239
11561	27630165	1428	1431	GeneOrGeneProduct	CD4	12504
11562	27630165	1504	1509	GeneOrGeneProduct	IL-10	16153
11563	27630165	1555	1572	DiseaseOrPhenotypicFeature	malaria infection	D008288
11564	27630165	1583	1588	GeneOrGeneProduct	IL-10	16153
11565	27630165	1654	1657	GeneOrGeneProduct	CD4	12504
11566	27630165	1820	1825	GeneOrGeneProduct	IL-10	16153
11567	27630165	1836	1839	GeneOrGeneProduct	CD4	12504
11568	27630165	1896	1901	GeneOrGeneProduct	IL-10	16153
11569	27630165	2007	2025	DiseaseOrPhenotypicFeature	malaria infections	D008288
11570	27643404	0	7	ChemicalEntity	Alcohol	D000438
11571	27643404	24	39	DiseaseOrPhenotypicFeature	prostate cancer	D011471
11572	27643404	100	115	DiseaseOrPhenotypicFeature	Prostate cancer	D011471
11573	27643404	135	141	DiseaseOrPhenotypicFeature	cancer	D009369
11574	27643404	145	148	OrganismTaxon	men	9606
11575	27643404	235	242	ChemicalEntity	alcohol	D000438
11576	27643404	258	273	DiseaseOrPhenotypicFeature	prostate cancer	D011471
11577	27643404	456	463	ChemicalEntity	alcohol	D000438
11578	27643404	488	503	DiseaseOrPhenotypicFeature	prostate cancer	D011471
11579	27643404	557	560	OrganismTaxon	men	9606
11580	27643404	566	581	DiseaseOrPhenotypicFeature	prostate cancer	D011471
11581	27643404	743	750	ChemicalEntity	alcohol	D000438
11582	27643404	771	793	GeneOrGeneProduct	Alcohol Dehydrogenases	125
11583	27643404	795	799	GeneOrGeneProduct	ADHs	125
11584	27643404	805	828	GeneOrGeneProduct	Aldehyde Dehydrogenases	8854
11585	27643404	830	835	GeneOrGeneProduct	ALDHs	8854
11586	27643404	843	858	DiseaseOrPhenotypicFeature	prostate cancer	D011471
11587	27643404	873	888	DiseaseOrPhenotypicFeature	prostate cancer	D011471
11588	27643404	1127	1134	ChemicalEntity	alcohol	D000438
11589	27643404	1175	1190	DiseaseOrPhenotypicFeature	prostate cancer	D011471
11590	27643404	1291	1306	DiseaseOrPhenotypicFeature	prostate cancer	D011471
11591	27643404	1360	1367	GeneOrGeneProduct	ALDH1A2	8854
11592	27643404	1384	1399	DiseaseOrPhenotypicFeature	prostate cancer	D011471
11593	27643404	1415	1424	SequenceVariant	rs1441817	rs1441817
11594	27643404	1533	1543	SequenceVariant	rs12910509	rs12910509
11595	27643404	1602	1611	SequenceVariant	rs8041922	rs8041922
11596	27643404	1728	1735	GeneOrGeneProduct	ALDH1B1	219
11597	27643404	1737	1747	SequenceVariant	rs10973794	rs10973794
11598	27643404	1821	1836	DiseaseOrPhenotypicFeature	prostate cancer	D011471
11599	27643404	1850	1853	OrganismTaxon	men	9606
11600	27643404	1869	1884	DiseaseOrPhenotypicFeature	prostate cancer	D011471
11601	27643404	1913	1920	ChemicalEntity	alcohol	D000438
11602	27643404	1955	1970	DiseaseOrPhenotypicFeature	prostate cancer	D011471
11603	27729412	8	19	GeneOrGeneProduct	adiponectin	11450
11604	27729412	97	104	GeneOrGeneProduct	ALDH1A1	11668
11605	27729412	117	139	GeneOrGeneProduct	retinoic acid receptor	19401,19411,20181
11606	27729412	169	180	GeneOrGeneProduct	Adiponectin	11450
11607	27729412	205	214	GeneOrGeneProduct	adipokine	11450
11608	27729412	246	258	DiseaseOrPhenotypicFeature	inflammatory	D007249
11609	27729412	347	356	DiseaseOrPhenotypicFeature	adiposity	D009765
11610	27729412	366	378	DiseaseOrPhenotypicFeature	inflammatory	D007249
11611	27729412	385	408	DiseaseOrPhenotypicFeature	cardiovascular diseases	D002318
11612	27729412	422	433	GeneOrGeneProduct	adiponectin	11450
11613	27729412	445	454	ChemicalEntity	Vitamin A	D014801
11614	27729412	467	476	ChemicalEntity	retinoids	D012176
11615	27729412	603	614	GeneOrGeneProduct	adiponectin	11450
11616	27729412	669	678	ChemicalEntity	vitamin A	D014801
11617	27729412	693	697	OrganismTaxon	mice	10090
11618	27729412	713	724	GeneOrGeneProduct	adiponectin	11450
11619	27729412	771	796	GeneOrGeneProduct	aldehyde dehydrogenase A1	11668
11620	27729412	798	805	GeneOrGeneProduct	ALDH1A1	11668
11621	27729412	832	845	ChemicalEntity	retinoic acid	D014212
11622	27729412	908	912	OrganismTaxon	mice	10090
11623	27729412	926	935	ChemicalEntity	vitamin A	D014801
11624	27729412	960	971	GeneOrGeneProduct	adiponectin	11450
11625	27729412	1011	1015	OrganismTaxon	mice	10090
11626	27729412	1027	1036	ChemicalEntity	vitamin A	D014801
11627	27729412	1105	1134	GeneOrGeneProduct	retinoic acid receptor (RAR)a	19401
11628	27729412	1140	1144	GeneOrGeneProduct	RARg	19411
11629	27729412	1188	1207	GeneOrGeneProduct	retinoid X receptor	20181
11630	27729412	1237	1248	GeneOrGeneProduct	adiponectin	11450
11631	27729412	1269	1276	GeneOrGeneProduct	ALDH1A1	11668
11632	27729412	1308	1311	GeneOrGeneProduct	RAR	19401,19411,20181
11633	27729412	1347	1358	GeneOrGeneProduct	adiponectin	11450
11634	27729412	1433	1440	GeneOrGeneProduct	ALDH1A1	11668
11635	27729412	1501	1514	ChemicalEntity	retinoic acid	D014212
11636	27729412	1534	1537	GeneOrGeneProduct	RAR	19401,19411,20181
11637	27729412	1579	1592	ChemicalEntity	retinoic acid	D014212
11638	27729412	1637	1640	GeneOrGeneProduct	RAR	19401,19411,20181
11639	27729412	1671	1682	GeneOrGeneProduct	adiponectin	11450
11640	27729412	1852	1863	GeneOrGeneProduct	adiponectin	11450
11641	27729412	1941	1948	GeneOrGeneProduct	ALDH1A1	11668
11642	27729412	1961	1983	GeneOrGeneProduct	retinoic acid receptor	19401,19411,20181
11643	27798239	0	33	GeneOrGeneProduct	Phosphatidylinositol 4-kinase IIb	55300
11644	27798239	128	165	GeneOrGeneProduct	type II phosphatidylinositol 4-kinase	55300,55361
11645	27798239	167	173	GeneOrGeneProduct	PI4KII	55300,55361
11646	27798239	198	203	ChemicalEntity	lipid	D008055
11647	27798239	204	236	ChemicalEntity	phosphatidylinositol 4-phosphate	C037178
11648	27798239	238	244	ChemicalEntity	PI(4)P	C037178
11649	27798239	332	340	GeneOrGeneProduct	clathrin	1213
11650	27798239	483	490	GeneOrGeneProduct	PI4KIIa	55361
11651	27798239	495	502	GeneOrGeneProduct	PI4KIIb	55300
11652	27798239	538	543	GeneOrGeneProduct	actin	60
11653	27798239	569	576	GeneOrGeneProduct	PI4KIIb	55300
11654	27798239	630	670	GeneOrGeneProduct	membrane type I matrix metalloproteinase	4323
11655	27798239	672	679	GeneOrGeneProduct	MT1-MMP	4323
11656	27798239	695	701	GeneOrGeneProduct	PI4KII	55300,55361
11657	27798239	775	781	ChemicalEntity	PI(4)P	C037178
11658	27798239	804	811	GeneOrGeneProduct	PI4KIIb	55300
11659	27798239	839	846	GeneOrGeneProduct	MT1-MMP	4323
11660	27798239	954	961	GeneOrGeneProduct	MT1-MMP	4323
11661	27798239	1010	1014	GeneOrGeneProduct	Rab5	5868
11662	27798239	1019	1023	GeneOrGeneProduct	Rab7	338382
11663	27798239	1069	1073	GeneOrGeneProduct	Rab8	4218
11664	27798239	1088	1095	GeneOrGeneProduct	PI4KIIb	55300
11665	27798239	1176	1180	CellLine	HeLa	9606
11666	27798239	1185	1190	CellLine	MCF-7	9606
11667	27798239	1258	1264	GeneOrGeneProduct	PI4K2B	55300
11668	27798239	1295	1302	GeneOrGeneProduct	PI4KIIb	55300
11669	27798239	1328	1333	OrganismTaxon	human	9606
11670	27798239	1334	1341	DiseaseOrPhenotypicFeature	cancers	D009369
11671	27798239	1397	1404	GeneOrGeneProduct	PI4KIIb	55300
11672	27798239	1477	1484	GeneOrGeneProduct	PI4KIIb	55300
11673	27798239	1507	1513	ChemicalEntity	PI(4)P	C037178
11674	27798239	1529	1536	GeneOrGeneProduct	MT1-MMP	4323
11675	27840894	28	32	GeneOrGeneProduct	PHEX	5251
11676	27840894	51	59	OrganismTaxon	patients	9606
11677	27840894	65	89	DiseaseOrPhenotypicFeature	hypophosphatemic rickets	D063730
11678	27840894	117	195	GeneOrGeneProduct	phosphate-regulating gene with homologies to endopeptidase on the X chromosome	5251
11679	27840894	197	201	GeneOrGeneProduct	PHEX	5251
11680	27840894	238	271	DiseaseOrPhenotypicFeature	X-linked hypophosphatemic rickets	D053098
11681	27840894	273	276	DiseaseOrPhenotypicFeature	XLH	D053098
11682	27840894	278	289	DiseaseOrPhenotypicFeature	OMIM 307800	D053098
11683	27840894	329	337	OrganismTaxon	patients	9606
11684	27840894	391	415	DiseaseOrPhenotypicFeature	hypophosphatemic rickets	D063730
11685	27840894	527	531	GeneOrGeneProduct	PHEX	5251
11686	27840894	582	609	GeneOrGeneProduct	fibroblast growth factor 23	8074
11687	27840894	611	616	GeneOrGeneProduct	FGF23	8074
11688	27840894	683	687	GeneOrGeneProduct	PHEX	5251
11689	27840894	777	785	SequenceVariant	c.304G>A	c|SUB|G|304|A
11690	27840894	787	798	SequenceVariant	p.Gly102Arg	p|SUB|G|102|R
11691	27840894	811	819	SequenceVariant	c.229T>C	c|SUB|T|229|C
11692	27840894	821	831	SequenceVariant	p.Cys77Arg	p|SUB|C|77|R
11693	27840894	847	855	SequenceVariant	c.824T>C	c|SUB|T|284|C
11694	27840894	857	868	SequenceVariant	p.Leu275Pro	p|SUB|L|275|P
11695	27840894	913	922	SequenceVariant	c.528delT	c|DEL|528|T
11696	27840894	924	940	SequenceVariant	p.Glu177LysfsX44	p|SUB|E|177|K|44
11697	27840894	956	966	SequenceVariant	c.1234delA	c|DEL|1234|A
11698	27840894	968	984	SequenceVariant	p.Ser412ValfsX12	p|SUB|S|412|V|12
11699	27840894	1046	1062	SequenceVariant	c.436_436+1delAG	c|DEL|436_436+1|AG
11700	27840894	1103	1114	SequenceVariant	c.1483-1G>C	c|SUB|G|1483-1|C
11701	27840894	1332	1337	GeneOrGeneProduct	FGF23	8074
11702	27840894	1362	1370	OrganismTaxon	patients	9606
11703	27840894	1376	1379	DiseaseOrPhenotypicFeature	XLH	D053098
11704	27840894	1553	1557	GeneOrGeneProduct	PHEX	5251
11705	27840894	1623	1627	GeneOrGeneProduct	PHEX	5251
11706	27840894	1689	1694	GeneOrGeneProduct	FGF23	8074
11707	27840894	1714	1722	OrganismTaxon	patients	9606
11708	27840894	1728	1731	DiseaseOrPhenotypicFeature	XLH	D053098
11709	27840894	1799	1802	DiseaseOrPhenotypicFeature	XLH	D053098
11710	27860244	8	44	GeneOrGeneProduct	protein arginine methyltransferase 5	10419
11711	27860244	48	60	DiseaseOrPhenotypicFeature	inflammation	D007249
11712	27860244	110	130	DiseaseOrPhenotypicFeature	rheumatoid arthritis	D001172
11713	27860244	153	189	GeneOrGeneProduct	protein arginine methyltransferase 5	10419
11714	27860244	191	196	GeneOrGeneProduct	PRMT5	10419
11715	27860244	212	224	DiseaseOrPhenotypicFeature	inflammation	D007249
11716	27860244	313	321	OrganismTaxon	patients	9606
11717	27860244	327	347	DiseaseOrPhenotypicFeature	rheumatoid arthritis	D001172
11718	27860244	349	351	DiseaseOrPhenotypicFeature	RA	D001172
11719	27860244	407	415	OrganismTaxon	patients	9606
11720	27860244	421	423	DiseaseOrPhenotypicFeature	RA	D001172
11721	27860244	428	442	DiseaseOrPhenotypicFeature	osteoarthritis	D010003
11722	27860244	444	446	DiseaseOrPhenotypicFeature	OA	D010003
11723	27860244	465	470	GeneOrGeneProduct	PRMT5	10419
11724	27860244	472	481	ChemicalEntity	EPZ015666	C000599896
11725	27860244	526	531	GeneOrGeneProduct	PRMT5	10419
11726	27860244	553	558	GeneOrGeneProduct	PRMT5	10419
11727	27860244	687	699	DiseaseOrPhenotypicFeature	inflammatory	D007249
11728	27860244	966	971	GeneOrGeneProduct	PRMT5	10419
11729	27860244	1008	1016	OrganismTaxon	patients	9606
11730	27860244	1022	1024	DiseaseOrPhenotypicFeature	RA	D001172
11731	27860244	1029	1031	DiseaseOrPhenotypicFeature	RA	D001172
11732	27860244	1051	1056	GeneOrGeneProduct	PRMT5	10419
11733	27860244	1094	1099	GeneOrGeneProduct	IL-1b	3553
11734	27860244	1104	1109	GeneOrGeneProduct	TNF-a	7124
11735	27860244	1125	1130	GeneOrGeneProduct	PRMT5	10419
11736	27860244	1134	1143	ChemicalEntity	EPZ015666	C000599896
11737	27860244	1181	1185	GeneOrGeneProduct	IL-6	3569
11738	27860244	1190	1194	GeneOrGeneProduct	IL-8	3576
11739	27860244	1228	1230	DiseaseOrPhenotypicFeature	RA	D001172
11740	27860244	1264	1269	GeneOrGeneProduct	PRMT5	10419
11741	27860244	1315	1317	DiseaseOrPhenotypicFeature	RA	D001172
11742	27860244	1337	1346	ChemicalEntity	EPZ015666	C000599896
11743	27860244	1381	1392	GeneOrGeneProduct	IkB kinaseb	3551
11744	27860244	1397	1401	GeneOrGeneProduct	IkBa	4792
11745	27860244	1440	1443	GeneOrGeneProduct	p65	5970
11746	27860244	1455	1458	GeneOrGeneProduct	AKT	207
11747	27860244	1468	1473	GeneOrGeneProduct	PRMT5	10419
11748	27860244	1502	1514	DiseaseOrPhenotypicFeature	inflammatory	D007249
11749	27860244	1570	1572	DiseaseOrPhenotypicFeature	RA	D001172
11750	27860244	1604	1609	GeneOrGeneProduct	NF-kB	5970
11751	27860244	1614	1617	GeneOrGeneProduct	AKT	207
11752	27860244	1662	1667	GeneOrGeneProduct	PRMT5	10419
11753	27860244	1679	1700	DiseaseOrPhenotypicFeature	synovial inflammation	D013585
11754	27860244	1750	1752	DiseaseOrPhenotypicFeature	RA	D001172
11755	27866394	9	26	ChemicalEntity	otilonium bromide	C013934
11756	27866394	51	67	ChemicalEntity	neurotransmitter	D018377
11757	27866394	88	92	OrganismTaxon	rats	10116
11758	27866394	129	146	ChemicalEntity	Otilonium bromide	C013934
11759	27866394	148	150	ChemicalEntity	OB	C013934
11760	27866394	213	237	DiseaseOrPhenotypicFeature	irritable bowel syndrome	D043183
11761	27866394	239	242	DiseaseOrPhenotypicFeature	IBS	D043183
11762	27866394	294	323	GeneOrGeneProduct	L- and T-type Ca(2+) channels	24239,83810
11763	27866394	328	363	GeneOrGeneProduct	muscarinic and tachykinin receptors	1128,6869
11764	27866394	410	414	OrganismTaxon	rats	10116
11765	27866394	425	427	ChemicalEntity	OB	C013934
11766	27866394	452	468	ChemicalEntity	neurotransmitter	D018377
11767	27866394	580	582	ChemicalEntity	OB	C013934
11768	27866394	669	673	OrganismTaxon	rats	10116
11769	27866394	780	783	DiseaseOrPhenotypicFeature	IBS	D043183
11770	27866394	824	826	ChemicalEntity	OB	C013934
11771	27866394	831	835	OrganismTaxon	rats	10116
11772	27866394	969	971	ChemicalEntity	OB	C013934
11773	27866394	996	1013	ChemicalEntity	neurotransmitters	D018377
11774	27866394	1086	1088	GeneOrGeneProduct	SP	24806
11775	27866394	1091	1095	GeneOrGeneProduct	NK1r	24807
11776	27866394	1098	1102	GeneOrGeneProduct	nNOS	24598
11777	27866394	1105	1108	GeneOrGeneProduct	VIP	117064
11778	27866394	1115	1120	GeneOrGeneProduct	S100b	25742
11779	27866394	1163	1167	GeneOrGeneProduct	CGRP	24241
11780	27866394	1174	1179	GeneOrGeneProduct	CRF1r	58959
11781	27866394	1201	1203	ChemicalEntity	OB	C013934
11782	27866394	1236	1241	GeneOrGeneProduct	CRF2r	64680
11783	27866394	1269	1273	OrganismTaxon	rats	10116
11784	27866394	1311	1331	DiseaseOrPhenotypicFeature	mucosal inflammation	D052016
11785	27866394	1353	1355	ChemicalEntity	OB	C013934
11786	27866394	1377	1380	GeneOrGeneProduct	Mr2	81645
11787	27866394	1453	1457	GeneOrGeneProduct	ChAT	290567
11788	27866394	1575	1577	ChemicalEntity	OB	C013934
11789	27866394	1586	1590	OrganismTaxon	rats	10116
11790	27866394	1607	1609	ChemicalEntity	OB	C013934
11791	27866394	1619	1641	GeneOrGeneProduct	L-type Ca(2+) channels	24239
11792	27866394	1729	1731	ChemicalEntity	OB	C013934
11793	27930654	61	67	GeneOrGeneProduct	RAB-28	189429
11794	27930654	87	93	GeneOrGeneProduct	GTPase	189429
11795	27930654	114	120	GeneOrGeneProduct	BBSome	260219
11796	27930654	313	338	DiseaseOrPhenotypicFeature	inherited human disorders	D030342
11797	27930654	340	352	DiseaseOrPhenotypicFeature	ciliopathies	D000072661
11798	27930654	362	382	DiseaseOrPhenotypicFeature	retinitis pigmentosa	D012174
11799	27930654	387	408	DiseaseOrPhenotypicFeature	Bardet-Biedl syndrome	D020788
11800	27930654	410	413	DiseaseOrPhenotypicFeature	BBS	D020788
11801	27930654	652	661	GeneOrGeneProduct	kinesin-2	177685
11802	27930654	670	676	GeneOrGeneProduct	dynein	172041
11803	27930654	705	762	GeneOrGeneProduct	Bardet-Biedl syndrome (BBS) cargo-adaptor protein complex	260219
11804	27930654	767	773	GeneOrGeneProduct	BBSome	260219
11805	27930654	841	851	OrganismTaxon	C. elegans	6239
11806	27930654	1124	1131	GeneOrGeneProduct	FAM-161	189695
11807	27930654	1133	1140	GeneOrGeneProduct	FAM161A	84140
11808	27930654	1154	1162	GeneOrGeneProduct	CCDC-104	112942
11809	27930654	1164	1171	GeneOrGeneProduct	CCDC104	112942
11810	27930654	1178	1183	GeneOrGeneProduct	RPI-1	189281
11811	27930654	1185	1188	GeneOrGeneProduct	RP1	6101
11812	27930654	1189	1194	GeneOrGeneProduct	RP1L1	94137
11813	27930654	1315	1320	OrganismTaxon	human	9606
11814	27930654	1321	1325	GeneOrGeneProduct	MAP9	79884
11815	27930654	1327	1330	GeneOrGeneProduct	YAP	10413
11816	27930654	1332	1339	GeneOrGeneProduct	CCDC149	91050
11817	27930654	1345	1350	GeneOrGeneProduct	RAB28	9364
11818	27930654	1414	1424	OrganismTaxon	C. elegans	6239
11819	27930654	1425	1431	GeneOrGeneProduct	RAB-28	189429
11820	27930654	1478	1496	DiseaseOrPhenotypicFeature	cone-rod dystrophy	D000071700
11821	27930654	1521	1527	GeneOrGeneProduct	GTPase	189429
11822	27930654	1639	1642	ChemicalEntity	GDP	D006153
11823	27930654	1649	1655	GeneOrGeneProduct	RAB-28	189429
11824	27930654	1707	1710	ChemicalEntity	GTP	D006160
11825	27930654	1729	1735	GeneOrGeneProduct	RAB-28	189429
11826	27930654	1782	1788	GeneOrGeneProduct	BBSome	260219
11827	27930654	1947	1953	GeneOrGeneProduct	rab-28	189429
11828	27930654	1995	1998	ChemicalEntity	GDP	D006153
11829	27930654	2002	2005	ChemicalEntity	GTP	D006160
11830	27930654	2025	2031	GeneOrGeneProduct	RAB-28	189429
11831	27930654	2188	2193	GeneOrGeneProduct	RAB28	9364
11832	27930654	2197	2203	GeneOrGeneProduct	GTPase	9364
11833	27930654	2232	2235	DiseaseOrPhenotypicFeature	BBS	D020788
11834	27930654	2244	2249	GeneOrGeneProduct	RABL4	11020
11835	27930654	2250	2255	GeneOrGeneProduct	IFT27	11020
11836	27930654	2289	2295	GeneOrGeneProduct	BBSome	260219
11837	27941998	0	33	GeneOrGeneProduct	Voltage-Dependent Anion Channel 1	7416,83529
11838	27941998	34	39	GeneOrGeneProduct	VDAC1	7416,83529
11839	27941998	75	100	DiseaseOrPhenotypicFeature	Mitochondrial Dysfunction	D028361
11840	27941998	104	116	DiseaseOrPhenotypicFeature	Desminopathy	C563319
11841	27941998	118	132	DiseaseOrPhenotypicFeature	Desminopathies	C563319
11842	27941998	179	185	GeneOrGeneProduct	desmin	1674
11843	27941998	222	232	DiseaseOrPhenotypicFeature	myopathies	D009135
11844	27941998	234	259	DiseaseOrPhenotypicFeature	Mitochondrial dysfunction	D028361
11845	27941998	298	312	DiseaseOrPhenotypicFeature	desminopathies	C563319
11846	27941998	364	388	DiseaseOrPhenotypicFeature	mitochondria dysfunction	D028361
11847	27941998	392	406	DiseaseOrPhenotypicFeature	desminopathies	C563319
11848	27941998	425	430	GeneOrGeneProduct	VDAC1	7416
11849	27941998	568	582	DiseaseOrPhenotypicFeature	desminopathies	C563319
11850	27941998	587	620	GeneOrGeneProduct	Voltage-dependent anion channel 1	7416
11851	27941998	622	627	GeneOrGeneProduct	VDAC1	7416
11852	27941998	682	694	DiseaseOrPhenotypicFeature	desminopathy	C563319
11853	27941998	695	698	OrganismTaxon	rat	10116
11854	27941998	914	919	GeneOrGeneProduct	VDAC1	7416,83529
11855	27941998	943	949	GeneOrGeneProduct	desmin	1674,64362
11856	27941998	990	1002	DiseaseOrPhenotypicFeature	desminopathy	C563319
11857	27941998	1003	1011	OrganismTaxon	patients	9606
11858	27941998	1015	1027	DiseaseOrPhenotypicFeature	desminopathy	C563319
11859	27941998	1028	1031	OrganismTaxon	rat	10116
11860	27941998	1104	1107	GeneOrGeneProduct	bax	24887,581
11861	27941998	1112	1116	GeneOrGeneProduct	ATF2	1386,81647
11862	27941998	1134	1146	DiseaseOrPhenotypicFeature	desminopathy	C563319
11863	27941998	1147	1155	OrganismTaxon	patients	9606
11864	27941998	1160	1172	DiseaseOrPhenotypicFeature	desminopathy	C563319
11865	27941998	1173	1176	OrganismTaxon	rat	10116
11866	27941998	1192	1197	GeneOrGeneProduct	bcl-2	24224,596
11867	27941998	1199	1205	GeneOrGeneProduct	bcl-xl	24888,598
11868	27941998	1209	1212	GeneOrGeneProduct	HK2	25059,3099
11869	27941998	1213	1218	GeneOrGeneProduct	VDAC1	7416,83529
11870	27941998	1223	1229	GeneOrGeneProduct	desmin	1674,64362
11871	27941998	1290	1298	OrganismTaxon	patients	9606
11872	27941998	1303	1307	OrganismTaxon	rats	10116
11873	27941998	1313	1325	DiseaseOrPhenotypicFeature	desminopathy	C563319
11874	27941998	1398	1412	DiseaseOrPhenotypicFeature	desminopathies	C563319
11875	27941998	1419	1422	GeneOrGeneProduct	bax	24887,581
11876	27941998	1424	1428	GeneOrGeneProduct	ATF2	1386,81647
11877	27941998	1438	1443	GeneOrGeneProduct	bcl-2	24224,596
11878	27941998	1445	1451	GeneOrGeneProduct	bcl-xl	24888,598
11879	27941998	1455	1458	GeneOrGeneProduct	HK2	25059,3099
11880	27941998	1520	1525	GeneOrGeneProduct	VDAC1	7416,83529
11881	27941998	1530	1536	GeneOrGeneProduct	desmin	1674,64362
11882	27941998	1591	1603	DiseaseOrPhenotypicFeature	desminopathy	C563319
11883	27941998	1631	1634	OrganismTaxon	rat	10116
11884	27941998	1644	1656	DiseaseOrPhenotypicFeature	desminopathy	C563319
11885	27941998	1682	1688	GeneOrGeneProduct	desmin	64362
11886	27941998	1697	1705	DiseaseOrPhenotypicFeature	myopathy	D009135
11887	27959382	0	5	GeneOrGeneProduct	Bach1	12013
11888	27959382	23	32	ChemicalEntity	bleomycin	D001761
11889	27959382	41	59	DiseaseOrPhenotypicFeature	pulmonary fibrosis	D011658
11890	27959382	94	98	OrganismTaxon	mice	10090
11891	27959382	144	156	DiseaseOrPhenotypicFeature	inflammation	D007249
11892	27959382	161	169	DiseaseOrPhenotypicFeature	fibrosis	D005355
11893	27959382	171	176	GeneOrGeneProduct	Bach1	12013
11894	27959382	314	332	DiseaseOrPhenotypicFeature	pulmonary fibrosis	D011658
11895	27959382	334	336	DiseaseOrPhenotypicFeature	PF	D011658
11896	27959382	370	375	GeneOrGeneProduct	Bach1	12013
11897	27959382	464	469	GeneOrGeneProduct	Bach1	12013
11898	27959382	516	520	OrganismTaxon	mice	10090
11899	27959382	526	535	ChemicalEntity	bleomycin	D001761
11900	27959382	537	540	ChemicalEntity	BLM	D001761
11901	27959382	550	552	DiseaseOrPhenotypicFeature	PF	D011658
11902	27959382	554	559	OrganismTaxon	Mouse	10090
11903	27959382	604	639	GeneOrGeneProduct	transforming growth factor (TGF)-b1	21803
11904	27959382	708	713	GeneOrGeneProduct	Bach1	12013
11905	27959382	725	730	GeneOrGeneProduct	Bach1	12013
11906	27959382	819	824	GeneOrGeneProduct	Bach1	12013
11907	27959382	906	911	OrganismTaxon	mouse	10090
11908	27959382	921	924	ChemicalEntity	BLM	D001761
11909	27959382	933	935	DiseaseOrPhenotypicFeature	PF	D011658
11910	27959382	957	962	GeneOrGeneProduct	Bach1	12013
11911	27959382	1005	1009	OrganismTaxon	mice	10090
11912	27959382	1059	1064	GeneOrGeneProduct	Bach1	12013
11913	27959382	1125	1130	GeneOrGeneProduct	Bach1	12013
11914	27959382	1174	1179	GeneOrGeneProduct	Bach1	12013
11915	27959382	1244	1260	GeneOrGeneProduct	heme oxygenase-1	15368
11916	27959382	1265	1289	GeneOrGeneProduct	glutathione peroxidase 1	14775
11917	27959382	1315	1321	GeneOrGeneProduct	TGF-b1	21803
11918	27959382	1326	1339	GeneOrGeneProduct	interleukin-6	16193
11919	27959382	1400	1406	GeneOrGeneProduct	TGF-b1	21803
11920	27959382	1414	1419	GeneOrGeneProduct	Bach1	12013
11921	27959382	1471	1490	GeneOrGeneProduct	antioxidant factors	14775,15368
11922	27959382	1515	1523	DiseaseOrPhenotypicFeature	fibrosis	D005355
11923	27959382	1545	1549	OrganismTaxon	mice	10090
11924	27959382	1568	1571	ChemicalEntity	BLM	D001761
11925	27959382	1592	1604	DiseaseOrPhenotypicFeature	inflammatory	D007249
11926	27959382	1746	1751	GeneOrGeneProduct	Bach1	12013
11927	27959382	1785	1788	ChemicalEntity	BLM	D001761
11928	27959382	1840	1845	GeneOrGeneProduct	Bach1	12013
11929	27959382	1886	1889	ChemicalEntity	BLM	D001761
11930	27959382	1898	1900	DiseaseOrPhenotypicFeature	PF	D011658
11931	27959382	1904	1908	OrganismTaxon	mice	10090
11932	27959382	2006	2008	DiseaseOrPhenotypicFeature	PF	D011658
11933	27959387	22	27	CellLine	MCF-7	9606
11934	27959387	28	41	DiseaseOrPhenotypicFeature	breast cancer	D001943
11935	27959387	51	58	ChemicalEntity	ethanol	D000431
11936	27959387	90	97	ChemicalEntity	Alcohol	D000438
11937	27959387	131	144	DiseaseOrPhenotypicFeature	breast cancer	D001943
11938	27959387	215	227	ChemicalEntity	acetaldehyde	D000079
11939	27959387	231	239	ChemicalEntity	estrogen	D004967
11940	27959387	326	333	ChemicalEntity	ethanol	D000431
11941	27959387	341	348	ChemicalEntity	alcohol	D000438
11942	27959387	361	368	CellLine	MCF-12A	9606
11943	27959387	372	377	OrganismTaxon	human	9606
11944	27959387	530	535	OrganismTaxon	human	9606
11945	27959387	536	549	DiseaseOrPhenotypicFeature	breast cancer	D001943
11946	27959387	560	565	CellLine	MCF-7	9606
11947	27959387	597	604	ChemicalEntity	ethanol	D000431
11948	27959387	745	752	ChemicalEntity	ethanol	D000431
11949	27959387	797	804	ChemicalEntity	alcohol	D000438
11950	27959387	881	885	GeneOrGeneProduct	Oct4	5460
11951	27959387	890	895	GeneOrGeneProduct	Nanog	79923
11952	27959387	981	988	ChemicalEntity	ethanol	D000431
11953	27959387	1005	1009	GeneOrGeneProduct	Oct4	5460
11954	27959387	1014	1019	GeneOrGeneProduct	Nanog	79923
11955	27959387	1045	1055	DiseaseOrPhenotypicFeature	malignancy	D009369
11956	27959387	1063	1070	GeneOrGeneProduct	Ceacam6	4680
11957	27959387	1157	1172	GeneOrGeneProduct	metallothionein	4501
11958	27959387	1193	1197	GeneOrGeneProduct	MT1X	4501
11959	27959387	1249	1259	DiseaseOrPhenotypicFeature	malignancy	D009369
11960	27959387	1275	1281	GeneOrGeneProduct	STEAP4	79689
11961	27959387	1283	1291	GeneOrGeneProduct	SERPINA3	12
11962	27959387	1293	1298	GeneOrGeneProduct	SAMD9	54809
11963	27959387	1300	1305	GeneOrGeneProduct	GDF15	9518
11964	27959387	1307	1312	GeneOrGeneProduct	KRT15	3866
11965	27959387	1314	1319	GeneOrGeneProduct	ITGB6	3694
11966	27959387	1321	1325	GeneOrGeneProduct	TP63	8626
11967	27959387	1331	1334	GeneOrGeneProduct	PGR	5241
11968	27959387	1351	1357	GeneOrGeneProduct	CEACAM	4680
11969	27959387	1359	1369	GeneOrGeneProduct	interferon	282617
11970	27959387	1383	1386	GeneOrGeneProduct	HLA	3123
11971	27959387	1540	1544	GeneOrGeneProduct	Oct4	5460
11972	27959387	1592	1602	DiseaseOrPhenotypicFeature	malignancy	D009369
11973	27959387	1620	1628	ChemicalEntity	estrogen	D004967
11974	27959387	1659	1666	ChemicalEntity	ethanol	D000431
11975	27959387	1790	1802	ChemicalEntity	acetaldehyde	D000079
11976	27959387	1857	1864	ChemicalEntity	ethanol	D000431
11977	27959387	1887	1894	ChemicalEntity	alcohol	D000438
11978	27959387	2010	2017	ChemicalEntity	alcohol	D000438
11979	27959387	2070	2083	DiseaseOrPhenotypicFeature	breast cancer	D001943
11980	27993978	0	5	GeneOrGeneProduct	CenpH	26886
11981	27993978	58	67	GeneOrGeneProduct	APC/CCdh1	56371
11982	27993978	68	77	GeneOrGeneProduct	cyclin B1	268697
11983	27993978	258	263	GeneOrGeneProduct	CenpH	26886
11984	27993978	355	360	OrganismTaxon	mouse	10090
11985	27993978	383	388	GeneOrGeneProduct	CenpH	26886
11986	27993978	392	402	ChemicalEntity	morpholino	D060172
11987	27993978	423	432	GeneOrGeneProduct	cyclin B1	268697
11988	27993978	469	496	GeneOrGeneProduct	maturation-promoting factor	268697
11989	27993978	498	501	GeneOrGeneProduct	MPF	268697
11990	27993978	560	565	GeneOrGeneProduct	CenpH	26886
11991	27993978	575	584	GeneOrGeneProduct	cyclin B1	268697
11992	27993978	634	639	GeneOrGeneProduct	APC/C	56371
11993	27993978	640	644	GeneOrGeneProduct	Cdh1	56371
11994	27993978	677	682	GeneOrGeneProduct	CenpH	26886
11995	27993978	737	746	GeneOrGeneProduct	cyclin B1	268697
11996	27993978	771	776	GeneOrGeneProduct	CenpH	26886
11997	27993978	918	923	GeneOrGeneProduct	CenpH	26886
11998	27993978	980	985	GeneOrGeneProduct	APC/C	56371
11999	27993978	986	990	GeneOrGeneProduct	Cdh1	56371
12000	27993978	992	1001	GeneOrGeneProduct	cyclin B1	268697
12001	27999109	24	50	GeneOrGeneProduct	Type I Interferon Receptor	288264,686326
12002	27999109	68	87	DiseaseOrPhenotypicFeature	Autoimmune Diabetes	D003922
12003	27999109	91	95	OrganismTaxon	Rats	10116
12004	27999109	117	122	OrganismTaxon	human	9606
12005	27999109	123	138	DiseaseOrPhenotypicFeature	type 1 diabetes	D003922
12006	27999109	183	190	GeneOrGeneProduct	insulin	3630
12007	27999109	243	258	DiseaseOrPhenotypicFeature	viral infection	D014777
12008	27999109	332	349	GeneOrGeneProduct	type I interferon	3456
12009	27999109	351	354	GeneOrGeneProduct	IFN	3439
12010	27999109	360	372	GeneOrGeneProduct	IFN receptor	3454
12011	27999109	451	456	OrganismTaxon	human	9606
12012	27999109	457	472	DiseaseOrPhenotypicFeature	type 1 diabetes	D003922
12013	27999109	494	499	OrganismTaxon	human	9606
12014	27999109	500	515	DiseaseOrPhenotypicFeature	type 1 diabetes	D003922
12015	27999109	563	566	OrganismTaxon	rat	10116
12016	27999109	574	582	DiseaseOrPhenotypicFeature	Diabetes	D003920
12017	27999109	619	623	OrganismTaxon	rats	10116
12018	27999109	672	703	ChemicalEntity	polyinosinic:polycytidylic acid	D011070
12019	27999109	705	713	ChemicalEntity	poly I:C	D011070
12020	27999109	760	779	GeneOrGeneProduct	type I IFN receptor	288264,686326
12021	27999109	781	804	GeneOrGeneProduct	type I IFN a/b receptor	288264,686326
12022	27999109	806	811	GeneOrGeneProduct	IFNAR	288264,686326
12023	27999109	827	830	GeneOrGeneProduct	IFN	25712
12024	27999109	897	905	DiseaseOrPhenotypicFeature	diabetes	D003920
12025	27999109	920	926	GeneOrGeneProduct	IFNAR1	288264
12026	27999109	954	958	OrganismTaxon	rats	10116
12027	27999109	1116	1122	GeneOrGeneProduct	Ifnar1	288264
12028	27999109	1129	1135	GeneOrGeneProduct	IFNAR1	288264
12029	27999109	1196	1204	DiseaseOrPhenotypicFeature	diabetes	D003920
12030	27999109	1242	1251	DiseaseOrPhenotypicFeature	insulitis	D007410
12031	27999109	1258	1266	ChemicalEntity	poly I:C	D011070
12032	27999109	1296	1312	OrganismTaxon	Kilham rat virus	12441
12033	27999109	1321	1329	DiseaseOrPhenotypicFeature	diabetes	D003920
12034	27999109	1353	1359	GeneOrGeneProduct	IFNAR1	288264
12035	27999109	1471	1490	DiseaseOrPhenotypicFeature	autoimmune diabetes	D003922
12036	27999109	1573	1588	DiseaseOrPhenotypicFeature	type 1 diabetes	D003922
12037	28068934	20	26	GeneOrGeneProduct	PIK3CA	5290
12038	28068934	95	129	DiseaseOrPhenotypicFeature	esophageal squamous cell carcinoma	D000077277
12039	28068934	143	149	GeneOrGeneProduct	PIK3CA	5290
12040	28068934	213	247	DiseaseOrPhenotypicFeature	esophageal squamous cell carcinoma	D000077277
12041	28068934	249	253	DiseaseOrPhenotypicFeature	ESCC	D000077277
12042	28068934	300	306	GeneOrGeneProduct	PIK3CA	5290
12043	28068934	457	463	GeneOrGeneProduct	PIK3CA	5290
12044	28068934	470	475	SequenceVariant	E542K	rs121913273
12045	28068934	477	482	SequenceVariant	E545K	rs104886003
12046	28068934	484	489	SequenceVariant	E546K	p|SUB|E|546|K
12047	28068934	491	497	SequenceVariant	H1047R	rs121913279
12048	28068934	503	509	SequenceVariant	H1047L	rs121913279
12049	28068934	514	522	ChemicalEntity	formalin	D005557
12050	28068934	533	541	ChemicalEntity	paraffin	D010232
12051	28068934	638	646	OrganismTaxon	patients	9606
12052	28068934	681	685	DiseaseOrPhenotypicFeature	ESCC	D000077277
12053	28068934	916	922	GeneOrGeneProduct	PIK3CA	5290
12054	28068934	1192	1200	OrganismTaxon	patients	9606
12055	28068934	1208	1214	GeneOrGeneProduct	PIK3CA	5290
12056	28068934	1285	1291	GeneOrGeneProduct	PIK3CA	5290
12057	28068934	1410	1416	GeneOrGeneProduct	PIK3CA	5290
12058	28068934	1598	1604	GeneOrGeneProduct	PIK3CA	5290
12059	28068934	1639	1645	GeneOrGeneProduct	PIK3CA	5290
12060	28068934	1758	1765	OrganismTaxon	patient	9606
12061	28068934	1844	1850	GeneOrGeneProduct	PIK3CA	5290
12062	28068934	1864	1872	OrganismTaxon	patients	9606
12063	28068934	1878	1882	DiseaseOrPhenotypicFeature	ESCC	D000077277
12064	28075473	0	9	OrganismTaxon	Spirulina	551299
12065	28075473	10	29	ChemicalEntity	lipopolysaccharides	D008070
12066	28075473	38	43	DiseaseOrPhenotypicFeature	tumor	D009369
12067	28075473	56	76	GeneOrGeneProduct	Toll-like receptor 4	21898
12068	28075473	131	145	GeneOrGeneProduct	interleukin-17	16171
12069	28075473	146	160	GeneOrGeneProduct	interleukin-23	83430
12070	28075473	164	176	GeneOrGeneProduct	interferon-g	15978
12071	28075473	220	239	GeneOrGeneProduct	interleukin (IL)-17	16171,3605
12072	28075473	267	272	DiseaseOrPhenotypicFeature	tumor	D009369
12073	28075473	288	294	OrganismTaxon	humans	9606
12074	28075473	302	306	OrganismTaxon	mice	10090
12075	28075473	308	312	GeneOrGeneProduct	IL-6	16193
12076	28075473	317	322	GeneOrGeneProduct	IL-23	83430
12077	28075473	425	444	ChemicalEntity	lipopolysaccharides	D008070
12078	28075473	446	449	ChemicalEntity	LPS	D008070
12079	28075473	503	525	GeneOrGeneProduct	inflammatory cytokines	-
12080	28075473	539	555	OrganismTaxon	Escherichia coli	562
12081	28075473	557	564	OrganismTaxon	E. coli	562
12082	28075473	566	569	ChemicalEntity	LPS	D008070
12083	28075473	571	574	ChemicalEntity	LPS	D008070
12084	28075473	580	589	OrganismTaxon	Spirulina	551299
12085	28075473	598	606	DiseaseOrPhenotypicFeature	toxicity	D064420
12086	28075473	648	652	GeneOrGeneProduct	IL-6	16193
12087	28075473	657	662	GeneOrGeneProduct	IL-23	83430
12088	28075473	666	670	OrganismTaxon	mice	10090
12089	28075473	709	718	OrganismTaxon	Spirulina	551299
12090	28075473	719	722	ChemicalEntity	LPS	D008070
12091	28075473	735	742	OrganismTaxon	E. coli	562
12092	28075473	743	746	ChemicalEntity	LPS	D008070
12093	28075473	753	758	CellLine	MH134	10090
12094	28075473	759	767	DiseaseOrPhenotypicFeature	hepatoma	D006528
12095	28075473	793	802	OrganismTaxon	Spirulina	551299
12096	28075473	803	806	ChemicalEntity	LPS	D008070
12097	28075473	818	823	DiseaseOrPhenotypicFeature	tumor	D009369
12098	28075473	842	846	OrganismTaxon	mice	10090
12099	28075473	859	879	GeneOrGeneProduct	Toll-like receptor 4	21898
12100	28075473	881	885	GeneOrGeneProduct	TLR4	21898
12101	28075473	902	906	OrganismTaxon	mice	10090
12102	28075473	936	941	GeneOrGeneProduct	IL-17	16171
12103	28075473	946	951	GeneOrGeneProduct	IL-23	83430
12104	28075473	970	988	GeneOrGeneProduct	interferon (IFN)-g	15978
12105	28075473	1024	1029	GeneOrGeneProduct	IFN-g	15978
12106	28075473	1110	1119	OrganismTaxon	Spirulina	551299
12107	28075473	1120	1123	ChemicalEntity	LPS	D008070
12108	28075473	1197	1202	GeneOrGeneProduct	IL-17	16171
12109	28075473	1224	1249	GeneOrGeneProduct	toll-like receptor (TLR)4	21898
12110	28075473	1295	1300	GeneOrGeneProduct	IL-17	16171
12111	28075473	1313	1318	DiseaseOrPhenotypicFeature	tumor	D009369
12112	28075473	1335	1339	OrganismTaxon	mice	10090
12113	28075473	1358	1367	OrganismTaxon	Spirulina	551299
12114	28075473	1368	1371	ChemicalEntity	LPS	D008070
12115	28075473	1392	1397	DiseaseOrPhenotypicFeature	tumor	D009369
12116	28075473	1419	1424	GeneOrGeneProduct	IFN-g	15978
12117	28075473	1478	1483	GeneOrGeneProduct	IFN-g	15978
12118	28075473	1488	1493	GeneOrGeneProduct	IL-17	16171
12119	28075473	1494	1499	GeneOrGeneProduct	IL-23	83430
12120	28075473	1544	1549	DiseaseOrPhenotypicFeature	tumor	D009369
12121	28075473	1569	1578	OrganismTaxon	Spirulina	551299
12122	28075473	1579	1582	ChemicalEntity	LPS	D008070
12123	28075473	1612	1617	GeneOrGeneProduct	IFN-g	15978
12124	28075473	1618	1623	GeneOrGeneProduct	IL-17	16171
12125	28075473	1624	1629	GeneOrGeneProduct	IL-23	83430
12126	28075473	1643	1648	GeneOrGeneProduct	IFN-g	15978
12127	28075473	1676	1681	DiseaseOrPhenotypicFeature	tumor	D009369
12128	28075473	1707	1716	OrganismTaxon	Spirulina	551299
12129	28075473	1717	1720	ChemicalEntity	LPS	D008070
12130	28075473	1774	1788	DiseaseOrPhenotypicFeature	mammary tumors	D001943
12131	28075473	1852	1855	GeneOrGeneProduct	TLR	21898
12132	28075473	1883	1889	DiseaseOrPhenotypicFeature	cancer	D009369
12133	28101574	0	4	GeneOrGeneProduct	NEK2	4751
12134	28101574	42	66	DiseaseOrPhenotypicFeature	hepatocellular carcinoma	D006528
12135	28101574	68	115	GeneOrGeneProduct	Never in mitosis gene A (NIMA)-related kinase 2	4751
12136	28101574	117	121	GeneOrGeneProduct	NEK2	4751
12137	28101574	128	158	GeneOrGeneProduct	microtubule-associated protein	4130
12138	28101574	194	199	OrganismTaxon	human	9606
12139	28101574	238	250	DiseaseOrPhenotypicFeature	malignancies	D009369
12140	28101574	273	277	GeneOrGeneProduct	NEK2	4751
12141	28101574	281	305	DiseaseOrPhenotypicFeature	hepatocellular carcinoma	D006528
12142	28101574	307	310	DiseaseOrPhenotypicFeature	HCC	D006528
12143	28101574	362	365	DiseaseOrPhenotypicFeature	HCC	D006528
12144	28101574	376	385	CellLine	SMMC-7721	9606
12145	28101574	417	424	CellLine	HL-7702	9606
12146	28101574	454	458	GeneOrGeneProduct	NEK2	4751
12147	28101574	582	585	DiseaseOrPhenotypicFeature	HCC	D006528
12148	28101574	664	668	GeneOrGeneProduct	NEK2	4751
12149	28101574	700	708	OrganismTaxon	patients	9606
12150	28101574	714	717	DiseaseOrPhenotypicFeature	HCC	D006528
12151	28101574	757	763	DiseaseOrPhenotypicFeature	Cancer	D009369
12152	28101574	849	853	GeneOrGeneProduct	NEK2	4751
12153	28101574	863	866	GeneOrGeneProduct	AKT	207
12154	28101574	871	876	GeneOrGeneProduct	MMP-2	4130
12155	28101574	930	933	DiseaseOrPhenotypicFeature	HCC	D006528
12156	28101574	1103	1107	GeneOrGeneProduct	NEK2	4751
12157	28101574	1121	1124	GeneOrGeneProduct	AKT	207
12158	28101574	1129	1134	GeneOrGeneProduct	MMP-2	4130
12159	28101574	1323	1326	DiseaseOrPhenotypicFeature	HCC	D006528
12160	28101574	1328	1332	GeneOrGeneProduct	NEK2	4751
12161	28101574	1431	1434	DiseaseOrPhenotypicFeature	HCC	D006528
12162	28101574	1481	1485	GeneOrGeneProduct	NEK2	4751
12163	28101574	1507	1510	DiseaseOrPhenotypicFeature	HCC	D006528
12164	28101574	1552	1555	DiseaseOrPhenotypicFeature	HCC	D006528
12165	28101574	1556	1564	OrganismTaxon	patients	9606
12166	28101574	1591	1595	GeneOrGeneProduct	NEK2	4751
12167	28101574	1684	1688	GeneOrGeneProduct	NEK2	4751
12168	28101574	1692	1695	DiseaseOrPhenotypicFeature	HCC	D006528
12169	28101574	1758	1763	DiseaseOrPhenotypicFeature	tumor	D009369
12170	28101574	1814	1818	GeneOrGeneProduct	NEK2	4751
12171	28101574	1887	1890	GeneOrGeneProduct	AKT	207
12172	28101574	1913	1918	GeneOrGeneProduct	MMP-2	4130
12173	28101574	1956	1960	GeneOrGeneProduct	NEK2	4751
12174	28101574	2026	2033	OrganismTaxon	patient	9606
12175	28101574	2060	2064	GeneOrGeneProduct	NEK2	4751
12176	28101574	2102	2105	DiseaseOrPhenotypicFeature	HCC	D006528
12177	28101574	2121	2125	GeneOrGeneProduct	NEK2	4751
12178	28101574	2172	2189	DiseaseOrPhenotypicFeature	metastasis of HCC	D006528,D009362
12179	28101574	2229	2232	GeneOrGeneProduct	AKT	207
12180	28101574	2260	2265	GeneOrGeneProduct	MMP-2	4130
12181	28148288	0	27	GeneOrGeneProduct	Metalloprotease-disintegrin	8038
12182	28148288	28	34	GeneOrGeneProduct	ADAM12	8038
12183	28148288	85	92	GeneOrGeneProduct	claudin	9076
12184	28148288	97	110	DiseaseOrPhenotypicFeature	breast cancer	D001943
12185	28148288	124	130	GeneOrGeneProduct	ADAM12	8038
12186	28148288	149	154	OrganismTaxon	human	9606
12187	28148288	155	169	DiseaseOrPhenotypicFeature	breast cancers	D001943
12188	28148288	211	228	GeneOrGeneProduct	estrogen receptor	2099
12189	28148288	238	244	DiseaseOrPhenotypicFeature	tumors	D009369
12190	28148288	246	252	GeneOrGeneProduct	ADAM12	8038
12191	28148288	335	342	GeneOrGeneProduct	claudin	9076
12192	28148288	347	360	DiseaseOrPhenotypicFeature	breast tumors	D001943
12193	28148288	384	390	DiseaseOrPhenotypicFeature	cancer	D009369
12194	28148288	448	454	GeneOrGeneProduct	ADAM12	8038
12195	28148288	510	523	DiseaseOrPhenotypicFeature	breast cancer	D001943
12196	28148288	540	546	GeneOrGeneProduct	ADAM12	8038
12197	28148288	594	601	GeneOrGeneProduct	claudin	9076
12198	28148288	606	619	DiseaseOrPhenotypicFeature	breast cancer	D001943
12199	28148288	632	640	CellLine	SUM159PT	9606
12200	28148288	645	651	CellLine	Hs578T	9606
12201	28148288	852	856	GeneOrGeneProduct	ALDH	217
12202	28148288	889	893	GeneOrGeneProduct	CD44	960
12203	28148288	898	902	GeneOrGeneProduct	CD24	100133941
12204	28148288	938	943	DiseaseOrPhenotypicFeature	tumor	D009369
12205	28148288	957	961	OrganismTaxon	mice	10090
12206	28148288	1104	1110	GeneOrGeneProduct	ADAM12	8038
12207	28148288	1152	1160	CellLine	SUM159PT	9606
12208	28148288	1188	1194	GeneOrGeneProduct	ADAM12	8038
12209	28148288	1288	1294	GeneOrGeneProduct	ADAM12	8038
12210	28148288	1411	1417	GeneOrGeneProduct	ADAM12	8038
12211	28148288	1461	1465	GeneOrGeneProduct	CD44	960
12212	28148288	1470	1474	GeneOrGeneProduct	CD24	100133941
12213	28148288	1527	1540	DiseaseOrPhenotypicFeature	tumorigenesis	D009369
12214	28148288	1544	1548	OrganismTaxon	mice	10090
12215	28148288	1614	1620	GeneOrGeneProduct	ADAM12	8038
12216	28148288	1626	1658	GeneOrGeneProduct	Epidermal Growth Factor Receptor	1956
12217	28148288	1660	1664	GeneOrGeneProduct	EGFR	1956
12218	28148288	1697	1703	GeneOrGeneProduct	ADAM12	8038
12219	28148288	1752	1756	GeneOrGeneProduct	EGFR	1956
12220	28148288	1791	1801	ChemicalEntity	batimastat	C080985
12221	28148288	1805	1822	GeneOrGeneProduct	metalloproteinase	8038
12222	28148288	1890	1893	GeneOrGeneProduct	EGF	1950
12223	28148288	1926	1930	GeneOrGeneProduct	CD44	960
12224	28148288	1935	1939	GeneOrGeneProduct	CD24	100133941
12225	28148288	1965	1971	GeneOrGeneProduct	ADAM12	8038
12226	28148288	2024	2030	GeneOrGeneProduct	ADAM12	8038
12227	28148288	2070	2077	GeneOrGeneProduct	claudin	9076
12228	28148288	2082	2095	DiseaseOrPhenotypicFeature	breast cancer	D001943
12229	28148288	2124	2128	GeneOrGeneProduct	EGFR	1956
12230	28151486	0	8	GeneOrGeneProduct	Star-PAP	64852
12231	28151486	12	30	GeneOrGeneProduct	poly(A) polymerase	64852
12232	28151486	47	52	DiseaseOrPhenotypicFeature	tumor	D009369
12233	28151486	81	86	OrganismTaxon	human	9606
12234	28151486	87	100	DiseaseOrPhenotypicFeature	breast cancer	D001943
12235	28151486	108	116	GeneOrGeneProduct	Star-PAP	64852
12236	28151486	135	153	GeneOrGeneProduct	poly(A) polymerase	64852
12237	28151486	246	254	GeneOrGeneProduct	Star-PAP	64852
12238	28151486	258	264	DiseaseOrPhenotypicFeature	cancer	D009369
12239	28151486	341	349	GeneOrGeneProduct	Star-PAP	64852
12240	28151486	353	366	DiseaseOrPhenotypicFeature	breast cancer	D001943
12241	28151486	399	407	GeneOrGeneProduct	Star-PAP	64852
12242	28151486	480	493	DiseaseOrPhenotypicFeature	breast cancer	D001943
12243	28151486	504	517	DiseaseOrPhenotypicFeature	breast cancer	D001943
12244	28151486	518	526	OrganismTaxon	patients	9606
12245	28151486	543	551	GeneOrGeneProduct	Star-PAP	64852
12246	28151486	633	636	GeneOrGeneProduct	BIK	638
12247	28151486	638	661	GeneOrGeneProduct	BCL2-interacting killer	638
12248	28151486	664	672	GeneOrGeneProduct	Star-PAP	64852
12249	28151486	694	707	DiseaseOrPhenotypicFeature	breast cancer	D001943
12250	28151486	763	776	DiseaseOrPhenotypicFeature	breast cancer	D001943
12251	28151486	795	799	DiseaseOrPhenotypicFeature	SCID	D016511
12252	28151486	800	804	OrganismTaxon	mice	10090
12253	28151486	831	842	ChemicalEntity	doxycycline	D004318
12254	28151486	851	859	GeneOrGeneProduct	Star-PAP	64852
12255	28151486	889	897	GeneOrGeneProduct	Star-PAP	64852
12256	28151486	909	922	DiseaseOrPhenotypicFeature	breast cancer	D001943
12257	28151486	1007	1015	GeneOrGeneProduct	Star-PAP	64852
12258	28151486	1159	1167	GeneOrGeneProduct	Star-PAP	64852
12259	28151486	1178	1183	DiseaseOrPhenotypicFeature	tumor	D009369
12260	28151486	1253	1259	DiseaseOrPhenotypicFeature	cancer	D009369
12261	28204828	0	5	GeneOrGeneProduct	TIEG1	21847
12262	28204828	63	78	DiseaseOrPhenotypicFeature	infarcted heart	D009203
12263	28204828	96	100	GeneOrGeneProduct	Pten	19211
12264	28204828	101	104	GeneOrGeneProduct	Akt	11651
12265	28204828	129	186	GeneOrGeneProduct	transforming growth factor (TGF)-b-inducible early gene-1	21847
12266	28204828	188	193	GeneOrGeneProduct	TIEG1	21847
12267	28204828	298	315	DiseaseOrPhenotypicFeature	pancreatic cancer	D010190
12268	28204828	317	326	DiseaseOrPhenotypicFeature	leukaemia	D007938
12269	28204828	331	343	DiseaseOrPhenotypicFeature	osteoporosis	D010024
12270	28204828	377	382	GeneOrGeneProduct	TIEG1	21847
12271	28204828	473	478	GeneOrGeneProduct	TIEG1	21847
12272	28204828	482	505	DiseaseOrPhenotypicFeature	ischaemic heart disease	D017202
12273	28204828	572	577	GeneOrGeneProduct	TIEG1	21847
12274	28204828	611	615	OrganismTaxon	mice	10090
12275	28204828	917	938	DiseaseOrPhenotypicFeature	myocardial infarction	D009203
12276	28204828	940	942	DiseaseOrPhenotypicFeature	MI	D009203
12277	28204828	971	976	GeneOrGeneProduct	TIEG1	21847
12278	28204828	987	991	OrganismTaxon	mice	10090
12279	28204828	1046	1048	DiseaseOrPhenotypicFeature	MI	D009203
12280	28204828	1108	1110	DiseaseOrPhenotypicFeature	MI	D009203
12281	28204828	1180	1187	DiseaseOrPhenotypicFeature	infarct	D007238
12282	28204828	1226	1262	GeneOrGeneProduct	terminal deoxynucleotidyltransferase	1791
12283	28204828	1272	1276	ChemicalEntity	dUTP	C027078
12284	28204828	1335	1356	GeneOrGeneProduct	a-smooth muscle actin	11475
12285	28204828	1358	1363	GeneOrGeneProduct	a-SMA	11475
12286	28204828	1365	1369	GeneOrGeneProduct	CD31	18613
12287	28204828	1488	1493	GeneOrGeneProduct	TIEG1	21847
12288	28204828	1674	1679	GeneOrGeneProduct	TIEG1	21847
12289	28204828	1908	1913	GeneOrGeneProduct	TIEG1	21847
12290	28204828	1917	1921	OrganismTaxon	mice	10090
12291	28204828	1970	2000	GeneOrGeneProduct	phosphatase and tensin homolog	19211
12292	28204828	2002	2006	GeneOrGeneProduct	Pten	19211
12293	28204828	2009	2012	GeneOrGeneProduct	Akt	11651
12294	28204828	2017	2022	GeneOrGeneProduct	Bcl-2	12043
12295	28204828	2023	2026	GeneOrGeneProduct	Bax	12028
12296	28204828	2039	2073	GeneOrGeneProduct	vascular endothelial growth factor	22339
12297	28204828	2075	2079	GeneOrGeneProduct	VEGF	22339
12298	28204828	2138	2143	GeneOrGeneProduct	TIEG1	21847
12299	28204828	2177	2200	DiseaseOrPhenotypicFeature	ischaemic heart disease	D017202
12300	28204828	2225	2229	GeneOrGeneProduct	Pten	19211
12301	28204828	2230	2233	GeneOrGeneProduct	Akt	11651
12302	28259923	0	31	GeneOrGeneProduct	Pleomorphic adenoma gene like-2	5326
12303	28259923	78	81	GeneOrGeneProduct	Wnt	7474
12304	28259923	82	91	GeneOrGeneProduct	b-catenin	1499
12305	28259923	113	118	OrganismTaxon	human	9606
12306	28259923	119	144	DiseaseOrPhenotypicFeature	colorectal adenocarcinoma	D015179
12307	28259923	261	266	DiseaseOrPhenotypicFeature	tumor	D009369
12308	28259923	274	299	DiseaseOrPhenotypicFeature	Colorectal adenocarcinoma	D015179
12309	28259923	301	304	DiseaseOrPhenotypicFeature	CRC	D015179
12310	28259923	318	324	DiseaseOrPhenotypicFeature	cancer	D009369
12311	28259923	331	341	DiseaseOrPhenotypicFeature	metastasis	D009362
12312	28259923	364	371	OrganismTaxon	patient	9606
12313	28259923	407	438	GeneOrGeneProduct	pleomorphic adenoma gene like-2	5326
12314	28259923	440	446	GeneOrGeneProduct	PLAGL2	5326
12315	28259923	461	466	DiseaseOrPhenotypicFeature	tumor	D009369
12316	28259923	545	551	DiseaseOrPhenotypicFeature	cancer	D009369
12317	28259923	600	606	GeneOrGeneProduct	PLAGL2	5326
12318	28259923	627	630	DiseaseOrPhenotypicFeature	CRC	D015179
12319	28259923	631	639	OrganismTaxon	patients	9606
12320	28259923	674	680	GeneOrGeneProduct	PLAGL2	5326
12321	28259923	697	700	DiseaseOrPhenotypicFeature	CRC	D015179
12322	28259923	711	716	CellLine	SW480	9606
12323	28259923	732	738	GeneOrGeneProduct	PLAGL2	5326
12324	28259923	773	781	ChemicalEntity	paraffin	D010232
12325	28259923	791	794	DiseaseOrPhenotypicFeature	CRC	D015179
12326	28259923	873	879	GeneOrGeneProduct	PLAGL2	5326
12327	28259923	908	914	GeneOrGeneProduct	PLAGL2	5326
12328	28259923	1064	1074	GeneOrGeneProduct	N-cadherin	1000
12329	28259923	1079	1087	GeneOrGeneProduct	vimentin	7431
12330	28259923	1140	1150	GeneOrGeneProduct	E-cadherin	999
12331	28259923	1208	1214	GeneOrGeneProduct	PLAGL2	5326
12332	28259923	1234	1237	GeneOrGeneProduct	wnt	7474
12333	28259923	1258	1267	GeneOrGeneProduct	b-catenin	1499
12334	28259923	1288	1291	DiseaseOrPhenotypicFeature	CRC	D015179
12335	28259923	1297	1307	DiseaseOrPhenotypicFeature	metastasis	D009362
12336	28259923	1343	1349	GeneOrGeneProduct	PLAGL2	5326
12337	28259923	1365	1370	CellLine	SW480	9606
12338	28259923	1413	1417	OrganismTaxon	rats	10116
12339	28259923	1454	1460	GeneOrGeneProduct	PLAGL2	5326
12340	28259923	1504	1510	GeneOrGeneProduct	PLAGL2	5326
12341	28259923	1576	1579	GeneOrGeneProduct	Wnt	7474
12342	28259923	1580	1589	GeneOrGeneProduct	b-catenin	1499
12343	28260056	0	37	GeneOrGeneProduct	Insulin-like growth factor 1 receptor	16001
12344	28260056	64	71	DiseaseOrPhenotypicFeature	hypoxia	D000860
12345	28260056	133	137	GeneOrGeneProduct	PI3K	18706
12346	28260056	138	141	GeneOrGeneProduct	Akt	11651
12347	28260056	142	146	GeneOrGeneProduct	mTOR	56717
12348	28260056	166	173	DiseaseOrPhenotypicFeature	Hypoxia	D000860
12349	28260056	325	353	GeneOrGeneProduct	Insulin-like growth factor-1	16000
12350	28260056	355	360	GeneOrGeneProduct	IGF-1	16000
12351	28260056	455	462	DiseaseOrPhenotypicFeature	Hypoxia	D000860
12352	28260056	493	496	GeneOrGeneProduct	IGF	16000
12353	28260056	529	543	GeneOrGeneProduct	IGF-1 receptor	16001
12354	28260056	545	551	GeneOrGeneProduct	IGF-1R	16001
12355	28260056	556	563	DiseaseOrPhenotypicFeature	hypoxia	D000860
12356	28260056	671	677	GeneOrGeneProduct	IGF-1R	16001
12357	28260056	705	712	DiseaseOrPhenotypicFeature	hypoxic	D000860
12358	28260056	725	730	OrganismTaxon	Mouse	10090
12359	28260056	796	802	GeneOrGeneProduct	IGF-1R	16001
12360	28260056	901	924	ChemicalEntity	reactive oxygen species	D017382
12361	28260056	926	929	ChemicalEntity	ROS	D017382
12362	28260056	956	971	ChemicalEntity	3-methyladenine	C025946
12363	28260056	1018	1021	ChemicalEntity	ROS	D017382
12364	28260056	1053	1060	DiseaseOrPhenotypicFeature	hypoxic	D000860
12365	28260056	1124	1153	GeneOrGeneProduct	phosphatidylinositol 3-kinase	18706
12366	28260056	1155	1159	GeneOrGeneProduct	PI3K	18706
12367	28260056	1161	1187	GeneOrGeneProduct	threonine protein kinase B	11651
12368	28260056	1189	1192	GeneOrGeneProduct	Akt	11651
12369	28260056	1194	1223	GeneOrGeneProduct	mammalian target of rapamycin	56717
12370	28260056	1225	1229	GeneOrGeneProduct	mTOR	56717
12371	28260056	1301	1308	DiseaseOrPhenotypicFeature	hypoxia	D000860
12372	28260056	1338	1341	ChemicalEntity	ROS	D017382
12373	28260056	1510	1513	ChemicalEntity	ROS	D017382
12374	28260056	1646	1649	ChemicalEntity	ROS	D017382
12375	28260056	1740	1746	GeneOrGeneProduct	IGF-1R	16001
12376	28260056	1763	1767	GeneOrGeneProduct	PI3K	18706
12377	28260056	1768	1771	GeneOrGeneProduct	Akt	11651
12378	28260056	1772	1776	GeneOrGeneProduct	mTOR	56717
12379	28260056	1897	1901	GeneOrGeneProduct	PI3K	18706
12380	28260056	1912	1920	ChemicalEntity	LY294002	C085911
12381	28260056	1951	1957	GeneOrGeneProduct	IGF-1R	16001
12382	28260056	1992	1999	DiseaseOrPhenotypicFeature	hypoxic	D000860
12383	28260056	2049	2052	ChemicalEntity	ROS	D017382
12384	28260056	2086	2090	GeneOrGeneProduct	PI3K	18706
12385	28260056	2091	2094	GeneOrGeneProduct	Akt	11651
12386	28260056	2095	2099	GeneOrGeneProduct	mTOR	56717
12387	28260077	0	12	ChemicalEntity	Atorvastatin	D000069059
12388	28260077	30	58	DiseaseOrPhenotypicFeature	contrast-induced nephropathy	D007674
12389	28260077	101	106	GeneOrGeneProduct	Hsp27	24471
12390	28260077	129	157	DiseaseOrPhenotypicFeature	Contrast-induced nephropathy	D007674
12391	28260077	159	162	DiseaseOrPhenotypicFeature	CIN	D007674
12392	28260077	181	200	DiseaseOrPhenotypicFeature	acute renal failure	D058186
12393	28260077	331	334	DiseaseOrPhenotypicFeature	CIN	D007674
12394	28260077	413	425	ChemicalEntity	atorvastatin	D000069059
12395	28260077	443	446	DiseaseOrPhenotypicFeature	CIN	D007674
12396	28260077	497	502	GeneOrGeneProduct	Hsp27	24471
12397	28260077	546	558	ChemicalEntity	atorvastatin	D000069059
12398	28260077	570	573	DiseaseOrPhenotypicFeature	CIN	D007674
12399	28260077	579	591	DiseaseOrPhenotypicFeature	inflammatory	D007249
12400	28260077	639	642	OrganismTaxon	rat	10116
12401	28260077	652	661	ChemicalEntity	iopamidol	D007479
12402	28260077	670	673	DiseaseOrPhenotypicFeature	CIN	D007674
12403	28260077	688	693	OrganismTaxon	human	9606
12404	28260077	721	724	CellLine	HK2	9606
12405	28260077	756	760	OrganismTaxon	rats	10116
12406	28260077	830	834	OrganismTaxon	rats	10116
12407	28260077	836	840	OrganismTaxon	rats	10116
12408	28260077	841	853	ChemicalEntity	atorvastatin	D000069059
12409	28260077	855	859	OrganismTaxon	rats	10116
12410	28260077	862	871	ChemicalEntity	iopamidol	D007479
12411	28260077	873	877	OrganismTaxon	rats	10116
12412	28260077	878	887	ChemicalEntity	iopamidol	D007479
12413	28260077	888	900	ChemicalEntity	atorvastatin	D000069059
12414	28260077	916	919	CellLine	HK2	9606
12415	28260077	944	953	ChemicalEntity	iopamidol	D007479
12416	28260077	984	996	ChemicalEntity	atorvastatin	D000069059
12417	28260077	998	1024	GeneOrGeneProduct	heat shock protein (Hsp)27	3315
12418	28260077	1063	1068	GeneOrGeneProduct	Hsp27	3315
12419	28260077	1187	1199	ChemicalEntity	atorvastatin	D000069059
12420	28260077	1216	1261	DiseaseOrPhenotypicFeature	apoptosis and deterioration of renal function	D007674
12421	28260077	1285	1297	ChemicalEntity	atorvastatin	D000069059
12422	28260077	1310	1319	ChemicalEntity	iopamidol	D007479
12423	28260077	1340	1386	GeneOrGeneProduct	B cell lymphoma-2 (Bcl-2)-associated X protein	24887
12424	28260077	1388	1391	GeneOrGeneProduct	Bax	24887
12425	28260077	1393	1402	GeneOrGeneProduct	caspase-3	25402
12426	28260077	1435	1440	GeneOrGeneProduct	Bcl-2	24224
12427	28260077	1497	1502	GeneOrGeneProduct	Hsp27	3315
12428	28260077	1521	1526	GeneOrGeneProduct	Hsp27	3315
12429	28260077	1546	1555	ChemicalEntity	iopamidol	D007479
12430	28260077	1597	1600	GeneOrGeneProduct	Bax	581
12431	28260077	1601	1610	GeneOrGeneProduct	caspase-3	836
12432	28260077	1633	1638	GeneOrGeneProduct	Bcl-2	596
12433	28260077	1646	1649	CellLine	HK2	9606
12434	28260077	1719	1731	ChemicalEntity	atorvastatin	D000069059
12435	28260077	1750	1795	DiseaseOrPhenotypicFeature	contrast-induced renal tubular cell apoptosis	D007674
12436	28260077	1824	1829	GeneOrGeneProduct	Hsp27	24471
12437	28260110	21	27	ChemicalEntity	emodin	D004642
12438	28260110	31	50	GeneOrGeneProduct	fatty acid synthase	2194
12439	28260110	52	64	DiseaseOrPhenotypicFeature	colon cancer	D015179
12440	28260110	94	113	GeneOrGeneProduct	Fatty acid synthase	2194
12441	28260110	115	119	GeneOrGeneProduct	FASN	2194
12442	28260110	158	168	ChemicalEntity	fatty acid	D005227
12443	28260110	221	236	DiseaseOrPhenotypicFeature	colon carcinoma	D015179
12444	28260110	261	265	GeneOrGeneProduct	FASN	2194
12445	28260110	313	325	DiseaseOrPhenotypicFeature	colon cancer	D015179
12446	28260110	335	341	ChemicalEntity	Emodin	D004642
12447	28260110	365	378	ChemicalEntity	anthraquinone	D000880
12448	28260110	430	435	OrganismTaxon	human	9606
12449	28260110	436	442	DiseaseOrPhenotypicFeature	cancer	D009369
12450	28260110	454	466	DiseaseOrPhenotypicFeature	colon cancer	D015179
12451	28260110	669	678	GeneOrGeneProduct	Annexin V	308
12452	28260110	679	695	ChemicalEntity	propidium iodide	D011419
12453	28260110	706	710	GeneOrGeneProduct	FASN	2194
12454	28260110	760	803	ChemicalEntity	nicotinamide adenine dinucleotide phosphate	D009249
12455	28260110	849	864	ChemicalEntity	free fatty acid	D005230
12456	28260110	894	909	ChemicalEntity	Free Fatty Acid	D005230
12457	28260110	1138	1142	GeneOrGeneProduct	FASN	2194
12458	28260110	1187	1193	ChemicalEntity	emodin	D004642
12459	28260110	1199	1204	OrganismTaxon	human	9606
12460	28260110	1205	1217	DiseaseOrPhenotypicFeature	colon cancer	D015179
12461	28260110	1229	1235	ChemicalEntity	Emodin	D004642
12462	28260110	1276	1282	CellLine	HCT116	9606
12463	28260110	1319	1323	GeneOrGeneProduct	FASN	2194
12464	28260110	1361	1366	CellLine	SW480	9606
12465	28260110	1368	1375	CellLine	SNU-C2A	9606
12466	28260110	1379	1385	CellLine	SNU-C5	9606
12467	28260110	1393	1399	ChemicalEntity	Emodin	D004642
12468	28260110	1454	1458	GeneOrGeneProduct	FASN	2194
12469	28260110	1462	1468	CellLine	HCT116	9606
12470	28260110	1556	1562	ChemicalEntity	Emodin	D004642
12471	28260110	1592	1596	GeneOrGeneProduct	FASN	2194
12472	28260110	1656	1672	ChemicalEntity	free fatty acids	D005230
12473	28260110	1674	1680	ChemicalEntity	Emodin	D004642
12474	28260110	1786	1792	ChemicalEntity	emodin	D004642
12475	28260110	1797	1806	ChemicalEntity	cerulenin	D002569
12476	28260110	1821	1825	GeneOrGeneProduct	FASN	2194
12477	28260110	1881	1890	ChemicalEntity	Palmitate	D010168
12478	28260110	1917	1921	GeneOrGeneProduct	FASN	2194
12479	28260110	1940	1946	ChemicalEntity	emodin	D004642
12480	28260110	1993	1999	ChemicalEntity	emodin	D004642
12481	28260110	2008	2012	GeneOrGeneProduct	FASN	2194
12482	28260110	2052	2081	GeneOrGeneProduct	phosphatidylinositol 3-kinase	5291
12483	28260110	2082	2085	GeneOrGeneProduct	Akt	207
12484	28260110	2090	2166	GeneOrGeneProduct	mitogen-activated protein kinases/extracellular signal-regulated kinases 1/2	5594,5595
12485	28260110	2197	2203	ChemicalEntity	emodin	D004642
12486	28260110	2268	2272	GeneOrGeneProduct	FASN	2194
12487	28260110	2307	2319	DiseaseOrPhenotypicFeature	colon cancer	D015179
12488	28346429	38	53	GeneOrGeneProduct	liver kinase B1	20869
12489	28346429	81	86	DiseaseOrPhenotypicFeature	tumor	D009369
12490	28346429	98	132	GeneOrGeneProduct	vascular endothelial growth factor	22339
12491	28346429	134	149	GeneOrGeneProduct	Liver kinase B1	20869
12492	28346429	151	155	GeneOrGeneProduct	LKB1	20869
12493	28346429	162	193	GeneOrGeneProduct	serine/threonine protein kinase	20869
12494	28346429	264	286	DiseaseOrPhenotypicFeature	Peutz-Jeghers syndrome	D010580
12495	28346429	292	297	DiseaseOrPhenotypicFeature	tumor	D009369
12496	28346429	335	339	GeneOrGeneProduct	LKB1	20869
12497	28346429	367	372	DiseaseOrPhenotypicFeature	tumor	D009369
12498	28346429	446	450	GeneOrGeneProduct	LKB1	20869
12499	28346429	461	465	GeneOrGeneProduct	LKB1	20869
12500	28346429	476	480	OrganismTaxon	mice	10090
12501	28346429	498	527	GeneOrGeneProduct	vascular endothelial-cadherin	12562
12502	28346429	532	536	OrganismTaxon	mice	10090
12503	28346429	542	546	GeneOrGeneProduct	LKB1	20869
12504	28346429	558	562	OrganismTaxon	mice	10090
12505	28346429	564	598	GeneOrGeneProduct	Vascular endothelial growth factor	22339
12506	28346429	600	604	GeneOrGeneProduct	VEGF	22339
12507	28346429	681	685	GeneOrGeneProduct	LKB1	20869
12508	28346429	695	699	OrganismTaxon	mice	10090
12509	28346429	715	719	GeneOrGeneProduct	LKB1	20869
12510	28346429	729	734	OrganismTaxon	mouse	10090
12511	28346429	826	832	DiseaseOrPhenotypicFeature	Tumors	D009369
12512	28346429	846	850	GeneOrGeneProduct	LKB1	20869
12513	28346429	860	864	OrganismTaxon	mice	10090
12514	28346429	893	897	GeneOrGeneProduct	LKB1	20869
12515	28346429	907	911	OrganismTaxon	mice	10090
12516	28346429	1039	1043	OrganismTaxon	mice	10090
12517	28346429	1058	1062	GeneOrGeneProduct	VEGF	22339
12518	28346429	1174	1179	DiseaseOrPhenotypicFeature	tumor	D009369
12519	28346429	1209	1213	GeneOrGeneProduct	LKB1	20869
12520	28346429	1232	1237	OrganismTaxon	mouse	10090
12521	28346429	1286	1290	GeneOrGeneProduct	VEGF	22339
12522	28346429	1389	1393	GeneOrGeneProduct	LKB1	20869
12523	28346429	1410	1425	GeneOrGeneProduct	VEGF receptor 2	16542
12524	28346429	1485	1489	GeneOrGeneProduct	LKB1	20869
12525	28346429	1523	1527	GeneOrGeneProduct	LKB1	20869
12526	28346429	1546	1550	GeneOrGeneProduct	VEGF	22339
12527	28346429	1573	1594	GeneOrGeneProduct	specificity protein 1	20683
12528	28346429	1596	1599	GeneOrGeneProduct	Sp1	20683
12529	28346429	1638	1641	GeneOrGeneProduct	Sp1	20683
12530	28346429	1649	1653	GeneOrGeneProduct	VEGF	22339
12531	28346429	1673	1677	GeneOrGeneProduct	VEGF	22339
12532	28346429	1702	1706	GeneOrGeneProduct	LKB1	20869
12533	28346429	1749	1754	DiseaseOrPhenotypicFeature	tumor	D009369
12534	28346429	1776	1779	GeneOrGeneProduct	Sp1	20683
12535	28346429	1789	1793	GeneOrGeneProduct	VEGF	22339
12536	28368423	0	3	GeneOrGeneProduct	Myc	17869
12537	28368423	13	28	GeneOrGeneProduct	B-cell receptor	16019
12538	28368423	42	54	DiseaseOrPhenotypicFeature	precancerous	D011230
12539	28368423	89	92	GeneOrGeneProduct	Btk	12229
12540	28368423	157	160	GeneOrGeneProduct	MYC	17869
12541	28368423	211	238	DiseaseOrPhenotypicFeature	B-cell non-Hodgkin lymphoma	D016393
12542	28368423	240	245	DiseaseOrPhenotypicFeature	B-NHL	D016393
12543	28368423	248	251	GeneOrGeneProduct	MYC	17869
12544	28368423	270	275	DiseaseOrPhenotypicFeature	B-NHL	D016393
12545	28368423	390	393	GeneOrGeneProduct	MYC	17869
12546	28368423	413	428	GeneOrGeneProduct	B-cell receptor	16019
12547	28368423	430	433	GeneOrGeneProduct	BCR	16019
12548	28368423	458	463	DiseaseOrPhenotypicFeature	B-NHL	D016393
12549	28368423	497	500	GeneOrGeneProduct	Myc	17869
12550	28368423	653	656	GeneOrGeneProduct	Myc	17869
12551	28368423	661	664	GeneOrGeneProduct	BCR	16019
12552	28368423	718	721	GeneOrGeneProduct	myc	17869
12553	28368423	722	727	OrganismTaxon	mouse	10090
12554	28368423	741	744	GeneOrGeneProduct	Myc	17869
12555	28368423	813	816	GeneOrGeneProduct	BCR	16019
12556	28368423	845	857	DiseaseOrPhenotypicFeature	precancerous	D011230
12557	28368423	880	883	GeneOrGeneProduct	myc	17869
12558	28368423	884	888	OrganismTaxon	mice	10090
12559	28368423	949	952	GeneOrGeneProduct	Myc	17869
12560	28368423	1005	1010	GeneOrGeneProduct	CD79a	12518
12561	28368423	1012	1015	GeneOrGeneProduct	Btk	12229
12562	28368423	1017	1022	GeneOrGeneProduct	Plcg2	234779
12563	28368423	1027	1033	GeneOrGeneProduct	Erk1/2	26413,26417
12564	28368423	1044	1047	GeneOrGeneProduct	Myc	17869
12565	28368423	1091	1094	GeneOrGeneProduct	BCR	16019
12566	28368423	1128	1137	ChemicalEntity	ibrutinib	C551803
12567	28368423	1141	1165	GeneOrGeneProduct	Bruton's tyrosine kinase	695
12568	28368423	1190	1194	GeneOrGeneProduct	PI3K	18708
12569	28368423	1195	1198	GeneOrGeneProduct	Akt	11651
12570	28368423	1242	1245	GeneOrGeneProduct	myc	17869
12571	28368423	1303	1312	ChemicalEntity	ibrutinib	C551803
12572	28368423	1344	1347	GeneOrGeneProduct	Btk	12229
12573	28368423	1392	1401	ChemicalEntity	ibrutinib	C551803
12574	28368423	1405	1408	GeneOrGeneProduct	BCR	16019
12575	28368423	1465	1468	GeneOrGeneProduct	Myc	17869
12576	28368423	1510	1513	GeneOrGeneProduct	BCR	16019
12577	28368423	1518	1522	GeneOrGeneProduct	PI3K	18708
12578	28368423	1523	1526	GeneOrGeneProduct	Akt	11651
12579	28368423	1587	1590	GeneOrGeneProduct	BCR	16019
12580	28368423	1638	1650	DiseaseOrPhenotypicFeature	precancerous	D011230
12581	28368423	1764	1767	GeneOrGeneProduct	MYC	17869
12582	28368423	1824	1827	GeneOrGeneProduct	BCR	16019
12583	28368423	1878	1883	DiseaseOrPhenotypicFeature	B-NHL	D016393
12584	28368537	32	44	GeneOrGeneProduct	LIF Receptor	16880
12585	28368537	52	58	OrganismTaxon	Murine	10090
12586	28368537	124	150	GeneOrGeneProduct	leukemia inhibitory factor	16878
12587	28368537	152	155	GeneOrGeneProduct	LIF	16878
12588	28368537	237	241	OrganismTaxon	mice	10090
12589	28368537	243	255	GeneOrGeneProduct	LIF receptor	16880
12590	28368537	268	272	GeneOrGeneProduct	LIFR	16880
12591	28368537	336	339	GeneOrGeneProduct	LIF	16878
12592	28368537	398	402	GeneOrGeneProduct	LIFR	16880
12593	28368537	419	431	GeneOrGeneProduct	Janus kinase	16452
12594	28368537	432	490	GeneOrGeneProduct	signal transducer and activation of transcription (STAT) 3	20848
12595	28368537	492	495	GeneOrGeneProduct	Jak	16452
12596	28368537	496	501	GeneOrGeneProduct	Stat3	20848
12597	28368537	532	535	GeneOrGeneProduct	JAK	16452
12598	28368537	536	540	GeneOrGeneProduct	STAT	20848
12599	28368537	665	669	GeneOrGeneProduct	LIFR	16880
12600	28368537	702	706	OrganismTaxon	mice	10090
12601	28368537	765	776	GeneOrGeneProduct	lactoferrin	17002
12602	28368537	783	786	GeneOrGeneProduct	Ltf	16878
12603	28368537	793	804	GeneOrGeneProduct	Lactoferrin	17002
12604	28368537	961	965	GeneOrGeneProduct	LIFR	16880
12605	28368537	1008	1013	OrganismTaxon	mouse	10090
12606	28368537	1051	1055	GeneOrGeneProduct	Lifr	16880
12607	28368537	1079	1082	GeneOrGeneProduct	Ltf	16878
12608	28368537	1087	1091	OrganismTaxon	mice	10090
12609	28368537	1097	1101	GeneOrGeneProduct	Lifr	16880
12610	28368537	1110	1114	OrganismTaxon	mice	10090
12611	28368537	1125	1129	GeneOrGeneProduct	Lifr	16880
12612	28368537	1136	1139	GeneOrGeneProduct	Ltf	16878
12613	28368537	1316	1320	GeneOrGeneProduct	Lifr	16880
12614	28368537	1327	1330	GeneOrGeneProduct	Ltf	16878
12615	28368537	1510	1514	GeneOrGeneProduct	Lifr	16880
12616	28368537	1547	1552	GeneOrGeneProduct	STAT3	20848
12617	28368537	1626	1629	GeneOrGeneProduct	LIF	16878
12618	28368537	1645	1649	GeneOrGeneProduct	Msx1	17701
12619	28368537	1738	1742	GeneOrGeneProduct	LIFR	16880
12620	28368537	1821	1824	GeneOrGeneProduct	LIF	16878
12621	28393239	0	9	GeneOrGeneProduct	Psoriasin	6278
12622	28393239	57	74	DiseaseOrPhenotypicFeature	pancreatic cancer	D010190
12623	28393239	120	129	GeneOrGeneProduct	Psoriasin	6278
12624	28393239	131	137	GeneOrGeneProduct	S100A7	6278
12625	28393239	158	181	GeneOrGeneProduct	calcium binding protein	6278
12626	28393239	206	228	DiseaseOrPhenotypicFeature	psoriatic skin lesions	D011565
12627	28393239	248	252	GeneOrGeneProduct	S100	6278
12628	28393239	406	415	GeneOrGeneProduct	Psoriasin	6278
12629	28393239	461	468	DiseaseOrPhenotypicFeature	cancers	D009369
12630	28393239	546	555	GeneOrGeneProduct	Psoriasin	6278
12631	28393239	559	576	DiseaseOrPhenotypicFeature	pancreatic cancer	D010190
12632	28393239	657	666	GeneOrGeneProduct	Psoriasin	6278
12633	28393239	733	751	DiseaseOrPhenotypicFeature	pancreatic tumours	D010190
12634	28393239	832	841	GeneOrGeneProduct	Psoriasin	6278
12635	28393239	845	862	DiseaseOrPhenotypicFeature	pancreatic cancer	D010190
12636	28393239	946	955	GeneOrGeneProduct	Psoriasin	6278
12637	28393239	994	999	OrganismTaxon	human	9606
12638	28393239	1000	1009	GeneOrGeneProduct	Psoriasin	6278
12639	28393239	1027	1036	GeneOrGeneProduct	Psoriasin	6278
12640	28393239	1142	1151	GeneOrGeneProduct	Psoriasin	6278
12641	28393239	1166	1183	DiseaseOrPhenotypicFeature	pancreatic cancer	D010190
12642	28393239	1272	1290	DiseaseOrPhenotypicFeature	pancreatic cancers	D010190
12643	28393239	1347	1356	GeneOrGeneProduct	Psoriasin	6278
12644	28393239	1387	1394	DiseaseOrPhenotypicFeature	cancers	D009369
12645	28393239	1421	1436	DiseaseOrPhenotypicFeature	Primary tumours	D009369
12646	28393239	1450	1460	DiseaseOrPhenotypicFeature	metastases	D009362
12647	28393239	1495	1504	GeneOrGeneProduct	Psoriasin	6278
12648	28393239	1506	1515	GeneOrGeneProduct	Psoriasin	6278
12649	28393239	1637	1646	GeneOrGeneProduct	Psoriasin	6278
12650	28393239	1684	1701	DiseaseOrPhenotypicFeature	pancreatic cancer	D010190
12651	28393239	1758	1784	GeneOrGeneProduct	matrix metalloproteinase-2	4313
12652	28393239	1786	1791	GeneOrGeneProduct	MMP-2	4313
12653	28393239	1797	1802	GeneOrGeneProduct	MMP-9	4318
12654	28393239	1822	1831	GeneOrGeneProduct	Psoriasin	6278
12655	28393239	1874	1891	DiseaseOrPhenotypicFeature	pancreatic cancer	D010190
12656	28393239	1961	1970	GeneOrGeneProduct	Psoriasin	6278
12657	28393239	2009	2027	DiseaseOrPhenotypicFeature	pancreatic cancers	D010190
12658	28393239	2029	2038	GeneOrGeneProduct	Psoriasin	6278
12659	28393239	2069	2086	DiseaseOrPhenotypicFeature	pancreatic cancer	D010190
12660	28393239	2164	2168	GeneOrGeneProduct	MMPs	4313,4318
12661	28393239	2208	2217	GeneOrGeneProduct	Psoriasin	6278
12662	28398555	47	58	GeneOrGeneProduct	hippocalcin	3208
12663	28398555	83	88	OrganismTaxon	human	9606
12664	28398555	89	97	DiseaseOrPhenotypicFeature	dystonia	D004421
12665	28398555	99	107	DiseaseOrPhenotypicFeature	Dystonia	D004421
12666	28398555	113	143	DiseaseOrPhenotypicFeature	neurological movement disorder	D009069
12667	28398555	326	330	SequenceVariant	T71N	rs775863165
12668	28398555	335	340	SequenceVariant	A190T	rs550921485
12669	28398555	348	371	GeneOrGeneProduct	neuronal calcium sensor	3208
12670	28398555	373	376	GeneOrGeneProduct	NCS	3208
12671	28398555	378	389	GeneOrGeneProduct	hippocalcin	3208
12672	28398555	430	455	DiseaseOrPhenotypicFeature	primary isolated dystonia	D004421
12673	28398555	457	461	GeneOrGeneProduct	DYT2	3208
12674	28398555	462	470	DiseaseOrPhenotypicFeature	dystonia	D004421
12675	28398555	541	552	GeneOrGeneProduct	hippocalcin	3208
12676	28398555	639	650	GeneOrGeneProduct	hippocalcin	3208
12677	28398555	669	676	ChemicalEntity	calcium	D002118
12678	28398555	707	737	GeneOrGeneProduct	voltage-gated calcium channels	783
12679	28398555	749	753	SequenceVariant	T71N	rs775863165
12680	28398555	758	763	SequenceVariant	A190T	rs550921485
12681	28398555	767	778	GeneOrGeneProduct	hippocalcin	3208
12682	28398555	805	812	ChemicalEntity	calcium	D002118
12683	28398555	870	874	ChemicalEntity	Ca2+	D000069285
12684	28398555	937	948	GeneOrGeneProduct	hippocalcin	3208
12685	28398555	974	977	GeneOrGeneProduct	NCS	3208
12686	28398555	1324	1331	ChemicalEntity	calcium	D002118
12687	28398555	1342	1345	ChemicalEntity	KCl	D011189
12688	28398555	1383	1394	GeneOrGeneProduct	hippocalcin	3208
12689	28398555	1413	1450	GeneOrGeneProduct	N-type voltage-gated calcium channels	774
12690	28398555	1482	1490	DiseaseOrPhenotypicFeature	dystonia	D004421
12691	28398555	1525	1536	GeneOrGeneProduct	hippocalcin	3208
12692	28398555	1599	1606	ChemicalEntity	calcium	D002118
12693	28398555	1621	1625	GeneOrGeneProduct	DYT2	3208
12694	28398555	1626	1634	DiseaseOrPhenotypicFeature	dystonia	D004421
12695	28411266	25	46	GeneOrGeneProduct	Sulfonylurea Receptor	6833
12696	28411266	48	63	DiseaseOrPhenotypicFeature	Type 2 Diabetes	D003924
12697	28411266	69	91	DiseaseOrPhenotypicFeature	Coronary Heart Disease	D003324
12698	28411266	145	160	DiseaseOrPhenotypicFeature	type 2 diabetes	D003924
12699	28411266	176	188	ChemicalEntity	sulfonylurea	D013453
12700	28411266	449	470	GeneOrGeneProduct	sulfonylurea receptor	6833
12701	28411266	472	477	GeneOrGeneProduct	ABCC8	6833
12702	28411266	478	486	SequenceVariant	p.A1369S	rs757110
12703	28411266	530	542	ChemicalEntity	sulfonylurea	D013453
12704	28411266	584	591	GeneOrGeneProduct	insulin	3630
12705	28411266	633	645	ChemicalEntity	sulfonylurea	D013453
12706	28411266	880	895	DiseaseOrPhenotypicFeature	type 2 diabetes	D003924
12707	28411266	901	923	DiseaseOrPhenotypicFeature	coronary heart disease	D003324
12708	28411266	929	937	SequenceVariant	p.A1369S	rs757110
12709	28411266	996	1011	DiseaseOrPhenotypicFeature	type 2 diabetes	D003924
12710	28411266	1276	1284	SequenceVariant	p.A1369S	rs757110
12711	28411266	1323	1345	DiseaseOrPhenotypicFeature	coronary heart disease	D003324
12712	28411266	1483	1495	ChemicalEntity	sulfonylurea	D013453
12713	28411266	1527	1549	DiseaseOrPhenotypicFeature	coronary heart disease	D003324
12714	28416580	2	6	GeneOrGeneProduct	TSPO	12257
12715	28416580	25	37	DiseaseOrPhenotypicFeature	brain injury	D001927
12716	28416580	44	68	DiseaseOrPhenotypicFeature	intracerebral hemorrhage	D002543
12717	28416580	70	94	DiseaseOrPhenotypicFeature	Intracerebral hemorrhage	D002543
12718	28416580	96	99	DiseaseOrPhenotypicFeature	ICH	D002543
12719	28416580	161	164	DiseaseOrPhenotypicFeature	ICH	D002543
12720	28416580	290	310	GeneOrGeneProduct	translocator protein	12257
12721	28416580	312	316	GeneOrGeneProduct	TSPO	12257
12722	28416580	319	323	GeneOrGeneProduct	TSPO	12257
12723	28416580	348	360	DiseaseOrPhenotypicFeature	inflammatory	D007249
12724	28416580	405	415	DiseaseOrPhenotypicFeature	CNS injury	D002493
12725	28416580	462	466	GeneOrGeneProduct	TSPO	12257
12726	28416580	475	484	ChemicalEntity	etifoxine	C002125
12727	28416580	489	501	DiseaseOrPhenotypicFeature	brain injury	D001927
12728	28416580	506	518	DiseaseOrPhenotypicFeature	inflammation	D007249
12729	28416580	524	529	OrganismTaxon	mouse	10090
12730	28416580	540	543	DiseaseOrPhenotypicFeature	ICH	D002543
12731	28416580	545	549	GeneOrGeneProduct	TSPO	706
12732	28416580	570	574	GeneOrGeneProduct	Iba1	199
12733	28416580	599	607	OrganismTaxon	patients	9606
12734	28416580	613	616	DiseaseOrPhenotypicFeature	ICH	D002543
12735	28416580	624	629	GeneOrGeneProduct	CD11b	16409
12736	28416580	632	636	GeneOrGeneProduct	CD45	19264
12737	28416580	653	657	OrganismTaxon	mice	10090
12738	28416580	671	682	ChemicalEntity	collagenase	D017364
12739	28416580	691	694	DiseaseOrPhenotypicFeature	ICH	D002543
12740	28416580	696	705	ChemicalEntity	Etifoxine	C002125
12741	28416580	728	741	DiseaseOrPhenotypicFeature	neurodeficits	D001927
12742	28416580	760	771	DiseaseOrPhenotypicFeature	brain edema	D001929
12743	28416580	778	781	DiseaseOrPhenotypicFeature	ICH	D002543
12744	28416580	835	846	ChemicalEntity	collagenase	D017364
12745	28416580	851	862	ChemicalEntity	collagenase	D017364
12746	28416580	871	874	DiseaseOrPhenotypicFeature	ICH	D002543
12747	28416580	875	879	OrganismTaxon	mice	10090
12748	28416580	899	908	ChemicalEntity	etifoxine	C002125
12749	28416580	1004	1008	GeneOrGeneProduct	IL-6	16193
12750	28416580	1013	1018	GeneOrGeneProduct	TNF-a	21926
12751	28416580	1020	1029	ChemicalEntity	Etifoxine	C002125
12752	28416580	1130	1139	ChemicalEntity	etifoxine	C002125
12753	28416580	1157	1161	OrganismTaxon	mice	10090
12754	28416580	1195	1231	GeneOrGeneProduct	colony-stimulating factor 1 receptor	12978
12755	28416580	1275	1279	GeneOrGeneProduct	TSPO	12257
12756	28416580	1287	1296	ChemicalEntity	etifoxine	C002125
12757	28416580	1308	1320	DiseaseOrPhenotypicFeature	brain injury	D001927
12758	28416580	1325	1337	DiseaseOrPhenotypicFeature	inflammation	D007249
12759	28416580	1344	1347	DiseaseOrPhenotypicFeature	ICH	D002543
12760	28416580	1349	1353	GeneOrGeneProduct	TSPO	12257
12761	28416580	1429	1432	DiseaseOrPhenotypicFeature	ICH	D002543
12762	28416580	1487	1491	GeneOrGeneProduct	TSPO	12257
12763	28416580	1510	1522	DiseaseOrPhenotypicFeature	brain injury	D001927
12764	28416580	1529	1553	DiseaseOrPhenotypicFeature	intracerebral hemorrhage	D002543
12765	28428256	48	60	DiseaseOrPhenotypicFeature	inflammatory	D007249
12766	28428256	74	90	ChemicalEntity	prostaglandin A2	C100008
12767	28428256	100	112	GeneOrGeneProduct	EP4 receptor	19219
12768	28428256	126	142	ChemicalEntity	prostaglandin A2	C100008
12769	28428256	144	148	ChemicalEntity	PGA2	C100008
12770	28428256	236	240	ChemicalEntity	PGA2	C100008
12771	28428256	293	305	DiseaseOrPhenotypicFeature	inflammatory	D007249
12772	28428256	368	372	ChemicalEntity	PGA2	C100008
12773	28428256	468	476	GeneOrGeneProduct	thrombin	14061
12774	28428256	481	496	DiseaseOrPhenotypicFeature	proinflammatory	D007249
12775	28428256	512	530	ChemicalEntity	lipopolysaccharide	D008070
12776	28428256	532	535	ChemicalEntity	LPS	D008070
12777	28428256	626	629	GeneOrGeneProduct	EP4	5734
12778	28428256	641	654	GeneOrGeneProduct	PGA2 receptor	5734
12779	28428256	656	659	GeneOrGeneProduct	EP4	5734
12780	28428256	699	703	ChemicalEntity	PGA2	C100008
12781	28428256	718	734	GeneOrGeneProduct	Rap1/Rac1 GTPase	5879,5906
12782	28428256	739	755	GeneOrGeneProduct	protein kinase A	5566
12783	28428256	800	811	GeneOrGeneProduct	VE-cadherin	1003
12784	28428256	813	825	GeneOrGeneProduct	p120-catenin	1500
12785	28428256	827	831	GeneOrGeneProduct	ZO-1	7082
12786	28428256	833	842	GeneOrGeneProduct	cortactin	2017
12787	28428256	848	852	GeneOrGeneProduct	VASP	7408
12788	28428256	854	858	ChemicalEntity	PGA2	C100008
12789	28428256	875	878	ChemicalEntity	LPS	D008070
12790	28428256	887	899	DiseaseOrPhenotypicFeature	inflammatory	D007249
12791	28428256	928	932	GeneOrGeneProduct	NFkB	19697
12792	28428256	959	980	GeneOrGeneProduct	EC adhesion molecules	3383,7412
12793	28428256	981	986	GeneOrGeneProduct	ICAM1	3383
12794	28428256	991	996	GeneOrGeneProduct	VCAM1	7412
12795	28428256	1073	1076	GeneOrGeneProduct	EP4	5734
12796	28428256	1087	1091	ChemicalEntity	PGA2	C100008
12797	28428256	1133	1150	DiseaseOrPhenotypicFeature	acute lung injury	D055371
12798	28428256	1152	1155	DiseaseOrPhenotypicFeature	ALI	D055371
12799	28428256	1158	1161	ChemicalEntity	LPS	D008070
12800	28428256	1170	1189	DiseaseOrPhenotypicFeature	inflammatory injury	D007249
12801	28428256	1202	1205	DiseaseOrPhenotypicFeature	ALI	D055371
12802	28428256	1267	1284	GeneOrGeneProduct	thrombin receptor	14062
12803	28428256	1348	1352	OrganismTaxon	mice	10090
12804	28428256	1379	1382	GeneOrGeneProduct	EP4	19219
12805	28428256	1434	1438	ChemicalEntity	PGA2	C100008
12806	28428256	1439	1442	GeneOrGeneProduct	EP4	5734
12807	28428256	1577	1589	DiseaseOrPhenotypicFeature	inflammation	D007249
12808	28468941	9	19	GeneOrGeneProduct	caveolin-1	857
12809	28468941	29	33	GeneOrGeneProduct	Smad	4086,4090,4093
12810	28468941	88	108	SequenceVariant	adenine 474 deletion	rs587777017
12811	28468941	119	128	SequenceVariant	c.474delA	rs587777017
12812	28468941	133	140	OrganismTaxon	patient	9606
12813	28468941	192	214	DiseaseOrPhenotypicFeature	pulmonary hypertension	D006976
12814	28468941	231	241	GeneOrGeneProduct	caveolin-1	857
12815	28468941	242	251	SequenceVariant	c.474delA	rs587777017
12816	28468941	308	339	DiseaseOrPhenotypicFeature	pulmonary arterial hypertension	D000081029
12817	28468941	341	344	DiseaseOrPhenotypicFeature	PAH	D000081029
12818	28468941	383	393	GeneOrGeneProduct	caveolin-1	857
12819	28468941	555	565	GeneOrGeneProduct	caveolin-1	857
12820	28468941	582	589	OrganismTaxon	patient	9606
12821	28468941	681	690	SequenceVariant	c.474delA	rs587777017
12822	28468941	745	755	GeneOrGeneProduct	caveolin-1	857
12823	28468941	759	769	GeneOrGeneProduct	caveolin-1	12389
12824	28468941	775	780	OrganismTaxon	mouse	10090
12825	28468941	937	947	GeneOrGeneProduct	caveolin-1	857
12826	28468941	961	971	GeneOrGeneProduct	caveolin-1	857
12827	28468941	1144	1153	GeneOrGeneProduct	Smad1/5/8	4086,4090,4093
12828	28468941	1212	1222	GeneOrGeneProduct	caveolin-1	857
12829	28468941	1238	1259	GeneOrGeneProduct	type I TGFb receptors	657,658,90,94
12830	28468941	1260	1270	GeneOrGeneProduct	ALK1/2/3/6	657,658,90,94
12831	28468941	1306	1315	GeneOrGeneProduct	Smad1/5/8	4086,4090,4093
12832	28468941	1355	1364	SequenceVariant	c.474delA	rs587777017
12833	28468941	1453	1463	GeneOrGeneProduct	caveolin-1	857
12834	28468941	1516	1520	GeneOrGeneProduct	Smad	4086,4090,4093
12835	28468941	1558	1562	GeneOrGeneProduct	Smad	4086,4090,4093
12836	28468941	1655	1658	DiseaseOrPhenotypicFeature	PAH	D000081029
12837	28468941	1662	1670	OrganismTaxon	patients	9606
12838	28468941	1676	1686	GeneOrGeneProduct	caveolin-1	857
12839	28468941	1687	1696	SequenceVariant	c.474delA	rs587777017
12840	28472177	0	39	GeneOrGeneProduct	Ubiquitin carboxyl-terminal esterase L1	7345
12841	28472177	41	46	GeneOrGeneProduct	UCHL1	7345
12842	28472177	77	83	DiseaseOrPhenotypicFeature	cancer	D009369
12843	28472177	123	129	DiseaseOrPhenotypicFeature	glioma	D005910
12844	28472177	152	159	DiseaseOrPhenotypicFeature	gliomas	D005910
12845	28472177	191	197	DiseaseOrPhenotypicFeature	tumors	D009369
12846	28472177	283	289	DiseaseOrPhenotypicFeature	tumors	D009369
12847	28472177	381	388	DiseaseOrPhenotypicFeature	gliomas	D005910
12848	28472177	411	416	CellLine	SF188	9606
12849	28472177	421	428	CellLine	SJ-GBM2	9606
12850	28472177	469	508	GeneOrGeneProduct	ubiquitin carboxyl-terminal esterase L1	7345
12851	28472177	510	515	GeneOrGeneProduct	UCHL1	7345
12852	28472177	559	566	DiseaseOrPhenotypicFeature	cancers	D009369
12853	28472177	592	599	DiseaseOrPhenotypicFeature	gliomas	D005910
12854	28472177	601	606	GeneOrGeneProduct	UCHL1	7345
12855	28472177	620	625	CellLine	SF188	9606
12856	28472177	630	637	CellLine	SJ-GBM2	9606
12857	28472177	638	644	DiseaseOrPhenotypicFeature	glioma	D005910
12858	28472177	759	763	ChemicalEntity	agar	D000362
12859	28472177	832	835	GeneOrGeneProduct	Wnt	7474
12860	28472177	871	876	CellLine	SF188	9606
12861	28472177	881	888	CellLine	SJ-GBM2	9606
12862	28472177	889	894	GeneOrGeneProduct	UCHL1	7345
12863	28472177	920	923	GeneOrGeneProduct	TCF	6934
12864	28472177	988	993	GeneOrGeneProduct	UCHL1	7345
12865	28472177	1158	1164	DiseaseOrPhenotypicFeature	cancer	D009369
12866	28472177	1170	1175	GeneOrGeneProduct	ACTA2	59
12867	28472177	1177	1182	GeneOrGeneProduct	POSTN	10631
12868	28472177	1184	1187	GeneOrGeneProduct	LIF	3976
12869	28472177	1189	1194	GeneOrGeneProduct	FBXL7	23194
12870	28472177	1196	1202	GeneOrGeneProduct	FBXW11	23291
12871	28472177	1204	1209	GeneOrGeneProduct	GDF15	9518
12872	28472177	1211	1215	GeneOrGeneProduct	HEY2	23493
12873	28472177	1256	1261	GeneOrGeneProduct	IGLL5	100423062
12874	28472177	1263	1268	GeneOrGeneProduct	ABCA4	24
12875	28472177	1270	1274	GeneOrGeneProduct	AQP3	360
12876	28472177	1276	1280	GeneOrGeneProduct	AQP4	361
12877	28472177	1282	1287	GeneOrGeneProduct	CALB1	793
12878	28472177	1293	1296	GeneOrGeneProduct	ALK	238
12879	28472177	1725	1733	GeneOrGeneProduct	Clathrin	1213
12880	28472177	1843	1868	GeneOrGeneProduct	High Mobility Group-Box 1	3146
12881	28472177	1870	1875	GeneOrGeneProduct	HMGB1	3146
12882	28472177	1911	1915	GeneOrGeneProduct	FGF2	2247
12883	28472177	1917	1921	GeneOrGeneProduct	IL1B	3553
12884	28472177	1923	1926	GeneOrGeneProduct	TNF	7124
12885	28472177	1931	1936	GeneOrGeneProduct	PDGFB	5155
12886	28472177	2003	2008	GeneOrGeneProduct	UCHL1	7345
12887	28472177	2061	2066	GeneOrGeneProduct	UCHL1	7345
12888	28472177	2091	2098	DiseaseOrPhenotypicFeature	gliomas	D005910
12889	28472177	2203	2206	GeneOrGeneProduct	Wnt	7474
12890	28472177	2207	2219	GeneOrGeneProduct	Beta catenin	1499
12891	28472177	2230	2235	GeneOrGeneProduct	UCHL1	7345
12892	28472177	2264	2270	DiseaseOrPhenotypicFeature	glioma	D005910
12893	28472177	2343	2349	DiseaseOrPhenotypicFeature	cancer	D009369
12894	28487437	32	39	GeneOrGeneProduct	Ghrelin	58991
12895	28487437	44	61	GeneOrGeneProduct	Glucagon Receptor	14527
12896	28487437	72	89	GeneOrGeneProduct	Glucagon receptor	2642
12897	28487437	91	95	GeneOrGeneProduct	GcgR	2642
12898	28487437	145	152	GeneOrGeneProduct	insulin	3630
12899	28487437	178	193	DiseaseOrPhenotypicFeature	type 1 diabetes	D003922
12900	28487437	226	231	GeneOrGeneProduct	GcgRs	2642
12901	28487437	241	254	DiseaseOrPhenotypicFeature	hyperglycemia	D006943
12902	28487437	268	276	DiseaseOrPhenotypicFeature	diabetes	D003920
12903	28487437	301	309	ChemicalEntity	glycemia	D001786
12904	28487437	333	340	GeneOrGeneProduct	insulin	3630
12905	28487437	345	353	GeneOrGeneProduct	glucagon	2641
12906	28487437	406	413	GeneOrGeneProduct	ghrelin	51738
12907	28487437	427	434	GeneOrGeneProduct	ghrelin	51738
12908	28487437	457	464	ChemicalEntity	glucose	D005947
12909	28487437	474	481	GeneOrGeneProduct	ghrelin	51738
12910	28487437	533	546	ChemicalEntity	blood glucose	D001786
12911	28487437	590	597	GeneOrGeneProduct	ghrelin	58991
12912	28487437	615	627	DiseaseOrPhenotypicFeature	hypoglycemia	D007003
12913	28487437	646	654	GeneOrGeneProduct	glucagon	14526
12914	28487437	670	674	GeneOrGeneProduct	GcgR	14527
12915	28487437	685	689	GeneOrGeneProduct	Gcgr	14527
12916	28487437	696	700	OrganismTaxon	mice	10090
12917	28487437	711	715	OrganismTaxon	mice	10090
12918	28487437	739	743	GeneOrGeneProduct	GcgR	14527
12919	28487437	780	793	ChemicalEntity	blood glucose	D001786
12920	28487437	832	839	GeneOrGeneProduct	ghrelin	58991
12921	28487437	900	914	ChemicalEntity	streptozotocin	D013311
12922	28487437	923	936	DiseaseOrPhenotypicFeature	hyperglycemia	D006943
12923	28487437	955	962	GeneOrGeneProduct	ghrelin	58991
12924	28487437	983	987	OrganismTaxon	mice	10090
12925	28487437	989	1002	DiseaseOrPhenotypicFeature	hyperglycemia	D006943
12926	28487437	1036	1040	GeneOrGeneProduct	Gcgr	14527
12927	28487437	1046	1050	OrganismTaxon	mice	10090
12928	28487437	1066	1073	GeneOrGeneProduct	ghrelin	58991
12929	28487437	1132	1148	GeneOrGeneProduct	ghrelin receptor	208188
12930	28487437	1176	1189	ChemicalEntity	blood glucose	D001786
12931	28487437	1255	1269	ChemicalEntity	streptozotocin	D013311
12932	28487437	1278	1282	GeneOrGeneProduct	Gcgr	14527
12933	28487437	1288	1292	OrganismTaxon	mice	10090
12934	28487437	1304	1317	ChemicalEntity	blood glucose	D001786
12935	28487437	1363	1377	ChemicalEntity	streptozotocin	D013311
12936	28487437	1386	1402	GeneOrGeneProduct	ghrelin receptor	208188
12937	28487437	1408	1412	OrganismTaxon	mice	10090
12938	28487437	1436	1440	GeneOrGeneProduct	GcgR	14527
12939	28487437	1491	1499	GeneOrGeneProduct	glucagon	14526
12940	28487437	1538	1553	DiseaseOrPhenotypicFeature	type 1 diabetes	D003922
12941	28487437	1566	1573	GeneOrGeneProduct	ghrelin	58991
12942	28487437	1598	1610	DiseaseOrPhenotypicFeature	hypoglycemia	D007003
12943	28512644	67	71	GeneOrGeneProduct	SOD1	6647
12944	28512644	73	77	GeneOrGeneProduct	SOD2	6648
12945	28512644	83	86	GeneOrGeneProduct	CAT	847
12946	28512644	90	100	DiseaseOrPhenotypicFeature	Erysipelas	D004886
12947	28512644	101	109	OrganismTaxon	Patients	9606
12948	28512644	193	216	DiseaseOrPhenotypicFeature	streptococcus infection	D013290
12949	28512644	237	247	DiseaseOrPhenotypicFeature	erysipelas	D004886
12950	28512644	248	256	OrganismTaxon	patients	9606
12951	28512644	310	313	GeneOrGeneProduct	CAT	847
12952	28512644	315	319	GeneOrGeneProduct	SOD1	6647
12953	28512644	325	329	GeneOrGeneProduct	SOD2	6648
12954	28512644	384	394	DiseaseOrPhenotypicFeature	erysipelas	D004886
12955	28512644	473	493	DiseaseOrPhenotypicFeature	erysipelas infection	D004886
12956	28512644	510	518	OrganismTaxon	patients	9606
12957	28512644	550	560	DiseaseOrPhenotypicFeature	erysipelas	D004886
12958	28512644	567	575	OrganismTaxon	patients	9606
12959	28512644	626	635	DiseaseOrPhenotypicFeature	infection	D007239
12960	28512644	653	657	GeneOrGeneProduct	SOD1	6647
12961	28512644	658	663	SequenceVariant	G7958	c|Aelle|G|7958
12962	28512644	665	669	GeneOrGeneProduct	SOD2	6648
12963	28512644	670	675	SequenceVariant	T2734	c|Aelle|T|2734
12964	28512644	681	684	GeneOrGeneProduct	CAT	847
12965	28512644	685	689	SequenceVariant	C262	c|Aelle|C|262
12966	28512644	712	722	DiseaseOrPhenotypicFeature	erysipelas	D004886
12967	28512644	759	763	GeneOrGeneProduct	SOD2	6648
12968	28512644	764	770	SequenceVariant	T2734C	c|SYB|T2734|C
12969	28512644	799	807	OrganismTaxon	patients	9606
12970	28512644	825	848	DiseaseOrPhenotypicFeature	erythematous erysipelas	D004886
12971	28512644	883	887	GeneOrGeneProduct	SOD1	6647
12972	28512644	888	894	SequenceVariant	G7958A	rs4998557
12973	28512644	983	992	DiseaseOrPhenotypicFeature	infection	D007239
12974	28512644	1024	1032	GeneOrGeneProduct	IL-1beta	3553
12975	28512644	1034	1039	GeneOrGeneProduct	CCL11	6356
12976	28512644	1041	1051	GeneOrGeneProduct	IL-2Ralpha	3559
12977	28512644	1053	1058	GeneOrGeneProduct	CXCL9	4283
12978	28512644	1060	1065	GeneOrGeneProduct	TRAIL	8743
12979	28512644	1067	1074	GeneOrGeneProduct	PDGF-BB	5155
12980	28512644	1080	1084	GeneOrGeneProduct	CCL4	6351
12981	28512644	1132	1141	DiseaseOrPhenotypicFeature	infection	D007239
12982	28512644	1149	1153	GeneOrGeneProduct	IL-6	3569
12983	28512644	1155	1159	GeneOrGeneProduct	IL-9	3578
12984	28512644	1161	1166	GeneOrGeneProduct	IL-10	3586
12985	28512644	1168	1173	GeneOrGeneProduct	IL-13	3596
12986	28512644	1175	1180	GeneOrGeneProduct	IL-15	3600
12987	28512644	1182	1187	GeneOrGeneProduct	IL-17	3605
12988	28512644	1189	1194	GeneOrGeneProduct	G-CSF	1440
12989	28512644	1200	1204	GeneOrGeneProduct	VEGF	7422
12990	28512644	1259	1269	DiseaseOrPhenotypicFeature	erysipelas	D004886
12991	28512644	1291	1299	GeneOrGeneProduct	IL-1beta	3553
12992	28512644	1301	1305	GeneOrGeneProduct	IL-7	3574
12993	28512644	1307	1311	GeneOrGeneProduct	IL-8	3576
12994	28512644	1313	1318	GeneOrGeneProduct	IL-17	3605
12995	28512644	1320	1324	GeneOrGeneProduct	CCL5	6352
12996	28512644	1330	1333	GeneOrGeneProduct	HGF	3082
12997	28512644	1359	1363	GeneOrGeneProduct	SOD2	6648
12998	28512644	1364	1370	SequenceVariant	T2734C	c|SYB|T2734|C
12999	28512644	1390	1397	GeneOrGeneProduct	PDFG-BB	5155
13000	28512644	1402	1406	GeneOrGeneProduct	CCL2	6347
13001	28512644	1432	1435	GeneOrGeneProduct	CAT	847
13002	28512644	1436	1441	SequenceVariant	C262T	c|SUB|C|262|T
13003	28518143	0	24	GeneOrGeneProduct	Calcium sensing receptor	24247
13004	28518143	39	46	ChemicalEntity	glucose	D005947
13005	28518143	62	81	DiseaseOrPhenotypicFeature	metabolism disorder	D008659
13006	28518143	95	99	GeneOrGeneProduct	gp78	361367
13007	28518143	130	153	DiseaseOrPhenotypicFeature	Diabetic cardiomyopathy	D058065
13008	28518143	155	158	DiseaseOrPhenotypicFeature	DCM	D002311
13009	28518143	207	215	OrganismTaxon	patients	9606
13010	28518143	221	229	DiseaseOrPhenotypicFeature	diabetes	D003920
13011	28518143	235	259	GeneOrGeneProduct	calcium sensing receptor	24247
13012	28518143	261	265	GeneOrGeneProduct	CaSR	24247
13013	28518143	272	298	GeneOrGeneProduct	G protein-coupled receptor	24247
13014	28518143	333	340	ChemicalEntity	calcium	D002118
13015	28518143	447	451	GeneOrGeneProduct	CaSR	24247
13016	28518143	478	485	ChemicalEntity	calcium	D002118
13017	28518143	550	553	DiseaseOrPhenotypicFeature	DCM	D002311
13018	28518143	554	558	OrganismTaxon	rats	10116
13019	28518143	658	662	GeneOrGeneProduct	CaSR	24247
13020	28518143	666	703	DiseaseOrPhenotypicFeature	myocardial energy metabolism disorder	D009202
13021	28518143	720	727	ChemicalEntity	glucose	D005947
13022	28518143	828	832	GeneOrGeneProduct	CaSR	24247
13023	28518143	865	869	GeneOrGeneProduct	Mfn1	192647
13024	28518143	871	875	GeneOrGeneProduct	Mfn2	64476
13025	28518143	914	918	GeneOrGeneProduct	Cx43	24392
13026	28518143	920	932	GeneOrGeneProduct	beta-catenin	84353
13027	28518143	934	944	GeneOrGeneProduct	N-cadherin	83501
13028	28518143	965	968	ChemicalEntity	ATP	D000255
13029	28518143	1024	1027	ChemicalEntity	ATP	D000255
13030	28518143	1061	1065	GeneOrGeneProduct	gp78	361367
13031	28518143	1099	1103	GeneOrGeneProduct	Fis1	288584
13032	28518143	1105	1109	GeneOrGeneProduct	Drp1	114114
13033	28518143	1145	1149	GeneOrGeneProduct	Mfn1	192647
13034	28518143	1151	1155	GeneOrGeneProduct	Mfn2	64476
13035	28518143	1160	1164	GeneOrGeneProduct	Cx43	24392
13036	28518143	1176	1180	GeneOrGeneProduct	CaSR	24247
13037	28518143	1193	1197	GeneOrGeneProduct	gp78	361367
13038	28518143	1299	1336	DiseaseOrPhenotypicFeature	myocardial energy metabolism disorder	D009202
13039	28518143	1353	1357	GeneOrGeneProduct	CaSR	24247
13040	28518143	1388	1392	GeneOrGeneProduct	gp78	361367
13041	28518143	1549	1552	ChemicalEntity	ATP	D000255
13042	28518143	1581	1584	ChemicalEntity	ATP	D000255
13043	28518143	1609	1613	GeneOrGeneProduct	CaSR	24247
13044	28518143	1650	1687	DiseaseOrPhenotypicFeature	abnormal myocardial energy metabolism	D009202
13045	28518143	1700	1704	GeneOrGeneProduct	CaSR	24247
13046	28518143	1759	1762	DiseaseOrPhenotypicFeature	DCM	D002311
13047	28584052	13	55	GeneOrGeneProduct	N-acetylglucosamine (O-GlcNAc) transferase	8473
13048	28584052	59	67	OrganismTaxon	patients	9606
13049	28584052	73	105	DiseaseOrPhenotypicFeature	X-linked intellectual disability	D038901
13050	28584052	107	149	GeneOrGeneProduct	N-Acetylglucosamine (O-GlcNAc) transferase	8473
13051	28584052	151	154	GeneOrGeneProduct	OGT	8473
13052	28584052	174	189	GeneOrGeneProduct	O-GlcNAcylation	8473
13053	28584052	253	261	GeneOrGeneProduct	O-GlcNAc	8473
13054	28584052	463	478	GeneOrGeneProduct	O-GlcNAcylation	8473
13055	28584052	505	526	DiseaseOrPhenotypicFeature	developmental defects	D003147
13056	28584052	531	548	DiseaseOrPhenotypicFeature	neurodegeneration	D019636
13057	28584052	576	579	GeneOrGeneProduct	OGT	8473
13058	28584052	629	635	OrganismTaxon	humans	9606
13059	28584052	684	687	GeneOrGeneProduct	OGT	8473
13060	28584052	708	740	DiseaseOrPhenotypicFeature	X-linked intellectual disability	D038901
13061	28584052	742	746	DiseaseOrPhenotypicFeature	XLID	D038901
13062	28584052	796	807	SequenceVariant	p.Arg284Pro	rs1114167891
13063	28584052	856	866	SequenceVariant	c.463-6T>G	c|SUB|T463-6|G
13064	28584052	927	930	GeneOrGeneProduct	OGT	8473
13065	28584052	1016	1019	GeneOrGeneProduct	OGT	8473
13066	28584052	1070	1081	GeneOrGeneProduct	O-GlcNAcase	10724
13067	28584052	1090	1097	OrganismTaxon	patient	9606
13068	28584052	1130	1138	GeneOrGeneProduct	O-GlcNAc	8473
13069	28584052	1235	1250	GeneOrGeneProduct	O-GlcNAcylation	8473
13070	28584052	1270	1281	GeneOrGeneProduct	O-GlcNAcase	10724
13071	28584052	1317	1327	SequenceVariant	c.463-6T>G	c|SUB|T463-6|G
13072	28584052	1436	1443	OrganismTaxon	patient	9606
13073	28584052	1477	1480	GeneOrGeneProduct	OGT	8473
13074	28584052	1493	1504	SequenceVariant	p.Arg284Pro	rs1114167891
13075	28584052	1689	1707	GeneOrGeneProduct	host cell factor 1	3054
13076	28584052	1737	1741	DiseaseOrPhenotypicFeature	XLID	D038901
13077	28584052	1787	1795	GeneOrGeneProduct	O-GlcNAc	8473
13078	28584052	1812	1830	GeneOrGeneProduct	host cell factor 1	3054
13079	28584052	1874	1878	DiseaseOrPhenotypicFeature	XLID	D038901
13080	28584052	1899	1902	GeneOrGeneProduct	OGT	8473
13081	28604678	28	37	GeneOrGeneProduct	ESCRT-III	128866,27243,51652
13082	28604678	65	69	GeneOrGeneProduct	Vps4	27183,9525
13083	28604678	126	186	GeneOrGeneProduct	endosomal sorting complex required for transport (ESCRT)-III	128866,27243,51652
13084	28604678	271	280	GeneOrGeneProduct	ESCRT-III	128866,27243,51652
13085	28604678	413	422	GeneOrGeneProduct	ESCRT-III	128866,27243,51652
13086	28604678	441	446	OrganismTaxon	human	9606
13087	28604678	547	556	GeneOrGeneProduct	ESCRT-III	128866,27243,51652
13088	28604678	582	588	GeneOrGeneProduct	ATPase	27183,9525
13089	28604678	589	593	GeneOrGeneProduct	VPS4	27183,9525
13090	28604678	648	657	GeneOrGeneProduct	ESCRT-III	128866,27243,51652
13091	28604678	712	721	GeneOrGeneProduct	ESCRT-III	128866,27243,51652
13092	28604678	748	752	GeneOrGeneProduct	Vps2	27243
13093	28604678	753	758	GeneOrGeneProduct	Vps24	51652
13094	28604678	771	780	GeneOrGeneProduct	ESCRT-III	128866,27243,51652
13095	28604678	816	820	GeneOrGeneProduct	Snf7	128866,29082
13096	28604678	919	923	GeneOrGeneProduct	Vps4	27183,9525
13097	28604678	928	931	ChemicalEntity	ATP	D000255
13098	28604678	1032	1041	GeneOrGeneProduct	ESCRT-III	128866,27243,51652
13099	28604678	1069	1073	GeneOrGeneProduct	Vps4	27183,9525
13100	28604678	1086	1095	GeneOrGeneProduct	ESCRT-III	128866,27243,51652
13101	28650467	58	76	GeneOrGeneProduct	opioid receptor u1	4988
13102	28650467	99	113	ChemicalEntity	L-asparaginase	D001215
13103	28650467	138	166	DiseaseOrPhenotypicFeature	acute lymphoblastic leukemia	D054198
13104	28650467	168	182	ChemicalEntity	L-asparaginase	D001215
13105	28650467	224	252	DiseaseOrPhenotypicFeature	acute lymphoblastic leukemia	D054198
13106	28650467	254	257	DiseaseOrPhenotypicFeature	ALL	D054198
13107	28650467	281	291	ChemicalEntity	asparagine	D001216
13108	28650467	297	306	ChemicalEntity	aspartate	D001224
13109	28650467	311	314	ChemicalEntity	NH3	D000641
13110	28650467	324	342	DiseaseOrPhenotypicFeature	asparagine deficit	OMIM:615574
13111	28650467	395	403	DiseaseOrPhenotypicFeature	leukemic	D007938
13112	28650467	425	432	OrganismTaxon	patient	9606
13113	28650467	521	524	DiseaseOrPhenotypicFeature	ALL	D054198
13114	28650467	553	567	ChemicalEntity	L-asparaginase	D001215
13115	28650467	640	654	ChemicalEntity	L-asparaginase	D001215
13116	28650467	677	685	DiseaseOrPhenotypicFeature	leukemic	D007938
13117	28650467	766	769	DiseaseOrPhenotypicFeature	ALL	D054198
13118	28650467	796	816	GeneOrGeneProduct	opioid receptor mu 1	4988
13119	28650467	818	823	GeneOrGeneProduct	oprm1	4988
13120	28650467	844	864	GeneOrGeneProduct	carbonic anhydrase 1	759
13121	28650467	866	869	GeneOrGeneProduct	ca1	759
13122	28650467	901	933	GeneOrGeneProduct	ubiquitin-conjugating enzyme E2C	11065
13123	28650467	935	940	GeneOrGeneProduct	ube2c	11065
13124	28650467	962	967	GeneOrGeneProduct	OPRM1	4988
13125	28650467	988	996	DiseaseOrPhenotypicFeature	leukemic	D007938
13126	28650467	1033	1038	GeneOrGeneProduct	OPRM1	4988
13127	28650467	1047	1061	ChemicalEntity	L-asparaginase	D001215
13128	28650467	1142	1151	ChemicalEntity	Methadone	D008691
13129	28650467	1167	1172	GeneOrGeneProduct	OPRM1	4988
13130	28650467	1211	1219	DiseaseOrPhenotypicFeature	leukemic	D007938
13131	28650467	1235	1240	GeneOrGeneProduct	OPRM1	4988
13132	28650467	1260	1274	ChemicalEntity	L-asparaginase	D001215
13133	28650467	1302	1307	GeneOrGeneProduct	OPRM1	4988
13134	28650467	1350	1364	ChemicalEntity	L-asparaginase	D001215
13135	28650467	1369	1378	ChemicalEntity	methadone	D008691
13136	28650467	1389	1394	GeneOrGeneProduct	OPRM1	4988
13137	28650467	1409	1417	DiseaseOrPhenotypicFeature	leukemic	D007938
13138	28650467	1469	1474	GeneOrGeneProduct	OPRM1	4988
13139	28650467	1533	1540	OrganismTaxon	patient	9606
13140	28650467	1541	1549	DiseaseOrPhenotypicFeature	leukemic	D007938
13141	28650467	1587	1592	GeneOrGeneProduct	OPRM1	4988
13142	28650467	1615	1629	ChemicalEntity	L-asparaginase	D001215
13143	28650467	1652	1657	GeneOrGeneProduct	OPRM1	4988
13144	28650467	1667	1675	DiseaseOrPhenotypicFeature	leukemic	D007938
13145	28650467	1707	1712	GeneOrGeneProduct	OPRM1	4988
13146	28650467	1740	1754	ChemicalEntity	L-asparaginase	D001215
13147	28650467	1769	1777	DiseaseOrPhenotypicFeature	leukemic	D007938
13148	28650467	1778	1786	OrganismTaxon	patients	9606
13149	28650467	1845	1850	GeneOrGeneProduct	OPRM1	4988
13150	28650467	1874	1888	ChemicalEntity	L-asparaginase	D001215
13151	28650467	1903	1906	DiseaseOrPhenotypicFeature	ALL	D054198
13152	28650467	1923	1928	GeneOrGeneProduct	OPRM1	4988
13153	28650467	2045	2050	GeneOrGeneProduct	Oprm1	4988
13154	28650467	2099	2113	ChemicalEntity	L-asparaginase	D001215
13155	28650467	2124	2127	DiseaseOrPhenotypicFeature	ALL	D054198
13156	28660748	0	34	GeneOrGeneProduct	Angiotensin II subtype 1a receptor	11607
13157	28660748	85	101	DiseaseOrPhenotypicFeature	liver metastasis	D008113
13158	28660748	113	129	DiseaseOrPhenotypicFeature	Liver metastases	D008113
13159	28660748	135	152	DiseaseOrPhenotypicFeature	colorectal cancer	D015179
13160	28660748	154	157	DiseaseOrPhenotypicFeature	CRC	D015179
13161	28660748	201	206	GeneOrGeneProduct	renin	19701
13162	28660748	207	218	GeneOrGeneProduct	angiotensin	11606
13163	28660748	241	246	DiseaseOrPhenotypicFeature	tumor	D009369
13164	28660748	258	268	DiseaseOrPhenotypicFeature	metastases	D009362
13165	28660748	318	352	GeneOrGeneProduct	angiotensin II subtype receptor 1a	11607
13166	28660748	354	358	GeneOrGeneProduct	AT1a	11607
13167	28660748	380	396	DiseaseOrPhenotypicFeature	liver metastasis	D008113
13168	28660748	400	403	DiseaseOrPhenotypicFeature	CRC	D015179
13169	28660748	416	432	DiseaseOrPhenotypicFeature	liver metastasis	D008113
13170	28660748	476	481	OrganismTaxon	mouse	10090
13171	28660748	482	494	DiseaseOrPhenotypicFeature	colon cancer	D015179
13172	28660748	496	502	CellLine	CMT-93	10090
13173	28660748	509	513	GeneOrGeneProduct	AT1a	11607
13174	28660748	523	527	OrganismTaxon	mice	10090
13175	28660748	529	533	GeneOrGeneProduct	AT1a	11607
13176	28660748	552	559	CellLine	C57BL/6	10090
13177	28660748	561	565	OrganismTaxon	mice	10090
13178	28660748	589	593	OrganismTaxon	mice	10090
13179	28660748	616	632	DiseaseOrPhenotypicFeature	liver metastatic	D008113
13180	28660748	666	670	GeneOrGeneProduct	AT1a	11607
13181	28660748	693	697	GeneOrGeneProduct	CD31	18613
13182	28660748	699	729	GeneOrGeneProduct	transforming growth factor- b1	21803
13183	28660748	731	737	GeneOrGeneProduct	TGF-b1	21803
13184	28660748	744	749	GeneOrGeneProduct	F4/80	13733
13185	28660748	769	773	GeneOrGeneProduct	AT1a	11607
13186	28660748	867	872	GeneOrGeneProduct	F4/80	13733
13187	28660748	893	899	GeneOrGeneProduct	TGF-b1	21803
13188	28660748	945	949	GeneOrGeneProduct	AT1a	11607
13189	28660748	957	961	GeneOrGeneProduct	AT1a	11607
13190	28660748	982	986	GeneOrGeneProduct	AT1a	11607
13191	28660748	1027	1043	DiseaseOrPhenotypicFeature	liver metastasis	D008113
13192	28660748	1094	1104	DiseaseOrPhenotypicFeature	metastasis	D009362
13193	28660748	1137	1141	GeneOrGeneProduct	AT1a	11607
13194	28660748	1158	1162	GeneOrGeneProduct	AT1a	11607
13195	28660748	1197	1202	GeneOrGeneProduct	F4/80	13733
13196	28660748	1219	1235	DiseaseOrPhenotypicFeature	liver metastasis	D008113
13197	28660748	1256	1261	GeneOrGeneProduct	F4/80	13733
13198	28660748	1300	1305	GeneOrGeneProduct	F4/80	13733
13199	28660748	1343	1348	GeneOrGeneProduct	F4/80	13733
13200	28660748	1376	1382	GeneOrGeneProduct	TGF-b1	21803
13201	28660748	1384	1398	GeneOrGeneProduct	Angiotensin II	11606
13202	28660748	1408	1414	GeneOrGeneProduct	TGF-b1	21803
13203	28660748	1465	1475	ChemicalEntity	clodronate	D004002
13204	28660748	1497	1513	DiseaseOrPhenotypicFeature	liver metastasis	D008113
13205	28660748	1529	1535	GeneOrGeneProduct	TGF-b1	21803
13206	28660748	1539	1544	GeneOrGeneProduct	F4/80	13733
13207	28660748	1585	1601	DiseaseOrPhenotypicFeature	liver metastasis	D008113
13208	28660748	1618	1626	GeneOrGeneProduct	collagen	12842
13209	28660748	1685	1689	GeneOrGeneProduct	AT1a	11607
13210	28660748	1767	1783	DiseaseOrPhenotypicFeature	liver metastasis	D008113
13211	28660748	1810	1816	GeneOrGeneProduct	TGF-b1	21803
13212	28660748	1825	1829	GeneOrGeneProduct	AT1a	11607
13213	28747658	75	80	OrganismTaxon	HIV-1	11676
13214	28747658	96	99	GeneOrGeneProduct	p17	155348
13215	28747658	140	158	DiseaseOrPhenotypicFeature	HIV-1-seropositive	D006679
13216	28747658	159	167	OrganismTaxon	patients	9606
13217	28747658	173	181	DiseaseOrPhenotypicFeature	lymphoma	D008223
13218	28747658	186	189	GeneOrGeneProduct	p17	155348
13219	28747658	272	287	DiseaseOrPhenotypicFeature	lymphomagenesis	D008223
13220	28747658	392	395	GeneOrGeneProduct	p17	155348
13221	28747658	422	426	SequenceVariant	S75X	p|SUB|S|75|X
13222	28747658	456	507	SequenceVariant	Arginine (R) to Glycine (G) mutation at position 76	p|SUB|R|76|G
13223	28747658	532	535	GeneOrGeneProduct	p17	155348
13224	28747658	535	539	SequenceVariant	R76G	p|SUB|R|76|G
13225	28747658	552	556	SequenceVariant	S75X	p|SUB|S|75|X
13226	28747658	688	692	GeneOrGeneProduct	PTEN	5728
13227	28747658	693	697	GeneOrGeneProduct	PI3K	5291
13228	28747658	698	701	GeneOrGeneProduct	Akt	207
13229	28747658	775	781	GeneOrGeneProduct	CASP-9	842
13230	28747658	783	789	GeneOrGeneProduct	CASP-7	840
13231	28747658	791	797	GeneOrGeneProduct	DFF-45	1676
13232	28747658	799	802	GeneOrGeneProduct	NPM	4869
13233	28747658	804	809	GeneOrGeneProduct	YWHAZ	7534
13234	28747658	811	814	GeneOrGeneProduct	Src	6714
13235	28747658	816	820	GeneOrGeneProduct	PAX2	5076
13236	28747658	822	827	GeneOrGeneProduct	MAPK8	5599
13237	28747658	855	861	DiseaseOrPhenotypicFeature	cancer	D009369
13238	28747658	875	879	GeneOrGeneProduct	CDK1	983
13239	28747658	881	885	GeneOrGeneProduct	CDK2	1017
13240	28747658	887	891	GeneOrGeneProduct	CDK8	1024
13241	28747658	893	898	GeneOrGeneProduct	CHEK1	1111
13242	28747658	900	905	GeneOrGeneProduct	CHEK2	11200
13243	28747658	907	917	GeneOrGeneProduct	GSK-3 beta	2932
13244	28747658	919	922	GeneOrGeneProduct	NPM	4869
13245	28747658	924	928	GeneOrGeneProduct	PAK1	5058
13246	28747658	930	940	GeneOrGeneProduct	PP2C-alpha	5494
13247	28747658	962	992	SequenceVariant	R to G mutation at position 76	p|SUB|R|76|G
13248	28747658	1145	1148	GeneOrGeneProduct	p17	155348
13249	28747658	1149	1153	SequenceVariant	R76G	p|SUB|R|76|G
13250	28777492	0	8	GeneOrGeneProduct	Gankyrin	53380
13251	28777492	17	22	GeneOrGeneProduct	STAT3	20848
13252	28777492	37	42	DiseaseOrPhenotypicFeature	tumor	D009369
13253	28777492	64	73	ChemicalEntity	sorafenib	D000077157
13254	28777492	88	112	DiseaseOrPhenotypicFeature	hepatocellular carcinoma	D006528
13255	28777492	119	144	DiseaseOrPhenotypicFeature	hepatocellular carcinomas	D006528
13256	28777492	146	149	DiseaseOrPhenotypicFeature	HCC	D006528
13257	28777492	174	200	DiseaseOrPhenotypicFeature	chronic liver inflammation	D007249
13258	28777492	225	236	GeneOrGeneProduct	oncoprotein	53380
13259	28777492	237	245	GeneOrGeneProduct	gankyrin	53380
13260	28777492	262	274	DiseaseOrPhenotypicFeature	inflammation	D007249
13261	28777492	283	296	DiseaseOrPhenotypicFeature	tumorigenesis	D009369
13262	28777492	345	353	GeneOrGeneProduct	gankyrin	5716
13263	28777492	442	450	GeneOrGeneProduct	gankyrin	53380
13264	28777492	458	463	DiseaseOrPhenotypicFeature	tumor	D009369
13265	28777492	484	488	OrganismTaxon	mice	10090
13266	28777492	526	534	GeneOrGeneProduct	gankyrin	53380
13267	28777492	545	548	GeneOrGeneProduct	Alb	11657
13268	28777492	553	561	GeneOrGeneProduct	gankyrin	53380
13269	28777492	573	581	GeneOrGeneProduct	gankyrin	53380
13270	28777492	644	647	GeneOrGeneProduct	Mx1	17857
13271	28777492	652	660	GeneOrGeneProduct	gankyrin	53380
13272	28777492	669	677	GeneOrGeneProduct	Gankyrin	5716
13273	28777492	690	724	GeneOrGeneProduct	vascular endothelial growth factor	22339
13274	28777492	739	744	DiseaseOrPhenotypicFeature	tumor	D009369
13275	28777492	752	760	GeneOrGeneProduct	Gankyrin	53380
13276	28777492	770	833	GeneOrGeneProduct	Src homology 2 domain-containing protein tyrosine phosphatase-1	15170
13277	28777492	835	840	GeneOrGeneProduct	SHP-1	15170
13278	28777492	939	989	GeneOrGeneProduct	signal transducer and activator of transcription 3	20848
13279	28777492	991	996	GeneOrGeneProduct	STAT3	20848
13280	28777492	999	1007	GeneOrGeneProduct	Gankyrin	53380
13281	28777492	1083	1088	GeneOrGeneProduct	STAT3	20848
13282	28777492	1099	1117	GeneOrGeneProduct	interleukin (IL)-6	16193
13283	28777492	1134	1140	DiseaseOrPhenotypicFeature	cancer	D009369
13284	28777492	1159	1163	GeneOrGeneProduct	Bmi1	12151
13285	28777492	1168	1201	GeneOrGeneProduct	epithelial cell adhesion molecule	17075
13286	28777492	1203	1208	GeneOrGeneProduct	EpCAM	17075
13287	28777492	1245	1256	DiseaseOrPhenotypicFeature	tumorigenic	D009369
13288	28777492	1268	1288	DiseaseOrPhenotypicFeature	Chronic inflammation	D007249
13289	28777492	1298	1306	GeneOrGeneProduct	gankyrin	5716
13290	28777492	1325	1330	OrganismTaxon	human	9606
13291	28777492	1338	1346	GeneOrGeneProduct	Gankyrin	5716
13292	28777492	1365	1370	DiseaseOrPhenotypicFeature	tumor	D009369
13293	28777492	1447	1455	OrganismTaxon	patients	9606
13294	28777492	1467	1476	ChemicalEntity	sorafenib	D000077157
13295	28777492	1491	1494	DiseaseOrPhenotypicFeature	HCC	D006528
13296	28777492	1502	1510	GeneOrGeneProduct	gankyrin	53380
13297	28777492	1560	1565	DiseaseOrPhenotypicFeature	tumor	D009369
13298	28777492	1674	1677	DiseaseOrPhenotypicFeature	HCC	D006528
13299	28846666	0	13	GeneOrGeneProduct	Interleukin 6	3569
13300	28846666	15	19	GeneOrGeneProduct	IL-6	3569
13301	28846666	25	52	GeneOrGeneProduct	Tumor Necrosis Factor alpha	7124
13302	28846666	54	63	GeneOrGeneProduct	TNF-alpha	7124
13303	28846666	105	117	DiseaseOrPhenotypicFeature	Inflammation	D007249
13304	28846666	136	165	DiseaseOrPhenotypicFeature	Gestational Diabetes Mellitus	D016640
13305	28846666	196	225	DiseaseOrPhenotypicFeature	Gestational diabetes mellitus	D016640
13306	28846666	227	230	DiseaseOrPhenotypicFeature	GDM	D016640
13307	28846666	262	265	DiseaseOrPhenotypicFeature	GDM	D016640
13308	28846666	266	271	OrganismTaxon	women	9606
13309	28846666	281	293	DiseaseOrPhenotypicFeature	inflammatory	D007249
13310	28846666	298	323	DiseaseOrPhenotypicFeature	metabolisms abnormalities	D008659
13311	28846666	381	386	GeneOrGeneProduct	IL-65	3569
13312	28846666	386	392	SequenceVariant	-72C/G	rs1800796
13313	28846666	397	406	GeneOrGeneProduct	TNF-alpha	7124
13314	28846666	407	414	SequenceVariant	-857C/T	rs1799724
13315	28846666	455	467	DiseaseOrPhenotypicFeature	inflammatory	D007249
13316	28846666	505	510	OrganismTaxon	women	9606
13317	28846666	516	519	DiseaseOrPhenotypicFeature	GDM	D016640
13318	28846666	627	632	GeneOrGeneProduct	IL-65	3569
13319	28846666	632	638	SequenceVariant	-72C/G	rs1800796
13320	28846666	643	652	GeneOrGeneProduct	TNF-alpha	7124
13321	28846666	653	660	SequenceVariant	-857C/T	rs1799724
13322	28846666	671	683	DiseaseOrPhenotypicFeature	inflammation	D007249
13323	28846666	712	717	OrganismTaxon	women	9606
13324	28846666	723	726	DiseaseOrPhenotypicFeature	GDM	D016640
13325	28846666	798	803	OrganismTaxon	women	9606
13326	28846666	809	812	DiseaseOrPhenotypicFeature	GDM	D016640
13327	28846666	821	826	OrganismTaxon	women	9606
13328	28846666	1006	1011	GeneOrGeneProduct	IL-65	3569
13329	28846666	1011	1017	SequenceVariant	-72C/G	rs1800796
13330	28846666	1022	1031	GeneOrGeneProduct	TNF-alpha	7124
13331	28846666	1032	1039	SequenceVariant	-857C/T	rs1799724
13332	28846666	1113	1125	DiseaseOrPhenotypicFeature	inflammatory	D007249
13333	28846666	1141	1151	GeneOrGeneProduct	adipokines	3952,9370
13334	28846666	1187	1196	GeneOrGeneProduct	TNF-alpha	7124
13335	28846666	1197	1203	SequenceVariant	-857CT	rs1799724
13336	28846666	1247	1252	OrganismTaxon	women	9606
13337	28846666	1258	1261	DiseaseOrPhenotypicFeature	GDM	D016640
13338	28846666	1309	1314	OrganismTaxon	women	9606
13339	28846666	1341	1346	OrganismTaxon	Women	9606
13340	28846666	1352	1355	DiseaseOrPhenotypicFeature	GDM	D016640
13341	28846666	1431	1435	DiseaseOrPhenotypicFeature	T2DM	D003924
13342	28846666	1440	1443	DiseaseOrPhenotypicFeature	GDM	D016640
13343	28846666	1465	1470	OrganismTaxon	women	9606
13344	28846666	1509	1521	DiseaseOrPhenotypicFeature	Inflammatory	D007249
13345	28846666	1546	1549	GeneOrGeneProduct	CRP	1401
13346	28846666	1551	1555	GeneOrGeneProduct	IL-6	3569
13347	28846666	1557	1561	GeneOrGeneProduct	IL-8	3576
13348	28846666	1563	1567	GeneOrGeneProduct	IL-6	3569
13349	28846666	1568	1573	GeneOrGeneProduct	IL-10	3586
13350	28846666	1596	1605	GeneOrGeneProduct	NF-kappaB	4790
13351	28846666	1607	1611	GeneOrGeneProduct	IL-6	3569
13352	28846666	1613	1617	GeneOrGeneProduct	IL-8	3576
13353	28846666	1619	1623	GeneOrGeneProduct	IL-6	3569
13354	28846666	1624	1629	GeneOrGeneProduct	IL-10	3586
13355	28846666	1637	1642	GeneOrGeneProduct	IL-1b	3553
13356	28846666	1644	1653	GeneOrGeneProduct	TNF-alpha	7124
13357	28846666	1704	1709	OrganismTaxon	women	9606
13358	28846666	1715	1718	DiseaseOrPhenotypicFeature	GDM	D016640
13359	28846666	1723	1728	OrganismTaxon	women	9606
13360	28846666	1837	1842	GeneOrGeneProduct	IRS-1	3667
13361	28846666	1844	1849	GeneOrGeneProduct	IRS-2	8660
13362	28846666	1851	1857	GeneOrGeneProduct	leptin	3952
13363	28846666	1859	1870	GeneOrGeneProduct	adiponectin	9370
13364	28846666	1872	1880	GeneOrGeneProduct	visfatin	10135
13365	28846666	1882	1887	GeneOrGeneProduct	RBP-4	5950
13366	28846666	1889	1897	GeneOrGeneProduct	chemerin	5919
13367	28846666	1899	1909	GeneOrGeneProduct	nesfatin-1	4925
13368	28846666	1911	1917	GeneOrGeneProduct	FATP-4	10999
13369	28846666	1919	1921	GeneOrGeneProduct	EL	9388
13370	28846666	1923	1926	GeneOrGeneProduct	LPL	4023
13371	28846666	1928	1934	GeneOrGeneProduct	FABP-1	2168
13372	28846666	1936	1942	GeneOrGeneProduct	FABP-3	2170
13373	28846666	1944	1950	GeneOrGeneProduct	FABP-4	2167
13374	28846666	1956	1962	GeneOrGeneProduct	FABP-5	2171
13375	28846666	1976	1985	GeneOrGeneProduct	TNF-alpha	7124
13376	28846666	1986	1993	SequenceVariant	-857C/T	rs1799724
13377	28846666	2002	2005	GeneOrGeneProduct	CRP	1401
13378	28846666	2007	2011	GeneOrGeneProduct	IL-6	3569
13379	28846666	2013	2017	GeneOrGeneProduct	IL-8	3576
13380	28846666	2023	2027	GeneOrGeneProduct	IL-6	3569
13381	28846666	2028	2033	GeneOrGeneProduct	IL-10	3586
13382	28846666	2055	2058	DiseaseOrPhenotypicFeature	GDM	D016640
13383	28846666	2062	2067	OrganismTaxon	women	9606
13384	28846666	2104	2116	DiseaseOrPhenotypicFeature	inflammation	D007249
13385	28846666	2121	2161	DiseaseOrPhenotypicFeature	disordered lipid and glucose metabolisms	D044882,D052439
13386	28851297	3	12	GeneOrGeneProduct	Ag-globin	3047
13387	28851297	13	17	SequenceVariant	G->A	rs368698783
13388	28851297	52	77	GeneOrGeneProduct	b(0)39 thalassemia globin	3043
13389	28851297	92	108	GeneOrGeneProduct	fetal hemoglobin	3040,3048
13390	28851297	163	171	GeneOrGeneProduct	g-globin	3047,3048
13391	28851297	200	216	GeneOrGeneProduct	fetal hemoglobin	3040,3048
13392	28851297	218	221	GeneOrGeneProduct	HbF	3040,3048
13393	28851297	226	239	DiseaseOrPhenotypicFeature	b-thalassemia	D017086
13394	28851297	240	248	OrganismTaxon	patients	9606
13395	28851297	341	344	GeneOrGeneProduct	HbF	3040,3048
13396	28851297	389	395	GeneOrGeneProduct	BCL11A	53335
13397	28851297	400	403	GeneOrGeneProduct	MYB	4602
13398	28851297	477	490	DiseaseOrPhenotypicFeature	b-thalassemia	D017086
13399	28851297	491	499	OrganismTaxon	patients	9606
13400	28851297	598	601	GeneOrGeneProduct	HbF	3040,3048
13401	28851297	664	673	GeneOrGeneProduct	Ag-globin	3047
13402	28851297	747	760	DiseaseOrPhenotypicFeature	b-thalassemia	D017086
13403	28851297	761	769	OrganismTaxon	patients	9606
13404	28851297	940	951	SequenceVariant	rs368698783	rs368698783
13405	28851297	979	992	DiseaseOrPhenotypicFeature	b-thalassemia	D017086
13406	28851297	993	1001	OrganismTaxon	patients	9606
13407	28851297	1037	1046	GeneOrGeneProduct	Ag-globin	3047
13408	28851297	1073	1077	GeneOrGeneProduct	LYAR	55646
13409	28851297	1079	1084	OrganismTaxon	human	9606
13410	28851297	1098	1103	OrganismTaxon	mouse	10090
13411	28851297	1104	1132	GeneOrGeneProduct	Ly-1 antibody reactive clone	17089
13412	28851297	1166	1168	GeneOrGeneProduct	Ag	3047
13413	28851297	1169	1177	SequenceVariant	+25 G->A	rs368698783
13414	28851297	1215	1224	GeneOrGeneProduct	Gg-globin	3048
13415	28851297	1272	1285	GeneOrGeneProduct	b(0)39-globin	3043
13416	28851297	1309	1328	GeneOrGeneProduct	b(+)IVSI-110-globin	3043
13417	28851297	1399	1403	GeneOrGeneProduct	LYAR	55646
13418	28851297	1440	1442	GeneOrGeneProduct	Ag	3047
13419	28851297	1443	1451	SequenceVariant	+25 G->A	rs368698783
13420	28851297	1457	1466	GeneOrGeneProduct	Gg-globin	3048
13421	28851297	1511	1514	GeneOrGeneProduct	HbF	3040,3048
13422	28851297	1558	1583	DiseaseOrPhenotypicFeature	b(0)39/b(0)39 thalassemia	D017086
13423	28851297	1584	1592	OrganismTaxon	patients	9606
13424	28851297	1674	1687	DiseaseOrPhenotypicFeature	b-thalassemia	D017086
13425	28851297	1692	1701	GeneOrGeneProduct	Gg-globin	3048
13426	28851297	1707	1716	GeneOrGeneProduct	Ag-globin	3047
13427	28851297	1718	1722	SequenceVariant	G->A	rs368698783
13428	28851297	1774	1790	DiseaseOrPhenotypicFeature	b(0)-thalassemia	D017086
13429	28851297	1819	1835	DiseaseOrPhenotypicFeature	b(+)-thalassemia	D017086
13430	28851297	1955	1971	DiseaseOrPhenotypicFeature	b(0)-thalassemia	D017086
13431	28851297	1972	1980	OrganismTaxon	patients	9606
13432	28851297	2022	2025	GeneOrGeneProduct	HbF	3040,3048
13433	28851297	2072	2083	SequenceVariant	rs368698783	rs368698783
13434	28851297	2085	2093	SequenceVariant	+25 G->A	rs368698783
13435	28851297	2115	2124	GeneOrGeneProduct	Ag-globin	3047
13436	28851297	2144	2162	DiseaseOrPhenotypicFeature	b(0)39 thalassemia	D017086
13437	28851297	2163	2171	OrganismTaxon	patients	9606
13438	28851297	2182	2185	GeneOrGeneProduct	HbF	3040,3048
13439	28883039	32	37	OrganismTaxon	human	9606
13440	28883039	38	43	GeneOrGeneProduct	BICD2	23299
13441	28883039	70	76	GeneOrGeneProduct	dynein	1778
13442	28883039	77	85	GeneOrGeneProduct	dynactin	1639
13443	28883039	87	98	GeneOrGeneProduct	Bicaudal D2	23299
13444	28883039	100	105	GeneOrGeneProduct	BICD2	23299
13445	28883039	113	119	GeneOrGeneProduct	dynein	1778
13446	28883039	125	133	GeneOrGeneProduct	dynactin	1639
13447	28883039	165	168	GeneOrGeneProduct	DDB	1639,1778,23299
13448	28883039	225	230	GeneOrGeneProduct	BICD2	23299
13449	28883039	260	268	OrganismTaxon	patients	9606
13450	28883039	293	316	DiseaseOrPhenotypicFeature	spinal muscular atrophy	D009134
13451	28883039	455	458	GeneOrGeneProduct	DDB	1639,1778,76895
13452	28883039	463	468	GeneOrGeneProduct	BICD2	76895
13453	28883039	501	513	GeneOrGeneProduct	GTPase Rab6a	5870
13454	28883039	515	524	GeneOrGeneProduct	Rab6a-GTP	5870
13455	28883039	588	593	GeneOrGeneProduct	BICD2	76895
13456	28883039	642	648	GeneOrGeneProduct	dynein	1778
13457	28883039	649	657	GeneOrGeneProduct	dynactin	1639
13458	28883039	686	691	GeneOrGeneProduct	BICD2	76895
13459	28883039	742	745	GeneOrGeneProduct	DDB	1639,1778,23299
13460	28883039	791	796	GeneOrGeneProduct	BICD2	76895
13461	28883039	900	903	OrganismTaxon	rat	10116
13462	28883039	941	946	GeneOrGeneProduct	BICD2	76895
13463	28883039	1027	1032	GeneOrGeneProduct	BICD2	76895
13464	28883039	1047	1050	GeneOrGeneProduct	DDB	1639,1778,23299
13465	28883039	1169	1192	DiseaseOrPhenotypicFeature	spinal muscular atrophy	D009134
13466	29049388	13	18	OrganismTaxon	mouse	10090
13467	29049388	28	35	GeneOrGeneProduct	podocin	170484
13468	29049388	53	71	DiseaseOrPhenotypicFeature	nephrotic syndrome	D009404
13469	29049388	90	95	GeneOrGeneProduct	NPHS2	7827
13470	29049388	111	118	GeneOrGeneProduct	podocin	7827
13471	29049388	137	155	DiseaseOrPhenotypicFeature	nephrotic syndrome	D009404
13472	29049388	173	180	GeneOrGeneProduct	podocin	7827
13473	29049388	191	196	SequenceVariant	R138Q	rs74315342
13474	29049388	272	285	DiseaseOrPhenotypicFeature	renal disease	D007674
13475	29049388	296	300	OrganismTaxon	mice	10090
13476	29049388	312	317	SequenceVariant	R140Q	p|SUB|R|140|Q
13477	29049388	332	337	OrganismTaxon	mouse	10090
13478	29049388	350	355	OrganismTaxon	human	9606
13479	29049388	356	361	SequenceVariant	R138Q	rs74315342
13480	29049388	413	426	DiseaseOrPhenotypicFeature	renal failure	D051437
13481	29049388	474	481	GeneOrGeneProduct	podocin	170484
13482	29049388	503	508	GeneOrGeneProduct	NPHS2	170484
13483	29049388	509	514	SequenceVariant	R140Q	p|SUB|R|140|Q
13484	29049388	526	535	ChemicalEntity	tamoxifen	D013629
13485	29049388	658	663	SequenceVariant	R140Q	p|SUB|R|140|Q
13486	29049388	709	720	DiseaseOrPhenotypicFeature	proteinuria	D011507
13487	29049388	799	812	DiseaseOrPhenotypicFeature	renal failure	D051437
13488	29049388	1231	1258	DiseaseOrPhenotypicFeature	tubulointerstitial fibrosis	D007674
13489	29049388	1346	1357	DiseaseOrPhenotypicFeature	proteinuria	D011507
13490	29049388	1389	1394	SequenceVariant	R140Q	p|SUB|R|140|Q
13491	29049388	1395	1402	GeneOrGeneProduct	podocin	170484
13492	29049388	1525	1532	GeneOrGeneProduct	miRNA21	406991
13493	29049388	1593	1603	GeneOrGeneProduct	miRNA-193a	406968
13494	29049388	1676	1681	SequenceVariant	R140Q	p|SUB|R|140|Q
13495	29049388	1682	1689	GeneOrGeneProduct	podocin	170484
13496	29049388	1690	1695	OrganismTaxon	mouse	10090
13497	29049388	1761	1766	OrganismTaxon	human	9606
13498	29049388	1767	1785	DiseaseOrPhenotypicFeature	nephrotic syndrome	D009404
13499	29049388	1849	1854	OrganismTaxon	human	9606
13500	29049388	2027	2038	DiseaseOrPhenotypicFeature	proteinuria	D011507
13501	29049388	2040	2058	DiseaseOrPhenotypicFeature	glomerulosclerosis	D005921
13502	29049388	2075	2088	DiseaseOrPhenotypicFeature	renal failure	D051437
13503	29183288	0	10	GeneOrGeneProduct	Arginase 1	11846
13504	29183288	49	61	DiseaseOrPhenotypicFeature	inflammatory	D007249
13505	29183288	83	89	DiseaseOrPhenotypicFeature	asthma	D001249
13506	29183288	125	129	OrganismTaxon	mice	10090
13507	29183288	164	172	GeneOrGeneProduct	arginase	11846
13508	29183288	218	230	ChemicalEntity	nitric oxide	D009569
13509	29183288	278	287	GeneOrGeneProduct	arginase1	11846
13510	29183288	289	293	GeneOrGeneProduct	ARG1	11846
13511	29183288	355	372	DiseaseOrPhenotypicFeature	lung inflammation	D011014
13512	29183288	383	387	OrganismTaxon	mice	10090
13513	29183288	393	402	GeneOrGeneProduct	ovalbumin	66222
13514	29183288	404	407	GeneOrGeneProduct	OVA	66222
13515	29183288	426	432	DiseaseOrPhenotypicFeature	asthma	D001249
13516	29183288	443	447	GeneOrGeneProduct	Arg1	11846
13517	29183288	484	488	GeneOrGeneProduct	Arg1	11846
13518	29183288	512	516	OrganismTaxon	mice	10090
13519	29183288	518	521	GeneOrGeneProduct	OVA	66222
13520	29183288	577	589	ChemicalEntity	methacholine	D016210
13521	29183288	702	705	GeneOrGeneProduct	IgE	629822
13522	29183288	813	817	GeneOrGeneProduct	Arg1	11846
13523	29183288	866	869	GeneOrGeneProduct	OVA	66222
13524	29183288	898	901	GeneOrGeneProduct	OVA	66222
13525	29183288	937	941	GeneOrGeneProduct	Arg2	11847
13526	29183288	946	950	GeneOrGeneProduct	Nos2	18126
13527	29183288	952	958	GeneOrGeneProduct	Slc7a1	11987
13528	29183288	960	966	GeneOrGeneProduct	Slc7a2	11988
13529	29183288	972	978	GeneOrGeneProduct	Slc7a7	20540
13530	29183288	980	1001	GeneOrGeneProduct	arginine transporters	11987,11988,20540
13531	29183288	1004	1007	GeneOrGeneProduct	Il4	16189
13532	29183288	1009	1012	GeneOrGeneProduct	Il5	16191
13533	29183288	1017	1021	GeneOrGeneProduct	Il13	16163
13534	29183288	1023	1041	GeneOrGeneProduct	TH2-type cytokines	16163,16189,16191
13535	29183288	1044	1048	GeneOrGeneProduct	Ccl2	20296
13536	29183288	1053	1058	GeneOrGeneProduct	Ccl11	20292
13537	29183288	1060	1070	GeneOrGeneProduct	chemokines	20292,20296
13538	29183288	1073	1077	GeneOrGeneProduct	Ifng	15978
13539	29183288	1079	1096	GeneOrGeneProduct	TH1-type cytokine	15978
13540	29183288	1099	1104	GeneOrGeneProduct	Clca3	23844
13541	29183288	1109	1115	GeneOrGeneProduct	Muc5ac	17833
13542	29183288	1143	1146	GeneOrGeneProduct	OVA	66222
13543	29183288	1156	1159	GeneOrGeneProduct	IgE	629822
13544	29183288	1171	1176	GeneOrGeneProduct	IL-10	16153
13545	29183288	1208	1212	GeneOrGeneProduct	IL-4	16189
13546	29183288	1214	1218	GeneOrGeneProduct	IL-5	16191
13547	29183288	1220	1225	GeneOrGeneProduct	IL-13	16163
13548	29183288	1227	1235	GeneOrGeneProduct	TNFalpha	21926
13549	29183288	1240	1248	GeneOrGeneProduct	IFNgamma	15978
13550	29183288	1302	1306	GeneOrGeneProduct	Arg1	11846
13551	29183288	1417	1429	DiseaseOrPhenotypicFeature	inflammatory	D007249
13552	29183288	1444	1447	GeneOrGeneProduct	OVA	66222
13553	29183288	1448	1451	GeneOrGeneProduct	OVA	66222
13554	29183288	1467	1471	OrganismTaxon	mice	10090
13555	29183288	1473	1476	GeneOrGeneProduct	OVA	66222
13556	29183288	1477	1480	GeneOrGeneProduct	OVA	66222
13557	29183288	1496	1500	OrganismTaxon	mice	10090
13558	29183288	1518	1521	GeneOrGeneProduct	OVA	66222
13559	29183288	1522	1525	GeneOrGeneProduct	IgE	629822
13560	29183288	1593	1605	DiseaseOrPhenotypicFeature	inflammation	D007249
13561	29183288	1617	1621	GeneOrGeneProduct	Arg1	11846
13562	29183288	1632	1635	GeneOrGeneProduct	OVA	66222
13563	29183288	1636	1639	GeneOrGeneProduct	OVA	66222
13564	29183288	1796	1799	GeneOrGeneProduct	OVA	66222
13565	29183288	1809	1812	GeneOrGeneProduct	IgE	629822
13566	29183288	1904	1908	GeneOrGeneProduct	Arg1	11846
13567	29183288	2002	2014	DiseaseOrPhenotypicFeature	inflammatory	D007249
13568	29183288	2030	2042	ChemicalEntity	methacholine	D016210
13569	29183288	2077	2089	DiseaseOrPhenotypicFeature	inflammatory	D007249
13570	30836660	0	11	ChemicalEntity	Salidroside	C009172
13571	30836660	24	51	DiseaseOrPhenotypicFeature	Renal Interstitial Fibrosis	D007674
13572	30836660	70	74	GeneOrGeneProduct	TLR4	21898,7099
13573	30836660	75	84	GeneOrGeneProduct	NF-kappaB	18033,4790
13574	30836660	89	93	GeneOrGeneProduct	MAPK	26413,5594
13575	30836660	114	125	ChemicalEntity	Salidroside	C009172
13576	30836660	127	130	ChemicalEntity	Sal	C009172
13577	30836660	178	192	OrganismTaxon	Rhodiola rosea	203015
13578	30836660	231	243	DiseaseOrPhenotypicFeature	inflammatory	D007249
13579	30836660	307	310	ChemicalEntity	Sal	C009172
13580	30836660	314	328	DiseaseOrPhenotypicFeature	renal fibrosis	D007674
13581	30836660	434	437	ChemicalEntity	Sal	C009172
13582	30836660	446	473	DiseaseOrPhenotypicFeature	renal interstitial fibrosis	D007674
13583	30836660	475	478	DiseaseOrPhenotypicFeature	RIF	D007674
13584	30836660	594	625	DiseaseOrPhenotypicFeature	unilateral ureteric obstruction	D014517
13585	30836660	627	630	DiseaseOrPhenotypicFeature	UUO	D014517
13586	30836660	635	645	ChemicalEntity	folic acid	D005492
13587	30836660	647	649	ChemicalEntity	FA	D005492
13588	30836660	659	663	OrganismTaxon	mice	10090
13589	30836660	664	691	DiseaseOrPhenotypicFeature	renal interstitial fibrosis	D007674
13590	30836660	708	746	GeneOrGeneProduct	transforming growth factor (TGF)-beta1	21803
13591	30836660	758	763	OrganismTaxon	human	9606
13592	30836660	798	802	CellLine	HK-2	9606
13593	30836660	867	879	DiseaseOrPhenotypicFeature	inflammatory	D007249
13594	30836660	927	939	DiseaseOrPhenotypicFeature	renal damage	D007674
13595	30836660	944	952	DiseaseOrPhenotypicFeature	fibrosis	D005355
13596	30836660	1077	1080	ChemicalEntity	Sal	C009172
13597	30836660	1089	1092	DiseaseOrPhenotypicFeature	RIF	D007674
13598	30836660	1131	1134	ChemicalEntity	Sal	C009172
13599	30836660	1150	1164	DiseaseOrPhenotypicFeature	tubular injury	D007674
13600	30836660	1236	1247	GeneOrGeneProduct	collagen SH	1281,12825
13601	30836660	1252	1262	GeneOrGeneProduct	collagen I	1277,1278,12842,12843
13602	30836660	1278	1281	ChemicalEntity	Sal	C009172
13603	30836660	1405	1414	GeneOrGeneProduct	alpha-SMA	11475,59
13604	30836660	1416	1424	GeneOrGeneProduct	vimentin	22352,7431
13605	30836660	1426	1435	GeneOrGeneProduct	TGF-beta1	21803,7040
13606	30836660	1437	1442	GeneOrGeneProduct	snail	20613,6615
13607	30836660	1444	1448	GeneOrGeneProduct	slug	20583,6591
13608	30836660	1487	1497	GeneOrGeneProduct	E-cadherin	12550,999
13609	30836660	1513	1516	ChemicalEntity	Sal	C009172
13610	30836660	1577	1587	ChemicalEntity	creatinine	D003404
13611	30836660	1600	1604	ChemicalEntity	urea	D014508
13612	30836660	1605	1613	ChemicalEntity	nitrogen	D009584
13613	30836660	1624	1633	ChemicalEntity	uric acid	D014527
13614	30836660	1635	1637	ChemicalEntity	UA	D014527
13615	30836660	1668	1680	DiseaseOrPhenotypicFeature	inflammatory	D007249
13616	30836660	1692	1700	GeneOrGeneProduct	IL-1beta	16176,3553
13617	30836660	1702	1706	GeneOrGeneProduct	IL-6	16193,3569
13618	30836660	1708	1717	GeneOrGeneProduct	TNF-alpha	21926,7124
13619	30836660	1762	1765	ChemicalEntity	Sal	C009172
13620	30836660	1769	1796	DiseaseOrPhenotypicFeature	renal interstitial fibrosis	D007674
13621	30836660	1840	1844	GeneOrGeneProduct	TLR4	21898,7099
13622	30836660	1848	1860	GeneOrGeneProduct	IkappaBalpha	18035,4792
13623	30836660	1864	1873	GeneOrGeneProduct	NF-kappaB	18033,4790
13624	30836660	1878	1911	GeneOrGeneProduct	mitogen-activated protein kinases	26413,5594
13625	30836660	1913	1917	GeneOrGeneProduct	MAPK	26413,5594
13626	30836660	1962	1965	ChemicalEntity	Sal	C009172
13627	30836660	2101	2106	OrganismTaxon	mouse	10090
13628	30836660	2119	2123	CellLine	HK-2	9606
13629	30836660	2144	2147	ChemicalEntity	Sal	C009172
13630	30836660	2197	2209	DiseaseOrPhenotypicFeature	inflammatory	D007249
13631	30836660	2237	2241	GeneOrGeneProduct	TLR4	21898,7099
13632	30836660	2242	2251	GeneOrGeneProduct	NF-kappaB	18033,4790
13633	30836660	2256	2260	GeneOrGeneProduct	MAPK	26413,5594
13634	30836660	2344	2347	ChemicalEntity	Sal	C009172
13635	30836660	2398	2412	DiseaseOrPhenotypicFeature	renal fibrosis	D007674
